Citrus Sinensis ID: 048425
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 780 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RWW0 | 744 | Receptor-like serine/thre | yes | no | 0.905 | 0.948 | 0.738 | 0.0 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.475 | 0.524 | 0.483 | 2e-90 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.525 | 0.602 | 0.436 | 3e-87 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.425 | 0.728 | 0.495 | 8e-86 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.370 | 0.443 | 0.523 | 7e-85 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.365 | 0.555 | 0.517 | 3e-84 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.412 | 0.449 | 0.483 | 1e-82 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.364 | 0.557 | 0.506 | 1e-82 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.457 | 0.468 | 0.449 | 1e-82 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.480 | 0.522 | 0.425 | 3e-82 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1033 bits (2670), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 543/735 (73%), Positives = 602/735 (81%), Gaps = 29/735 (3%)
Query: 49 AKAISMRLSFTQLRQHQMHVVAPSFVPYMAPAPSPIHQASIATPGIDPLPRRHRGGHHHH 108
A+ M L FT+ + HQMH P P +AP PSP + + I PL + H
Sbjct: 25 ARLFPMSLPFTRSKAHQMHFFHPYLNPSVAPTPSPAFSPNPSR--IPPLRHKGHHRHRRW 82
Query: 109 HSKPHA--VTPASSVRPGCDQICVEPLTATPYGSPCGCVFPMKVRLLLDVAPYSVFPVMN 166
H + +A V+P+S C Q CVEPLT+TP+GSPCGCVFPMKV+LLL VAP+S+FPV N
Sbjct: 83 HLRRNATAVSPSSH---DCQQTCVEPLTSTPFGSPCGCVFPMKVQLLLSVAPFSIFPVTN 139
Query: 167 ELEIEIAAGTYLQQSQVKIMGASADSQNQGKTVVDINLVPLGEKFDNTTAVLTYDRLWHK 226
ELEIE+AAGTYL+QSQVKIMGASADS+NQGKTVVDINLVPLGEKFDNTTA L Y R HK
Sbjct: 140 ELEIEVAAGTYLEQSQVKIMGASADSENQGKTVVDINLVPLGEKFDNTTATLIYQRFRHK 199
Query: 227 KVPLNLTLFGIYEVIYISYPGIPSSPPYESSTESGPSVSVGSLPISAN---FGNKNQRMN 283
KVPLN T+FG YEV +ISYPGIPSS P T P G LPI N F NK+Q +
Sbjct: 200 KVPLNETVFGDYEVTHISYPGIPSSSPNGDVTGDAP----GGLPIPINATTFANKSQGIG 255
Query: 284 FRTIAIIALSAFVLLLVFVGAISILIKWRKARKPSSAVGPAFASSINKRSGIGSILSSSI 343
FRTIAIIALS FVL+LV VGAISI++KW+K K S+AVGPA A SINKR G GS+ SSS
Sbjct: 256 FRTIAIIALSGFVLILVLVGAISIIVKWKKIGKSSNAVGPALAPSINKRPGAGSMFSSSA 315
Query: 344 ASSTSVSLMSTMATCILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVA 403
SS S SLMS+MATC LSVKTF LS+LEKAT++FS+KR+LGEGGFG VY G M++GTEVA
Sbjct: 316 RSSGSDSLMSSMATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVA 375
Query: 404 VKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLH 463
VKLLTR+NQN DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL+YELVHNGSVESHLH
Sbjct: 376 VKLLTRDNQNRDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH 435
Query: 464 GVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 523
G LDW+AR+KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG
Sbjct: 436 -----EGTLDWDARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 490
Query: 524 LAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQ 583
LAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL+GR+PVDMSQ
Sbjct: 491 LAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQ 550
Query: 584 PQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMG 643
P G+ENLVTWARPLL REGLEQLVDP+LAG+Y+FDDMAKVAAIASMCVH EV+HRPFMG
Sbjct: 551 PSGEENLVTWARPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMG 610
Query: 644 EVVQALKLIYNDTDETCGDCCSPKDSSVPDS-DFKGELVPSDSSWWNAGALTPRLTYGQA 702
EVVQALKLIYND DETCGD CS KDSSVPDS DFKG+L PSDSSWWN LTPRL YGQA
Sbjct: 611 EVVQALKLIYNDADETCGDYCSQKDSSVPDSADFKGDLAPSDSSWWN---LTPRLRYGQA 667
Query: 703 SSFITMEHSSGPLEETENRAFSASSLAG-DGMSLPTRHRNRSGPLRTVRSKANFYRLRGS 761
SSFITM++SSGPLE+ ENR SASS+ G+ LP NRSGPLR +RS+ NF+RLRGS
Sbjct: 668 SSFITMDYSSGPLEDMENRPHSASSIPRVGGLILP----NRSGPLRPMRSRRNFFRLRGS 723
Query: 762 MSEHGG-LLPRHIWN 775
MSEHGG RH+W+
Sbjct: 724 MSEHGGPSSSRHLWS 738
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 334 bits (856), Expect = 2e-90, Method: Compositional matrix adjust.
Identities = 186/385 (48%), Positives = 238/385 (61%), Gaps = 14/385 (3%)
Query: 277 NKNQRMNFRTIAIIALSAFVLLLVFVGAISILIKWRKARKPSSAVG-----PAFASSINK 331
N T A++ +S V L+VF + RK K SAV P+ SS +
Sbjct: 269 NSTNNSGIGTGAVVGISVAVALVVFTLFGIFVWCLRKREKRLSAVSGGDVTPSPMSSTAR 328
Query: 332 RSGIGSILSSSI---ASSTSVSLMSTMATCILSVKTFALSDLEKATEKFSSKRILGEGGF 388
+ SS AS S S S S F+ +L KAT FS + +LGEGGF
Sbjct: 329 SDSAFFRMQSSAPVGASKRSGSYQSQSGGLGNSKALFSYEELVKATNGFSQENLLGEGGF 388
Query: 389 GCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448
GCVY G++ +G VAVK L GDREF AEVE LSR+HHR+LV ++G CI G R L
Sbjct: 389 GCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLL 448
Query: 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASN 508
+Y+ V N + HLHG + LDW R+KIA GAARGLAYLHED +PR+IHRD K+SN
Sbjct: 449 IYDYVSNNDLYFHLHG---EKSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSN 505
Query: 509 VLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV 568
+LLED+F +VSDFGLAR A + + HI+TRV+GTFGY+APEYA +G L KSDV+S+GVV
Sbjct: 506 ILLEDNFDARVSDFGLARLALDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVV 565
Query: 569 LLELLSGRKPVDMSQPQGQENLVTWARPLLT---TREGLEQLVDPSLAGSYDFDDMAKVA 625
LLEL++GRKPVD SQP G E+LV WARPL++ E + L DP L G+Y +M ++
Sbjct: 566 LLELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPKLGGNYVESEMFRMI 625
Query: 626 AIASMCVHPEVTHRPFMGEVVQALK 650
A CV T RP MG++V+A +
Sbjct: 626 EAAGACVRHLATKRPRMGQIVRAFE 650
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (829), Expect = 3e-87, Method: Compositional matrix adjust.
Identities = 188/431 (43%), Positives = 264/431 (61%), Gaps = 21/431 (4%)
Query: 260 SGPSVSVGSLPISANFGNKNQRMNFRTIAIIALSAFVLLLVFVGAISILIKWRKARKPSS 319
+GP+ + G+ + ++ K++ +AI + V L +FV + K RK + P +
Sbjct: 212 TGPASNNGNNTLPSSSPGKSEVGTGGIVAIGVIVGLVFLSLFVMGVWFTRK-RKRKDPGT 270
Query: 320 AVGPAFA-SSINKRSGIGSILSSSIAS--------STSVSLMSTMATCILSVKT--FALS 368
VG S+ + G +L +S +S S S + ++ + ++S + F+
Sbjct: 271 FVGYTMPPSAYSSPQGSDVVLFNSRSSAPPKMRSHSGSDYMYASSDSGMVSNQRSWFSYD 330
Query: 369 DLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL 428
+L + T FS K +LGEGGFGCVY GV+ +G EVAVK L G+REF AEVE++SR+
Sbjct: 331 ELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISRV 390
Query: 429 HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGL 488
HHR+LV L+G CI + R LVY+ V N ++ HLH R + WE R+++A GAARG+
Sbjct: 391 HHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHA--PGRPVMTWETRVRVAAGAARGI 448
Query: 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE--GSQHISTRVMGTFGYV 546
AYLHED +PR+IHRD K+SN+LL++ F V+DFGLA+ A E + H+STRVMGTFGY+
Sbjct: 449 AYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGYM 508
Query: 547 APEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLL---TTREG 603
APEYA +G L K+DVYSYGV+LLEL++GRKPVD SQP G E+LV WARPLL E
Sbjct: 509 APEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIENEE 568
Query: 604 LEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDETCGDC 663
++LVDP L ++ +M ++ A+ CV RP M +VV+AL + TD T G
Sbjct: 569 FDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEATDITNG-- 626
Query: 664 CSPKDSSVPDS 674
P S V DS
Sbjct: 627 MRPGQSQVFDS 637
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (816), Expect = 8e-86, Method: Compositional matrix adjust.
Identities = 166/335 (49%), Positives = 214/335 (63%), Gaps = 3/335 (0%)
Query: 323 PAFASSINKRSGIGSILSSSI-ASSTSVSLMSTMATCILSVKTFALSDLEKATEKFSSKR 381
P +++I+ G LSS S L+ ++ TFA +L AT F
Sbjct: 31 PTVSNNISGLPSGGEKLSSKTNGGSKRELLLPRDGLGQIAAHTFAFRELAAATMNFHPDT 90
Query: 382 ILGEGGFGCVYHGVMDN-GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGIC 440
LGEGGFG VY G +D+ G VAVK L RN G+REF+ EV MLS LHH NLV LIG C
Sbjct: 91 FLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 150
Query: 441 IEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVI 500
+G R LVYE + GS+E HLH + ++ LDW RMKIA GAA+GL +LH+ +NP VI
Sbjct: 151 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAAGAAKGLEFLHDKANPPVI 210
Query: 501 HRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVK 559
+RDFK+SN+LL++ F PK+SDFGLA+ G + H+STRVMGT+GY APEYAMTG L VK
Sbjct: 211 YRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVK 270
Query: 560 SDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFD 619
SDVYS+GVV LEL++GRK +D P G++NLV WARPL R +L DP L G +
Sbjct: 271 SDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDRRKFIKLADPRLKGRFPTR 330
Query: 620 DMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654
+ + A+ASMC+ + RP + +VV AL + N
Sbjct: 331 ALYQALAVASMCIQEQAATRPLIADVVTALSYLAN 365
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 315 bits (808), Expect = 7e-85, Method: Compositional matrix adjust.
Identities = 154/294 (52%), Positives = 209/294 (71%), Gaps = 5/294 (1%)
Query: 360 LSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFI 419
S TF +L +AT FS +LG+GGFG V+ G++ +G EVAVK L + G+REF
Sbjct: 263 FSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQ 322
Query: 420 AEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMK 479
AEVE++SR+HHR+LV LIG C+ G R LVYE V N ++E HLHG K R ++W R+K
Sbjct: 323 AEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG--KGRPTMEWSTRLK 380
Query: 480 IALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRV 539
IALG+A+GL+YLHED NP++IHRD KASN+L++ F KV+DFGLA+ A++ + H+STRV
Sbjct: 381 IALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRV 440
Query: 540 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLT 599
MGTFGY+APEYA +G L KSDV+S+GVVLLEL++GR+PVD + ++LV WARPLL
Sbjct: 441 MGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLN 500
Query: 600 --TREG-LEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650
+ EG E L D + YD ++MA++ A A+ CV RP M ++V+AL+
Sbjct: 501 RASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALE 554
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 313 bits (802), Expect = 3e-84, Method: Compositional matrix adjust.
Identities = 150/290 (51%), Positives = 203/290 (70%), Gaps = 5/290 (1%)
Query: 364 TFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVE 423
TF +L +AT KFS +LGEGGFG VY G+++NG EVAVK L + G++EF AEV
Sbjct: 170 TFTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVN 229
Query: 424 MLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALG 483
++S++HHRNLV L+G CI G R LVYE V N ++E HLHG K R ++W R+KIA+
Sbjct: 230 IISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHG--KGRPTMEWSLRLKIAVS 287
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF 543
+++GL+YLHE+ NP++IHRD KA+N+L++ F KV+DFGLA+ A + + H+STRVMGTF
Sbjct: 288 SSKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAKIALDTNTHVSTRVMGTF 347
Query: 544 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTT--- 600
GY+APEYA +G L KSDVYS+GVVLLEL++GR+PVD + ++LV WARPLL
Sbjct: 348 GYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLLVQALE 407
Query: 601 REGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650
E L D L YD ++MA++ A A+ CV RP M +VV+ L+
Sbjct: 408 ESNFEGLADIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVLE 457
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 308 bits (789), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 160/331 (48%), Positives = 220/331 (66%), Gaps = 9/331 (2%)
Query: 364 TFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVE 423
TF +L +AT FS +LG+GGFG V+ G++ NG EVAVK L + G+REF AEV
Sbjct: 341 TFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVG 400
Query: 424 MLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALG 483
++SR+HHR+LV L+G CI R LVYE V N ++E HLHG K R ++W +R+KIA+G
Sbjct: 401 IISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHG--KGRPTMEWSSRLKIAVG 458
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF 543
+A+GL+YLHE+ NP++IHRD KASN+L++ F KV+DFGLA+ A++ + H+STRVMGTF
Sbjct: 459 SAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTF 518
Query: 544 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREG 603
GY+APEYA +G L KSDV+S+GVVLLEL++GR+P+D++ +LV WARPLL
Sbjct: 519 GYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQVSE 578
Query: 604 L---EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDETC 660
L E +VD L YD ++MA++ A A+ CV RP M +V + L+ + +D
Sbjct: 579 LGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGNISPSDLNQ 638
Query: 661 GDCCSPKDSSVPDSDFKGELVPSDSSWWNAG 691
G +P S+V S G DSS N G
Sbjct: 639 G--ITPGHSNVYGS--SGGSTDYDSSQDNEG 665
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 308 bits (789), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 147/290 (50%), Positives = 202/290 (69%), Gaps = 6/290 (2%)
Query: 365 FALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEM 424
F DL KAT FS+ +LG+GGFG V+ GV+ +GT VA+K L + G+REF AE++
Sbjct: 131 FTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAEIQT 190
Query: 425 LSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGA 484
+SR+HHR+LV L+G CI G R LVYE V N ++E HLH +K R ++W RMKIALGA
Sbjct: 191 ISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLH--EKERPVMEWSKRMKIALGA 248
Query: 485 ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFG 544
A+GLAYLHED NP+ IHRD KA+N+L++D + K++DFGLAR + + H+STR+MGTFG
Sbjct: 249 AKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTFG 308
Query: 545 YVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LVTWARPLLT---T 600
Y+APEYA +G L KSDV+S GVVLLEL++GR+PVD SQP ++ +V WA+PL+
Sbjct: 309 YLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQALN 368
Query: 601 REGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650
+ LVDP L +D ++M ++ A A+ V RP M ++V+A +
Sbjct: 369 DGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFE 418
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 308 bits (788), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 168/374 (44%), Positives = 229/374 (61%), Gaps = 17/374 (4%)
Query: 290 IALSAFVLLLVFVGAISILIKWRKAR-----------KPSSAVGPAFASSINKRSGIGSI 338
+++ ++LL +G + +K RK R P + P S++ K +
Sbjct: 333 VSIGVALVLLTLIGVVVCCLKKRKKRLSTIGGGYVMPTPMESSSPRSDSALLKTQSSAPL 392
Query: 339 LSSSIASSTSVSLMSTMATCILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDN 398
+ + ++ T +S S S + F+ +L AT FS + +LGEGGFG VY GV+ +
Sbjct: 393 VGNRSSNRTYLS-QSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPD 451
Query: 399 GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSV 458
VAVK L GDREF AEV+ +SR+HHRNL+ ++G CI R L+Y+ V N ++
Sbjct: 452 ERVVAVKQLKIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNL 511
Query: 459 ESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPK 518
HLH LDW R+KIA GAARGLAYLHED +PR+IHRD K+SN+LLE++F
Sbjct: 512 YFHLHAAGTPG--LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHAL 569
Query: 519 VSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
VSDFGLA+ A + + HI+TRVMGTFGY+APEYA +G L KSDV+S+GVVLLEL++GRKP
Sbjct: 570 VSDFGLAKLALDCNTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 629
Query: 579 VDMSQPQGQENLVTWARPLL---TTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPE 635
VD SQP G E+LV WARPLL T E L DP L +Y +M ++ A+ C+
Sbjct: 630 VDASQPLGDESLVEWARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHS 689
Query: 636 VTHRPFMGEVVQAL 649
T RP M ++V+A
Sbjct: 690 ATKRPRMSQIVRAF 703
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 306 bits (785), Expect = 3e-82, Method: Compositional matrix adjust.
Identities = 169/397 (42%), Positives = 240/397 (60%), Gaps = 22/397 (5%)
Query: 285 RTIAIIALSAFVLLLVFVGAISILIKWRKARK--------PSSAVGPAFASSINKRSGIG 336
+T+ I ++ +++L G + K +K P + V I+ R G
Sbjct: 261 KTVIGIGIAGVLVILFIAGVFFVRRKQKKGSSSPRSNQYLPPANVSVNTEGFIHYRQKPG 320
Query: 337 SILSSSIASSTSVSLMS-------TMATCILSVKT--FALSDLEKATEKFSSKRILGEGG 387
+ SS+ SS + + T + ++ F +L + TE F ++GEGG
Sbjct: 321 NGNSSAQNSSPDTNSLGNPKHGRGTPDSAVIGTSKIHFTYEELSQITEGFCKSFVVGEGG 380
Query: 388 FGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRC 447
FGCVY G++ G VA+K L + G REF AEVE++SR+HHR+LV L+G CI + R
Sbjct: 381 FGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEIISRVHHRHLVSLVGYCISEQHRF 440
Query: 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKAS 507
L+YE V N +++ HLHG KN L+W R++IA+GAA+GLAYLHED +P++IHRD K+S
Sbjct: 441 LIYEFVPNNTLDYHLHG--KNLPVLEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSS 498
Query: 508 NVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGV 567
N+LL+D+F +V+DFGLAR HISTRVMGTFGY+APEYA +G L +SDV+S+GV
Sbjct: 499 NILLDDEFEAQVADFGLARLNDTAQSHISTRVMGTFGYLAPEYASSGKLTDRSDVFSFGV 558
Query: 568 VLLELLSGRKPVDMSQPQGQENLVTWARPLL---TTREGLEQLVDPSLAGSYDFDDMAKV 624
VLLEL++GRKPVD SQP G+E+LV WARP L + + ++VDP L Y ++ K+
Sbjct: 559 VLLELITGRKPVDTSQPLGEESLVEWARPRLIEAIEKGDISEVVDPRLENDYVESEVYKM 618
Query: 625 AAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDETCG 661
A+ CV RP M +VV+AL + +D T G
Sbjct: 619 IETAASCVRHSALKRPRMVQVVRALDTRDDLSDLTNG 655
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 780 | ||||||
| 255585904 | 730 | ATP binding protein, putative [Ricinus c | 0.934 | 0.998 | 0.817 | 0.0 | |
| 224132288 | 734 | predicted protein [Populus trichocarpa] | 0.930 | 0.989 | 0.807 | 0.0 | |
| 359480330 | 783 | PREDICTED: receptor-like serine/threonin | 0.975 | 0.971 | 0.771 | 0.0 | |
| 449468722 | 778 | PREDICTED: receptor-like serine/threonin | 0.983 | 0.985 | 0.758 | 0.0 | |
| 356570688 | 786 | PREDICTED: receptor-like serine/threonin | 0.857 | 0.851 | 0.809 | 0.0 | |
| 356503650 | 809 | PREDICTED: receptor-like serine/threonin | 0.858 | 0.828 | 0.813 | 0.0 | |
| 30680947 | 744 | protein kinase domain-containing protein | 0.905 | 0.948 | 0.738 | 0.0 | |
| 297836780 | 743 | kinase family protein [Arabidopsis lyrat | 0.907 | 0.952 | 0.737 | 0.0 | |
| 357510313 | 762 | Protein kinase [Medicago truncatula] gi| | 0.907 | 0.929 | 0.719 | 0.0 | |
| 356536862 | 733 | PREDICTED: receptor-like serine/threonin | 0.921 | 0.980 | 0.688 | 0.0 |
| >gi|255585904|ref|XP_002533625.1| ATP binding protein, putative [Ricinus communis] gi|223526483|gb|EEF28754.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1187 bits (3071), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 596/729 (81%), Positives = 646/729 (88%)
Query: 52 ISMRLSFTQLRQHQMHVVAPSFVPYMAPAPSPIHQASIATPGIDPLPRRHRGGHHHHHSK 111
+SM + F Q + +MH V PSF P APA SP HQAS ++P P PRRH HH K
Sbjct: 2 VSMSVPFAQSQPPRMHAVKPSFGPSSAPALSPAHQASASSPRTAPSPRRHGHHHHRRRVK 61
Query: 112 PHAVTPASSVRPGCDQICVEPLTATPYGSPCGCVFPMKVRLLLDVAPYSVFPVMNELEIE 171
P V P+ S GCDQ+C+EPLTATP+GSPCGCVFPMKVRLLLDVAPY++FPVMN+LEIE
Sbjct: 62 PIIVAPSPSEDQGCDQVCIEPLTATPFGSPCGCVFPMKVRLLLDVAPYAIFPVMNQLEIE 121
Query: 172 IAAGTYLQQSQVKIMGASADSQNQGKTVVDINLVPLGEKFDNTTAVLTYDRLWHKKVPLN 231
+AAGTYL+QSQVKIMGASADSQNQGKTVVDINLVPLGEKFDNTTA+LTYDR WHKKVPLN
Sbjct: 122 VAAGTYLEQSQVKIMGASADSQNQGKTVVDINLVPLGEKFDNTTAILTYDRFWHKKVPLN 181
Query: 232 LTLFGIYEVIYISYPGIPSSPPYESSTESGPSVSVGSLPISANFGNKNQRMNFRTIAIIA 291
TLFG YEV+ ISYPGIPSSPPY SGPS S G+LPI+ANF K+Q+MNFRTIAIIA
Sbjct: 182 DTLFGDYEVVAISYPGIPSSPPYPDYMGSGPSGSAGNLPITANFVGKSQKMNFRTIAIIA 241
Query: 292 LSAFVLLLVFVGAISILIKWRKARKPSSAVGPAFASSINKRSGIGSILSSSIASSTSVSL 351
LSAFV+LLVF+GA+ I I+WRK +PSSAVGP F SSINKR GIGS LSSSIASSTS+SL
Sbjct: 242 LSAFVVLLVFIGAVFIFIRWRKFGRPSSAVGPGFTSSINKRPGIGSFLSSSIASSTSMSL 301
Query: 352 MSTMATCILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNN 411
MSTMATC+LSVKTF ++LEKATEKFSSKRILGEGGFG VY G M++G EVAVKLLTR+N
Sbjct: 302 MSTMATCMLSVKTFPYAELEKATEKFSSKRILGEGGFGRVYRGTMEDGAEVAVKLLTRDN 361
Query: 412 QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGP 471
QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHG+DK++GP
Sbjct: 362 QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGLDKSKGP 421
Query: 472 LDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531
LDW++R+KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG
Sbjct: 422 LDWDSRLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 481
Query: 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV 591
S HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV
Sbjct: 482 SHHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV 541
Query: 592 TWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651
TWARPLLTTREGLEQLVDPSL G+YDFDDMAKVAAIASMCVHPEVT+RPFMGEVVQALKL
Sbjct: 542 TWARPLLTTREGLEQLVDPSLEGTYDFDDMAKVAAIASMCVHPEVTNRPFMGEVVQALKL 601
Query: 652 IYNDTDETCGDCCSPKDSSVPDSDFKGELVPSDSSWWNAGALTPRLTYGQASSFITMEHS 711
IYND DETCGD CS K+SS +SDFKG+L PSDSSWWNAG L+P LTYGQASSFITME+S
Sbjct: 602 IYNDMDETCGDYCSQKESSALESDFKGDLAPSDSSWWNAGGLSPVLTYGQASSFITMEYS 661
Query: 712 SGPLEETENRAFSASSLAGDGMSLPTRHRNRSGPLRTVRSKANFYRLRGSMSEHGGLLPR 771
SGPL+E ENR FSASSL GD ++L R NRSGPLRTVRSK +FYR RGSMSEHGGLL R
Sbjct: 662 SGPLQEMENRPFSASSLGGDQLNLAIRQGNRSGPLRTVRSKPSFYRSRGSMSEHGGLLSR 721
Query: 772 HIWNDEYWA 780
WND YWA
Sbjct: 722 RNWNDGYWA 730
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224132288|ref|XP_002321302.1| predicted protein [Populus trichocarpa] gi|222862075|gb|EEE99617.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1164 bits (3011), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 590/731 (80%), Positives = 640/731 (87%), Gaps = 5/731 (0%)
Query: 53 SMRLSFTQLRQHQMHVVAPSFVPYMAPAPSPIHQASIATPGIDPLPRRHRGGHHHHHS-- 110
+M LSF + R HVV S P ++PAPSP HQ + P PLPRRH G H HHH
Sbjct: 4 AMSLSFARSRPSHSHVVQSSLGPSLSPAPSPAHQDFLPVPHSAPLPRRHGGHHRHHHRPV 63
Query: 111 KPHAVTPASSVRPGCDQICVEPLTATPYGSPCGCVFPMKVRLLLDVAPYSVFPVMNELEI 170
KP P+ S CDQIC EPLTA P+GSPCGCVFPMKVRLLLDVAPY+VFPVM ELE
Sbjct: 64 KPAVTAPSPSEDQSCDQICTEPLTAVPFGSPCGCVFPMKVRLLLDVAPYAVFPVMRELES 123
Query: 171 EIAAGTYLQQSQVKIMGASADSQNQGKTVVDINLVPLGEKFDNTTAVLTYDRLWHKKVPL 230
E+AAGTYL++SQVKIMGA+ADSQNQGKTVVDINLVPLGEKFDNTTA+LTYDR W KKVPL
Sbjct: 124 EVAAGTYLEESQVKIMGAAADSQNQGKTVVDINLVPLGEKFDNTTAILTYDRFWKKKVPL 183
Query: 231 NLTLFGIYEVIYISYPGIPSSPPYESSTESGPSVSVGSLPISANFGNKNQRMNFRTIAII 290
N+TLFG YEV+YISYPGIPSS PY + T SGPS S LPI+ANF NKNQRMN RTI II
Sbjct: 184 NITLFGNYEVVYISYPGIPSSSPYPNYTGSGPSGSTRDLPITANFVNKNQRMNLRTIVII 243
Query: 291 ALSAFVLLLVFVGAISILIKWRKARKPSSAVGPAFASSINKRSGIGSILSSSIASSTSVS 350
LSAFV+L+VF+GAI+I+I+WRK+ +PSSAVGPAF SSINKRSGIGS LSSSIASST +S
Sbjct: 244 TLSAFVVLVVFIGAIAIVIRWRKSGRPSSAVGPAFMSSINKRSGIGSFLSSSIASSTPMS 303
Query: 351 LMSTMATCILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRN 410
LMS MA+C+LSVKTF ++LEKAT+KFSSKRILGEGGFG V+ G M++GTEVAVKLLTRN
Sbjct: 304 LMSNMASCMLSVKTFTFTELEKATDKFSSKRILGEGGFGRVFDGSMEDGTEVAVKLLTRN 363
Query: 411 NQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRG 470
NQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV NGSVESHLHGVD ++G
Sbjct: 364 NQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVRNGSVESHLHGVDNDKG 423
Query: 471 PLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530
PLDW+AR+KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE+DFTPKVSDFGLAREATE
Sbjct: 424 PLDWDARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEEDFTPKVSDFGLAREATE 483
Query: 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENL 590
GS HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQP GQENL
Sbjct: 484 GSHHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPPGQENL 543
Query: 591 VTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650
VTWARPLLT+REGLEQLVDPSLAGSYDFDDMAKVAAIASMCVH EV +RPFMGEVVQALK
Sbjct: 544 VTWARPLLTSREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHSEVANRPFMGEVVQALK 603
Query: 651 LIYNDTDETCGDCCSPKDSSVPDSDFKGELVPSDSSWWNAGALTPRLTYGQASSFITMEH 710
LIYNDTDETCGD CS K SSV +SDFKG+LVP DSSWWNAG ++PRLTYG+ASSFITM++
Sbjct: 604 LIYNDTDETCGDYCSQKGSSVLESDFKGDLVPLDSSWWNAGGISPRLTYGRASSFITMQY 663
Query: 711 SSGPLEETENRAFSASSLAGD-GMSLPTRHRNRSGPLRTVRSKANFYRLRGSMSEH-GGL 768
SSGPLEE ENR FSASSL GD +SLP H NRSGPL+TVRSK FYRLRGSMSEH GGL
Sbjct: 664 SSGPLEEMENRPFSASSLDGDRWLSLPI-HGNRSGPLKTVRSKPAFYRLRGSMSEHGGGL 722
Query: 769 LPRHIWNDEYW 779
L R WND YW
Sbjct: 723 LSRRFWNDGYW 733
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359480330|ref|XP_002268450.2| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Vitis vinifera] gi|297744251|emb|CBI37221.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1159 bits (2997), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 591/766 (77%), Positives = 657/766 (85%), Gaps = 5/766 (0%)
Query: 18 ACLGHPLFHLNLSPSVQSNRLLSTREVLVEHAKAISMRLSFTQLRQHQMHVVAPSFVPYM 77
+C GHPL H+ LSP++ + STR++ +E A+ + M + FT R + V PS P
Sbjct: 18 SCCGHPLLHIFLSPTILPKQQQSTRKISLEQARPMPMSVLFTLSRSPRTRVFKPSLEPST 77
Query: 78 APAPSPIHQASIATPGIDPLPRRHRGGHHHHHSKPH----AVTPASSVRPGCDQICVEPL 133
APAPSP + S++ P +PR H HHH+H AV+PA S GCDQIC EPL
Sbjct: 78 APAPSPAYHGSVSGPSSTTIPRHHHHHHHHYHHHQGKQHHAVSPAPSTGTGCDQICTEPL 137
Query: 134 TATPYGSPCGCVFPMKVRLLLDVAPYSVFPVMNELEIEIAAGTYLQQSQVKIMGASADSQ 193
ATP+GSPCGCVFPMKVRLLLDVA Y+VFPV+ EL IE+AAGTYL+QSQVKI+GASADSQ
Sbjct: 138 AATPFGSPCGCVFPMKVRLLLDVALYAVFPVVAELAIEVAAGTYLEQSQVKIVGASADSQ 197
Query: 194 NQGKTVVDINLVPLGEKFDNTTAVLTYDRLWHKKVPLNLTLFGIYEVIYISYPGIPSSPP 253
NQGKTVVDINLVPLGEKFDNTTA+LT +R W KKVPLN TLFG Y+V+YI+YPGIPSSPP
Sbjct: 198 NQGKTVVDINLVPLGEKFDNTTAMLTCERFWQKKVPLNRTLFGNYDVLYINYPGIPSSPP 257
Query: 254 YESSTESGPSVSVGSLPISANFGNKNQRMNFRTIAIIALSAFVLLLVFVGAISILIKWRK 313
S SGPS S G LPI+A+F NK+Q++N RTIAIIALS FVL+LV +GAISI++KWRK
Sbjct: 258 SGSYMGSGPSGSAGGLPITADFVNKSQKLNPRTIAIIALSGFVLVLVCIGAISIVLKWRK 317
Query: 314 ARKPSSAVGPAFASSINKRSGIGSILSSSIASSTSVSLMSTMATCILSVKTFALSDLEKA 373
+PSSAVGP F SSINKRSGIGS+LSSSIASSTS SL+STMATC+LSVKTF L++LEKA
Sbjct: 318 IGRPSSAVGPVFTSSINKRSGIGSMLSSSIASSTSASLISTMATCVLSVKTFPLAELEKA 377
Query: 374 TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL 433
T KFSSKRILGEGGFG VYHG M++GTEVAVKLLTR++Q+GDREFIAEVEMLSRLHHRNL
Sbjct: 378 THKFSSKRILGEGGFGRVYHGTMEDGTEVAVKLLTRDHQSGDREFIAEVEMLSRLHHRNL 437
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
VKLIGICIEG TRCLVYELVHNGSVESHLHG DK +GPLDW+ARMKIALGAARGLAYLHE
Sbjct: 438 VKLIGICIEGHTRCLVYELVHNGSVESHLHGADKGKGPLDWDARMKIALGAARGLAYLHE 497
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT 553
DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS HISTRVMGTFGYVAPEYAMT
Sbjct: 498 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSHHISTRVMGTFGYVAPEYAMT 557
Query: 554 GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613
GHLLVKSDVYSYGVVLLELLSGRKPVDMSQP GQENLVTWARPLLT REGLEQLVDPSLA
Sbjct: 558 GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPPGQENLVTWARPLLTVREGLEQLVDPSLA 617
Query: 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDETCGDCCSPKDSSVPD 673
G+YDFD++AKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND DETCGDCCS K+SS PD
Sbjct: 618 GNYDFDNVAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDKDETCGDCCSQKESSGPD 677
Query: 674 SDFKGELVPSDSSWWNAGALTPRLTYGQASSFITMEHSSGPLEETENRAFSASSLAGDGM 733
SD +G+L PSDSSWWNAG +TPRLTYG A+ FITME+SSGPLEETENR FSASSL G+G
Sbjct: 678 SDLRGDLDPSDSSWWNAGGITPRLTYGHATPFITMEYSSGPLEETENRPFSASSLVGEGA 737
Query: 734 SLPTRHRNRSGPLRTVRSKANFYRLRGSMSEHGGLLPRHIWNDEYW 779
SL H NRSGPLRT+RSK FYRL+GSMSEH G+L + +WND W
Sbjct: 738 SLQITHGNRSGPLRTIRSKPGFYRLKGSMSEH-GVLSKRVWNDGAW 782
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449468722|ref|XP_004152070.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1128 bits (2918), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 592/780 (75%), Positives = 646/780 (82%), Gaps = 13/780 (1%)
Query: 4 LILLLLH-FVLSFISACLGHPLF--HLNLSPSVQSNRLLSTREVLVEHAKAISMRLSFTQ 60
L LL+LH F L F +C G H+ LSPS+Q + + EHA+ S+ SF
Sbjct: 7 LPLLVLHVFDLRF--SCSGQSSVSPHIYLSPSLQPSLQTMIPGMSTEHARLESISFSFVP 64
Query: 61 LRQHQMHVVAPSFVPYMAPAPSPIHQASIATPGIDPLPRRHRGGHHHHHSKPHAVTPASS 120
+ + +PAPSP ++ P PLP R H +PH V P S
Sbjct: 65 SKLRDNWISKSLLGSSTSPAPSPGYEG----PSSAPLPVRR---HRRRRGRPHVVAPTPS 117
Query: 121 VRPGCDQICVEPLTATPYGSPCGCVFPMKVRLLLDVAPYSVFPVMNELEIEIAAGTYLQQ 180
GCDQIC+EPLTA P+GSPCGCVFPMKVRLLLD+APY+VFPVMNELE EIA GTYL+Q
Sbjct: 118 KDQGCDQICMEPLTAAPFGSPCGCVFPMKVRLLLDIAPYAVFPVMNELESEIAVGTYLEQ 177
Query: 181 SQVKIMGASADSQNQGKTVVDINLVPLGEKFDNTTAVLTYDRLWHKKVPLNLTLFGIYEV 240
SQVKIMGASADSQNQG+T+VDINLVPLGEKFDNTTAVLTY R W KKV LN+TLFG YEV
Sbjct: 178 SQVKIMGASADSQNQGRTMVDINLVPLGEKFDNTTAVLTYRRFWDKKVHLNMTLFGDYEV 237
Query: 241 IYISYPGIPSSPPYESSTESGPSVSVGSLPISANFGNKNQRMNFRTIAIIALSAFVLLLV 300
+YISYPGIPSSPPY S PS S G LPI+ANF NK+Q+MN +TIAIIALSAFV+LLV
Sbjct: 238 VYISYPGIPSSPPYGGYMGSAPSGSAGDLPITANFVNKSQKMNVKTIAIIALSAFVVLLV 297
Query: 301 FVGAISILIKWRKARKPSSAVGPAFASSINKRSGIGSILSSSIASSTSVSLMSTMATCIL 360
F+GA+SI KWRK +PS+AVGP F SINKRSG+GS LSSSIASSTSVSLMSTM T +
Sbjct: 298 FIGALSIFFKWRKVGRPSNAVGPVFTPSINKRSGLGSALSSSIASSTSVSLMSTMPTSLQ 357
Query: 361 SVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIA 420
SVKTFALS+LEKAT+KFSSKRILGEGGFG VY G++D+G EVAVKLLTR+NQN DREFIA
Sbjct: 358 SVKTFALSELEKATDKFSSKRILGEGGFGRVYCGILDDGNEVAVKLLTRDNQNRDREFIA 417
Query: 421 EVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKI 480
EVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHG+DK GPLDW+AR+KI
Sbjct: 418 EVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGIDKRNGPLDWDARLKI 477
Query: 481 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM 540
ALGAARGLAYLHEDSNPRVIHRDFKASNVLLE DFTPKVSDFGLAREATEGS+HISTRVM
Sbjct: 478 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEVDFTPKVSDFGLAREATEGSEHISTRVM 537
Query: 541 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTT 600
GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQP G+ENLVTWARPLLT+
Sbjct: 538 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPHGEENLVTWARPLLTS 597
Query: 601 REGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDETC 660
REGLEQLVDPSLAG+YDFDDMAKVAAIASMCVHPEVT RPFMGEVVQALKLIYNDTDETC
Sbjct: 598 REGLEQLVDPSLAGTYDFDDMAKVAAIASMCVHPEVTQRPFMGEVVQALKLIYNDTDETC 657
Query: 661 GDCCSPKDSSVPDSDFKGELVPSDSSWWNAGALTPRLTYGQASSFITMEHSSGPLEETEN 720
D CS K+SS DSDFKG+LVPSDSSWWNAG LTPRLTYGQASSFITME+SSGPLEE EN
Sbjct: 658 ADYCSQKESSARDSDFKGDLVPSDSSWWNAGGLTPRLTYGQASSFITMEYSSGPLEEMEN 717
Query: 721 RAFSASSLAGDGMSLPTRHRNRSGPLRTVRSKANFYRLRGSMSEHGGLLPRHIWN-DEYW 779
R FS SSL GD +SLP RH NRSGPLRT RSK +FYR GS SEHGG L R WN + +W
Sbjct: 718 RPFSTSSLVGDEISLPIRHGNRSGPLRTARSKPSFYRFSGSRSEHGGFLSRPSWNSNGFW 777
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356570688|ref|XP_003553517.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1083 bits (2801), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 543/671 (80%), Positives = 596/671 (88%), Gaps = 2/671 (0%)
Query: 111 KPHAVTPASSVRPGCDQICVEPLTATPYGSPCGCVFPMKVRLLLDVAPYSVFPVMNELEI 170
+P+ P S CDQ C +PLT++P+GSPCGCVFPMK+RL LDVAPY+VFPVM ELE
Sbjct: 115 RPYVAAPPPSKDQACDQTCTDPLTSSPFGSPCGCVFPMKIRLTLDVAPYAVFPVMTELEN 174
Query: 171 EIAAGTYLQQSQVKIMGASADSQNQGKTVVDINLVPLGEKFDNTTAVLTYDRLWHKKVPL 230
EIA GTYL+QSQVKIMGA+ADSQNQG+T+VDINLVPLGEKFDNTTA LTY+R WHKKVPL
Sbjct: 175 EIALGTYLEQSQVKIMGATADSQNQGRTIVDINLVPLGEKFDNTTAALTYERFWHKKVPL 234
Query: 231 NLTLFGIYEVIYISYPGIPSSPPYESSTESGPSVSV-GSLPISANFGNKNQRMNFRTIAI 289
N +LFG Y V+YI YPG+PSSPPY S T S PS SV G LP+SANF +KNQ+MN RTI I
Sbjct: 235 NRSLFGDYAVVYIIYPGMPSSPPYGSLTGSSPSQSVDGILPVSANFVSKNQKMNLRTIII 294
Query: 290 IALSAFVLLLVFVGAISILIKWRKARKPSSAVGPAFASSINKRSGIGSILSSSIASSTSV 349
IALS+FVLLLV VGA SI++KWRK +PSSAVGPAF SS+NKRSG+GS+LSSSI SSTS+
Sbjct: 295 IALSSFVLLLVLVGAFSIILKWRKTGRPSSAVGPAFTSSLNKRSGLGSMLSSSITSSTSI 354
Query: 350 SLMSTMATCILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTR 409
SLMSTMAT +LSVKTF+LS+LEKAT+KFSSKR+LGEGGFG VY G +++G E+AVK+LTR
Sbjct: 355 SLMSTMATSLLSVKTFSLSELEKATDKFSSKRVLGEGGFGRVYSGTLEDGAEIAVKMLTR 414
Query: 410 NN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKN 468
+N QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGR RCLVYELV NGSVESHLHG DK
Sbjct: 415 DNHQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRRRCLVYELVRNGSVESHLHGDDKI 474
Query: 469 RGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528
+G LDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA
Sbjct: 475 KGMLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 534
Query: 529 TEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE 588
TEGS HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL+GRKPVDMSQPQGQE
Sbjct: 535 TEGSNHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPQGQE 594
Query: 589 NLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648
NLVTWARP+LT+REG+EQLVDPSLAGSY+FDDMAKVAAIASMCVH EVT RPFMGEVVQA
Sbjct: 595 NLVTWARPMLTSREGVEQLVDPSLAGSYNFDDMAKVAAIASMCVHSEVTQRPFMGEVVQA 654
Query: 649 LKLIYNDTDETCGDCCSPKDSSVPDSDFKGELVPSDSSWWNAGALTPRLTYGQASSFITM 708
LKLIYNDTDETCGD CS KDSS +SDF+G+L PSDSSWWNAG LTPR+TYGQASSFITM
Sbjct: 655 LKLIYNDTDETCGDYCSQKDSSAQESDFRGDLAPSDSSWWNAGGLTPRITYGQASSFITM 714
Query: 709 EHSSGPLEETENRAFSASSLAGDGMSLPTRHRNRSGPLRTVRSKANFYRLRGSMSEHGGL 768
E+SSGPLEE ENR FS SSL GD +SLP RH NRSGPLRTVR+K + YR GS SEHGG
Sbjct: 715 EYSSGPLEEMENRPFSTSSLIGDEISLPIRHGNRSGPLRTVRNKLSLYRFTGSRSEHGGP 774
Query: 769 LPRHIWNDEYW 779
+ WND YW
Sbjct: 775 SSKPNWNDGYW 785
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503650|ref|XP_003520619.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1082 bits (2798), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 547/672 (81%), Positives = 601/672 (89%), Gaps = 2/672 (0%)
Query: 110 SKPHAVTPASSVRPGCDQICVEPLTATPYGSPCGCVFPMKVRLLLDVAPYSVFPVMNELE 169
++P+ P S CDQIC +PLT+TP+GSPCGCVFPMK+RL LD+APY+VFPVM ELE
Sbjct: 137 TRPYVAAPPPSKDQACDQICTDPLTSTPFGSPCGCVFPMKIRLTLDIAPYAVFPVMTELE 196
Query: 170 IEIAAGTYLQQSQVKIMGASADSQNQGKTVVDINLVPLGEKFDNTTAVLTYDRLWHKKVP 229
EIA GTYL+QSQVKIMGA+ADSQNQG+T+VDINLVPLGEKFDNTTA LTY+R WHKKVP
Sbjct: 197 NEIALGTYLEQSQVKIMGATADSQNQGRTIVDINLVPLGEKFDNTTASLTYERFWHKKVP 256
Query: 230 LNLTLFGIYEVIYISYPGIPSSPPYESSTESGPSVSV-GSLPISANFGNKNQRMNFRTIA 288
LN +LFG Y V+YI+YPG+PSSPPY S T SGPS SV G LP+SANF +KNQ+MN RTI
Sbjct: 257 LNRSLFGDYAVVYITYPGMPSSPPYGSLTGSGPSQSVDGILPVSANFVSKNQKMNLRTII 316
Query: 289 IIALSAFVLLLVFVGAISILIKWRKARKPSSAVGPAFASSINKRSGIGSILSSSIASSTS 348
IIALS+FVLLLV VGA SI++KWRK R+PSSAVGPAF SS+NKRSG+GS+LSSSI SSTS
Sbjct: 317 IIALSSFVLLLVLVGAFSIILKWRKTRRPSSAVGPAFTSSLNKRSGLGSMLSSSITSSTS 376
Query: 349 VSLMSTMATCILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLT 408
+SLMSTMAT +LSVKTF+LS+LEKAT+KFSSKR+LGEGGFG VY G +++G EVAVKLLT
Sbjct: 377 MSLMSTMATSLLSVKTFSLSELEKATDKFSSKRVLGEGGFGRVYSGTLEDGAEVAVKLLT 436
Query: 409 RNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDK 467
R+N QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGR RCLVYELV NGSVESHLHG DK
Sbjct: 437 RDNHQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRRRCLVYELVRNGSVESHLHGDDK 496
Query: 468 NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527
+G LDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE
Sbjct: 497 IKGMLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 556
Query: 528 ATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ 587
ATEGS HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL+GRKPVDMSQPQGQ
Sbjct: 557 ATEGSNHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPQGQ 616
Query: 588 ENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647
ENLVTWARP+LT+REG+EQLVDPSLAGSY+FDDMAKVAAIASMCVHPEVT RPFMGEVVQ
Sbjct: 617 ENLVTWARPMLTSREGVEQLVDPSLAGSYNFDDMAKVAAIASMCVHPEVTQRPFMGEVVQ 676
Query: 648 ALKLIYNDTDETCGDCCSPKDSSVPDSDFKGELVPSDSSWWNAGALTPRLTYGQASSFIT 707
ALKLIYNDTDETCGD CS KDSS +SDF+G+L PSDSSWWNAG LTPRLTYGQASSFIT
Sbjct: 677 ALKLIYNDTDETCGDYCSQKDSSAQESDFRGDLAPSDSSWWNAGGLTPRLTYGQASSFIT 736
Query: 708 MEHSSGPLEETENRAFSASSLAGDGMSLPTRHRNRSGPLRTVRSKANFYRLRGSMSEHGG 767
ME+SSGPLEE ENR FS SSL GD +SLP +H NRSGPLRTVR+K + +R GS SEHGG
Sbjct: 737 MEYSSGPLEEMENRPFSTSSLIGDEISLPVKHGNRSGPLRTVRNKLSLHRFTGSRSEHGG 796
Query: 768 LLPRHIWNDEYW 779
+ WND W
Sbjct: 797 PSSKRNWNDGNW 808
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30680947|ref|NP_849998.1| protein kinase domain-containing protein [Arabidopsis thaliana] gi|75330719|sp|Q8RWW0.1|ALE2_ARATH RecName: Full=Receptor-like serine/threonine-protein kinase ALE2; AltName: Full=Protein ABNORMAL LEAF SHAPE 2; Flags: Precursor gi|20259543|gb|AAM13891.1| putative protein kinase [Arabidopsis thaliana] gi|22136896|gb|AAM91792.1| putative protein kinase [Arabidopsis thaliana] gi|110742054|dbj|BAE98959.1| protein kinase like protein [Arabidopsis thaliana] gi|330251897|gb|AEC06991.1| protein kinase domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1033 bits (2670), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 543/735 (73%), Positives = 602/735 (81%), Gaps = 29/735 (3%)
Query: 49 AKAISMRLSFTQLRQHQMHVVAPSFVPYMAPAPSPIHQASIATPGIDPLPRRHRGGHHHH 108
A+ M L FT+ + HQMH P P +AP PSP + + I PL + H
Sbjct: 25 ARLFPMSLPFTRSKAHQMHFFHPYLNPSVAPTPSPAFSPNPSR--IPPLRHKGHHRHRRW 82
Query: 109 HSKPHA--VTPASSVRPGCDQICVEPLTATPYGSPCGCVFPMKVRLLLDVAPYSVFPVMN 166
H + +A V+P+S C Q CVEPLT+TP+GSPCGCVFPMKV+LLL VAP+S+FPV N
Sbjct: 83 HLRRNATAVSPSSH---DCQQTCVEPLTSTPFGSPCGCVFPMKVQLLLSVAPFSIFPVTN 139
Query: 167 ELEIEIAAGTYLQQSQVKIMGASADSQNQGKTVVDINLVPLGEKFDNTTAVLTYDRLWHK 226
ELEIE+AAGTYL+QSQVKIMGASADS+NQGKTVVDINLVPLGEKFDNTTA L Y R HK
Sbjct: 140 ELEIEVAAGTYLEQSQVKIMGASADSENQGKTVVDINLVPLGEKFDNTTATLIYQRFRHK 199
Query: 227 KVPLNLTLFGIYEVIYISYPGIPSSPPYESSTESGPSVSVGSLPISAN---FGNKNQRMN 283
KVPLN T+FG YEV +ISYPGIPSS P T P G LPI N F NK+Q +
Sbjct: 200 KVPLNETVFGDYEVTHISYPGIPSSSPNGDVTGDAP----GGLPIPINATTFANKSQGIG 255
Query: 284 FRTIAIIALSAFVLLLVFVGAISILIKWRKARKPSSAVGPAFASSINKRSGIGSILSSSI 343
FRTIAIIALS FVL+LV VGAISI++KW+K K S+AVGPA A SINKR G GS+ SSS
Sbjct: 256 FRTIAIIALSGFVLILVLVGAISIIVKWKKIGKSSNAVGPALAPSINKRPGAGSMFSSSA 315
Query: 344 ASSTSVSLMSTMATCILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVA 403
SS S SLMS+MATC LSVKTF LS+LEKAT++FS+KR+LGEGGFG VY G M++GTEVA
Sbjct: 316 RSSGSDSLMSSMATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVA 375
Query: 404 VKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLH 463
VKLLTR+NQN DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL+YELVHNGSVESHLH
Sbjct: 376 VKLLTRDNQNRDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH 435
Query: 464 GVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 523
G LDW+AR+KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG
Sbjct: 436 -----EGTLDWDARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 490
Query: 524 LAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQ 583
LAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL+GR+PVDMSQ
Sbjct: 491 LAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQ 550
Query: 584 PQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMG 643
P G+ENLVTWARPLL REGLEQLVDP+LAG+Y+FDDMAKVAAIASMCVH EV+HRPFMG
Sbjct: 551 PSGEENLVTWARPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMG 610
Query: 644 EVVQALKLIYNDTDETCGDCCSPKDSSVPDS-DFKGELVPSDSSWWNAGALTPRLTYGQA 702
EVVQALKLIYND DETCGD CS KDSSVPDS DFKG+L PSDSSWWN LTPRL YGQA
Sbjct: 611 EVVQALKLIYNDADETCGDYCSQKDSSVPDSADFKGDLAPSDSSWWN---LTPRLRYGQA 667
Query: 703 SSFITMEHSSGPLEETENRAFSASSLAG-DGMSLPTRHRNRSGPLRTVRSKANFYRLRGS 761
SSFITM++SSGPLE+ ENR SASS+ G+ LP NRSGPLR +RS+ NF+RLRGS
Sbjct: 668 SSFITMDYSSGPLEDMENRPHSASSIPRVGGLILP----NRSGPLRPMRSRRNFFRLRGS 723
Query: 762 MSEHGG-LLPRHIWN 775
MSEHGG RH+W+
Sbjct: 724 MSEHGGPSSSRHLWS 738
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297836780|ref|XP_002886272.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297332112|gb|EFH62531.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1031 bits (2665), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 540/732 (73%), Positives = 603/732 (82%), Gaps = 24/732 (3%)
Query: 49 AKAISMRLSFTQLRQHQMHVVAPSFVPYMAPAPSPIHQASIATPGIDPLPRRHRGGHHHH 108
A+ M L FT+ + HQMH P P +AP SP + + I PL R H
Sbjct: 25 ARLFPMSLPFTRSKSHQMHFFHPYLNPSVAPTSSPAFPPNPSR--IPPLRHRGHHRHRRW 82
Query: 109 HSKPHA--VTPASSVRPGCDQICVEPLTATPYGSPCGCVFPMKVRLLLDVAPYSVFPVMN 166
H + +A V+P+S C Q CVEPLT+TP+GSPCGCVFPMKV+LLL VAP+S+FPV N
Sbjct: 83 HLRRNATAVSPSSH---DCQQTCVEPLTSTPFGSPCGCVFPMKVQLLLSVAPFSIFPVTN 139
Query: 167 ELEIEIAAGTYLQQSQVKIMGASADSQNQGKTVVDINLVPLGEKFDNTTAVLTYDRLWHK 226
ELEIE+AAGTYL+QSQVKIMGASAD++NQGKTVVDINLVPLGEKFDNTTA L Y R HK
Sbjct: 140 ELEIEVAAGTYLEQSQVKIMGASADNENQGKTVVDINLVPLGEKFDNTTATLIYQRFRHK 199
Query: 227 KVPLNLTLFGIYEVIYISYPGIPSSPPYESSTESGPSVSVGSLPISANFGNKNQRMNFRT 286
KVPLN T+FG YEV +ISYPGIPSS P + T P +PI+A F NK++ + FRT
Sbjct: 200 KVPLNETVFGDYEVTHISYPGIPSSSPNGAVTADAPGGF--PIPINATFANKSEGIGFRT 257
Query: 287 IAIIALSAFVLLLVFVGAISILIKWRKARKPSSAVGPAFASSINKRSGIGSILSSSIASS 346
IAIIALS FVL+LV VGAISI++KW+K K S+AVGPA A SINKR G GS+ SSS SS
Sbjct: 258 IAIIALSGFVLILVLVGAISIIVKWKKIGKSSNAVGPALAPSINKRPGAGSMFSSSARSS 317
Query: 347 TSVSLMSTMATCILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKL 406
S SLMS+MATC LSVKTF LS+LEKAT++FS+KR+LGEGGFG VY G M++GTEVAVKL
Sbjct: 318 GSDSLMSSMATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKL 377
Query: 407 LTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVD 466
LTR+NQN DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL+YELVHNGSVESHLH
Sbjct: 378 LTRDNQNRDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH--- 434
Query: 467 KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526
G LDW+AR+KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR
Sbjct: 435 --EGTLDWDARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 492
Query: 527 EATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQG 586
EATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL+GR+PVDMSQP G
Sbjct: 493 EATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSG 552
Query: 587 QENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVV 646
+ENLVTWARPLL REGLEQLVDP+LAG+Y+FDDMAKVAAIASMCVH EV+HRPFMGEVV
Sbjct: 553 EENLVTWARPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVV 612
Query: 647 QALKLIYNDTDETCGDCCSPKDSSVPDS-DFKGELVPSDSSWWNAGALTPRLTYGQASSF 705
QALKLIYND DETCGD CS KDSSVPDS DFKG+L PSDSSWWN LTPRL YGQASSF
Sbjct: 613 QALKLIYNDADETCGDYCSQKDSSVPDSADFKGDLAPSDSSWWN---LTPRLRYGQASSF 669
Query: 706 ITMEHSSGPLEETENRAFSASSLAGD-GMSLPTRHRNRSGPLRTVRSKANFYRLRGSMSE 764
ITME+SSGPLE+ ENR SASS+ + G+ LP NRSGPLR +RS+ NF+RLRGSMSE
Sbjct: 670 ITMEYSSGPLEDMENRPHSASSIPREGGLILP----NRSGPLRPMRSRRNFFRLRGSMSE 725
Query: 765 HGG-LLPRHIWN 775
HGG RH+W+
Sbjct: 726 HGGPSSSRHLWS 737
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357510313|ref|XP_003625445.1| Protein kinase [Medicago truncatula] gi|355500460|gb|AES81663.1| Protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1020 bits (2637), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 542/753 (71%), Positives = 603/753 (80%), Gaps = 45/753 (5%)
Query: 50 KAISMRLSFTQLRQHQMHVVAPSFVPYMAPAPSPIHQASIATPGIDPLPRRHRGGHHHHH 109
++ S+ +SF L Q + V PS P AP PSP +Q P + P + H HH
Sbjct: 26 ESFSLSMSFASLEQTKSWFVKPSSAPTSAPVPSPSYQG----PSVTPRHKHHHHHRRHHS 81
Query: 110 SKP-HAVTPASSVRPGCDQICVEPLTATPYGSPCGCVFPMKVRLLLDVAPYSVFPVMNEL 168
++P +A P S P CDQIC +PLT+TP+GSPCGCVFPMKVRL LDVAP++VFPV+NEL
Sbjct: 82 TRPPYAGAPPPSTDPACDQICTDPLTSTPFGSPCGCVFPMKVRLTLDVAPFAVFPVLNEL 141
Query: 169 EIEIAAGTYLQQSQVKIMGASADSQNQGKTVVDINLVPLGEKFDNTTAVLTYDRLWHKKV 228
E E+A GTYL+QSQVKIMGA+ADSQNQG+T VDINLVPLGEKFDNTTA LTY+R WHKKV
Sbjct: 142 EYEVALGTYLEQSQVKIMGATADSQNQGRTSVDINLVPLGEKFDNTTAALTYERFWHKKV 201
Query: 229 PLNLTLFGIYEVIYISYPG--------------------------IPSSPPYESSTESGP 262
PLN +LFG Y V+YI+YPG +PSS P + SGP
Sbjct: 202 PLNRSLFGDYAVMYITYPGSCFSPNNILLYQCHVYCLRLKPLLSGLPSSLPSGTPIGSGP 261
Query: 263 SVSV-GSLPISANFGNKNQRMNFRTIAIIALSAFVLLLVFVGAISILIKWRKARKPSSAV 321
S + G LP SANF +K+Q+ N RTI IIALS+FVLLLV +GA + +KWRK R+PSSAV
Sbjct: 262 SQNDDGILPFSANFDSKSQKTNLRTIVIIALSSFVLLLVLIGAFFVTLKWRKTRRPSSAV 321
Query: 322 GPAFASSINKRSGIGSILSSSIASSTSVSLMSTMATCILSVKTFALSDLEKATEKFSSKR 381
GPAF SS+NKRSG+GS+LSSSIASSTS+SLMSTM T ILSVKTF+LS++EKAT+KF++KR
Sbjct: 322 GPAFTSSLNKRSGLGSMLSSSIASSTSMSLMSTMPTSILSVKTFSLSEIEKATDKFNTKR 381
Query: 382 ILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICI 441
+LGEGGFG VY G +++G NGDREFIAEVEMLSRLHHRNLVKLIGICI
Sbjct: 382 VLGEGGFGRVYSGTLEDG-------------NGDREFIAEVEMLSRLHHRNLVKLIGICI 428
Query: 442 EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIH 501
EGR RCLVYELV NGSVESHLHG DKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIH
Sbjct: 429 EGRRRCLVYELVPNGSVESHLHGDDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIH 488
Query: 502 RDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSD 561
RDFKASNVLLEDDFTPKVSDFGLAREATEGS HISTRVMGTFGYVAPEYAMTGHLLVKSD
Sbjct: 489 RDFKASNVLLEDDFTPKVSDFGLAREATEGSNHISTRVMGTFGYVAPEYAMTGHLLVKSD 548
Query: 562 VYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDM 621
VYSYGVVLLELL+GRKPVDMSQPQGQENLVTWAR LLT+REGLEQLVDPSLAG Y+FDDM
Sbjct: 549 VYSYGVVLLELLTGRKPVDMSQPQGQENLVTWARALLTSREGLEQLVDPSLAGGYNFDDM 608
Query: 622 AKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDETCGDCCSPKDSSVPDSDFKGELV 681
AKVAAIASMCVH EVT RPFMGEVVQALKLIYNDTDET GD CS KDSS +SDF+GEL
Sbjct: 609 AKVAAIASMCVHSEVTQRPFMGEVVQALKLIYNDTDETGGDYCSQKDSSAQESDFRGELA 668
Query: 682 PSDSSWWNAGALTPRLTYGQASSFITMEHSSGPLEETENRAFSASSLAGDGMSLPTRHRN 741
PSDSSWWN G LTPRLTYGQASSFITME+SSGPLE+ ENR FS SS GD +SLP RH N
Sbjct: 669 PSDSSWWNGGGLTPRLTYGQASSFITMEYSSGPLEDMENRPFSTSSFNGDELSLPIRHGN 728
Query: 742 RSGPLRTVRSKANFYRLRGSMSEHGGLLPRHIW 774
RSGPLRT RSK + YR GS SEHG + + W
Sbjct: 729 RSGPLRTTRSKLSLYRFSGSRSEHGEVSSKRNW 761
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356536862|ref|XP_003536952.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 981 bits (2537), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/732 (68%), Positives = 578/732 (78%), Gaps = 13/732 (1%)
Query: 51 AISMRLSFTQLRQHQMHVVAPSFVPYMAPAPSPIHQASIATPGIDPLPRRHRGGHHHHHS 110
++S + F + +M +V PS P AP SP +Q IATP LP H H H+
Sbjct: 11 SVSTNVPFASAERAKMWLVKPSSGPSFAPVQSPSYQVPIATPRPQ-LPHYH---HRHNCG 66
Query: 111 KPHAVTPASSVRPGCDQICVEPLTATPYGSPCGCVFPMKVRLLLDVAPYSVFPVMNELEI 170
KP+A P+ S C QIC +PLTATP+GSPCGCVFPMKVRL+LD AP +VFPV++ELEI
Sbjct: 67 KPYAAAPSLSKDQACSQICTDPLTATPFGSPCGCVFPMKVRLVLDAAPLAVFPVIDELEI 126
Query: 171 EIAAGTYLQQSQVKIMGASADSQNQGKTVVDINLVPLGEKFDNTTAVLTYDRLWHKKVPL 230
E+++GTYL+QSQV+IMG +ADSQNQGKT +DI LVPLGEKFDNTTAVL R WH +VPL
Sbjct: 127 ELSSGTYLKQSQVRIMGVTADSQNQGKTTIDIYLVPLGEKFDNTTAVLLSKRFWHNEVPL 186
Query: 231 NLTLFGIYEVIYISYPGIPSSPPYESSTESG--PSVSVGSLPISANFGNKNQRMNFRTIA 288
N +LFG Y ++ I+YPGIPS P E+ T G P S+ LPI+A+ ++N++MN RTI
Sbjct: 187 NRSLFGDYAILCITYPGIPSPRPPETLTGRGHMPRESINVLPITADMNSENEKMNLRTII 246
Query: 289 IIALSAFVLLLVFVGAISILIKWRKARKPSSAVGPAFASSINKRSGIGSILSSSIASSTS 348
+IALS+ VLLLV VGA I++KWRK R+PSSAVGPAF S +NKRSG+ +LS I SS S
Sbjct: 247 VIALSSVVLLLVLVGAFYIILKWRKIRRPSSAVGPAFTSCLNKRSGMEFMLSRRIMSSRS 306
Query: 349 VSLMSTMATCILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLT 408
+SL S +A ILSVKTF+ S+LEKAT KFSS+R+LGEGGFG VY G +D+G EVAVKLLT
Sbjct: 307 MSLASALAHSILSVKTFSFSELEKATTKFSSQRVLGEGGFGRVYCGTLDDGNEVAVKLLT 366
Query: 409 RNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKN 468
R+ QNGDREF+AEVEMLSRLHHRNLVKLIGICIEG RCLVYEL NGSVESHLHG DK
Sbjct: 367 RDGQNGDREFVAEVEMLSRLHHRNLVKLIGICIEGPRRCLVYELFRNGSVESHLHGDDKK 426
Query: 469 RGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528
R PL+WEAR KIALG+ARGLAYLHEDS P VIHRDFKASNVLLEDDFTPKVSDFGLAREA
Sbjct: 427 RSPLNWEARTKIALGSARGLAYLHEDSTPPVIHRDFKASNVLLEDDFTPKVSDFGLAREA 486
Query: 529 TEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE 588
TEG+ HISTRVMGTFGYVAPEYAMTGHLLVKSDVYS+GVVLLELL+GRKPVDMSQPQGQE
Sbjct: 487 TEGNSHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSFGVVLLELLTGRKPVDMSQPQGQE 546
Query: 589 NLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648
NLVTWARPLL +REGLEQLVDPSLAGSYDFDDMAK+A IA MCVHPEV RPFMGEVVQA
Sbjct: 547 NLVTWARPLLRSREGLEQLVDPSLAGSYDFDDMAKMAGIAFMCVHPEVNQRPFMGEVVQA 606
Query: 649 LKLIYNDTDETCGDCCSPKDSSVPDSDFKGELVPSDSSWWNAGALTPRLTYGQASSFITM 708
LKLI+NDT+E S K+SS SDF GELV SDSSW +A L PRL YGQAS+ ITM
Sbjct: 607 LKLIHNDTNE------SNKESSAWASDFGGELVFSDSSWLDAEELAPRLAYGQASTLITM 660
Query: 709 EHSSGPLEETENRAFSASSLAGDGMSLPTRHRNRSGPLRTVRSKANFYRLRGSMSEHGGL 768
+ +S LE ENR FSASSL GD +SLP RHR RSGPLR +SK F +L S SE
Sbjct: 661 DFNSDHLEMMENRPFSASSLNGDEISLPIRHRVRSGPLRIAKSKLPFTKLTRSQSERVVH 720
Query: 769 LPRHIWNDE-YW 779
+ +WND+ YW
Sbjct: 721 PSKRVWNDDGYW 732
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 780 | ||||||
| TAIR|locus:2038992 | 744 | ALE2 "Abnormal Leaf Shape 2" [ | 0.907 | 0.951 | 0.678 | 6.9e-253 | |
| TAIR|locus:504954886 | 1113 | AT5G56890 [Arabidopsis thalian | 0.5 | 0.350 | 0.625 | 1.6e-161 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.374 | 0.402 | 0.637 | 4.6e-101 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.362 | 0.399 | 0.557 | 2.2e-84 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.392 | 0.449 | 0.520 | 5.8e-82 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.414 | 0.499 | 0.493 | 3.2e-81 | |
| TAIR|locus:2018209 | 509 | PERK15 "proline-rich extensin- | 0.442 | 0.677 | 0.451 | 4.6e-80 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.388 | 0.664 | 0.521 | 9.7e-80 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.383 | 0.774 | 0.521 | 1.6e-79 | |
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.371 | 0.761 | 0.529 | 2e-79 |
| TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2435 (862.2 bits), Expect = 6.9e-253, P = 6.9e-253
Identities = 497/733 (67%), Positives = 550/733 (75%)
Query: 49 AKAISMRLSFTQLRQHQMHVVAPSFVPYMAPAPSPIHQASIATPGIDPLPXXXXXXXXXX 108
A+ M L FT+ + HQMH P P +AP PSP + + I PL
Sbjct: 25 ARLFPMSLPFTRSKAHQMHFFHPYLNPSVAPTPSPAFSPNPSR--IPPLRHKGHHRHRRW 82
Query: 109 XSKPHAVTPASSVRPGCDQICVEPLTATPYGSPCGCVFPMKVRLLLDVAPYSVFPVMNEL 168
+ +A T S C Q CVEPLT+TP+GSPCGCVFPMKV+LLL VAP+S+FPV NEL
Sbjct: 83 HLRRNA-TAVSPSSHDCQQTCVEPLTSTPFGSPCGCVFPMKVQLLLSVAPFSIFPVTNEL 141
Query: 169 EIEIAAGTYLQQSQVKIMGASADSQNQGKTVVDINLVPLGEKFDNTTAVLTYDRLWHKKV 228
EIE+AAGTYL+QSQVKIMGASADS+NQGKTVVDINLVPLGEKFDNTTA L Y R HKKV
Sbjct: 142 EIEVAAGTYLEQSQVKIMGASADSENQGKTVVDINLVPLGEKFDNTTATLIYQRFRHKKV 201
Query: 229 PLNLTLFGIYEVXXXXXXXXXXXXXXXXXXXXXXXVSVGSLPISAN---FGNKNQRMNFR 285
PLN T+FG YEV + G LPI N F NK+Q + FR
Sbjct: 202 PLNETVFGDYEVTHISYPGIPSSSPNGDVTGD----APGGLPIPINATTFANKSQGIGFR 257
Query: 286 TXXXXXXXXXXXXXXXXXXXSILIKWRKARKPSSAVGPAFASSINKRXXXXXXXXXXXXX 345
T SI++KW+K K S+AVGPA A SINKR
Sbjct: 258 TIAIIALSGFVLILVLVGAISIIVKWKKIGKSSNAVGPALAPSINKRPGAGSMFSSSARS 317
Query: 346 XXXXXXXXXXXTCILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVK 405
TC LSVKTF LS+LEKAT++FS+KR+LGEGGFG VY G M++GTEVAVK
Sbjct: 318 SGSDSLMSSMATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVK 377
Query: 406 LLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGV 465
LLTR+NQN DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL+YELVHNGSVESHLH
Sbjct: 378 LLTRDNQNRDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH-- 435
Query: 466 DKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525
G LDW+AR+KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA
Sbjct: 436 ---EGTLDWDARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 492
Query: 526 REATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQ 585
REATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL+GR+PVDMSQP
Sbjct: 493 REATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPS 552
Query: 586 GQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEV 645
G+ENLVTWARPLL REGLEQLVDP+LAG+Y+FDDMAKVAAIASMCVH EV+HRPFMGEV
Sbjct: 553 GEENLVTWARPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEV 612
Query: 646 VQALKLIYNDTDETCGDCCSPKDSSVPDS-DFKGELVPSDSSWWNAGALTPRLTYGQASS 704
VQALKLIYND DETCGD CS KDSSVPDS DFKG+L PSDSSWWN LTPRL YGQASS
Sbjct: 613 VQALKLIYNDADETCGDYCSQKDSSVPDSADFKGDLAPSDSSWWN---LTPRLRYGQASS 669
Query: 705 FITMEHSSGPLEETENRAFSASSLAG-DGMSLPTRHRNRSGPLRTVRSKANFYRLRGSMS 763
FITM++SSGPLE+ ENR SASS+ G+ LP NRSGPLR +RS+ NF+RLRGSMS
Sbjct: 670 FITMDYSSGPLEDMENRPHSASSIPRVGGLILP----NRSGPLRPMRSRRNFFRLRGSMS 725
Query: 764 EHGG-LLPRHIWN 775
EHGG RH+W+
Sbjct: 726 EHGGPSSSRHLWS 738
|
|
| TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1231 (438.4 bits), Expect = 1.6e-161, Sum P(3) = 1.6e-161
Identities = 259/414 (62%), Positives = 308/414 (74%)
Query: 360 LSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFI 419
LS KTF S++ KAT F R+LGEGGFG VY GV D+GT+VAVK+L R++Q G REF+
Sbjct: 706 LSAKTFTASEIMKATNNFDESRVLGEGGFGRVYEGVFDDGTKVAVKVLKRDDQQGSREFL 765
Query: 420 AEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMK 479
AEVEMLSRLHHRNLV LIGICIE R R LVYEL+ NGSVESHLHG+DK PLDW+AR+K
Sbjct: 766 AEVEMLSRLHHRNLVNLIGICIEDRNRSLVYELIPNGSVESHLHGIDKASSPLDWDARLK 825
Query: 480 IALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT--EGSQHIST 537
IALGAARGLAYLHEDS+PRVIHRDFK+SN+LLE+DFTPKVSDFGLAR A E ++HIST
Sbjct: 826 IALGAARGLAYLHEDSSPRVIHRDFKSSNILLENDFTPKVSDFGLARNALDDEDNRHIST 885
Query: 538 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL 597
RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL+GRKPVDMSQP GQENLV+W RP
Sbjct: 886 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPPGQENLVSWTRPF 945
Query: 598 LTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657
LT+ EGL ++D SL FD +AKVAAIASMCV PEV+HRPFMGEVVQALKL+ N+ D
Sbjct: 946 LTSAEGLAAIIDQSLGPEISFDSIAKVAAIASMCVQPEVSHRPFMGEVVQALKLVSNECD 1005
Query: 658 ETCGDCCSPKDSSVPDSDFKGELVPSDSSWWNAGALTPRLTYGQASSFITMEHSSGPLEE 717
E + S +S+ DF+ + ++SS ++ A R + + S P +
Sbjct: 1006 EA-KELNSL--TSISKDDFRDD-TQAESSCGDSSARMARYP-------LLPNYDSEP--D 1052
Query: 718 TENRAFSASSL-AGDGMSLPTRHRNRSGPLRTVRSKANFYRLR----GSMSEHG 766
TE R S S + G G ++ SGPL + R K+ + ++R GS+SEHG
Sbjct: 1053 TE-RGLSTSEMYTGSGRF---ERQSNSGPLTSGRGKSFWQKMRRLSTGSLSEHG 1102
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 954 (340.9 bits), Expect = 4.6e-101, Sum P(2) = 4.6e-101
Identities = 188/295 (63%), Positives = 224/295 (75%)
Query: 361 SVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIA 420
S + + +L++AT F S ILGEGGFG VY G++ +GT VA+K LT GD+EF
Sbjct: 364 STRFLSYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQGDKEFQV 423
Query: 421 EVEMLSRLHHRNLVKLIGICI--EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARM 478
E++MLSRLHHRNLVKL+G + L YELV NGS+E+ LHG PLDW+ RM
Sbjct: 424 EIDMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNCPLDWDTRM 483
Query: 479 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG-SQHIST 537
KIAL AARGLAYLHEDS P VIHRDFKASN+LLE++F KV+DFGLA++A EG H+ST
Sbjct: 484 KIALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLAKQAPEGRGNHLST 543
Query: 538 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL 597
RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL+GRKPVDMSQP GQENLVTW RP+
Sbjct: 544 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWTRPV 603
Query: 598 LTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652
L ++ LE+LVD L G Y +D +V IA+ CV PE + RP MGEVVQ+LK++
Sbjct: 604 LRDKDRLEELVDSRLEGKYPKEDFIRVCTIAAACVAPEASQRPTMGEVVQSLKMV 658
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 819 (293.4 bits), Expect = 2.2e-84, Sum P(2) = 2.2e-84
Identities = 161/289 (55%), Positives = 205/289 (70%)
Query: 365 FALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEM 424
F+ +L KAT FS + +LGEGGFGCVY G++ +G VAVK L GDREF AEVE
Sbjct: 365 FSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVET 424
Query: 425 LSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGA 484
LSR+HHR+LV ++G CI G R L+Y+ V N + HLHG + LDW R+KIA GA
Sbjct: 425 LSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHG---EKSVLDWATRVKIAAGA 481
Query: 485 ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFG 544
ARGLAYLHED +PR+IHRD K+SN+LLED+F +VSDFGLAR A + + HI+TRV+GTFG
Sbjct: 482 ARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHITTRVIGTFG 541
Query: 545 YVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLT---TR 601
Y+APEYA +G L KSDV+S+GVVLLEL++GRKPVD SQP G E+LV WARPL++
Sbjct: 542 YMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAIET 601
Query: 602 EGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650
E + L DP L G+Y +M ++ A CV T RP MG++V+A +
Sbjct: 602 EEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFE 650
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 799 (286.3 bits), Expect = 5.8e-82, Sum P(2) = 5.8e-82
Identities = 164/315 (52%), Positives = 213/315 (67%)
Query: 365 FALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEM 424
F+ +L + T FS K +LGEGGFGCVY GV+ +G EVAVK L G+REF AEVE+
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386
Query: 425 LSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGA 484
+SR+HHR+LV L+G CI + R LVY+ V N ++ HLH R + WE R+++A GA
Sbjct: 387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHA--PGRPVMTWETRVRVAAGA 444
Query: 485 ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG--SQHISTRVMGT 542
ARG+AYLHED +PR+IHRD K+SN+LL++ F V+DFGLA+ A E + H+STRVMGT
Sbjct: 445 ARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGT 504
Query: 543 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLL---T 599
FGY+APEYA +G L K+DVYSYGV+LLEL++GRKPVD SQP G E+LV WARPLL
Sbjct: 505 FGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAI 564
Query: 600 TREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDET 659
E ++LVDP L ++ +M ++ A+ CV RP M +VV+AL + TD T
Sbjct: 565 ENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEATDIT 624
Query: 660 CGDCCSPKDSSVPDS 674
G P S V DS
Sbjct: 625 NG--MRPGQSQVFDS 637
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 790 (283.2 bits), Expect = 3.2e-81, Sum P(2) = 3.2e-81
Identities = 164/332 (49%), Positives = 224/332 (67%)
Query: 361 SVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIA 420
S TF +L +AT FS +LG+GGFG V+ GV+ +G EVAVK L + G+REF A
Sbjct: 259 SKSTFTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSGQGEREFQA 318
Query: 421 EVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKI 480
EVE++SR+HHR+LV L+G CI G R LVYE V N ++E HLHG + R ++W R+KI
Sbjct: 319 EVEIISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHLHG--EGRPTMEWSTRLKI 376
Query: 481 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM 540
ALG+A+GL+YLHED NP++IHRD KASN+L++ F KV+DFGLA+ A++ + H+STRVM
Sbjct: 377 ALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVM 436
Query: 541 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLT- 599
GTFGY+APEYA +G L KSDV+S+GVVLLEL++GR+PVD + ++LV WARPLL
Sbjct: 437 GTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNR 496
Query: 600 -TREG-LEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657
+ +G E L D + YD ++MA++ A A+ CV RP M ++V+AL+ + +D
Sbjct: 497 ASEQGDFEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSD 556
Query: 658 ETCGDCCSPKDSSVPDSDFKGELVPSDSSWWN 689
G P S+V S G DSS +N
Sbjct: 557 LNEG--MRPGQSNVYSS--YGGSTDYDSSQYN 584
|
|
| TAIR|locus:2018209 PERK15 "proline-rich extensin-like receptor kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 780 (279.6 bits), Expect = 4.6e-80, Sum P(2) = 4.6e-80
Identities = 162/359 (45%), Positives = 230/359 (64%)
Query: 365 FALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEM 424
F DL KAT FS+ +LG+GGFG V+ GV+ +GT VA+K L + G+REF AE++
Sbjct: 131 FTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAEIQT 190
Query: 425 LSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGA 484
+SR+HHR+LV L+G CI G R LVYE V N ++E HLH +K R ++W RMKIALGA
Sbjct: 191 ISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLH--EKERPVMEWSKRMKIALGA 248
Query: 485 ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFG 544
A+GLAYLHED NP+ IHRD KA+N+L++D + K++DFGLAR + + H+STR+MGTFG
Sbjct: 249 AKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTFG 308
Query: 545 YVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQP-QGQENLVTWARPLL--TTR 601
Y+APEYA +G L KSDV+S GVVLLEL++GR+PVD SQP +++V WA+PL+
Sbjct: 309 YLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQALN 368
Query: 602 EG-LEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDETC 660
+G + LVDP L +D ++M ++ A A+ V RP M ++V+A + + D T
Sbjct: 369 DGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFEGNISIDDLTE 428
Query: 661 GDCCSPKDSSV----PDSDFKGELVPSDSSWWNAGALTPRLTYGQAS-SFITMEHSSGP 714
G +P S++ SD+ D + A + T+G + S +T ++ P
Sbjct: 429 G--AAPGQSTIYSLDGSSDYSSTQYKEDLKKFKKMAFESK-TFGSSECSGLTSDNGQNP 484
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 801 (287.0 bits), Expect = 9.7e-80, P = 9.7e-80
Identities = 159/305 (52%), Positives = 203/305 (66%)
Query: 360 LSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDN-GTEVAVKLLTRNNQNGDREF 418
++ TFA +L AT F LGEGGFG VY G +D+ G VAVK L RN G+REF
Sbjct: 69 IAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREF 128
Query: 419 IAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARM 478
+ EV MLS LHH NLV LIG C +G R LVYE + GS+E HLH + ++ LDW RM
Sbjct: 129 LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRM 188
Query: 479 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ-HIST 537
KIA GAA+GL +LH+ +NP VI+RDFK+SN+LL++ F PK+SDFGLA+ G + H+ST
Sbjct: 189 KIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVST 248
Query: 538 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL 597
RVMGT+GY APEYAMTG L VKSDVYS+GVV LEL++GRK +D P G++NLV WARPL
Sbjct: 249 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPL 308
Query: 598 LTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657
R +L DP L G + + + A+ASMC+ + RP + +VV AL + N
Sbjct: 309 FNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLANQAY 368
Query: 658 ETCGD 662
+ D
Sbjct: 369 DPSKD 373
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 799 (286.3 bits), Expect = 1.6e-79, P = 1.6e-79
Identities = 158/303 (52%), Positives = 208/303 (68%)
Query: 360 LSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEV-AVKLLTRNNQNGDREF 418
+S F +L AT+ F+ LGEGGFG VY G ++ +V AVK L RN G+REF
Sbjct: 65 ISAHIFTFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQVVAVKQLDRNGYQGNREF 124
Query: 419 IAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRG-PLDWEAR 477
+ EV MLS LHH+NLV L+G C +G R LVYE + NGS+E HL + +N+ PLDW+ R
Sbjct: 125 LVEVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDHLLELARNKKKPLDWDTR 184
Query: 478 MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA-TEGSQHIS 536
MK+A GAARGL YLHE ++P VI+RDFKASN+LL+++F PK+SDFGLA+ T G H+S
Sbjct: 185 MKVAAGAARGLEYLHETADPPVIYRDFKASNILLDEEFNPKLSDFGLAKVGPTGGETHVS 244
Query: 537 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARP 596
TRVMGT+GY APEYA+TG L VKSDVYS+GVV LE+++GR+ +D ++P ++NLVTWA P
Sbjct: 245 TRVMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRRVIDTTKPTEEQNLVTWASP 304
Query: 597 LLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK-LIYND 655
L R + DP L G Y + + A+A+MC+ E RP M +VV AL+ L
Sbjct: 305 LFKDRRKFTLMADPLLEGKYPIKGLYQALAVAAMCLQEEAATRPMMSDVVTALEYLAVTK 364
Query: 656 TDE 658
T+E
Sbjct: 365 TEE 367
|
|
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 798 (286.0 bits), Expect = 2.0e-79, P = 2.0e-79
Identities = 154/291 (52%), Positives = 205/291 (70%)
Query: 363 KTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEV 422
++F +L AT F +LGEGGFG VY G +D+G VA+K L + G+REFI EV
Sbjct: 64 RSFTFKELAAATRNFREVNLLGEGGFGRVYKGRLDSGQVVAIKQLNPDGLQGNREFIVEV 123
Query: 423 EMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIAL 482
MLS LHH NLV LIG C G R LVYE + GS+E HL ++ N+ PL W RMKIA+
Sbjct: 124 LMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKIAV 183
Query: 483 GAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ-HISTRVMG 541
GAARG+ YLH +NP VI+RD K++N+LL+ +F+PK+SDFGLA+ G + H+STRVMG
Sbjct: 184 GAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRVMG 243
Query: 542 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTR 601
T+GY APEYAM+G L VKSD+Y +GVVLLEL++GRK +D+ Q QG++NLVTW+RP L +
Sbjct: 244 TYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTWSRPYLKDQ 303
Query: 602 EGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652
+ LVDPSL G Y + AI +MC++ E +RPF+G++V AL+ +
Sbjct: 304 KKFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYL 354
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8RWW0 | ALE2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7387 | 0.9051 | 0.9489 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_LG_XIV001361 | hypothetical protein (734 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 780 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-51 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-36 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-35 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-32 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-32 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-31 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-31 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-30 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-29 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-29 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-28 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-26 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-24 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-23 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-22 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-22 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-21 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-17 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-15 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-12 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.002 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.003 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 1e-52
Identities = 83/278 (29%), Positives = 122/278 (43%), Gaps = 32/278 (11%)
Query: 380 KRILGEGGFGCVYHGV-----MDNGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRNL 433
+ LGEG FG VY G EVAVK L + EF+ E ++ +L H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
VKL+G+C E +V E + G + S+L KNR L + AL ARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT 553
IHRD A N L+ ++ K+SDFGL+R+ + + ++APE
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 554 GHLLVKSDVYSYGVVLLELLS-GRKP-VDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611
G KSDV+S+GV+L E+ + G +P MS + L L Q +
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE--------VLEYLKNGYRLPQPPNCP 229
Query: 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649
++ + C + RP E+V+ L
Sbjct: 230 ----------PELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 2e-51
Identities = 81/282 (28%), Positives = 127/282 (45%), Gaps = 41/282 (14%)
Query: 381 RILGEGGFGCVYHGVM-----DNGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRNLV 434
+ LGEG FG VY G + T+VAVK L +R EF+ E ++ +L H N+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+L+G+C +G +V E + G + L K+ L + +++AL A+G+ YL
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESK 121
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYV-----APE 549
+HRD A N L+ ++ K+SDFGL+R+ E + G + APE
Sbjct: 122 ---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY----RKRGGGKLPIKWMAPE 174
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLS-GRKP-VDMSQPQGQENLVTWARPLLTTREGLEQL 607
G KSDV+S+GV+L E+ + G +P MS + LL L +
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE--------VLELLEDGYRLPR- 225
Query: 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649
P ++ + C + RP E+V+ L
Sbjct: 226 --PENC-------PDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 3e-51
Identities = 74/194 (38%), Positives = 108/194 (55%), Gaps = 11/194 (5%)
Query: 383 LGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDRE-FIAEVEMLSRLHHRNLVKLIGIC 440
LGEGGFG VY G +VA+K++ + + + E + E+E+L +L+H N+VKL G+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 441 IEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVI 500
+ LV E GS++ L +N G L + ++I L GL YLH SN +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLH--SNG-II 114
Query: 501 HRDFKASNVLL-EDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLL-V 558
HRD K N+LL D+ K++DFGL++ T + T V GT Y+APE +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSE 173
Query: 559 KSDVYSYGVVLLEL 572
KSD++S GV+L EL
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 2e-50
Identities = 78/279 (27%), Positives = 120/279 (43%), Gaps = 33/279 (11%)
Query: 380 KRILGEGGFGCVYHGV-----MDNGTEVAVKLLTRNNQNGD--REFIAEVEMLSRLHHRN 432
+ LGEG FG VY G EVAVK L + + + EF+ E ++ +L H N
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHPN 62
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
+VKL+G+C E +V E + G + +L L + AL ARG+ YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM 552
IHRD A N L+ ++ K+SDFGL+R+ + + ++APE
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 553 TGHLLVKSDVYSYGVVLLELLS-GRKP-VDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610
G KSDV+S+GV+L E+ + G +P MS + L L + +
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE--------VLEYLKKGYRLPKPPNC 229
Query: 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649
++ + C + RP E+V+ L
Sbjct: 230 P----------PELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 5e-48
Identities = 81/289 (28%), Positives = 130/289 (44%), Gaps = 46/289 (15%)
Query: 381 RILGEGGFGCVYHGVMDNG----TEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRNLVK 435
+ LGEG FG VY G + TEVAVK L + +R +F+ E ++ +L H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 436 LIGICIEGRTRCLVYELVHNGSVESHL-----HGVDKNRGPLDWEARMKIALGAARGLAY 490
L+G+C E LV E + G + +L + L + + A+ A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE-------ATEGSQHISTRVMGTF 543
L + +HRD A N L+ +D K+SDFGL+R+ + + R M
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM--- 174
Query: 544 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP-VDMSQPQGQENLVTWARPLLTTR 601
APE G KSDV+S+GV+L E+ + G P +S E ++ + R
Sbjct: 175 ---APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS----NEEVLEY------LR 221
Query: 602 EGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650
+G +L P ++ + C + RP E+V+ L+
Sbjct: 222 KG-YRLPKPEYCPD-------ELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 1e-47
Identities = 77/206 (37%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 377 FSSKRILGEGGFGCVYHGV-MDNGTEVAVKLL--TRNNQNGDREFIAEVEMLSRLHHRNL 433
+ R LG G FG VY G VAVK+L D+ E+ +L RL H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
V+LI + LV E G L GPL + KIAL RGL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGD----LFDYLSRGGPLSEDEAKKIALQILRGLEYLHS 116
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE-YAM 552
+ +IHRD K N+LL+++ K++DFGLA++ + S ++T V GT Y+APE
Sbjct: 117 N---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLG 172
Query: 553 TGHLLVKSDVYSYGVVLLELLSGRKP 578
K DV+S GV+L ELL+G+ P
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 3e-44
Identities = 72/205 (35%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 377 FSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDRE-FIAEVEMLSRLHHRNLV 434
+ LGEG FG VY G VA+K++ + DRE + E+++L +L H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLD-WEARMKIALGAARGLAYLHE 493
+L + + LV E G + L K RG L EAR L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEAR-FYLRQILSALEYLHS 115
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT 553
++HRD K N+LL++D K++DFGLAR+ G + ++T V GT Y+APE +
Sbjct: 116 K---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFV-GTPEYMAPEVLLG 170
Query: 554 GHLLVKSDVYSYGVVLLELLSGRKP 578
D++S GV+L ELL+G+ P
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 381 RILGEGGFGCVYHGVM-DNGTEVAVK--LLTRNNQNGDREFIAEVEMLSRLHHRNLVKLI 437
+LG G FG VY + D G +AVK L+ +++ E+ +LS L H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 438 GICI--EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKI-ALGAARGLAYLHED 494
G E T + E V GS+ S L K G L E ++ GLAYLH +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL----KKFGKLP-EPVIRKYTRQILEGLAYLHSN 120
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM-GTFGYVAPEYAMT 553
++HRD K +N+L++ D K++DFG A+ + T + GT ++APE
Sbjct: 121 ---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 554 GHLLVKSDVYSYGVVLLELLSGRKP 578
+D++S G ++E+ +G+ P
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 8e-36
Identities = 71/204 (34%), Positives = 113/204 (55%), Gaps = 6/204 (2%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHH 430
E+ E+F+ +R LG G FG V+ G+ N VA+K+L ++ ++F EV+ L RL H
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY 490
++L+ L +C G ++ EL+ GS+ + L + L + + +A A G+AY
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV--LPVASLIDMACQVAEGMAY 119
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
L E IHRD A N+L+ +D KV+DFGLAR E ++S+ + + APE
Sbjct: 120 LEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAPEA 175
Query: 551 AMTGHLLVKSDVYSYGVVLLELLS 574
A G KSDV+S+G++L E+ +
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 86/296 (29%), Positives = 132/296 (44%), Gaps = 38/296 (12%)
Query: 376 KFSSKRILGEGGFGCVYHGVMDN-----GTEVAVKLLTRN-NQNGDREFIAEVEMLSRLH 429
KF + LGEG FG V D G +VAVK L + + +F E+E+L L
Sbjct: 7 KFIKQ--LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD 64
Query: 430 HRNLVKLIGICIE--GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARG 487
H N+VK G+C + GR+ L+ E + +GS+ +L ++R ++ + + + +G
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ---RHRDQINLKRLLLFSSQICKG 121
Query: 488 LAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMG---TFG 544
+ YL + R IHRD A N+L+E + K+SDFGLA+ E + + G F
Sbjct: 122 MDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 545 YVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRK-------PVDMSQPQGQENLVTWARP 596
Y APE T SDV+S+GV L EL + G + M + +VT
Sbjct: 179 Y-APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237
Query: 597 LLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652
LL E L P D V + +C E RP +++ + +
Sbjct: 238 LLKEGERL-----PRPPSCPDE-----VYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 70/199 (35%), Positives = 107/199 (53%), Gaps = 16/199 (8%)
Query: 383 LGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIE 442
+G+G FG V G G +VAVK L +++ + F+AE +++ L H NLV+L+G+ ++
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 443 GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHR 502
G +V E + GS+ +L + R + ++ AL G+ YL E +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 503 DFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF--GYVAPEYAMTGHLLVKS 560
D A NVL+ +D KVSDFGLA+EA++G G + APE KS
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQD------SGKLPVKWTAPEALREKKFSTKS 180
Query: 561 DVYSYGVVLLELLS-GRKP 578
DV+S+G++L E+ S GR P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 86/282 (30%), Positives = 117/282 (41%), Gaps = 39/282 (13%)
Query: 383 LGEGGFGCVYHGV--MDNGTE--VAVKLLTRN-NQNGDREFIAEVEMLSRLHHRNLVKLI 437
LG G FG V GV M +G E VAVK L + G +EF+ E ++++L H +V+LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 438 GICIEGRTRCLVYELVHNGSVESHL--HGVDKNRGPLDWEARMKIALGAARGLAYLHEDS 495
G+C +G LV EL G + +L + A A G+AYL
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESK- 114
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF--GYVAPEYAMT 553
+HRD A NVLL + K+SDFG++R GS + G + + APE
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 554 GHLLVKSDVYSYGVVLLELLS-GRKPV-DMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611
G KSDV+SYGV L E S G KP +M + L E E+L P
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML-----------ESGERLPRPE 221
Query: 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIY 653
+ M C RP E+ +
Sbjct: 222 ECPQEIYSIMLS-------CWKYRPEDRPTFSELESTFRRDP 256
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 72/207 (34%), Positives = 109/207 (52%), Gaps = 21/207 (10%)
Query: 380 KRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGI 439
R LG G FG V+ G+ +N T VAVK L + +F+AE +++ +L H L++L +
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAV 69
Query: 440 CIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRV 499
C +V EL+ GS+ +L G L + +A A G+AYL +
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQN---Y 124
Query: 500 IHRDFKASNVLLEDDFTPKVSDFGLAR-------EATEGSQHISTRVMGTFGYVAPEYAM 552
IHRD A NVL+ ++ KV+DFGLAR EA EG++ + APE A+
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF-------PIKWTAPEAAL 177
Query: 553 TGHLLVKSDVYSYGVVLLELLS-GRKP 578
+KSDV+S+G++L E+++ GR P
Sbjct: 178 YNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 72/224 (32%), Positives = 104/224 (46%), Gaps = 34/224 (15%)
Query: 380 KRILGEGGFGCVYHGVMDNG------TEVAVKLLTRNNQNGDRE-FIAEVEMLSRLHHRN 432
KR LGEG FG V+ G + VAVK L N R+ F E E+L+ H N
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHL--HGVDKNR--------GPLDWEARMKIAL 482
+VK G+C EG +V+E + +G + L HG D G L ++IA+
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 483 GAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA-------TEGSQHI 535
A G+ YL ++ +HRD N L+ D K+ DFG++R+ G +
Sbjct: 130 QIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 536 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
R M PE M +SDV+S+GVVL E+ + G++P
Sbjct: 187 PIRWM------PPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 72/198 (36%), Positives = 108/198 (54%), Gaps = 10/198 (5%)
Query: 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDRE-FIAEVEMLSRLHHRNLVKLIGI 439
+G+G FG VY GV+ TEVAVK + F+ E E+L + H N+VKLIG+
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 440 CIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRV 499
C++ + +V ELV GS+ + L K + L + ++++L AA G+ YL E N
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLR---KKKNRLTVKKLLQMSLDAAAGMEYL-ESKN--C 114
Query: 500 IHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF--GYVAPEYAMTGHLL 557
IHRD A N L+ ++ K+SDFG++RE EG + + + + APE G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRE-EEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 558 VKSDVYSYGVVLLELLSG 575
+SDV+SYG++L E S
Sbjct: 174 SESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 67/209 (32%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 376 KFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGD--REFIAEVEMLSRLHHRN 432
+ ++G G FG VY G+ ++ G VA+K ++ + + + E+++L L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAA---RGLA 489
+VK IG + ++ E NGS L + K GP +A+ +GLA
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGS----LRQIIKKFGPFP---ESLVAVYVYQVLQGLA 113
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549
YLHE VIHRD KA+N+L D K++DFG+A + + S+ ++ V+GT ++APE
Sbjct: 114 YLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWMAPE 169
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
SD++S G ++ELL+G P
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 75/236 (31%), Positives = 115/236 (48%), Gaps = 27/236 (11%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
E +R LG G FG V+ G + T+VAVK L + + F+ E +++ +L H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLV 64
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+L +C E +V E + GS+ L + + L + +A A G+AYL
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLESR 122
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR--EATEGSQHISTRVMGTFGYVAPEYAM 552
IHRD A N+L+ ++ K++DFGLAR E E + + + APE A
Sbjct: 123 ---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAAN 177
Query: 553 TGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607
G +KSDV+S+G++L E+++ GR P P +T RE LEQ+
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVPY----------------PGMTNREVLEQV 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 8/199 (4%)
Query: 383 LGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIE 442
+G G FG V+ G +VA+K + R + +FI E +++ +L H LV+L G+C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 443 GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHR 502
CLV+E + +G + +L RG E + + L G+AYL + VIHR
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 503 DFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDV 562
D A N L+ ++ KVSDFG+ R + ST + +PE KSDV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 563 YSYGVVLLELLS-GRKPVD 580
+S+GV++ E+ S G+ P +
Sbjct: 185 WSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 9/204 (4%)
Query: 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
F +G+GGFG VY G EVA+K++ ++ + I E+++L + H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
K G ++ +V E GS++ L L + +GL YLH +
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG 554
+IHRD KA+N+LL D K+ DFGL+ + ++ + +GT ++APE
Sbjct: 118 ---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM--VGTPYWMAPEVINGK 172
Query: 555 HLLVKSDVYSYGVVLLELLSGRKP 578
K+D++S G+ +EL G+ P
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 63/195 (32%), Positives = 97/195 (49%), Gaps = 7/195 (3%)
Query: 383 LGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIE 442
LG G FG V+ G +VA+K++ + D +FI E +++ +L H NLV+L G+C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-DFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 443 GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHR 502
R +V E + NG + ++L + +G L E + + + YL + IHR
Sbjct: 71 QRPIFIVTEYMANGCLLNYLR---ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHR 124
Query: 503 DFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDV 562
D A N L+ +D KVSDFGLAR + S + PE KSDV
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 563 YSYGVVLLELLSGRK 577
+S+GV++ E+ S K
Sbjct: 185 WSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 79/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 381 RILGEGGFGCVYHGVMDN------GTEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRNL 433
R LG+G FG VY G+ T VA+K + N +R EF+ E ++ + ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHG------VDKNRGPLDWEARMKIALGAARG 487
V+L+G+ G+ +V EL+ G ++S+L + GP + +++A A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 488 LAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH-ISTRVMGTFGYV 546
+AYL + +HRD A N ++ +D T K+ DFG+ R+ E + + + ++
Sbjct: 132 MAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 547 APEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQP-QGQENLVTWARPLLTTREGLE 605
APE G KSDV+S+GVVL E+ + QP QG N E
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMATL-----AEQPYQGLSN---------------E 228
Query: 606 QLVDPSLAGSYDFDDM-------AKVAAIASMCVHPEVTHRPFMGEVVQALK 650
+++ + G + + K+ + MC RP E+V +LK
Sbjct: 229 EVLKFVIDGGH----LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 116 bits (290), Expect = 6e-28
Identities = 71/218 (32%), Positives = 101/218 (46%), Gaps = 19/218 (8%)
Query: 376 KFSSKRILGEGGFGCVYHGVMDNGTEVAVKLL---TRNNQNGDREFIAEVEMLSRL-HHR 431
+ R LGEG FG VY + VA+K+L + F+ E+++L+ L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
N+VKL + + LV E V GS+E L +GPL + I L YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYL 117
Query: 492 HEDSNPRVIHRDFKASNVLL-EDDFTPKVSDFGLAREATEGSQHISTR-----VMGTFGY 545
H +IHRD K N+LL D K+ DFGLA+ + S +GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 546 VAPEYAM---TGHLLVKSDVYSYGVVLLELLSGRKPVD 580
+APE + + SD++S G+ L ELL+G P +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212
|
Length = 384 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 77/212 (36%), Positives = 113/212 (53%), Gaps = 9/212 (4%)
Query: 382 ILGEGGFGCVYHGVMDNGTEVAVKLLTRN-NQNGDREFIAEVEMLSRLHHRNLVKLIGIC 440
+LG+G FG V+ G + + T VAVK + Q +F++E +L + H N+VKLIG+C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 441 IEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVI 500
+ + +V ELV G S L K + L + +K AL AA G+AYL E N I
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLR---KKKDELKTKQLVKFALDAAAGMAYL-ESKN--CI 115
Query: 501 HRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKS 560
HRD A N L+ ++ K+SDFG++R+ +G S + APE G +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 561 DVYSYGVVLLELLS-GRKPV-DMSQPQGQENL 590
DV+SYG++L E S G P M+ Q +E +
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 28/217 (12%)
Query: 381 RILGEGGFGCVYHGVMDNGTE----VAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRNLVK 435
+++G G FG V G + + VA+K L + + R +F+ E ++ + H N+++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 436 LIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS 495
L G+ + R ++ E + NGS++ L +N G + + G A G+ YL S
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLR---ENDGKFTVGQLVGMLRGIASGMKYL---S 123
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLARE--------ATEGSQHISTRVMGTFGYVA 547
+HRD A N+L+ + KVSDFGL+R T+G + I R + A
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGK-IPIR------WTA 176
Query: 548 PEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPV-DMS 582
PE SDV+S+G+V+ E++S G +P DMS
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 71/220 (32%), Positives = 110/220 (50%), Gaps = 30/220 (13%)
Query: 383 LGEGGFGCVYHG------VMDNGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRNLVK 435
LGEG FG VY G + T VA+K L N + + EF E E++S L H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 436 LIGICIEGRTRCLVYELVHNGSVESHL------------HGVDKNRGPLDWEARMKIALG 483
L+G+C + + C+++E + +G + L G + + LD + IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGT- 542
A G+ YL S+ +HRD A N L+ + T K+SDFGL+R+ + RV
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY---RVQSKS 186
Query: 543 ---FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
++ PE + G +SD++S+GVVL E+ S G +P
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 59/209 (28%), Positives = 109/209 (52%), Gaps = 17/209 (8%)
Query: 381 RILGEGGFGCVYHGVM-----DNGTEVAVK-LLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
++LG G FG VY GV VA+K L + ++E + E +++ + H ++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+L+GIC+ L+ +L+ G + ++ ++ + + + + A+G++YL E
Sbjct: 73 RLLGICL-SSQVQLITQLMPLGCLLDYVR---NHKDNIGSQYLLNWCVQIAKGMSYLEEK 128
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR--EATEGSQHISTRVMGTFGYVAPEYAM 552
R++HRD A NVL++ K++DFGLA+ + E ++ + ++A E +
Sbjct: 129 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE-KEYHAEGGKVPIKWMALESIL 184
Query: 553 TGHLLVKSDVYSYGVVLLELLS-GRKPVD 580
KSDV+SYGV + EL++ G KP +
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 23/214 (10%)
Query: 376 KFSSKRILGEGGFGCVY---HGVMDNGTEVAVKL--LTRNNQNGDREFIAEVEMLSRLHH 430
K+ + +G+G FG VY +G +K L+ ++ + + EV++L +L+H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRK--SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH 58
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY 490
N++K E C+V E G + + K P E + + L Y
Sbjct: 59 PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE- 549
LH +++HRD K N+ L + K+ DFG+++ + T V GT Y++PE
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPEL 174
Query: 550 -----YAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
Y KSD++S G VL EL + + P
Sbjct: 175 CQNKPYN------YKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 68/200 (34%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGIC 440
+ +G+G FG V G G +VAVK + N + F+AE ++++L H NLV+L+G+
Sbjct: 12 QTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 441 IEGRTRC-LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRV 499
+E + +V E + GS+ +L + R L + +K +L + YL ++
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEANN---F 123
Query: 500 IHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVK 559
+HRD A NVL+ +D KVSDFGL +EA+ V T APE K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 179
Query: 560 SDVYSYGVVLLELLS-GRKP 578
SDV+S+G++L E+ S GR P
Sbjct: 180 SDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 93/294 (31%), Positives = 130/294 (44%), Gaps = 40/294 (13%)
Query: 381 RILGEGGFGCV----YHGVMDN-GTEVAVKLLTRNNQNGDRE-FIAEVEMLSRLHHRNLV 434
R+LGEG FG V Y D G VAVK L R + + E+ +L L+H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 435 KLIGICIE--GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
K G C E G+ L+ E V GS+ +L + L+ + A G+AYLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMG---TFGYVAPE 549
IHRD A NVLL++D K+ DFGLA+ EG ++ R G F Y A E
Sbjct: 125 SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVE 180
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLSG--------RKPVDMSQP-QGQENLVTWARPLLTT 600
SDV+S+GV L ELL+ +K +M P QGQ +V L+
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV----RLIEL 236
Query: 601 REGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654
E +L P + +V + C E RP ++ LK +++
Sbjct: 237 LERGMRLPCPK-------NCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 63/208 (30%), Positives = 91/208 (43%), Gaps = 22/208 (10%)
Query: 383 LGEGGFGCVYHGVMDNGT----EVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLI 437
LG+G FG V G VAVK L + + +F+ E ++ L H NL++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 438 GICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLD--WEARMKIALGAARGLAYLHEDS 495
G+ + +V EL GS+ L + + ++IA G+ YL
Sbjct: 63 GVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGMRYLESK- 116
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIST----RVMGTFGYVAPEYA 551
R IHRD A N+LL D K+ DFGL R + H +V F + APE
Sbjct: 117 --RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESL 172
Query: 552 MTGHLLVKSDVYSYGVVLLELLS-GRKP 578
T SDV+ +GV L E+ + G +P
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 83/284 (29%), Positives = 132/284 (46%), Gaps = 33/284 (11%)
Query: 381 RILGEGGFGCVYHGVM----DNGTEVAVKLLTRNNQNGDRE-FIAEVEMLSRLHHRNLVK 435
R++G+G FGCVYHG + AVK L R + E F+ E ++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 436 LIGICI--EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
L+GIC+ EG ++ + H G + + + N D + L A+G+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKH-GDLRNFIRSETHNPTVKDL---IGFGLQVAKGMEYL-- 114
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG---SQHISTRVMGTFGYVAPEY 550
++ + +HRD A N +L++ FT KV+DFGLAR+ + S H T ++A E
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 551 AMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610
T KSDV+S+GV+L EL++ P P + LL R +L+ P
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVDSFDITVYLLQGR----RLLQP 224
Query: 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654
++ M C HP+ RP E+V ++ I++
Sbjct: 225 EYCPDPLYEVMLS-------CWHPKPEMRPTFSELVSRIEQIFS 261
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 71/222 (31%), Positives = 111/222 (50%), Gaps = 33/222 (14%)
Query: 381 RILGEGGFGCVYHG----VMDNGTE---VAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRN 432
LG G FG VY G ++ G+ VAVK L + + ++ EF+ E ++S +H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGP---LDWEARMKIALGAARGLA 489
+VKL+G+C+ + ++ EL+ G + S+L R L + + I L A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 490 YLHEDSNPRVIHRDFKASNVLLED-----DFTPKVSDFGLARE-------ATEGSQHIST 537
YL + IHRD A N L+ + D K+ DFGLAR+ EG +
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 538 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
R M APE + G +SDV+S+GV++ E+L+ G++P
Sbjct: 178 RWM------APESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 74/214 (34%), Positives = 113/214 (52%), Gaps = 22/214 (10%)
Query: 375 EKFSSKRI--LGEGGFG----CVYHGVMDN-GTEVAVKLL---TRNNQNGDREFIAEVEM 424
EK KRI LGEG FG C Y DN G +VAVK L + N D + E+E+
Sbjct: 2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK--KEIEI 59
Query: 425 LSRLHHRNLVKLIGICIE--GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIAL 482
L L+H N+VK GIC E G L+ E + +GS++ +L +N+ ++ + ++K A+
Sbjct: 60 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAV 116
Query: 483 GAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR--EATEGSQHISTRVM 540
+G+ YL + + +HRD A NVL+E + K+ DFGL + E + + +
Sbjct: 117 QICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLD 173
Query: 541 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS 574
+ APE + + SDV+S+GV L ELL+
Sbjct: 174 SPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 78/268 (29%), Positives = 130/268 (48%), Gaps = 31/268 (11%)
Query: 383 LGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIE 442
LG G FG V +G +VA+K++ + + D EFI E +++ +L H LV+L G+C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 443 GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHR 502
R +V E + NG + ++L K P +++ G+AYL + + IHR
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYLE---SKQFIHR 124
Query: 503 DFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGT---FGYVAPEYAMTGHLLVK 559
D A N L++D KVSDFGL+R + ++ S+ +G+ + PE + K
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLD-DEYTSS--VGSKFPVRWSPPEVLLYSKFSSK 181
Query: 560 SDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDF 618
SDV+++GV++ E+ S G+ P + + + +GL +L P LA
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYE---------RFNNSETVEKVSQGL-RLYRPHLASE--- 228
Query: 619 DDMAKVAAIASMCVHPEVTHRPFMGEVV 646
KV AI C H + RP +++
Sbjct: 229 ----KVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 383 LGEGGFGCVYHGVMDN------GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKL 436
LGEG FG V+ N VAVK L +++ ++F E E+L+ L H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 437 IGICIEGRTRCLVYELVHNGSVESHL--HGVDKN---------RGPLDWEARMKIALGAA 485
G+C EGR +V+E + +G + L HG D G L + IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH-ISTRVMGTFG 544
G+ YL ++ +HRD N L+ K+ DFG++R+ + + R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 545 YVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
++ PE + +SD++S+GVVL E+ + G++P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 73/202 (36%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 383 LGEGGFG----CVYHGVMDN-GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLI 437
LG+G FG C Y + DN G VAVK L + R+F E+E+L L H N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 438 GICIE-GRTRC-LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS 495
G+C GR LV E + GS+ +L K+R LD + A +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYL---G 125
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMG---TFGYVAPEYAM 552
+ R +HRD N+L+E + K+ DFGL + + ++ R G F Y APE
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLT 184
Query: 553 TGHLLVKSDVYSYGVVLLELLS 574
V SDV+S+GVVL EL +
Sbjct: 185 ESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 67/213 (31%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 377 FSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGD---REFIAEVEMLSRLHHRN 432
+ LGEG +G VY G VA+K + R + + + E+ +L L H N
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPN 59
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHG-VDKNRGPLDWEARMK-IALGAARGLAY 490
+VKL+ + R LV+E + L +DK GPL +K I RGLAY
Sbjct: 60 IVKLLDVIHTERKLYLVFEYC-----DMDLKKYLDKRPGPLS-PNLIKSIMYQLLRGLAY 113
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
H S+ R++HRD K N+L+ D K++DFGLAR + + V+ T Y APE
Sbjct: 114 CH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPE- 168
Query: 551 AMTGHLLVKSDVYSYGV-------VLLELLSGR 576
+L+ S YS V + E+++G+
Sbjct: 169 -----ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 381 RILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGD-----REFIAEVEMLSRLHHRNLV 434
+LG G FG VY G+ +D+G AVK ++ + ++ E+ +LS+L H N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+ +G E + ELV GS+ L K G GL YLH
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQILLGLEYLH-- 119
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM-T 553
+ +HRD K +N+L++ + K++DFG+A++ E S S G+ ++APE
Sbjct: 120 -DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQQ 176
Query: 554 GHLLVKSDVYSYGVVLLELLSGRKP 578
G + +D++S G +LE+ +G+ P
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 69/208 (33%), Positives = 103/208 (49%), Gaps = 18/208 (8%)
Query: 382 ILGEGGFGCVYHGVMDNGTEVAVK---LLTRNNQNGDREFIA---EVEMLSRLHHRNLVK 435
+LG+G +G VY G+ + G +AVK L T N ++E+ EV++L L H N+V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 436 LIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS 495
+G C++ T + E V GS+ S L GPL K G+AYLH +
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM-----GTFGYVAPEY 550
V+HRD K +NV+L + K+ DFG AR H + M GT ++APE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 551 AMTGHLLVKSDVYSYGVVLLELLSGRKP 578
KSD++S G + E+ +G+ P
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 12/214 (5%)
Query: 377 FSSKRILGEGGFGCVYHGV-MDNGTEVAVKL--LTRNNQNGDREFIAEVEMLSRLHHRNL 433
F +G+G FG V+ V + A+K L++ N+ E I E +L++L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRG-PLDWEARMKIALGAARGLAYLH 492
++ ++ +V E NG + L RG PL + + + GLA+LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLK---MQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM 552
+++HRD K+ N+ L+ K+ D G+A+ ++ + +T ++GT Y++PE
Sbjct: 119 SK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCE 174
Query: 553 TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQG 586
KSDV++ GVVL E +G+ P D + QG
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFD-ANNQG 207
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 3e-23
Identities = 70/198 (35%), Positives = 108/198 (54%), Gaps = 14/198 (7%)
Query: 382 ILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICI 441
I+GEG FG V G G +VAVK + + + F+ E ++++LHH+NLV+L+G+ +
Sbjct: 13 IIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 442 EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIH 501
+V EL+ G++ + L + R + ++ +L A G+ YL + +++H
Sbjct: 70 HNGLY-IVMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVH 123
Query: 502 RDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSD 561
RD A N+L+ +D KVSDFGLAR + G + V T APE KSD
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSD 179
Query: 562 VYSYGVVLLELLS-GRKP 578
V+SYGV+L E+ S GR P
Sbjct: 180 VWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 16/205 (7%)
Query: 383 LGEGGFGCVYHGV-MDNGTEVAVKL--LTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGI 439
+G G FG VY V +D G +AVK + N+ +E E+++L L H NLVK G+
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 440 CIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRV 499
+ + E G++E L + LD L GLAYLH +
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSH---GI 120
Query: 500 IHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRV---MGTFGYVAPE---YAMT 553
+HRD K +N+ L+ + K+ DFG A + + + V GT Y+APE
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 554 GHLLVKSDVYSYGVVLLELLSGRKP 578
+D++S G V+LE+ +G++P
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 6e-23
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 374 TEKFSSKRILGEGGFGCVYHGVMDNGT--EVAVKLLTRNNQNGDREFIAEVEMLSRLHHR 431
E + + +GEG G VY D T EVA+K + QN I E+ ++ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKAT-DRATGKEVAIKKMRLRKQN-KELIINEILIMKDCKHP 75
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMK-IALGAARGLAY 490
N+V + G +V E + GS+ + +N ++ E ++ + +GL Y
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDI---ITQNFVRMN-EPQIAYVCREVLQGLEY 131
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE- 549
LH + VIHRD K+ N+LL D + K++DFG A + T+ ++ V GT ++APE
Sbjct: 132 LH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEV 187
Query: 550 -----YAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
Y K D++S G++ +E+ G P
Sbjct: 188 IKRKDYGP------KVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 7e-23
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 11/209 (5%)
Query: 380 KRILGEGGFGCVYHGVMDN-GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIG 438
K LG G +G VY GV VAVK L + + EF+ E ++ + H NLV+L+G
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 69
Query: 439 ICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPR 498
+C ++ E + G++ +L + NR ++ + +A + + YL + +
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVNAVVLLYMATQISSAMEYLEKKN--- 124
Query: 499 VIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLV 558
IHRD A N L+ ++ KV+DFGL+R T + + APE +
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 559 KSDVYSYGVVLLELLS-GRKP---VDMSQ 583
KSDV+++GV+L E+ + G P +D+SQ
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDLSQ 213
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 7e-23
Identities = 66/222 (29%), Positives = 113/222 (50%), Gaps = 29/222 (13%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGVM------DNGTEVAVKLLTRNNQNGDR-EFIAEVE 423
E A EK + R LG+G FG VY G+ + T VA+K + +R EF+ E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 424 MLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGV------DKNRGPLDWEAR 477
++ + ++V+L+G+ +G+ ++ EL+ G ++S+L + + + P +
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 478 MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE------- 530
+++A A G+AYL+ + + +HRD A N ++ +DFT K+ DFG+ R+ E
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLEL 572
G + R M +PE G SDV+S+GVVL E+
Sbjct: 179 GKGLLPVRWM------SPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-23
Identities = 79/291 (27%), Positives = 144/291 (49%), Gaps = 25/291 (8%)
Query: 363 KTFALSDLEKATEKFSSKRILGEGGFGCVYHG-VMDNGTEVAVKLLTRNNQNGDREFIAE 421
K+ ++D+ + ++ + ++ G G Y G + NG + VK + N IA+
Sbjct: 681 KSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS-SEIAD 736
Query: 422 VEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIA 481
+ +L H N+VKLIG+C + L++E + ++ L L WE R KIA
Sbjct: 737 ---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIA 786
Query: 482 LGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMG 541
+G A+ L +LH +P V+ + ++++ P + R + G T+
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFI 840
Query: 542 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTR 601
+ YVAPE T + KSD+Y +G++L+ELL+G+ P D ++ ++V WAR +
Sbjct: 841 SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD-AEFGVHGSIVEWARYCYSDC 899
Query: 602 EGLEQLVDPSLAG--SYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650
L+ +DPS+ G S + +++ +V +A C + T RP +V++ L+
Sbjct: 900 H-LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 67/217 (30%), Positives = 116/217 (53%), Gaps = 23/217 (10%)
Query: 383 LGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIE 442
LG G FG V+ G + T+VA+K L + + + + F+AE ++ +L H LV+L + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYAV-VT 71
Query: 443 GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHR 502
++ E + NGS+ L + + ++ + +A A G+A++ E N IHR
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTIN--KLIDMAAQIAEGMAFI-ERKN--YIHR 126
Query: 503 DFKASNVLLEDDFTPKVSDFGLAR-------EATEGSQHISTRVMGTFGYVAPEYAMTGH 555
D +A+N+L+ + K++DFGLAR A EG++ + APE G
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-------PIKWTAPEAINYGT 179
Query: 556 LLVKSDVYSYGVVLLELLS-GRKPV-DMSQPQGQENL 590
+KSDV+S+G++L E+++ GR P M+ P+ +NL
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL 216
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 74/238 (31%), Positives = 113/238 (47%), Gaps = 24/238 (10%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHH 430
E E + LG G FG V+ G + T+VAVK L + + F+ E +++ +L H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRH 60
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY 490
LV+L + E +V E + GS+ L D L + +A A G+AY
Sbjct: 61 DKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLK--DGEGRALKLPNLVDMAAQVAAGMAY 117
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
+ E N IHRD +++N+L+ D K++DFGLAR + + APE
Sbjct: 118 I-ERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 551 AMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607
A+ G +KSDV+S+G++L EL++ GR P P + RE LEQ+
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPY----------------PGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 23/219 (10%)
Query: 380 KRILGEGGFGCVYHGVMDNGTE------VAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL 433
KR LGEG FG V+ N + VAVK L ++F E E+L+ L H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHL--HGVD----------KNRGPLDWEARMKIA 481
VK G+C +G +V+E + +G + L HG D + +G L + IA
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 482 LGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH-ISTRVM 540
A G+ YL ++ +HRD N L+ + K+ DFG++R+ + + M
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 541 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
++ PE M +SDV+S+GV+L E+ + G++P
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 71/228 (31%), Positives = 106/228 (46%), Gaps = 23/228 (10%)
Query: 370 LEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL 428
L T F ++GEG +G VY G VA+K++ ++ + E E +L +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKY 59
Query: 429 -HHRNLVKLIGICIEGRTRC------LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIA 481
+H N+ G I+ LV EL GSV + G+ K L E I
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119
Query: 482 LGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE--ATEGSQHISTRV 539
RGLAYLHE+ +VIHRD K N+LL + K+ DFG++ + +T G ++
Sbjct: 120 RETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-- 174
Query: 540 MGTFGYVAPE-----YAMTGHLLVKSDVYSYGVVLLELLSGRKPV-DM 581
GT ++APE +SDV+S G+ +EL G+ P+ DM
Sbjct: 175 -GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 72/281 (25%), Positives = 116/281 (41%), Gaps = 41/281 (14%)
Query: 368 SDLEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQ-NGDREFIAEVEML 425
SDLE+ ++LG+G G VY G A+K + + ++ + E++ L
Sbjct: 1 SDLER-------VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTL 53
Query: 426 SRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAA 485
+VK G + +V E + GS L + K G + IA
Sbjct: 54 RSCESPYVVKCYGAFYKEGEISIVLEYMDGGS----LADLLKKVGKIPEPVLAYIARQIL 109
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGY 545
+GL YLH + +IHRD K SN+L+ K++DFG+++ +T V GT Y
Sbjct: 110 KGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTY 166
Query: 546 VAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLE 605
++PE +D++S G+ LLE G+ P P GQ + E ++
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFPF---LPPGQPSFF----------ELMQ 213
Query: 606 QLVD------PSLAGSYDFDDMAKVAAIASMCVHPEVTHRP 640
+ D P+ S +F D S C+ + RP
Sbjct: 214 AICDGPPPSLPAEEFSPEFRD------FISACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 19/214 (8%)
Query: 381 RILGEGGFGCVYHGVM--DNGT--EVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLV 434
+ILGEG FG V G + D+G+ +VAVK + + + EF++E + H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 435 KLIGICIEGRTR------CLVYELVHNGSVESHLHGVDKNRGPLDWEARM--KIALGAAR 486
KLIG+C E + ++ + +G + S L P + K + A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGT-FGY 545
G+ YL SN IHRD A N +L +D T V+DFGL+++ G + R+ +
Sbjct: 125 GMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 546 VAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
+A E KSDV+++GV + E+ + G+ P
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 68/214 (31%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGVM----DNGTEVAVKLLTRNNQNGDRE-FIAEVEML 425
E E + R +GEG FG VY GV + VAVK RE F+ E ++
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 426 SRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAA 485
+ H ++VKLIG+ E +V EL G + S+L N+ LD + + + +
Sbjct: 62 RQFDHPHIVKLIGVITENPV-WIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLS 117
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGY 545
LAYL + R +HRD A NVL+ K+ DFGL+R + S + +++ +
Sbjct: 118 TALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKW 174
Query: 546 VAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
+APE SDV+ +GV + E+L G KP
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 4e-22
Identities = 69/242 (28%), Positives = 117/242 (48%), Gaps = 41/242 (16%)
Query: 380 KRILGEGGFGCVYHGVMDNGTE-----------------VAVKLLTRN-NQNGDREFIAE 421
K LGEG FG V+ + N + VAVK+L + N+N +F+ E
Sbjct: 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKE 69
Query: 422 VEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHL--HGVDKNRGP-------- 471
V++LSRL N+++L+G+C++ C++ E + NG + L H +D
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 472 -----LDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526
+ + + + +AL A G+ YL S+ +HRD N L+ ++ T K++DFG++R
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186
Query: 527 EATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQ 585
G + I R + ++A E + G SDV+++GV L E+L + QP
Sbjct: 187 NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM----LCKEQPY 242
Query: 586 GQ 587
G+
Sbjct: 243 GE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 4e-22
Identities = 70/270 (25%), Positives = 121/270 (44%), Gaps = 25/270 (9%)
Query: 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGIC 440
+ LG G FG V+ G +VA+K + + +FI E +++ +L H LV+L G+C
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 441 IEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVI 500
+ + +V E + NG + L+ + + +G L + + + G+ YL +S I
Sbjct: 69 TQQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FI 122
Query: 501 HRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKS 560
HRD A N L+ KVSDFG+ R + S+ + PE KS
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 561 DVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFD 619
DV+S+GV++ E+ + G+ P + +++ G +L P LA ++
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS---------RG-FRLYRPKLASMTVYE 232
Query: 620 DMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649
M C H + RP E+++A+
Sbjct: 233 VMY-------SCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 4e-22
Identities = 68/216 (31%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 380 KRILGEGGFGCVYHGVMDN------GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL 433
KR LGEG FG V+ N VAVK L + N ++F E E+L+ L H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHL--HGVD-----KNRGP--LDWEARMKIALGA 484
VK G+C+EG +V+E + +G + L HG D + P L + IA
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 485 ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH-ISTRVMGTF 543
A G+ YL ++ +HRD N L+ ++ K+ DFG++R+ + + M
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 544 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
++ PE M +SDV+S GVVL E+ + G++P
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL 433
E F LGEG +G VY + + G VA+K++ +E I E+ +L + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL--QEIIKEISILKQCDSPYI 60
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
VK G + +V E GSV + +K L E I +GL YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLH- 116
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT 553
+ + IHRD KA N+LL ++ K++DFG++ + T+ +T V+GT ++APE
Sbjct: 117 --SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQE 173
Query: 554 GHLLVKSDVYSYGVVLLELLSGRKP 578
K+D++S G+ +E+ G+ P
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 71/216 (32%), Positives = 110/216 (50%), Gaps = 24/216 (11%)
Query: 381 RILGEGGFGCVYHGV---MDNGT---EVAVKLLTRN-NQNGDREFIAEVEMLSRLHHRNL 433
R LG G FG VY G+ D +VAVK L + ++ + +F+ E ++S+ +H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNR------GPLDWEARMKIALGAARG 487
V+LIG+ E R ++ EL+ G ++S L +NR L + + A A+G
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLR---ENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 488 LAYLHEDSNPRVIHRDFKASNVLLED---DFTPKVSDFGLAREATEGSQH-ISTRVMGTF 543
YL E+ IHRD A N LL K++DFG+AR+ S + R M
Sbjct: 129 CKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 544 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
++ PE + G K+DV+S+GV+L E+ S G P
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 7e-22
Identities = 89/304 (29%), Positives = 139/304 (45%), Gaps = 53/304 (17%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGVM------DNGTEVAVKLLTRNNQNGDR-EFIAEVE 423
E + EK + R LG+G FG VY G + T VAVK + + +R EF+ E
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 424 MLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGV------DKNRGPLDWEAR 477
++ ++V+L+G+ +G+ +V EL+ +G ++S+L + + R P +
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 478 MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE------- 530
+++A A G+AYL+ + +HRD A N ++ DFT K+ DFG+ R+ E
Sbjct: 122 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQP-QGQEN 589
G + R M APE G SD++S+GVVL E+ S + QP QG N
Sbjct: 179 GKGLLPVRWM------APESLKDGVFTTSSDMWSFGVVLWEITSLAE-----QPYQGLSN 227
Query: 590 LVTWARPLLTTREGLEQLVDPSLAGSY-DFDDMA--KVAAIASMCVHPEVTHRPFMGEVV 646
EQ++ + G Y D D +V + MC RP E+V
Sbjct: 228 ---------------EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 272
Query: 647 QALK 650
LK
Sbjct: 273 NLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 9e-22
Identities = 67/226 (29%), Positives = 100/226 (44%), Gaps = 14/226 (6%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMD--NGTEVAVKL-LTRNNQNGDREFIAEVEMLSRLHHR 431
EK LGEG G V G A+K T N + ++ + E+E+
Sbjct: 1 EKIVELSRLGEGAGGSV-TKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSP 59
Query: 432 NLVKLIGICIEGRTRCL--VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLA 489
+VK G ++ + + E GS++S V K G + + KIA +GL+
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549
YLH ++IHRD K SN+LL K+ DFG++ E T GT Y+APE
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPE 173
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLSGRKPV--DMSQPQGQENLVTW 593
+ SDV+S G+ LLE+ R P + P G L+++
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY 219
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 9e-22
Identities = 68/231 (29%), Positives = 106/231 (45%), Gaps = 42/231 (18%)
Query: 381 RILGEGGFGCVYH----GVM--DNGTEVAVKLLTRN-NQNGDREFIAEVEMLSRLHHRNL 433
R +G+G FG V+ G++ + T VAVK+L + + +F E +++ H N+
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70
Query: 434 VKLIGICIEGRTRCLVYELVHNG------------SVESHLHGVDK------NRGPLDWE 475
VKL+G+C G+ CL++E + G + S H N PL
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 476 ARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE-------A 528
++ IA A G+AYL E + +HRD N L+ ++ K++DFGL+R
Sbjct: 131 EQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 529 TEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
+ I R M PE +SDV++YGVVL E+ S G +P
Sbjct: 188 ASENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 382 ILGEGGFGCVY----HGVMDNGTE--VAVKLL-TRNNQNGDREFIAEVEMLSRLHHRNLV 434
LG G FG V+ G+ + G E V VK L ++N EF E++M +L H+N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHL----HGVDKNRG-PLDWEARMKIALGAARGLA 489
+L+G+C E ++ E G ++ L +K + PL + ++ + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549
+L SN R +HRD A N L+ KVS L+++ + + ++APE
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLS 574
KSDV+S+GV++ E+ +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 67/249 (26%), Positives = 114/249 (45%), Gaps = 32/249 (12%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGVMDNGTE-----------------VAVKLLTRN-NQ 412
E + + LGEG FG V+ D + VAVK+L + +
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60
Query: 413 NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLH-------GV 465
N +F+ EV++LSRL N+ +L+G+C C++ E + NG + L G+
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 466 DKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525
N L + + +A A G+ YL + +HRD N L+ ++T K++DFG++
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 526 REATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS--GRKPVD-M 581
R + + R ++A E + G KSDV+++GV L E+L+ +P + +
Sbjct: 178 RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237
Query: 582 SQPQGQENL 590
+ Q EN
Sbjct: 238 TDQQVIENA 246
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 382 ILGEGGFGCVYHGV-MDNGTEVAVKLL----TRNNQNGDRE------FIAEVEMLSRLHH 430
++G+G +G VY + + G +AVK + T ++ R+ +E+E L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY 490
N+V+ +G + E V GS+ S L + G + + GLAY
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM-GTFGYVAPE 549
LH + ++HRD KA N+L++ D K+SDFG+++++ + + M G+ ++APE
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 550 YAMTGH--LLVKSDVYSYGVVLLELLSGRKP 578
+ K D++S G V+LE+ +GR+P
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 8/197 (4%)
Query: 383 LGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIE 442
LG+G FG V+ G + T VA+K L + + F+ E +++ +L H LV+L + E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 443 GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHR 502
+V E + GS+ L G + L + +A A G+AY+ E N +HR
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYV-ERMN--YVHR 126
Query: 503 DFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDV 562
D +A+N+L+ ++ KV+DFGLAR + + APE A+ G +KSDV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 563 YSYGVVLLELLS-GRKP 578
+S+G++L EL + GR P
Sbjct: 187 WSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 14/203 (6%)
Query: 383 LGEGGFGCVYHGVM---DNGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRNLVKLIG 438
LG G FGCV GV +VA+K+L N+ R E + E E++ +L + +V++IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 439 ICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPR 498
+C E LV E+ G + L G + + +++ + G+ YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 499 VIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF--GYVAPEYAMTGHL 556
+HRD A NVLL + K+SDFGL++ + R G + + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 557 LVKSDVYSYGVVLLELLS-GRKP 578
+SDV+SYG+ + E S G+KP
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 67/202 (33%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 383 LGEGGFGCVYH-GVMDNGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIG 438
LG+GGFG V V G A K L + + G++ + E ++L ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 439 ICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKI-ALGAARGLAYLHEDSN 496
E + CLV L++ G ++ H++ V + P EAR A GL +LH+
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP---EARAIFYAAQIICGLEHLHQR-- 114
Query: 497 PRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHL 556
R+++RD K NVLL+D ++SD GLA E G + I R GT GY+APE
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK-IKGRA-GTPGYMAPEVLQGEVY 171
Query: 557 LVKSDVYSYGVVLLELLSGRKP 578
D ++ G L E+++GR P
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 4e-21
Identities = 73/220 (33%), Positives = 111/220 (50%), Gaps = 29/220 (13%)
Query: 383 LGEGGFGCVYHGVM--DNGTEVAVKLLTRNNQNGD--REFIAEVEMLSRLHHRNLVKLIG 438
+G G FG V+ G + DN T VAVK R D +F+ E +L + H N+V+LIG
Sbjct: 3 IGRGNFGEVFSGRLRADN-TPVAVKS-CRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 439 ICIEGRTRCLVYELVHNGSVESHLHGVDKNRGP-LDWEARMKIALGAARGLAYLHEDSNP 497
+C + + +V ELV G + L + GP L + +++ AA G+ YL +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFL----RTEGPRLKVKELIQMVENAAAGMEYLE---SK 113
Query: 498 RVIHRDFKASNVLLEDDFTPKVSDFGLARE-------ATEGSQHISTRVMGTFGYVAPEY 550
IHRD A N L+ + K+SDFG++RE +T G + I + + APE
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK------WTAPEA 167
Query: 551 AMTGHLLVKSDVYSYGVVLLELLS-GRKP-VDMSQPQGQE 588
G +SDV+S+G++L E S G P ++S Q +E
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE 207
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 4e-21
Identities = 72/226 (31%), Positives = 110/226 (48%), Gaps = 24/226 (10%)
Query: 383 LGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIE 442
LG+G FG V+ G + T+VA+K L + F+ E +++ +L H LV L + E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 443 GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHR 502
+V E + GS+ L D L + +A A G+AY+ E N IHR
Sbjct: 73 -EPIYIVTEFMGKGSLLDFLKEGDGKY--LKLPQLVDMAAQIADGMAYI-ERMN--YIHR 126
Query: 503 DFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDV 562
D +A+N+L+ D+ K++DFGLAR + + APE A+ G +KSDV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 563 YSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607
+S+G++L EL++ GR P P + RE LEQ+
Sbjct: 187 WSFGILLTELVTKGRVPY----------------PGMVNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 5e-21
Identities = 69/209 (33%), Positives = 103/209 (49%), Gaps = 30/209 (14%)
Query: 383 LGEGGFGCVYHGVMDNGTEV--AVKLL--TRNNQNGDREF-IAEVEMLSRLHHRNLVKLI 437
LG+G FG V V T A+K+L + + + E + E +LSR++H +VKL
Sbjct: 1 LGKGSFGKVL-LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 438 GICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK-----IALGAARGLAYL 491
+ + LV E G + SHL G E R + I L L YL
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHL----SKEGRFS-EERARFYAAEIVLA----LEYL 109
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA 551
H + +I+RD K N+LL+ D K++DFGLA+E + +T GT Y+APE
Sbjct: 110 H---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVL 165
Query: 552 M-TGHLLVKS-DVYSYGVVLLELLSGRKP 578
+ G+ K+ D +S GV+L E+L+G+ P
Sbjct: 166 LGKGY--GKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 68/227 (29%), Positives = 103/227 (45%), Gaps = 55/227 (24%)
Query: 377 FSSKRILGEGGFGCVYHGVMDNGTE--VAVKLLTRNNQNGDREF----IAEVEMLSRLHH 430
+ +GEG +G VY + T VA+K + +N F I E+++L +L H
Sbjct: 1 YEKIAQIGEGTYGQVYKA-RNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRH 57
Query: 431 RNLVKLIGICIE-GRTRC-LVYE--------LVHNGSV---ESHLHGVDKNRGPLDWEAR 477
N+V+L I G+ +V+E L+ + V ES +
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCY------------ 105
Query: 478 MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT-EGSQHIS 536
MK L GL YLH + ++HRD K SN+L+ +D K++DFGLAR T S +
Sbjct: 106 MKQLL---EGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159
Query: 537 TRVMGTFGYVAPEYAMTGHLLV-------KSDVYSYGVVLLELLSGR 576
RV+ T Y PE LL+ + D++S G +L EL G+
Sbjct: 160 NRVI-TLWYRPPE------LLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 13/207 (6%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGT--EVAVKLLTRNNQNGDREFIA-EVEMLSRLHHR 431
E F+ +G+G FG VY + D T VA+K++ + E I E++ LS+
Sbjct: 1 ELFTLLECIGKGSFGEVYKAI-DKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
+ K G ++G ++ E GS L G LD I GL YL
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYL 114
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA 551
HE+ IHRD KA+N+LL ++ K++DFG++ + T +T V GT ++APE
Sbjct: 115 HEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVI 170
Query: 552 MTGHLLVKSDVYSYGVVLLELLSGRKP 578
K+D++S G+ +EL G P
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 8e-21
Identities = 64/205 (31%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 381 RILGEGGFGCVYHGVM------DNGTEVAVKLLTRNNQNGDRE-FIAEVEMLSRL-HHRN 432
+ LG G FG V D +VAVK+L + +RE ++E++++S L +H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
+V L+G C G ++ E G + + L K L E + + A+G+A+L
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI---STRVMGTFGYVAPE 549
+ IHRD A NVLL K+ DFGLAR+ S ++ + R+ ++APE
Sbjct: 159 SKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPE 213
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLS 574
+SDV+SYG++L E+ S
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 9e-21
Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 26/205 (12%)
Query: 383 LGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA--EVEMLSRLHHRNLVKLIGI 439
+GEG +G VY G VA+K + ++ A E+++L L+H N++KL+ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 440 CIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRV 499
LV+E + + + L +GLA+ H +
Sbjct: 67 FRHKGDLYLVFEFMD----TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 500 IHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH------ISTRVMGTFGYVAPE--YA 551
+HRD K N+L+ + K++DFGLAR GS + TR Y APE
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTR-----WYRAPELLLG 172
Query: 552 MTGHLLVKSDVYSYGVVLLELLSGR 576
G+ D++S G + ELLS R
Sbjct: 173 DKGY-STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 32/225 (14%)
Query: 375 EKFSSKRILGEGGFGCVYHG------VMDNGTEVAVKLLTRNNQNGD-REFIAEVEMLSR 427
++ + + LGEG FG V + + VAVK+L + D + ++E+EM+
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 428 L-HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLH-----GVDKN-------RGPLDW 474
+ H+N++ L+G+C + +V E +G++ L G + L
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 475 EARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534
+ + A ARG+ +L ++ + IHRD A NVL+ +D K++DFGLAR+ H
Sbjct: 132 KDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI----HH 184
Query: 535 ISTRVMGTFG-----YVAPEYAMTGHLLVKSDVYSYGVVLLELLS 574
I T G ++APE +SDV+S+GV+L E+ +
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 64/205 (31%), Positives = 108/205 (52%), Gaps = 19/205 (9%)
Query: 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGIC 440
+ LG G FG V+ G +N T+VAVK L + + F+ E ++ L H LV+L +
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV-QAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 441 IEGRTRCLVYELVHNGSVESHLHGVDKNRGPL----DWEARMKIALGAARGLAYLHEDSN 496
+ ++ E + GS+ L + + L D+ A++ A G+AY+ +
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI------AEGMAYIERKN- 123
Query: 497 PRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF--GYVAPEYAMTG 554
IHRD +A+NVL+ + K++DFGLAR E +++ + R F + APE G
Sbjct: 124 --YIHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEY-TAREGAKFPIKWTAPEAINFG 179
Query: 555 HLLVKSDVYSYGVVLLELLS-GRKP 578
+KSDV+S+G++L E+++ G+ P
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 381 RILGEGGFGCVYHGV------MDNGTEVAVKLLTRN-NQNGDREFIAEVEMLSRLHHRNL 433
+ LGEG FG V T VAVK+L N + + R+ ++E +L +++H ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHLH----------GVDKNRG----------PLD 473
+KL G C + L+ E GS+ S L G D NR L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 474 WEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533
+ A +RG+ YL E ++HRD A NVL+ + K+SDFGL+R+ E
Sbjct: 126 MGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 534 HIS-TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLV 591
++ ++ ++A E +SDV+S+GV+L E+++ G P P+ NL+
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLL 242
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 375 EKFSSKRILGEGGFGCVYHG-VMDNGTEVAVK--LLTRNNQNGDREFIAEVEMLSRLHHR 431
K+ ++GEG +G V G VA+K + ++++ + + EV++L +L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
N+V L LV+E V + L ++ + G L +A + +AY
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVER----TLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA 551
H +IHRD K N+L+ + K+ DFG AR T + T Y APE
Sbjct: 117 HSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE-- 171
Query: 552 MTGHLLVKS-------DVYSYGVVLLELLSGR 576
LLV DV++ G ++ ELL G
Sbjct: 172 ----LLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 7e-20
Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 32/216 (14%)
Query: 380 KRILGEGGFGCVYHGV-MDNGTEVAVKLLTR---NNQNGDREFIAEVEMLSRLHHRNLVK 435
+ +G G +G V V G +VA+K ++ + + R E+++L L H N++
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHENIIG 63
Query: 436 LIGICIEGRTRC-----LVYELVHNGSVESHLHGVDKNRGPLDWEARMK-IALGAARGLA 489
L+ I +V EL+ E+ LH V K+ PL + ++ RGL
Sbjct: 64 LLDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLT-DDHIQYFLYQILRGLK 117
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYV--- 546
YLH +N VIHRD K SN+L+ + K+ DFGLAR + T YV
Sbjct: 118 YLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDP--DEDEKGFL-T-EYVVTR 170
Query: 547 ---APEYAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
APE ++ K+ D++S G + ELL RKP
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 7e-20
Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 17/214 (7%)
Query: 380 KRILGEGGFGCVYHGVMD----NGTEVAVKLLTRN-NQNGDREFIAEVEMLSRLHHRNLV 434
+ ++G G FG V G + VA+K L + R+F++E ++ + H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
L G+ + R ++ E + NG+++S L D + ++ G A G+ YL E
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEM 125
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIS-TRVMG---TFGYVAPEY 550
+ +HRD A N+L+ + KVSDFGL+R + + + T +G + APE
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 551 AMTGHLLVKSDVYSYGVVLLELLS-GRKPV-DMS 582
SDV+SYG+V+ E++S G +P DMS
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 60/214 (28%), Positives = 107/214 (50%), Gaps = 15/214 (7%)
Query: 378 SSKRILGEGGFGCVYHGVMD----NGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRN 432
+ ++++G G FG V+ G++ VA+K L R +F++E ++ + H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
+++L G+ + + ++ E + NG+++ +L D ++ G A G+ YL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL- 123
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFG--YVAPEY 550
S+ +HRD A N+L+ + KVSDFGL+R + + T G + APE
Sbjct: 124 --SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 551 AMTGHLLVKSDVYSYGVVLLELLS-GRKPV-DMS 582
SDV+S+G+V+ E++S G +P DMS
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 70/226 (30%), Positives = 119/226 (52%), Gaps = 27/226 (11%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHH 430
E E ++ LG G FG V+ + T+VAVK + + + + F+AE ++ L H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQH 60
Query: 431 RNLVKLIGICIEGRTRCLVY---ELVHNGSVESHLHGVDKNRGPL----DWEARMKIALG 483
LVKL + T+ +Y E + GS+ L + ++ PL D+ A++
Sbjct: 61 DKLVKLHAVV----TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI----- 111
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF 543
A G+A++ + + IHRD +A+N+L+ K++DFGLAR E +++ + R F
Sbjct: 112 -AEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTA-REGAKF 165
Query: 544 --GYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPV-DMSQPQ 585
+ APE G +KSDV+S+G++L+E+++ GR P MS P+
Sbjct: 166 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 58/220 (26%), Positives = 104/220 (47%), Gaps = 28/220 (12%)
Query: 380 KRILGEGGFG----CVYHGVM-----------DNGTEVAVKLLTRN-NQNGDREFIAEVE 423
K LGEG FG C G+ VAVK+L + + +F+ E++
Sbjct: 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69
Query: 424 MLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLH--------GVDKNRGPLDWE 475
++SRL + N+++L+G+C+ C++ E + NG + L N +
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 476 ARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH- 534
+ +A+ A G+ YL ++ +HRD N L+ + +T K++DFG++R G +
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186
Query: 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS 574
I R + ++A E + G SDV+++GV L E+ +
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 29/226 (12%)
Query: 375 EKFSSKRILGEGGFG----CVYHGVMDNGTE-------------VAVKLLTRN-NQNGDR 416
++ + K LGEG FG C G+ + VAVK+L + N+N
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 417 EFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHL-------HGVDKNR 469
+F+ E++++SRL N+++L+ +CI C++ E + NG + L +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 470 GPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529
+ + + +A A G+ YL S+ +HRD N L+ ++T K++DFG++R
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 530 EGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS 574
G + I R + +++ E + G SDV+++GV L E+L+
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 382 ILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA-EVEMLSRLHH---RNLVKL 436
++G G +G VY G + G VA+K++ + + D I EV +LS+L N+ K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 437 IGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSN 496
G ++G ++ E GSV + + GP+ + I L Y+H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG- 121
Query: 497 PRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHL 556
VIHRD KA+N+L+ + K+ DFG+A + S ST V GT ++APE G
Sbjct: 122 --VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 557 L-VKSDVYSYGVVLLELLSGRKP 578
K+D++S G+ + E+ +G P
Sbjct: 179 YDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 381 RILGEGGFGCVYHGV-MDNGTEVAVKLLT--RNNQNGDREFIA---EVEMLSRLHHRNLV 434
++LG+G FG VY +D G E+AVK + ++ +E A E+++L L H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+ G + T + E + GSV+ L K G L K G+ YLH +
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR--EATEGSQHISTRVMGTFGYVAPEYAM 552
++HRD K +N+L + K+ DFG ++ + S V GT +++PE +
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE-VI 179
Query: 553 TGHLL-VKSDVYSYGVVLLELLSGRKP 578
+G K+DV+S G ++E+L+ + P
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 68/208 (32%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 383 LGEGGFGCVYHGV--MDNGTE-VAVKLLTRNNQNG--DREFIAEVEMLSRLHHRNLVKLI 437
LG G FG V G+ M + VAVK+L +N + E + E ++ +L + +V++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 438 GICIEGRTRCLVYELVHNGSVESHL----HGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
GIC E + LV EL G + L H +KN L + M G+ YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM--------GMKYLEE 113
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF--GYVAPEYA 551
+ +HRD A NVLL K+SDFGL++ + + G + + APE
Sbjct: 114 TN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170
Query: 552 MTGHLLVKSDVYSYGVVLLELLS-GRKP 578
KSDV+S+GV++ E S G+KP
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 69/212 (32%), Positives = 111/212 (52%), Gaps = 23/212 (10%)
Query: 381 RILGEGGFGCVYHGVMDNGTE-----VAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLV 434
++LG G FG VY G+ E VA+K+L + EF+ E +++ + H +LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGP---LDWEARMKIALGAARGLAYL 491
+L+G+C+ + LV +L+ +G + ++H N G L+W ++ A+G+ YL
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 125
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR--EATEGSQHISTRVMGTFGYVAPE 549
E R++HRD A NVL++ K++DFGLAR E E + M ++A E
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM-PIKWMALE 181
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLS-GRKPVD 580
+SDV+SYGV + EL++ G KP D
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 33/209 (15%)
Query: 383 LGEGGFGCVYH-GVMDNGTEVAVKLLTRNNQNG--DREFIAEVEMLSRLHHRNLVKLIGI 439
+GEG G V+ + G VA+K + G + + E++ L H +VKL+ +
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 440 CIEGRTRCLVYELVHNGSVESHLHGVDKN-RGPL-DWEAR--MKIALGAARGLAYLHEDS 495
G LV E + S L V ++ PL + + + M++ L +G+AY+H +
Sbjct: 68 FPHGSGFVLVMEYM-----PSDLSEVLRDEERPLPEAQVKSYMRMLL---KGVAYMHAN- 118
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAR-EATEGSQHISTRVMGTFGYVAPEYAMTG 554
++HRD K +N+L+ D K++DFGLAR + E + S +V T Y APE
Sbjct: 119 --GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPE----- 170
Query: 555 HLLVKS-------DVYSYGVVLLELLSGR 576
LL + D+++ G + ELL+G
Sbjct: 171 -LLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 381 RILGEGGFGCVYHGVMD--NGTEVAVKLLT--RNNQNGD----REFIAEVEMLSRLHHRN 432
+ LG G F Y D GT +AVK +T RN + E+ +++RL+H +
Sbjct: 6 QQLGTGAFSSCY-QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
+++++G E L E + GSV L G + RGL+YLH
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLH 120
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTP---KVSDFGLAREATE---GSQHISTRVMGTFGYV 546
E+ ++IHRD K +N+L+ D T +++DFG A G+ +++GT ++
Sbjct: 121 EN---QIIHRDVKGANLLI--DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 547 APEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
APE DV+S G V++E+ + + P
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 380 KRILGEGGFGCVYHGVMD----NGTEVAVKLLTRN-NQNGDREFIAEVEMLSRLHHRNLV 434
++++G G FG V G + VA+K L + R+F++E ++ + H N++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
L G+ + + +V E + NGS+++ L K+ G + + G A G+ YL
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLR---KHDGQFTVIQLVGMLRGIASGMKYL--- 122
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFG--YVAPEYAM 552
S+ +HRD A N+L+ + KVSDFGL+R + + T G + APE
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 553 TGHLLVKSDVYSYGVVLLELLS-GRKPV-DMS 582
SDV+SYG+V+ E++S G +P +MS
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 36/213 (16%)
Query: 383 LGEGGFGCVYHGV-MDNGTEVAVK---LLTR-NNQNG-DREFIAEVEMLSRLHHRNLVKL 436
LGEG + VY + G VA+K L R ++G + + E+++L L H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 437 IGICIEGRTRCLVYELVHNGSVESHLHGVDKNR----GPLDWEARMKIALGAARGLAYLH 492
+ + LV+E + E+ L V K++ P D ++ M + L RGL YLH
Sbjct: 68 LDVFGHKSNINLVFEFM-----ETDLEKVIKDKSIVLTPADIKSYMLMTL---RGLEYLH 119
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM 552
+ ++HRD K +N+L+ D K++DFGLAR ++ ++ +V+ T Y APE
Sbjct: 120 SNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPE--- 172
Query: 553 TGHLLVKS-------DVYSYGVVLLELLSGRKP 578
LL + D++S G + ELL R P
Sbjct: 173 ---LLFGARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 74/222 (33%), Positives = 109/222 (49%), Gaps = 25/222 (11%)
Query: 365 FALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTE--VAVKLLTRNNQNGD---REFI 419
F+ D EK F+ R +G G FG VY D T VA+K ++ + + + ++ I
Sbjct: 8 FSKDDPEK---LFTDLREIGHGSFGAVYFA-RDVRTNEVVAIKKMSYSGKQSNEKWQDII 63
Query: 420 AEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMK 479
EV L +L H N ++ G + T LV E + S ++ ++ PL
Sbjct: 64 KEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC----LGSASDILEVHKKPLQEVEIAA 119
Query: 480 IALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRV 539
I GA +GLAYLH + IHRD KA N+LL + T K++DFG A + + +
Sbjct: 120 ICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV---- 172
Query: 540 MGTFGYVAPE--YAM-TGHLLVKSDVYSYGVVLLELLSGRKP 578
GT ++APE AM G K DV+S G+ +E L+ RKP
Sbjct: 173 -GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 67/217 (30%), Positives = 109/217 (50%), Gaps = 24/217 (11%)
Query: 383 LGEGGFGCVYHGV-----MDNGTEVAVKLLTR-NNQNGDREFIAEVEMLSRLHHRNLVKL 436
LGE FG +Y G MD+ VA+K L NN EF E +++ LHH N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 437 IGICIEGRTRCLVYELVHNGSVESHL-----H-----GVDKN---RGPLDWEARMKIALG 483
+G+ + + C+++E ++ G + L H D++ + LD + IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH-ISTRVMGT 542
A G+ YL S+ +H+D A N+L+ + K+SD GL+RE + + + +
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 543 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
++ PE M G SD++S+GVVL E+ S G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 10/201 (4%)
Query: 383 LGEGGFGCVYHGVMD-NGTEVAVKLLTRN---NQNGDREFIAEVEMLSRLHHRNLVKLIG 438
LG+GGFG V M G A K L + + G + E +L+++H R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 439 ICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNP 497
+ +T CLV +++ G + H++ VD+ GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 498 RVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLL 557
R+I+RD K NVLL++D ++SD GLA E +G Q + GT G++APE
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG-QSKTKGYAGTPGFMAPELLQGEEYD 175
Query: 558 VKSDVYSYGVVLLELLSGRKP 578
D ++ GV L E+++ R P
Sbjct: 176 FSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 76/283 (26%), Positives = 118/283 (41%), Gaps = 44/283 (15%)
Query: 368 SDLEKATEKFSSKRILGEGGFGCVY---HGVMDNGTEVAVKLLTRNNQNGDREFIA-EVE 423
DLE E LG G G V H G +AVK + ++ I E++
Sbjct: 1 DDLEYLGE-------LGAGNSGVVSKVLH--RPTGKIMAVKTIRLEINEAIQKQILRELD 51
Query: 424 MLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALG 483
+L + + +V G + E + GS++ L + +G + KIA+
Sbjct: 52 ILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVA 108
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF 543
+GL YLHE +IHRD K SN+L+ K+ DFG++ + ++ +GT
Sbjct: 109 VLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFVGTS 163
Query: 544 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREG 603
Y+APE VKSD++S G+ L+EL +GR P P E
Sbjct: 164 SYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP-----------PENDPPDGIFEL 212
Query: 604 LEQLVD---PSLAG---SYDFDDMAKVAAIASMCVHPEVTHRP 640
L+ +V+ P L S DF D ++C+ + RP
Sbjct: 213 LQYIVNEPPPRLPSGKFSPDFQDF------VNLCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 382 ILGEGGFGCVYHGVMD--NGTEVAVKLLT-RNNQNGDRE-FIAEVEMLSRLHHRNLVKLI 437
+G+G FG V V +G + K + N +++ ++EV +L L H N+V+
Sbjct: 7 TIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 438 GICI--EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH--E 493
I +T +V E G + + K R ++ E +I L H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT 553
D V+HRD K +N+ L+ + K+ DFGLA+ S T V GT Y++PE
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNH 184
Query: 554 GHLLVKSDVYSYGVVLLELLSGRKP 578
KSD++S G ++ EL + P
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 16/214 (7%)
Query: 380 KRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIG 438
+ +LG+G +G VY + +A+K + + + E+ + S L HRN+V+ +G
Sbjct: 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 439 ICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPL-DWEARMKI-ALGAARGLAYLHEDSN 496
E + E V GS+ + L GPL D E + GL YLH++
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLR---SKWGPLKDNEQTIIFYTKQILEGLKYLHDN-- 127
Query: 497 PRVIHRDFKASNVLLED-DFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE---YAM 552
+++HRD K NVL+ K+SDFG ++ G + GT Y+APE
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFTGTLQYMAPEVIDKGP 185
Query: 553 TGHLLVKSDVYSYGVVLLELLSGRKP-VDMSQPQ 585
G+ +D++S G ++E+ +G+ P +++ +PQ
Sbjct: 186 RGY-GAPADIWSLGCTIVEMATGKPPFIELGEPQ 218
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 82/293 (27%), Positives = 134/293 (45%), Gaps = 35/293 (11%)
Query: 372 KATEKFSSKRILGEGGFGCVYHGVMDNGTE-----VAVKLLTRNNQ-NGDREFIAEVEML 425
K TE ++LG G FG VY G+ E VA+K+L N ++E + E ++
Sbjct: 5 KETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVM 63
Query: 426 SRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAA 485
+ + + +L+GIC+ + LV +L+ G + + V +N+ + + + + A
Sbjct: 64 AGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDY---VRENKDRIGSQDLLNWCVQIA 119
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR--EATEGSQHISTRVMGTF 543
+G++YL E R++HRD A NVL++ K++DFGLAR + E H +
Sbjct: 120 KGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV-PI 175
Query: 544 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTRE 602
++A E + +SDV+SYGV + EL++ G KP D AR + E
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP----------AREIPDLLE 225
Query: 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655
E+L P + + M K I S C RP E+V + D
Sbjct: 226 KGERLPQPPICTIDVYMIMVKCWMIDSEC-------RPRFRELVDEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 62/213 (29%), Positives = 113/213 (53%), Gaps = 15/213 (7%)
Query: 381 RILGEGGFGCVYHGVM---DNGTEVAVKLLTRNNQNGDREFIAEVE-MLS--RLHHRNLV 434
++LG G FG V+ G+ + ++ V + T +++G + F + ML+ L H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+L+GIC G + LV +L GS+ H+ ++R LD + + + A+G+ YL E
Sbjct: 73 RLLGIC-PGASLQLVTQLSPLGSLLDHVR---QHRDSLDPQRLLNWCVQIAKGMYYLEEH 128
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA-TEGSQHISTRVMGTFGYVAPEYAMT 553
R++HR+ A N+LL+ D +++DFG+A + ++ + ++A E +
Sbjct: 129 ---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185
Query: 554 GHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQ 585
G +SDV+SYGV + E++S G +P +P
Sbjct: 186 GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 80/288 (27%), Positives = 129/288 (44%), Gaps = 31/288 (10%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTE--VAVKLLTRNNQNGDREFIA-EVEMLSRLHHR 431
E F+ +G+G FG V+ G+ DN T+ VA+K++ + E I E+ +LS+
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGI-DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
+ K G ++ ++ E + GS L GPLD I +GL YL
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYL 117
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA 551
H + + IHRD KA+NVLL + K++DFG+A + T+ +Q +GT ++APE
Sbjct: 118 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD-TQIKRNTFVGTPFWMAPEVI 173
Query: 552 MTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611
K+D++S G+ +EL G P P L+ P P+
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PT 220
Query: 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDET 659
L G+Y + C++ E + RP E+++ K I +T
Sbjct: 221 LEGNYS----KPLKEFVEACLNKEPSFRPTAKELLKH-KFIVRFAKKT 263
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-18
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 377 FSSKRILGEGGFG--CVYHGVMDNGTEVAVKLLTRN---NQNGDREFIAEVEMLSRLHHR 431
F R+LG+GGFG C V G A K L + + G+ + E ++L +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQ-VRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGA--ARGLA 489
+V L CLV L++ G ++ H++ + G +E + A GL
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIY----HMGEAGFEEGRAVFYAAEICCGLE 116
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549
LH++ R+++RD K N+LL+D ++SD GLA EG Q I RV GT GY+APE
Sbjct: 117 DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRV-GTVGYMAPE 171
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
D ++ G +L E+++G+ P
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 4e-18
Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMD---NGTEVAVKLLTR-NNQNGDREFIAEVEMLSRL-H 429
E + ++GEG FG V ++ A+K+L ++N R+F E+E+L +L H
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNR---------------GPLDW 474
H N++ L+G C R +Y + + L + K+R L
Sbjct: 62 HPNIINLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118
Query: 475 EARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534
+ ++ A A G+ YL S + IHRD A NVL+ ++ K++DFGL+R G +
Sbjct: 119 QQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEV 171
Query: 535 ISTRVMGTFG--YVAPEYAMTGHLLVKSDVYSYGVVLLELLS 574
+ MG ++A E KSDV+S+GV+L E++S
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 4e-18
Identities = 64/234 (27%), Positives = 107/234 (45%), Gaps = 34/234 (14%)
Query: 368 SDLEKATEKFSSKRILGEGGFGCVY----HGV----MDNGTEVAVKLLTRNNQNGD-REF 418
E ++ + LGEG FG V +G+ D VAVK+L N + D +
Sbjct: 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADL 64
Query: 419 IAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLH------------GV 465
I+E+E++ + H+N++ L+G+C + ++ E G++ L
Sbjct: 65 ISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDIT 124
Query: 466 DKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525
L ++ + A ARG+ YL + R IHRD A NVL+ +D K++DFGLA
Sbjct: 125 KVPEEQLSFKDLVSCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 526 REATEGSQHISTRVMGTFG-----YVAPEYAMTGHLLVKSDVYSYGVVLLELLS 574
R G I + G ++APE +SDV+S+G+++ E+ +
Sbjct: 182 R----GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 375 EKFSSKRILGEGGFGCVY---HGVMDNGTEVAVKLLTRNNQNGDREFIA--EVEMLSRLH 429
EK+ + ++GEG +G V H + G VA+K + + + IA E+ ML +L
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKH--KETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLA 489
H NLV LI + + LV+E V + + L ++K LD K RG+
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIE 114
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549
+ H + +IHRD K N+L+ K+ DFG AR + T + T Y APE
Sbjct: 115 FCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPE 170
Query: 550 YAMTGHLLVKS-------DVYSYGVVLLELLSG 575
LLV D+++ G ++ E+L+G
Sbjct: 171 ------LLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 43/232 (18%)
Query: 377 FSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTR---NNQNGDREFIAEVEMLSRL-HHR 431
F +I+GEG F V + E A+K+L + + + E E+L+RL H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 432 NLVKLIGICIEGRT----RCL--VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAA 485
++KL T L V E NG + ++ + G LD + A
Sbjct: 63 GIIKLYY------TFQDEENLYFVLEYAPNGELLQYI----RKYGSLDEKCTRFYAAEIL 112
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM----- 540
L YLH + +IHRD K N+LL+ D K++DFG A+ S S +
Sbjct: 113 LALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 541 --------------GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
GT YV+PE SD+++ G ++ ++L+G+ P
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 74/295 (25%), Positives = 133/295 (45%), Gaps = 40/295 (13%)
Query: 377 FSSKRILGEGGFGCVYHGV--MDNGT--EVAVKLLTRN-NQNGD-REFIAEVEMLSRLHH 430
F+ R+LG+G FG V ++G+ +VAVK+L + + D EF+ E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 431 RNLVKLIGICIEGRTR------CLVYELVHNGSVESHL--HGVDKNRGPLDWEARMKIAL 482
N++KLIG+ + R + ++ + +G + + L + + L + ++ +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 483 GAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS---QHISTRV 539
A G+ YL S+ IHRD A N +L ++ T V+DFGL+++ G Q ++++
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 540 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLL 598
++A E SDV+++GV + E+++ G+ P G EN + L
Sbjct: 178 --PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY-----AGVENSEIYN--YL 228
Query: 599 TTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIY 653
L+Q D + V + C PE RP + L+LI+
Sbjct: 229 IKGNRLKQPPDC----------LEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 15/210 (7%)
Query: 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL 433
E + + +G G +G VY G VA+K++ + E+ ML H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
V G + +V E GS++ RGPL + +GLAYLHE
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQ---VTRGPLSELQIAYVCRETLKGLAYLHE 119
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR--VMGTFGYVAPEYA 551
IHRD K +N+LL +D K++DFG++ + T I+ R +GT ++APE A
Sbjct: 120 T---GKIHRDIKGANILLTEDGDVKLADFGVSAQLT---ATIAKRKSFIGTPYWMAPEVA 173
Query: 552 ---MTGHLLVKSDVYSYGVVLLELLSGRKP 578
G K D+++ G+ +EL + P
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 76/277 (27%), Positives = 124/277 (44%), Gaps = 32/277 (11%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEV-AVKLLTRNNQNGDREFIA-EVEMLSRLHHRN 432
E F+ +G+G FG VY G+ + EV A+K++ + E I E+ +LS+
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
+ + G ++G ++ E + GS L GPL+ I +GL YLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLH 118
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM 552
+ R IHRD KA+NVLL + K++DFG+A + T+ +Q +GT ++APE
Sbjct: 119 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD-TQIKRNTFVGTPFWMAPEVIK 174
Query: 553 TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612
K+D++S G+ +EL G P P L+ P P+L
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTL 221
Query: 613 AGSYD--FDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647
G Y F + + C++ + RP E+++
Sbjct: 222 EGQYSKPFKEFVEA------CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 383 LGEGGFGCVYHGVMDN-GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICI 441
LG+G FG VY G A K++ ++ +F+ E+++LS H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 442 EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIH 501
++ E G+++S + +++ L + L +LH +VIH
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 502 RDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLL---- 557
RD KA N+LL D K++DFG++ + Q T + GT ++APE
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPY 185
Query: 558 -VKSDVYSYGVVLLELLSGRKP 578
K+D++S G+ L+EL P
Sbjct: 186 DYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 13/210 (6%)
Query: 380 KRILGEGGFGCVYHGVMDNGTE----VAVKLLTRNNQNGDRE-FIAEVEMLSRLHHRNLV 434
+RILG G FG + G + ++ VA+ L + R F+AE L + H N+V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+L G+ G T +V E + NG+++S L K+ G L M + G A G+ YL E
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLASGMKYLSEM 126
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG 554
+H+ A VL+ D K+S F +E + + + + APE
Sbjct: 127 G---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 555 HLLVKSDVYSYGVVLLELLS-GRKPV-DMS 582
H SDV+S+G+V+ E++S G +P DMS
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERPYWDMS 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 19/209 (9%)
Query: 377 FSSKRILGEGGFGCVY---HGVMDNGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHH 430
F R++G+G FG V D A+K + + + R + E +L L+H
Sbjct: 2 FELLRVIGKGAFGKVCIVQK--RDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH 59
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGA-ARGLA 489
LV L + LV +L+ G + HL + E ++K + L
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL----SQKVKFS-EEQVKFWICEIVLALE 114
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549
YLH +IHRD K N+LL++ ++DF +A + T + +T GT GY+APE
Sbjct: 115 YLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPE 169
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
V D +S GV E L G++P
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 382 ILGEGGFGCVYHG-VMDNG--TEVAVKLLTR-NNQNGDREFIAEVEMLSRL-HHRNLVKL 436
++GEG FG V + +G + A+K + +++ R+F E+E+L +L HH N++ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 437 IGICIEGRTRCLVYELVHNGSVESHLHG------------VDKNRGPLDWEARMKIALGA 484
+G C L E +G++ L + L + + A
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 485 ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFG 544
ARG+ YL S + IHRD A N+L+ +++ K++DFGL+R G + + MG
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRLP 186
Query: 545 --YVAPEYAMTGHLLVKSDVYSYGVVLLELLS 574
++A E SDV+SYGV+L E++S
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 68/276 (24%), Positives = 125/276 (45%), Gaps = 33/276 (11%)
Query: 383 LGEGGFGCVYHGVMDNGTE--VAVKLLTRNNQN---GDRE-------FIAEVEML-SRLH 429
LG G FGCVY N + +A+K + +N RE ++EV ++ +L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLA 489
H N+V+ +E +V +L+ + H + + + + E I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549
YLH++ R++HRD +N++L +D ++DFGLA++ S+ T V+GT Y PE
Sbjct: 128 YLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGTILYSCPE 183
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609
K+DV+++G +L ++ + P N+++ A + +E + +
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQM------CTLQPPFYSTNMLSLATKI------VEAVYE 231
Query: 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEV 645
P G Y V + + C+ P+ RP + +V
Sbjct: 232 PLPEGMYS----EDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 54/208 (25%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 377 FSSKRILGEGGFGCVY--HGVMDNGT----EVAVKLLTRNNQNGDREFIAEVEMLSRLHH 430
F + LG+G +G VY + DN EV + + +Q + + E+ +L+ ++H
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM---SQKEREDAVNEIRILASVNH 58
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY 490
N++ ++G C+V E G + + K R + + +I + RGL
Sbjct: 59 PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
LHE +++HRD K++N+LL + K+ D G+++ ++++ +GT Y+APE
Sbjct: 119 LHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQIGTPHYMAPEV 172
Query: 551 AMTGHLLVKSDVYSYGVVLLELLSGRKP 578
KSD++S G +L E+ + P
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 51/168 (30%), Positives = 82/168 (48%), Gaps = 9/168 (5%)
Query: 416 REFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWE 475
++ + E++++ +V G + C+ E + GS L + K GP+ E
Sbjct: 48 KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGS----LDRIYKKGGPIPVE 103
Query: 476 ARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535
KIA+ GL YL+ R++HRD K SN+L+ K+ DFG++ E I
Sbjct: 104 ILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---I 158
Query: 536 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQ 583
+ +GT Y++PE G VKSDV+S G+ ++EL G+ P S
Sbjct: 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 6e-17
Identities = 67/220 (30%), Positives = 103/220 (46%), Gaps = 34/220 (15%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLT---RNNQNGDREFIAEVEMLSRL-H 429
K+ + LG+G +G V+ + VA+K + RN + R F E+ L L
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGD 65
Query: 430 HRNLVKLIGI--CIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARG 487
H N+VKL+ + + LV+E + E+ LH V + L+ + I +
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIR-ANILEDVHKRYIMYQLLKA 119
Query: 488 LAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM----GTF 543
L Y+H + VIHRD K SN+LL D K++DFGLAR +E ++ V+ T
Sbjct: 120 LKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 544 GYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLSGR 576
Y APE +L+ S Y+ GV +L E+L G+
Sbjct: 177 WYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 67/232 (28%), Positives = 114/232 (49%), Gaps = 25/232 (10%)
Query: 382 ILGEGGFGCVYHGVMD--NGTEVAVK---LLTRNNQNGDRE------FIAEVEMLSRLHH 430
++G G FG VY G M+ +G +AVK L + + + DR+ E+ +L L H
Sbjct: 7 LIGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY 490
N+V+ +G ++ + E V GSV + L+ N G + +GL Y
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNY 121
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR-----VMGTFGY 545
LH N +IHRD K +N+L+++ K+SDFG++++ S T + G+ +
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 546 VAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPV-DMSQPQGQENLVTWARP 596
+APE K+D++S G +++E+L+G+ P D +Q Q + A P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP 230
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 15/208 (7%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTE--VAVKLLTRNNQNGDREFIA-EVEMLSRLHHR 431
E F+ +G+G FG V+ G+ DN T+ VA+K++ + E I E+ +LS+
Sbjct: 4 ELFTKLERIGKGSFGEVFKGI-DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAA-RGLAY 490
+ K G ++G ++ E + GS L GP D E ++ L +GL Y
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-----GPFD-EFQIATMLKEILKGLDY 116
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
LH + + IHRD KA+NVLL + K++DFG+A + T+ +Q +GT ++APE
Sbjct: 117 LHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD-TQIKRNTFVGTPFWMAPEV 172
Query: 551 AMTGHLLVKSDVYSYGVVLLELLSGRKP 578
K+D++S G+ +EL G P
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 8e-17
Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 375 EKFSSKRILGEGGFGCV---YHGVMDNGTEVAVKLLTR-NNQNGDREFIAEVEMLSRLHH 430
++ + +GEG +G V H G +VA+K ++ +Q + + E+++L R H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKP--TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKH 62
Query: 431 RNLVKLIGICIEGRTRC------LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGA 484
N++ ++ I I + +V EL+ E+ L+ + K + L +
Sbjct: 63 ENIIGILDI-IRPPSFESFNDVYIVQELM-----ETDLYKLIKTQ-HLSNDHIQYFLYQI 115
Query: 485 ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIS--TRVMGT 542
RGL Y+H +N V+HRD K SN+LL + K+ DFGLAR A H T + T
Sbjct: 116 LRGLKYIHS-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172
Query: 543 FGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLSGR 576
Y APE + K+ D++S G +L E+LS R
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 66/286 (23%), Positives = 125/286 (43%), Gaps = 24/286 (8%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVA---VKLLTRNNQNGDREFIAEVEMLSRLH 429
F ++ +G+G F VY + + +G VA V++ + ++ + E+++L +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLA 489
H N++K + IE +V EL G + + K + + K + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549
++H R++HRD K +NV + K+ D GL R + + + V GT Y++PE
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609
KSD++S G +L E+ + + P + L + + +E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----------LYSLCKKIEKCDY 225
Query: 610 PSL-AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654
P L A Y ++ + S C++P+ RP + V+Q K ++
Sbjct: 226 PPLPADHYS----EELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 375 EKFSSKRILGEGGFGCVY---HGVMDNGTEVAVKLLTRNNQNGDREFIA--EVEMLSRLH 429
EK+ +GEG +G V+ + + G VA+K + + + IA E+ ML +L
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRN--RETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK 58
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLA 489
H NLV LI + R LV+E + + L+ ++KN + KI + +
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYCDH----TVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549
+ H+ + IHRD K N+L+ K+ DFG AR T + V T Y APE
Sbjct: 115 FCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPE 170
Query: 550 YAMTGHLLVKS-------DVYSYGVVLLELLSG 575
LLV DV++ G V ELL+G
Sbjct: 171 ------LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 34/231 (14%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGV---MDNG-----TEVAVKLLTRNNQNGD-REFIAE 421
E ++ + LGEG FG V +D T+VAVK+L + D + I+E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 422 VEMLSRL-HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLH-----GVDKNRGP---- 471
+EM+ + H+N++ L+G C + ++ E G++ +L G++ P
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 472 ---LDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528
L ++ + A ARG+ YL ++ + IHRD A NVL+ +D K++DFGLAR+
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 529 TEGSQHISTRVMGTFG-----YVAPEYAMTGHLLVKSDVYSYGVVLLELLS 574
HI T G ++APE +SDV+S+GV+L E+ +
Sbjct: 191 ----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 32/215 (14%)
Query: 382 ILGEGGFGCVYHGVMDNG---TEVAVKLLTR-NNQNGDREFIAEVEMLSRL-HHRNLVKL 436
++GEG FG V + + A+K + +++ R+F E+E+L +L HH N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 437 IGICIEGRTRCLVYELVHNGSVESHLHGVDKNR---------------GPLDWEARMKIA 481
+G C R +Y + + L + K+R L + + A
Sbjct: 62 LGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 482 LGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMG 541
ARG+ YL + + IHRD A N+L+ +++ K++DFGL+R G + + MG
Sbjct: 119 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMG 171
Query: 542 TFG--YVAPEYAMTGHLLVKSDVYSYGVVLLELLS 574
++A E SDV+SYGV+L E++S
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 72/271 (26%), Positives = 126/271 (46%), Gaps = 28/271 (10%)
Query: 383 LGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICI 441
LG+G FG VY + G A K++ ++ +++ E+E+L+ +H +VKL+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 442 EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIH 501
++ E G+V++ + +D RG + + ++ I L YLH + ++IH
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQV-ICRQMLEALQYLH---SMKIIH 133
Query: 502 RDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLL---- 557
RD KA NVLL D K++DFG++ + + Q + +GT ++APE M +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS-FIGTPYWMAPEVVMCETMKDTPY 192
Query: 558 -VKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSY 616
K+D++S G+ L+E+ P P R LL + + S
Sbjct: 193 DYKADIWSLGITLIEMAQIEPPHHELNPM---------RVLLKIAKSEPPTLSQPSKWSM 243
Query: 617 DFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647
+F D K A + HPE RP ++++
Sbjct: 244 EFRDFLKTA----LDKHPET--RPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 22/210 (10%)
Query: 377 FSSKRILGEGGFGCVY--HGVMDNGTEVAVKLLTRNNQNGD---REFIAEVEMLSRLHHR 431
F+ R +G G FG VY V N VA+K ++ + + + ++ I EV+ L R+ H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHP 85
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
N ++ G + T LV E GS L + ++ PL I GA +GLAYL
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCL-GSASDLL---EVHKKPLQEVEIAAITHGALQGLAYL 141
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA 551
H + +IHRD KA N+LL + K++DFG A A+ + + GT ++APE
Sbjct: 142 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVI 193
Query: 552 MT---GHLLVKSDVYSYGVVLLELLSGRKP 578
+ G K DV+S G+ +E L+ RKP
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIE-LAERKP 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 77/259 (29%), Positives = 116/259 (44%), Gaps = 26/259 (10%)
Query: 365 FALSDLEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGD---REFIA 420
F D EK FS R +G G FG VY + N VA+K ++ + + + ++ I
Sbjct: 8 FFKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 421 EVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKI 480
EV L +L H N ++ G + T LV E GS L + ++ PL +
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLL---EVHKKPLQEVEIAAV 120
Query: 481 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM 540
GA +GLAYLH + +IHRD KA N+LL + K+ DFG A + +
Sbjct: 121 THGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV----- 172
Query: 541 GTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLSGRKPV-DMSQPQGQENLVTWARP 596
GT ++APE + G K DV+S G+ +EL + P+ +M+ ++ P
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232
Query: 597 LLTTR---EGLEQLVDPSL 612
L + E VD L
Sbjct: 233 ALQSGHWSEYFRNFVDSCL 251
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 19/210 (9%)
Query: 377 FSSKRILGEGGFG--CVYHGVMDNGTEVAVKLLTRN---NQNGDREFIAEVEMLSRLHHR 431
F R+LG+GGFG C V G A K L + + G+ + E ++L +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQ-VRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAAR---GL 488
+V L CLV +++ G ++ H++ N G +E + AA GL
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIY----NMGNPGFEEE-RALFYAAEILCGL 115
Query: 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAP 548
LH ++ ++RD K N+LL+D ++SD GLA + EG + I RV GT GY+AP
Sbjct: 116 EDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRGRV-GTVGYMAP 170
Query: 549 EYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
E + D + G ++ E++ G+ P
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 66/220 (30%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 383 LGEGGFGCVYHGVM------DNGTEVAVKLLTRNNQNGDRE-FIAEVEMLSRLHHRNLVK 435
LGE FG VY G + + VA+K L + RE F E M SRL H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 436 LIGICIEGRTRCLVYELVHNGSVESHL--HGVDKNRGPLDWEARMKIALGA--------- 484
L+G+ + + +++ + + L + G D + +K L
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 485 -ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGT- 542
A G+ +L S+ V+H+D NVL+ D K+SD GL RE + ++MG
Sbjct: 133 IAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY---KLMGNS 186
Query: 543 ---FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
+++PE M G + SD++SYGVVL E+ S G +P
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 381 RILGEGGFGCVYHGVM---DNGTEVAVKLL-----TRNNQNGDREFIAEVEMLSRLHHRN 432
+ LGEG FG V G + D+ +VAVK + TR+ +F++E + H N
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEM---EDFLSEAVCMKEFDHPN 61
Query: 433 LVKLIGICIEGRTR------CLVYELVHNGSVESHLHGVDKNRGPLDWEARM--KIALGA 484
+++LIG+C++ ++ + +G + S L P +M K
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 485 ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGT-F 543
A G+ YL S+ IHRD A N +L ++ V+DFGL+++ G + R+
Sbjct: 122 ASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 544 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
++A E KSDV+S+GV + E+ + G+ P
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 383 LGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA-EVEMLSRLHHRNLVKLIGIC 440
+G G VY + + N +VA+K + + + EV+ +S+ +H N+VK
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 441 IEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIAL---GAARGLAYLHEDSNP 497
+ G LV + GS L + K+ P IA +GL YLH SN
Sbjct: 69 VVGDELWLVMPYLSGGS----LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--SNG 122
Query: 498 RVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR---VMGTFGYVAPEYAMTG 554
+ IHRD KA N+LL +D + K++DFG++ +G +GT ++APE
Sbjct: 123 Q-IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 555 H-LLVKSDVYSYGVVLLELLSGRKP 578
H K+D++S+G+ +EL +G P
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 31/216 (14%)
Query: 377 FSSKRILGEGGFG--CVYHGVMDNGTEVAVKLLTRN---NQNGDREFIAEVEMLSRLHHR 431
F R+LG+GGFG C V G A K L + + G+ + E ++L +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQ-VRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGA--ARGLA 489
+V L CLV L++ G ++ H++ N G ++ + A GL
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIY----NMGNPGFDEERAVFYAAEITCGLE 116
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549
LH + R+++RD K N+LL+D ++SD GLA E EG + I RV GT GY+APE
Sbjct: 117 DLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIRGRV-GTVGYMAPE 171
Query: 550 YAMTGHLLVKSDVYSY-------GVVLLELLSGRKP 578
+VK++ Y++ G ++ E++ G+ P
Sbjct: 172 -------VVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 4e-16
Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 44/214 (20%)
Query: 383 LGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA--EVEMLSRL-HHRNLVKLIG 438
LG+G FG VY + G VA+K + + + + E + EV+ L +L H N+VKL
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 439 ICIEGRTRCLVYELVHNGSVESHLHGVDKNR--GPLDWEARMK-IALGAARGLAYLHEDS 495
+ E V+E + E +L+ + K+R P E+ ++ I +GLA++H+
Sbjct: 66 VFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFS-ESVIRSIIYQILQGLAHIHKHG 119
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA------TEGSQHISTRVMGTFGYVAPE 549
HRD K N+L+ K++DFGLARE T+ ++STR Y APE
Sbjct: 120 ---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD---YVSTR-----WYRAPE 168
Query: 550 YAMTGHLLVKSDVYS-------YGVVLLELLSGR 576
+L++S YS G ++ EL + R
Sbjct: 169 ------ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 67/203 (33%), Positives = 104/203 (51%), Gaps = 20/203 (9%)
Query: 383 LGEGGFGCVYHGVMDNGTE-VAVKLLTRNNQNGD---REFIAEVEMLSRLHHRNLVKLIG 438
+G G FG VY + E VAVK ++ + + + ++ I EV+ L +L H N ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 439 ICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPR 498
++ T LV E GS L + ++ PL I GA +GLAYLH +
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 499 VIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT---GH 555
+IHRD KA N+LL + K++DFG A +++ + + GT ++APE + G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQ 196
Query: 556 LLVKSDVYSYGVVLLELLSGRKP 578
K DV+S G+ +E L+ RKP
Sbjct: 197 YDGKVDVWSLGITCIE-LAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 64/234 (27%), Positives = 111/234 (47%), Gaps = 40/234 (17%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGVM-----------DNGTEVAVKLLTRNNQNGD-REF 418
E + +K + + LGEG FG V VM VAVK+L + D +
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQV---VMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 67
Query: 419 IAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHL---------HGVDKN 468
++E+EM+ + H+N++ L+G C + ++ E G++ +L + D
Sbjct: 68 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIA 127
Query: 469 RGP---LDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525
R P + ++ + ARG+ YL ++ + IHRD A NVL+ ++ K++DFGLA
Sbjct: 128 RVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA 184
Query: 526 REATEGSQHISTRVMGTFG-----YVAPEYAMTGHLLVKSDVYSYGVVLLELLS 574
R+ + T T G ++APE +SDV+S+GV++ E+ +
Sbjct: 185 RDVNNIDYYKKT----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-16
Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 12/215 (5%)
Query: 381 RILGEGGFG--CVYHGVMDNGTEVAVKL-LTRNNQNGDREFIAEVEMLSRLHHRNLVKLI 437
R+LG+G FG +Y D+ V ++ LTR ++ R+ + E+ +LS L H N++
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 438 GICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNP 497
++ T + E + G++ + + + +A ++Y+H+
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA--VSYIHKAG-- 121
Query: 498 RVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLL 557
++HRD K N+ L K+ DFG+++ T V+GT Y++PE
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYN 179
Query: 558 VKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVT 592
KSD+++ G VL ELL+ ++ D + P NLV
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPL---NLVV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 66/234 (28%), Positives = 113/234 (48%), Gaps = 40/234 (17%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGVM-----------DNGTEVAVKLLTRNNQNGD-REF 418
E + + + + LGEG FG V VM + VAVK+L + + D +
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL 64
Query: 419 IAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHL---------HGVDKN 468
++E+EM+ + H+N++ L+G C + ++ E G++ +L + D
Sbjct: 65 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124
Query: 469 RGP---LDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525
+ P L ++ + A ARG+ YL ++ + IHRD A NVL+ +D K++DFGLA
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 526 REATEGSQHISTRVMGTFG-----YVAPEYAMTGHLLVKSDVYSYGVVLLELLS 574
R+ + T T G ++APE +SDV+S+GV+L E+ +
Sbjct: 182 RDVHNIDYYKKT----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 383 LGEGGFG--CVYHGVMDNGTEVAVKLLTRN---NQNGDREFIAEVEMLSRLHHRNLVKLI 437
LG+GGFG C V + G A K L + ++G++ + E E+L +++ +V L
Sbjct: 1 LGKGGFGEVCAVQ-VKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL- 58
Query: 438 GICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSN 496
E +T CLV L++ G ++ H++ V + RG L+ E + + G+ +LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGE-RG-LEMERVIHYSAQITCGILHLHS--- 113
Query: 497 PRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHL 556
+++RD K NVLL+D ++SD GLA E +G T+ GT GY+APE
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPY 171
Query: 557 LVKSDVYSYGVVLLELLSGRKP 578
D ++ G + E+++GR P
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 67/221 (30%), Positives = 113/221 (51%), Gaps = 24/221 (10%)
Query: 372 KATEKFSSKRILGEGGFGCVYHGVMDNGTE-----VAVKLLTR-NNQNGDREFIAEVEML 425
K TE F ++LG G FG VY G+ E VA+K L + ++E + E ++
Sbjct: 5 KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63
Query: 426 SRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGP---LDWEARMKIAL 482
+ + + ++ +L+GIC+ + L+ +L+ G + ++ N G L+W ++
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 118
Query: 483 GAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR--EATEGSQHISTRVM 540
A+G+ YL E R++HRD A NVL++ K++DFGLA+ A E H +
Sbjct: 119 --AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173
Query: 541 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVD 580
++A E + +SDV+SYGV + EL++ G KP D
Sbjct: 174 -PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 13/207 (6%)
Query: 377 FSSKRILGEGGFG--CVYHGVMDNGTEVAVKLLTRN---NQNGDREFIAEVEMLSRLHHR 431
F R+LG+GGFG C V G A K L + + G+ + E +L +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQ-VRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
+V L CLV +++ G ++ H++ + N G D + + A GL L
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG-NPG-FDEQRAIFYAAELCCGLEDL 118
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA 551
+ R+++RD K N+LL+D ++SD GLA + EG + + RV GT GY+APE
Sbjct: 119 QRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVRGRV-GTVGYMAPEVI 173
Query: 552 MTGHLLVKSDVYSYGVVLLELLSGRKP 578
D + G ++ E++ G+ P
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 68/219 (31%), Positives = 105/219 (47%), Gaps = 13/219 (5%)
Query: 381 RILGEGGFGCVYHGVMD--NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKL 436
R +G G FG V+ V D +G VA+K + QN + E++ML H N++
Sbjct: 6 RPIGYGAFGVVW-SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 437 IGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIAL-GAARGLAYLHEDS 495
+ I V ++S LH + + PL + +K+ L RGL YLH
Sbjct: 65 LDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSD-HVKVFLYQILRGLKYLH--- 120
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAR-EATEGSQHISTRVMGTFGYVAPEYAM-T 553
+ ++HRD K N+L+ + K+ DFGLAR E + S+H++ V+ + Y APE M +
Sbjct: 121 SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEILMGS 179
Query: 554 GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVT 592
H D++S G + ELL R P Q +L+T
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 66/231 (28%), Positives = 99/231 (42%), Gaps = 59/231 (25%)
Query: 383 LGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA--EVEMLSRLHHRNLVKLIGI 439
LGEG FG VY + G VA+K + +N+ A E+++L +L H N+V LI +
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 440 CIE-----GRTRCLVYE-----------LVHNGSV---ESHLHGVDKNRGPLDWEARMKI 480
+E R R VY L+ N SV ES + M
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCY------------MLQ 123
Query: 481 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE---------- 530
L G+ YLHE+ ++HRD KA+N+L+++ K++DFGLAR
Sbjct: 124 LL---EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 531 GSQHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLSGR 576
G T ++ T Y PE + T + D++ G V E+ + R
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 73/233 (31%), Positives = 108/233 (46%), Gaps = 19/233 (8%)
Query: 365 FALSDLEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVE 423
L L T+ + +G+G +G VY +G+ AVK+L + D E AE
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYN 70
Query: 424 MLSRL-HHRNLVKLIGI------CIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEA 476
+L L +H N+VK G+ + G+ LV EL + GSV + G+ LD
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQL-WLVLELCNGGSVTELVKGLLICGQRLDEAM 129
Query: 477 RMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIS 536
I GA GL +LH N R+IHRD K +N+LL + K+ DFG++ + T +
Sbjct: 130 ISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186
Query: 537 TRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLSGRKPVDMSQP 584
T V GT ++APE + DV+S G+ +EL G P+ P
Sbjct: 187 TSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 383 LGEGGFGCVYHGV-MDNGTEVAVK-LLTRNNQNG-DREFIAEVEMLSRLH---HRNLVKL 436
+G G +G VY +G VA+K + + N++G + EV +L RL H N+V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 437 IGICIEGRTR-----CLVYELVHNGSVESHLHGVDKNRGPLD-WEARMKIALGAARGLAY 490
+ +C RT LV+E V + + ++L V P + + M+ L RGL +
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFL---RGLDF 123
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
LH + ++HRD K N+L+ K++DFGLAR Q T V+ T Y APE
Sbjct: 124 LHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR--IYSCQMALTPVVVTLWYRAPEV 178
Query: 551 AMTGHLLVKSDVYSYGVVLLELLSGRKPV 579
+ D++S G + E+ RKP+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 79/282 (28%), Positives = 125/282 (44%), Gaps = 60/282 (21%)
Query: 383 LGEGGFGCVYHG----VMDNG----TEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
LG+G F ++ G V D G TEV +K+L ++++N F M+S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY-LHE 493
G+C+ G +V E V GS++++L +KN + W+ L A+ LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKK-NKNLINISWK------LEVAKQLAWALHF 115
Query: 494 DSNPRVIHRDFKASNVLL---EDDFTP-----KVSDFG-----LAREATEGSQHISTRVM 540
+ + H + A NVLL ED T K+SD G L +E + R+
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI------LLERI- 168
Query: 541 GTFGYVAPE-YAMTGHLLVKSDVYSYGVVLLELLSG-RKPVDMSQPQGQENLVTWARPLL 598
+V PE +L + +D +S+G L E+ SG KP+ Q + L
Sbjct: 169 ---PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK----------L 215
Query: 599 TTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRP 640
E QL P ++A + + C+ E RP
Sbjct: 216 QFYEDRHQLPAPK---------WTELANLINQCMDYEPDFRP 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTR---NNQNGDREFIAEVEMLSRLH 429
T ++ + +G G FG V G VA+K + + R + E+++L L
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLR 67
Query: 430 HRNLVKLIGICIEGRTRC-LVYELVHNGSVESHLHGVDKNR----GPLDWEARMKIALGA 484
H N++ L I I V EL+ G D +R PL+ +
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELL----------GTDLHRLLTSRPLEKQFIQYFLYQI 117
Query: 485 ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR-EATEGSQHISTRVMGTF 543
RGL Y+H V+HRD K SN+L+ ++ K+ DFGLAR + + + ++STR
Sbjct: 118 LRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY---- 170
Query: 544 GYVAPEYAMTGHLL-VKSDVYSYGVVLLELLSGRKPV 579
Y APE +T V+ D++S G + E+L G KP+
Sbjct: 171 -YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 31/221 (14%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTR--NNQNGDREFIAEVEMLSRLHH 430
K+ + +G G +G V + +VA+K + +N+ + + E+++L L H
Sbjct: 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDH 63
Query: 431 RNLVKLIGICI-EGRTRC----LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAA 485
N++ + I R +VYEL+ ++ LH + ++ L +
Sbjct: 64 ENVIAIKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLL 118
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGY 545
RGL Y+H + V+HRD K SN+LL + K+ DFGLAR +E ++ V+ T Y
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 546 VAPEYAMTGHLLVKS-------DVYSYGVVLLELLSGRKPV 579
APE LL+ DV+S G + ELL GRKP+
Sbjct: 175 RAPE------LLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 70/229 (30%), Positives = 108/229 (47%), Gaps = 34/229 (14%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDRE-----FIAEVEM 424
++ +KF +GEG +G VY D G VA+K + +N+ +E I E+++
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE---KEGFPITAIREIKI 59
Query: 425 LSRLHHRNLVKLIGICI----------EGRTRCLVYELV-HN--GSVESHLHGVDKNRGP 471
L +L+HRN+V L I + LV+E + H+ G +ES L V +
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL--VHFSEDH 117
Query: 472 LDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531
+ ++ MK L GL Y H +HRD K SN+LL + K++DFGLAR
Sbjct: 118 I--KSFMKQLL---EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
Query: 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLSGRKPV 579
T + T Y PE + + DV+S G +L EL + +KP+
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 68/208 (32%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 382 ILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA-----EVEMLSRLHHRNLVK 435
+GEG +G VY +G VA+K + +N+ R+ I E+ +L L H N+V+
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNE---RDGIPISSLREITLLLNLRHPNIVE 70
Query: 436 LIGICIEGR---TRCLVYELVHNGSVESHLHG-VDKNRGPLDWEARMK-IALGAARGLAY 490
L + + G+ + LV E E L +D P E+++K + L RGL Y
Sbjct: 71 LKEV-VVGKHLDSIFLVMEYC-----EQDLASLLDNMPTPFS-ESQVKCLMLQLLRGLQY 123
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE- 549
LHE+ +IHRD K SN+LL D K++DFGLAR T + T Y APE
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR-TYGLPAKPMTPKVVTLWYRAPEL 179
Query: 550 -YAMTGHLLVKSDVYSYGVVLLELLSGR 576
T + D+++ G +L ELL+ +
Sbjct: 180 LLGCTTYTT-AIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 68/279 (24%), Positives = 123/279 (44%), Gaps = 24/279 (8%)
Query: 377 FSSKRILGEGGFGCVYHGV--MDNGTEVAVK---LLTRNNQNGDREFIAEVEMLSRLHHR 431
F ++ +G G F VY +D VA+K + + ++ + E+++L +L+H
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKP-VALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
N++K + IE +V EL G + + K + + K + + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA 551
H + RV+HRD K +NV + K+ D GL R + + + V GT Y++PE
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 552 MTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611
KSD++S G +L E+ + + P + L + + +EQ P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----------LFSLCQKIEQCDYPP 227
Query: 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650
L + + K+ + SMC++P+ RP +G V Q K
Sbjct: 228 LPTEHYSE---KLRELVSMCIYPDPDQRPDIGYVHQIAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 11/209 (5%)
Query: 376 KFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA--EVEMLSRLHHRN 432
K+ R++G G FG V+ + V +K + D A E ++L L H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
+++ +E + +V E G++ ++ + LD + + + L ++H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLALHHVH 118
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTP-KVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA 551
++HRD K N+LL+ K+ DFG+++ S+ + V+GT Y++PE
Sbjct: 119 ---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELC 173
Query: 552 MTGHLLVKSDVYSYGVVLLELLSGRKPVD 580
KSD+++ G VL EL S ++ +
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 62/196 (31%), Positives = 93/196 (47%), Gaps = 11/196 (5%)
Query: 383 LGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRNLVKLIGIC 440
LGEG + VY G NG VA+K++ + G I E +L L H N+V L I
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 441 IEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVI 500
T LV+E VH + +DK+ G L E RGL+Y+H+ ++
Sbjct: 73 HTKETLTLVFEYVHTDLCQY----MDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---IL 125
Query: 501 HRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM-TGHLLVK 559
HRD K N+L+ D K++DFGLAR + S S V+ T Y P+ + +
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYSTC 184
Query: 560 SDVYSYGVVLLELLSG 575
D++ G + +E++ G
Sbjct: 185 LDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 383 LGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICI 441
LG+G FG VY + G A K++ ++ +++ E+++L+ H N+VKL+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 442 EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAA-RGLAYLHEDSNPRVI 500
++ E G+V++ + +++ PL E ++++ L YLHE+ ++I
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELER---PLT-EPQIRVVCKQTLEALNYLHEN---KII 125
Query: 501 HRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGH----- 555
HRD KA N+L D K++DFG++ + T Q + +GT ++APE M
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSKDRP 184
Query: 556 LLVKSDVYSYGVVLLELLSGRKP 578
K+DV+S G+ L+E+ P
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-14
Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 397 DNGTEVAVKLLTRNNQNGDRE---FIAEVEMLSRLHHRNLVKLI--GICIEGRTRCLVYE 451
G EVA+KLL + + + F E + +RL+H N+V L+ G G V+E
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFE 59
Query: 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL 511
V ++ L G L ++ L LA H N ++HRD K N+++
Sbjct: 60 YVPGRTLREVL----AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMV 112
Query: 512 -EDDFTP--KVSDFGL------AREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDV 562
+ P KV DFG+ R+A + +T V+GT Y APE + SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 563 YSYGVVLLELLSGRK----------------PVDMSQPQ 585
Y++G++ LE L+G++ PVD+S P
Sbjct: 173 YAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPP 211
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 383 LGEGGFGCVYHGVMDNGTEVA---VKLLTRNNQNGDRE--FIAEVEMLSRLHHRNLVKLI 437
+G G FG V G G A VK L R + D + F+ EV+ L+H N+++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKEL-RASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 438 GICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEAR----MKIALGAARGLAYLHE 493
G CIE LV E G ++++L NRG + A+ ++A A GL +LH+
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLR---SNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGT-FGYVAPEYAM 552
IH D N L D + K+ D+GLA E +I+ ++APE
Sbjct: 119 AD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 553 TGH--LLV-----KSDVYSYGVVLLEL 572
LL KS+++S GV + EL
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 43/132 (32%), Positives = 72/132 (54%), Gaps = 7/132 (5%)
Query: 479 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR 538
K+++ RGLAYL E +++HRD K SN+L+ K+ DFG++ + + ++
Sbjct: 107 KVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 161
Query: 539 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLL 598
+GT Y++PE H V+SD++S G+ L+EL GR P+ P +E + RP++
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI--PPPDAKELEAIFGRPVV 219
Query: 599 TTREGLEQLVDP 610
EG + P
Sbjct: 220 DGEEGEPHSISP 231
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 34/223 (15%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTR---NNQNGDREFIAEVEMLSRLHH 430
++ +G G +G V + +G +VA+K + R E+++L H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKILRHFKH 63
Query: 431 RNLVKLIGICI----EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAA- 485
N++ + I + + +V +L+ ES LH + + PL E ++ L
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLT-EEHIRYFLYQLL 117
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS--------QHIST 537
RGL Y+H + VIHRD K SN+L+ +D ++ DFG+AR + ++++T
Sbjct: 118 RGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 538 RVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLSGRKPV 579
R Y APE ++ + D++S G + E+L GR+ +
Sbjct: 175 R-----WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 383 LGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNG-DREFIAEVEMLSRLHHRNLVKLIGIC 440
LGEG + VY G+ NG VA+K+++ + G I E +L L H N+V L I
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 441 IEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVI 500
T V+E +H + + ++ G L RGLAY+H ++
Sbjct: 73 HTKETLTFVFEYMHTDLAQY----MIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HIL 125
Query: 501 HRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKS 560
HRD K N+L+ K++DFGLAR + SQ S+ V+ T Y P+ + G S
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPD-VLLGATDYSS 183
Query: 561 --DVYSYGVVLLELLSGR 576
D++ G + +E+L G+
Sbjct: 184 ALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 88/303 (29%), Positives = 134/303 (44%), Gaps = 38/303 (12%)
Query: 360 LSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMD--NGTEVAVKLLTRNNQNGDRE 417
LS KT ++ + +G+G +G V+ V++ NG++ AVK+L + + D E
Sbjct: 3 LSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIH-DIDEE 60
Query: 418 FIAEVEMLSRLH-HRNLVKLIGI-----CIEGRTRCLVYELVHNGSVESHLHGVDKNRGP 471
AE +L L H N+VK G+ G LV EL + GSV + G K RG
Sbjct: 61 IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLK-RGE 119
Query: 472 LDWEARMKIALGAA-RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530
E + L A GL +LH + + IHRD K +N+LL + K+ DFG++ + T
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176
Query: 531 GSQHISTRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLSGRKPVDMSQPQ 585
+T V GT ++APE L + DV+S G+ +EL G P+ P
Sbjct: 177 TRLRRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235
Query: 586 GQENLVTWARPLLTT-REGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGE 644
R L R L P L S +F+D C+ + RP + +
Sbjct: 236 ---------RALFKIPRNPPPTLHQPEL-WSNEFNDF------IRKCLTKDYEKRPTVSD 279
Query: 645 VVQ 647
++Q
Sbjct: 280 LLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 70/235 (29%), Positives = 105/235 (44%), Gaps = 21/235 (8%)
Query: 361 SVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFI 419
S+ LS L F ++G G +G VY G + G A+K++ ++ + E
Sbjct: 2 SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIK 60
Query: 420 AEVEMLSRL-HHRNLVKLIGICIEGR------TRCLVYELVHNGSVESHLHGVDKNRGPL 472
E+ ML + HHRN+ G I+ LV E GSV + N
Sbjct: 61 LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120
Query: 473 DWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532
DW A I RGLA+LH +VIHRD K NVLL ++ K+ DFG++ +
Sbjct: 121 DWIAY--ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175
Query: 533 QHISTRVMGTFGYVAPEYAMTGH-----LLVKSDVYSYGVVLLELLSGRKPV-DM 581
+T +GT ++APE +SD++S G+ +E+ G P+ DM
Sbjct: 176 GRRNT-FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 54/216 (25%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 375 EKFSSKRILGEGGFGCVYHGVM-----DNGTEVAVKLLTRNNQNGDRE-FIAEVEMLSRL 428
++ + +L EG FG +++G++ EV VK + + + E +L L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 429 HHRNLVKLIGICIEGRTRCLV-YELVHNGSVESHL----HGVDKNRGPLDWEARMKIALG 483
H+N++ ++ +CIE V Y ++ G+++ L G N L + + +A+
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGT- 542
A G++YLH VIH+D A N +++++ K++D L+R+ H +G
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH----CLGDN 178
Query: 543 ----FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS 574
++A E + SDV+S+GV+L EL++
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 74/303 (24%), Positives = 121/303 (39%), Gaps = 71/303 (23%)
Query: 365 FALSDLEKATEKFSSKRILGEGGFGCVYHGVM---DNGTEVAVKLLTRNNQNGD-REFIA 420
F DL+ E +G G FG V M +GT +AVK + + + +
Sbjct: 1 FTAEDLKDLGE-------IGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKRLLM 51
Query: 421 EVEMLSRLHH-RNLVKLIG---------ICIEGRTRCL--VYELVHNGSVESHLHGVDKN 468
+++++ R +VK G IC+E L Y+ V+ +
Sbjct: 52 DLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVY-----------EVL 100
Query: 469 RGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528
+ + E KIA+ + L YL E+ +IHRD K SN+LL+ + K+ DFG+
Sbjct: 101 KSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGI---- 154
Query: 529 TEGSQHI-----STRVMGTFGYVAPEYAMTGHLL---VKSDVYSYGVVLLELLSGRKPVD 580
S + TR G Y+APE V+SDV+S G+ L E+ +G+ P
Sbjct: 155 ---SGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211
Query: 581 MSQPQGQENLVTWARPLLTTREGLEQLVD---PSLAGSYDFDDMAKVAAIASMCVHPEVT 637
W + L Q+V P L+ S + + ++C+ + +
Sbjct: 212 -----------KWNSVF----DQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDES 256
Query: 638 HRP 640
RP
Sbjct: 257 KRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 69/261 (26%), Positives = 114/261 (43%), Gaps = 29/261 (11%)
Query: 376 KFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
++ R LG G G V+ V D VAVK + + + + E++++ RL H N+V
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65
Query: 435 KL--------------IGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKI 480
K+ +G E + +V E +E+ L V +GPL E
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEY-----METDLANV-LEQGPLSEEHARLF 119
Query: 481 ALGAARGLAYLHEDSNPRVIHRDFKASNVLL-EDDFTPKVSDFGLAREATEGSQHISTRV 539
RGL Y+H + V+HRD K +NV + +D K+ DFGLAR H
Sbjct: 120 MYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176
Query: 540 MG--TFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARP 596
G T Y +P ++ + K+ D+++ G + E+L+G+ + Q L+ + P
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236
Query: 597 LLTTREGLEQL-VDPSLAGSY 616
++ + E L V PS +
Sbjct: 237 VVREEDRNELLNVIPSFVRND 257
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 65/268 (24%), Positives = 120/268 (44%), Gaps = 22/268 (8%)
Query: 377 FSSKRILGEGGFGCVYHGV-MDNGTEVAVK---LLTRNNQNGDREFIAEVEMLSRLHHRN 432
F ++ +G G F VY + +G VA+K + + + I E+++L +L+H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
++K IE +V EL G + + K + + + K + L ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM 552
+ RV+HRD K +NV + K+ D GL R + + + V GT Y++PE
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
Query: 553 TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612
KSD++S G +L E+ + + P + NL + + +EQ P L
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLCKK-------IEQCDYPPL 228
Query: 613 AGSYDFDDMAKVAAIASMCVHPEVTHRP 640
+ +++ + + +MC++P+ RP
Sbjct: 229 PSDHYSEELRQ---LVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 382 ILGEGGFGCVYHGV-MDNGTEVAVK-LLTRNNQNGD-----REFIAEVEMLSRLHHRNLV 434
+GEG +G VY ++ G VA+K + ++ G RE IA ++ L H N+V
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE-IALLKQLESFEHPNIV 64
Query: 435 KLIGICIEGRT-RCLVYELV--HNGSVESHLHGVDKN---RGPLDWEAR--MKIALGAAR 486
+L+ +C RT R L LV H V+ L G + M+ L R
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEH---VDQDLATYLSKCPKPGLPPETIKDLMRQLL---R 118
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYV 546
G+ +LH S+ R++HRD K N+L+ D K++DFGLAR + T V+ T Y
Sbjct: 119 GVDFLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLAR--IYSFEMALTSVVVTLWYR 173
Query: 547 APEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
APE + D++S G + EL R+P
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 67/209 (32%), Positives = 99/209 (47%), Gaps = 31/209 (14%)
Query: 383 LGEGGFGCVYHGVMDNGTEV--AVKLLTRNN--QNGDREFI-AEVEMLSRLHHRNLVKLI 437
LG GGFG V V A+K + + + + G +E I +E E+L +H +VKL
Sbjct: 1 LGVGGFGRVEL-VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 438 GICIEGRT---RCLVY---ELVHNGSVESHLHGVDKNRGPLD-WEARMKIALGAARGLAY 490
RT + +Y E G + + L +RG D + AR IA Y
Sbjct: 60 ------RTFKDKKYIYMLMEYCLGGELWTILR----DRGLFDEYTARFYIA-CVVLAFEY 108
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
LH +I+RD K N+LL+ + K+ DFG A++ G + + GT YVAPE
Sbjct: 109 LHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT--FCGTPEYVAPEI 163
Query: 551 AMT-GHLLVKSDVYSYGVVLLELLSGRKP 578
+ G+ D +S G++L ELL+GR P
Sbjct: 164 ILNKGYDFS-VDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 377 FSSKRILGEGGFGCVYHGVMDNGTEV-AVKLLTRNN--QNGDRE-FIAEVEMLSRLHHRN 432
F+ +LG+G FG V E+ A+K+L ++ Q+ D E + E +L+
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 433 LVKLIGICIEGRTRC-LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
+ + C + R V E V+ G + H+ V K + P +I++G L +L
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG----LFFL 117
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA-TEGSQHISTRVM-GTFGYVAPE 549
H +I+RD K NV+L+ + K++DFG+ +E +G ++TR GT Y+APE
Sbjct: 118 HRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCGTPDYIAPE 171
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLSGRKPVD 580
D ++YGV+L E+L+G+ P D
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQN---GDREFIAEVEMLSRLHH 430
E++ + +G G +G V G VAVK L+R Q+ R + E+ +L + H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKH 75
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNR----GPLDWEARMKIALGAAR 486
N++ L+ + R+ E ++ + +HL G D N L + + R
Sbjct: 76 ENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 131
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE-ATEGSQHISTRVMGTFGY 545
GL Y+H + +IHRD K SN+ + +D K+ DFGLAR E + +++TR Y
Sbjct: 132 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 183
Query: 546 VAPEYAMTG-HLLVKSDVYSYGVVLLELLSGR 576
APE + H D++S G ++ ELL+GR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 10/211 (4%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL 433
+K++ +G+G G VY + + G EVA+K + Q I E+ ++ + N+
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
V + + G +V E + GS+ + + G + R + + L +LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHS 133
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT 553
+ +VIHRD K+ N+LL D + K++DFG + T ST V GT ++APE
Sbjct: 134 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 189
Query: 554 GHLLVKSDVYSYGVVLLELLSGRKPVDMSQP 584
K D++S G++ +E++ G P P
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 11/247 (4%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL 433
+K++ +G+G G VY + + G EVA++ + Q I E+ ++ + N+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
V + + G +V E + GS+ + + G + R + + L +LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHS 134
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT 553
+ +VIHRD K+ N+LL D + K++DFG + T Q + ++GT ++APE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVTR 190
Query: 554 GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV-TWARPLLTTREGLEQLVDPSL 612
K D++S G++ +E++ G P P L+ T P L E L + L
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250
Query: 613 AGSYDFD 619
D D
Sbjct: 251 NRCLDMD 257
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 69/262 (26%), Positives = 116/262 (44%), Gaps = 12/262 (4%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL 433
+K++ +G+G G VY + + G EVA+K + Q I E+ ++ H N+
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI 78
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
V + + G +V E + GS+ + + G + R + + L +LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHS 133
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT 553
+ +VIHRD K+ N+LL D + K++DFG + T ST V GT ++APE
Sbjct: 134 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 189
Query: 554 GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV-TWARPLLTTREGLEQLVDPSL 612
K D++S G++ +E++ G P P L+ T P L E L + L
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 249
Query: 613 AGSYDFDDMAKVAAIASMCVHP 634
+ D+ K + + HP
Sbjct: 250 NRCLEM-DVEKRGSAKELLQHP 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 30/217 (13%)
Query: 386 GGFGCVYHGVMDN-GTEVAVKLLTRNNQNGDREF---IAEVEMLSRLHHRNLVKLIGICI 441
G +G V+ + G A+K++ + + + + E ++LS+ +VKL
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 442 EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWE-ARMKIALGAARGLAYLHEDSNPRVI 500
+ LV E + G + S L N G LD + AR+ IA L YLH + +I
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLE----NVGSLDEDVARIYIAEIVL-ALEYLH---SNGII 115
Query: 501 HRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI-------STRVMGTFGYVAPEYAMT 553
HRD K N+L++ + K++DFGL++ Q R++GT Y+APE
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV--- 172
Query: 554 GHLLVKS-----DVYSYGVVLLELLSGRKPVDMSQPQ 585
+L + D +S G +L E L G P P+
Sbjct: 173 --ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 383 LGEGGFGCVYHGVMDN-GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICI 441
+GEG G V + G +VAVK + Q EV ++ HH N+V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 442 EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIH 501
G +V E + G++ + N E + L R L+YLH N VIH
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIATVCLSVLRALSYLH---NQGVIH 141
Query: 502 RDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR--VMGTFGYVAPEYAMTGHLLVK 559
RD K+ ++LL D K+SDFG + S+ + R ++GT ++APE +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 560 SDVYSYGVVLLELLSGRKP 578
D++S G++++E++ G P
Sbjct: 199 VDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 382 ILGEGGFGCVYH-GVMDNGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLI 437
I+G GGFG VY D G A+K L + + G+ + E MLS + + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 438 GICIEGRTR---CLVYELVHNGSVESHL--HGVDKNRGPLDWEARMKIALGAARGLAYLH 492
+ T C + +L++ G + HL HGV + + + + GL ++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMH 114
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM 552
N V++RD K +N+LL++ ++SD GLA + ++ H S +GT GY+APE
Sbjct: 115 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQ 168
Query: 553 TGHLLVKS-DVYSYGVVLLELLSGRKP 578
G S D +S G +L +LL G P
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 383 LGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGD-REFIAEVEMLSRLHHRNLVKLIGIC 440
LGEG + VY G G VA+K + + + G I E+ ++ L H N+V+L +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 441 IEGRTRCLVYELVHNG---SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNP 497
LV+E + +++H RG LD +G+A+ HE+
Sbjct: 68 HTENKLMLVFEYMDKDLKKYMDTH-----GVRGALDPNTVKSFTYQLLKGIAFCHEN--- 119
Query: 498 RVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLL 557
RV+HRD K N+L+ K++DFGLAR S V+ T Y AP+ +
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTY 178
Query: 558 VKS-DVYSYGVVLLELLSGR 576
S D++S G ++ E+++GR
Sbjct: 179 STSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 383 LGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA-----EVEMLSRLHHRNLVKL 436
+GEG +G V+ + VA+K R + D E + E+ +L L H+N+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKELKHKNIVRL 64
Query: 437 IGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSN 496
+ + LV+E + ++ + D G +D E +GLA+ H
Sbjct: 65 YDVLHSDKKLTLVFEYC-DQDLKKYF---DSCNGDIDPEIVKSFMFQLLKGLAFCHSH-- 118
Query: 497 PRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHL 556
V+HRD K N+L+ + K++DFGLAR + S V+ T Y P+ L
Sbjct: 119 -NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKL 176
Query: 557 LVKS-DVYSYGVVLLELLSGRKPV 579
S D++S G + EL + +P+
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 21/219 (9%)
Query: 377 FSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLV 434
F ++G G +G VY G + G A+K++ + E E+ ML + HHRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 66
Query: 435 KLIGICIEGR------TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGL 488
G I+ LV E GSV + N +W A I RGL
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 124
Query: 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAP 548
++LH+ +VIHRD K NVLL ++ K+ DFG++ + +T +GT ++AP
Sbjct: 125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAP 180
Query: 549 EYAMTGH-----LLVKSDVYSYGVVLLELLSGRKPV-DM 581
E KSD++S G+ +E+ G P+ DM
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 29/206 (14%)
Query: 383 LGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREF--IAEVEMLSRLHHRNLVKLIGI 439
LGEG + VY G G VA+K + ++ G F I E +L L H N+V L I
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDI 71
Query: 440 CIEGRTRCLVYELVHNG---SVESHLHGVDKNRGPLDWEARMKIAL-GAARGLAYLHEDS 495
+T LV+E + ++ G+ + +++ L RGLAY H+
Sbjct: 72 IHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHN--------VRLFLFQLLRGLAYCHQR- 122
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM--- 552
RV+HRD K N+L+ + K++DFGLAR + S+ S V+ T Y P+ +
Sbjct: 123 --RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLLGST 179
Query: 553 --TGHLLVKSDVYSYGVVLLELLSGR 576
+ L D++ G + E+ +GR
Sbjct: 180 EYSTSL----DMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 8e-13
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 383 LGEGGFGCV----YHGVMDNGTEVAVKLLTR--NNQNGDREFIAEVEMLSRLH-HRNLVK 435
LG+G +G V + VA+K +T + + + + E+++L H+N+
Sbjct: 8 LGQGAYGIVCSARNAETSE-EETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 436 LIGICI---EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIAL-GAARGLAYL 491
L + I +YE + +E+ LH + ++ PL +A + + GL Y+
Sbjct: 67 LYDMDIVFPGNFNELYLYEEL----MEADLHQIIRSGQPLT-DAHFQSFIYQILCGLKYI 121
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR----EATEGSQHISTRVMGTFGYVA 547
H + V+HRD K N+L+ D K+ DFGLAR E + + T + T Y A
Sbjct: 122 H---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVATRWYRA 177
Query: 548 PEYAMTGHLLVKS-DVYSYGVVLLELLSGRKPV 579
PE ++ K+ DV+S G +L ELL GRKPV
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 381 RILGEGGFGCVYHGVM-DNGTEVAVKLLTRNN--QNGDRE-FIAEVEMLSRLHHRNLVKL 436
R+LG+G FG V + ++G AVK+L ++ Q+ D E + E +LS + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 437 IGICIEGRTRCL-VYELVHNGSVESHLHGVDKNRGPLDWEARMKI-ALGAARGLAYLHED 494
+ C + R V E V+ G + H + K+R D EAR + A L +LH+
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFH---IQKSR-RFD-EARARFYAAEITSALMFLHDK 115
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG 554
+I+RD K NVLL+ + K++DFG+ +E + ST GT Y+APE
Sbjct: 116 G---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEM 171
Query: 555 HLLVKSDVYSYGVVLLELLSGRKPVD 580
D ++ GV+L E+L G P +
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 8e-13
Identities = 68/262 (25%), Positives = 115/262 (43%), Gaps = 12/262 (4%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL 433
+K++ +G+G G V+ + + G EVA+K + Q I E+ ++ L + N+
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
V + + G +V E + GS+ + +D + + L +LH
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALEFLHA 133
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT 553
+ +VIHRD K+ NVLL D + K++DFG + T ST V GT ++APE
Sbjct: 134 N---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 189
Query: 554 GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV-TWARPLLTTREGLEQLVDPSL 612
K D++S G++ +E++ G P P L+ T P L E L + L
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFL 249
Query: 613 AGSYDFDDMAKVAAIASMCVHP 634
+ D+ K + + HP
Sbjct: 250 NRCLEM-DVEKRGSAKELLQHP 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 68/256 (26%), Positives = 109/256 (42%), Gaps = 16/256 (6%)
Query: 383 LGEGGFGCV-YHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICI 441
+GEG G V V +G VAVK + Q EV ++ H N+V++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 442 EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIH 501
G +V E + G++ + N E + L + L+ LH VIH
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 502 RDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSD 561
RD K+ ++LL D K+SDFG + ++ + V GT ++APE + D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVD 198
Query: 562 VYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYD---F 618
++S G++++E++ G P P ++ R L + V PSL G D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPKLKNLHKVSPSLKGFLDRLLV 255
Query: 619 DDMAKVAAIASMCVHP 634
D A+ A A + HP
Sbjct: 256 RDPAQRATAAELLKHP 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 9e-13
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 382 ILGEGGFGCVYHGV--MDNGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKL 436
I+G GGFG VY G D G A+K L + + G+ + E MLS + + +
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 437 IGICIEGRTR---CLVYELVHNGSVESHL--HGVDKNRGPLDWEARMKI-ALGAARGLAY 490
+ + T + +L++ G + HL HGV EA M+ A GL +
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-------EAEMRFYAAEIILGLEH 112
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
+H N V++RD K +N+LL++ ++SD GLA + ++ H S +GT GY+APE
Sbjct: 113 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEV 166
Query: 551 AMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
G S D +S G +L +LL G P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 36/112 (32%), Positives = 62/112 (55%), Gaps = 5/112 (4%)
Query: 479 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR 538
KI++ RGL YL E +++HRD K SN+L+ K+ DFG++ + + ++
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 157
Query: 539 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENL 590
+GT Y++PE H V+SD++S G+ L+E+ GR P+ + E +
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 381 RILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGD--REFIA---EVEMLSRLHHRNLV 434
++LG+G FG VY D G E+AVK + + ++ + +E A E+++L L H +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 435 KLIGICIEG---RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
+ G C+ RT + E + GS++ L K+ G L K G++YL
Sbjct: 68 QYYG-CLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVSYL 122
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE----ATEGSQHISTRVMGTFGYVA 547
H + ++HRD K +N+L + K+ DFG ++ G+ S V GT +++
Sbjct: 123 HSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPYWMS 177
Query: 548 PEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
PE K+D++S G ++E+L+ + P
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 381 RILGEGGFGCVYHGVMDNGTEV-AVKLLTRN--NQNGDREF-IAEVEMLSRL-HHRNLVK 435
++LG+G FG V + E+ AVK+L ++ Q+ D E + E +L+ H L +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 436 LIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKI-ALGAARGLAYLHE 493
L C + + R V E V+ G + H+ + D E R + A GL +LHE
Sbjct: 61 LHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGR----FD-EPRARFYAAEIVLGLQFLHE 114
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT 553
+I+RD K NVLL+ + K++DFG+ +E G ST GT Y+APE ++
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST-FCGTPDYIAPE-ILS 169
Query: 554 GHLLVKS-DVYSYGVVLLELLSGRKPVD 580
+ D ++ GV+L E+L+G+ P +
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 66/209 (31%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 383 LGEGGFGCVYHG--VMDNGTEVAVKLL-TRNNQNG-DREFIAEVEMLSRLH---HRNLVK 435
+GEG +G V+ + + G VA+K + + + G I EV +L L H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 436 LIGICIEGRTR-----CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY 490
L +C RT LV+E V + + ++L V + P + M L RGL +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQL--LRGLDF 125
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
LH RV+HRD K N+L+ K++DFGLAR Q T V+ T Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVVVTLWYRAPEV 180
Query: 551 AMTGHLLVKSDVYSYGVVLLELLSGRKPV 579
+ D++S G + E+ RKP+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 45/172 (26%), Positives = 75/172 (43%), Gaps = 11/172 (6%)
Query: 421 EVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH-NGSVESHLHGVDKNRGPLDWEARMK 479
E +L ++H +++++ + G C+V L H + + ++L K PL + +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV--LPHYSSDLYTYL---TKRSRPLPIDQALI 161
Query: 480 IALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRV 539
I GL YLH R+IHRD K N+ + D + D G A+ + +
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216
Query: 540 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV 591
GT APE K+D++S G+VL E+L+ + P E V
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYV 268
|
Length = 357 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 382 ILGEGGFGCVYHG-VMDNGTEVAVKLLTRN-NQNGDREFIAEVEMLSRLHHRNLVKLIG- 438
ILG G G VY + +AVK++ + ++ ++E+E+L + ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 439 ICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPR 498
+E R + E + GS++ + + +IA+ +GL YL + +
Sbjct: 68 FFVENRIS-ICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLW---SLK 115
Query: 499 VIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLV 558
++HRD K SN+L+ K+ DFG++ + I+ +GT Y+APE +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGI 172
Query: 559 KSDVYSYGVVLLELLSGRKPVDMSQPQGQEN 589
SDV+S G+ +EL GR P PQ Q+N
Sbjct: 173 HSDVWSLGISFMELALGRFPY----PQIQKN 199
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 52/225 (23%), Positives = 90/225 (40%), Gaps = 56/225 (24%)
Query: 384 GEGGFGCVYHGVMDN---GTEVAVKLLTRNNQNGD---REFIAEVEMLSRLHHRNLVKLI 437
G G +G VY N G E A+K + + + E+ +L L H N+V L+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 438 GICIEGRTRC--LVYE-------------------LVHNGSVESHLHGVDKNRGPLDWEA 476
+ +E + L+++ + V+S L + L+
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI------LN--- 119
Query: 477 RMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP----KVSDFGLAREATEGS 532
G+ YLH + V+HRD K +N+L+ + K+ D GLAR
Sbjct: 120 ----------GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 533 QHIST--RVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLS 574
+ ++ V+ T Y APE + K+ D+++ G + ELL+
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 383 LGEGGFGCVYHGVMDNG---TEVAVKLLTRNNQNGD-REFIAEVEMLSRLHHRNLVKLIG 438
+G G FG V G +++G +V VK L + + +F+ E + L H NL++ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 439 ICIEGRTRCLVYELVHNGSVESHLHG--VDKNRGPLDWEARMKIALGAARGLAYLHEDSN 496
C E LV E G ++ +L + P D ++A A GL +LH+++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-DPTTLQRMACEIALGLLHLHKNN- 120
Query: 497 PRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI-STRVMGTFGYVAPEYA--MT 553
IH D N LL D T K+ D+GL+ + ++ ++ ++APE +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 554 GHLLV-----KSDVYSYGVVLLELLS-GRKP 578
G+LLV +S+V+S GV + EL G +P
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 23/214 (10%)
Query: 377 FSSKRILGEGGFGCVYHGVMDNGTEV-AVKLLTRNN--QNGDRE-FIAEVEMLSRLHHRN 432
F+ +LG+G FG V E+ A+K+L ++ Q+ D E + E +L+
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 433 LVKLIGICIEGRTRC-LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
+ + C + R V E V+ G + H+ V K + P +IA+G L +L
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG----LFFL 117
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM-GTFGYVAPE- 549
H +I+RD K NV+L+ + K++DFG+ +E G + +TR GT Y+APE
Sbjct: 118 HSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEI 172
Query: 550 --YAMTGHLLVKS-DVYSYGVVLLELLSGRKPVD 580
Y G KS D +++GV+L E+L+G+ P D
Sbjct: 173 IAYQPYG----KSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 59/207 (28%), Positives = 88/207 (42%), Gaps = 21/207 (10%)
Query: 386 GGFGCVYHG-VMDNGTEVAVKLLTRNNQNGDREFI---AE-VEMLSRLHHRNLVKLIGIC 440
G FG VY G A+K+L +++ + AE M+ + + KL
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 441 IEGRTRCLVYELVHNGSVESHLHGVDKNRGPL--DWEARMKIALGAARGLAYLHEDSNPR 498
LV E ++ G S + K G L DW A+ IA G+ LH+
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI----KTLGGLPEDW-AKQYIA-EVVLGVEDLHQRG--- 117
Query: 499 VIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLV 558
+IHRD K N+L++ K++DFGL+R + + +GT Y+APE +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNG-----LENKKFVGTPDYLAPETILGVGDDK 172
Query: 559 KSDVYSYGVVLLELLSGRKPVDMSQPQ 585
SD +S G V+ E L G P P
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 41/113 (36%), Positives = 62/113 (54%), Gaps = 11/113 (9%)
Query: 471 PLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530
PLD + ++ + A+G+ +L ++ IHRD A NVLL D K+ DFGLAR+
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 531 GSQHISTRVMGT----FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
S ++ V G ++APE V+SDV+SYG++L E+ S G+ P
Sbjct: 265 DSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 67/238 (28%), Positives = 106/238 (44%), Gaps = 46/238 (19%)
Query: 382 ILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA--EVEMLSRLHHRNLVKLIG 438
+G+G FG V+ VA+K + N+ A E+++L L H N+V LI
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78
Query: 439 IC---IEGRTRC-----LVYELVHNGSVESHLHGVDKNRG----PLDWEARMKIALGAAR 486
IC R LV+E E L G+ N+ + + MK+ L
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFC-----EHDLAGLLSNKNVKFTLSEIKKVMKMLLN--- 130
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE---ATEGSQHISTRVMGTF 543
GL Y+H N +++HRD KA+N+L+ D K++DFGLAR + + T + T
Sbjct: 131 GLYYIH--RN-KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 544 GYVAPEYAMTGHLLV-------KSDVYSYGVVLLELLSGRKPVDM--SQPQGQENLVT 592
Y PE LL+ D++ G ++ E+ + R P+ M + Q Q L++
Sbjct: 188 WYRPPE------LLLGERDYGPPIDMWGAGCIMAEMWT-RSPI-MQGNTEQHQLTLIS 237
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 54/179 (30%), Positives = 76/179 (42%), Gaps = 32/179 (17%)
Query: 479 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR 538
KIA+ + L YLH VIHRD K SNVL+ + K+ DFG++ + T
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--AKTI 162
Query: 539 VMGTFGYVAPEY----AMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWA 594
G Y+APE VKSDV+S G+ ++EL +GR P D +W
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD-----------SWK 211
Query: 595 RPLLTTREGLEQLVD---PSLAG---SYDFDDMAKVAAIASMCVHP---EVTHRPFMGE 644
P + L+Q+V+ P L S +F D + P E+ PF
Sbjct: 212 TPF----QQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 383 LGEGGFGCVYHGVMDNGT--EVAVKLLTRN-----NQNGDREFIAEVEMLSRLHHRNLVK 435
LG+G FG VY V D E +K+L N N + E ++LS+L H +VK
Sbjct: 8 LGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 436 LIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS 495
+E C++ E ++ L + L + + G+ Y+H+
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR- 125
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGH 555
R++HRD KA N+ L+++ K+ DFG++R GS ++T GT Y++PE
Sbjct: 126 --RILHRDLKAKNIFLKNNLL-KIGDFGVSR-LLMGSCDLATTFTGTPYYMSPEALKHQG 181
Query: 556 LLVKSDVYSYGVVLLEL 572
KSD++S G +L E+
Sbjct: 182 YDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 60/198 (30%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 383 LGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRNLVKLIGIC 440
LGEG + V+ G VA+K + ++ G I EV +L L H N+V L I
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 441 IEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIAL-GAARGLAYLHEDSNPRV 499
R LV+E + +S L N G L +KI + RGL+Y H+ ++
Sbjct: 73 HTERCLTLVFEYL-----DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124
Query: 500 IHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM-TGHLLV 558
+HRD K N+L+ + K++DFGLAR + ++ S V+ T Y P+ + +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 559 KSDVYSYGVVLLELLSGR 576
D++ G +L E+ +GR
Sbjct: 184 PIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 8e-12
Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGT--EVAVKLLTRNNQN---GDREFIAEVEMLSRLH 429
+++ + +G G +G V D T +VA+K L+R Q+ R + E+ +L +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAF-DTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMD 72
Query: 430 HRNLVKLIGICIEGRTR---CLVYELVHNGSVESHLHGVDKNR----GPLDWEARMKIAL 482
H N++ L+ + + VY LV +HL G D N L + +
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVY-LV------THLMGADLNNIVKCQKLSDDHIQFLVY 125
Query: 483 GAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA-TEGSQHISTRVMG 541
RGL Y+H + +IHRD K SN+ + +D K+ DFGLAR E + +++TR
Sbjct: 126 QILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR--- 179
Query: 542 TFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGR 576
Y APE + H D++S G ++ ELL+G+
Sbjct: 180 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 56/214 (26%), Positives = 104/214 (48%), Gaps = 20/214 (9%)
Query: 376 KFSSKRILGEGGFGCVY--HGVMDNGTEVAVKL-LTRNNQNGDREFIAEVEMLSRLHHRN 432
++ + +GEG FG +Y D+ V ++ LT+ EV +L+++ H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARM-----KIALGAARG 487
+V E +V E G + + +++ RG L E ++ +I+LG
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDL---MKRINRQRGVLFSEDQILSWFVQISLG---- 113
Query: 488 LAYLHEDSNPRVIHRDFKASNVLLEDD-FTPKVSDFGLAREATEGSQHISTRVMGTFGYV 546
L ++H+ +++HRD K+ N+ L + K+ DFG+AR+ + S ++ +GT Y+
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SMELAYTCVGTPYYL 169
Query: 547 APEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVD 580
+PE K+D++S G VL EL + + P +
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 19/209 (9%)
Query: 381 RILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGD--REFIA---EVEMLSRLHHRNLV 434
++LG+G FG VY +D G E+A K + + ++ + +E A E+++L L H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 435 KLIGICIEG---RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
+ G C+ +T + E + GSV+ L K G L K G++YL
Sbjct: 68 QYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILEGMSYL 122
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA-REATEGSQHISTR-VMGTFGYVAPE 549
H + ++HRD K +N+L + K+ DFG + R T R V GT +++PE
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
K+DV+S G ++E+L+ + P
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 479 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR 538
K+ + + L YL E VIHRD K SN+LL+ K+ DFG++ + TR
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TR 173
Query: 539 VMGTFGYVAPEY----AMTGHLLVKSDVYSYGVVLLELLSGRKP 578
G Y+APE +++DV+S G+ L+EL +G+ P
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 61/241 (25%), Positives = 100/241 (41%), Gaps = 47/241 (19%)
Query: 373 ATEKFSSKRI------LGEGGFGCVYHGVMD--NGTEVAVKLLT----RNNQNGDREFIA 420
S+R LGEG +G V D G VA+K + N+ DR+ +
Sbjct: 1 NMSFSISERYIQKGAHLGEGTYGKVEKA-YDTLTGKIVAIKKVKIIEISNDVTKDRQLVG 59
Query: 421 ----------EVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRG 470
E+++++ + H N++ L+ + +EG LV +++ S L V +
Sbjct: 60 MCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-----SDLKKVVDRKI 114
Query: 471 PLDWEARMK-IALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR--- 526
L E+++K I L GL LH +HRD +N+ + K++DFGLAR
Sbjct: 115 RLT-ESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYG 170
Query: 527 ------EATEGSQHISTRVMG----TFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLSG 575
++ M T Y APE M + D++S G + ELL+G
Sbjct: 171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
Query: 576 R 576
+
Sbjct: 231 K 231
|
Length = 335 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 33/252 (13%)
Query: 345 SSTSVSLMSTMATCILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVA 403
SS+S S S+ A+ +LS+LE+ +G G G VY + G A
Sbjct: 51 SSSSSSSSSSSASGSAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYA 103
Query: 404 VKLLTRNNQNGDREFIA-EVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHL 462
+K++ N+++ R I E+E+L ++H N+VK + ++ E + GS+E
Sbjct: 104 LKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH 163
Query: 463 HGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDF 522
D + +A G+AYLH ++HRD K SN+L+ K++DF
Sbjct: 164 IA--------DEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADF 212
Query: 523 GLAREATEGSQHISTRVMGTFGYVAPEYAMT--------GHLLVKSDVYSYGVVLLELLS 574
G++R + ++ V GT Y++PE T G+ D++S GV +LE
Sbjct: 213 GVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYDGY---AGDIWSLGVSILEFYL 268
Query: 575 GRKPVDMSQPQG 586
GR P + + QG
Sbjct: 269 GRFPFGVGR-QG 279
|
Length = 353 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 67/249 (26%), Positives = 111/249 (44%), Gaps = 37/249 (14%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDN--GTEVAVKLLTR--NNQNGDREFIAEVEMLSRLHH 430
+++ + +G G G V D G VAVK L+R NQ + E+ +L ++H
Sbjct: 21 KRYQQLKPIGSGAQGIVC-AAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 79
Query: 431 RNLVKLIGICIEGRTR------CLVYELVHNGSVES-HLHGVDKNRGPLDWEARMKIALG 483
+N++ L+ + ++ LV EL+ + H+ LD E +
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME--------LDHERMSYLLYQ 131
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF 543
G+ +LH +IHRD K SN++++ D T K+ DFGLAR A + + T + T
Sbjct: 132 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAC--TNFMMTPYVVTR 186
Query: 544 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREG 603
Y APE + D++S G ++ EL+ G QG +++ W +
Sbjct: 187 YYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF-----QGTDHIDQWNKV------- 234
Query: 604 LEQLVDPSL 612
+EQL PS
Sbjct: 235 IEQLGTPSA 243
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 383 LGEGGFG--CVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGIC 440
+GEG G C+ G +VAVK + Q EV ++ H N+V++
Sbjct: 27 IGEGSTGIVCIAT-DKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 441 IEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVI 500
+ G +V E + G++ V R ++ E + L + L++LH VI
Sbjct: 86 LVGDELWVVMEFLEGGALTDI---VTHTR--MNEEQIATVCLAVLKALSFLH---AQGVI 137
Query: 501 HRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR--VMGTFGYVAPEYAMTGHLLV 558
HRD K+ ++LL D K+SDFG + S+ + R ++GT ++APE
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPEVISRLPYGT 194
Query: 559 KSDVYSYGVVLLELLSGRKPVDMSQP 584
+ D++S G++++E++ G P P
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYFNEPP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 369 DLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDR-EFIAEVEMLS 426
D EK +E LG G G V+ +G +A KL+ + R + I E+++L
Sbjct: 6 DFEKISE-------LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58
Query: 427 RLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAAR 486
+ +V G + E + GS++ L K G + + K+++ +
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIK 114
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYV 546
GL YL E +++HRD K SN+L+ K+ DFG++ + + ++ +GT Y+
Sbjct: 115 GLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYM 169
Query: 547 APEYAMTGHLLVKSDVYSYGVVLLELLSGRKPV 579
+PE H V+SD++S G+ L+E+ GR P+
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGT--EVAVKLLTRNNQN--GDREFIAEVEMLSRLHH 430
E++ + +G G +G V D +VAVK L+R Q+ R E+ +L + H
Sbjct: 15 ERYQNLTPVGSGAYGSVC-SAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKH 73
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNR----GPLDWEARMKIALGAAR 486
N++ L+ + T E + + ++L G D N L E + R
Sbjct: 74 ENVIGLLDVF----TPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR 129
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA-TEGSQHISTRVMGTFGY 545
GL Y+H +IHRD K SNV + +D ++ DFGLAR+A E + +++TR Y
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WY 181
Query: 546 VAPEYAMTG-HLLVKSDVYSYGVVLLELLSGR 576
APE + H D++S G ++ ELL G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 383 LGEGGFGCVYHG---VMDNGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRNLVKLIG 438
LGEG + V+ G + +N VA+K + ++ G I EV +L L H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTEN--LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 439 ICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIAL-GAARGLAYLHEDSNP 497
I ++ LV+E + + L + G + +KI L RGLAY H
Sbjct: 72 IVHTDKSLTLVFEYL-----DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR--- 123
Query: 498 RVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM-TGHL 556
+V+HRD K N+L+ + K++DFGLAR + ++ S V+ T Y P+ + +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEY 182
Query: 557 LVKSDVYSYGVVLLELLSGR 576
+ D++ G + E+ SGR
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 68/245 (27%), Positives = 120/245 (48%), Gaps = 38/245 (15%)
Query: 381 RILGEGGFGCVY--HGVM--DNGTEVAVKLLT--------RNNQNGDREFIAEVEMLSRL 428
++LG+G FG V+ + D G A+K+L R +R+ +AEV
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------ 55
Query: 429 HHRNLVKL-IGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGA-AR 486
+H +VKL EG+ L+ + + G + + L ++ + E +K L A
Sbjct: 56 NHPFIVKLHYAFQTEGKLY-LILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAELAL 109
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYV 546
L +LH + +I+RD K N+LL+++ K++DFGL++E+ + + + GT Y+
Sbjct: 110 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVEYM 165
Query: 547 APEYA-MTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLE 605
APE GH +D +S+GV++ E+L+G P QG++ T +L + G+
Sbjct: 166 APEVVNRRGHTQ-SADWWSFGVLMFEMLTGSLPF-----QGKDRKETMTM-ILKAKLGMP 218
Query: 606 QLVDP 610
Q + P
Sbjct: 219 QFLSP 223
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 383 LGEGGFGCVYHG---VMDNGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRNLVKLIG 438
LGEG + VY G + DN VA+K + ++ G I EV +L L H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDN--LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 439 ICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIAL-GAARGLAYLHEDSNP 497
I ++ LV+E + + L + G +K+ L RGL Y H
Sbjct: 72 IIHTEKSLTLVFEYL-----DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR--- 123
Query: 498 RVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM-TGHL 556
+V+HRD K N+L+ + K++DFGLAR + ++ S V+ T Y P+ + +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDY 182
Query: 557 LVKSDVYSYGVVLLELLSGR 576
+ D++ G + E+ +GR
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 381 RILGEGGFGCVYHGV-MDNGTEVAVKLL--TRNNQNGDREFIA---EVEMLSRLHHRNLV 434
++LG G FG VY D G E+AVK + ++Q +E A E+++L L H +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 435 KLIGICI---EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
+ G C+ E + + E + GS++ L K G L + +G++YL
Sbjct: 68 QYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQGVSYL 122
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIST---------RVMGT 542
H + ++HRD K +N+L + K+ DFG S+ I T V GT
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFG-------ASKRIQTICMSGTGIKSVTGT 172
Query: 543 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
+++PE K+DV+S ++E+L+ + P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 62/223 (27%), Positives = 107/223 (47%), Gaps = 31/223 (13%)
Query: 375 EKFSSKRILGEGGFGCV---YHGVMDNGTEVAVKLLTR--NNQNGDREFIAEVEMLSRLH 429
+++ + + +G G G V Y V+D VA+K L+R NQ + E+ ++ ++
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDR--NVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 430 HRNLVKLIGICIEGRTR------CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALG 483
H+N++ L+ + ++ LV EL+ +++L V + LD E +
Sbjct: 75 HKNIISLLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIQME--LDHERMSYLLYQ 127
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF 543
G+ +LH +IHRD K SN++++ D T K+ DFGLAR T G+ + T + T
Sbjct: 128 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 182
Query: 544 GYVAPEYAMTGHLLVKSDVYSYGVVLLE------LLSGRKPVD 580
Y APE + D++S G ++ E L GR +D
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 67/237 (28%), Positives = 98/237 (41%), Gaps = 36/237 (15%)
Query: 383 LGEGGFGCVYHG-VMDNGTEVAVKLLTRN---NQNGDREFIAEVEMLSRLHHRNLVKLIG 438
+G+GG+G V+ D G VA+K + ++ N R + E ++L+ LVKL+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 439 ICIEGRTRCLVYELVHNGSVESHLH--GVDKNRGPLDWEARMKIALGAARGLAYLHEDSN 496
+ L E V G + L+ GV + A M A+ A L Y
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY------ 122
Query: 497 PRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE------Y 550
IHRD K N L++ K++DFGL++ + V+G+ Y+APE Y
Sbjct: 123 ---IHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKGY 175
Query: 551 AMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ-ENLVTWA----RPLLTTRE 602
T D +S G +L E L G P S P ENL W RP+
Sbjct: 176 DFT------VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPR 226
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 382 ILGEGGFGCVYHGV-MDNGTEVAVKLLTR--NNQNGDREFIAEVEMLSRLHHRNLVKLIG 438
++G+G +G V + G +VA+K + + + + E+++L L H ++V++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 439 ICI-----EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
I + E + +V+EL+ ES LH V K L E R L Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT 121
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE--GSQHISTRVMGTFGYVAPEYA 551
+ V HRD K N+L D K+ DFGLAR A + T + T Y APE
Sbjct: 122 AN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-- 176
Query: 552 MTGHLLVKS----DVYSYGVVLLELLSGR 576
+ G K D++S G + E+L+G+
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 11/149 (7%)
Query: 436 LIGI--CIEGRTRC-LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
L+G+ C + +R LV E V+ G + H+ + R + AR A L +LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ---RQRKLPEEHARF-YAAEICIALNFLH 113
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM 552
E +I+RD K NVLL+ D K++D+G+ +E ST GT Y+APE
Sbjct: 114 ERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILR 169
Query: 553 TGHLLVKSDVYSYGVVLLELLSGRKPVDM 581
D ++ GV++ E+++GR P D+
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 383 LGEGGFGCV-YHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICI 441
+GEG G V +G +VAVK++ Q EV ++ H+N+V++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 442 EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIH 501
G ++ E + G++ + N E + + L YLH VIH
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTRLNE-----EQIATVCESVLQALCYLHSQG---VIH 140
Query: 502 RDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR--VMGTFGYVAPEYAMTGHLLVK 559
RD K+ ++LL D K+SDFG + S+ + R ++GT ++APE +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 560 SDVYSYGVVLLELLSGRKP 578
D++S G++++E++ G P
Sbjct: 198 VDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 9e-11
Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 33/221 (14%)
Query: 377 FSSKRILGEGGFGCVY---HGVMDNGTEVAVKLLT-----RNNQNGDREFIAEVEMLSRL 428
F + LG G FG V H +G A+K+L+ + Q + E +L +
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHK--GSGKYYALKILSKAKIVKLKQ--VEHVLNEKRILQSI 58
Query: 429 HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARM---KIALGAA 485
H LV L G + LV E V G + SHL R P AR ++ L
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPV-ARFYAAQVVLA-- 113
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGY 545
L YLH + +++RD K N+LL+ D K++DFG A+ + + GT Y
Sbjct: 114 --LEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEY 164
Query: 546 VAPEYAM-TGHLLVKS-DVYSYGVVLLELLSGRKPVDMSQP 584
+APE + G+ K+ D ++ G+++ E+L+G P P
Sbjct: 165 LAPEIILSKGY--GKAVDWWALGILIYEMLAGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 383 LGEGGFGCVYHGVMDN-GTEVAVK--LLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGI 439
+GEG +G VY G G VA+K L + I E+ +L L H N+V L +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 440 CIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRV 499
++ L++E + + ++ +L + K +D E +G+ + H RV
Sbjct: 68 LMQESRLYLIFEFL-SMDLKKYLDSLPKG-QYMDAELVKSYLYQILQGILFCHSR---RV 122
Query: 500 IHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRV----MGTFGYVAPEYAMTGH 555
+HRD K N+L+++ K++DFGLAR + I RV + T Y APE +
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLAR-----AFGIPVRVYTHEVVTLWYRAPEVLLGSP 177
Query: 556 LL-VKSDVYSYGVVLLELLSGRKPV 579
D++S G + E+ + +KP+
Sbjct: 178 RYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 70/261 (26%), Positives = 110/261 (42%), Gaps = 46/261 (17%)
Query: 375 EKFSSKRILGEGGFGCVY---HGVMDNGTEVAVKLLTRNN---QNGDREFIAEVEMLSRL 428
E F + +++ G +G VY H + A+K + + N +N ++ E ++L+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRH--KETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA 58
Query: 429 HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWE-ARMKIALGAARG 487
+ +V + R C+V E V G + L KN G L + ARM A
Sbjct: 59 ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL----KNIGALPVDMARMYFA-ETVLA 113
Query: 488 LAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR--------EATEGSQHISTR- 538
L YLH N ++HRD K N+L+ K++DFGL++ EG TR
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 539 -----VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP--------------- 578
V GT Y+APE + D ++ G++L E L G P
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 230
Query: 579 VDMSQPQGQENLVTWARPLLT 599
D+ P+G E L A+ L++
Sbjct: 231 DDIEWPEGDEALPADAQDLIS 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 67/286 (23%), Positives = 119/286 (41%), Gaps = 49/286 (17%)
Query: 383 LGEGGFGCVYHGVMDN---------GTEVAVKL-LTRNNQNGDREFIAEVEMLSRLHHRN 432
LG+G F +Y GV+ G EV+V L + ++ F ++S+L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
LVKL G+C+ +V E V G ++ LH + + + ++ +A A L YL
Sbjct: 63 LVKLYGVCVRDENI-MVEEYVKFGPLDVFLH---REKNNVSLHWKLDVAKQLASALHYL- 117
Query: 493 EDSNPRVIHRDFKASNVLL-----EDDFTP--KVSDFGLAREATEGSQHISTRVMGTFGY 545
ED ++H + N+L+ + + P K+SD G+ + + +
Sbjct: 118 EDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-----RIPW 170
Query: 546 VAPEYAMTGH--LLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREG 603
+APE G L + +D +S+G LLE+ S +S E +
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICS-NGEEPLSTLSSSEKERFYQDQ------- 222
Query: 604 LEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649
+L P D A++A + + C + T RP +++ L
Sbjct: 223 -HRLPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 38/120 (31%), Positives = 63/120 (52%), Gaps = 8/120 (6%)
Query: 458 VESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP 517
VE G + + PL E + + ARG+ +L ++ + IHRD A N+LL ++
Sbjct: 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVV 212
Query: 518 KVSDFGLAREATEGSQHI---STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS 574
K+ DFGLAR+ + ++ R+ ++APE +SDV+S+GV+L E+ S
Sbjct: 213 KICDFGLARDIYKDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 4/92 (4%)
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYV 546
GL +LH +I+RD K NV+L+ D K++DFG+ +E G ST GT Y+
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYI 163
Query: 547 APEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
APE D +S+GV+L E+L G+ P
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQN---GDREFIAEVEMLSRLHH 430
E+++S + +G G +G V + G +VA+K L+R Q+ R + E+ +L + H
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQH 73
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVD--KNRG-PLDWEARMKIALGAARG 487
N++ L+ + T + + + + D K G PL + + G
Sbjct: 74 ENVIGLLDV----FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCG 129
Query: 488 LAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA-TEGSQHISTRVMGTFGYV 546
L Y+H +IHRD K N+ + +D K+ DFGLAR A E + ++ TR Y
Sbjct: 130 LKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYR 181
Query: 547 APEYAMTG-HLLVKSDVYSYGVVLLELLSGR 576
APE + H D++S G ++ E+L+G+
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 17/211 (8%)
Query: 377 FSSKRILGEGGFGCVYHGVMDNGTEV-AVKLLTRNN--QNGDRE-FIAEVEMLSRLHHRN 432
F+ +LG+G FG V E+ A+K+L ++ Q+ D E + E +L+
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 433 LVKLIGICIEGRTRC-LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
+ + C + R V E V+ G + + V + + P +IA+G L +L
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LFFL 117
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT-EGSQHISTRVM-GTFGYVAPE 549
H +I+RD K NV+L+ + K++DFG+ +E +G ++T+ GT Y+APE
Sbjct: 118 HSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTPDYIAPE 171
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLSGRKPVD 580
D +++GV+L E+L+G+ P +
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 376 KFSSKRILGEGGFG---CVYHGVMDNG---TEVAVKLLTRNNQNGDREFIAEVEMLSRLH 429
+++ R++GEG FG V H D E+ + + ++ +E + +L+++
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAV----LLAKMK 56
Query: 430 HRNLVKLIGICIEGRTRC-LVYELVHNGSVESHLHGVDKNRGPL-------DWEARMKIA 481
H N+V E +V E G + + + RG L W +M +
Sbjct: 57 HPNIVAFKE-SFEADGHLYIVMEYCDGGDL---MQKIKLQRGKLFPEDTILQWFVQMCL- 111
Query: 482 LGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMG 541
G+ ++HE RV+HRD K+ N+ L + K+ DFG AR T + T V G
Sbjct: 112 -----GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-G 162
Query: 542 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
T YV PE KSD++S G +L EL + + P
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 383 LGEGGFGCVYHGVMDNGTEVA---VKLLTRN-NQNGDREFIAEVEMLSRLHHRNLVKLIG 438
+G G FG V + T VA VK L N + EF+ + + L H N+++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 439 ICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPR 498
C+E LV+E G ++S+L +R ++A A G+ ++H+ +
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--- 119
Query: 499 VIHRDFKASNVLLEDDFTPKVSDFGLA----RE---ATEGSQHISTRVMGTFGYVAPEY- 550
+H D N L D T KV D+G+ +E TE + + R ++APE
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR------WLAPELV 173
Query: 551 -AMTGHLLVK-----SDVYSYGVVLLELL 573
G L+ S+V++ GV L EL
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 52/195 (26%), Positives = 80/195 (41%), Gaps = 21/195 (10%)
Query: 388 FGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRC 447
F C HG +V VK +T G + E+++L + HR ++ LI T C
Sbjct: 109 FVCTKHGDEQR-KKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHAYRWKSTVC 162
Query: 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKAS 507
+V + + +++ GPL E + I LAYLH +IHRD K
Sbjct: 163 MVMP-KYKCDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTE 214
Query: 508 NVLLEDDFTPKVSDFGLAREATEGSQHISTRV----MGTFGYVAPEYAMTGHLLVKSDVY 563
N+ L++ + DFG A + H T GT +PE K+D++
Sbjct: 215 NIFLDEPENAVLGDFGAACKLDA---HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIW 271
Query: 564 SYGVVLLELLSGRKP 578
S G+VL E+
Sbjct: 272 SAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 4/92 (4%)
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYV 546
GL +LH +++RD K N+LL+ D K++DFG+ +E G T GT Y+
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYI 163
Query: 547 APEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
APE + D +S+GV+L E+L G+ P
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 33/210 (15%)
Query: 385 EGGFGCVYHGVMDNGTE--VAVKLLT-RNNQNGDREF----IAEVEMLSRLHHRNLVKLI 437
EG +G VY D T VA+K L + G F + E+ +L +L H N+V +
Sbjct: 15 EGTYGVVYRA-RDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIVTVK 70
Query: 438 GICIEGRTRCLVYELVHNGSVESHLHGV-DKNRGPLDWEARMKIALGAARGLAYLHEDSN 496
+ + G +Y +V VE L + + + P + L G+A+LH++
Sbjct: 71 EVVV-GSNLDKIY-MVME-YVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW- 126
Query: 497 PRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHL 556
++HRD K SN+LL + K+ DFGLARE + T+++ T Y APE L
Sbjct: 127 --ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVVTLWYRAPE------L 177
Query: 557 LV-------KSDVYSYGVVLLELLSGRKPV 579
L+ D++S G + ELL+ +KP+
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKL----LTRNNQNGDREFIAEVEMLSRLHH 430
+++ +GEG +G VY D T + L L + ++ I E+ +L + H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKA-RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGV-DKNRGPLDWEARMKIALGAARGLA 489
N+V+L + + LV+E + + ++ H+ D + P + + L RG+A
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL---RGIA 116
Query: 490 YLHEDSNPRVIHRDFKASNVLLE-DDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAP 548
Y H RV+HRD K N+L++ K++DFGLAR + + V+ T Y AP
Sbjct: 117 YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAP 172
Query: 549 EYAM-TGHLLVKSDVYSYGVVLLELLSGR 576
E + + H D++S G + E+++ +
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 38/93 (40%), Positives = 55/93 (59%), Gaps = 6/93 (6%)
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYV 546
GL +LH+ +I+RD K NVLL+ D K++DFG+ +E G ST GT Y+
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYI 163
Query: 547 APEYAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
APE + G +S D +S+GV+L E+L G+ P
Sbjct: 164 APE-ILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 44/149 (29%), Positives = 74/149 (49%), Gaps = 11/149 (7%)
Query: 436 LIGI--CIEGRTRCL-VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
L+G+ C + +R V E V+ G + H+ + R + AR A + L YLH
Sbjct: 58 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSA-EISLALNYLH 113
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM 552
E +I+RD K NVLL+ + K++D+G+ +E ++ GT Y+APE
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTFCGTPNYIAPEILR 169
Query: 553 TGHLLVKSDVYSYGVVLLELLSGRKPVDM 581
D ++ GV++ E+++GR P D+
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 11/198 (5%)
Query: 383 LGEGGFGCVYHGV-MDNGTEVAVK--LLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGI 439
+GEG +G VY G VA+K L + I E+ +L L+H N+VKL+ +
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 440 CIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRV 499
LV+E +H ++ + + PL L +GLA+ H RV
Sbjct: 68 IHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCHSH---RV 121
Query: 500 IHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM-TGHLLV 558
+HRD K N+L+ + K++DFGLAR + + V+ T Y APE + +
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYST 180
Query: 559 KSDVYSYGVVLLELLSGR 576
D++S G + E+++ R
Sbjct: 181 AVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 26/208 (12%)
Query: 383 LGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIA-EVEMLSRLHHRNLVKLIG--I 439
+G G +G VY + E+A + + D I E+ M+ H N+V G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 440 CIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIAL---GAARGLAYLHEDSN 496
E C+ Y GS++ H GPL + ++IA +GLAYLH
Sbjct: 77 SREKLWICMEY--CGGGSLQDIYHVT----GPL---SELQIAYVCRETLQGLAYLHSKGK 127
Query: 497 PRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR--VMGTFGYVAPEYAM-- 552
+HRD K +N+LL D+ K++DFG+A + T I+ R +GT ++APE A
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVAAKITAT---IAKRKSFIGTPYWMAPEVAAVE 181
Query: 553 -TGHLLVKSDVYSYGVVLLELLSGRKPV 579
G D+++ G+ +EL + P+
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 383 LGEGGFGCVYH------GVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKL 436
LG+G +G VY GV E+ ++L +++ + I E+++L + +V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLEL----DESKFNQIIMELDILHKAVSPYIVDF 64
Query: 437 IG-ICIEGRTRCLVY--ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
G IEG + E + GS++ L+ + + +I +GL +L E
Sbjct: 65 YGAFFIEG---AVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT 553
+ N +IHRD K +NVL+ + K+ DFG++ ++ +G Y+APE +
Sbjct: 121 EHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---LAKTNIGCQSYMAPERIKS 175
Query: 554 GHLL------VKSDVYSYGVVLLELLSGRKP 578
G V+SDV+S G+ +LE+ GR P
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 36/208 (17%)
Query: 383 LGEGGFGCVYHG-VMDNGTEVAVKLLTRNNQNGDREFI---AEVEMLSRL-HHRNLVKLI 437
+GEG F V G A+K + E + E++ L RL H N+++LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 438 GICIEGRTRC--LVYELVHNGSVESHLHGVDKNRG-PLDWEARMKIAL-GAARGLAYLHE 493
+ + +T LV+EL+ + +L+ + K R PL E R+K + + L ++H
Sbjct: 65 EVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLP-EKRVKSYMYQLLKSLDHMHR 118
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA------TEGSQHISTRVMGTFGYVA 547
+ + HRD K N+L++DD K++DFG R TE +ISTR Y A
Sbjct: 119 NG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE---YISTR-----WYRA 166
Query: 548 PEYAMT-GHLLVKSDVYSYGVVLLELLS 574
PE +T G+ K D+++ G V E+LS
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 48/218 (22%)
Query: 383 LGEGGFGCVYHGV-MDNGTEVAVK--LLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGI 439
+GEG +G VY G VA+K L ++ I E+ +L L+H N+V+L+ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 440 CIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARM----KIALGAA---------- 485
LV+E + LD + M L
Sbjct: 67 VHSENKLYLVFEFLD-----------------LDLKKYMDSSPLTGLDPPLIKSYLYQLL 109
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMG---- 541
+G+AY H S+ RV+HRD K N+L++ + K++DFGLAR + + R
Sbjct: 110 QGIAYCH--SH-RVLHRDLKPQNLLIDREGALKLADFGLAR-----AFGVPVRTYTHEVV 161
Query: 542 TFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKP 578
T Y APE + D++S G + E+++ R+P
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 19/162 (11%)
Query: 436 LIGI--CIEGRTRC-LVYELVHNGSVESHLHGVDKNRGPLDWEARM---KIALGAARGLA 489
L+G+ C + +R V E V G + H+ + R + AR +I+L L
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQ---RQRKLPEEHARFYSAEISLA----LN 110
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549
+LHE +I+RD K NVLL+ + K++D+G+ +E ST GT Y+APE
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYIAPE 166
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLSGRKPVDM--SQPQGQEN 589
D ++ GV++ E+++GR P D+ +N
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 62/212 (29%), Positives = 93/212 (43%), Gaps = 36/212 (16%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNN--QNGDREFIAEVEMLSRL 428
EKAT ++ + +IL + V+ EVA LT N QN F+ ++ +
Sbjct: 16 EKATGRYYAMKILKKE--------VIVAKDEVA-HTLTENRVLQNSRHPFLTALKYSFQT 66
Query: 429 HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGA--AR 486
H R C V E + G + HL +R + E R + GA
Sbjct: 67 HDR--------------LCFVMEYANGGELFFHL-----SRERVFSEDRARF-YGAEIVS 106
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYV 546
L YLH + N V++RD K N++L+ D K++DFGL +E + + T GT Y+
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYL 163
Query: 547 APEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
APE D + GVV+ E++ GR P
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 375 EKFSSKRILGEGGFGCV---YHGVMDNGTEVAVKLLTR--NNQNGDREFIAEVEMLSRLH 429
+++ + + +G G G V Y +++ VA+K L+R NQ + E+ ++ ++
Sbjct: 24 KRYQNLKPIGSGAQGIVCAAYDAILER--NVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 430 HRNLVKLIGICI------EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALG 483
H+N++ L+ + E + +V EL+ +++L V + LD E +
Sbjct: 82 HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQME--LDHERMSYLLYQ 134
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF 543
G+ +LH +IHRD K SN++++ D T K+ DFGLAR T G+ + T + T
Sbjct: 135 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 189
Query: 544 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGR 576
Y APE + D++S G ++ E++ G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 376 KFSSKRILGEGGFG-CVYHGVMDNGTEVAVKLL--TRNNQNGDREFIAEVEMLSRLHHRN 432
K+ + +GEG FG + ++G + +K + ++ + E EV +LS + H N
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGP-------LDWEARMKIALGAA 485
+V+ E +V + G + ++ RG LDW ++ +AL
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDL---YKKINAQRGVLFPEDQILDWFVQICLAL--- 114
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGY 545
++H+ +++HRD K+ N+ L D T K+ DFG+AR + ++ +GT Y
Sbjct: 115 ---KHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYY 167
Query: 546 VAPEYAMTGHLLVKSDVYSYGVVLLELLS 574
++PE KSD+++ G VL E+ +
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 376 KFSSKRILGEGGFGCVYHGVMDNGTE-VAVKLL--TRNNQNGDREFIAEVEMLSRLHHRN 432
KF ++GEG +G V E VA+K + N+ + E++ML L N
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVE---SHLHGV--DKNRGPLDWEARMKIALGAARG 487
+V+L LV+E V +E +GV +K R + +
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI---------YQLIKA 112
Query: 488 LAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVA 547
+ + H++ ++HRD K N+L+ + K+ DFG AR +EGS T + T Y +
Sbjct: 113 IHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRS 169
Query: 548 PEYAMTGHLLVKSDVYSYGVVLLELLSGR 576
PE + D++S G +L EL G+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 381 RILGEGGFG---CVYHGVMDNGTEVAVKLLTRNNQNGDREFI-AEVEMLSRLHHRNLVKL 436
R++G+G +G V H D V KL RN +R+ E ++LS+L H N+V
Sbjct: 6 RVVGKGSYGEVSLVRHR-TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-A 63
Query: 437 IGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEAR-MKIALGAARGLAYLHEDS 495
EG L+Y ++ H + + +G L E + ++ + A L YLHE
Sbjct: 64 YRESWEGED-GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK- 121
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGH 555
++HRD K NV L KV D G+AR E +++ ++GT Y++PE
Sbjct: 122 --HILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPELFSNKP 178
Query: 556 LLVKSDVYSYGVVLLEL 572
KSDV++ G + E+
Sbjct: 179 YNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 22/221 (9%)
Query: 381 RILGEGGFGCVY----HGVMDNGTEVAVKLLTR----NNQNGDREFIAEVEMLSRLHHRN 432
R+LG G +G V+ G D G A+K+L + E ++L +
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 433 LVKLIGICIEGRTRC-LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGA-ARGLAY 490
+ + + T+ L+ + V+ G + +HL+ R E+ +++ + L +
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLY----QREHFT-ESEVRVYIAEIVLALDH 120
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
LH+ +I+RD K N+LL+ + ++DFGL++E + + GT Y+APE
Sbjct: 121 LHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177
Query: 551 AMT---GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE 588
GH D +S GV+ ELL+G P + Q +
Sbjct: 178 IRGGSGGHDKA-VDWWSLGVLTFELLTGASPFTVDGEQNSQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 381 RILGEGGFG-CVYHGVMDNGTEVAVKLLTRNNQNGDREF---IAEVEMLSRLHHRNLVKL 436
++LG+G FG + +G A+K+L + E + E +L H L L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 437 IGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGA--ARGLAYLHE 493
+ + R C V E V+ G + HL +R + E R + GA L YLH
Sbjct: 61 -KYSFQTKDRLCFVMEYVNGGELFFHL-----SRERVFSEDRTRF-YGAEIVSALDYLHS 113
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT 553
++++RD K N++L+ D K++DFGL +E + + T GT Y+APE
Sbjct: 114 G---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLED 169
Query: 554 GHLLVKSDVYSYGVVLLELLSGRKP 578
D + GVV+ E++ GR P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 13/203 (6%)
Query: 381 RILGEGGFGCVYHGV-MDNGTEVAVKLLTRN---NQNGDREFIAEVE-MLSRLHHRNLVK 435
+++G+G FG V +G AVK+L + + + +AE +L + H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 436 LIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS 495
L V + V+ G + HL + R + AR A A L YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQ---RERSFPEPRARF-YAAEIASALGYLHS-- 114
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGH 555
+I+RD K N+LL+ ++DFGL +E E S+ ST GT Y+APE
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLRKQP 172
Query: 556 LLVKSDVYSYGVVLLELLSGRKP 578
D + G VL E+L G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 380 KRILGEGGFGCVYHGVM----DNGTEVAVKLLTR----NNQNGDREFIAEVEMLSRLHHR 431
++LG+GG+G V+ D G A+K+L + NQ AE +L + H
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGA-ARGLAY 490
+V LI G L+ E + G + HL R + E L + L +
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLE-----REGIFMEDTACFYLSEISLALEH 115
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
LH+ +I+RD K N+LL+ K++DFGL +E+ T GT Y+APE
Sbjct: 116 LHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYMAPEI 171
Query: 551 AM-TGHLLVKS-DVYSYGVVLLELLSGRKP 578
M +GH K+ D +S G ++ ++L+G P
Sbjct: 172 LMRSGH--GKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA-----EVEMLSRL 428
+++ + +G G +G V + G +VA+K L R Q+ E A E+ +L +
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS---ELFAKRAYRELRLLKHM 71
Query: 429 HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNR----GPLDWEARMKIALGA 484
H N++ L+ + T L + H+ + G D + L + +
Sbjct: 72 KHENVIGLLDVF----TPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM 127
Query: 485 ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA-TEGSQHISTRVMGTF 543
+GL Y+H +IHRD K N+ + +D K+ DFGLAR+ +E + ++ TR
Sbjct: 128 LKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR----- 179
Query: 544 GYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGR 576
Y APE + H D++S G ++ E+L+G+
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 38/112 (33%), Positives = 58/112 (51%), Gaps = 11/112 (9%)
Query: 472 LDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531
LD E + + A+G+++L ++ IHRD A N+LL K+ DFGLAR+
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 532 SQHISTRVMGT----FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
S ++ V G ++APE +SDV+SYG++L E+ S G P
Sbjct: 268 SNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 35/217 (16%)
Query: 376 KFSSKRILGEGGFGCV---YHGVMDNGTEVAVKLLTRNNQN------GDREFIAEVEMLS 426
++ + + +G G G V Y V VA+K L+R QN RE + ++
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQ--NVAIKKLSRPFQNVTHAKRAYRELV----LMK 70
Query: 427 RLHHRNLVKLIGICIEGRTR------CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKI 480
++H+N++ L+ + ++ LV EL+ +++L V + LD E RM
Sbjct: 71 LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIQMD--LDHE-RMSY 122
Query: 481 ALGAAR-GLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRV 539
L G+ +LH + +IHRD K SN++++ D T K+ DFGLAR T G+ + T
Sbjct: 123 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPY 177
Query: 540 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGR 576
+ T Y APE + D++S G ++ E++ G
Sbjct: 178 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 381 RILGEGGFGCVYHGVMDNGTEV-AVKLLTRNN--QNGDRE-FIAEVEMLSRLHHRNLVKL 436
++LG+G FG V + EV A+K+L ++ Q+ D + + E +L+ +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 437 IGICIEGRTRCL-VYELVHNGSVESHLHGVDKNRGPLDWEARMKI-ALGAARGLAYLHED 494
+ C + + R V E V+ G + + + ++R D E R + A L +LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSR-KFD-EPRSRFYAAEVTLALMFLHRH 115
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG 554
VI+RD K N+LL+ + K++DFG+ +E +T GT Y+APE
Sbjct: 116 G---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFCGTPDYIAPEILQEL 171
Query: 555 HLLVKSDVYSYGVVLLELLSGRKP 578
D ++ GV++ E+++G+ P
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 5e-09
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIA-EVEMLSRLHHRNL 433
E F + +G G +G VY N E+A + + D + E+ M+ H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
V G + + E GS++ H GPL ++ +GL YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLH- 123
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR--VMGTFGYVAPEYA 551
+ +HRD K +N+LL D+ K++DFG++ + T I+ R +GT ++APE A
Sbjct: 124 --SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT---IAKRKSFIGTPYWMAPEVA 178
Query: 552 MT---GHLLVKSDVYSYGVVLLELLSGRKPV 579
G D+++ G+ +EL + P+
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 7e-09
Identities = 41/131 (31%), Positives = 64/131 (48%), Gaps = 21/131 (16%)
Query: 488 LAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE-ATEGSQHISTRVMGTFGYV 546
L +H + +IHRD K++N+LL + K+ DFG ++ A S + GT YV
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 547 APEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606
APE K+D++S GV+L ELL+ ++P D E +E+
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD--------------------GENMEE 252
Query: 607 LVDPSLAGSYD 617
++ +LAG YD
Sbjct: 253 VMHKTLAGRYD 263
|
Length = 496 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 38/112 (33%), Positives = 61/112 (54%), Gaps = 9/112 (8%)
Query: 471 PLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530
PL E + + ARG+ +L ++ + IHRD A N+LL ++ K+ DFGLAR+ +
Sbjct: 170 PLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 531 GSQHI---STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
++ S R+ ++APE +SDV+S+GV+L E+ S G P
Sbjct: 227 DPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 63/218 (28%), Positives = 89/218 (40%), Gaps = 44/218 (20%)
Query: 382 ILGEGGFGCVYHGVMDNGTEV-AVKLLTRNNQNGDREFIA---EVEML----------SR 427
+LG G FG V E+ A+K L + I EVE L +
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKK-------GDIIARDEVESLMCEKRIFETANS 58
Query: 428 LHHRNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKI-ALGAA 485
H LV L C + C V E G + H+H + E R A
Sbjct: 59 ERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIH---TDVFS---EPRAVFYAACVV 111
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGY 545
GL YLHE+ ++++RD K N+LL+ + K++DFGL +E ST GT +
Sbjct: 112 LGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEF 167
Query: 546 VAPEYAMTGHLLVKS-----DVYSYGVVLLELLSGRKP 578
+APE L S D + GV++ E+L G P
Sbjct: 168 LAPEV-----LTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-09
Identities = 59/234 (25%), Positives = 108/234 (46%), Gaps = 34/234 (14%)
Query: 368 SDLEKATEK-FSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEML 425
+D+ ++ K + I+G G FG VY + +D +VA+K + ++ Q +RE + ++
Sbjct: 58 NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IM 113
Query: 426 SRLHHRNLVKLIGI----CIEGRTRCLVYELVHN---GSVESHLHGVDKNRGPLDWEARM 478
L+H N++ L C + + + +V +V ++ +N L
Sbjct: 114 KNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVK 173
Query: 479 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE-DDFTPKVSDFGLAREATEGSQHIST 537
+ R LAY+H + + HRD K N+L++ + T K+ DFG A+ G + +S
Sbjct: 174 LYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY 230
Query: 538 RVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLE------LLSGRKPVD 580
+ F Y APE + T H+ D++S G ++ E + SG+ VD
Sbjct: 231 -ICSRF-YRAPELMLGATNYTTHI----DLWSLGCIIAEMILGYPIFSGQSSVD 278
|
Length = 440 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 61/212 (28%), Positives = 90/212 (42%), Gaps = 37/212 (17%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNN--QNGDREFIAEVEMLSRL 428
EKAT K+ + +IL + V+ EVA LT + QN F+ ++ +
Sbjct: 16 EKATGKYYAMKILKKE--------VIIAKDEVA-HTLTESRVLQNTRHPFLTALKYSFQT 66
Query: 429 HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGA--AR 486
H R C V E + G + HL +R + E R + GA
Sbjct: 67 HDR--------------LCFVMEYANGGELFFHL-----SRERVFSEDRARF-YGAEIVS 106
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYV 546
L YLH V++RD K N++L+ D K++DFGL +E + T GT Y+
Sbjct: 107 ALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYL 162
Query: 547 APEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
APE D + GVV+ E++ GR P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 36/117 (30%), Positives = 62/117 (52%), Gaps = 9/117 (7%)
Query: 466 DKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525
D + L E + + A+G+ +L ++ + IHRD A N+LL ++ K+ DFGLA
Sbjct: 170 DLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLA 226
Query: 526 REATEGSQHI---STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
R+ + ++ R+ ++APE ++SDV+S+GV+L E+ S G P
Sbjct: 227 RDIYKDPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 63/236 (26%), Positives = 100/236 (42%), Gaps = 52/236 (22%)
Query: 362 VKTFALSDLEKATEKFSSKRILGEGGFG----CVYHGVMDNGTEVAVKLLTRNNQNGDRE 417
++ LSD E LG G FG + G G A+K L + RE
Sbjct: 12 TSSWKLSDFEM-------GETLGTGSFGRVRIAKHKG---TGEYYAIKCLKK------RE 55
Query: 418 FI---------AEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKN 468
+ E +L L H +V ++ + + E V G + +HL
Sbjct: 56 ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA--G 113
Query: 469 RGPLD----WEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524
R P D + A + +A YLH + +I+RD K N+LL++ KV+DFG
Sbjct: 114 RFPNDVAKFYHAELVLAF------EYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGF 164
Query: 525 AREATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKS-DVYSYGVVLLELLSGRKP 578
A++ + + + GT Y+APE + GH K+ D ++ GV+L E ++G P
Sbjct: 165 AKKVPDRTFTLC----GTPEYLAPEVIQSKGH--GKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 67/255 (26%), Positives = 117/255 (45%), Gaps = 41/255 (16%)
Query: 397 DNGTE--VAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454
+NG E V +K+L ++++ F ++S++ H +L + G+C+ G +V E V
Sbjct: 40 NNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVE 99
Query: 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVL---- 510
+G ++ L +K R P+ W ++ +A A L+YL ED N ++H + A N+L
Sbjct: 100 HGPLDVCLRK-EKGRVPVAW--KITVAQQLASALSYL-EDKN--LVHGNVCAKNILLARL 153
Query: 511 -LEDDFTP--KVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYG 566
L + +P K+SD G++ A + + ++APE G L +D +S+G
Sbjct: 154 GLAEGTSPFIKLSDPGVSFTALSREERVE-----RIPWIAPECVPGGNSLSTAADKWSFG 208
Query: 567 VVLLEL-LSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVA 625
LLE+ G P+ P +E E +L +PS ++A
Sbjct: 209 TTLLEICFDGEVPLKERTPSEKERFY----------EKKHRLPEPSC---------KELA 249
Query: 626 AIASMCVHPEVTHRP 640
+ S C+ E T RP
Sbjct: 250 TLISQCLTYEPTQRP 264
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 61/206 (29%), Positives = 90/206 (43%), Gaps = 20/206 (9%)
Query: 381 RILGEGGFGCVYHGVMD--NGTEVAVKLLTRNNQNGDREF---IAEVEMLSRLHHRNLVK 435
++LG+G FG V V + G A+K+L + E + E +L H L
Sbjct: 1 KLLGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 436 LIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGA--ARGLAYLH 492
L + R C V E + G + HL +R + E R + GA L YLH
Sbjct: 60 L-KYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARF-YGAEIVSALEYLH 112
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM 552
V++RD K N++L+ D K++DFGL +E + T GT Y+APE
Sbjct: 113 SRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLE 168
Query: 553 TGHLLVKSDVYSYGVVLLELLSGRKP 578
D + GVV+ E++ GR P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 41/200 (20%), Positives = 92/200 (46%), Gaps = 22/200 (11%)
Query: 391 VYHGVMDNGTEVAVKLLTRNNQNGD---REFIAEVEMLSRLHHRNLVKLIGICIEGRTRC 447
+Y G+ +N EV ++ + ++ E++ L R+ N++K+ G I+
Sbjct: 36 IYKGIFNN-KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE-DSNPRVIHRDFKA 506
L+ +L V L ++ ++ +A+ +GL L++ + P +++ +
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTS 151
Query: 507 SNVLLEDDFTPKVSDFGLAR-EATEGSQHISTRVMGTFGY-----VAPEYAMTGHLLVKS 560
+ L+ +++ K+ GL + ++ ++++ M F Y + EY +K
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSPPFKNVNF--MVYFSYKMLNDIFSEY------TIKD 203
Query: 561 DVYSYGVVLLELLSGRKPVD 580
D+YS GVVL E+ +G+ P +
Sbjct: 204 DIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 57/234 (24%), Positives = 100/234 (42%), Gaps = 42/234 (17%)
Query: 377 FSSKRILGEGGFGCVY----HGVMDNGTEVAVKLL----------TRNNQNGDR---EFI 419
F ++LG G +G V+ D G A+K+L T + +R E +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 420 AEVEMLSRLHHRNLVKLIGICIEGRTRC-LVYELVHNGSVESHLHGVDKNRGPLDWEARM 478
+ L LH+ + + L+ + V G + +HL+ D E +
Sbjct: 62 RQSPFLVTLHY---------AFQTEAKLHLILDYVSGGEMFTHLYQRDNFS-----EDEV 107
Query: 479 KIALGAA-RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIST 537
+ G L +LH+ +++RD K N+LL+ + ++DFGL++E + +
Sbjct: 108 RFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY 164
Query: 538 RVMGTFGYVAPEY--AMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN 589
GT Y+APE GH D +S G+++ ELL+G P + +G+ N
Sbjct: 165 SFCGTIEYMAPEIIRGKGGHGKA-VDWWSLGILIFELLTGASPFTL---EGERN 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 485 ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF- 543
ARG+ +L ++ +HRD A NVLL K+ DFGLAR+ S ++S TF
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STFL 301
Query: 544 --GYVAPEYAMTGHLLVKSDVYSYGVVLLELLS 574
++APE SDV+SYG++L E+ S
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDRE---FIAEVE-MLSRLHHRNLVK 435
+++G+G FG V +G+ AVK+L + +E +AE +L L H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 436 LIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS 495
L V + V+ G + HL + R L+ AR A A + YLH +
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQ---RERCFLEPRARF-YAAEVASAIGYLHSLN 116
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGH 555
+I+RD K N+LL+ ++DFGL +E E + ST GT Y+APE
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEP 172
Query: 556 LLVKSDVYSYGVVLLELLSGRKPV---DMSQ 583
D + G VL E+L G P D+SQ
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 13/203 (6%)
Query: 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRN---NQNGDREFIAEVE-MLSRLHHRNLVK 435
+++G+G FG V +G AVK+L + N+ + +AE +L + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 436 LIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS 495
L V + V+ G + HL + R + AR A A L YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQ---RERSFPEPRARFYAA-EIASALGYLH--- 113
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGH 555
+ +++RD K N+LL+ ++DFGL +E S +T GT Y+APE
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTTTFCGTPEYLAPEVIRKQP 172
Query: 556 LLVKSDVYSYGVVLLELLSGRKP 578
D + G VL E+L G P
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGT--EVAVKLLTRNN---QNGDREFIAEVEMLSRLH 429
E F+ R LG G FG V N VA+K ++ Q +E ++L+ ++
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLD----WEARMKIALGAA 485
H V L G + LV E V G + L R P D + A++ +
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR--RNKRFPNDVGCFYAAQIVLIFEYL 147
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR---VMGT 542
+ L +++RD K N+LL+ D K++DFG A+ + TR + GT
Sbjct: 148 QSL---------NIVYRDLKPENLLLDKDGFIKMTDFGFAKV-------VDTRTYTLCGT 191
Query: 543 FGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQP 584
Y+APE + GH +D ++ G+ + E+L G P ++P
Sbjct: 192 PEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (130), Expect = 2e-07
Identities = 47/187 (25%), Positives = 81/187 (43%), Gaps = 27/187 (14%)
Query: 417 EFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL--VYELVHNGSVESHLHGVDKNRGPLDW 474
+ + EV ++ L H+N+V+ I + + L + E G + ++ K G ++
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 475 EARMKIALGAARGLAYLHE----DSNPRVIHRDFKASNVLLEDDF--------------- 515
A + I LAY H + RV+HRD K N+ L
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 516 --TPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVLLE 571
K+ DFGL++ G + ++ +GT Y +PE + T KSD+++ G ++ E
Sbjct: 178 RPIAKIGDFGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235
Query: 572 LLSGRKP 578
L SG+ P
Sbjct: 236 LCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 31/229 (13%)
Query: 377 FSSKRILGEGGFGCVY-------HGVMDNGTEVAVKLLTR----NNQNGDREFIAEVEML 425
F ++LG G +G V+ H D+G A+K+L + E ++L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGH---DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 58
Query: 426 SRLHHRNLVKLIGICIEGRTRC-LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGA 484
+ + + + T+ L+ + ++ G + +HL + R E ++I G
Sbjct: 59 EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL--SQRERFK---EQEVQIYSGE 113
Query: 485 -ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF 543
L +LH+ +I+RD K N+LL+ + ++DFGL++E E + GT
Sbjct: 114 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
Query: 544 GYVAPEYAM---TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN 589
Y+AP+ GH D +S GV++ ELL+G P + G++N
Sbjct: 171 EYMAPDIVRGGDGGHDKA-VDWWSMGVLMYELLTGASPFTVD---GEKN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 29/89 (32%), Positives = 52/89 (58%), Gaps = 1/89 (1%)
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG-SQHISTRVMGTFGYVAPE 549
L E + +++HRD K++N+ L K+ DFG +++ ++ S +++ GT Y+APE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
K+D++S GV+L ELL+ +P
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 65/238 (27%), Positives = 98/238 (41%), Gaps = 43/238 (18%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTE--VAVKLLTRN---NQNGDREFIAEVEMLSRLH 429
+ F +++G G FG V+ V D T A+K+L ++ +N AE ++L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWL-VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD 59
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIA-LGAARGL 488
+VKL + LV E + G + + L + K+ P + AR IA L A L
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEET-ARFYIAELVLA--L 114
Query: 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA----------------------- 525
+H IHRD K N+L++ D K++DFGL
Sbjct: 115 DSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 526 REATEGSQHISTRVM-----GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
H RV GT Y+APE ++ D +S GV+L E+L G P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 44/167 (26%), Positives = 76/167 (45%), Gaps = 13/167 (7%)
Query: 421 EVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKI 480
E +L + H +++L + R ++ E V G + S+L +N G +
Sbjct: 51 EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL----RNSGRFSNSTGLFY 106
Query: 481 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM 540
A L YLH +++RD K N+LL+ + K++DFG A++ + + +
Sbjct: 107 ASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC---- 159
Query: 541 GTFGYVAPE-YAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQG 586
GT Y+APE GH D ++ G+++ E+L G P P G
Sbjct: 160 GTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 485 ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF- 543
A G+ +L ++ +HRD A NVL+ + K+ DFGLAR+ S +IS TF
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG--STFL 303
Query: 544 --GYVAPEYAMTGHLLVKSDVYSYGVVLLELLS 574
++APE SDV+S+G++L E+ +
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 68/243 (27%), Positives = 106/243 (43%), Gaps = 28/243 (11%)
Query: 381 RILGEGGFGCVYHGVMDNGTEV-AVKLLTRN---NQNGDREFIAEVE-MLSRLHHRNLVK 435
+++G+G FG V + AVK+L + + ++ ++E +L + H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 436 LIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS 495
L V + ++ G + HL + R L+ AR A A L YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQ---RERCFLEPRARF-YAAEIASALGYLH--- 113
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGH 555
+ +++RD K N+LL+ ++DFGL +E E + ST GT Y+APE
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQP 172
Query: 556 LLVKSDVYSYGVVLLELLSGRKPVD-----------MSQP-QGQENLVTWARPLLTTREG 603
D + G VL E+L G P +++P Q + N+ AR LL EG
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL---EG 229
Query: 604 LEQ 606
L Q
Sbjct: 230 LLQ 232
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 24/224 (10%)
Query: 367 LSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEV-AVKLLTRNN--QNGDREFI-AEV 422
+ DL E + +++G G FG V + +V A+KLL++ + D F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 423 EMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWE----ARM 478
++++ + +V+L + R +V E + G + + + D P W A +
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV---PEKWARFYTAEV 151
Query: 479 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR 538
+AL A + + IHRD K N+LL+ K++DFG + +
Sbjct: 152 VLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202
Query: 539 VMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVLLELLSGRKP 578
+GT Y++PE + G+ + D +S GV L E+L G P
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 34/151 (22%), Positives = 56/151 (37%), Gaps = 16/151 (10%)
Query: 378 SSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV--K 435
SS ++L G VY + + +K+ + DRE EV +L L + L K
Sbjct: 1 SSIKLLKGGLTNRVYL-LGTKDEDYVLKINPSREKGADRE--REVAILQLLARKGLPVPK 57
Query: 436 LIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS 495
++ L+ E + G + E + IA A LA LH+
Sbjct: 58 VLASGESDGWSYLLME---------WIEGET--LDEVSEEEKEDIAEQLAELLAKLHQLP 106
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526
+ H D N+L++D + D+ A
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 370 LEKATEKFSSKRILGEGGFGCVYHGVMDNGTEV-AVKLLTRNN--QNGDREFI-AEVEML 425
L+ E + +++G G FG V + +V A+KLL++ + D F E +++
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 426 SRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWE----ARMKIA 481
+ + +V+L + + +V E + G + + + D P W A + +A
Sbjct: 98 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV---PEKWAKFYTAEVVLA 154
Query: 482 LGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE-GSQHISTRVM 540
L A + +IHRD K N+LL+ K++DFG + E G T V
Sbjct: 155 LDAIHSMG---------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV- 204
Query: 541 GTFGYVAPEYAMT----GHLLVKSDVYSYGVVLLELLSGRKP 578
GT Y++PE + G+ + D +S GV L E+L G P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 19/214 (8%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVK--LLTRNNQNGDREFIAEVEMLSRLHHR 431
+ + +GEG +G VY + G VA+K L + + + E+ +L L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 432 N-LVKLIGI--CIEGRTRCLVYELVHNGSVESHLHG-VDKNRG----PLDWEARMKIALG 483
+V+L+ + E + +Y LV ++S L +D N PL +
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLY-LVFE-YLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP-KVSDFGLAREATEGSQHISTRVMGT 542
+G+A+ H+ V+HRD K N+L++ K++D GL R + + + ++ T
Sbjct: 119 LLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-T 174
Query: 543 FGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSG 575
Y APE + H D++S G + E+
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 29/84 (34%), Positives = 43/84 (51%), Gaps = 8/84 (9%)
Query: 381 RILGEGGFGCVYH------GVMDNGTEVAVKLLTRNNQNGDRE-FIAEVEMLSRL-HHRN 432
+ LG G FG V G DN VAVK+L + +RE ++E+++LS L H+N
Sbjct: 44 KTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKN 103
Query: 433 LVKLIGICIEGRTRCLVYELVHNG 456
+V L+G C G ++ E G
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYG 127
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 36/117 (30%), Positives = 52/117 (44%), Gaps = 19/117 (16%)
Query: 471 PLDWE----ARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA- 525
P W A + +AL A + + IHRD K N+LL+ K++DFG
Sbjct: 140 PEKWARFYTAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCM 190
Query: 526 REATEGSQHISTRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVLLELLSGRKP 578
+ G T V GT Y++PE + G+ + D +S GV L E+L G P
Sbjct: 191 KMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 37/158 (23%), Positives = 66/158 (41%), Gaps = 8/158 (5%)
Query: 419 IAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARM 478
E +L ++H ++++L G + CL+ + + + + K + +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAIC--DIL 185
Query: 479 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR 538
I R + YLHE+ R+IHRD KA N+ + + DFG A + + +
Sbjct: 186 AIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242
Query: 539 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGR 576
GT APE D++S G+VL E+ +
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 54/201 (26%), Positives = 82/201 (40%), Gaps = 22/201 (10%)
Query: 399 GTEVAVKLLTRNNQNGDREFIAEVEMLSR--LHHRNLVKLIGICIEGRTRCLVYELVHNG 456
GT V V++ N + + E++ H N++ + G ++ + G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 457 SVESHLHGVDKNRGPLDWEARM--KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD 514
S S L K P + I GA RGL YLH++ IHR+ KAS++L+ D
Sbjct: 85 SANSLL----KTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGD 137
Query: 515 FTPKVSDFG-LAREATEGSQH--------ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSY 565
+S L G + ST V+ + G+ VKSD+YS
Sbjct: 138 GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGY-NVKSDIYSV 196
Query: 566 GVVLLELLSGRKP-VDMSQPQ 585
G+ EL +GR P DM + Q
Sbjct: 197 GITACELATGRVPFQDMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-05
Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 45/233 (19%)
Query: 381 RILGEGGFGCVYHGVMDN--GTEVAVKLLTRN---NQNGDREFIAEVEMLSRLHHRNLVK 435
R++G+GG G VY D VA+K + + N + F+ E ++ + L H +V
Sbjct: 8 RLIGKGGMGEVYLA-YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 436 LIGIC------------IEGRT-RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIAL 482
+ IC IEG T + L+ + S+ L +K A + I
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELA--EKTSVG----AFLSIFH 120
Query: 483 GAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA--REATE---------- 530
+ Y+H V+HRD K N+LL + D+G A ++ E
Sbjct: 121 KICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 531 -GSQH----ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
+ I +++GT Y+APE + +D+Y+ GV+L ++L+ P
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 28/227 (12%)
Query: 383 LGEGGFGCVYH-GVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVK------ 435
+G+G FG VY D A+K+L++ +E +A+ E+ + RN++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 436 ---LIGICIEGRTRC---LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLA 489
++G+ +T LV + + G + HL + R D A+ IA L
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ--KEGRFSED-RAKFYIA-ELVLALE 110
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549
+LH+ +++RD K N+LL+ + DFGL++ A + GT Y+APE
Sbjct: 111 HLHKYD---IVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPE 166
Query: 550 YAMTGHLLVKS-DVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWAR 595
+ K D +S GV++ E+ G P Q + + +
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEV-AVKLLTRNNQNGDRE---FIAEVEMLSRLHH 430
E F +++G G FG V + N +V A+K+L + E F E ++L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLD----WEARMKIALGAAR 486
+ + L + LV + G + + L + +R P D + A M IA+ +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVH 119
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYV 546
L Y +HRD K N+L++ + +++DFG + E S+ +GT Y+
Sbjct: 120 QLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 170
Query: 547 APEY--AM---TGHLLVKSDVYSYGVVLLELLSGRKP 578
+PE AM G + D +S GV + E+L G P
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-05
Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 11/156 (7%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEV-AVKLLTRN---NQNGDREFIAEVEMLSRLHH 430
E+F + + G FG VY G N +++ AVK++ + N+N + AE + L+
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY 490
+V L LV E + G V+S LH G D E +K A L Y
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDY 119
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526
LH +IHRD K N+L+ ++ K++DFGL++
Sbjct: 120 LHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 52/216 (24%), Positives = 97/216 (44%), Gaps = 42/216 (19%)
Query: 383 LGEGGFGCVYHGVM----DN-----GTEVAVKLLTRNNQNGDRE----FIAEVEMLSRLH 429
LG G +Y G++ D+ E +K++ + R+ F M+ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLA 489
H+++V L G+C+ +V E V G ++ +H + L + K+A A L+
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASALS 119
Query: 490 YLHEDSNPRVIHRDFKASNVLL-----EDDFTP--KVSDFG-----LAREATEGSQHIST 537
YL ED + ++H + N+LL + + P K+SD G L+R+ E + I
Sbjct: 120 YL-EDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ--ECVERIP- 173
Query: 538 RVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLEL 572
++APE + +L + +D +S+G L E+
Sbjct: 174 -------WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 26/183 (14%)
Query: 405 KLLTRNNQNGDREFIA---EVEMLSRLHHRNLVKLIGIC--------IEGRTRCLVYELV 453
+L+ + + G R I E+ L RL+H N++K+ I I + +Y +
Sbjct: 194 RLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFM 253
Query: 454 HNGSVESHLHGVDKNRGPLDWEAR--MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL 511
++ + + K+R PL + R MK L A + Y+H+ ++IHRD K N+ L
Sbjct: 254 YDEAFDW------KDR-PLLKQTRAIMKQLLCA---VEYIHDK---KLIHRDIKLENIFL 300
Query: 512 EDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLE 571
D + DFG A + + +GT +PE +D++S G++LL+
Sbjct: 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLD 360
Query: 572 LLS 574
+LS
Sbjct: 361 MLS 363
|
Length = 501 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 6/85 (7%)
Query: 500 IHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY--AMTGHLL 557
+HRD K NVL++ K++DFG A T S +GT Y+APE M G
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 558 ----VKSDVYSYGVVLLELLSGRKP 578
V+ D +S GV+ E++ GR P
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 10/94 (10%)
Query: 488 LAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVS--DFGLAREATEGSQHISTRVMGTFGY 545
L LH+ + VI+RD K N+LL D+ ++ DFGL + + +T GT Y
Sbjct: 106 LENLHKFN---VIYRDLKPENILL--DYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEY 159
Query: 546 VAPEYAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
+APE + GH K+ D ++ GV+L E+L+G P
Sbjct: 160 LAPEL-LLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 46/182 (25%), Positives = 72/182 (39%), Gaps = 19/182 (10%)
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPL--DWEARMKIALGAARGLA 489
N+V L + + LV + G + SH+ W A M +AL A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549
LH + ++ RD +N+LL+D +++ F E + + M Y APE
Sbjct: 101 -LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPE 152
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREG---LEQ 606
D +S G +L ELL+G+ V+ P G T P + E L+Q
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGKTLVE-CHPSGINTHTTLNIPEWVSEEARSLLQQ 211
Query: 607 LV 608
L+
Sbjct: 212 LL 213
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
+H +HRD K NVLL+ + +++DFG + + S+ +GT Y++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 551 --AM---TGHLLVKSDVYSYGVVLLELLSGRKP 578
AM G + D +S GV + E+L G P
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 61/252 (24%), Positives = 96/252 (38%), Gaps = 51/252 (20%)
Query: 375 EKFSSKRILGEGGFGCV-YHGVMDNGTEVAVKLLTRNNQNGDREFIA----EVEMLSRLH 429
+ F S +++G G FG V D G A+K+L R ++E +A E ++L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKIL-RKADMLEKEQVAHIRAERDILVEAD 59
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVD--KNRGPLDWEARMKIALGAARG 487
+VK+ + R L+ E + G + + L D + A +A+ A
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ 119
Query: 488 LAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL----------------------- 524
L + IHRD K N+LL+ K+SDFGL
Sbjct: 120 LGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170
Query: 525 -----------AREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL 573
A + + ++ +GT Y+APE M D +S GV++ E+L
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 574 SGRKPVDMSQPQ 585
G P PQ
Sbjct: 231 IGYPPFCSETPQ 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 61/235 (25%), Positives = 90/235 (38%), Gaps = 47/235 (20%)
Query: 381 RILGEGGFGCVYHGVMDNGTEV--AVKLLTRN---NQNGDREFIAEVEMLSRLHHRNLVK 435
++LG+G G V+ V GT A+K+L + +N + + E E+L+ L H L
Sbjct: 7 KLLGKGDVGRVFL-VRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPT 65
Query: 436 LIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIA-LGAARGLAYLHED 494
L CLV + G + L + AR A + A L YLH
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE-VARFYAAEVLLA--LEYLH-- 120
Query: 495 SNPRVIHRDFKASNVLL-ED------DF---------TPKVSDFGLAREATEGSQHISTR 538
+++RD K N+LL E DF P VS I +
Sbjct: 121 -LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 539 V------------MGTFGYVAPEY-AMTGHLLVKSDV--YSYGVVLLELLSGRKP 578
+GT Y+APE + GH S V ++ G++L E+L G P
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGH---GSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 33/108 (30%), Positives = 49/108 (45%), Gaps = 14/108 (12%)
Query: 476 ARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535
A M +A+ + L Y +HRD K NVLL+ + +++DFG
Sbjct: 109 AEMVLAIDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159
Query: 536 STRVMGTFGYVAPEY--AM---TGHLLVKSDVYSYGVVLLELLSGRKP 578
S +GT Y++PE AM G + D +S GV + E+L G P
Sbjct: 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 48/214 (22%), Positives = 81/214 (37%), Gaps = 28/214 (13%)
Query: 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDR--EFIAEVEMLSRLHHRNLVKLIG 438
+ + + T VAVK + ++ + + E+ +L H N++ +
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 439 ICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIAL---GAARGLAYLHEDS 495
I +V L+ GS E L P + IA L Y+H
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKDVLNALDYIH--- 118
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFG--------YVA 547
+ IHR KAS++LL D +S + + + RV+ F +++
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR--QRVVHDFPKSSVKNLPWLS 176
Query: 548 PEY---AMTGHLLVKSDVYSYGVVLLELLSGRKP 578
PE + G+ KSD+YS G+ EL +G P
Sbjct: 177 PEVLQQNLQGYN-EKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 383 LGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNG-DREFIAEVEMLSRLHHRNLVKLIGICI 441
+G G +G VY +G + L + G E+ +L L H N++ L + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 442 EGRTR--CLVYELV-HNGSVESHLHGVDK-NRGPLDWEARMKIAL--GAARGLAYLHEDS 495
R L+++ H+ H K N+ P+ M +L G+ YLH +
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN- 127
Query: 496 NPRVIHRDFKASNVLLEDDFTP----KVSDFGLAREATEGSQHIS--TRVMGTFGYVAPE 549
V+HRD K +N+L+ + K++D G AR + ++ V+ TF Y APE
Sbjct: 128 --WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 550 YAMTGHLLVKS-DVYSYGVVLLELLS 574
+ K+ D+++ G + ELL+
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 36/142 (25%), Positives = 52/142 (36%), Gaps = 45/142 (31%)
Query: 500 IHRDFKASNVLLEDDFTPKVSDFGLA--------REATEGSQHISTRVM----------- 540
IHRD K N+L++ D K++DFGL + + H M
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 541 -----------------------GTFGYVAPE-YAMTGHLLVKSDVYSYGVVLLELLSGR 576
GT Y+APE TG+ + D +S GV+L E+L G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQ 241
Query: 577 KPVDMSQPQG-QENLVTWARPL 597
P P Q ++ W L
Sbjct: 242 PPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 62/266 (23%), Positives = 100/266 (37%), Gaps = 52/266 (19%)
Query: 375 EKFSSKRILGEGGFGCV-YHGVMDNGTEVAVKLLTRNNQNGDREFI----AEVEMLSRLH 429
E F S +++G G FG V D G A+K+L R ++E + AE ++L
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKIL-RKADMLEKEQVGHIRAERDILVEAD 59
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDK--NRGPLDWEARMKIALGAARG 487
+VK+ + L+ E + G + + L D + A +A+ +
Sbjct: 60 SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ 119
Query: 488 LAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL----------------------- 524
L + IHRD K N+LL+ K+SDFGL
Sbjct: 120 LGF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170
Query: 525 -----------AREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL 573
A + ++ +GT Y+APE M D +S GV++ E+L
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 574 SGRKPVDMSQPQGQ-ENLVTWARPLL 598
G P PQ + ++ W L+
Sbjct: 231 IGYPPFCSETPQETYKKVMNWKETLI 256
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 63/275 (22%), Positives = 105/275 (38%), Gaps = 64/275 (23%)
Query: 377 FSSKRILGEGGFG--CVYHGVMDNGTEVAVKLLTRN---NQNGDREFIAEVEMLSRLHHR 431
F + LG G FG C+ V D A+K L + N+N AE ++L+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKV-DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNE 61
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHL--HGVDKNRGPLDWEARMKIALGAARGLA 489
+VKL + V + + G + S L V + A + +A+ + +
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG 121
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA-------------------REATE 530
+ IHRD K N+L++ D K++DFGL +++ E
Sbjct: 122 F---------IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172
Query: 531 GS------------------------QH---ISTRVMGTFGYVAPEYAMTGHLLVKSDVY 563
S QH ++ ++GT Y+APE + D +
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232
Query: 564 SYGVVLLELLSGRKPVDMSQP-QGQENLVTWARPL 597
S GV+L E+L G+ P P + Q ++ W L
Sbjct: 233 SVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 34/145 (23%), Positives = 54/145 (37%), Gaps = 47/145 (32%)
Query: 500 IHRDFKASNVLLEDDFTPKVSDFGLA---------------------------------- 525
IHRD K N+L++ D K++DFGL
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 526 ------------REATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL 573
R A + + ++ ++GT Y+APE + D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 574 SGRKPVDMSQP-QGQENLVTWARPL 597
G+ P P + Q ++ W L
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 9e-04
Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 383 LGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNG-DREFIAEVEMLSRLHHRNLVKLIGICI 441
+G G +G VY +G + L + G E+ +L L H N++ L + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 442 E--GRTRCLVYELV-HNGSVESHLHGVDK-NRGPLDWEARMKIAL--GAARGLAYLHEDS 495
R L+++ H+ H K N+ P+ M +L G+ YLH +
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN- 127
Query: 496 NPRVIHRDFKASNVLLEDDFTP----KVSDFGLAREATEGSQHIS--TRVMGTFGYVAPE 549
V+HRD K +N+L+ + K++D G AR + ++ V+ TF Y APE
Sbjct: 128 --WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 550 YAMTGHLLVKS-DVYSYGVVLLELLS 574
+ K+ D+++ G + ELL+
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 0.002
Identities = 36/116 (31%), Positives = 48/116 (41%), Gaps = 15/116 (12%)
Query: 467 KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKV--SDFGL 524
K G L KI L LH +IH D K NVL D ++ D+GL
Sbjct: 101 KKEGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLY-DRAKDRIYLCDYGL 156
Query: 525 AR-EATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
+ T GT Y +PE + GH S D ++ GV+ ELL+G+ P
Sbjct: 157 CKIIGTPSCYD------GTLDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.003
Identities = 30/116 (25%), Positives = 41/116 (35%), Gaps = 37/116 (31%)
Query: 500 IHRDFKASNVLLEDDFTPKVSDFGL----------------------AREATEGSQHIST 537
IHRD K N+LL+ K+SDFGL S
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 538 R---------------VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
R +GT Y+APE + + D +S GV++ E+L G P
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 780 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.02 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.02 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.95 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.89 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.8 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.73 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.73 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.66 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.53 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.42 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.41 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.34 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.26 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.25 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.25 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.11 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.05 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.04 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.91 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.9 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.87 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.84 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.81 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.8 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.75 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.71 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.54 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.48 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.47 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.41 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.3 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.12 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.09 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.99 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.94 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.82 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.72 | |
| PLN02236 | 344 | choline kinase | 96.43 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.19 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.72 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.71 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.51 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.4 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.36 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.31 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.11 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.03 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 94.91 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.82 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.68 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.49 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.04 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.85 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 93.67 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 93.44 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.15 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.99 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 92.18 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-61 Score=533.36 Aligned_cols=290 Identities=57% Similarity=0.972 Sum_probs=261.1
Q ss_pred cccccchHHHHHHhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeee
Q 048425 361 SVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGIC 440 (780)
Q Consensus 361 ~~~~f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~ 440 (780)
..+.|+++||++||++|+..++||+|+||.||+|.+++|+.||||++.....+..++|.+|++++++++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999988765443256799999999999999999999999
Q ss_pred eecc-eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCee
Q 048425 441 IEGR-TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKV 519 (780)
Q Consensus 441 ~~~~-~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKL 519 (780)
.+.+ +.+||||||+||+|+++|++.... +|+|..|++||.++|+||+|||+.+.|+|||||||++|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9998 599999999999999999964322 8999999999999999999999999999999999999999999999999
Q ss_pred ecccccccccC-CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccc
Q 048425 520 SDFGLAREATE-GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLL 598 (780)
Q Consensus 520 sDFGLA~~~~~-~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll 598 (780)
+|||+|+.... .... .+...||++|+||||+..+.+++|+|||||||||+||+||+++.+...+.+..++++|+++.+
T Consensus 219 sDFGLa~~~~~~~~~~-~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSV-STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCccccce-eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999987765 3222 222179999999999999999999999999999999999999999877777778999999888
Q ss_pred ccccccccccCCccC-CCCCh-hhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 599 TTREGLEQLVDPSLA-GSYDF-DDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 599 ~~~~~l~~lvDp~L~-~~~~~-ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
..+ .+.+++|+.+. +.+.. +++.++.+++.+|++.+|++||+|.||+++|+.+..
T Consensus 298 ~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 298 EEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 876 78999999987 66664 789999999999999999999999999999976654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=416.98 Aligned_cols=257 Identities=35% Similarity=0.596 Sum_probs=213.2
Q ss_pred cceeecccCceEEEEEEEeCCcE-EEEEEeeccCCcc--hHHHHHHHHHhhhcCCCceeeeeeeeeecc-eeEEEEeecC
Q 048425 379 SKRILGEGGFGCVYHGVMDNGTE-VAVKLLTRNNQNG--DREFIAEVEMLSRLHHRNLVKLIGICIEGR-TRCLVYELVH 454 (780)
Q Consensus 379 ~~~~LG~G~fG~VYkg~l~~g~~-VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-~~~LV~Ey~~ 454 (780)
..+.||.|+||+||+|.+. |+. ||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||+
T Consensus 45 ~~~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhcccCCceeEEEEEeC-CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3456999999999999995 555 9999997764433 458999999999999999999999999887 7999999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC-CCeeecccccccccCCCc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF-TPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~-~vKLsDFGLA~~~~~~~~ 533 (780)
+|+|.++|+.. .+..++|..+++||.|||+||+|||+++ + |||||||++||||+.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~-~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 124 GGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEG-P-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC-C-eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 99999999853 4678999999999999999999999986 3 99999999999999997 99999999998776532
Q ss_pred cceeccccCccccCchhhc--cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCc
Q 048425 534 HISTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~--~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
...+...||..|||||++. ...++.|+|||||||+||||+||+.||....+. + +. ..++...
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-~--~~-------------~~v~~~~ 262 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-Q--VA-------------SAVVVGG 262 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-H--HH-------------HHHHhcC
Confidence 2234478999999999999 669999999999999999999999999765431 1 11 1111111
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 612 L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
.....+.+....+..++.+||+.||++||++.|++..|+.+.....
T Consensus 263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 1122233355678899999999999999999999999998876543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=437.99 Aligned_cols=271 Identities=28% Similarity=0.526 Sum_probs=221.9
Q ss_pred cchHHHHHHhcCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeec
Q 048425 365 FALSDLEKATEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEG 443 (780)
Q Consensus 365 f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~ 443 (780)
++++++. ..|...++||+|+||.||+|+. .+|..||||+++..... ...|++++++++|||||+++|+|.++
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 4555554 4577788999999999999997 47899999998654322 23568899999999999999999999
Q ss_pred ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccc
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFG 523 (780)
+..++||||+++|+|.++++ .++|..+.+|+.|+|+||+|||..+.++|+||||||+||++++++.+++. ||
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~ 827 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS 827 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence 99999999999999999995 38999999999999999999997766779999999999999999988876 66
Q ss_pred ccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccc
Q 048425 524 LAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREG 603 (780)
Q Consensus 524 LA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~ 603 (780)
.+...... ....||..|+|||++.+..++.|+|||||||++|||+||+.|++.... ....++.|++...... .
T Consensus 828 ~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~-~ 900 (968)
T PLN00113 828 LPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDC-H 900 (968)
T ss_pred cccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCcc-c
Confidence 65443221 223588999999999999999999999999999999999999965432 2355777776554332 3
Q ss_pred cccccCCccCCC--CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 604 LEQLVDPSLAGS--YDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 604 l~~lvDp~L~~~--~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
...++|+.+... .+.+++.++.+++.+||+.+|++||+|+||+++|+.+.....
T Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 455667766443 345677889999999999999999999999999998876443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=419.96 Aligned_cols=263 Identities=30% Similarity=0.489 Sum_probs=218.0
Q ss_pred cCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 447 (780)
.+....+.||+|.||+||+|... +...||||.|+..... ...+|.+|+++++.++|+|||+|+|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34455678999999999999853 3456999999988766 6679999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhcccccC----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCC
Q 048425 448 LVYELVHNGSVESHLHGVDK----------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP 517 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~----------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~v 517 (780)
||+|||..|+|.+||..... ...+|+..+.+.||.|||.||+||-+.. +|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 99999999999999963211 1345899999999999999999999887 9999999999999999999
Q ss_pred eeecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcc
Q 048425 518 KVSDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWAR 595 (780)
Q Consensus 518 KLsDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~ 595 (780)
||+||||+|.....+.+ ...+-.-.++||+||.++.+++|.+||||||||||||++| |+.|+..-..+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---------- 712 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---------- 712 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH----------
Confidence 99999999987654432 2223345678999999999999999999999999999999 99998653321
Q ss_pred cccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 596 PLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 596 ~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
+.++-+-+..+ -..+.....++..|+..||+.+|++||+++||-..|+.....++
T Consensus 713 ------EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 713 ------EVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred ------HHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 12222222222 23456677899999999999999999999999999998765543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=401.57 Aligned_cols=255 Identities=31% Similarity=0.484 Sum_probs=213.5
Q ss_pred ccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCC
Q 048425 378 SSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGS 457 (780)
Q Consensus 378 ~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GS 457 (780)
...+.||+|.||.||.|.+++...||||.++... ...++|.+|+++|++|+|+|||+|+|+|..++..+||||||++|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 3457899999999999999877799999997763 356789999999999999999999999999889999999999999
Q ss_pred hhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcccee
Q 048425 458 VESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIST 537 (780)
Q Consensus 458 L~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t 537 (780)
|.++|.. .....++..+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+...++......
T Consensus 288 Ll~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 288 LLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred HHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 9999974 35678999999999999999999999998 999999999999999999999999999965554433333
Q ss_pred ccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccCCCC
Q 048425 538 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSY 616 (780)
Q Consensus 538 ~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~ 616 (780)
...-...|.|||.+..++++.|||||||||+||||+| |+.|+...... .++. .++.+.. + ..
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~---ev~~----~le~GyR---l-------p~ 425 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE---EVLE----LLERGYR---L-------PR 425 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH---HHHH----HHhccCc---C-------CC
Confidence 3344568999999999999999999999999999999 88887643321 1111 1111211 1 22
Q ss_pred ChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 617 DFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 617 ~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
+..+...+.+|+..||+.+|++|||++.+...|+++...
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 344567899999999999999999999999999887654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=380.01 Aligned_cols=256 Identities=29% Similarity=0.433 Sum_probs=211.3
Q ss_pred cchHHHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeee
Q 048425 365 FALSDLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIE 442 (780)
Q Consensus 365 f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~ 442 (780)
.++.||++. +.||+|..|+|||+.++ +++.+|+|.+..+.. ...+++.+|++++.+.+|||||.++|.|..
T Consensus 76 i~~~dle~~-------~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLERL-------GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhhh-------hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 556666654 78999999999999986 788999999955433 345789999999999999999999999999
Q ss_pred cc-eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeec
Q 048425 443 GR-TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSD 521 (780)
Q Consensus 443 ~~-~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsD 521 (780)
.. +..++||||++|||++++. ..+.+++...-+|+.+|++||.|||+.. +||||||||+||||+..|++||||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k----~~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicD 222 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILK----RVGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICD 222 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEecc
Confidence 88 5999999999999999984 3467999999999999999999999632 499999999999999999999999
Q ss_pred ccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccc
Q 048425 522 FGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTR 601 (780)
Q Consensus 522 FGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~ 601 (780)
||.++.+... .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+-... .....|+
T Consensus 223 FGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~----~~~~~~~------- 288 (364)
T KOG0581|consen 223 FGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN----PPYLDIF------- 288 (364)
T ss_pred ccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC----CCCCCHH-------
Confidence 9999988664 4466789999999999999999999999999999999999999996541 1111221
Q ss_pred cccccccCCccCCCCCh-hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 602 EGLEQLVDPSLAGSYDF-DDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 602 ~~l~~lvDp~L~~~~~~-ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
+-+..+++.... ..+. ....++..++..|+++||.+||+..|+++.
T Consensus 289 ~Ll~~Iv~~ppP-~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 289 ELLCAIVDEPPP-RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHHHHhcCCCC-CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 123334432111 1122 245678999999999999999999998763
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=401.98 Aligned_cols=272 Identities=26% Similarity=0.471 Sum_probs=225.5
Q ss_pred cccchHHHHHHhcCc---------ccceeecccCceEEEEEEEe-C---CcEEEEEEeeccCCc-chHHHHHHHHHhhhc
Q 048425 363 KTFALSDLEKATEKF---------SSKRILGEGGFGCVYHGVMD-N---GTEVAVKLLTRNNQN-GDREFIAEVEMLSRL 428 (780)
Q Consensus 363 ~~f~~~el~~at~~f---------~~~~~LG~G~fG~VYkg~l~-~---g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L 428 (780)
..++|||--+|-..| .++++||.|.||.||+|.++ . ...||||.|+....+ ..++|+.|+.||.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 456777665555444 45699999999999999986 2 356999999887543 456899999999999
Q ss_pred CCCceeeeeeeeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcc
Q 048425 429 HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASN 508 (780)
Q Consensus 429 ~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsN 508 (780)
+||||++|.|+....+..++|.|||+||+|+.||+ ++.+.++|.++..++.+||.||.||-+.+ +|||||.++|
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR---~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARN 761 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLR---QNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARN 761 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHh---hcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhh
Confidence 99999999999999999999999999999999997 45567999999999999999999999998 9999999999
Q ss_pred eEEcCCCCCeeecccccccccCCCccceecccc--CccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCcc
Q 048425 509 VLLEDDFTPKVSDFGLAREATEGSQHISTRVMG--TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQ 585 (780)
Q Consensus 509 ILLd~~~~vKLsDFGLA~~~~~~~~~~~t~~~G--T~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~ 585 (780)
|||+.+..+||+||||++.+.++.....+...| ..+|.|||.+..+++|.+|||||||||+||.++ |.+|+-....+
T Consensus 762 ILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ 841 (996)
T KOG0196|consen 762 ILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 841 (996)
T ss_pred eeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH
Confidence 999999999999999999887665333333333 358999999999999999999999999999998 99997433221
Q ss_pred ccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 586 GQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 586 ~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
+ .+. -++...+-..+.++...+.+|+++||++|-.+||++.+|+..|+++...-+
T Consensus 842 d----------------VIk-aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 842 D----------------VIK-AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred H----------------HHH-HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 1 111 112222223456788899999999999999999999999999998876543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=367.99 Aligned_cols=201 Identities=32% Similarity=0.556 Sum_probs=181.0
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
.+|...+.||.|.||+||+|+++ ++.+||||.+.+.. ....+-...|+++|+.++|+|||.|++++..++..+||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 57777788999999999999986 68999999997763 3344568899999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC------CCCeeeccccc
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD------FTPKVSDFGLA 525 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~------~~vKLsDFGLA 525 (780)
||.+|+|.+||+ ..+.++......+..|+|.||++||+++ ||||||||.||||+.+ -.+||+|||+|
T Consensus 90 yC~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 90 YCNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999996 3458999999999999999999999998 9999999999999765 45899999999
Q ss_pred ccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCc
Q 048425 526 REATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQP 584 (780)
Q Consensus 526 ~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~ 584 (780)
+.+..+. .....+|++-|||||+++.++|+.|+|+||.|++|||+++|+.||+...+
T Consensus 163 R~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 163 RFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 9987543 33668999999999999999999999999999999999999999986554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=379.76 Aligned_cols=247 Identities=28% Similarity=0.461 Sum_probs=208.6
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
..|...++||+|||++||+++. ..|+.||+|++.+.. ....+...+||+|.+.|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688889999999999999997 799999999997642 334467889999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
|+|.+++|.+++ +.+.++++.++..+..||+.||.|||+.+ |||||||..|++|+++.++||+|||||.....
T Consensus 98 ELC~~~sL~el~----Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELL----KRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHH----HhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999998 46778999999999999999999999998 99999999999999999999999999998864
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
... .....+||+.|.|||++.....+..+||||+|||||-||.|++||+...-++.- ..+.... -
T Consensus 171 ~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety------~~Ik~~~--------Y 235 (592)
T KOG0575|consen 171 DGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY------NKIKLNE--------Y 235 (592)
T ss_pred ccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH------HHHHhcC--------c
Confidence 422 235679999999999999999999999999999999999999999754321110 0000000 0
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..+........+|+..+|++||.+||++++|+.
T Consensus 236 ----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 ----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011122345678999999999999999999975
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=367.39 Aligned_cols=263 Identities=25% Similarity=0.449 Sum_probs=206.3
Q ss_pred HhcCcccceeecccCceEEEEEEE------eCCcEEEEEEeeccCCc-chHHHHHHHHHhhhc-CCCceeeeeeeeeecc
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVM------DNGTEVAVKLLTRNNQN-GDREFIAEVEMLSRL-HHRNLVKLIGICIEGR 444 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l------~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~ 444 (780)
..++|...+.||+|+||.||+|.. .++..||||+++..... ..+.+.+|++++.++ +|+||++++++|...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346788999999999999999974 23568999999754332 235789999999999 8999999999987644
Q ss_pred -eeEEEEeecCCCChhhhcccccC--------------------------------------------------------
Q 048425 445 -TRCLVYELVHNGSVESHLHGVDK-------------------------------------------------------- 467 (780)
Q Consensus 445 -~~~LV~Ey~~~GSL~~~L~~~~~-------------------------------------------------------- 467 (780)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999864211
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc-eeccccCcc
Q 048425 468 --NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI-STRVMGTFG 544 (780)
Q Consensus 468 --~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~-~t~~~GT~~ 544 (780)
...++++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++......... .....++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 0235889999999999999999999988 9999999999999999999999999998764332221 223446788
Q ss_pred ccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCChhhHHH
Q 048425 545 YVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAK 623 (780)
Q Consensus 545 Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~ 623 (780)
|+|||++.+..++.++|||||||+||||++ |+.||...... ..+.. . ..... ... .+......
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~~~---~-~~~~~------~~~----~~~~~~~~ 305 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEFCQ---R-LKDGT------RMR----APENATPE 305 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHH---H-HhcCC------CCC----CCCCCCHH
Confidence 999999999999999999999999999997 99998653321 11111 0 01000 000 11122346
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 624 VAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 624 l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
+.+++.+||+.||++||++.||++.|+.+..
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.73 Aligned_cols=261 Identities=19% Similarity=0.359 Sum_probs=209.1
Q ss_pred cccccchHHHHHHhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcc---hHHHHHHHHHhhhcCCCceeeee
Q 048425 361 SVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNG---DREFIAEVEMLSRLHHRNLVKLI 437 (780)
Q Consensus 361 ~~~~f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~L~ 437 (780)
..+.++.++++. .....||+|++|.||+|.+ +|+.||||+++...... .+.|.+|+++|++++||||++++
T Consensus 11 ~~~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDIDK-----YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcCC-----CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 456667777732 2336899999999999998 78999999997654433 36688999999999999999999
Q ss_pred eeeee----cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCcEEecccCCcceEEc
Q 048425 438 GICIE----GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED-SNPRVIHRDFKASNVLLE 512 (780)
Q Consensus 438 g~~~~----~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~-~~p~IvHrDIKpsNILLd 512 (780)
|++.+ ....++||||+++|+|.+++.. ...++|...++++.+++.||+|||+. + ++||||||+|||++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~ 157 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVT 157 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEEC
Confidence 99876 3467899999999999999953 45789999999999999999999985 5 77999999999999
Q ss_pred CCCCCeeecccccccccCCCccceeccccCccccCchhhcc--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchh
Q 048425 513 DDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENL 590 (780)
Q Consensus 513 ~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~--~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~L 590 (780)
+++.+||+|||+++...... ....||..|+|||++.+ ..++.++|||||||++|||++|+.||...... .+
T Consensus 158 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~ 230 (283)
T PHA02988 158 ENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EI 230 (283)
T ss_pred CCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HH
Confidence 99999999999998764322 23458899999999976 68999999999999999999999999754321 11
Q ss_pred hhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 591 VTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 591 v~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
... +..... .+ ..+......+.+++.+||+.||++||++.||++.|++++.
T Consensus 231 ~~~---i~~~~~------~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 231 YDL---IINKNN------SL----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHH---HHhcCC------CC----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 111 111100 00 1112234568899999999999999999999999998753
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=368.98 Aligned_cols=268 Identities=28% Similarity=0.492 Sum_probs=213.7
Q ss_pred chHHHHHHhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeec
Q 048425 366 ALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEG 443 (780)
Q Consensus 366 ~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~ 443 (780)
+.++++...+.+.+...||+|.||+||+|.+- | .||||+|+..... ..+.|++|+..+++-+|.||+-++|||.+.
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 34667777777888899999999999999984 2 5999999877544 346899999999999999999999999987
Q ss_pred ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccc
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFG 523 (780)
.. .+|..+|++.+|+.+||. .+..++..+.++||.|||.||.|||.++ |||||||+.||+|.++++|||+|||
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred ce-eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccc
Confidence 66 999999999999999995 3467999999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCC-ccceeccccCccccCchhhcc---CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccc
Q 048425 524 LAREATEGS-QHISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLT 599 (780)
Q Consensus 524 LA~~~~~~~-~~~~t~~~GT~~Y~APE~l~~---~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~ 599 (780)
|+.....-. ........|...|||||+++. .+|+..+||||||+|+|||+||..||..... ++ + -|+ ..
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-dq--I-ifm---VG 606 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-DQ--I-IFM---VG 606 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-hh--e-EEE---ec
Confidence 996432211 111122347778999999864 4789999999999999999999999973221 11 1 111 11
Q ss_pred cccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 600 TREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 600 ~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
.+..+. |... ...+....|.+|+..||..++++||.+.+|+..|+.+...
T Consensus 607 rG~l~p---d~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 607 RGYLMP---DLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccccCc---cchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 111111 1111 1234556788999999999999999999999999888764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=360.36 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=201.0
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcc-------hHHHHHHHHHhhhcCCCceeeeeeeeeeccee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNG-------DREFIAEVEMLSRLHHRNLVKLIGICIEGRTR 446 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~-------~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 446 (780)
+.|...+.||+|+||.|-+|..+ +|+.||||++++..... .....+|+++|++|+|||||++++++.+.+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 55677899999999999999864 89999999997643221 22347999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC---CCCeeeccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD---FTPKVSDFG 523 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~---~~vKLsDFG 523 (780)
|||||||++|.|.+.+- .++.+.......++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 252 YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred EEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999985 3456777778889999999999999999 9999999999999766 789999999
Q ss_pred ccccccCCCccceeccccCccccCchhhccCCC---CchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccc
Q 048425 524 LAREATEGSQHISTRVMGTFGYVAPEYAMTGHL---LVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTT 600 (780)
Q Consensus 524 LA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~---t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~ 600 (780)
+|+...+. ......+||+.|.|||++.++.+ ..|.|+||+|||||-+++|..||...... ..+.
T Consensus 325 lAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~--------- 391 (475)
T KOG0615|consen 325 LAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLK--------- 391 (475)
T ss_pred hhhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHH---------
Confidence 99988643 34467899999999999987643 34889999999999999999999754321 1011
Q ss_pred ccccccccCCccC--CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 601 REGLEQLVDPSLA--GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 601 ~~~l~~lvDp~L~--~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+++...... .....+..++..+++.+++..||++||++.|+++
T Consensus 392 ----eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 392 ----EQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ----HHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111111110 0112234567889999999999999999999875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=361.59 Aligned_cols=264 Identities=27% Similarity=0.458 Sum_probs=216.0
Q ss_pred hcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcch-HHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGD-REFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~-~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
......++.||+|-||.|..+....+..||||.++....... ++|.+|+++|.+++|||||.|+|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 345566789999999999999998889999999988765544 7999999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
|++|+|..||..... ..+.-...++|+.|||.||+||.+.+ +|||||.++|||+|.++++||+|||+++.+..+.
T Consensus 617 mEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999964221 22456677889999999999999987 9999999999999999999999999999776554
Q ss_pred c-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh--CCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 533 Q-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS--GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 533 ~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT--Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
. ++..+.+-.++|||+|.+..+++|.++|||+|||.|||+++ ...||.... .++.++-+..++.....-.-+..
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVVENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHHHhhhhhcCCCCcceeccC
Confidence 3 34556667789999999999999999999999999999876 677875432 23344433334433322121222
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
| .-+...+.+++..||+.+-++||+++++...|++.
T Consensus 769 P-------~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 769 P-------PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred C-------CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2 23446788999999999999999999999988754
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=343.19 Aligned_cols=255 Identities=26% Similarity=0.394 Sum_probs=204.8
Q ss_pred cCcccceeecccCceEEEEEEEe----CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD----NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~----~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
++|+..+.||+|+||.||+|.++ .+..||+|.++..... ..+.|.+|+.++++++|+||++++|++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888899999999999999864 3568999999765332 335799999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++|+|.+++.. ....++|..+++++.|++.||+|||+.+ ++||||||+|||+++++.+|++|||.+....
T Consensus 85 ~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999863 3457899999999999999999999988 9999999999999999999999999876543
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
...........++..|+|||++.++.++.++|||||||++|||++ |+.||...... .+.... ... .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~----~~~------~ 225 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAV----EDG------F 225 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH----HCC------C
Confidence 222111122345678999999999999999999999999999875 99999654321 111111 000 0
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
.. .........+.+++..||+.+|++||++.||.+.|+.+
T Consensus 226 ~~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 RL----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CC----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00 11122345688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=392.27 Aligned_cols=264 Identities=30% Similarity=0.466 Sum_probs=214.6
Q ss_pred cCcccceeecccCceEEEEEEEe--CCc----EEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD--NGT----EVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~--~g~----~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 447 (780)
++....+.||+|.||.||+|... +|. .||||.+++... +...+|++|..+|+.++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 45566789999999999999975 343 499999987754 44568999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhcccccCC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccc
Q 048425 448 LVYELVHNGSVESHLHGVDKN---RGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~---~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGL 524 (780)
+++|||++|+|..||+..+.. ...|+..+.+.++.|||+|+.||+++. +|||||.++|+||++...|||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999754322 456899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCccc-eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccc
Q 048425 525 AREATEGSQHI-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 525 A~~~~~~~~~~-~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
|+......... ..+..-...|||||.++.+.++.|+|||||||+||||+| |..||...... +-+..| ++.+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~--~v~~~~----~~gg- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF--EVLLDV----LEGG- 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH--HHHHHH----HhCC-
Confidence 99655443222 222233468999999999999999999999999999999 88898643321 111111 1111
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCCC
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDE 658 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~~ 658 (780)
+| ..+..+...+.+++..||+.+|++||++..|++.+..+.+....
T Consensus 922 --------RL--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 922 --------RL--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred --------cc--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 11 22344567888999999999999999999999999988776543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=348.28 Aligned_cols=263 Identities=27% Similarity=0.453 Sum_probs=203.3
Q ss_pred cCcccceeecccCceEEEEEEEeC-----------------CcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDN-----------------GTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKL 436 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~-----------------g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L 436 (780)
++|...+.||+|+||.||++.+++ +..||+|.+..... ....+|.+|++++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578888999999999999998542 34699999876432 234579999999999999999999
Q ss_pred eeeeeecceeEEEEeecCCCChhhhccccc---------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEe
Q 048425 437 IGICIEGRTRCLVYELVHNGSVESHLHGVD---------------KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIH 501 (780)
Q Consensus 437 ~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~---------------~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvH 501 (780)
++++.+.+..++||||+++|+|.+++.... .....++|..+++++.||+.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885321 11235889999999999999999999998 999
Q ss_pred cccCCcceEEcCCCCCeeecccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh--CCCC
Q 048425 502 RDFKASNVLLEDDFTPKVSDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS--GRKP 578 (780)
Q Consensus 502 rDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT--Gr~P 578 (780)
|||||+|||+++++.+||+|||+++....... .......++..|+|||++.++.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999987644322 12233456889999999999999999999999999999997 4556
Q ss_pred CCCCCccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 579 VDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 579 ~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
+..... .....++........ .... ..........+.+++.+||+.+|++||+|.||++.|+
T Consensus 242 ~~~~~~---~~~~~~~~~~~~~~~--~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTD---EQVIENAGEFFRDQG--RQVY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCH---HHHHHHHHHHhhhcc--cccc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 654321 112222111111110 0000 0011123357889999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=351.88 Aligned_cols=243 Identities=25% Similarity=0.356 Sum_probs=203.1
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
.++|+..++||+|+||+||..+.+ +++.+|+|++++..- ...+...+|..+|.+++||.||+++-.|++++.++||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 378999999999999999999864 689999999987632 3345688999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
+||+.||.|..+|. +.+.++.....-++..|+.||.|||+.+ ||||||||+|||||++|+++|+||||++...
T Consensus 104 ld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999994 5678999988889999999999999999 9999999999999999999999999999765
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
..... ...++||+.|||||++....++..+|.||+|+++|||++|..||.... ...+...+...+
T Consensus 177 ~~~~~-t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k-------- 241 (357)
T KOG0598|consen 177 KDGDA-TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGK-------- 241 (357)
T ss_pred cCCCc-cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCc--------
Confidence 54332 344799999999999999999999999999999999999999997543 223333332222
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCC
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPF 641 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs 641 (780)
+ ...+.-......+++...+..||++|--
T Consensus 242 --~-~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 242 --L-PLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred --C-CCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 0 0111112246778999999999999963
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=346.56 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=207.7
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeee-eeeecce-eEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIG-ICIEGRT-RCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g-~~~~~~~-~~LV 449 (780)
.+|.+++.||+|.||+|||+.. .+|..||.|.++-+..+ ..++...|+.+|++|+|||||++++ -+.++.+ ..||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4566778999999999999984 58999999998754332 3356899999999999999999999 4555555 7999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCc--EEecccCCcceEEcCCCCCeeeccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPR--VIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~--IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
|||+..|+|...+...++.+..++.+.+++++.|+++||+.+|..- ++ |+||||||.||+|+.+|.+||+||||++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999887788889999999999999999999999842 33 99999999999999999999999999998
Q ss_pred ccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 528 ATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 528 ~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
+..... .....+||+-||+||.+....|+.||||||+||++|||..-+.||.+. ++....+.+... ..
T Consensus 178 l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qg--d~--- 245 (375)
T KOG0591|consen 178 LSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQG--DY--- 245 (375)
T ss_pred hcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcC--CC---
Confidence 876543 235578999999999999999999999999999999999999999754 222211111111 00
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
+.+. +.-....+.+|+..|+..||+.||+.-.+++.+
T Consensus 246 --~~~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 246 --PPLP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred --CCCc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 1111 122346788999999999999999975554443
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=336.43 Aligned_cols=251 Identities=27% Similarity=0.450 Sum_probs=204.1
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
++|+..+.||+|+||.||++.++++..+|+|.+.... ...++|.+|++++++++|+||++++++|.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4577789999999999999999888899999986443 345689999999999999999999999999999999999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+|+|.++++. ....++|..+++++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 9999999863 2346899999999999999999999988 999999999999999999999999999876433222
Q ss_pred ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .....+... . . ....+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~~---~-~---~~~~~--- 223 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMISR---G-F---RLYRP--- 223 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHC---C-C---CCCCC---
Confidence 2222345668999999998899999999999999999999 8989864332 111111111 0 0 01111
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
......+.+++.+||+.+|++||++.|+++.|
T Consensus 224 ----~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 ----KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ----CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=337.49 Aligned_cols=255 Identities=25% Similarity=0.411 Sum_probs=208.6
Q ss_pred hcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
.++|+..+.||+|+||.||+|...++..||+|.+..... ..+.|.+|+.++++++|+||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 367888999999999999999988889999999865432 4568999999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++|+|.++++. .....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 84 ~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 84 AKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999964 23456899999999999999999999987 99999999999999999999999999987654332
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
.......++..|+|||++..+.++.++|||||||++|||+| |+.||...... .+..+.... .....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~----------~~~~~ 225 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSALQRG----------YRMPR 225 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHHHcC----------CCCCC
Confidence 22233446778999999999999999999999999999999 99998643221 111111100 00000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~ 651 (780)
.......+.+++.+|++.+|++||+++++.+.|+.
T Consensus 226 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 ----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=370.97 Aligned_cols=268 Identities=28% Similarity=0.446 Sum_probs=214.1
Q ss_pred hHHHHHHhcCcccceeecccCceEEEEEEEeC--C--cE-EEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeee
Q 048425 367 LSDLEKATEKFSSKRILGEGGFGCVYHGVMDN--G--TE-VAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIG 438 (780)
Q Consensus 367 ~~el~~at~~f~~~~~LG~G~fG~VYkg~l~~--g--~~-VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g 438 (780)
.+.++-..++....+.||+|.||.||+|.+.. + .. ||||..+... .....+|++|+++|+.++|+|||++||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 33444445666667999999999999999763 3 23 8999987532 445678999999999999999999999
Q ss_pred eeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCe
Q 048425 439 ICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPK 518 (780)
Q Consensus 439 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vK 518 (780)
++......++|||+|.||+|.++|. ++...++..++++++.++|+||+|||+++ +|||||.++|+|++.++.+|
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~---k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLK---KNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHH---hCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEE
Confidence 9999999999999999999999996 34447999999999999999999999998 99999999999999999999
Q ss_pred eecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccc
Q 048425 519 VSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPL 597 (780)
Q Consensus 519 LsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~l 597 (780)
|+||||++....-... .....-...|+|||.+..+.++.|+|||||||++||+++ |..|+...... .+..++
T Consensus 303 ISDFGLs~~~~~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~kI--- 375 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAKI--- 375 (474)
T ss_pred eCccccccCCcceeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHHH---
Confidence 9999998865411111 001124568999999999999999999999999999999 88888754432 111111
Q ss_pred cccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 598 LTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 598 l~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
+-....-..+......+..++.+||..+|++||+|.+|.+.|+.+.....
T Consensus 376 ----------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 376 ----------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ----------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 01111112223445677888899999999999999999999999886654
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=337.00 Aligned_cols=256 Identities=29% Similarity=0.427 Sum_probs=208.0
Q ss_pred HhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
..++|+..+.||+|++|.||+|...+++.||||.++... ...++|.+|++++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 346788899999999999999998888899999986543 3457899999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++++|.+++... ....++|..+.+++.+++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999642 2356899999999999999999999988 9999999999999999999999999998775332
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
.........+..|+|||++.+..++.++||||||+++|||+| |+.||...... .+.... ...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~----~~~---------- 220 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQQV----DQG---------- 220 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----HcC----------
Confidence 211122223457999999999999999999999999999999 99898643321 111100 000
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048425 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651 (780)
Q Consensus 612 L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~ 651 (780)
............+.+++.+|++.+|++||++.++++.|+.
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 221 YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0001112234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=342.38 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=201.3
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
.|+..+.||+|+||+||++... +|+.||||.+.... ......+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677899999999999999874 79999999986543 2233468899999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++|+|.+++.. .....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999999988853 23346899999999999999999999998 999999999999999999999999999876433
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
.. .....||..|+|||++.+..++.++|||||||+||||++|+.||............ ... +.+..
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~--~~~----------~~~~~ 221 (285)
T cd05631 156 ET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV--DRR----------VKEDQ 221 (285)
T ss_pred Ce--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH--HHH----------hhccc
Confidence 22 23456999999999999999999999999999999999999999754321111000 000 00000
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 048425 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPF-----MGEVVQ 647 (780)
Q Consensus 612 L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs-----m~EVv~ 647 (780)
..+..+....+.+++..||+.||++||+ ++|+++
T Consensus 222 --~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 --EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1112223356789999999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=359.58 Aligned_cols=260 Identities=27% Similarity=0.429 Sum_probs=204.6
Q ss_pred hcCcccceeecccCceEEEEEEE------eCCcEEEEEEeeccCC-cchHHHHHHHHHhhhc-CCCceeeeeeeeeecce
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVM------DNGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRT 445 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~ 445 (780)
.++|+..+.||+|+||.||+|.. +++..||||+++.... ...+.+.+|+.++..+ +||||++++++|.+++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35688889999999999999974 2456899999975432 2345689999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhhcccccC----------------------------------------------------------
Q 048425 446 RCLVYELVHNGSVESHLHGVDK---------------------------------------------------------- 467 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~---------------------------------------------------------- 467 (780)
.++||||+++|+|.++++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864211
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 468 -------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 468 -------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
....++|..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1235899999999999999999999987 999999999999999999999999999876543221
Q ss_pred -ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 535 -ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 535 -~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
......++..|+|||++.+..++.++|||||||++|||++ |..||...... ..+..+... .. . .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~~~----~~--~-~----- 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMIKE----GY--R-M----- 336 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHHHh----Cc--c-C-----
Confidence 1122345678999999999999999999999999999998 88888643211 111111110 00 0 0
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
..+......+.+++.+|++.||++||+|.||++.|++.
T Consensus 337 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 --LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00111234688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=338.25 Aligned_cols=257 Identities=30% Similarity=0.485 Sum_probs=213.1
Q ss_pred HHhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 372 KATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 372 ~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
++.++|+..+.||+|+||.||+|...++..+|+|.+.........++.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 45678889999999999999999998899999999987665556789999999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++|+|.+++.. .....+++..+++++.+++.||+|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999964 23456899999999999999999999988 999999999999999999999999999876543
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
... .....++..|+|||.+.++.++.++||||||++++||++ |+.||..... .....+...
T Consensus 158 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~-------------- 219 (261)
T cd05148 158 VYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQITA-------------- 219 (261)
T ss_pred ccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHHh--------------
Confidence 221 223346778999999998999999999999999999998 8999865332 111111110
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~ 651 (780)
.............+.+++.+|++.+|++||++.++++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 220 GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 00011122334578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=335.59 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=207.1
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
.+|...+.||+|+||.||+|... +++.||+|+++.. .....+|.+|++++++++|+||++++++|..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45778899999999999999975 5889999998654 334567999999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++++|.+++.. .....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999999864 23456899999999999999999999987 99999999999999999999999999987654332
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
.......++..|+|||++.+..++.++|||||||++|||++ |..|+...... .+... +. ...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~---~~-----------~~~ 222 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL---LE-----------KGY 222 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH---HH-----------CCC
Confidence 22222334668999999999999999999999999999998 88888643221 11111 00 000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
...........+.+++.+|++.+|++||++.|++++|+.+
T Consensus 223 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1111122335788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=358.47 Aligned_cols=261 Identities=28% Similarity=0.457 Sum_probs=205.0
Q ss_pred hcCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCCc-chHHHHHHHHHhhhc-CCCceeeeeeeeeecce
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRL-HHRNLVKLIGICIEGRT 445 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~ 445 (780)
.++|...+.||+|+||.||+|+.. ++..||||+++..... ....+.+|+++++.+ +|+||++++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357888899999999999998742 3457999999765332 235688999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhhcccccC----------------------------------------------------------
Q 048425 446 RCLVYELVHNGSVESHLHGVDK---------------------------------------------------------- 467 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~---------------------------------------------------------- 467 (780)
.++||||+++|+|.++++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999998853210
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc-ceec
Q 048425 468 --------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH-ISTR 538 (780)
Q Consensus 468 --------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~-~~t~ 538 (780)
...++++..+++|+.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1235889999999999999999999987 999999999999999999999999999876443221 1122
Q ss_pred cccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCC
Q 048425 539 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYD 617 (780)
Q Consensus 539 ~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~ 617 (780)
..++..|||||++.+..++.++|||||||++|||++ |+.||....... .+.. ..... ..+ ...
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~----~~~~~------~~~----~~~ 337 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYK----MVKRG------YQM----SRP 337 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHH----HHHcc------cCc----cCC
Confidence 345678999999999999999999999999999997 999986432211 1100 00000 000 001
Q ss_pred hhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 048425 618 FDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIY 653 (780)
Q Consensus 618 ~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~ 653 (780)
......+.+++.+||+.+|++||++.||++.|+++.
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 112356889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=362.99 Aligned_cols=246 Identities=28% Similarity=0.486 Sum_probs=205.0
Q ss_pred HhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
..+....++.||.|+.|.||+|++ .++.||||+++.-.. .+|+-|++|+|+||+.+.|+|.....+||||||
T Consensus 122 PFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf 193 (904)
T KOG4721|consen 122 PFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF 193 (904)
T ss_pred CHHHhhhhhhhccCcccceeeeec-cCceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence 334445568899999999999999 468999998854322 588999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
|..|-|.+.| +...+++-.....+..+||.||.|||... |||||||+-||||..+..+||+|||-++...+..
T Consensus 194 Ca~GqL~~VL----ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S 266 (904)
T KOG4721|consen 194 CAQGQLYEVL----KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS 266 (904)
T ss_pred cccccHHHHH----hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh
Confidence 9999999999 45678888999999999999999999987 9999999999999999999999999999876643
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
.. -.++||..|||||++.+.+.++|+|||||||||||||||..||..... ..+-| .-+.. .|
T Consensus 267 Tk--MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIw-----GVGsN-------sL 328 (904)
T KOG4721|consen 267 TK--MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIW-----GVGSN-------SL 328 (904)
T ss_pred hh--hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEE-----eccCC-------cc
Confidence 22 347899999999999999999999999999999999999999964321 11122 11111 12
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~ 651 (780)
.-..+..+...+.-|+++||+..|.+||++.+|+..|+-
T Consensus 329 ~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 329 HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 122334556678889999999999999999999988853
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=340.17 Aligned_cols=249 Identities=33% Similarity=0.563 Sum_probs=193.8
Q ss_pred cceeecccCceEEEEEEEe-----CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 379 SKRILGEGGFGCVYHGVMD-----NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 379 ~~~~LG~G~fG~VYkg~l~-----~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
..+.||.|.||.||+|.+. .+..|+||.++..... ..++|.+|++.+++++|+||++++|+|.+.+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999987 3578999999654332 357899999999999999999999999988889999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++|+|.++|+.. ....+++..+++|+.|||+||+|||+.+ ++|+||+++|||+++++.+||+|||+++......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 9999999999752 3567999999999999999999999987 9999999999999999999999999998773322
Q ss_pred c-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 533 Q-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 533 ~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
. .......+...|+|||.+.+..++.|+||||||+++|||+| |+.|+..... ..+.. .+ .....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~---~~-~~~~~------- 223 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIE---KL-KQGQR------- 223 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHH---HH-HTTEE-------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccc---cc-ccccc-------
Confidence 1 12223456778999999999999999999999999999999 6788754321 11111 11 11100
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
...+......+.+++..||+.+|++||+|.|+++.|
T Consensus 224 ---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 ---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 011122345688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=348.24 Aligned_cols=265 Identities=24% Similarity=0.359 Sum_probs=205.3
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
.++|+..+.||+|+||.||+++.. +|..||+|.+..... ...+.|.+|++++++++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 368899999999999999999976 688999999876532 234579999999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++|+|.+++.. ...+++..+.+++.|++.||+|||+.+ .|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999853 346899999999999999999999853 3999999999999999999999999999866432
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccc---------
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTRE--------- 602 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~--------- 602 (780)
. .....||..|+|||++.+..++.++|||||||++|||+||+.||............. .+......
T Consensus 158 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDGEEGEPHSISPR 232 (331)
T ss_pred c---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--ccccccccCCccccCcc
Confidence 2 234568999999999999999999999999999999999999996543211110000 00000000
Q ss_pred -----------------------ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 603 -----------------------GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 603 -----------------------~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
....++...............+.+++.+||+.||++||+++|+++.-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000000000000111234688999999999999999999997653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=339.23 Aligned_cols=266 Identities=22% Similarity=0.274 Sum_probs=203.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
++|...+.||+|+||+||+++.+ +++.||||+++.... ...+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999986 688999999876432 234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|++++++..+.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999987765542 3456899999999999999999999987 999999999999999999999999999876543
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-hhhhcccccc-------cccc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LVTWARPLLT-------TREG 603 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-Lv~wa~~ll~-------~~~~ 603 (780)
.........||..|+|||++.+..++.++|||||||++|||++|+.||......+... +.....++.. ....
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 3333344578999999999999999999999999999999999999997543221100 0000000000 0000
Q ss_pred cccccCCccCCC------CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 604 LEQLVDPSLAGS------YDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 604 l~~lvDp~L~~~------~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
......+..... +.......+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000111000 00112346899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=346.21 Aligned_cols=270 Identities=29% Similarity=0.447 Sum_probs=203.1
Q ss_pred CcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhh--cCCCceeeeeeeeeecc----eeEEE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSR--LHHRNLVKLIGICIEGR----TRCLV 449 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~--L~HpNIV~L~g~~~~~~----~~~LV 449 (780)
.....++||+|.||.||||.+. ++.||||++.. +..+.|++|-+|.+. ++|+||++++++-..+. +++||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 3345578999999999999994 59999999843 345678899888876 58999999999876555 88999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhC------CCCcEEecccCCcceEEcCCCCCeeeccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED------SNPRVIHRDFKASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~------~~p~IvHrDIKpsNILLd~~~~vKLsDFG 523 (780)
+||.++|||.+||. ...++|....+||..+++||+|||+. .+|+|+|||||++||||.+|+++.|+|||
T Consensus 287 t~fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeeccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999995 35799999999999999999999985 36789999999999999999999999999
Q ss_pred ccccccCCCcc-ceeccccCccccCchhhccCC-C-----CchhhHHhHHHHHHHHHhCCCCCCC-CCccccchh-----
Q 048425 524 LAREATEGSQH-ISTRVMGTFGYVAPEYAMTGH-L-----LVKSDVYSYGVVLLELLSGRKPVDM-SQPQGQENL----- 590 (780)
Q Consensus 524 LA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~-~-----t~ksDVySfGVvLlELlTGr~P~~~-~~~~~~~~L----- 590 (780)
||..+..+... .....+||.+|||||++.+.- + -.+.||||+|.|||||++.-.-++. ..+.-+.-.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 99988654322 122367999999999987642 2 2478999999999999986554432 111100000
Q ss_pred ----hhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCCC
Q 048425 591 ----VTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDE 658 (780)
Q Consensus 591 ----v~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~~ 658 (780)
.+-.+.+.-.++....+.|.... ...+..+.+.+..||+.||+.|.|+.=|-+++.++....+.
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 00011111111111122222111 24577899999999999999999999999999888765543
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=337.96 Aligned_cols=257 Identities=30% Similarity=0.521 Sum_probs=206.6
Q ss_pred cCcccceeecccCceEEEEEEEeC------CcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDN------GTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~------g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 447 (780)
++|+..+.||+|+||.||+|.... ...||+|.++.... ....+|.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467788999999999999998643 25799999875433 23457899999999999999999999999888999
Q ss_pred EEEeecCCCChhhhcccccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC
Q 048425 448 LVYELVHNGSVESHLHGVDK------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF 515 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~ 515 (780)
++|||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999964211 1156899999999999999999999998 99999999999999999
Q ss_pred CCeeecccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhh
Q 048425 516 TPKVSDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTW 593 (780)
Q Consensus 516 ~vKLsDFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~w 593 (780)
.+||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ |+.||...... .+..+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999986543321 12233456888999999999999999999999999999998 99998754322 12211
Q ss_pred cccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048425 594 ARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651 (780)
Q Consensus 594 a~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~ 651 (780)
+. .... ..........+.+|+.+||+.+|++||++.||++.|+.
T Consensus 239 i~-------------~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 IR-------------SRQL-LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HH-------------cCCc-CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 0000 11122334678899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=344.03 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=205.6
Q ss_pred cCcccceeecccCceEEEEEEEe-CCc----EEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGT----EVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~----~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
.+|+..+.||+|+||.||+|++. +|+ .||||.++.... ...++|.+|+.+++.++|+||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999864 344 389999875432 3346799999999999999999999999864 5689
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
|+||+++|+|.+++.. ....+++..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 9999999999999963 3456899999999999999999999988 999999999999999999999999999977
Q ss_pred cCCCccce-eccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccc
Q 048425 529 TEGSQHIS-TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 529 ~~~~~~~~-t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
........ ....++..|+|||++.+..++.++|||||||++|||++ |+.|++...... +..+ ..... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~---~ 229 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LEKGE---R 229 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HhCCC---C
Confidence 54332211 22334678999999999999999999999999999998 999986533211 1111 11100 0
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
... .......+.+++.+||+.+|.+||++.+++..|..+..+.
T Consensus 230 ~~~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 230 LPQ-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 000 1112346788999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=332.83 Aligned_cols=255 Identities=25% Similarity=0.438 Sum_probs=206.2
Q ss_pred cCcccceeecccCceEEEEEEEeC----CcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDN----GTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~----g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
++|+..+.||+|+||+||+|.+.. ...||||.++..... ...+|.+|+.++++++|+||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578889999999999999999752 457999998655332 345799999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++++|.+++.. ....+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999999963 3347899999999999999999999987 9999999999999999999999999999875
Q ss_pred CCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 530 EGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 530 ~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
..... ......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ..+....... .
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~---------~ 225 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAVEDG---------Y 225 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHHcC---------C
Confidence 22211 1222345678999999999999999999999999999998 9999854321 1111111100 0
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
.. .........+.+++.+|++.+|++||++.||++.|+.+
T Consensus 226 ~~-----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 RL-----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CC-----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 01122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=330.05 Aligned_cols=260 Identities=25% Similarity=0.384 Sum_probs=209.7
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||.||+|+.. +++.||||.++.... .....|.+|++++++++|+||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999975 789999998864322 22356899999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++.........++...+++++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988654444567899999999999999999999987 99999999999999999999999999987654
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
.... .....|+..|+|||++.+..++.++||||||+++|||++|+.|+...... ...+...+ .....+
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~-------~~~~~~ 226 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKI-------EQCDYP 226 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHH-------hcCCCC
Confidence 3221 12345888999999999888999999999999999999999998543211 11111111 000011
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
.. ........+.+++.+||+.+|++||++.||++.|+++
T Consensus 227 ~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 PL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11 1112335688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.98 Aligned_cols=252 Identities=27% Similarity=0.432 Sum_probs=203.9
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
++|...+.||+|+||+||+|...++..||||.++... ....+|.+|+.++.+++||||++++++|.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577789999999999999998777789999986543 345679999999999999999999999998888999999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+|+|.+++.. ....++|..+++++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 9999999863 2336899999999999999999999988 999999999999999999999999999876543322
Q ss_pred ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
......++..|++||++.+..++.++|||||||++|||++ |+.||...... .+.... .... . .
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~---~~~~---~----~--- 220 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEKV---SQGL---R----L--- 220 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH---hcCC---C----C---
Confidence 2222345678999999998899999999999999999999 99998643321 111111 0000 0 0
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
.........+.+++.+||+.+|.+||++.+|++.|+
T Consensus 221 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 -YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001112357899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.19 Aligned_cols=256 Identities=29% Similarity=0.479 Sum_probs=207.1
Q ss_pred cCcccceeecccCceEEEEEEEeC------CcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDN------GTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~------g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 447 (780)
++|...+.||+|+||.||+|...+ +..||||.++..... ..+.|.+|++++++++|+||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 567788999999999999998643 478999999765443 3568999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhccccc----------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCC
Q 048425 448 LVYELVHNGSVESHLHGVD----------KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP 517 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~----------~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~v 517 (780)
+||||+++++|.+++.... .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999996431 22356899999999999999999999998 9999999999999999999
Q ss_pred eeecccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcc
Q 048425 518 KVSDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWAR 595 (780)
Q Consensus 518 KLsDFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~ 595 (780)
||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ |+.||..... ..+.....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIECIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHH
Confidence 9999999986543221 12233456788999999999999999999999999999999 9999864332 12222111
Q ss_pred cccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 596 PLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 596 ~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
. . .. ...+......+.+++..||+.+|++||++.||++.|+
T Consensus 239 ---~-~-~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 ---Q-G-RL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---c-C-Cc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0 0 00 0111123357889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=337.69 Aligned_cols=261 Identities=26% Similarity=0.439 Sum_probs=210.5
Q ss_pred cCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
++|...+.||+|+||.||+|... ++..+++|.++.......+.|.+|++++++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45778899999999999999853 355699999876655555789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhccccc------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC
Q 048425 449 VYELVHNGSVESHLHGVD------------KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT 516 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~------------~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~ 516 (780)
||||+++++|.+++.... .....++|..+++++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999996421 12345899999999999999999999998 999999999999999999
Q ss_pred CeeecccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhc
Q 048425 517 PKVSDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWA 594 (780)
Q Consensus 517 vKLsDFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa 594 (780)
+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||+| |+.||...... .+....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~ 238 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIECI 238 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence 99999999986644321 12234457788999999999999999999999999999999 99998653321 111111
Q ss_pred ccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 595 RPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 595 ~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
... ... .........+.+++.+|++.+|++||++.+|+++|+.+...
T Consensus 239 ----~~~-~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 239 ----TQG-RVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred ----hCC-CCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 000 000 01112235688999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=348.05 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=205.1
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++.+++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46888999999999999999976 58999999997642 223457889999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++. ....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999995 3456899999999999999999999998 99999999999999999999999999986644
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCcccc-chhhhhcccccccccccccccC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ-ENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~-~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+..|... +. .
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-------~~---~ 219 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET-------LQ---R 219 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-------cc---C
Confidence 22345699999999999999999999999999999999999999976543221 111122110 00 0
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
+.. ..........+.+++.+|++.+|++||++.|+++.
T Consensus 220 ~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 100 00001223467889999999999999999999764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=336.60 Aligned_cols=263 Identities=26% Similarity=0.437 Sum_probs=210.8
Q ss_pred cCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
++|...+.||+|+||+||++... ++..+|+|.+........+.|.+|++++++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57888899999999999999852 345699999876655556679999999999999999999999999999999
Q ss_pred EEeecCCCChhhhccccc---------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCee
Q 048425 449 VYELVHNGSVESHLHGVD---------KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKV 519 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~---------~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKL 519 (780)
||||+++++|.+++.... .....+++..+++++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986421 12235999999999999999999999988 999999999999999999999
Q ss_pred ecccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccc
Q 048425 520 SDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPL 597 (780)
Q Consensus 520 sDFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~l 597 (780)
+|||+++....... .......++..|+|||++.+..++.++|||||||++|||+| |+.||...... ......
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~~i--- 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIECI--- 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---
Confidence 99999986643321 11233446788999999999999999999999999999999 88888654321 111110
Q ss_pred cccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 598 LTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 598 l~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
.. .. . ... .......+.+++.+|++.+|.+||++.||.+.|+.+....+
T Consensus 236 ~~-~~-~-----~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~ 284 (288)
T cd05093 236 TQ-GR-V-----LQR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284 (288)
T ss_pred Hc-CC-c-----CCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence 00 00 0 001 11123468999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=335.49 Aligned_cols=260 Identities=27% Similarity=0.420 Sum_probs=206.9
Q ss_pred CcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
+|...+.||+|+||.||+|... ....+++|.+...... ..+++.+|+.+++.++|+||+++++.|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999863 2357999988655432 23578999999999999999999999999999999
Q ss_pred EEeecCCCChhhhccccc--------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcc
Q 048425 449 VYELVHNGSVESHLHGVD--------------------KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASN 508 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~--------------------~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsN 508 (780)
|+||+.+|+|.+++.... +....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999986421 12246899999999999999999999987 9999999999
Q ss_pred eEEcCCCCCeeecccccccccCCCccc-eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccc
Q 048425 509 VLLEDDFTPKVSDFGLAREATEGSQHI-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQG 586 (780)
Q Consensus 509 ILLd~~~~vKLsDFGLA~~~~~~~~~~-~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~ 586 (780)
||+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||+| |+.||....+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 999999999999999998654332211 223345778999999999999999999999999999999 99998654322
Q ss_pred cchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 587 QENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 587 ~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
.+..+... .............+.+++.+|++.+|++||++.|+++.|+++...
T Consensus 237 --~~~~~~~~--------------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 237 --RLFNLLKT--------------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred --HHHHHHhC--------------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 12221111 000111122235688999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=326.04 Aligned_cols=261 Identities=24% Similarity=0.380 Sum_probs=211.7
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|+..+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 67889999999999999999987 89999999886432 223457999999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++.........+++.++++++.+++.||+|||+.+ |+||||||+||++++++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998654445567899999999999999999999988 99999999999999999999999999986644
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
.... .....|+..|+|||++.+..++.++|||||||++|||++|+.|+..... ++..+...... ....+
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~------~~~~~ 227 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEK------CDYPP 227 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhhc------CCCCC
Confidence 3221 2334588899999999998999999999999999999999999854321 11111111100 00001
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIY 653 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~ 653 (780)
+ ........+.+++.+|++.+|++||++.+|+++|+++.
T Consensus 228 -~---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 -L---PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -C---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 01123346889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=335.11 Aligned_cols=259 Identities=27% Similarity=0.483 Sum_probs=204.8
Q ss_pred HHhcCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecc
Q 048425 372 KATEKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGR 444 (780)
Q Consensus 372 ~at~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 444 (780)
.++++|+..+.||+|+||.||+|... .+..||||+++.... ....+|.+|+.+++.++|+||+++++++.++.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999999753 356799999865432 23457899999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhhcccccCC------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCe
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKN------RGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPK 518 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~------~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vK 518 (780)
..++||||+++|+|.+++...... ...++|..++.++.|++.||+|||+.+ ++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 999999999999999998643221 235789999999999999999999987 99999999999999999999
Q ss_pred eecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccc
Q 048425 519 VSDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARP 596 (780)
Q Consensus 519 LsDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ 596 (780)
|+|||+++........ ......++..|+|||++.++.++.++|||||||++|||++ |..||...... ....+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~~-- 234 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRFV-- 234 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH--
Confidence 9999999865433221 1122345778999999999999999999999999999999 68888643321 111110
Q ss_pred ccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 597 LLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 597 ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
. +... ..........+.+++.+|++.+|++||++.|+++.|+
T Consensus 235 -~----------~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 -M----------EGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -H----------cCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0 0000 0111223356889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=329.78 Aligned_cols=251 Identities=28% Similarity=0.434 Sum_probs=202.7
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
.+|+..+.||+|+||.||+|..+++..+|+|.+..... ...+|.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35677889999999999999987778899999865432 34678999999999999999999999999999999999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+++|.+++.. ....++|..+++++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 83 NGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 9999999863 2347899999999999999999999998 999999999999999999999999999876443222
Q ss_pred ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
......++..|+|||++.+..++.++||||||+++|||++ |+.||+..... ..... +......
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----------~~~~~~~--- 220 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVES----------VSAGYRL--- 220 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHH----------HHcCCcC---
Confidence 1122234557999999999999999999999999999999 88888653321 11110 0000011
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
.........+.+++.+|++.+|++||+|.||++.|
T Consensus 221 -~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 -YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11112345789999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=346.03 Aligned_cols=255 Identities=25% Similarity=0.381 Sum_probs=201.2
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecc--eeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGR--TRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~--~~~LV~E 451 (780)
.++...+.||+|.||+||++... +|...|||.+........+.+.+|+.+|++++|||||+.+|.....+ .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45666789999999999999976 49999999987664333566899999999999999999999855444 6899999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC-CCCCeeecccccccccC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED-DFTPKVSDFGLAREATE 530 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~-~~~vKLsDFGLA~~~~~ 530 (780)
|+++|||.+++.+ ..+.|+...+.+.+.||++||+|||+++ |||||||++||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~---~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKR---YGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999963 2227999999999999999999999998 999999999999999 79999999999998764
Q ss_pred --CCccceeccccCccccCchhhccCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 531 --GSQHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 531 --~~~~~~t~~~GT~~Y~APE~l~~~~~-t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
..........||+.|||||++.++.. ..++|||||||+++||+||+.||... .....+.-.+....
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~------ 239 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED------ 239 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC------
Confidence 11222345789999999999996533 35999999999999999999999642 01111111111110
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
.-| ..+........+++..|++.+|++|||++|+++.--
T Consensus 240 ~~P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 240 SLP----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CCC----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 111 222223356788999999999999999999977543
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=333.84 Aligned_cols=258 Identities=26% Similarity=0.431 Sum_probs=203.3
Q ss_pred cCcccceeecccCceEEEEEEEe-CCc----EEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGT----EVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~----~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
++|...+.||+|+||+||+|.+. +|. .|++|.+..... ....++..|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 45677789999999999999864 454 477787754322 223568889999999999999999999864 55789
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
++||+++|+|.++++. ....++|..+++++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999963 3457999999999999999999999987 999999999999999999999999999876
Q ss_pred cCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccc
Q 048425 529 TEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 529 ~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
...... ......++..|+|||++.++.++.++|||||||++|||+| |+.||....+.. +.++. .... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~----~~~~---~ 229 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDLL----EKGE---R 229 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----HCCC---c
Confidence 543222 2234567789999999999999999999999999999998 999987543321 11111 1111 1
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
...+. .....+.+++.+|+..+|++||++.|+++.|+.+.++.
T Consensus 230 ~~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 230 LAQPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred CCCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 11111 11235678899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=328.35 Aligned_cols=253 Identities=27% Similarity=0.431 Sum_probs=204.8
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
++|+..+.||+|+||.||+|...++..||+|.++.... ..+.|.+|++++++++|+||+++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 56788899999999999999988888999999876443 4567999999999999999999999885 456799999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+++|.++++. .....+++..+++++.+++.||+|||+.+ |+||||||+||++++++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 84 KGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999964 23346899999999999999999999988 999999999999999999999999999876543322
Q ss_pred ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ....+... ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~--------------~~~ 221 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQVER--------------GYR 221 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHc--------------CCC
Confidence 2222345678999999998999999999999999999999 88888643211 11111100 000
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~ 651 (780)
.....+....+.+++.+|++.+|++|||+.++.+.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122334578999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=332.77 Aligned_cols=268 Identities=28% Similarity=0.382 Sum_probs=204.0
Q ss_pred cCcccceeecccCceEEEEEEEe-----CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeec--ceeE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-----NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEG--RTRC 447 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-----~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~ 447 (780)
++|...+.||+|+||.||++..+ ++..||||.++.......+.|.+|++++++++|+||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 56788899999999999999752 5789999998766555567899999999999999999999987543 4678
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+||||+++|+|.+++.. ....++|..++.++.|++.||+|||+.+ |+||||||+||++++++++||+|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 99999999999999963 3456899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCccc--eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccc---c
Q 048425 528 ATEGSQHI--STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTR---E 602 (780)
Q Consensus 528 ~~~~~~~~--~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~---~ 602 (780)
........ .....++..|+|||++.+..++.++|||||||++|||++|..++...... ............ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIVY 233 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccchH
Confidence 65433211 11222445699999999999999999999999999999988765432110 000000000000 0
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
.+.+.++..............+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00111111110011122345789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=333.55 Aligned_cols=265 Identities=22% Similarity=0.309 Sum_probs=206.7
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
+.|+...++|+|+||.|||++.+ +|+.||||++.....+ ..+-.++||++|++++|+|+|.|+++|.....+.||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45777788999999999999986 6999999999665432 23457999999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|++.--|.++ ......++.....+++.|+++|+.|+|+++ +|||||||+||||+.++.+||||||+|+.+...
T Consensus 82 ~~dhTvL~eL----e~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDHTVLHEL----ERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecchHHHHHH----HhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9987544433 244556889999999999999999999998 999999999999999999999999999988742
Q ss_pred CccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhc-c-------ccccccc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWA-R-------PLLTTRE 602 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa-~-------~ll~~~~ 602 (780)
....|..+.|.+|.|||.+.+ .+|....|||+.|||+.||++|..-|-+...-++-.++... . .+.....
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 334577788999999999887 68899999999999999999999888766544433222111 1 1111111
Q ss_pred ccccccCCccCCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 603 GLEQLVDPSLAGSYD-----FDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~-----~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
....+.-|......+ .....-+++++..|++.||.+|++-+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 122222222211111 122346889999999999999999998874
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.52 Aligned_cols=244 Identities=22% Similarity=0.312 Sum_probs=200.1
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|+..+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888899999999999999976 689999999865422 23456889999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++. ....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999985 3457899999999999999999999998 99999999999999999999999999987644
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.. .+....
T Consensus 154 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~~---~i~~~~--------- 214 (291)
T cd05612 154 RT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IYE---KILAGK--------- 214 (291)
T ss_pred Cc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHhCC---------
Confidence 22 23568999999999999999999999999999999999999997543211 111 111100
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPF-----MGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs-----m~EVv~ 647 (780)
+ .++......+.+++.+|++.||.+||+ ++|+++
T Consensus 215 -~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 215 -L--EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred -c--CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 0 011111246789999999999999995 666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=349.09 Aligned_cols=249 Identities=27% Similarity=0.410 Sum_probs=205.7
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeecc----CC-cchHHHHHHHHHhhhcC-CCceeeeeeeeeecce
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRN----NQ-NGDREFIAEVEMLSRLH-HRNLVKLIGICIEGRT 445 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~----~~-~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~ 445 (780)
..++|...+.||+|.||+|++|... +|..||||++++. .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3468889999999999999999864 7899999987664 11 23455678999999998 9999999999999999
Q ss_pred eEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC-CCCeeecccc
Q 048425 446 RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD-FTPKVSDFGL 524 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~-~~vKLsDFGL 524 (780)
.++||||+.+|+|.+++. ..+++......+++.|++.|++|||+.+ |+|||||++|||+|.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 999999999999999995 3678889999999999999999999998 9999999999999999 9999999999
Q ss_pred cccccCCCccceeccccCccccCchhhccCC-CC-chhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccc
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMTGH-LL-VKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~-~t-~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.... ....+.+....-
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~~ki~~~~~ 240 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLYRKIRKGEF 240 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHHHHHhcCCc
Confidence 99884 2223446678999999999999977 76 789999999999999999999986321 111111111111
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHH
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVV 646 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv 646 (780)
.+...++ ...+..++.+|+..||.+|+++.||+
T Consensus 241 ~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 241 KIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred cCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1111110 35678999999999999999999997
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=342.93 Aligned_cols=262 Identities=27% Similarity=0.438 Sum_probs=205.5
Q ss_pred HhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhh--cCCCceeeeeeeeeec----cee
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSR--LHHRNLVKLIGICIEG----RTR 446 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~--L~HpNIV~L~g~~~~~----~~~ 446 (780)
...+....+.||+|.||.||+|.+ .|+.||||++.. .+++.+.+|.++.+. |+|+||+.+++.-..+ .++
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 346777889999999999999999 589999999843 345678889998886 5999999999886543 367
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-----CCCCcEEecccCCcceEEcCCCCCeeec
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE-----DSNPRVIHRDFKASNVLLEDDFTPKVSD 521 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~-----~~~p~IvHrDIKpsNILLd~~~~vKLsD 521 (780)
+||.+|.++|||+|||. +..++-...+++++.+|.||++||. +++|.|.|||||+.||||..++.+.|+|
T Consensus 285 wLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 99999999999999995 3679999999999999999999996 4789999999999999999999999999
Q ss_pred ccccccccCCCccc---eeccccCccccCchhhccC------CCCchhhHHhHHHHHHHHHh----C------CCCCCCC
Q 048425 522 FGLAREATEGSQHI---STRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVLLELLS----G------RKPVDMS 582 (780)
Q Consensus 522 FGLA~~~~~~~~~~---~t~~~GT~~Y~APE~l~~~------~~t~ksDVySfGVvLlELlT----G------r~P~~~~ 582 (780)
+|||-........+ ....+||.+|||||++... .-...+||||||.|+||+.. | +.||..-
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 99998876553322 3446799999999988643 12357899999999999974 2 2343322
Q ss_pred Cccccchhhhhcccccccccccccc-c----CCccCCC-CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 583 QPQGQENLVTWARPLLTTREGLEQL-V----DPSLAGS-YDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 583 ~~~~~~~Lv~wa~~ll~~~~~l~~l-v----Dp~L~~~-~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
.+.+. .. +.+.++ - .|.+... .+.+.+..|.++++.||..||..|-|+-.|.+.|.++.+.
T Consensus 440 Vp~DP-----------s~-eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 440 VPSDP-----------SF-EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCCC-----------CH-HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 22111 11 111111 1 2222222 2357788999999999999999999999999999988753
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=353.44 Aligned_cols=263 Identities=25% Similarity=0.392 Sum_probs=207.4
Q ss_pred HhcCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcC-CCceeeeeeeeeecc
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLH-HRNLVKLIGICIEGR 444 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~ 444 (780)
..++|...++||+|+||.||+|... .+..||||+++..... ..+.|.+|++++++++ ||||++++++|.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3568888999999999999999853 2347999999754332 2357999999999996 999999999999999
Q ss_pred eeEEEEeecCCCChhhhcccccC---------------------------------------------------------
Q 048425 445 TRCLVYELVHNGSVESHLHGVDK--------------------------------------------------------- 467 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~--------------------------------------------------------- 467 (780)
..+|||||+++|+|.++|+....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999999864211
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc
Q 048425 468 -----------------------------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE 512 (780)
Q Consensus 468 -----------------------------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd 512 (780)
....+++..+++++.|+++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 0135889999999999999999999987 99999999999999
Q ss_pred CCCCCeeecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchh
Q 048425 513 DDFTPKVSDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENL 590 (780)
Q Consensus 513 ~~~~vKLsDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~L 590 (780)
+++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ..+
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~~ 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--STF 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HHH
Confidence 9999999999999876433221 1223457788999999999999999999999999999997 99998643211 111
Q ss_pred hhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 591 VTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 591 v~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
... ..... .. .........+.+++.+||+.+|++||++.+|+++|+.+..
T Consensus 350 ~~~----~~~~~------~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 YNK----IKSGY------RM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHH----HhcCC------CC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 110 00000 00 1111233578899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=328.39 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=205.5
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
++|+..+.||+|+||.||+|..++...||+|+++... ...++|.+|++++++++|+||+++++++.+ +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 5688899999999999999998777789999997533 245679999999999999999999998754 56799999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+|+|.+++... ....++|..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 84 KGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 99999999632 2346899999999999999999999987 999999999999999999999999999876543322
Q ss_pred ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
......++..|+|||+..++.++.++||||||+++|||+| |+.||....... +.. ..... ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~~---~~~~~-------~~---- 221 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLD---QVERG-------YR---- 221 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HHH---HHhcC-------CC----
Confidence 2223446778999999999999999999999999999999 788886443211 100 00000 00
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIY 653 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~ 653 (780)
.....+....+.+++.+|++.+|++||++.++.+.|+...
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 0111233457889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=328.00 Aligned_cols=261 Identities=25% Similarity=0.383 Sum_probs=210.6
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|+..+.||+|+||.||++... +|..+|||.+..... ....+|.+|+++++.++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46778899999999999999964 889999998865432 23357899999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++++|.+++.........+++..+++++.++++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998654444567999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
.... .....|+..|+|||++.+..++.++||||||+++|||++|..||...... ...+... +.....+
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-------~~~~~~~ 226 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-------IEQCDYP 226 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhh-------hhcCCCC
Confidence 3221 22346889999999999989999999999999999999999998643211 1111111 1111111
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIY 653 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~ 653 (780)
.+. .......+.+++.+|++.+|++||||.+|.++++++.
T Consensus 227 ~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 227 PLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 111 1123356889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=345.27 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=199.5
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888899999999999999975 68999999987542 223457899999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++. ....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999985 3456889999999999999999999998 99999999999999999999999999987644
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. +. ..+...
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~---~~i~~~---------- 230 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IY---EKILAG---------- 230 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HH---HHHhcC----------
Confidence 32 23569999999999999999999999999999999999999996533211 10 011110
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPF-----MGEVV 646 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs-----m~EVv 646 (780)
.+ .++......+.+++..||+.||++||+ ++|++
T Consensus 231 ~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 231 RL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred Cc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 00 011112245789999999999999997 45554
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=327.65 Aligned_cols=254 Identities=25% Similarity=0.413 Sum_probs=206.5
Q ss_pred hcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
.++|...++||+|+||.||+|..++++.||+|.+..... ...+|.+|++++++++|+||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 467888999999999999999998999999999875443 4568999999999999999999999874 45789999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++++|.+++.. .....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 83 ENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999864 23457899999999999999999999987 99999999999999999999999999987653332
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
.......++..|+|||++....++.++||||||+++|||++ |+.||...... .+.... ... ...
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~----~~~------~~~-- 222 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQNL----ERG------YRM-- 222 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHHH----HcC------CCC--
Confidence 22233346778999999999999999999999999999999 99999643321 111110 000 000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~ 651 (780)
.........+.+++.+|++.+|++||+++++.+.|+.
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 --PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0111223468999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=327.52 Aligned_cols=256 Identities=24% Similarity=0.455 Sum_probs=205.3
Q ss_pred hcCcccceeecccCceEEEEEEEe-CC---cEEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NG---TEVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g---~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
.++|+..+.||+|+||.||+|.+. ++ ..+|+|.++... ....++|.+|++++++++|+||+++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357888899999999999999975 33 379999986553 2234679999999999999999999999999999999
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||+++++|.+++.. ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999863 3457999999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCcccee--ccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccc
Q 048425 529 TEGSQHIST--RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLE 605 (780)
Q Consensus 529 ~~~~~~~~t--~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~ 605 (780)
......... ....+..|+|||++.++.++.++|||||||++|||++ |+.||...... .+... +.. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~~~~---i~~-~---- 226 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EVMKA---IND-G---- 226 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHH---Hhc-C----
Confidence 543222111 1223457999999999999999999999999999998 99998643321 11111 100 0
Q ss_pred cccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 606 QLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 606 ~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
.......+....+.+++.+|++.+|++||+|.+|++.|+++
T Consensus 227 ------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00011122345788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=342.40 Aligned_cols=201 Identities=26% Similarity=0.447 Sum_probs=176.0
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
.++|+..+.||+|+||.||++... +|..+|+|++..... .....|.+|++++++++|+||++++++|.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 378999999999999999999976 688899998876432 233578999999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++|+|.+++. ....+++....+++.+++.||+|||+.+ .|+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999985 3446899999999999999999999752 3999999999999999999999999999765432
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQ 583 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~ 583 (780)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred c---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 1 233568999999999999899999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=347.07 Aligned_cols=260 Identities=26% Similarity=0.358 Sum_probs=205.9
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeec--ceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEG--RTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LV 449 (780)
+.|+..++||+|.||.||||+. .+|+.||+|++..+.. ....-..+||.||++|+||||++|.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 5566778899999999999985 5899999999977653 3335568899999999999999999998876 688999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
+|||+. +|.-++. ...-.++..++..++.|++.||+|+|..+ |+|||||.+|||||++|.+||+|||||+.+.
T Consensus 197 FeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 999976 6777775 34557999999999999999999999998 9999999999999999999999999999887
Q ss_pred CCCccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhh----------hhccccc
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV----------TWARPLL 598 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv----------~wa~~ll 598 (780)
.......|..+-|.+|.|||++.+. .|+.+.|+||.||||.||++|+..+.+....+|...+ .|....+
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 6665555667789999999998874 7899999999999999999999998876644332211 1211011
Q ss_pred ccccccccccCCccCCCCC--h-----hhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 599 TTREGLEQLVDPSLAGSYD--F-----DDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 599 ~~~~~l~~lvDp~L~~~~~--~-----ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.. ...+.+.- .|. . ......++|+..+|..||.+|.|+.++++
T Consensus 350 P~----~~~~kp~~--~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 350 PH----ATIFKPQQ--PYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred Cc----ccccCCCC--cccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00 01111111 111 1 11246788999999999999999998864
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=331.38 Aligned_cols=256 Identities=28% Similarity=0.488 Sum_probs=203.0
Q ss_pred cCcccceeecccCceEEEEEEE-----eCCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-----DNGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
++|+..+.||+|+||.||+|.+ .++..||+|.++.... ....+|.+|++++++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4677789999999999999985 2567899999975432 233578999999999999999999999999999999
Q ss_pred EEeecCCCChhhhcccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC
Q 048425 449 VYELVHNGSVESHLHGVDK-------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF 515 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~-------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~ 515 (780)
||||+++++|.+++..... ....+++.+.+.++.|++.||+|||+.+ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853211 1235889999999999999999999998 99999999999999999
Q ss_pred CCeeecccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhh
Q 048425 516 TPKVSDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTW 593 (780)
Q Consensus 516 ~vKLsDFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~w 593 (780)
.+||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ |..||....+. .+...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999987643321 12233446778999999998899999999999999999999 88888643321 11111
Q ss_pred cccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 594 ARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 594 a~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
... .. . . .........+.+++.+|++.+|++||++.+|.+.|+
T Consensus 239 ~~~----~~-~-----~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 239 VRK----RQ-L-----L----PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred HHc----CC-c-----C----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 100 00 0 0 111122356888999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=334.91 Aligned_cols=262 Identities=26% Similarity=0.423 Sum_probs=208.3
Q ss_pred HHhcCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCC-cchHHHHHHHHHhhhc-CCCceeeeeeeeeec
Q 048425 372 KATEKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRL-HHRNLVKLIGICIEG 443 (780)
Q Consensus 372 ~at~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~ 443 (780)
...++|+..+.||+|+||.||++... +...+|+|.+..... ....++.+|++++.++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34467888899999999999999864 236799999875432 2335688999999999 899999999999999
Q ss_pred ceeEEEEeecCCCChhhhccccc------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE
Q 048425 444 RTRCLVYELVHNGSVESHLHGVD------------KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL 511 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~------------~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL 511 (780)
+..++||||+++|+|.++++... .....+++..+++++.|++.||+|||+.+ |+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 99999999999999999986421 23457999999999999999999999987 9999999999999
Q ss_pred cCCCCCeeecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccch
Q 048425 512 EDDFTPKVSDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQEN 589 (780)
Q Consensus 512 d~~~~vKLsDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~ 589 (780)
++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..|+.......
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--- 242 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---
Confidence 99999999999999876543221 1122335678999999999999999999999999999998 888886432211
Q ss_pred hhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 048425 590 LVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIY 653 (780)
Q Consensus 590 Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~ 653 (780)
+... +........+......+.+++.+|++.+|++|||+.||++.|+.+.
T Consensus 243 ~~~~--------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKL--------------LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHH--------------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1110 0000011112233457889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=323.75 Aligned_cols=247 Identities=32% Similarity=0.463 Sum_probs=199.6
Q ss_pred eeecccCceEEEEEEEeCCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCChh
Q 048425 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVE 459 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL~ 459 (780)
++||+|+||.||+|...++..||+|.++..... ....|.+|++++++++|+||++++++|...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 369999999999999888999999998655432 2346899999999999999999999999999999999999999999
Q ss_pred hhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccceecc
Q 048425 460 SHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRV 539 (780)
Q Consensus 460 ~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~~ 539 (780)
+++.. ....+++..+++++.+++.||.|||+.+ ++||||||+||++++++.+||+|||++..............
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRK---KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 99853 3346899999999999999999999988 99999999999999999999999999976543322222223
Q ss_pred ccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCCh
Q 048425 540 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDF 618 (780)
Q Consensus 540 ~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ 618 (780)
.++..|+|||++.++.++.++||||||+++|||++ |..||...... ...... .... ......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~~----------~~~~----~~~~~~ 217 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQV----------EKGY----RMSCPQ 217 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHH----------HcCC----CCCCCC
Confidence 45678999999999999999999999999999999 99998643221 111100 0000 001112
Q ss_pred hhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 619 DDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 619 ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
.....+.+++.+|++.+|++||++.|+++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 23467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=333.36 Aligned_cols=265 Identities=23% Similarity=0.324 Sum_probs=200.3
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|...+.||+|+||+||+|... ++..||+|+++.... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999875 689999999875432 2345688999999999999999999999988899999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
++ |+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LD-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CC-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 97 489888852 3346889999999999999999999988 9999999999999999999999999998654322
Q ss_pred ccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhh-hhc-------ccccccccc
Q 048425 533 QHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV-TWA-------RPLLTTREG 603 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv-~wa-------~~ll~~~~~ 603 (780)
. ......||..|+|||.+.+ ..++.++|||||||++|||+||+.||............ ... ++.......
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 2 1233468999999998865 56899999999999999999999999764432211110 000 000000011
Q ss_pred cccccCCccCCCC----ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 604 LEQLVDPSLAGSY----DFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 604 l~~lvDp~L~~~~----~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
......+...... .........+++..|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111111110000 0011245789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=343.90 Aligned_cols=241 Identities=24% Similarity=0.327 Sum_probs=196.1
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCC
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNG 456 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~G 456 (780)
++||+|+||.||++... +|+.||||+++... ......+.+|++++++++|+||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 78999999997643 223356889999999999999999999999999999999999999
Q ss_pred ChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccce
Q 048425 457 SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIS 536 (780)
Q Consensus 457 SL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~ 536 (780)
+|.+++. ....+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 152 (323)
T cd05571 81 ELFFHLS----RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cc
Confidence 9999985 3457899999999999999999999998 99999999999999999999999999986432221 22
Q ss_pred eccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCC
Q 048425 537 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSY 616 (780)
Q Consensus 537 t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~ 616 (780)
....||+.|+|||.+.+..++.++|||||||++|||+||+.||..... ..+.... ... +. .+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~~---~~~--------~~----~~ 214 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELI---LME--------EI----RF 214 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHHHH---HcC--------CC----CC
Confidence 345799999999999999999999999999999999999999964322 1111110 000 01 11
Q ss_pred ChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048425 617 DFDDMAKVAAIASMCVHPEVTHRP-----FMGEVVQ 647 (780)
Q Consensus 617 ~~ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv~ 647 (780)
+......+.+++.+|++.||++|| ++.|+++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 112234678999999999999999 7887754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=345.23 Aligned_cols=262 Identities=27% Similarity=0.436 Sum_probs=205.4
Q ss_pred hcCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCCc-chHHHHHHHHHhhhc-CCCceeeeeeeeeec-c
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRL-HHRNLVKLIGICIEG-R 444 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~-~ 444 (780)
.++|...+.||+|+||.||+|... +++.||+|+++..... ..+.+..|++++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457888999999999999999642 3578999998754322 235688899999999 899999999988654 5
Q ss_pred eeEEEEeecCCCChhhhcccccCC--------------------------------------------------------
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKN-------------------------------------------------------- 468 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~-------------------------------------------------------- 468 (780)
..+++|||+++|+|.++|......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 678999999999999998532110
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc-eeccccCcccc
Q 048425 469 -RGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI-STRVMGTFGYV 546 (780)
Q Consensus 469 -~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~-~t~~~GT~~Y~ 546 (780)
...++|..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 237899999999999999999999987 9999999999999999999999999998765433222 22345677899
Q ss_pred CchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCChhhHHHHH
Q 048425 547 APEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVA 625 (780)
Q Consensus 547 APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~ 625 (780)
|||++.+..++.++|||||||+||||++ |+.||...... +.+... ..... . . ..+......+.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~~~~~~----~~~~~--~----~----~~~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EEFCRR----LKEGT--R----M----RAPEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--HHHHHH----HhccC--C----C----CCCccCCHHHH
Confidence 9999999999999999999999999998 99998653321 111110 00000 0 0 01112235688
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 626 AIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 626 ~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
+++.+|++.+|++||++.||++.|+.++.
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=329.93 Aligned_cols=261 Identities=24% Similarity=0.418 Sum_probs=209.4
Q ss_pred hcCcccceeecccCceEEEEEEEeC-----CcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeee-ccee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDN-----GTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIE-GRTR 446 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~-----g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~~ 446 (780)
.++|...++||+|+||.||+|...+ +..|++|+++.... ...+.+.+|+.++++++|+||+++++++.+ +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999999865 78899999865432 234568999999999999999999999876 4678
Q ss_pred EEEEeecCCCChhhhcccccCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecc
Q 048425 447 CLVYELVHNGSVESHLHGVDKN----RGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDF 522 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~----~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDF 522 (780)
++++||+++|+|.+++...... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998643221 156999999999999999999999987 999999999999999999999999
Q ss_pred cccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccc
Q 048425 523 GLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTT 600 (780)
Q Consensus 523 GLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~ 600 (780)
|+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.||+...+ ..+..+...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~---- 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLKD---- 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHHc----
Confidence 999876443222 1223456778999999999999999999999999999999 9999975432 122222111
Q ss_pred ccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 601 REGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 601 ~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
... + .........+.+++.+||+.+|++||++.||++.|+.+..
T Consensus 235 ~~~---~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 GYR---L-------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCC---C-------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 000 0 0011123467899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=359.05 Aligned_cols=252 Identities=19% Similarity=0.281 Sum_probs=204.9
Q ss_pred CcccceeecccCceEEEEEEEe-C-CcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-N-GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~-g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
.|...+.||+|+||.||+|... + +..||+|.+..........+.+|+++++.++|||||+++++|..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3778899999999999999864 3 6788999875554444456888999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++|+|.++|+.......++++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999998654445567899999999999999999999987 99999999999999999999999999987654322
Q ss_pred -cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 534 -HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 534 -~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
.......||++|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .+... ..++
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~~---~~~~~------~~~~-- 290 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIMQ---QVLYG------KYDP-- 290 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHhC------CCCC--
Confidence 2234567999999999999999999999999999999999999999653221 1111 11100 0000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
........+.+++..|++.+|++||++.+++.
T Consensus 291 ---~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 ---FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11122346889999999999999999999865
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=347.22 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=208.5
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeE
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~ 447 (780)
..++|...+.||+|.|++||+|+.. .++++|||++.+.- ....+....|-++|.+| +||.|++|+-.|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3478888999999999999999864 78999999986542 22334567799999999 8999999999999999999
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+|+||++||+|.++|+ +.+.|+......+|.+|+.||+|||+.| ||||||||+|||||+|+++||+|||-|+.
T Consensus 151 FvLe~A~nGdll~~i~----K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIK----KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHH----HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 9999999999999995 4578999999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCc----------cce--eccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcc
Q 048425 528 ATEGSQ----------HIS--TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWAR 595 (780)
Q Consensus 528 ~~~~~~----------~~~--t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~ 595 (780)
+..... ..+ ..++||..|.+||++..+..+..+|+|+|||+||+|+.|+.||....+ .+.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----yli---- 295 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----YLI---- 295 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----HHH----
Confidence 754311 111 448899999999999999999999999999999999999999976442 111
Q ss_pred cccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 596 PLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 596 ~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
++.+++- .-+++......+.+|+...|..||.+|++.++|.+.
T Consensus 296 --------FqkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 --------FQKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred --------HHHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1112211 112233334677899999999999999999888764
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=331.73 Aligned_cols=265 Identities=23% Similarity=0.274 Sum_probs=195.9
Q ss_pred cCcccceeecccCceEEEEEEEe--CCcEEEEEEeeccCC--cchHHHHHHHHHhhhc---CCCceeeeeeeeee-----
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD--NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRL---HHRNLVKLIGICIE----- 442 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~--~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~----- 442 (780)
++|+..+.||+|+||+||+|... +|+.||||+++.... .....+.+|+++++++ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 478899999865432 2234577788877766 69999999999852
Q ss_pred cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecc
Q 048425 443 GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDF 522 (780)
Q Consensus 443 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDF 522 (780)
....++||||++ ++|.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 346799999996 689998863 23346899999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc-hhhhhcccccccc
Q 048425 523 GLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE-NLVTWARPLLTTR 601 (780)
Q Consensus 523 GLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~-~Lv~wa~~ll~~~ 601 (780)
|+++..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||......+.. .+.+.........
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 999876543 2224456899999999999999999999999999999999999999765432111 1111100000000
Q ss_pred c-----ccccccCCccCC---CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 602 E-----GLEQLVDPSLAG---SYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 602 ~-----~l~~lvDp~L~~---~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
. .....+.+.-.. ....+....+.+++.+|++.||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 000000000000 000112245679999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=325.01 Aligned_cols=247 Identities=28% Similarity=0.424 Sum_probs=197.1
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCCh
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSV 458 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL 458 (780)
+.||+|+||.||+|... +|+.||+|....... .....|.+|++++++++|+||++++++|..++..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999975 789999998764432 2346799999999999999999999999999999999999999999
Q ss_pred hhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc-ee
Q 048425 459 ESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI-ST 537 (780)
Q Consensus 459 ~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~-~t 537 (780)
.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......... ..
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999852 3446899999999999999999999988 9999999999999999999999999998654321111 01
Q ss_pred ccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccCCCC
Q 048425 538 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSY 616 (780)
Q Consensus 538 ~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~ 616 (780)
...++..|+|||++.++.++.++||||||+++|||++ |..|+....... .... ++.......
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~~~~--------------~~~~~~~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---TREA--------------IEQGVRLPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---HHHH--------------HHcCCCCCC
Confidence 1123457999999999999999999999999999998 888886432211 1000 000000111
Q ss_pred ChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 617 DFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 617 ~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
.......+.+++.+|++.+|++||++.||.++|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1222357889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=339.28 Aligned_cols=264 Identities=22% Similarity=0.353 Sum_probs=196.2
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeec-----ceeE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEG-----RTRC 447 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~~~ 447 (780)
+|+..+.||+|+||.||+|+.. +|..||||+++... ......+.+|++++++++|+||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999965 78999999986532 22345689999999999999999999998643 2479
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+||||+. ++|.+++. ....+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 68888884 3456999999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCCc--cceeccccCccccCchhhcc--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhh-hhc--------
Q 048425 528 ATEGSQ--HISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV-TWA-------- 594 (780)
Q Consensus 528 ~~~~~~--~~~t~~~GT~~Y~APE~l~~--~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv-~wa-------- 594 (780)
...... .......||..|+|||++.+ ..++.++|||||||++|||+||+.||...........+ +..
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 533211 12234579999999999876 67899999999999999999999999654321111100 000
Q ss_pred cccccc--ccccccccCC---ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 595 RPLLTT--REGLEQLVDP---SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 595 ~~ll~~--~~~l~~lvDp---~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
..+... ...+..+... .+...+ ......+.+++..|++.+|++||+++|+++.
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 0000000000 000000 0112457899999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=340.47 Aligned_cols=241 Identities=22% Similarity=0.253 Sum_probs=194.3
Q ss_pred ecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCCh
Q 048425 383 LGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSV 458 (780)
Q Consensus 383 LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL 458 (780)
||+|+||.||++... +++.||+|+++... ......+.+|++++.+++|+||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999975 68899999987542 23345688999999999999999999999999999999999999999
Q ss_pred hhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccceec
Q 048425 459 ESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR 538 (780)
Q Consensus 459 ~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~ 538 (780)
.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ....
T Consensus 81 ~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 152 (312)
T cd05585 81 FHHLQ----REGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNT 152 (312)
T ss_pred HHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-cccc
Confidence 99985 3456899999999999999999999998 99999999999999999999999999986433222 2244
Q ss_pred cccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCCh
Q 048425 539 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDF 618 (780)
Q Consensus 539 ~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ 618 (780)
..||+.|+|||++.+..++.++|||||||++|||+||+.||...... .......... . .++.
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~~~--------~----~~~~ 214 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQEP--------L----RFPD 214 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCC--------C----CCCC
Confidence 57999999999999999999999999999999999999999643211 1111111110 0 1111
Q ss_pred hhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 619 DDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 619 ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
.....+.+++.+|++.||++||++..+.+.|
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 2224678899999999999998754443434
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=344.06 Aligned_cols=247 Identities=25% Similarity=0.373 Sum_probs=192.3
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
+|...+.||+|+||+||+|+.. +|+.||||++...... ..+.|.+|++++++++|+||+++++++.+++..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3445578999999999999875 7899999998654332 3457899999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++|+|.+.. .+++..+.+++.||+.||+|||+.+ |+|||||++|||+++++.+||+|||+++.......
T Consensus 155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999986543 3467788899999999999999998 99999999999999999999999999987643321
Q ss_pred cceeccccCccccCchhhcc-----CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 534 HISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~-----~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
......||..|+|||++.. ...+.++|||||||++|||++|+.||..........+.... . .. .
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~-----~~--~ 292 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---C-----MS--Q 292 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---h-----cc--C
Confidence 1234569999999998743 23346899999999999999999999733221111111000 0 00 0
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.+ .........+.+++.+||+.||++||++.||++.
T Consensus 293 ~~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 PP----EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CC----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01 1111223468899999999999999999999763
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=323.70 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=203.9
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
++|...+.||+|++|.||+|...++..||+|.+.... ...+.|.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688889999999999999998777789999886543 34567999999999999999999999875 456789999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+|+|.++++.. ....++|..++.++.+++.||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999642 3346899999999999999999999987 999999999999999999999999999876443222
Q ss_pred ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
......++..|+|||+..++.++.++|||||||++|||+| |+.||...... ....+... . ...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~---~-------~~~--- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQVER---G-------YRM--- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc---C-------CCC---
Confidence 2223346778999999999999999999999999999999 88898653321 11111100 0 000
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~ 651 (780)
.........+.+++.+|++.+|++||++++|++.|++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 -PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1112234578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.70 Aligned_cols=256 Identities=26% Similarity=0.429 Sum_probs=202.1
Q ss_pred cccceeecccCceEEEEEEEeC----CcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecce-----
Q 048425 377 FSSKRILGEGGFGCVYHGVMDN----GTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRT----- 445 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~~----g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~----- 445 (780)
|...+.||+|+||.||+|.+.. +..||||+++.... .....|.+|+++++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998752 36799999875432 233579999999999999999999999876554
Q ss_pred -eEEEEeecCCCChhhhccccc--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecc
Q 048425 446 -RCLVYELVHNGSVESHLHGVD--KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDF 522 (780)
Q Consensus 446 -~~LV~Ey~~~GSL~~~L~~~~--~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDF 522 (780)
.++|+||+++|+|..++.... .....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 699999999999999985432 22347899999999999999999999987 999999999999999999999999
Q ss_pred cccccccCCCccc-eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccc
Q 048425 523 GLAREATEGSQHI-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTT 600 (780)
Q Consensus 523 GLA~~~~~~~~~~-~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~ 600 (780)
|+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||..... ..+.++... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~~~---~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYLRH---G 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc---C
Confidence 9998765432221 122335678999999988899999999999999999999 8888864322 111111110 0
Q ss_pred ccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 601 REGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 601 ~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
. .. .........+.+++.+|++.||++||++.||++.|+++
T Consensus 232 -~------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 -N------RL----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -C------CC----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00 11123345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=344.60 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=204.0
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||+||+|... +|+.||||+++... ......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999976 78999999997642 234467899999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999963 367899999999999999999999987 99999999999999999999999999987654
Q ss_pred CC----------------------------ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 048425 531 GS----------------------------QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMS 582 (780)
Q Consensus 531 ~~----------------------------~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~ 582 (780)
.. ........||..|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11223456999999999999999999999999999999999999999754
Q ss_pred Ccccc-chhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 048425 583 QPQGQ-ENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPF-MGEVVQA 648 (780)
Q Consensus 583 ~~~~~-~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs-m~EVv~~ 648 (780)
..... ..+..|... +.-+. .......+.+++..|++ +|.+||+ ++|+++.
T Consensus 234 ~~~~~~~~i~~~~~~----------~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWKES----------LRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccCCc----------ccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 42211 011111100 00000 01123567889999997 9999999 9998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.86 Aligned_cols=267 Identities=30% Similarity=0.403 Sum_probs=205.4
Q ss_pred cccceeecccCceEEEEEEE-----eCCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeec--ceeEE
Q 048425 377 FSSKRILGEGGFGCVYHGVM-----DNGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEG--RTRCL 448 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l-----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~L 448 (780)
|...+.||+|+||+||++.. .++..||+|.++.... .....|.+|++++++++|+||++++++|... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988653 3678899999876533 2346789999999999999999999998754 35789
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||+++|+|.+++.. ..+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999853 35999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCcc--ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 529 TEGSQH--ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 529 ~~~~~~--~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
...... ......++..|+|||.+.+..++.++||||||+++|||+||+.|+...... ...+..+....... ..+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~-~~~~~ 235 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTV-VRLIE 235 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccch-hhhhh
Confidence 543221 112234566799999999889999999999999999999999998643221 11111111111100 11112
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIY 653 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~ 653 (780)
+.+.......+......+.+++..|++.+|++||++++|++.|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 22222211222334568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.89 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=208.2
Q ss_pred HhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
..++|...+.||+|+||.||+|..+++..||||.+.... ...+++.+|++++++++|+||+++++++..+...++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 347888999999999999999998888899999987543 3457899999999999999999999999988899999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++++|.+++.. .....+++..++.++.+++.||+|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999999964 23346899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
........++..|+|||.+.+..++.++||||||+++|||+| |+.||...... ......... ..
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~~~------~~------ 222 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVERG------YR------ 222 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC------CC------
Confidence 221222335668999999999999999999999999999999 99998643321 111111000 00
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048425 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651 (780)
Q Consensus 612 L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~ 651 (780)
...+.+....+.+++.+|++.+|++||+++|+.+.|+.
T Consensus 223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 --MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00111223568899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=321.67 Aligned_cols=249 Identities=23% Similarity=0.383 Sum_probs=204.3
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
+|+..+.||+|++|.||+|... +|+.|++|.+.... ....+++.+|++++++++|+||+++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999975 68999999986542 23456799999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++++|.++++.. ....+++..+++++.+++.||.|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999999742 2457899999999999999999999987 9999999999999999999999999998765433
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
.. .....|+..|+|||++.++.++.++||||||+++|||++|+.||..... ....... . .....
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~---~------~~~~~--- 219 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALILKI---I------RGVFP--- 219 (256)
T ss_pred ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH---H------cCCCC---
Confidence 22 2334688999999999999999999999999999999999999975432 1111110 0 00000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.........+.+++.+||+.+|++||++.|+++
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 220 --PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred --CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 111122356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=340.68 Aligned_cols=241 Identities=24% Similarity=0.326 Sum_probs=195.2
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCC
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNG 456 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~G 456 (780)
+.||+|+||.||++... +|..||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999865 78999999997642 223356788999999999999999999999999999999999999
Q ss_pred ChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccce
Q 048425 457 SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIS 536 (780)
Q Consensus 457 SL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~ 536 (780)
+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 152 (323)
T cd05595 81 ELFFHLS----RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cc
Confidence 9998884 3457899999999999999999999998 99999999999999999999999999886433221 12
Q ss_pred eccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCC
Q 048425 537 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSY 616 (780)
Q Consensus 537 t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~ 616 (780)
....||+.|+|||++.++.++.++|||||||++|||++|+.||....... +.. .+..... .+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~-------------~~~~~~~--~~ 214 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE-------------LILMEEI--RF 214 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HHH-------------HHhcCCC--CC
Confidence 34569999999999999999999999999999999999999996533211 110 0000000 01
Q ss_pred ChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048425 617 DFDDMAKVAAIASMCVHPEVTHRP-----FMGEVVQ 647 (780)
Q Consensus 617 ~~ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv~ 647 (780)
+......+.+++.+|++.||++|| ++.++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 112234678999999999999998 7877764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=338.15 Aligned_cols=260 Identities=23% Similarity=0.370 Sum_probs=207.6
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcch-HHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGD-REFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~~-~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|+..++||.|..++||+|+. ..++.||||++.-+..+.. +++.+|+..|+.++||||++.+..|..+..+++||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 6788889999999999999985 5789999999987655444 7889999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
|.+||+.+.+... -...+++..+..|..++++||.|||.+| .||||||+.||||+++|.+||+|||.+..+.+..
T Consensus 106 Ma~GS~ldIik~~--~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 106 MAGGSLLDIIKTY--YPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hcCCcHHHHHHHH--ccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999753 3345999999999999999999999999 9999999999999999999999999988776544
Q ss_pred ccce---eccccCccccCchhhcc--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 533 QHIS---TRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 533 ~~~~---t~~~GT~~Y~APE~l~~--~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
.... ...+||+.|||||+++. ..|+.|+||||||+..+||.+|..||....|.. -|..- +.+.. ..+
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl~t---Lqn~p---p~~ 252 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLLLT---LQNDP---PTL 252 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHHHH---hcCCC---CCc
Confidence 3322 45689999999999654 478999999999999999999999997543321 11111 11110 000
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.-..+..+-+...-..+.+++..|++.||++|||++++++
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0000111111112247889999999999999999999876
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=339.59 Aligned_cols=251 Identities=22% Similarity=0.306 Sum_probs=198.2
Q ss_pred CcccceeecccCceEEEEEEE----eCCcEEEEEEeeccC----CcchHHHHHHHHHhhhc-CCCceeeeeeeeeeccee
Q 048425 376 KFSSKRILGEGGFGCVYHGVM----DNGTEVAVKLLTRNN----QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTR 446 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~ 446 (780)
+|+..+.||+|+||.||++.. .+|+.||+|++.+.. ....+.+..|++++.++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 578889999999999999875 368899999987532 22335688899999999 599999999999999999
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
++||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999985 3456899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccc
Q 048425 527 EATEGSQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLE 605 (780)
Q Consensus 527 ~~~~~~~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~ 605 (780)
..............||..|+|||++.+. .++.++|||||||++|||+||+.||.......... .....+..
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~------ 225 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK------ 225 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc------
Confidence 7654433333456799999999998865 47889999999999999999999996433211111 00000110
Q ss_pred cccCCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048425 606 QLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRP-----FMGEVVQ 647 (780)
Q Consensus 606 ~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv~ 647 (780)
.++.+. ......+.+++.+|++.||++|| +++++++
T Consensus 226 --~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 --CDPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred --CCCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 111111 12234678899999999999999 5666643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=324.63 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=198.1
Q ss_pred ccceeecccCceEEEEEEEeC-Cc--EEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeec------cee
Q 048425 378 SSKRILGEGGFGCVYHGVMDN-GT--EVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEG------RTR 446 (780)
Q Consensus 378 ~~~~~LG~G~fG~VYkg~l~~-g~--~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~~~ 446 (780)
...+.||+|+||.||+|.+.+ +. .||+|.++... ....+.|.+|++++++++|+||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999999764 33 58999886542 23346789999999999999999999988542 245
Q ss_pred EEEEeecCCCChhhhccccc--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccc
Q 048425 447 CLVYELVHNGSVESHLHGVD--KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~--~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGL 524 (780)
++||||+++|+|.+++.... .....+++...+.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999999874221 23346899999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCccc-eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccc
Q 048425 525 AREATEGSQHI-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 525 A~~~~~~~~~~-~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
++......... .....++..|+|||+..+..++.++||||||+++|||++ |+.||...... .+... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~----~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDY----LRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----HHcCC
Confidence 98765432211 122346678999999999999999999999999999999 78888643221 11111 11110
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
.. .........+.+++.+||+.+|++||++.||++.|+.+
T Consensus 232 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 01112335688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.25 Aligned_cols=247 Identities=25% Similarity=0.372 Sum_probs=197.0
Q ss_pred ecccCceEEEEEEEe-CCcEEEEEEeeccCCc---chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCCh
Q 048425 383 LGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN---GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSV 458 (780)
Q Consensus 383 LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL 458 (780)
||+|+||+||++... +|+.||||.+...... ..+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 7899999998754322 235678899999999999999999999999999999999999999
Q ss_pred hhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccceec
Q 048425 459 ESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR 538 (780)
Q Consensus 459 ~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~ 538 (780)
.+++.........+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 9888654445567999999999999999999999998 999999999999999999999999999876543222 234
Q ss_pred cccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCCh
Q 048425 539 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDF 618 (780)
Q Consensus 539 ~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ 618 (780)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... ..+..... .+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~----------~~~~~~~~--~~~~ 222 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELK----------QRILNDSV--TYPD 222 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHH----------HhhcccCC--CCcc
Confidence 5689999999999999999999999999999999999999965332110 00000 01111111 1122
Q ss_pred hhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048425 619 DDMAKVAAIASMCVHPEVTHRP-----FMGEVVQ 647 (780)
Q Consensus 619 ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv~ 647 (780)
.....+.+++..|++.||++|| +++|+++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 2345678999999999999999 5566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=332.15 Aligned_cols=260 Identities=27% Similarity=0.409 Sum_probs=204.1
Q ss_pred cCcccceeecccCceEEEEEEEe-CCc--EEEEEEeeccC-CcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGT--EVAVKLLTRNN-QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~--~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV 449 (780)
++|+..++||+|+||.||+|... +|. .+++|.++... ....+.|.+|++++.++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888899999999999999875 343 47888886432 23346799999999999 799999999999998899999
Q ss_pred EeecCCCChhhhcccccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCC
Q 048425 450 YELVHNGSVESHLHGVDK------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP 517 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~v 517 (780)
+||+++|+|.++++.... ....+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999964211 1235899999999999999999999987 9999999999999999999
Q ss_pred eeecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccc
Q 048425 518 KVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARP 596 (780)
Q Consensus 518 KLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ 596 (780)
||+|||++........ ......+..|+|||++.+..++.++|||||||++|||+| |+.||...... ++...
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~~~~--- 230 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---ELYEK--- 230 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH---
Confidence 9999999875322111 111223557999999999899999999999999999998 99999654321 11110
Q ss_pred ccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 597 LLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 597 ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
.. ..............+.+++.+|++.+|.+||++.+|++.|+.+.+..
T Consensus 231 ~~-----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 231 LP-----------QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred Hh-----------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 00 00000111122346789999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=321.70 Aligned_cols=250 Identities=31% Similarity=0.509 Sum_probs=205.6
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
++|...+.||+|+||.||+|.. .|+.||||.++.... ..+++.+|+.++++++|+||+++++++.+++..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 5778889999999999999987 488999999976644 56789999999999999999999999998899999999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+++|.+++.. .....++|..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 84 KGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999964 22336999999999999999999999998 99999999999999999999999999987743222
Q ss_pred ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
...++..|+|||++.++.++.++||||||+++|||++ |+.||..... ..+...... . ..
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~----~----------~~ 217 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHVEK----G----------YR 217 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhc----C----------CC
Confidence 2235668999999999999999999999999999998 9999864322 111111110 0 00
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
..........+.+++.+|++.+|++||+++|++++|+.+
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 011112245788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=331.79 Aligned_cols=265 Identities=25% Similarity=0.360 Sum_probs=198.5
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
.++|...+.||+|+||.||+|... +|+.||||+++..... ....+.+|++++++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999976 7899999998754332 33467899999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|++ ++|.+++. +....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMD---KHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 67877775 33456899999999999999999999998 999999999999999999999999999765332
Q ss_pred CccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhh--hc--ccc---cccccc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVT--WA--RPL---LTTREG 603 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~--wa--~~l---l~~~~~ 603 (780)
. .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ..+.. +. .+. +.....
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ-DQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhCCCChhhccchhh
Confidence 2 12234568999999998865 457899999999999999999999997533211 00000 00 000 000000
Q ss_pred cccccCCccC--CCCC-------hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 604 LEQLVDPSLA--GSYD-------FDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 604 l~~lvDp~L~--~~~~-------~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.......... .... ......+.+++..|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000 0000 011245778999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.69 Aligned_cols=258 Identities=29% Similarity=0.453 Sum_probs=203.3
Q ss_pred HhcCcccceeecccCceEEEEEEEeC------CcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecce
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMDN------GTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRT 445 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~~------g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 445 (780)
.+++|...+.||+|+||.||+|.+.+ +..||+|.+...... ....|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35788999999999999999999753 567899988654332 34579999999999999999999999999889
Q ss_pred eEEEEeecCCCChhhhcccccC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC---CCee
Q 048425 446 RCLVYELVHNGSVESHLHGVDK---NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF---TPKV 519 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~---~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~---~vKL 519 (780)
.++||||+++++|.++++.... ....++|..+++++.||+.||+|||+.+ ++||||||+||++++++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999965321 1236899999999999999999999998 99999999999998754 5899
Q ss_pred ecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccc
Q 048425 520 SDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPL 597 (780)
Q Consensus 520 sDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~l 597 (780)
+|||+++........ ......++..|+|||++.++.++.++|||||||++|||++ |+.||....... +... +
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~~---~ 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VMEF---V 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH---H
Confidence 999999876432211 1112234568999999999999999999999999999997 999987543221 1111 0
Q ss_pred cccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 598 LTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 598 l~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
... .....+......+.+++.+|++.+|++||++.||++.|+
T Consensus 235 ~~~-----------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGG-----------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcC-----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 000 001111223357889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.02 Aligned_cols=245 Identities=28% Similarity=0.422 Sum_probs=196.1
Q ss_pred eecccCceEEEEEEEe---CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCC
Q 048425 382 ILGEGGFGCVYHGVMD---NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNG 456 (780)
Q Consensus 382 ~LG~G~fG~VYkg~l~---~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~G 456 (780)
.||+|+||.||+|.++ ++..+|+|+++..... ..++|.+|+.++++++|+||+++++++. ++..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5999999999999753 5788999998654322 3467999999999999999999999985 45779999999999
Q ss_pred ChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc-
Q 048425 457 SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI- 535 (780)
Q Consensus 457 SL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~- 535 (780)
+|.+++. ....+++..+++++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999985 2346899999999999999999999988 9999999999999999999999999998765433221
Q ss_pred -eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 536 -STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 536 -~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
.....++..|+|||.+....++.++|||||||++|||++ |+.||...... .+..... ... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~i~----~~~----------~ 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQMIE----SGE----------R 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----CCC----------C
Confidence 122234678999999988889999999999999999998 99999754321 1111111 000 0
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~ 651 (780)
...+......+.+++.+|++.||++||++.+|++.|+.
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 01112233568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=320.66 Aligned_cols=251 Identities=29% Similarity=0.509 Sum_probs=203.4
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
.+|+..+.||+|+||.||+|.+.++..+|+|.+..... ...+|.+|++++++++|+||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46777899999999999999987788999999865432 45679999999999999999999999999899999999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+++|.+++.. ....+++..++.++.+++.||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 9999999863 3356899999999999999999999988 999999999999999999999999999866433221
Q ss_pred ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
......++.+|+|||++.++.++.++||||||+++|||++ |+.||+..... .+... +... .....+.+
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~---~~~~----~~~~~~~~- 225 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVET---INAG----FRLYKPRL- 225 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHH---HhCC----CCCCCCCC-
Confidence 1222335678999999998999999999999999999998 99998643321 11111 0000 01111111
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
....+.+++.+||+.+|++||++.||++.|
T Consensus 226 ------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 235788999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.16 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=202.2
Q ss_pred CcccceeecccCceEEEEEEEeC------CcEEEEEEeeccCCcc-hHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMDN------GTEVAVKLLTRNNQNG-DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~~------g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
+|...+.||+|+||.||+|...+ +..||||+++...... .+.|.+|+.++++++|+||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 45667889999999999998642 4789999997554322 3568999999999999999999999999999999
Q ss_pred EEeecCCCChhhhccccc------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC
Q 048425 449 VYELVHNGSVESHLHGVD------------KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT 516 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~------------~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~ 516 (780)
++||+++++|.+++.... .....+++..+++++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985211 12346899999999999999999999988 999999999999999999
Q ss_pred CeeecccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhc
Q 048425 517 PKVSDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWA 594 (780)
Q Consensus 517 vKLsDFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa 594 (780)
+||+|||+++....... .......+++.|+|||++.++.++.++||||||+++|||++ |..|+...... .+...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~- 238 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVIEM- 238 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH-
Confidence 99999999987643322 11223446788999999999999999999999999999998 77787643221 11111
Q ss_pred ccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 595 RPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 595 ~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
+.+... .....+....+.+++..|++.+|++||++.||++.|+
T Consensus 239 ------------i~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 239 ------------IRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred ------------HHcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 111110 1112233456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=321.32 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=202.0
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc-----chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN-----GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~-----~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
++|...+.||+|++|.||++... ++..||+|.+...... ..+.+.+|++++++++|+||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999864 6899999998654321 23468899999999999999999999999999999
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||+++++|.+++. ....+++....+++.+++.||+|||+.+ |+||||||+||++++++++||+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLK----AYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999985 2346889999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCccce--eccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 529 TEGSQHIS--TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 529 ~~~~~~~~--t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
........ ....|+..|+|||++.+..++.++||||||+++|||++|+.||....... .. .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~-~~~------------ 219 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA--AI-FKI------------ 219 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH--HH-HHH------------
Confidence 43222111 23467889999999999999999999999999999999999986432211 00 000
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.........+......+.+++..|++.+|++||++.|+++.
T Consensus 220 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 220 -ATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -hccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00000011112223467889999999999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=348.20 Aligned_cols=265 Identities=24% Similarity=0.412 Sum_probs=207.9
Q ss_pred HHHHhcCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCCcc-hHHHHHHHHHhhhcC-CCceeeeeeeee
Q 048425 370 LEKATEKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQNG-DREFIAEVEMLSRLH-HRNLVKLIGICI 441 (780)
Q Consensus 370 l~~at~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~-HpNIV~L~g~~~ 441 (780)
++...++|...+.||+|+||.||+|++. .+..||||+++...... .+.+.+|+++|.++. |+||++++|+|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4444567888899999999999999863 34689999997653332 347899999999997 999999999999
Q ss_pred ecceeEEEEeecCCCChhhhcccccC------------------------------------------------------
Q 048425 442 EGRTRCLVYELVHNGSVESHLHGVDK------------------------------------------------------ 467 (780)
Q Consensus 442 ~~~~~~LV~Ey~~~GSL~~~L~~~~~------------------------------------------------------ 467 (780)
..+..++||||+++|+|.++|+....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 98999999999999999999974321
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCc
Q 048425 468 ----------------------------------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKAS 507 (780)
Q Consensus 468 ----------------------------------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKps 507 (780)
....++|..+++++.|++.||+|||+.+ |+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 1135788899999999999999999887 999999999
Q ss_pred ceEEcCCCCCeeecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCcc
Q 048425 508 NVLLEDDFTPKVSDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQ 585 (780)
Q Consensus 508 NILLd~~~~vKLsDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~ 585 (780)
|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 999999999999999999865432211 1223457788999999999899999999999999999998 88888543211
Q ss_pred ccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 048425 586 GQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIY 653 (780)
Q Consensus 586 ~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~ 653 (780)
. .+.. .+........+......+.+++..||+.+|++||+++||++.|+.++
T Consensus 349 ~--~~~~--------------~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 E--QFYN--------------AIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H--HHHH--------------HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 0100 00000000111122357889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.20 Aligned_cols=257 Identities=29% Similarity=0.483 Sum_probs=205.9
Q ss_pred hcCcccceeecccCceEEEEEEEeC------CcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeeccee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDN------GTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTR 446 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~------g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 446 (780)
.++|...+.||+|+||.||+|...+ +..||+|.+..... ....+|.+|+.+++.++|+||+++++++..+...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3678889999999999999998742 36899999865432 2345789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhcccccC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeee
Q 048425 447 CLVYELVHNGSVESHLHGVDK------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVS 520 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLs 520 (780)
++||||+++|+|.+++..... ....++|..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999964322 2235899999999999999999999987 9999999999999999999999
Q ss_pred cccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccc
Q 048425 521 DFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLL 598 (780)
Q Consensus 521 DFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll 598 (780)
|||+++....... .......++..|+|||.+.++.++.++|||||||++|||+| |+.||...... .+..+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~~--- 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLKFVI--- 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHHHHh---
Confidence 9999986644321 12233456789999999998999999999999999999998 88888643321 1211111
Q ss_pred ccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 599 TTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 599 ~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
... . . ..+......+.+++.+|++.+|++|||+.|+++.|+
T Consensus 236 -~~~-~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -DGG-H-----L----DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -cCC-C-----C----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000 0 0 111222457889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=339.53 Aligned_cols=242 Identities=24% Similarity=0.332 Sum_probs=196.5
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCC
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNG 456 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~G 456 (780)
++||+|+||.||++... +|+.||||++++.. ......+.+|+++++.++|+||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 78999999997642 223457889999999999999999999999999999999999999
Q ss_pred ChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccce
Q 048425 457 SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIS 536 (780)
Q Consensus 457 SL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~ 536 (780)
+|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 152 (328)
T cd05593 81 ELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TM 152 (328)
T ss_pred CHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cc
Confidence 9998885 3457999999999999999999999998 99999999999999999999999999986433221 12
Q ss_pred eccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCC
Q 048425 537 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSY 616 (780)
Q Consensus 537 t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~ 616 (780)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .+... +..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~---~~~~~--------~~~~---- 214 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE---LILME--------DIKF---- 214 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHH---HhccC--------CccC----
Confidence 3457999999999999999999999999999999999999999653321 1111 01100 0011
Q ss_pred ChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 048425 617 DFDDMAKVAAIASMCVHPEVTHRP-----FMGEVVQA 648 (780)
Q Consensus 617 ~~ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv~~ 648 (780)
+......+.+++.+|++.||++|| ++.|+++.
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 112234678899999999999997 78888653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=331.42 Aligned_cols=263 Identities=26% Similarity=0.416 Sum_probs=208.4
Q ss_pred hcCcccceeecccCceEEEEEEEe--------CCcEEEEEEeeccC-CcchHHHHHHHHHhhhc-CCCceeeeeeeeeec
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD--------NGTEVAVKLLTRNN-QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEG 443 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~--------~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~ 443 (780)
.++|...+.||+|+||.||+++.. ++..||+|.++... ....+++.+|+.+++.+ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467888899999999999999741 34579999986543 23346799999999999 899999999999999
Q ss_pred ceeEEEEeecCCCChhhhcccccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDK------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL 511 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL 511 (780)
...++||||+++|+|.+++..... ....++|..++.++.||+.||+|||+.+ |+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999964321 1246899999999999999999999998 9999999999999
Q ss_pred cCCCCCeeecccccccccCCCccc-eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccch
Q 048425 512 EDDFTPKVSDFGLAREATEGSQHI-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQEN 589 (780)
Q Consensus 512 d~~~~vKLsDFGLA~~~~~~~~~~-~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~ 589 (780)
++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..|+...... .
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~ 247 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 247 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---H
Confidence 999999999999998765432221 222346678999999999999999999999999999998 77887543221 1
Q ss_pred hhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 590 LVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 590 Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
+.. .+. .... ..........+.+++.+||+.+|++||+|.||++.|+++....
T Consensus 248 ~~~---~~~-~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 248 LFK---LLK-EGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHH---HHH-cCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 111 110 0000 0111223457888999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=329.64 Aligned_cols=262 Identities=29% Similarity=0.465 Sum_probs=206.2
Q ss_pred HHhcCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecc
Q 048425 372 KATEKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGR 444 (780)
Q Consensus 372 ~at~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 444 (780)
...++|+..+.||+|+||.||+|..+ .+..||+|.++.... ....+|.+|+.++++++|+||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999754 245799998865432 22346889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhhcccccC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCe
Q 048425 445 TRCLVYELVHNGSVESHLHGVDK------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPK 518 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vK 518 (780)
..++||||+++|+|.+++..... ....+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 99999999999999999964221 1245678889999999999999999987 99999999999999999999
Q ss_pred eecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccc
Q 048425 519 VSDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARP 596 (780)
Q Consensus 519 LsDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ 596 (780)
|+|||+++........ ......++..|+|||++.++.++.++|||||||++|||++ |+.||...... .....
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~~--- 233 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLKF--- 233 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---
Confidence 9999999865432211 1222345678999999999999999999999999999999 78888643321 11111
Q ss_pred ccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 048425 597 LLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIY 653 (780)
Q Consensus 597 ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~ 653 (780)
+.+... ..........+.+++.+|++.+|++||++.|+++.|+...
T Consensus 234 ----------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 ----------VMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ----------HHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111100 0111122357899999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=347.49 Aligned_cols=266 Identities=23% Similarity=0.319 Sum_probs=208.7
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchH-HHHHHHHHhhhcC-CCceeeeeeeeeecc-eeEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRLH-HRNLVKLIGICIEGR-TRCLV 449 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~-~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~-~~~LV 449 (780)
.++|...+.||.|.||.||+|+.. +|..||||++++.-...++ -=++|++.|++|+ |||||+|.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 467888899999999999999954 7899999999876554333 2478999999999 999999999999887 99999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
||||+ .+|++++.+ ++..++...+..|+.||++||+|+|++| +.|||+||+|||+..+..+||+||||||...
T Consensus 89 fE~Md-~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhhh-hhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 99994 589999974 3678999999999999999999999999 9999999999999999999999999999886
Q ss_pred CCCccceeccccCccccCchhhc-cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhc-----ccccccccc
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWA-----RPLLTTREG 603 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~-~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa-----~~ll~~~~~ 603 (780)
.... .|..+.|.+|+|||++. .+-|+.+.|||++|||++||.+-+.-|-+....++..-+--+ +..+..+..
T Consensus 162 SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 SKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 6433 36778999999999775 678899999999999999999999888766544332111000 000111111
Q ss_pred cccccCCccCC--CCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 604 LEQLVDPSLAG--SYD-----FDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 604 l~~lvDp~L~~--~~~-----~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
+...+.-.+.. ..+ .....+.++++.+|++.||.+|||+.|.++.
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111111100 001 1244678999999999999999999998764
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=322.48 Aligned_cols=246 Identities=26% Similarity=0.468 Sum_probs=196.2
Q ss_pred ecccCceEEEEEEEe---CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCCh
Q 048425 383 LGEGGFGCVYHGVMD---NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSV 458 (780)
Q Consensus 383 LG~G~fG~VYkg~l~---~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL 458 (780)
||+|+||.||+|.+. ++..||+|++..... ...++|.+|++++++++|+||++++++|. .+..++||||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999864 456799999876533 23457999999999999999999999985 4577999999999999
Q ss_pred hhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccce--
Q 048425 459 ESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIS-- 536 (780)
Q Consensus 459 ~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~-- 536 (780)
.+++.. ....+++..+++++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++..........
T Consensus 82 ~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 82 NKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999863 3457899999999999999999999988 99999999999999999999999999986644322211
Q ss_pred eccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccCCC
Q 048425 537 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGS 615 (780)
Q Consensus 537 t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~ 615 (780)
+...++..|+|||++.+..++.++|||||||++|||++ |+.||....... +...+ .... ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~----------~~~ 218 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VMSFI----EQGK----------RLD 218 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----HCCC----------CCC
Confidence 12233578999999998889999999999999999997 999986543211 11111 0000 011
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 616 YDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 616 ~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
.+......+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1223345788899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=323.56 Aligned_cols=257 Identities=24% Similarity=0.397 Sum_probs=204.7
Q ss_pred HHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeE
Q 048425 369 DLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 369 el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 447 (780)
|++.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++..++..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 45667888888899999999999999865 67889999987766556678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhcccccCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC-CCCCeeecccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPL--DWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED-DFTPKVSDFGL 524 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L--~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~-~~~vKLsDFGL 524 (780)
+|+||+++++|.+++.. ....+ ++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+
T Consensus 82 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 82 IFMEQVPGGSLSALLRS---KWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEEecCCCCCHHHHHHH---hcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchh
Confidence 99999999999999963 22344 88889999999999999999987 999999999999986 67999999999
Q ss_pred cccccCCCccceeccccCccccCchhhccCC--CCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccc
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~--~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
+........ ......|+..|+|||++.+.. ++.++||||||+++|||++|+.|+...... ....|......
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~---~~~~~~~~~~~--- 228 (268)
T cd06624 156 SKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP---QAAMFKVGMFK--- 228 (268)
T ss_pred heecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh---hhhHhhhhhhc---
Confidence 976543222 122345889999999987644 789999999999999999999998643211 11111110000
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..+ ..+......+.+++.+|++.+|++||++.||++
T Consensus 229 -----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 -----IHP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -----cCC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 011 112223356789999999999999999999865
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=325.29 Aligned_cols=258 Identities=27% Similarity=0.434 Sum_probs=204.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCc----EEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGT----EVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~----~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
++|...+.||+|+||+||+|.+. +|. .||+|+++.... ...+++.+|+.++..++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 56788899999999999999854 454 489999865433 234678999999999999999999999975 45689
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
++||+++|+|.++++. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 86 ~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 86 VTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 9999999999999963 3457999999999999999999999988 999999999999999999999999999877
Q ss_pred cCCCccc-eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccc
Q 048425 529 TEGSQHI-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 529 ~~~~~~~-~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
....... .....++..|+|||...+..++.++|||||||++|||++ |..||+.... ..+..+.... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~----~~~-- 230 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLLEKG----ERL-- 230 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCC----CcC--
Confidence 5432211 112235678999999999999999999999999999998 8999864322 2222221110 000
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
.........+.+++.+||+.||++||++.|+++.|+.+....
T Consensus 231 --------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 --------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred --------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 001122346789999999999999999999999998776543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=350.31 Aligned_cols=266 Identities=27% Similarity=0.416 Sum_probs=220.5
Q ss_pred HHHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeeccee
Q 048425 368 SDLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTR 446 (780)
Q Consensus 368 ~el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 446 (780)
++++--.-+....++||-|.||.||.|+|+ -...||||.|+.+.. ..++|+.|..+|+.|+|||+|+|+|+|..+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 455555567788899999999999999997 356799999976543 578999999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
|||+|||.+|+|.+||++. ++..++-..++.+|.||+.||+||..++ +|||||.++|+|+.++..+||+||||++
T Consensus 339 YIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 9999999999999999753 4456778889999999999999999988 9999999999999999999999999999
Q ss_pred cccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccc
Q 048425 527 EATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLE 605 (780)
Q Consensus 527 ~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~ 605 (780)
.+..+.........-.+.|.|||.+....++.|+|||+|||+||||.| |-.|+-+-. +- .+.
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lS-----------qVY 476 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LS-----------QVY 476 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HH-----------HHH
Confidence 987654332222233567999999999999999999999999999999 777775321 11 111
Q ss_pred cccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 606 QLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 606 ~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
.++....+-+-+..+..++.+|+++||+.+|.+||++.|+.+.++.+..+.
T Consensus 477 ~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 477 GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 122222222334556789999999999999999999999999999887654
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=331.74 Aligned_cols=262 Identities=27% Similarity=0.418 Sum_probs=206.6
Q ss_pred hcCcccceeecccCceEEEEEEEe--------CCcEEEEEEeeccC-CcchHHHHHHHHHhhhc-CCCceeeeeeeeeec
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD--------NGTEVAVKLLTRNN-QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEG 443 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~--------~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~ 443 (780)
.++|...+.||+|+||.||++... ++..+|+|.++... .....++.+|++++.++ +|+||++++++|.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 367889999999999999999752 23579999997643 22345788999999999 799999999999999
Q ss_pred ceeEEEEeecCCCChhhhcccccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDK------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL 511 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL 511 (780)
+..++||||+++|+|.+++..... ....++|.++++++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999964321 1246899999999999999999999987 9999999999999
Q ss_pred cCCCCCeeecccccccccCCCccc-eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccch
Q 048425 512 EDDFTPKVSDFGLAREATEGSQHI-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQEN 589 (780)
Q Consensus 512 d~~~~vKLsDFGLA~~~~~~~~~~-~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~ 589 (780)
++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.|+...... .
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---~ 250 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E 250 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---H
Confidence 999999999999998664322111 112234568999999999999999999999999999998 88888543221 1
Q ss_pred hhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 590 LVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 590 Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
+... ..... ...........+.+++.+|++.+|++||+|.||++.|+++...
T Consensus 251 ~~~~----~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 251 LFKL----LKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHH----HHcCC----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1110 00000 0011122335778899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=340.86 Aligned_cols=252 Identities=22% Similarity=0.252 Sum_probs=201.8
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||+||++... +|+.||||+++.... ...+.+.+|+++++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47888999999999999999875 789999999976432 23456889999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999999963 3357999999999999999999999998 99999999999999999999999999987755
Q ss_pred CCccceeccccCccccCchhhc------cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccc
Q 048425 531 GSQHISTRVMGTFGYVAPEYAM------TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~------~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||....... ....+..... .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~-~ 227 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQR-F 227 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCC-c
Confidence 4333334457999999999986 4567899999999999999999999997543211 0111111100 0
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
... + ........+.+++..|++ +|++||++.++++
T Consensus 228 ~~~--~-----~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 228 LKF--P-----EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred cCC--C-----CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 000 0 011123457788899998 9999999998854
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=331.97 Aligned_cols=258 Identities=27% Similarity=0.429 Sum_probs=205.1
Q ss_pred hcCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCC-cchHHHHHHHHHhhhc-CCCceeeeeeeeeecce
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRT 445 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~ 445 (780)
.++|...+.||+|+||.||++... .+..||||+++.... ...+.|.+|+++++++ +|+||++++++|...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 367888999999999999999742 345799999875533 2335789999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccc
Q 048425 446 RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA 525 (780)
.++||||+++|+|.++++. .....+++.++++++.+++.||+|||+.+ |+|+||||+|||+++++.+||+|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999964 22334899999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccc
Q 048425 526 REATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREG 603 (780)
Q Consensus 526 ~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~ 603 (780)
+........ ......++..|+|||++.++.++.++|||||||++|||+| |+.|+...... ......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~~---------- 256 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYKL---------- 256 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHHH----------
Confidence 876543221 1122345778999999999999999999999999999998 99998643221 111111
Q ss_pred cccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 604 LEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 604 l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
++..............+.+++.+|++.+|++||++.||++.|+++
T Consensus 257 ----~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 ----IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----HHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000000001111234788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=323.88 Aligned_cols=255 Identities=26% Similarity=0.436 Sum_probs=204.5
Q ss_pred cCcccceeecccCceEEEEEEEe-C---CcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-N---GTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~---g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
++|...+.||+|+||.||+|... + +..+|+|.++.... ...+.|.+|++++.+++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56788899999999999999864 2 34799999865432 2345799999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++++|.+++.. ....+++.++++++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 999999999999963 3356899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCcccee--ccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccc
Q 048425 530 EGSQHIST--RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 530 ~~~~~~~t--~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
.......+ ...++..|+|||++.++.++.++||||||+++||+++ |+.||...... ....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~-------- 226 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIEEGY-------- 226 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHhCCC--------
Confidence 43322211 2233568999999999999999999999999999987 99998643321 1111111000
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
.. .........+.+++.+|++.+|++||+|.++++.|+.+
T Consensus 227 --~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 --RL----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --cC----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 01112235678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.11 Aligned_cols=244 Identities=24% Similarity=0.301 Sum_probs=199.0
Q ss_pred cCcccceeecccCceEEEEEEEeC--CcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDN--GTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~--g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
++|...+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 578888999999999999998653 3689999986542 22345788999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++++||+|||+++...
T Consensus 110 ~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999985 3456899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. ... .+....
T Consensus 183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~---~i~~~~-------- 244 (340)
T PTZ00426 183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---IYQ---KILEGI-------- 244 (340)
T ss_pred CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---HHH---HHhcCC--------
Confidence 32 134579999999999999999999999999999999999999997543211 000 011100
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRP-----FMGEVVQ 647 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv~ 647 (780)
. .++......+.+++.+|++.+|++|+ +++|+++
T Consensus 245 --~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 245 --I--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred --C--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 0 01111123567899999999999995 7877754
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=325.28 Aligned_cols=268 Identities=27% Similarity=0.405 Sum_probs=206.6
Q ss_pred cCcccceeecccCceEEEEEEEe-----CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeee--ccee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-----NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIE--GRTR 446 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-----~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~ 446 (780)
+.|...+.||+|+||.||+|.++ ++..||||.++..... ..++|.+|++++++++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45667789999999999999864 3688999999765443 45689999999999999999999999877 5578
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
++||||+++++|.+++.. ....++|..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999999963 3346999999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCCcc--ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccc--cccc
Q 048425 527 EATEGSQH--ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLL--TTRE 602 (780)
Q Consensus 527 ~~~~~~~~--~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll--~~~~ 602 (780)
........ ......++..|++||++.+..++.++||||||+++|||+||+.|+....... ..++.... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~ 233 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF----LRMIGIAQGQMIVT 233 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh----ccccccccccccHH
Confidence 77533221 1112345667999999998899999999999999999999999886432211 01000000 0000
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
.+.+.+...............+.+++.+|++.+|++||+|.||+++|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 01111111111111122336788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=348.66 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=209.3
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
..|.....||+|..|.||.+.. .+++.||||++........+-.++|+.+|+..+|+|||++++.|..++++++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4566668899999999999985 478999999998877666677899999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++|+|.|.+. ...+++.++..|+.+++.||+|||.++ |+|||||++|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 353 EGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred CCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999984 345999999999999999999999998 99999999999999999999999999988876543
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
. ....+||+.|||||+.....|..|.||||||++++||+-|..||-...|-....+. ... -.|.+.
T Consensus 425 K-R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI-------a~n------g~P~lk 490 (550)
T KOG0578|consen 425 K-RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATN------GTPKLK 490 (550)
T ss_pred c-cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH-------hhc------CCCCcC
Confidence 3 34567999999999999999999999999999999999999999754432211111 111 111111
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
........+.++..+|++.|+++|+++.|+++
T Consensus 491 --~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 491 --NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred --CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 11222357889999999999999999999976
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=337.04 Aligned_cols=241 Identities=25% Similarity=0.363 Sum_probs=194.4
Q ss_pred eeecccCceEEEEEEE----eCCcEEEEEEeeccC----CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 381 RILGEGGFGCVYHGVM----DNGTEVAVKLLTRNN----QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
+.||+|+||.||+++. .+++.||||+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 357899999997542 22234678899999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++|+|.+++. ....+.+.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999985 3456888899999999999999999998 9999999999999999999999999998653322
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+. ....
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~~~----------~~~~ 217 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDKIL----------KGKL 217 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHHHH----------cCCC
Confidence 2 2234579999999999999889999999999999999999999997543211 011111 1110
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRP-----FMGEVVQ 647 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv~ 647 (780)
..+......+.+++.+|++.+|++|| ++.++++
T Consensus 218 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 --NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11112234678999999999999999 6777654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=323.57 Aligned_cols=254 Identities=27% Similarity=0.416 Sum_probs=201.0
Q ss_pred HHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeeeec-----
Q 048425 371 EKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICIEG----- 443 (780)
Q Consensus 371 ~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~----- 443 (780)
+.+++.|+..+.||+|+||.||+|... +++.||+|++.... ....++.+|++++.++ +|+||+++++++...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 346788999999999999999999875 68899999986543 3456789999999998 799999999998753
Q ss_pred -ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecc
Q 048425 444 -RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDF 522 (780)
Q Consensus 444 -~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDF 522 (780)
...++||||+++|+|.+++.. .....++|..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccC
Confidence 357899999999999999864 23456899999999999999999999987 999999999999999999999999
Q ss_pred cccccccCCCccceeccccCccccCchhhc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccc
Q 048425 523 GLAREATEGSQHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL 597 (780)
Q Consensus 523 GLA~~~~~~~~~~~t~~~GT~~Y~APE~l~-----~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~l 597 (780)
|+++....... ......|+..|+|||++. +..++.++|||||||++|||++|+.|++...+.......
T Consensus 156 g~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~------ 228 (272)
T cd06637 156 GVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------ 228 (272)
T ss_pred CCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH------
Confidence 99986543222 223456899999999986 346788999999999999999999999643321111000
Q ss_pred cccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 598 LTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 598 l~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
. ....+.+. .......+.+++.+||+.+|.+||++.||++
T Consensus 229 ~-------~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 P-------RNPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred h-------cCCCCCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 00001110 1112346789999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=326.60 Aligned_cols=256 Identities=27% Similarity=0.461 Sum_probs=204.4
Q ss_pred cCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
.+|...+.||+|+||.||++... ++..+|+|.+..........|.+|++++++++|+||+++++++.+++..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999742 356899999876665556789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhcccccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCC
Q 048425 449 VYELVHNGSVESHLHGVDK-----------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP 517 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~-----------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~v 517 (780)
||||+++|+|.++++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864221 1135899999999999999999999988 9999999999999999999
Q ss_pred eeecccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcc
Q 048425 518 KVSDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWAR 595 (780)
Q Consensus 518 KLsDFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~ 595 (780)
||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||....... ....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~-- 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AIEC-- 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HHHH--
Confidence 9999999986543321 11223345778999999999999999999999999999998 888885433211 1110
Q ss_pred cccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 596 PLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 596 ~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
.... . .. ..+......+.+++.+||+.+|++||++.||.+.|+
T Consensus 237 -~~~~-~------~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 -ITQG-R------EL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -HHcC-c------cC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0000 0 00 011122346789999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=342.63 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=198.6
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|+..+.||+|+||+||++... +|+.||||+++... ......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999975 68999999997542 223356888999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999853 456999999999999999999999998 99999999999999999999999999976432
Q ss_pred CCcc-------------------------------------ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHH
Q 048425 531 GSQH-------------------------------------ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL 573 (780)
Q Consensus 531 ~~~~-------------------------------------~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELl 573 (780)
.... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011246999999999999999999999999999999999
Q ss_pred hCCCCCCCCCcccc-chhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 048425 574 SGRKPVDMSQPQGQ-ENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPF---MGEVVQ 647 (780)
Q Consensus 574 TGr~P~~~~~~~~~-~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs---m~EVv~ 647 (780)
+|+.||....+... ..+..|... +. .+ . .......+.+++..|+. +|.+|++ +.|+++
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~~~-------~~---~~---~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINWKET-------LQ---FP---D--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCc-------cC---CC---C--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99999975443211 111111100 00 00 0 00112356678888886 8999998 777754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=327.72 Aligned_cols=251 Identities=26% Similarity=0.394 Sum_probs=200.8
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
+|+..++||+|+||+||++... +++.||||++..... .....+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999875 689999999865432 223457889999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++|+|.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999988863 23356999999999999999999999998 999999999999999999999999999876433
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||......... .. +...+...
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~--~~-----------~~~~~~~~ 220 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR--EE-----------VERRVKED 220 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH--HH-----------HHHHhhhc
Confidence 22 12346899999999999999999999999999999999999999753321110 00 00000000
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048425 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRP-----FMGEVVQ 647 (780)
Q Consensus 612 L~~~~~~ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv~ 647 (780)
...+.......+.+++..|++.||++|| +++++++
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 221 -QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0111222335678999999999999999 7777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=331.42 Aligned_cols=261 Identities=25% Similarity=0.420 Sum_probs=204.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCc--EEEEEEeeccC-CcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGT--EVAVKLLTRNN-QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~--~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV 449 (780)
++|+..+.||+|+||.||+|.+. +|. .+|+|.++... ....++|.+|++++.++ +|+||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888899999999999999975 454 45777775433 22345789999999999 899999999999999999999
Q ss_pred EeecCCCChhhhcccccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCC
Q 048425 450 YELVHNGSVESHLHGVDK------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP 517 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~v 517 (780)
|||+++|+|.++++.... ....+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999964321 1236899999999999999999999988 9999999999999999999
Q ss_pred eeecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccc
Q 048425 518 KVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARP 596 (780)
Q Consensus 518 KLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ 596 (780)
||+|||+++....... .....++..|+|||++.+..++.++|||||||++|||+| |..||...... .+......
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~~ 238 (303)
T cd05088 164 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLPQ 238 (303)
T ss_pred EeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHHHHhc
Confidence 9999999874322111 112234667999999988889999999999999999998 99998643221 11111000
Q ss_pred ccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 597 LLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 597 ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
.............+.+++.+|++.+|++||++.++++.|+++.....
T Consensus 239 --------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 239 --------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred --------------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 00000111223467899999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=323.23 Aligned_cols=251 Identities=26% Similarity=0.426 Sum_probs=196.4
Q ss_pred eeecccCceEEEEEEEe-CCc--EEEEEEeeccC-CcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMD-NGT--EVAVKLLTRNN-QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~--~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
++||+|+||.||+|.+. +|. .+++|.++... ....+.|.+|++++.++ +|+||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46999999999999975 343 47888886543 23346789999999999 899999999999998899999999999
Q ss_pred CChhhhcccccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccc
Q 048425 456 GSVESHLHGVDK------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 456 GSL~~~L~~~~~------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFG 523 (780)
|+|.++++.... ....+++.++++++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999964321 1235889999999999999999999987 9999999999999999999999999
Q ss_pred ccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccc
Q 048425 524 LAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 524 LA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
+++....... ......+..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.... .. .
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~---~~-~- 227 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKL---PQ-G- 227 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHHHH---hC-C-
Confidence 9864322111 111223567999999999999999999999999999997 99998643221 111110 00 0
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIY 653 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~ 653 (780)
............+.+++.+|++.+|.+||++.|+++.|+.+.
T Consensus 228 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 ---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ---------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000011122346789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=323.08 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=203.1
Q ss_pred cCcccceeecccCceEEEEEEEe-CC---cEEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NG---TEVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g---~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
++|...+.||+|+||.||+|.+. +| ..||||.++... ....++|..|++++++++|+||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 34677899999999999999975 33 369999987542 22346799999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++|+|.+++.. ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999999863 3456899999999999999999999988 9999999999999999999999999998664
Q ss_pred CCCccc--eeccc--cCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccc
Q 048425 530 EGSQHI--STRVM--GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 530 ~~~~~~--~t~~~--GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
...... ..... .+..|+|||++.++.++.++|||||||++|||++ |+.||...... ....++....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~~------ 228 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQDY------ 228 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCC------
Confidence 432211 11111 2457999999999999999999999999999987 99998653321 2222221100
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
. -....+....+.+++..|++.+|.+||+|.+|+..|+.+
T Consensus 229 ----~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 ----R----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----c----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 001122335678999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=321.63 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=205.6
Q ss_pred hcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
.++|...+.||+|+||.||++...++..+|+|.+.... .....|.+|++++++++|+||+++.+++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 46788899999999999999998788889999886542 234679999999999999999999999887 7789999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++|+|.+++.. .....+++..++.++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 83 AKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCcHHHHHHh--CCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999964 23456899999999999999999999987 99999999999999999999999999987654332
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
.......++..|+|||++..+.++.++|||||||++|||+| |+.||...... .+..+.. .....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~----~~~~~-------- 222 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALE----RGYRM-------- 222 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHh----CCCCC--------
Confidence 22223345678999999999899999999999999999999 89898643221 1111110 00000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~ 651 (780)
.........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111233568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=340.30 Aligned_cols=202 Identities=26% Similarity=0.371 Sum_probs=176.1
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|+..+.||+|+||+||++... +|+.||||++++.. ......+.+|++++.+++|+||+++++.+.++...++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999865 68999999997542 223356888999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++. ....+++.....++.|++.||+|||+.+ |+||||||+|||+++++++||+|||+++....
T Consensus 81 E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999995 3457999999999999999999999998 99999999999999999999999999976432
Q ss_pred CCc----------------------------------cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCC
Q 048425 531 GSQ----------------------------------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGR 576 (780)
Q Consensus 531 ~~~----------------------------------~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr 576 (780)
... .......||+.|+|||++.+..++.++|||||||+||||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0112357999999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 048425 577 KPVDMSQ 583 (780)
Q Consensus 577 ~P~~~~~ 583 (780)
.||....
T Consensus 234 ~Pf~~~~ 240 (363)
T cd05628 234 PPFCSET 240 (363)
T ss_pred CCCCCCC
Confidence 9997544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=355.59 Aligned_cols=258 Identities=22% Similarity=0.296 Sum_probs=206.5
Q ss_pred HHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecc---
Q 048425 371 EKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGR--- 444 (780)
Q Consensus 371 ~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~--- 444 (780)
....++|...+.||+|+||+||++... +|+.||||++..... .....+.+|+.++..++|+||+++.+.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 344578999999999999999999864 799999999876532 23356889999999999999999988765432
Q ss_pred -----eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCee
Q 048425 445 -----TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKV 519 (780)
Q Consensus 445 -----~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKL 519 (780)
..++||||+++|+|.++|+........+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 357999999999999999754445567999999999999999999999987 999999999999999999999
Q ss_pred ecccccccccCCC-ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccc
Q 048425 520 SDFGLAREATEGS-QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLL 598 (780)
Q Consensus 520 sDFGLA~~~~~~~-~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll 598 (780)
+|||+++...... ........||+.|+|||++.+..++.++|||||||+||||++|+.||...... .......
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~~~~ 258 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMHKTL 258 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHh
Confidence 9999998764322 12234467999999999999999999999999999999999999999753321 1111111
Q ss_pred ccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 599 TTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 599 ~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.. ..++ .+......+.+++..||+.+|++||++.++++.
T Consensus 259 ~~------~~~~-----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AG------RYDP-----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cC------CCCC-----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 10 0111 112223568899999999999999999999763
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=329.90 Aligned_cols=263 Identities=25% Similarity=0.457 Sum_probs=201.1
Q ss_pred cCcccceeecccCceEEEEEEEeC---------------CcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDN---------------GTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIG 438 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~---------------g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g 438 (780)
++|...+.||+|+||.||++...+ ...||||.++.... .....|.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578888999999999999987632 23589999865432 23457999999999999999999999
Q ss_pred eeeecceeEEEEeecCCCChhhhcccccC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceE
Q 048425 439 ICIEGRTRCLVYELVHNGSVESHLHGVDK--------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVL 510 (780)
Q Consensus 439 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~--------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNIL 510 (780)
++...+..++||||+++++|.+++..... ....++|..+++++.|++.||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999854211 1134789999999999999999999998 999999999999
Q ss_pred EcCCCCCeeecccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh--CCCCCCCCCcccc
Q 048425 511 LEDDFTPKVSDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS--GRKPVDMSQPQGQ 587 (780)
Q Consensus 511 Ld~~~~vKLsDFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT--Gr~P~~~~~~~~~ 587 (780)
+++++.+||+|||++........ .......++..|+|||++.++.++.++|||||||++|||++ |..||......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-- 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-- 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence 99999999999999986543321 11223445778999999999999999999999999999998 55566543221
Q ss_pred chhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 588 ENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 588 ~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
.............. .... ...+......+.+++.+|++.+|++||+|.+|++.|+
T Consensus 240 -~~~~~~~~~~~~~~--~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 -QVIENTGEFFRNQG--RQIY-----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -HHHHHHHHhhhhcc--cccc-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111111010000 0000 0011112357899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=344.59 Aligned_cols=255 Identities=20% Similarity=0.275 Sum_probs=201.9
Q ss_pred HHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeE
Q 048425 372 KATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 372 ~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 447 (780)
...++|...+.||+|+||.||++... +|+.||+|++.+.. ......+.+|+++++.++|+||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34578999999999999999999875 68899999997532 223345789999999999999999999999999999
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+||||+++|+|.+++.. ..++......++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 120 lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999999853 24788888999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCccceeccccCccccCchhhccC----CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccc
Q 048425 528 ATEGSQHISTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREG 603 (780)
Q Consensus 528 ~~~~~~~~~t~~~GT~~Y~APE~l~~~----~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~ 603 (780)
.............||+.|+|||++.+. .++.++|||||||+||||++|+.||....... . ...+......
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~---~~~i~~~~~~ 265 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---T---YSKIMDHKNS 265 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH---H---HHHHHcCCCc
Confidence 654332223445799999999998653 47899999999999999999999997543211 0 0011111000
Q ss_pred cccccCCccCCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 048425 604 LEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTH--RPFMGEVVQA 648 (780)
Q Consensus 604 l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~--RPsm~EVv~~ 648 (780)
+ .... .......+.+++..|++.+|++ ||++.|+++.
T Consensus 266 ---~---~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 ---L---TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---C---CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 0000 1112356788999999999988 9999998654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=318.94 Aligned_cols=249 Identities=29% Similarity=0.464 Sum_probs=200.5
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeee-ecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICI-EGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~-~~~~~~LV~Ey~ 453 (780)
++|...+.||+|+||.||++.. .|..||+|.++... ..+.|.+|+.++++++|+|++++++++. +++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4678889999999999999987 47889999986432 3567999999999999999999999865 445789999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++++|.+++.. .....+++..+++++.+++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 83 AKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 99999999863 23345899999999999999999999988 9999999999999999999999999998654322
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
....++..|+|||++.+..++.++||||||+++|||++ |+.|+..... ..+..+... . ..+
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~----~------~~~-- 218 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEK----G------YKM-- 218 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhc----C------CCC--
Confidence 22335668999999999899999999999999999998 9988854321 112111110 0 000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
.........+.+++.+|++.+|++||++.++++.|+.+
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 --DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11122345788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=342.56 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=195.5
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
+|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999864 68899999997643 2234568999999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++|+|.+++. ....+++.....++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999985 3346889999999999999999999988 999999999999999999999999998643110
Q ss_pred C----------------------------------------------ccceeccccCccccCchhhccCCCCchhhHHhH
Q 048425 532 S----------------------------------------------QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSY 565 (780)
Q Consensus 532 ~----------------------------------------------~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySf 565 (780)
. ........||..|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 0 000123579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcccc-chhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHH--ccccCCCCCCCH
Q 048425 566 GVVLLELLSGRKPVDMSQPQGQ-ENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASM--CVHPEVTHRPFM 642 (780)
Q Consensus 566 GVvLlELlTGr~P~~~~~~~~~-~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~--Cl~~dP~~RPsm 642 (780)
||++|||+||+.||....+... ..+..|... +. + +. ...++ ..+.+++.+ |+..++..||++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-------~~-~--~~-~~~~s----~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENT-------LH-I--PP-QVKLS----PEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHccccc-------cC-C--CC-CCCCC----HHHHHHHHHHccCcccccCCCCH
Confidence 9999999999999976443211 111111100 00 0 00 00112 345556655 667777789999
Q ss_pred HHHHH
Q 048425 643 GEVVQ 647 (780)
Q Consensus 643 ~EVv~ 647 (780)
.|++.
T Consensus 300 ~~~l~ 304 (381)
T cd05626 300 DDIKA 304 (381)
T ss_pred HHHhc
Confidence 99975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=320.86 Aligned_cols=253 Identities=24% Similarity=0.359 Sum_probs=201.9
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
++|+..+.||+|+||.||+|+. .+|+.||+|+++.........+.+|+.++++++|+||+++++++..++..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5788889999999999999997 478899999997655445567889999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++++|.++++ ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 89 ~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 89 GGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999985 2356899999999999999999999987 99999999999999999999999999987643221
Q ss_pred cceeccccCccccCchhhc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 534 HISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~---~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
......|+..|+|||.+. ...++.++|||||||++|||++|+.|+....+... ...+... .+..+
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~~~~~~---------~~~~~ 229 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMSKS---------NFQPP 229 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--heeeecC---------CCCCC
Confidence 112346889999999874 44578899999999999999999999854332111 1111000 00111
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.... .......+.+++.+|++.+|++||++++|++.
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 1110 11123578899999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=337.81 Aligned_cols=242 Identities=24% Similarity=0.330 Sum_probs=195.1
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCC
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNG 456 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~G 456 (780)
+.||+|+||.||++... +|+.||+|+++... ......+.+|++++..++|+||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 78999999997642 223456788999999999999999999999999999999999999
Q ss_pred ChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 457 SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE-DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 457 SL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~-~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
+|.+++. ....+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~- 152 (325)
T cd05594 81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT- 152 (325)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-
Confidence 9999884 34578999999999999999999997 56 999999999999999999999999999864332221
Q ss_pred eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCC
Q 048425 536 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGS 615 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~ 615 (780)
.....||..|+|||++.++.++.++|||||||+||||+||+.||....... +... .... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~~~~---i~~~--------~~~---- 214 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFEL---ILME--------EIR---- 214 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---HHHH---HhcC--------CCC----
Confidence 234569999999999999999999999999999999999999996533211 1110 0000 001
Q ss_pred CChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 048425 616 YDFDDMAKVAAIASMCVHPEVTHRP-----FMGEVVQA 648 (780)
Q Consensus 616 ~~~ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv~~ 648 (780)
++......+.+++.+|++.||++|+ ++.|+++.
T Consensus 215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1112234678899999999999997 88888653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=326.03 Aligned_cols=264 Identities=26% Similarity=0.423 Sum_probs=205.2
Q ss_pred hcCcccceeecccCceEEEEEEEeC-----------------CcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDN-----------------GTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVK 435 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~-----------------g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~ 435 (780)
.++|+..+.||+|+||.||++...+ +..||+|.+..... ...++|.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999998642 24589999876543 23467999999999999999999
Q ss_pred eeeeeeecceeEEEEeecCCCChhhhcccccC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcc
Q 048425 436 LIGICIEGRTRCLVYELVHNGSVESHLHGVDK-------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASN 508 (780)
Q Consensus 436 L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~-------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsN 508 (780)
++++|..++..++|+||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999964321 1236899999999999999999999987 9999999999
Q ss_pred eEEcCCCCCeeecccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh--CCCCCCCCCcc
Q 048425 509 VLLEDDFTPKVSDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS--GRKPVDMSQPQ 585 (780)
Q Consensus 509 ILLd~~~~vKLsDFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT--Gr~P~~~~~~~ 585 (780)
|++++++.+||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ |..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999986543321 12234456789999999999899999999999999999998 6667754321
Q ss_pred ccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 586 GQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 586 ~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
......+............ ..........+.+++.+|++.+|++||++.||++.|+
T Consensus 240 --~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIY-------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhcccccccccc-------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1122221111111100000 0011122357899999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=335.56 Aligned_cols=243 Identities=21% Similarity=0.312 Sum_probs=192.6
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
++||+|+||.||++... +++.||||++++... ...+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999875 688999999976432 2335688899999998 799999999999999999999999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (329)
T cd05588 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-T 152 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC-c
Confidence 99998884 3457999999999999999999999998 99999999999999999999999999975332211 2
Q ss_pred eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccc--cchhhhhcccccccccccccccCCccC
Q 048425 536 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQG--QENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~--~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
.....||..|+|||++.+..++.++|||||||++|||+||+.||+...... .....++.... +.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------~~~~~~- 222 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV---------ILEKQI- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH---------HHcCCC-
Confidence 234679999999999999999999999999999999999999997432211 11111111111 111110
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFM 642 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm 642 (780)
..+......+.+++..|++.||.+||++
T Consensus 223 -~~p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 223 -RIPRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1111223467889999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=333.11 Aligned_cols=240 Identities=24% Similarity=0.362 Sum_probs=191.5
Q ss_pred cccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHh---hhcCCCceeeeeeeeeecceeEEE
Q 048425 377 FSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEML---SRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL---~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
|+..+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++ ++++|+||+++++++..++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999875 68999999997543 22234566676654 567899999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++|+|..+++ ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999998875 246999999999999999999999998 9999999999999999999999999987543
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.. .+....
T Consensus 153 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---~~~---~i~~~~-------- 217 (324)
T cd05589 153 GFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---VFD---SIVNDE-------- 217 (324)
T ss_pred CCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHhCC--------
Confidence 3221 2234679999999999999999999999999999999999999997543211 110 111100
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMG 643 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~ 643 (780)
.. ++......+.+++.+|++.||.+||++.
T Consensus 218 ~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 218 VR----YPRFLSREAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred CC----CCCCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence 00 1112234678899999999999999644
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=320.53 Aligned_cols=254 Identities=24% Similarity=0.439 Sum_probs=202.9
Q ss_pred CcccceeecccCceEEEEEEEeC--CcEEEEEEeeccC----------CcchHHHHHHHHHhhh-cCCCceeeeeeeeee
Q 048425 376 KFSSKRILGEGGFGCVYHGVMDN--GTEVAVKLLTRNN----------QNGDREFIAEVEMLSR-LHHRNLVKLIGICIE 442 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~~--g~~VAVK~l~~~~----------~~~~~~f~~Ei~iL~~-L~HpNIV~L~g~~~~ 442 (780)
+|+..+.||+|+||.||+|.... ++.+|||.+.... .....++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999864 6889999875432 1123457789988875 799999999999999
Q ss_pred cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCcEEecccCCcceEEcCCCCCeeec
Q 048425 443 GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE-DSNPRVIHRDFKASNVLLEDDFTPKVSD 521 (780)
Q Consensus 443 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~-~~~p~IvHrDIKpsNILLd~~~~vKLsD 521 (780)
++..++||||+++++|.+++.........+++..+++++.|++.||.|||+ .+ ++||||||+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999986544455679999999999999999999996 44 99999999999999999999999
Q ss_pred ccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccc
Q 048425 522 FGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTR 601 (780)
Q Consensus 522 FGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~ 601 (780)
||++....... ......|+..|+|||++.++.++.++||||||+++|||++|+.|+...... ........
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~~~~~-- 227 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLATKIVE-- 227 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHHHHhh--
Confidence 99998765433 224456899999999999999999999999999999999999998643221 11111100
Q ss_pred cccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 602 EGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 602 ~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
....+.. .......+.+++.+|++.||++||++.||..+++
T Consensus 228 ----~~~~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 ----AVYEPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ----ccCCcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0001111 1112356889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=324.99 Aligned_cols=270 Identities=26% Similarity=0.377 Sum_probs=203.1
Q ss_pred cCcccceeecccCceEEEEEEE-----eCCcEEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeeec--cee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-----DNGTEVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEG--RTR 446 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-----~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~ 446 (780)
..|...+.||+|+||.||++.. .++..||+|.++... ......|.+|++++++++|+||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467789999999999999974 357889999986543 22346799999999999999999999998775 567
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
++||||+++++|.+++.. ....++|..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 899999999999999853 2346899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCcc--ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccc
Q 048425 527 EATEGSQH--ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 527 ~~~~~~~~--~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
........ ......|+..|+|||++.++.++.++|||||||++|||+|++.|..............+... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 236 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQ-MTVTRLV 236 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccc-ccHHHHH
Confidence 76543221 12234567789999999988999999999999999999998776432111000000000000 0000000
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
..+.+. ............+.+++.+|++.+|++||++.++++.|+.+
T Consensus 237 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEG-KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcC-ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000000 00011122346789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=322.48 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=198.1
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|...++||+|+||.||+|... ++..||+|++.... ....++|.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36777899999999999999864 78899999986553 22346799999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++++|..+. .+++.....++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999996553 4678889999999999999999998 9999999999999999999999999998764332
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-hhhhcccccccccccccccCCc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
.....||..|+|||++.+..++.++||||||+++|||++|+.||.......... ...+ ...+.++.
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----------~~~~~~~~ 216 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL----------LQCIVDED 216 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH----------HHHHhccC
Confidence 233568999999999999999999999999999999999999996532211100 0000 00011110
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 612 L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
............+.+++.+|++.+|++||+++|+++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 217 PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000011123467899999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=318.13 Aligned_cols=248 Identities=33% Similarity=0.478 Sum_probs=198.5
Q ss_pred eeecccCceEEEEEEEe--C--CcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMD--N--GTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~--~--g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
++||+|+||.||+|+.. + +..+|+|.+...... ..+++.+|++++++++|+||+++++++. ++..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999753 2 268999998765442 4467999999999999999999999876 4568999999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
|+|.+++.. ...+++..+++++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999953 337899999999999999999999987 9999999999999999999999999998775443221
Q ss_pred e--eccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 536 S--TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 536 ~--t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
. ....++..|+|||.+.+..++.++||||||+++|||++ |+.||+.... ..+..+.... ...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~----~~~-------- 217 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESG----ERL-------- 217 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcC----CcC--------
Confidence 1 12224567999999999999999999999999999998 9999865432 1222221110 000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIY 653 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~ 653 (780)
.........+.+++.+|++.+|++||++.+|++.|+.+.
T Consensus 218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 111122357889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=335.92 Aligned_cols=263 Identities=26% Similarity=0.418 Sum_probs=203.5
Q ss_pred hcCcccceeecccCceEEEEEEE------eCCcEEEEEEeeccCCc-chHHHHHHHHHhhhc-CCCceeeeeeeeeec-c
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVM------DNGTEVAVKLLTRNNQN-GDREFIAEVEMLSRL-HHRNLVKLIGICIEG-R 444 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l------~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~-~ 444 (780)
.++|...+.||+|+||.||+|.. .+++.||||+++..... ..+.+.+|++++.++ +|+||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 36788899999999999999973 35788999999754332 335688999999999 789999999988654 4
Q ss_pred eeEEEEeecCCCChhhhcccccC---------------------------------------------------------
Q 048425 445 TRCLVYELVHNGSVESHLHGVDK--------------------------------------------------------- 467 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~--------------------------------------------------------- 467 (780)
..++||||+++|+|.++++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999864211
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc-ceeccc
Q 048425 468 ------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH-ISTRVM 540 (780)
Q Consensus 468 ------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~-~~t~~~ 540 (780)
....++|.++.+++.|++.||+|||+.+ |+||||||+|||+++++++||+|||+++........ ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0134789999999999999999999998 999999999999999999999999999876433221 112234
Q ss_pred cCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCChh
Q 048425 541 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFD 619 (780)
Q Consensus 541 GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~e 619 (780)
++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ..+.. ....... ... +..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~----~~~~~~~------~~~----~~~ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCR----RLKEGTR------MRA----PDY 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHH----HHhccCC------CCC----CCC
Confidence 5678999999999999999999999999999997 88888643211 11110 0000000 000 001
Q ss_pred hHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 620 DMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 620 e~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
....+.+++..||+.+|++||++.||++.|+.+.+.
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 123578999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.71 Aligned_cols=249 Identities=25% Similarity=0.378 Sum_probs=204.3
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
.+|+..+.||+|+||.||+|+.. ++..||+|.+........+.+.+|+++++.++|+||+++++++..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57888899999999999999864 78999999998766555678999999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++++|.+++.. ..+++.+++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999852 35899999999999999999999998 99999999999999999999999999886543321
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||....+.. .+..+.. .. . +.+
T Consensus 172 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~~~~----~~--~-----~~~- 236 (296)
T cd06654 172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLIAT----NG--T-----PEL- 236 (296)
T ss_pred c-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHHHhc----CC--C-----CCC-
Confidence 1 223468899999999999889999999999999999999999997544321 1111110 00 0 000
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.........+.+++.+|+..+|++||++.||++
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 011122346788999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=332.53 Aligned_cols=241 Identities=24% Similarity=0.332 Sum_probs=194.4
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCC-CceeeeeeeeeecceeEEEE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHH-RNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~H-pNIV~L~g~~~~~~~~~LV~ 450 (780)
+|+..+.||+|+||.||+|... +++.||||+++... ....+.+..|++++..++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5778899999999999999875 57899999997642 2334568889999999976 56888999999889999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999985 3456899999999999999999999998 99999999999999999999999999875432
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
... ......||..|+|||++.+..++.++|||||||++|||+||+.||...... .+.... .... .
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i---~~~~--------~ 218 (324)
T cd05587 154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQSI---MEHN--------V 218 (324)
T ss_pred CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH---HcCC--------C
Confidence 221 223456999999999999999999999999999999999999999754321 111110 0000 0
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFM 642 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm 642 (780)
.++......+.+++.+|++.+|++|++.
T Consensus 219 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 ----SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1111223467889999999999999987
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=315.80 Aligned_cols=247 Identities=32% Similarity=0.483 Sum_probs=199.9
Q ss_pred eeecccCceEEEEEEEeCCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCChh
Q 048425 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVE 459 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL~ 459 (780)
++||+|+||.||++...+++.||+|.+...... ....|.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765443 4467999999999999999999999999999999999999999999
Q ss_pred hhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccce-ec
Q 048425 460 SHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIS-TR 538 (780)
Q Consensus 460 ~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~-t~ 538 (780)
+++.. ....+++..++.++.+++.||+|||+.+ ++||||||+||++++++.+||+|||+++.......... ..
T Consensus 81 ~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 99863 3346899999999999999999999998 99999999999999999999999999986643222111 12
Q ss_pred cccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCC
Q 048425 539 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYD 617 (780)
Q Consensus 539 ~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~ 617 (780)
..++..|+|||++.++.++.++|||||||++|||+| |..||....... ....... ......+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~~~~--------------~~~~~~~ 217 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRERIES--------------GYRMPAP 217 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHHHhc--------------CCCCCCC
Confidence 234667999999999999999999999999999999 788886443211 1111000 0000111
Q ss_pred hhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 618 FDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 618 ~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
......+.+++.+|++.+|++||++.||++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 223457889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=326.48 Aligned_cols=263 Identities=25% Similarity=0.454 Sum_probs=202.2
Q ss_pred cCcccceeecccCceEEEEEEEe-----------------CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-----------------NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKL 436 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-----------------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L 436 (780)
++|+..+.||+|+||.||++... ++..||+|+++.... ....+|.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57888999999999999998532 244699999875532 234679999999999999999999
Q ss_pred eeeeeecceeEEEEeecCCCChhhhcccccC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcce
Q 048425 437 IGICIEGRTRCLVYELVHNGSVESHLHGVDK-------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNV 509 (780)
Q Consensus 437 ~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~-------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNI 509 (780)
++++..++..++||||+++|+|.+++..... ....+++.+.++++.|++.||+|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999864321 1235888999999999999999999998 99999999999
Q ss_pred EEcCCCCCeeecccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh--CCCCCCCCCccc
Q 048425 510 LLEDDFTPKVSDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS--GRKPVDMSQPQG 586 (780)
Q Consensus 510 LLd~~~~vKLsDFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT--Gr~P~~~~~~~~ 586 (780)
|+++++.+||+|||+++....... .......++..|++||...++.++.++|||||||++|||++ |..|+......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE- 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence 999999999999999986643321 11223345678999999988999999999999999999998 66777533221
Q ss_pred cchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 587 QENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 587 ~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
.............. .....+ ........+.+++.+||+.||++||+|.||++.|+
T Consensus 241 --~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 --QVIENTGEFFRDQG--RQVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred --HHHHHHHHHHhhcc--ccccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11110000000000 000001 01122357889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=343.28 Aligned_cols=259 Identities=19% Similarity=0.267 Sum_probs=196.8
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
++|...+.||+|+||.||++... +++.||+|... ...+.+|++++++++||||+++++++..+...++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 67999999999999999999874 78899999753 235778999999999999999999999999999999998
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
. ++|.+++. ....+++..++.|+.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 166 ~-~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 166 K-TDLYCYLA----AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred C-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 5 78888874 3356899999999999999999999998 99999999999999999999999999976433222
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCcccc-----chhhhhcccc--------ccc
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ-----ENLVTWARPL--------LTT 600 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~-----~~Lv~wa~~l--------l~~ 600 (780)
.......||+.|+|||++.+..++.++|||||||+||||+||+.|+........ ..+....... ...
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 223456799999999999999999999999999999999999988643221110 0000000000 000
Q ss_pred cccccccc---------CCccCCCC--ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 601 REGLEQLV---------DPSLAGSY--DFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 601 ~~~l~~lv---------Dp~L~~~~--~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
...+..+. .+...... ..+....+.+++.+|++.||++|||++|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 00000000 0122346889999999999999999999975
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=342.19 Aligned_cols=258 Identities=21% Similarity=0.280 Sum_probs=200.7
Q ss_pred HHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecc
Q 048425 369 DLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGR 444 (780)
Q Consensus 369 el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 444 (780)
++....++|+..+.||+|+||.||++... +++.||+|++.+.. ....+.+.+|+++++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678999999999999999999975 68899999986532 223456889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccc
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGL 524 (780)
..++||||+++|+|.+++.. ..+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccc
Confidence 99999999999999999852 25788999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCccceeccccCccccCchhhccC----CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccc
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTT 600 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~~----~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~ 600 (780)
++..............||+.|+|||.+.+. .++.++|||||||+||||++|+.||......+. ...+...
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~~~i~~~ 262 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------YSKIMDH 262 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------HHHHHhC
Confidence 987654332223456799999999998754 378899999999999999999999975432111 0111110
Q ss_pred ccccccccCCccCCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 048425 601 REGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTH--RPFMGEVVQA 648 (780)
Q Consensus 601 ~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~--RPsm~EVv~~ 648 (780)
...+ .+. ........+.+++..|++.++.+ |+++.|+++.
T Consensus 263 ~~~~------~~p--~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 KNSL------NFP--EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred Cccc------CCC--CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0000 000 01122345677888888755544 8899988663
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=323.97 Aligned_cols=247 Identities=25% Similarity=0.349 Sum_probs=195.4
Q ss_pred ecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCCh
Q 048425 383 LGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSV 458 (780)
Q Consensus 383 LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL 458 (780)
||+|+||.||++..+ +|+.||+|++..... ...+.+..|++++++++|+||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 689999999865322 2234567799999999999999999999999999999999999999
Q ss_pred hhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccceec
Q 048425 459 ESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR 538 (780)
Q Consensus 459 ~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~ 538 (780)
.+++.. .....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++....... ....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYN--VGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 988853 23446899999999999999999999988 9999999999999999999999999998765432 2234
Q ss_pred cccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCCh
Q 048425 539 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDF 618 (780)
Q Consensus 539 ~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ 618 (780)
..||..|+|||++.+..++.++|||||||++|||++|+.||....... ......+... ...+... ..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~----------~~~~~~~-~~ 220 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTL----------EDEVKFE-HQ 220 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhh----------ccccccc-cc
Confidence 568999999999999999999999999999999999999986432211 1111111111 1111000 01
Q ss_pred hhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 619 DDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 619 ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
.....+.+++..|++.||++||++.|+++.+
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 1234678999999999999999998876433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=318.74 Aligned_cols=248 Identities=28% Similarity=0.427 Sum_probs=199.7
Q ss_pred eeecccCceEEEEEEEeC--C--cEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMDN--G--TEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~--g--~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
+.||+|++|.||+|.+.+ + ..||||.+..... ...+.|.+|++++++++|+||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998743 3 3699999977655 455789999999999999999999999988 888999999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc-
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH- 534 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~- 534 (780)
|+|.+++..... ..++|...+.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999964321 57899999999999999999999997 999999999999999999999999999877543221
Q ss_pred -ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 535 -ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 535 -~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
......++..|+|||++.+..++.++|||||||++|||++ |+.||+..... .+.... .... ...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~---~~~~---~~~----- 220 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKI---DKEG---ERL----- 220 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---HhcC---CcC-----
Confidence 1123457889999999999999999999999999999999 99998643321 111110 0000 000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
.........+.+++.+|++.+|++||++.||++.|.
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 --ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011122357889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=320.09 Aligned_cols=257 Identities=28% Similarity=0.410 Sum_probs=204.8
Q ss_pred cCcccceeecccCceEEEEEEEeCC----cEEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNG----TEVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g----~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
++|...+.||+|+||.||+|...+. ..||||...... ....+.|.+|+.++++++|+||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 5677889999999999999986432 468999886554 3344679999999999999999999999875 557899
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++|+|.+++.. ....+++..++.++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 999999999999953 3346899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
.......+...++..|+|||.+....++.++||||||+++|||++ |+.||...... ....+.. .....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~----~~~~~---- 227 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRIE----NGERL---- 227 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH----cCCcC----
Confidence 443222223345568999999988889999999999999999996 99999654321 1111110 00000
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
.. .......+.+++.+|+..+|.+||++.|+++.|+.+.+.
T Consensus 228 --~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 --PM----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01 112234788899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=332.61 Aligned_cols=241 Identities=23% Similarity=0.316 Sum_probs=195.1
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
+|...+.||+|+||+||+|+.. +++.||||++++... ...+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5778899999999999999876 578999999976432 2334577788888877 6899999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999885 3356899999999999999999999998 99999999999999999999999999986432
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .+... +.. .
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~---i~~----------~ 216 (323)
T cd05616 154 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQS---IME----------H 216 (323)
T ss_pred CCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHH---HHh----------C
Confidence 221 223467999999999999999999999999999999999999999754321 11111 111 0
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFM 642 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm 642 (780)
.. .++......+.+++.+|++.+|++|++.
T Consensus 217 ~~--~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 217 NV--AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CC--CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 00 1112233567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=335.04 Aligned_cols=243 Identities=22% Similarity=0.324 Sum_probs=191.7
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
++||+|+||+||++... +++.||+|++++... ...+.+.+|+.++.++ +|+||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 678999999976422 2334578899988877 899999999999999999999999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~ 152 (329)
T cd05618 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T 152 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence 99998884 3457999999999999999999999998 99999999999999999999999999986432221 2
Q ss_pred eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCcccc--chhhhhcccccccccccccccCCccC
Q 048425 536 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ--ENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~--~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
.....||..|+|||++.+..++.++|||||||++|||++|+.||+....... .....+.... +.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------i~~~~~- 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV---------ILEKQI- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH---------HhcCCC-
Confidence 2346799999999999999999999999999999999999999964221110 1111111110 011100
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFM 642 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm 642 (780)
..+......+.+++.+|++.||++||+.
T Consensus 223 -~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 -RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1122233567899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=317.79 Aligned_cols=251 Identities=29% Similarity=0.491 Sum_probs=194.5
Q ss_pred eeecccCceEEEEEEEe----CCcEEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeee-cceeEEEEeecC
Q 048425 381 RILGEGGFGCVYHGVMD----NGTEVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIE-GRTRCLVYELVH 454 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~----~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~~~LV~Ey~~ 454 (780)
++||+|+||.||+|.+. ++..||+|++.... ....+.|.+|+.+++.++|+||++++++|.. ++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46999999999999864 24579999985432 2334678999999999999999999998764 456789999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc-
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ- 533 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~- 533 (780)
+|+|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999999963 3345788889999999999999999987 99999999999999999999999999986543211
Q ss_pred --cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCC-CCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 534 --HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGR-KPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 534 --~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr-~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
.......++..|+|||++.+..++.++|||||||++|||++|+ .|+..... ..+.... .... .+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~---~~~~-------~~ 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYL---LQGR-------RL 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH---hcCC-------CC
Confidence 1112345677899999999899999999999999999999965 45543221 1121111 1100 00
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
. .+......+.+++..||+.+|++||++.||++.|+.+.+
T Consensus 222 ~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 222 L----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred C----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0 011123468899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=332.07 Aligned_cols=238 Identities=26% Similarity=0.370 Sum_probs=190.4
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
+.||+|+||.||+|... +++.||||+++... ....+.+..|.+++..+ +|+||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 67899999997642 22334566777777654 899999999999999999999999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
|+|.+++. ....+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 99999885 3456899999999999999999999988 9999999999999999999999999998654322 22
Q ss_pred eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCC
Q 048425 536 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGS 615 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~ 615 (780)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .+... .+ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~---~i~~~--------~~----~ 214 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFD---SILND--------RP----H 214 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHcC--------CC----C
Confidence 34457999999999999999999999999999999999999999754321 1110 01100 01 1
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCCHHH
Q 048425 616 YDFDDMAKVAAIASMCVHPEVTHRPFMGE 644 (780)
Q Consensus 616 ~~~ee~~~l~~La~~Cl~~dP~~RPsm~E 644 (780)
++......+.+++..|++.+|++||++.+
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 11112345778999999999999999853
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.38 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=204.1
Q ss_pred cCcccceeecccCceEEEEEEEeC-CcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDN-GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~-g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
++|+..+.||+|+||.||+|...+ +..+++|.+..... .++|.+|++++++++|+||+++++++.++...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678888999999999999999864 78999999865533 678999999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++++|.+++.. ....++|..++.++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999852 3467899999999999999999999988 99999999999999999999999999987654322
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
......|+..|+|||++.+..++.++||||||+++|||++|+.|+....+... .... .. ...+.+.
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~~~----~~-------~~~~~~~ 220 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IFMI----PN-------KPPPTLS 220 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hhhh----cc-------CCCCCCC
Confidence 22334588899999999999999999999999999999999999975432211 0000 00 0000010
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+......+.+++.+|++.+|++||++.||++
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 --DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 01112246788999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.53 Aligned_cols=266 Identities=23% Similarity=0.351 Sum_probs=202.0
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|+..+.||+|+||.||++... +|..+|+|.++.... ....++.+|++++.+++|+||++++++|.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999875 688899998865432 2235688999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++++|.+++.. ...+++..+..++.|+++||+|||+.. +++||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999953 356899999999999999999999742 39999999999999999999999999987654322
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccc----------
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTRE---------- 602 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~---------- 602 (780)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 2335688999999999888899999999999999999999999865432211111100000000000
Q ss_pred ------ccccccCCccC---CCCC-hhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 603 ------GLEQLVDPSLA---GSYD-FDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 603 ------~l~~lvDp~L~---~~~~-~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
...++.+.... ...+ ......+.+++.+|++.+|++||++.||++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000000000 0000 01224588999999999999999999997753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=323.10 Aligned_cols=265 Identities=27% Similarity=0.402 Sum_probs=207.6
Q ss_pred ccchHHHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeee
Q 048425 364 TFALSDLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICI 441 (780)
Q Consensus 364 ~f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~ 441 (780)
.+.++++..+.++|+..+.||+|+||.||++... +++.+|+|+++... ....++.+|+.+++++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred eEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 3555677778899999999999999999999875 68899999886432 2346788999999999 6999999999984
Q ss_pred -----ecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC
Q 048425 442 -----EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT 516 (780)
Q Consensus 442 -----~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~ 516 (780)
.++..++||||+++++|.++++........+++..+..++.|++.||.|||+.+ |+||||||+||++++++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCC
Confidence 345689999999999999988654344567899999999999999999999987 999999999999999999
Q ss_pred CeeecccccccccCCCccceeccccCccccCchhhcc-----CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhh
Q 048425 517 PKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV 591 (780)
Q Consensus 517 vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~-----~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv 591 (780)
+||+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.|+....+. ..+.
T Consensus 163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~--~~~~ 239 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM--RALF 239 (286)
T ss_pred EEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh--HHHh
Confidence 99999999987643321 1233468999999998753 45788999999999999999999998654321 1111
Q ss_pred hhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 592 TWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 592 ~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.+. .. ....+.++. .....+.+++.+|++.+|++||++.||++.
T Consensus 240 ~~~----~~--~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 KIP----RN--PPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hcc----cc--CCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 100 00 000111111 112468899999999999999999999764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=324.38 Aligned_cols=258 Identities=27% Similarity=0.469 Sum_probs=204.3
Q ss_pred hcCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeeccee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTR 446 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 446 (780)
.++|+..+.||+|+||.||++..+ ++..||+|++..... ...++|.+|++++++++|+||++++++|.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999864 467899999875432 2346799999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhccccc------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcc
Q 048425 447 CLVYELVHNGSVESHLHGVD------------------KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASN 508 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~------------------~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsN 508 (780)
++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999996321 11235889999999999999999999987 9999999999
Q ss_pred eEEcCCCCCeeecccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccc
Q 048425 509 VLLEDDFTPKVSDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQG 586 (780)
Q Consensus 509 ILLd~~~~vKLsDFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~ 586 (780)
|++++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999986543221 11122335678999999999999999999999999999998 88888543221
Q ss_pred cchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048425 587 QENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651 (780)
Q Consensus 587 ~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~ 651 (780)
.+.... . +.... ..+......+.+++.+|++.+|++||++.|+++.|++
T Consensus 240 --~~~~~~---~----------~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 --EVIYYV---R----------DGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HHHHHH---h----------cCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111111 0 00000 0111233578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.74 Aligned_cols=250 Identities=30% Similarity=0.501 Sum_probs=203.7
Q ss_pred eeecccCceEEEEEEEeC----CcEEEEEEeeccCCcc-hHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMDN----GTEVAVKLLTRNNQNG-DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~----g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
+.||+|+||.||+|...+ +..|++|.++...... .+.+.+|++++++++|+||+++++++.++...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999864 7889999997664433 57899999999999999999999999999999999999999
Q ss_pred CChhhhcccccCC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 456 GSVESHLHGVDKN-----RGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 456 GSL~~~L~~~~~~-----~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
++|.+++...... ...+++.++++++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999753221 467999999999999999999999987 99999999999999999999999999988765
Q ss_pred CCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 531 GSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 531 ~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
... .......++..|+|||.+....++.++||||||++++||++ |+.||...... .+..... . ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~---~-~~------ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLEYLR---K-GY------ 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHH---c-CC------
Confidence 321 12234557889999999998899999999999999999999 68998754321 1111110 0 00
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
. ..........+.+++.+|++.+|++||++.|+++.|+
T Consensus 225 ~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 R----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred C----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 0111122357889999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=339.44 Aligned_cols=265 Identities=25% Similarity=0.341 Sum_probs=199.4
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecc-----eeE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGR-----TRC 447 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~~ 447 (780)
+|+..+.||+|+||.||++... +|+.||||++.... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999964 78999999986532 223467889999999999999999999998766 789
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+|+||+. ++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 57777773 3457999999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccc--ccc----c
Q 048425 528 ATEGSQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARP--LLT----T 600 (780)
Q Consensus 528 ~~~~~~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~--ll~----~ 600 (780)
.........+...+|..|+|||++.+. .++.++|||||||++|||++|+.||....+..+...+..... ... .
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 644333233445688999999998774 578999999999999999999999976543322111100000 000 0
Q ss_pred cccccccc-----C-CccCC--CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 601 REGLEQLV-----D-PSLAG--SYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 601 ~~~l~~lv-----D-p~L~~--~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.......+ . +.... ....+....+.+++.+|++.||++||++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000 0 00000 0111223567899999999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.93 Aligned_cols=263 Identities=25% Similarity=0.419 Sum_probs=206.6
Q ss_pred hcCcccceeecccCceEEEEEEEe--------CCcEEEEEEeeccCC-cchHHHHHHHHHhhhc-CCCceeeeeeeeeec
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD--------NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRL-HHRNLVKLIGICIEG 443 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~--------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~ 443 (780)
.++|...+.||+|+||.||++... ....||+|+++.... ....++.+|+++++++ +|+||++++++|..+
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 367888899999999999999742 245799999875432 2345789999999999 699999999999988
Q ss_pred ceeEEEEeecCCCChhhhcccccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDK------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL 511 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL 511 (780)
+..++||||+++|+|.+++..... ....++|.++++++.|++.||+|||+.+ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 899999999999999999964221 2346899999999999999999999987 9999999999999
Q ss_pred cCCCCCeeecccccccccCCCccc-eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccch
Q 048425 512 EDDFTPKVSDFGLAREATEGSQHI-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQEN 589 (780)
Q Consensus 512 d~~~~vKLsDFGLA~~~~~~~~~~-~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~ 589 (780)
++++.+||+|||+++......... .....++..|+|||.+.++.++.++|||||||++|||++ |+.||...... .
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~ 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---E 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---H
Confidence 999999999999998765322111 112234567999999999999999999999999999999 88888643321 1
Q ss_pred hhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 590 LVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 590 Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
+.... ..... ..........+.+++.+|++.+|++||++.|+++.|+.+....
T Consensus 245 ~~~~~----~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 245 LFKLL----REGHR----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHHH----HcCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 11110 00000 0111223346789999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=341.10 Aligned_cols=251 Identities=21% Similarity=0.315 Sum_probs=196.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||+||++... +|+.||||++.+.. ....+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47888999999999999999865 78999999986542 223456889999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++. ....+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999985 3456889999999999999999999998 99999999999999999999999999964321
Q ss_pred CCc------------c----------------------------------ceeccccCccccCchhhccCCCCchhhHHh
Q 048425 531 GSQ------------H----------------------------------ISTRVMGTFGYVAPEYAMTGHLLVKSDVYS 564 (780)
Q Consensus 531 ~~~------------~----------------------------------~~t~~~GT~~Y~APE~l~~~~~t~ksDVyS 564 (780)
... . ......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 100 0 001246999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcccc-chhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCC---C
Q 048425 565 YGVVLLELLSGRKPVDMSQPQGQ-ENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHR---P 640 (780)
Q Consensus 565 fGVvLlELlTGr~P~~~~~~~~~-~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~R---P 640 (780)
|||+||||+||+.||....+... ..+..|... +. + + .. ......+.+++..|++ +|.+| +
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------~~-~--p---~~--~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWRET-------LY-F--P---DD--IHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc-------cC-C--C---CC--CCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 99999999999999975443211 111111100 00 0 0 00 0112456788899997 66665 5
Q ss_pred CHHHHHHH
Q 048425 641 FMGEVVQA 648 (780)
Q Consensus 641 sm~EVv~~ 648 (780)
++.|+++.
T Consensus 298 ~~~~~l~h 305 (377)
T cd05629 298 GAHEIKSH 305 (377)
T ss_pred CHHHHhcC
Confidence 88888653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=332.47 Aligned_cols=238 Identities=26% Similarity=0.350 Sum_probs=192.4
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
++||+|+||+||+|+.+ +++.||||++++.. ....+.+..|++++..+ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 68899999997542 23345678899999876 699999999999999999999999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~ 152 (320)
T cd05590 81 GDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-T 152 (320)
T ss_pred chHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-c
Confidence 99999885 3356899999999999999999999998 99999999999999999999999999886433222 2
Q ss_pred eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCC
Q 048425 536 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGS 615 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~ 615 (780)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .+.... . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~---~i~~~~-----~-------~ 214 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLFE---AILNDE-----V-------V 214 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHH---HHhcCC-----C-------C
Confidence 23457999999999999999999999999999999999999999754321 1111 111110 0 0
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCCHHH
Q 048425 616 YDFDDMAKVAAIASMCVHPEVTHRPFMGE 644 (780)
Q Consensus 616 ~~~ee~~~l~~La~~Cl~~dP~~RPsm~E 644 (780)
++......+.+++.+|++.||++||++.+
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 11112246788999999999999999843
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=332.83 Aligned_cols=241 Identities=23% Similarity=0.331 Sum_probs=193.7
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
++||+|+||.||+|... +|+.||||+++... ....+.+..|.+++..+ +|+||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 57899999997642 23345678899999876 799999999999999999999999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 81 GDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence 99999885 3456899999999999999999999998 99999999999999999999999999986433221 2
Q ss_pred eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCC
Q 048425 536 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGS 615 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~ 615 (780)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .+.... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~---~i~~~~-----~~------- 214 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFE---SILHDD-----VL------- 214 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHH---HHHcCC-----CC-------
Confidence 23457999999999999999999999999999999999999999754322 1111 111100 00
Q ss_pred CChhhHHHHHHHHHHccccCCCCCC-------CHHHHHH
Q 048425 616 YDFDDMAKVAAIASMCVHPEVTHRP-------FMGEVVQ 647 (780)
Q Consensus 616 ~~~ee~~~l~~La~~Cl~~dP~~RP-------sm~EVv~ 647 (780)
++......+.+++..|++.+|++|| ++.++++
T Consensus 215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 0111124678899999999999999 6666653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.54 Aligned_cols=254 Identities=27% Similarity=0.388 Sum_probs=193.6
Q ss_pred eeecccCceEEEEEEEeC---CcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCC
Q 048425 381 RILGEGGFGCVYHGVMDN---GTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNG 456 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~---g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~G 456 (780)
+.||+|+||.||+|...+ +..+|+|.++.... .....|.+|+.++++++|+||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 359999999999998643 45799998865543 23357899999999999999999999999988999999999999
Q ss_pred ChhhhcccccC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc-
Q 048425 457 SVESHLHGVDK-NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH- 534 (780)
Q Consensus 457 SL~~~L~~~~~-~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~- 534 (780)
+|.++++.... ....+++..+.+++.|+++||+|||+.+ ++||||||+||++++++++||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999974322 2335778888999999999999999988 999999999999999999999999999765433221
Q ss_pred ceeccccCccccCchhhccC-------CCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccc
Q 048425 535 ISTRVMGTFGYVAPEYAMTG-------HLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~-------~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
......|+..|+|||++.+. .++.++||||||+++|||++ |+.||....... ...+. . ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~---~--~~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYT---V--REQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH---h--hcccCC
Confidence 12334578889999988642 35789999999999999996 999996543221 11110 0 001111
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
+.++.+.. .....+.+++..|+ .+|++||+++||++.|+
T Consensus 230 ~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22222221 12235677889998 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.51 Aligned_cols=258 Identities=26% Similarity=0.442 Sum_probs=205.8
Q ss_pred cCcccceeecccCceEEEEEEEe-CCc----EEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGT----EVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~----~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
.+|...+.||+|+||.||+|... +|. .||+|.+..... ....++.+|++++++++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56777899999999999999865 343 589998866543 234678999999999999999999999987 78899
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||+++|+|.+++.. ....+++..+++++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 9999999999999963 3446999999999999999999999987 999999999999999999999999999876
Q ss_pred cCCCccce-eccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccc
Q 048425 529 TEGSQHIS-TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 529 ~~~~~~~~-t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
........ ....++..|+|||.+....++.++||||||+++|||++ |+.||+..... .+..... . .. .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~---~-~~---~ 229 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDLLE---K-GE---R 229 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHh---C-CC---C
Confidence 54332211 12224568999999998899999999999999999999 99999754322 1111111 0 00 0
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
. ..+......+.+++.+||..+|++||++.++++.|+.+..+.
T Consensus 230 ~-------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 230 L-------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred C-------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 0 011112246788999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.59 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=203.6
Q ss_pred cCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 447 (780)
++|...+.||+|+||.||+|+.+ +...|++|.+...... ..++|.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888899999999999999864 3467999988654433 3467999999999999999999999999988999
Q ss_pred EEEeecCCCChhhhcccccCC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecc
Q 048425 448 LVYELVHNGSVESHLHGVDKN-----RGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDF 522 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~-----~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDF 522 (780)
+||||+++|+|.+++...... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999643211 126899999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccc
Q 048425 523 GLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTR 601 (780)
Q Consensus 523 GLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~ 601 (780)
|+++..............++..|+|||.+.+...+.++||||||+++|||++ |..||..... ..++....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~~~------ 232 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNRLQ------ 232 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHHHH------
Confidence 9987654322222233456778999999998889999999999999999999 7778853221 11111110
Q ss_pred cccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 602 EGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 602 ~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
...+...........+.+++.+|++.+|++||++.|++..|+
T Consensus 233 -------~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 -------AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -------cCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000000011123357889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.04 Aligned_cols=237 Identities=26% Similarity=0.484 Sum_probs=190.1
Q ss_pred eeecccCceEEEEEEEeCCc-----------EEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 381 RILGEGGFGCVYHGVMDNGT-----------EVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~g~-----------~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
+.||+|+||.||+|.+.+.. .|++|.+...... ...|.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999986433 5788887655433 6789999999999999999999999988 778999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC-------CCeeecc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF-------TPKVSDF 522 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~-------~vKLsDF 522 (780)
|||+++|+|.+++.. ....+++..+++++.|++.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHR---EKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 999999999999963 2337899999999999999999999987 99999999999999888 7999999
Q ss_pred cccccccCCCccceeccccCccccCchhhccC--CCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccc
Q 048425 523 GLAREATEGSQHISTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLT 599 (780)
Q Consensus 523 GLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~--~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~ 599 (780)
|++...... ....++..|+|||++... .++.++|||||||++|||++ |..|+......... .+..
T Consensus 153 g~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~---~~~~---- 220 (259)
T cd05037 153 GIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE---RFYQ---- 220 (259)
T ss_pred Ccccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH---HHHh----
Confidence 999876441 223467789999998876 78999999999999999999 56677543221111 1100
Q ss_pred cccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 600 TREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 600 ~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
.. . .........+.+++.+|++.+|.+||++.||++.|
T Consensus 221 ~~---~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 DQ---H---------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred cC---C---------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00 0 00111125788999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=313.58 Aligned_cols=263 Identities=25% Similarity=0.350 Sum_probs=205.5
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
.+|...+.||+|.||.||+|+. .+|+.||||+++..+.. ......+||+.|+.++|+||+.|+++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4577778999999999999996 48999999999765432 23568999999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
||+. +|+..+. .+...|+-.+...++.++.+||+|||.+. |+||||||.|+|++++|.+||+|||+|+.+...
T Consensus 82 fm~t-dLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9964 8888886 35668999999999999999999999998 999999999999999999999999999998754
Q ss_pred CccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccc----cccccc---
Q 048425 532 SQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL----LTTREG--- 603 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~l----l~~~~~--- 603 (780)
... .+..+-|.+|.|||.+.+ +.|+...||||.||++.||+-|..-|.+...-+| +....+.+ .+....
T Consensus 155 ~~~-~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ--L~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 155 NRI-QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ--LSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred Ccc-cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH--HHHHHHHcCCCCcccCccccc
Confidence 433 233367999999998876 5789999999999999999999876655443322 22111111 111111
Q ss_pred ------cccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 604 ------LEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 604 ------l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
+.....+.+..-++ ......++++..++..||.+|.++.|++++
T Consensus 232 lpdY~~~~~~P~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccHHHHhcCCCCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 12222222222121 233456899999999999999999998653
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.16 Aligned_cols=238 Identities=24% Similarity=0.337 Sum_probs=193.6
Q ss_pred eeecccCceEEEEEEE----eCCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 381 RILGEGGFGCVYHGVM----DNGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l----~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
+.||+|+||.||++.. .+|+.||+|+++.... .....+..|++++++++|+||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 3688999999976432 233457889999999999999999999999999999999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 999999985 3456899999999999999999999998 99999999999999999999999999986544322
Q ss_pred ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCC
Q 048425 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAG 614 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~ 614 (780)
......||..|+|||.+.+..++.++|||||||++|||++|+.||...... .... .+.... .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~---~i~~~~----------~-- 215 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMT---MILKAK----------L-- 215 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHHH---HHHcCC----------C--
Confidence 223467999999999999888999999999999999999999999754321 1111 011100 0
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHHH
Q 048425 615 SYDFDDMAKVAAIASMCVHPEVTHRPFMGE 644 (780)
Q Consensus 615 ~~~~ee~~~l~~La~~Cl~~dP~~RPsm~E 644 (780)
..+......+.+++.+|++.||++||++.+
T Consensus 216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 011112246778999999999999999766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.52 Aligned_cols=238 Identities=25% Similarity=0.427 Sum_probs=188.5
Q ss_pred eecccCceEEEEEEEeC-------------------------CcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeee
Q 048425 382 ILGEGGFGCVYHGVMDN-------------------------GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKL 436 (780)
Q Consensus 382 ~LG~G~fG~VYkg~l~~-------------------------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L 436 (780)
.||+|+||.||+|.+.. ...|++|++.........+|.+|++++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999998521 13589999866544445679999999999999999999
Q ss_pred eeeeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC-
Q 048425 437 IGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF- 515 (780)
Q Consensus 437 ~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~- 515 (780)
+++|.++...++||||+++|+|..++.. ....+++..+++++.|+++||+|||+.+ |+||||||+|||+++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999852 3457899999999999999999999987 99999999999998654
Q ss_pred ------CCeeecccccccccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHH-hCCCCCCCCCcccc
Q 048425 516 ------TPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELL-SGRKPVDMSQPQGQ 587 (780)
Q Consensus 516 ------~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELl-TGr~P~~~~~~~~~ 587 (780)
.+|++|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|+.|+....+...
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999998654322 12347788999998875 56899999999999999995 68988865432211
Q ss_pred chhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 588 ENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 588 ~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
. .+. .... .+ .......+.+++.+||+.+|++||+|.+|++.|
T Consensus 231 ~---~~~----~~~~--------~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 E---RFY----EKKH--------RL----PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred H---HHH----Hhcc--------CC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1 110 0000 00 011123678999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.68 Aligned_cols=239 Identities=22% Similarity=0.422 Sum_probs=189.6
Q ss_pred eeecccCceEEEEEEEeC-------------CcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeE
Q 048425 381 RILGEGGFGCVYHGVMDN-------------GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~-------------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 447 (780)
+.||+|+||.||+|++.+ ...|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 369999999999998532 2358999886655555567899999999999999999999999988999
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC-------Ceee
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT-------PKVS 520 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~-------vKLs 520 (780)
+||||+++|+|..+++. ....+++..+++++.||+.||+|||+.+ |+||||||+|||++.++. +|++
T Consensus 81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999998852 3456999999999999999999999987 999999999999987664 8999
Q ss_pred cccccccccCCCccceeccccCccccCchhhc-cCCCCchhhHHhHHHHHHHHH-hCCCCCCCCCccccchhhhhccccc
Q 048425 521 DFGLAREATEGSQHISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELL-SGRKPVDMSQPQGQENLVTWARPLL 598 (780)
Q Consensus 521 DFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~-~~~~t~ksDVySfGVvLlELl-TGr~P~~~~~~~~~~~Lv~wa~~ll 598 (780)
|||++...... ....|+..|+|||++. +..++.++|||||||++|||+ +|+.|+........... .
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-------~ 222 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-------Y 222 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-------H
Confidence 99998765432 2235788999999887 467899999999999999998 58888754321111000 0
Q ss_pred ccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 599 TTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 599 ~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
..... ........+.+++..||+.||++||++.+|++.|
T Consensus 223 ----------~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 ----------EGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ----------hcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00000 0111234678999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.04 Aligned_cols=239 Identities=25% Similarity=0.360 Sum_probs=192.1
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
+.||+|+||+||+|... +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 57899999997642 23345577788888764 899999999999999999999999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
|+|.+++. ....+++.+...++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 99999985 3356899999999999999999999998 99999999999999999999999999976432221 2
Q ss_pred eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCC
Q 048425 536 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGS 615 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~ 615 (780)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...... .+...+. . ..+.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i~---~--------~~~~~~~- 217 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSIR---M--------DNPCYPR- 217 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHH---h--------CCCCCCc-
Confidence 23457999999999999999999999999999999999999999754321 1111110 0 0111111
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCCHH-HH
Q 048425 616 YDFDDMAKVAAIASMCVHPEVTHRPFMG-EV 645 (780)
Q Consensus 616 ~~~ee~~~l~~La~~Cl~~dP~~RPsm~-EV 645 (780)
.....+.+++.+|++.+|++||++. ++
T Consensus 218 ---~~~~~~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 218 ---WLTREAKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred ---cCCHHHHHHHHHHhccCHhhcCCChHHH
Confidence 1224577899999999999999997 44
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=341.61 Aligned_cols=246 Identities=27% Similarity=0.407 Sum_probs=209.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcc--hHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNG--DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
++|...+.||+|.||+||||+-+ +++.||+|.+.+..... .+...+|++++++++|||||.+++.|....+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57788899999999999999975 68899999987654432 3568899999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+.+ +|..+|. ..+.|+......|+.++..||.|||+.. |+|||+||.|||++.++++|++|||+|+.+..+
T Consensus 82 ~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9977 9999994 5678999999999999999999999997 999999999999999999999999999988764
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
..+-+.+.||+-|||||...++.|+..+|.||+||+|||+.+|+.||... ++...++.+..+ +.
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d---------~v 217 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKD---------PV 217 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcC---------CC
Confidence 44567889999999999999999999999999999999999999999642 222222222221 11
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 612 L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.++.+....+..++...+.+||.+|.+-.+++.
T Consensus 218 ---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 ---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ---CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 122244457888999999999999999988865
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.26 Aligned_cols=246 Identities=25% Similarity=0.389 Sum_probs=196.7
Q ss_pred cccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 377 FSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
|+..+.||+|+||+||+|... +|+.||+|.+..... .....+.+|++++++++|+||+.+.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999875 789999999865432 2234578899999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++++|.+++.. .....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999998863 23346999999999999999999999988 9999999999999999999999999997654332
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ...+........
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~~~~~~----------- 221 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRRVLETE----------- 221 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhhhccc-----------
Confidence 2 1335689999999999999999999999999999999999999975432111 111110000000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMG 643 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~ 643 (780)
..+.......+.+++..|++.+|++||++.
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 222 -EVYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred -cccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 011112234678899999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=340.00 Aligned_cols=250 Identities=23% Similarity=0.302 Sum_probs=194.8
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
.+|+..+.||+|+||.||+++.. +|+.||||++.+.. ......+.+|++++++++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999865 68999999986532 223456889999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++.. ...++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|..+..
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999953 456888999999999999999999998 99999999999999999999999999853210
Q ss_pred C------------------------------------------CccceeccccCccccCchhhccCCCCchhhHHhHHHH
Q 048425 531 G------------------------------------------SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV 568 (780)
Q Consensus 531 ~------------------------------------------~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVv 568 (780)
. .........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 0 0000123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCccccc-hhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCC---CHHH
Q 048425 569 LLELLSGRKPVDMSQPQGQE-NLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRP---FMGE 644 (780)
Q Consensus 569 LlELlTGr~P~~~~~~~~~~-~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RP---sm~E 644 (780)
||||++|+.||....+.... .+..|... ...+. .......+.+++.+|+ .+|.+|+ ++.|
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~~~----------~~~~~-----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWETT----------LHIPS-----QAKLSREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccCcc----------ccCCC-----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 99999999999765432211 11111100 00000 0111234555666665 4999999 7787
Q ss_pred HHH
Q 048425 645 VVQ 647 (780)
Q Consensus 645 Vv~ 647 (780)
+++
T Consensus 298 ll~ 300 (376)
T cd05598 298 IKA 300 (376)
T ss_pred HhC
Confidence 754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=316.77 Aligned_cols=265 Identities=25% Similarity=0.310 Sum_probs=202.0
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
++|+..+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999986 689999999865432 234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++++|..++. ....++|..++.++.|++.||+|||+.+ |+||||||+||++++++++||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999998888763 3346899999999999999999999987 999999999999999999999999999876543
Q ss_pred CccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc-hhhhhccccc-------cccc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE-NLVTWARPLL-------TTRE 602 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~-~Lv~wa~~ll-------~~~~ 602 (780)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+.. .+........ ....
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 32 1223457889999999876 55789999999999999999999999754432111 0111000000 0000
Q ss_pred ccccccCCccCCCCCh-----hhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 603 GLEQLVDPSLAGSYDF-----DDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~-----ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
....+..+......+. .....+.+++.+|++.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0011111111111111 12356789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=321.60 Aligned_cols=264 Identities=28% Similarity=0.402 Sum_probs=209.1
Q ss_pred ccchHHHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeee
Q 048425 364 TFALSDLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICI 441 (780)
Q Consensus 364 ~f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~ 441 (780)
.++++++..++++|...+.||+|+||.||++... +++.+|+|++.... ....++.+|+.++.++ +|+||+++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 4667788888999999999999999999999874 78899999986532 2346788899999999 8999999999987
Q ss_pred ec-----ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC
Q 048425 442 EG-----RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT 516 (780)
Q Consensus 442 ~~-----~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~ 516 (780)
.. +..++||||+++|+|.++++........+++..++.++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 54 3579999999999999998654344567999999999999999999999987 999999999999999999
Q ss_pred CeeecccccccccCCCccceeccccCccccCchhhccC-----CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhh
Q 048425 517 PKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG-----HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV 591 (780)
Q Consensus 517 vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~-----~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv 591 (780)
+||+|||++......... .....|+..|+|||++..+ .++.++|||||||++|||++|+.|+....+. ..+.
T Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~ 243 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLF 243 (291)
T ss_pred EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHH
Confidence 999999999876543221 1234688999999987654 3688999999999999999999998653321 1111
Q ss_pred hhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 592 TWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 592 ~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+.+. ....+.+ ..+....+.+++.+|++.+|++||++.|+++
T Consensus 244 ~~~~~------~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 KIPRN------PPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHhcC------CCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11100 0001111 1122346889999999999999999999865
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=320.08 Aligned_cols=266 Identities=24% Similarity=0.339 Sum_probs=204.2
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
++|+..+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999976 68899999986543 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|++++.+..++. ....+++.++..++.+++.||+|||+.+ ++||||+++||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999877776653 3456899999999999999999999998 999999999999999999999999999887654
Q ss_pred CccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-hhhhccccc-------cccc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LVTWARPLL-------TTRE 602 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-Lv~wa~~ll-------~~~~ 602 (780)
.........++..|+|||++.+. .++.++||||||+++|||++|+.||......+... +..+..... ....
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 43233446688999999999888 88999999999999999999999987543221100 000000000 0000
Q ss_pred -----ccccccCCc-cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 603 -----GLEQLVDPS-LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 603 -----~l~~lvDp~-L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+....++. +...+.......+.+++.+||+.+|++||++++|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000000 000111122467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=330.89 Aligned_cols=244 Identities=22% Similarity=0.297 Sum_probs=192.8
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
++||+|+||+||++... +++.||||+++.... ...+.+.+|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 678999999976532 2335688999999888 699999999999999999999999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (327)
T cd05617 81 GDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-T 152 (327)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-c
Confidence 99998884 3356999999999999999999999998 99999999999999999999999999985432221 2
Q ss_pred eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCC
Q 048425 536 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGS 615 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~ 615 (780)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||+............+..... ..... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------~~~~~--~ 221 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI---------LEKPI--R 221 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH---------HhCCC--C
Confidence 234679999999999999999999999999999999999999996433221111111111110 01000 1
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCCHH
Q 048425 616 YDFDDMAKVAAIASMCVHPEVTHRPFMG 643 (780)
Q Consensus 616 ~~~ee~~~l~~La~~Cl~~dP~~RPsm~ 643 (780)
.+......+.+++.+|++.||++|+++.
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 1112234678999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.72 Aligned_cols=236 Identities=26% Similarity=0.361 Sum_probs=191.7
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
+.||+|+||+||++... +++.||||++++.. ......+..|++++..+ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 57899999997642 23345678899999888 799999999999999999999999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (318)
T cd05570 81 GDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T 152 (318)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence 99998885 3457999999999999999999999998 99999999999999999999999999976432222 1
Q ss_pred eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCC
Q 048425 536 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGS 615 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~ 615 (780)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .+.... . .
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~---~i~~~~--------~----~ 214 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQ---SILEDE--------V----R 214 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHH---HHHcCC--------C----C
Confidence 23456999999999999999999999999999999999999999754321 1111 011000 0 0
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCCH
Q 048425 616 YDFDDMAKVAAIASMCVHPEVTHRPFM 642 (780)
Q Consensus 616 ~~~ee~~~l~~La~~Cl~~dP~~RPsm 642 (780)
++......+.+++.+||+.||++||++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCC
Confidence 111223467899999999999999999
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=315.00 Aligned_cols=248 Identities=25% Similarity=0.450 Sum_probs=199.6
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcc---------hHHHHHHHHHhhhcCCCceeeeeeeeeecce
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNG---------DREFIAEVEMLSRLHHRNLVKLIGICIEGRT 445 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~---------~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 445 (780)
+|...+.||+|+||.||+|... +++.||+|.+....... .+.+.+|++++++++|+||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999864 68899999886543321 1458889999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccc
Q 048425 446 RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA 525 (780)
.++||||+++++|.+++. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999995 3356899999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCcc-----ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccc
Q 048425 526 REATEGSQH-----ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTT 600 (780)
Q Consensus 526 ~~~~~~~~~-----~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~ 600 (780)
+........ ......|+..|+|||++.+..++.++||||||+++|||++|+.||...... ..+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~-------- 223 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAIFK-------- 223 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HHHHH--------
Confidence 877532111 112345888999999999989999999999999999999999999753211 10000
Q ss_pred ccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 601 REGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 601 ~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
......+.+ +......+.+++.+||+.+|++||++.||++
T Consensus 224 ---~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 ---IGENASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---HhccCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000111111 1223357789999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=331.23 Aligned_cols=238 Identities=25% Similarity=0.334 Sum_probs=190.1
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHH-HhhhcCCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVE-MLSRLHHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~-iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
++||+|+||+||+|... +|+.||||++.... ....+++..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 78999999997542 222345556655 56789999999999999999999999999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
|+|.+++. ....+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 99999885 3457899999999999999999999998 9999999999999999999999999997643322 22
Q ss_pred eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCC
Q 048425 536 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGS 615 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~ 615 (780)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+ ...+.... ..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~---~~~i~~~~--------~~~~-- 216 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EM---YDNILNKP--------LRLK-- 216 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH---HH---HHHHHcCC--------CCCC--
Confidence 34457999999999999999999999999999999999999999653321 11 11111100 0111
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCCHHH
Q 048425 616 YDFDDMAKVAAIASMCVHPEVTHRPFMGE 644 (780)
Q Consensus 616 ~~~ee~~~l~~La~~Cl~~dP~~RPsm~E 644 (780)
......+.+++.+|++.+|++||++.+
T Consensus 217 --~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 217 --PNISVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred --CCCCHHHHHHHHHHhhcCHHhCCCCCC
Confidence 112356789999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=325.25 Aligned_cols=265 Identities=22% Similarity=0.326 Sum_probs=198.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|...+.||+|+||+||+|..+ +++.||+|+++.... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888899999999999999875 678899999875533 2335688999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++ +|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 88888753 3446899999999999999999999988 9999999999999999999999999998654322
Q ss_pred ccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcc--------cccccccc
Q 048425 533 QHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWAR--------PLLTTREG 603 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~--------~ll~~~~~ 603 (780)
. ......+|..|+|||.+.+ ..++.++|||||||++|||+||+.||......+......... +.......
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 2 1223457899999998865 567899999999999999999999997554322111110000 00000000
Q ss_pred cccccCCccCC----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 604 LEQLVDPSLAG----SYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 604 l~~lvDp~L~~----~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
....-.+.... .........+.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000 000112245679999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=339.39 Aligned_cols=201 Identities=25% Similarity=0.326 Sum_probs=173.3
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
+|+..+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++|+||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999874 68899999997543 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999853 346888999999999999999999998 999999999999999999999999998533100
Q ss_pred C----------------------------------------------ccceeccccCccccCchhhccCCCCchhhHHhH
Q 048425 532 S----------------------------------------------QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSY 565 (780)
Q Consensus 532 ~----------------------------------------------~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySf 565 (780)
. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000123569999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 048425 566 GVVLLELLSGRKPVDMSQ 583 (780)
Q Consensus 566 GVvLlELlTGr~P~~~~~ 583 (780)
||+||||++|+.||....
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (382)
T cd05625 235 GVILYEMLVGQPPFLAQT 252 (382)
T ss_pred hHHHHHHHhCCCCCCCCC
Confidence 999999999999997544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=324.89 Aligned_cols=258 Identities=27% Similarity=0.457 Sum_probs=203.6
Q ss_pred cCcccceeecccCceEEEEEEEe-CCc----EEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGT----EVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~----~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
++|+..+.||+|+||.||+|.+. +|. .||+|.+...... ...+|.+|+.++++++|+||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 56777789999999999999864 444 4788988654332 234789999999999999999999999754 5679
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
++||+++|+|.+++.. ....+++..+++++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 9999999999999863 3446899999999999999999999987 999999999999999999999999999876
Q ss_pred cCCCccc-eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccc
Q 048425 529 TEGSQHI-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 529 ~~~~~~~-~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
....... .....++..|+|||++.+..++.++|||||||++|||++ |+.|+..... ..+..+.. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~~~----~~~~--- 229 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDLLE----KGER--- 229 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH----CCCC---
Confidence 5432211 223345778999999999999999999999999999998 8999864322 12222211 1100
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
... .......+.+++..||..+|++||++.|+++.|+.+..+.
T Consensus 230 ~~~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 230 LPQ-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred CCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 000 1112346789999999999999999999999999886653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=313.14 Aligned_cols=265 Identities=23% Similarity=0.337 Sum_probs=215.9
Q ss_pred hcCcccceeecccCceEEEEEE-EeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecc-----eeE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGR-----TRC 447 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~-l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~~ 447 (780)
.++|++.++||+|||..||.++ +.++..+|+|++.-...++.+..++|++..++++|||++++++++..+. +.+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3688999999999999999998 5688999999998877777888999999999999999999999986544 489
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
|+++|...|||.+.+.....+...++..+.++|+.+|.+||++||+.. |+++||||||.|||+.+++.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999999876667778999999999999999999999984 7899999999999999999999999999987
Q ss_pred ccCCCcc--------ceeccccCccccCchhhc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccc
Q 048425 528 ATEGSQH--------ISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARP 596 (780)
Q Consensus 528 ~~~~~~~--------~~t~~~GT~~Y~APE~l~---~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ 596 (780)
..-.... .......|..|.|||.+. +...++++|||||||+||+|+.|..||+....++. ++.
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-Sla----- 252 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-SLA----- 252 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-eEE-----
Confidence 6422110 012234789999999885 45678999999999999999999999986544322 111
Q ss_pred ccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 048425 597 LLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIY 653 (780)
Q Consensus 597 ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~ 653 (780)
-.+..+.+.-.-+....+.+.+++.+|++.||.+||++.|++..++.+.
T Consensus 253 --------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 --------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 0111111111111124468999999999999999999999999988764
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=328.82 Aligned_cols=263 Identities=26% Similarity=0.405 Sum_probs=206.7
Q ss_pred cCcccceeecccCceEEEEEEEe--------CCcEEEEEEeeccCC-cchHHHHHHHHHhhhc-CCCceeeeeeeeeecc
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD--------NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRL-HHRNLVKLIGICIEGR 444 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~--------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~ 444 (780)
.+|...+.||+|+||.||++... ++..||+|.++.... ...+++.+|+++++++ +|+||++++++|.+++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888899999999999999742 123689998875432 2346799999999999 8999999999999999
Q ss_pred eeEEEEeecCCCChhhhccccc------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc
Q 048425 445 TRCLVYELVHNGSVESHLHGVD------------KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE 512 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~------------~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd 512 (780)
..++||||+++|+|.+++.... .....++|.++++++.|++.||+|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986421 12346899999999999999999999988 99999999999999
Q ss_pred CCCCCeeecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchh
Q 048425 513 DDFTPKVSDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENL 590 (780)
Q Consensus 513 ~~~~vKLsDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~L 590 (780)
+++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----- 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----- 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----
Confidence 9999999999999876443211 1122334567999999999999999999999999999999 88888643221
Q ss_pred hhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 591 VTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 591 v~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
++...+.. .. ...........+.+++.+|++.+|++||+|.|+++.|+.+.....
T Consensus 244 -~~~~~~~~-~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 244 -ELFKLLKE-GH----------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred -HHHHHHHc-CC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 11111110 00 001112233578899999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=329.21 Aligned_cols=240 Identities=25% Similarity=0.356 Sum_probs=192.5
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
++||+|+||.||+|... +|+.||||+++... ....+.+..|..++..+ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 68899999997642 22345677788888764 899999999999999999999999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
|+|.+++. ....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05620 81 GDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-R 152 (316)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-c
Confidence 99999885 3456899999999999999999999998 99999999999999999999999999875432221 2
Q ss_pred eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCC
Q 048425 536 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGS 615 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~ 615 (780)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...... .+... +.. ..+.+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~---~~~--------~~~~~~-- 216 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFES---IRV--------DTPHYP-- 216 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHH---HHh--------CCCCCC--
Confidence 34567999999999999999999999999999999999999999754321 11110 000 011111
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCCHH-HHH
Q 048425 616 YDFDDMAKVAAIASMCVHPEVTHRPFMG-EVV 646 (780)
Q Consensus 616 ~~~ee~~~l~~La~~Cl~~dP~~RPsm~-EVv 646 (780)
......+.+++.+|++.||++||++. ++.
T Consensus 217 --~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 --RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11224678899999999999999984 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.75 Aligned_cols=265 Identities=24% Similarity=0.356 Sum_probs=201.6
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
++|+..+.||+|+||.||+|..+ +++.||+|++...... ..+.+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999986 5899999998654332 34578899999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++++|.++.. ....++|.+++.++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999999988764 2345899999999999999999999987 999999999999999999999999999876443
Q ss_pred CccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCcccc-chhhhhcccccccc-------c
Q 048425 532 SQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ-ENLVTWARPLLTTR-------E 602 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~-~~Lv~wa~~ll~~~-------~ 602 (780)
. ...+...++..|+|||++.+ ..++.++||||||+++|||++|+.||........ ..+..+...+.... .
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 3 22234568899999999875 4578899999999999999999998864332110 01111111111000 0
Q ss_pred ccccccCCccCCCC-----ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 603 GLEQLVDPSLAGSY-----DFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 603 ~l~~lvDp~L~~~~-----~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.......+...... .......+.+++.+||+.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000111110000 0122356889999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=319.77 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=198.4
Q ss_pred cccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCC
Q 048425 377 FSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
|+..+.||+|+||.||+|... ++..+++|.+........+.|.+|+++++.++|+||+++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456688999999999999976 5788999998665544556799999999999999999999999999999999999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
++|.+++.. ...++++..+..++.|++.||+|||+.+ |+||||||+||+++.++++||+|||++........ .
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 999998863 3457999999999999999999999988 99999999999999999999999999976543221 1
Q ss_pred eeccccCccccCchhhc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 536 STRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~-----~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
.....||..|+|||++. +..++.++|||||||++|||++|+.||....+. ......... ..+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~-----------~~~ 226 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKS-----------EPP 226 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHHHhhc-----------CCC
Confidence 23346899999999884 345778999999999999999999998653321 111111000 000
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+. .+......+.+++.+||+.+|.+||++.++++
T Consensus 227 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 227 TLA--QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 01112246789999999999999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.44 Aligned_cols=250 Identities=28% Similarity=0.494 Sum_probs=197.6
Q ss_pred eeecccCceEEEEEEEeC-------CcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 381 RILGEGGFGCVYHGVMDN-------GTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~-------g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
+.||+|+||.||+|...+ +..+|||.+..... ....+|.+|++++++++|+||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998642 25799998865432 3456799999999999999999999999998999999999
Q ss_pred cCCCChhhhcccccC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC-----CCeeecccc
Q 048425 453 VHNGSVESHLHGVDK---NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF-----TPKVSDFGL 524 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~---~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~-----~vKLsDFGL 524 (780)
+++++|.+++..... ....++|.+++.++.|++.||+|||+.+ ++|+||||+||++++++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999964322 2345899999999999999999999987 99999999999999877 899999999
Q ss_pred cccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccc
Q 048425 525 AREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 525 A~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
++........ ......++..|+|||++.++.++.++|||||||++|||+| |+.||..... ........ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~----~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVT----AGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHh----cCC
Confidence 9866432211 1122345778999999999999999999999999999998 9999864321 11111110 000
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
. ..........+.+++.+|++.+|.+||++.+|++.|+
T Consensus 231 --------~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 --------R--LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred --------c--cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 0111223456789999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.82 Aligned_cols=252 Identities=30% Similarity=0.512 Sum_probs=200.4
Q ss_pred cccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchH--HHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 377 FSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDR--EFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~--~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
|+..+.||+|+||+||++... +++.||+|++......... ...+|+.++++++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 566789999999999999986 5678999999776543332 3456999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++++|.++|. ....+++..++.++.|+++||+|||+.+ |+|+||||+||+++++++++|+|||.+...... .
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-N 152 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST-T
T ss_pred cccccccccc----cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-c
Confidence 9999999995 3457899999999999999999999998 999999999999999999999999999865221 2
Q ss_pred cceeccccCccccCchhhc-cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 534 HISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~-~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
.......+|..|+|||.+. +...+.++||||+|+++|+|++|+.|+............. ... ........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~------~~~~~~~~ 223 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KIL------KRPLPSSS 223 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHH------HTHHHHHT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hcc------cccccccc
Confidence 2234567899999999998 8889999999999999999999999997542111111110 000 00000000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.........+.+++..|++.||++||++.++++
T Consensus 224 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 --QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000111368999999999999999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=331.41 Aligned_cols=248 Identities=26% Similarity=0.417 Sum_probs=208.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
..|+..++||+|.||.||||... .++.||+|++.-+... ..++..+|+.+|.+++++||.+.||.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45667789999999999999975 7889999999766433 457899999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
|.+|++.+.|. ....++.....-|..++..||.|||.++ .+|||||+.|||+..+|.+||+|||++-......
T Consensus 93 ~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999984 3445577778888999999999999998 9999999999999999999999999998877654
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
... ..++||+-|||||++....|+.|+||||||++.+||.+|..|+....|..... .+.+-.-|.+
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-------------lIpk~~PP~L 231 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-------------LIPKSAPPRL 231 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-------------eccCCCCCcc
Confidence 443 56789999999999998899999999999999999999999997655521111 1122233444
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+.+. ..+.+++..|++.||+.||++.++++
T Consensus 232 ~~~~S----~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 232 DGDFS----PPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccC----HHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 44333 45889999999999999999999876
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=312.04 Aligned_cols=254 Identities=23% Similarity=0.336 Sum_probs=203.3
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeee--cceeEEEE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIE--GRTRCLVY 450 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~LV~ 450 (780)
+|+..+.||+|+||.||++... +|..||+|+++.... ...+.+.+|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777899999999999999864 788999999875432 233568899999999999999999998764 34678999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS--NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~--~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||+++++|.+++.........+++..++.++.+++.||+|||..+ ...|+|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999754445678999999999999999999999332 334999999999999999999999999999877
Q ss_pred cCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 529 TEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 529 ~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
...... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ..+...... ..
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~----------~~ 226 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASKIKE----------GK 226 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHHHhc----------CC
Confidence 554321 2334689999999999999999999999999999999999999975431 111111100 00
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+ .........+.+++.+|++.+|++||++.||++
T Consensus 227 ~~----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 227 FR----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CC----CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 01 112233457889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=344.17 Aligned_cols=264 Identities=21% Similarity=0.293 Sum_probs=196.0
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeec--------
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEG-------- 443 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-------- 443 (780)
..++|...+.||+|+||.||+|... +++.||||++.... ....+|+.++++++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999974 68999999885432 2345799999999999999999986432
Q ss_pred ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC-CCeeecc
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF-TPKVSDF 522 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~-~vKLsDF 522 (780)
...++||||+++ +|.+++.........+++.....++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 235689999974 777777544445668999999999999999999999998 99999999999999664 7999999
Q ss_pred cccccccCCCccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccc-
Q 048425 523 GLAREATEGSQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTT- 600 (780)
Q Consensus 523 GLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~- 600 (780)
|+++........ ....||+.|+|||++.+. .++.++|||||||+||||+||+.||....... .+......+-..
T Consensus 216 Gla~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~~~~~p~ 291 (440)
T PTZ00036 216 GSAKNLLAGQRS--VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQVLGTPT 291 (440)
T ss_pred ccchhccCCCCc--ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCC
Confidence 999876543322 335689999999988764 68999999999999999999999997544321 111111000000
Q ss_pred ccc-------cccc-----cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 601 REG-------LEQL-----VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 601 ~~~-------l~~l-----vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.+. ...+ ....+...++......+.+++.+||+.+|.+||++.|+++.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000 0000 00011111111223568899999999999999999999753
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=321.14 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=199.4
Q ss_pred cccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc---chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 377 FSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN---GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
|+..+.||+|+||.||++... +++.||||.+...... ..+.+.+|+.++++++|+||+++++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999875 6889999998654322 234578899999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++++|.+++.. .....+++.+++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999999853 23346899999999999999999999987 9999999999999999999999999997654432
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
.. ....||..|+|||++.+..++.++|||||||++|||++|+.||........... ...+.+. .
T Consensus 157 ~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~-------------~~~~~~~-~ 220 (285)
T cd05630 157 TI--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE-------------VERLVKE-V 220 (285)
T ss_pred cc--cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH-------------HHhhhhh-h
Confidence 21 234689999999999999999999999999999999999999975322110000 0000000 0
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPF-----MGEVVQ 647 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPs-----m~EVv~ 647 (780)
...+.......+.+++..|++.||++||+ +.|+++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00111122345789999999999999999 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=329.26 Aligned_cols=202 Identities=24% Similarity=0.320 Sum_probs=175.2
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||+||+++.. +++.||||++.+.. ....+.|.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47888999999999999999975 68999999997532 223456889999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999852 3456899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccceeccccCccccCchhhcc-----CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLSGRKPVDMS 582 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~-----~~~t~ksDVySfGVvLlELlTGr~P~~~~ 582 (780)
..........||+.|+|||++.. +.++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 43333334569999999999863 45788999999999999999999999653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=320.85 Aligned_cols=249 Identities=24% Similarity=0.367 Sum_probs=204.1
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
.+|+..+.||+|+||.||+|.. .+|+.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 6788899999999999999996 479999999997766555677899999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++++|.+++.. ..+++.++.+++.+++.||.|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999999842 35889999999999999999999987 99999999999999999999999999986544322
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||....+.... .. ..... ...+.
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~--~~----~~~~~--~~~~~----- 236 (297)
T cd06656 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YL----IATNG--TPELQ----- 236 (297)
T ss_pred C-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe--ee----eccCC--CCCCC-----
Confidence 1 23346889999999999999999999999999999999999999654332110 00 00000 00000
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
........+.+++.+|++.+|++||+++||++
T Consensus 237 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 --NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11122345778999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=316.79 Aligned_cols=253 Identities=24% Similarity=0.369 Sum_probs=191.2
Q ss_pred eecccCceEEEEEEEeCCc---EEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCC
Q 048425 382 ILGEGGFGCVYHGVMDNGT---EVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGS 457 (780)
Q Consensus 382 ~LG~G~fG~VYkg~l~~g~---~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GS 457 (780)
.||+|+||+||+|...++. .+++|.++.... ...+.|.+|+++++.++||||++++++|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5999999999999865443 466776654432 334689999999999999999999999999999999999999999
Q ss_pred hhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC-ccce
Q 048425 458 VESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS-QHIS 536 (780)
Q Consensus 458 L~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~-~~~~ 536 (780)
|.++++........+++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999753333445777888999999999999999987 9999999999999999999999999986532221 1112
Q ss_pred eccccCccccCchhhcc-------CCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 537 TRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 537 t~~~GT~~Y~APE~l~~-------~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
....|+..|+|||++.. ..++.++|||||||++|||++ |..|+...... .... .... +....+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~---~~~~--~~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLN---HVIK--DQQVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---HHHh--hcccccC
Confidence 34568889999998753 245789999999999999997 46677543221 1111 1111 1122334
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
++.+...++ ..+.+++..|| .+|++||+++||++.|.
T Consensus 231 ~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 444433333 45677888999 67999999999988773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=316.38 Aligned_cols=248 Identities=27% Similarity=0.428 Sum_probs=202.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|+..+.||.|+||.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778889999999999999975 68999999987653 33346789999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999853 27899999999999999999999987 9999999999999999999999999998775432
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
. ......|+..|+|||++.+..++.++|||||||++|||+||+.||+...+... .. .. .....+.+
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~---~~-------~~~~~~~~ 218 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LF---LI-------PKNNPPSL 218 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HH---Hh-------hhcCCCCC
Confidence 2 12344688899999999998999999999999999999999999975432110 00 00 00011111
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
... .....+.+++.+|++.+|++||+++++++
T Consensus 219 ~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 219 EGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111 02345788999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=327.38 Aligned_cols=255 Identities=19% Similarity=0.245 Sum_probs=196.1
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||.||+++.+ +++.+|+|++.+.. ......|.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47888999999999999999976 57889999986532 222345888999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999963 3456899999999999999999999998 99999999999999999999999999986644
Q ss_pred CCccceeccccCccccCchhhc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccc
Q 048425 531 GSQHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLE 605 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~-----~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~ 605 (780)
..........||+.|+|||++. .+.++.++|||||||+||||++|+.||...... .....+........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~ 228 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKERFQ 228 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCCcccc
Confidence 3333334457999999999986 356789999999999999999999999754321 11111111110000
Q ss_pred cccCCccCCCCChhhHHHHHHHHHHccccC--CCCCCCHHHHHHH
Q 048425 606 QLVDPSLAGSYDFDDMAKVAAIASMCVHPE--VTHRPFMGEVVQA 648 (780)
Q Consensus 606 ~lvDp~L~~~~~~ee~~~l~~La~~Cl~~d--P~~RPsm~EVv~~ 648 (780)
+ +.. .......+.+++.+|+..+ +..|+++.|+++.
T Consensus 229 --~-p~~----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 --F-PAQ----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --C-CCc----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 000 0112245667777776544 4447889888654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=333.44 Aligned_cols=192 Identities=24% Similarity=0.383 Sum_probs=166.1
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
...+|...+.||+|+||.||+|... ++..||+|+.... ....|+.++++++|+||+++++++.++...++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3467999999999999999999975 5678999975332 23569999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+ .++|.+++. .....++|..+++|+.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 138 ~~-~~~l~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 138 HY-SSDLYTYLT---KRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred cc-CCcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 99 468888885 34457999999999999999999999998 999999999999999999999999999754332
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCC
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPV 579 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~ 579 (780)
. ......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 P--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 123456999999999999999999999999999999999976654
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=320.31 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=204.8
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|+..+.||+|+||+||++... +|+.||+|++..... ...+.|.+|+++++.++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56777789999999999999865 689999999865533 3356799999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++++|.+++.. .+.+++..+..++.+++.||.|||+.. .++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999998852 356899999999999999999999742 29999999999999999999999999987653321
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCcccc-----chhhhhcccccccccccccc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ-----ENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~-----~~Lv~wa~~ll~~~~~l~~l 607 (780)
.....|+..|+|||++.++.++.++|||||||++|||+||+.||+....... ..+..+........
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 229 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------ 229 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------
Confidence 1235689999999999888999999999999999999999999975443211 11111111111100
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
.+.+. ..+....+.+++.+|++.||++||++.||++...
T Consensus 230 -~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 230 -PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred -CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 11111 1123356889999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=312.81 Aligned_cols=250 Identities=21% Similarity=0.292 Sum_probs=202.1
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
+|+..+.||+|+||.||++... ++..+|+|.++... ....+.+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999875 68999999986543 233467889999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++|+|.+++.. .....+++...+.++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999998853 23446889999999999999999999988 99999999999999999999999999987644322
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||+...... . ...+... ... + +
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~---~~~~~~~--~~~----~-~- 220 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN---L---ILKVCQG--SYK----P-L- 220 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH---H---HHHHhcC--CCC----C-C-
Confidence 2234568999999999999899999999999999999999999997533211 1 0001000 000 0 1
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
+......+.+++.+||+.+|++||++.||+..
T Consensus 221 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 ---PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11122457889999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=318.09 Aligned_cols=264 Identities=23% Similarity=0.287 Sum_probs=194.8
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhc---CCCceeeeeeeeeec-----c
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRL---HHRNLVKLIGICIEG-----R 444 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~~-----~ 444 (780)
+|+..+.||+|+||+||+|... +|+.||+|.++..... ....+.+|+++++++ +|+||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999875 6899999998754322 234566788877765 799999999998642 4
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccc
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGL 524 (780)
..++||||++ ++|.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDK--VPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 5789999997 488888863 22345899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc-hhhhhcccccccc--
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE-NLVTWARPLLTTR-- 601 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~-~Lv~wa~~ll~~~-- 601 (780)
++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+.. .+..+........
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 98764322 223456899999999999999999999999999999999999998654322110 1111100000000
Q ss_pred ccc---ccccCCccCC---CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 602 EGL---EQLVDPSLAG---SYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 602 ~~l---~~lvDp~L~~---~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
... .....+.... ....+....+.+++.+|++.||++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 0000000000 001122346789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=313.76 Aligned_cols=250 Identities=28% Similarity=0.455 Sum_probs=200.1
Q ss_pred CcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCc------chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQN------GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
+|...+.||+|+||+||+|...+|+.+|||.++..... ..+.+.+|++++++++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 46778899999999999999888999999998654221 124588999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++++|.+++. ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999985 2346889999999999999999999987 9999999999999999999999999998653
Q ss_pred CCC-----ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccc
Q 048425 530 EGS-----QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 530 ~~~-----~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
... ........|+..|+|||++.+..++.++|||||||++|||++|+.||....... ..... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~~----~~~~--- 224 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFYI----GAHR--- 224 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHHh----hhcc---
Confidence 211 111233568999999999999899999999999999999999999996432211 10000 0000
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
-..+.+. ......+.+++.+|++.+|++||++.|+++
T Consensus 225 --~~~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 --GLMPRLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --CCCCCCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0011111 122356789999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=311.04 Aligned_cols=253 Identities=26% Similarity=0.374 Sum_probs=205.7
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
++|...+.||+|+||.||+|... +++.+++|.+........+.+.+|++++++++|+||+++++++.+++..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 67888999999999999999875 67889999998766556678999999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 83 GGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 99999999853 3357999999999999999999999987 99999999999999999999999999987654321
Q ss_pred cceeccccCccccCchhhccC---CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 534 HISTRVMGTFGYVAPEYAMTG---HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~---~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
......++..|+|||.+.+. .++.++||||||+++|||+||+.|+....+... ..... ...+..+
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~~~---------~~~~~~~ 224 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFLIS---------KSNFPPP 224 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH---------hccCCCc
Confidence 12335688899999998777 889999999999999999999999965432211 11100 0000011
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+. ........+.+++.+|++.+|.+||++++|+.
T Consensus 225 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111 11223456889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=311.07 Aligned_cols=250 Identities=21% Similarity=0.343 Sum_probs=203.6
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
+|+..+.||+|+||.||.+... ++..+++|.+.... ....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5788899999999999998864 68899999986543 33446789999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++++|.+++... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999999999642 2456899999999999999999999987 9999999999999999999999999998765433
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
. ......|+..|+|||++.+..++.++||||||+++|||++|+.||+...... . ...+... ..
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~---~~~~~~~----------~~ 218 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---L---VVKIVQG----------NY 218 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH---H---HHHHHcC----------CC
Confidence 2 2234568999999999998889999999999999999999999986533211 1 1011100 00
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
. .........+.+++.+|++.+|++||++.|+++.
T Consensus 219 ~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 219 T-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred C-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 0 0011223568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=328.03 Aligned_cols=242 Identities=24% Similarity=0.344 Sum_probs=194.5
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcC-CCceeeeeeeeeecceeEEEE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLH-HRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~ 450 (780)
+|+..+.||+|+||+||++... +|+.||||++++.. ....+.+..|++++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4777899999999999999865 68999999997642 223456788999998885 577888999998888999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++. ....+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999984 3456999999999999999999999998 99999999999999999999999999986433
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
... ......||..|+|||++.++.++.++|||||||++|||+||+.||...... .+... +.. .
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~---i~~----------~ 216 (323)
T cd05615 154 DGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQS---IME----------H 216 (323)
T ss_pred CCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHH---HHh----------C
Confidence 221 123456999999999999999999999999999999999999999754321 11111 111 0
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMG 643 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~ 643 (780)
.. .++......+.+++.+|++.+|.+|++..
T Consensus 217 ~~--~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 217 NV--SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CC--CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 00 11112234678899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=315.50 Aligned_cols=266 Identities=21% Similarity=0.298 Sum_probs=198.2
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
+|+..+.||+|++|.||+|... +|..||||+++... ....+.+.+|+.++++++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999975 68999999986543 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
++ ++|.+++... .....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSL-PKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcC-CCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 6888888642 22357999999999999999999999987 9999999999999999999999999998654322
Q ss_pred ccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc-hhh-hhcccc------cccccc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE-NLV-TWARPL------LTTREG 603 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~-~Lv-~wa~~l------l~~~~~ 603 (780)
.......++..|+|||.+.+. .++.++|||||||++|||+||+.||......... ... .+.... ......
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 112334578899999988654 5789999999999999999999999754321100 000 000000 000000
Q ss_pred cccccCCccCC---CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 604 LEQLVDPSLAG---SYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 604 l~~lvDp~L~~---~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
....++..... ........++.+++.+|++.||++||++.||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 000112346679999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.86 Aligned_cols=247 Identities=26% Similarity=0.438 Sum_probs=200.4
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
.|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++|+||+++++++..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3556678999999999999865 67899999986543 233457899999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++++|.+++. ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 9999999884 246899999999999999999999987 99999999999999999999999999987654321
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
......|+..|+|||++.+..++.++|||||||++|||+||+.|+....+.. ...+ . ..-..+.+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~----~------~~~~~~~~- 221 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLFL----I------PKNSPPTL- 221 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHhh----h------hcCCCCCC-
Confidence 1123458889999999999999999999999999999999999986433211 1100 0 00001111
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.......+.+++.+|++.+|++||+|.||++.
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 ---EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 12234568899999999999999999999874
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=310.20 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=200.0
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeec-ceeEEEEe
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEG-RTRCLVYE 451 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-~~~~LV~E 451 (780)
+|+..+.||+|++|.||++... +++.||+|.+..... ...+.+.+|++++++++|+|++++++.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999975 578899999865432 2345689999999999999999999987643 45789999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++++|.+++.. .....+++.++++++.+++.||+|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999964 23446899999999999999999999998 999999999999999999999999999876433
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
.. ......|+..|+|||++.+..++.++||||||++++||++|+.||+..... .+...+... .+ +
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~~~--~~-----~- 220 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRIIEG--KL-----P- 220 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHhc--CC-----C-
Confidence 22 223456889999999999999999999999999999999999998643221 111111110 00 0
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 612 L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.........+.+++.+|++.+|++||++.|+++
T Consensus 221 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 ---PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ---CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111223357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=310.93 Aligned_cols=247 Identities=25% Similarity=0.418 Sum_probs=200.2
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-----cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-----NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-----~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
+|+..+.||+|+||+||+|... ++..|++|.+..... ...+.|.+|++++++++|+||+++++++.+++..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999986 789999999865432 2346789999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999852 346899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCccceeccccCccccCchhhccCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~-~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
... ......|+..|++||.+.... ++.++|+||||+++|||++|+.||...... ..+..+. . .....
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~----~-~~~~~--- 221 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVFKIG----R-SKELP--- 221 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HHHHHHH----h-cccCC---
Confidence 432 223456889999999988776 899999999999999999999998654311 1111110 0 00000
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..+......+.+++.+|++.+|.+||++.++++
T Consensus 222 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 ------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111122356788999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=331.68 Aligned_cols=241 Identities=25% Similarity=0.317 Sum_probs=191.4
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHH-HhhhcCCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVE-MLSRLHHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~-iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
++||+|+||+||++... +|+.||||++.... .....++..|.. +++.++|+||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999865 78999999997542 223345666665 46779999999999999999999999999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
|+|..++. ....+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 152 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-T 152 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-C
Confidence 99998884 3457899999999999999999999998 99999999999999999999999999976432221 2
Q ss_pred eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCC
Q 048425 536 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGS 615 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~ 615 (780)
.....||..|+|||++.+..++.++|||||||++|||++|+.||....... +. ..+.. ..+ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~---~~~~~----------~~~--~ 214 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MY---DNILH----------KPL--V 214 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HH---HHHHc----------CCc--c
Confidence 244679999999999999999999999999999999999999996543211 11 11111 000 0
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 616 YDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 616 ~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
........+.+++..|++.+|++||++.+.++
T Consensus 215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 215 LRPGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 01112346778999999999999999875433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=320.84 Aligned_cols=249 Identities=25% Similarity=0.390 Sum_probs=204.1
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
.+|+..+.||.|+||.||+|.. .+|+.||+|.+........+.+.+|+++++.++|+||+++++++..++..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999986 478999999997665555678899999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++++|.+++.. ..+++.++..++.+++.||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999998842 35899999999999999999999998 99999999999999999999999999887644322
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
. .....|+..|+|||.+.+..++.++|||||||++|||++|+.||....+... +... .... . +.+.
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~~~----~~~~--~-----~~~~ 236 (296)
T cd06655 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLI----ATNG--T-----PELQ 236 (296)
T ss_pred c-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH----HhcC--C-----cccC
Confidence 1 2334688999999999999999999999999999999999999976443211 1100 0000 0 0000
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
........+.+++.+||+.+|++||++.+|+.
T Consensus 237 --~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 237 --NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred --CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 01112346778999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=331.60 Aligned_cols=264 Identities=23% Similarity=0.298 Sum_probs=197.8
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeec------
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEG------ 443 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------ 443 (780)
..++|...+.||+|+||.||++... .++.||||++..... ...+.+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 688999999975432 2335788999999999999999999988643
Q ss_pred ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccc
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFG 523 (780)
...++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 346899999965 6666663 24889999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-hh-----------
Q 048425 524 LAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LV----------- 591 (780)
Q Consensus 524 LA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-Lv----------- 591 (780)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||.......... ..
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 998654322 2234568999999999999999999999999999999999999997543211100 00
Q ss_pred ----hhcccccccccccccccCCcc-----C---CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 592 ----TWARPLLTTREGLEQLVDPSL-----A---GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 592 ----~wa~~ll~~~~~l~~lvDp~L-----~---~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
...............+..+.. . ..........+.+++.+|++.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000000000000000 0 00111123567899999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=341.37 Aligned_cols=241 Identities=24% Similarity=0.349 Sum_probs=204.4
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcC-CCceeeeeeeeeecceeE
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLH-HRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~ 447 (780)
..++|...++||+|.||+|+++.++ +++.+|||++++.. .+..+..+.|..++...+ ||.+++|+..+...++.+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3478999999999999999999986 67899999999875 334456788988888774 999999999999999999
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+||||+.||++..+. ..+.++.....-+|..|+.||+|||+++ ||+||||-+|||||.+|++||+||||++.
T Consensus 446 fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 999999999955554 3467999999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 528 ATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 528 ~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
...... ..++++||+.|||||++.+..|+...|.|||||+|||||.|..||.+...+ ++
T Consensus 518 ~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe--------------------e~ 576 (694)
T KOG0694|consen 518 GMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE--------------------EV 576 (694)
T ss_pred cCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH--------------------HH
Confidence 653333 346789999999999999999999999999999999999999999764321 12
Q ss_pred cCCccCC--CCChhhHHHHHHHHHHccccCCCCCCCH
Q 048425 608 VDPSLAG--SYDFDDMAKVAAIASMCVHPEVTHRPFM 642 (780)
Q Consensus 608 vDp~L~~--~~~~ee~~~l~~La~~Cl~~dP~~RPsm 642 (780)
+|..+.. .|+.-...+.+.|+.+.+..+|++|.-+
T Consensus 577 FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 577 FDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2222211 2444455678899999999999999887
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=313.30 Aligned_cols=246 Identities=31% Similarity=0.502 Sum_probs=198.3
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
++|+..+.||+|+||.||+|.. +++.||+|.++... ..+.|.+|+.++++++|+||+++++++.. +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence 4678889999999999999975 68889999986432 34678999999999999999999999875 45799999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+++|.+++.. .....+++..+++++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 82 KGNLVNFLRT--RGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 9999999964 23346899999999999999999999987 9999999999999999999999999997654321
Q ss_pred ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
.....+..|+|||++.++.++.++||||||+++|||++ |+.||....... +.... ... . .
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~--~--------~ 215 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---VKECV----EKG--Y--------R 215 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHH----hCC--C--------C
Confidence 12234567999999999999999999999999999998 999986543221 11110 000 0 0
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
..........+.+++.+|++.+|++||++++|++.|+
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 216 MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 0111122356789999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=335.54 Aligned_cols=261 Identities=21% Similarity=0.285 Sum_probs=203.1
Q ss_pred hHHHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeee
Q 048425 367 LSDLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIE 442 (780)
Q Consensus 367 ~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~ 442 (780)
+.++....++|+..+.||+|+||.||++... +++.||+|++.+.. ....+.+.+|+++++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455566789999999999999999999976 68899999986532 2233458899999999999999999999999
Q ss_pred cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecc
Q 048425 443 GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDF 522 (780)
Q Consensus 443 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDF 522 (780)
++..++||||+++|+|.+++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||+++++++||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999852 34788889999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCccceeccccCccccCchhhccC----CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccc
Q 048425 523 GLAREATEGSQHISTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLL 598 (780)
Q Consensus 523 GLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~----~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll 598 (780)
|+++..............||+.|+|||++... .++.++|||||||+||||++|+.||........ ...+.
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~ 260 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIM 260 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------HHHHH
Confidence 99987654333233456799999999998754 378999999999999999999999975432110 11111
Q ss_pred ccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 048425 599 TTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTH--RPFMGEVVQAL 649 (780)
Q Consensus 599 ~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~--RPsm~EVv~~L 649 (780)
.....+. +.+ .......+.+++..|+..++.+ |++++|+++..
T Consensus 261 ~~~~~~~-~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 261 NHKNSLT-FPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCCCccc-CCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1110000 000 1122346778899999844443 77888886643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=329.01 Aligned_cols=237 Identities=25% Similarity=0.332 Sum_probs=188.8
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHH-HhhhcCCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVE-MLSRLHHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~-iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
++||+|+||.||+|+.. +|+.||+|++.+.. .....++.+|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 68899999987542 122345556654 57889999999999999999999999999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
|+|..++. ....++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 99998884 3456888899999999999999999988 9999999999999999999999999998643222 12
Q ss_pred eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCC
Q 048425 536 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGS 615 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~ 615 (780)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+.. .+. ...+ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~---~i~----------~~~~--~ 214 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYD---NIL----------HKPL--Q 214 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHH---HHh----------cCCC--C
Confidence 34467999999999999999999999999999999999999999653211 1111 111 1101 1
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCCHH
Q 048425 616 YDFDDMAKVAAIASMCVHPEVTHRPFMG 643 (780)
Q Consensus 616 ~~~ee~~~l~~La~~Cl~~dP~~RPsm~ 643 (780)
.+......+.+++.+|++.+|++||+..
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1122335688999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=329.35 Aligned_cols=254 Identities=19% Similarity=0.237 Sum_probs=196.6
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||+||+++.. +++.||+|++.+.. ......|.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999975 67889999986532 222345888999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999963 2457899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCccceeccccCccccCchhhcc-----CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccc
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLE 605 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~-----~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~ 605 (780)
..........||+.|+|||++.+ +.++.++|||||||+||||++|+.||....... ....+........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~ 228 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEERFQ 228 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCccc
Confidence 33322334579999999999875 567899999999999999999999997543211 0001111000000
Q ss_pred cccCCccCCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 048425 606 QLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTH--RPFMGEVVQ 647 (780)
Q Consensus 606 ~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~--RPsm~EVv~ 647 (780)
+.+.+ .+....+.+++.+|+...+++ |++++++++
T Consensus 229 --~p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 229 --FPSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred --CCCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 00101 112346777888888765544 467777754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=314.30 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=200.7
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
++|...+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++|+||+++++++..++..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 56777889999999999999864 68899999987665444567889999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++++|.+++. ....+++.+.+.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 89 GGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 9999999985 3457899999999999999999999998 99999999999999999999999999976643221
Q ss_pred cceeccccCccccCchhhc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 534 HISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~---~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
......|+..|+|||++. .+.++.++|||||||++|||++|+.|+....+... +..... .....+
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~~~~---------~~~~~~ 229 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMTK---------SNFQPP 229 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHhhhc---------cCCCCC
Confidence 123456899999999874 45688999999999999999999999854332111 100000 000011
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..... ......+.+++.+|++.+|++||++++|++
T Consensus 230 ~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 230 KLKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11100 011235788999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=319.39 Aligned_cols=239 Identities=26% Similarity=0.453 Sum_probs=190.3
Q ss_pred eeecccCceEEEEEEEeC--------CcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 381 RILGEGGFGCVYHGVMDN--------GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
+.||+|+||.||+|.... ...||+|.+........++|.+|+.+++.++|+||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998642 235889988665555557899999999999999999999999998999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC--------Ceeecccc
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT--------PKVSDFGL 524 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~--------vKLsDFGL 524 (780)
+++|+|.++++. ....+++..+++++.||+.||+|||+.+ |+||||||+||+++.++. +|++|||+
T Consensus 81 ~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 999999999963 3346899999999999999999999988 999999999999988776 58999998
Q ss_pred cccccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCC-CCCCCCCccccchhhhhccccccccc
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGR-KPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr-~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
+...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .|+....+...... ....
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-------~~~~- 221 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-------YEDR- 221 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-------HHcc-
Confidence 8755332 23457889999999886 45789999999999999999985 55543222111000 0000
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
...+......+.+++.+||+.+|++||+++|+++.|
T Consensus 222 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 -----------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -----------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 011112235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=314.48 Aligned_cols=252 Identities=26% Similarity=0.349 Sum_probs=189.2
Q ss_pred eecccCceEEEEEEEeC---CcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCC
Q 048425 382 ILGEGGFGCVYHGVMDN---GTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGS 457 (780)
Q Consensus 382 ~LG~G~fG~VYkg~l~~---g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GS 457 (780)
.||+|+||+||+|...+ ...+|+|.+..... .....|.+|+++++.++|+||++++++|.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 59999999999998654 34688888754432 234578999999999999999999999999999999999999999
Q ss_pred hhhhcccccCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc-c
Q 048425 458 VESHLHGVDKN-RGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH-I 535 (780)
Q Consensus 458 L~~~L~~~~~~-~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~-~ 535 (780)
|.+++...... ....++...++++.|++.||+|||+.+ |+||||||+|||+++++++||+|||+++........ .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999653221 234578889999999999999999998 999999999999999999999999999764332211 1
Q ss_pred eeccccCccccCchhhcc-------CCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 536 STRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~~-------~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
.....++..|+|||++.. ..++.++|||||||++|||++ |+.||....+. +.+... .. .....+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~~~----~~--~~~~~~ 230 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--QVLKQV----VR--EQDIKL 230 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHH----hh--ccCccC
Confidence 123346778999998743 356789999999999999999 77787543221 111110 00 001112
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
.++.+.. .....+.+++..|+ .+|++||+++||++.|
T Consensus 231 ~~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 231 PKPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 2222221 22345667888888 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=342.13 Aligned_cols=268 Identities=21% Similarity=0.335 Sum_probs=196.4
Q ss_pred hHHHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCC------Cceeeeeee
Q 048425 367 LSDLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHH------RNLVKLIGI 439 (780)
Q Consensus 367 ~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H------pNIV~L~g~ 439 (780)
.+++...+++|...++||+|+||+||+|... +++.||||+++... ...+++..|++++.+++| .++++++++
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 3455566789999999999999999999875 67889999996532 233456677777777654 458999999
Q ss_pred eeec-ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCcEEecccCCcceEEcCCC--
Q 048425 440 CIEG-RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED-SNPRVIHRDFKASNVLLEDDF-- 515 (780)
Q Consensus 440 ~~~~-~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~-~~p~IvHrDIKpsNILLd~~~-- 515 (780)
+..+ ...++|||++ +++|.+++. ....+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIM----KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTV 271 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcc
Confidence 8764 4678999988 778888885 335799999999999999999999974 6 99999999999998765
Q ss_pred --------------CCeeecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 048425 516 --------------TPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDM 581 (780)
Q Consensus 516 --------------~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~ 581 (780)
.+||+|||++..... ..+...||..|+|||++.+..++.++|||||||+||||++|+.||+.
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 499999998864322 22456799999999999999999999999999999999999999976
Q ss_pred CCccccchhhh---------hccc--------ccccccccccccCCc----cCCCC---ChhhHHHHHHHHHHccccCCC
Q 048425 582 SQPQGQENLVT---------WARP--------LLTTREGLEQLVDPS----LAGSY---DFDDMAKVAAIASMCVHPEVT 637 (780)
Q Consensus 582 ~~~~~~~~Lv~---------wa~~--------ll~~~~~l~~lvDp~----L~~~~---~~ee~~~l~~La~~Cl~~dP~ 637 (780)
....+...++. |... +......+....++. +.... .......+.+|+..||+.||+
T Consensus 348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 54322111111 1100 000000000000000 00000 001124577999999999999
Q ss_pred CCCCHHHHHH
Q 048425 638 HRPFMGEVVQ 647 (780)
Q Consensus 638 ~RPsm~EVv~ 647 (780)
+|||++|+++
T Consensus 428 ~R~ta~e~L~ 437 (467)
T PTZ00284 428 KRLNARQMTT 437 (467)
T ss_pred hCCCHHHHhc
Confidence 9999999975
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=334.35 Aligned_cols=246 Identities=23% Similarity=0.322 Sum_probs=203.5
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
..++|..+..||+|+||.||.++-+ +|..+|+|+|++... .+.+...+|-.+|...++++||+|+-.|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999865 799999999988753 344568889999999999999999999999999999
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||++||++..+| .+.+.|+.......+.+++.|++-||+.| +|||||||+|+|||.+|++||+||||+.-+
T Consensus 219 iMEylPGGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL----MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 99999999999999 45678999999999999999999999999 999999999999999999999999999633
Q ss_pred cCC-----------------------Cc----cc-------------------eeccccCccccCchhhccCCCCchhhH
Q 048425 529 TEG-----------------------SQ----HI-------------------STRVMGTFGYVAPEYAMTGHLLVKSDV 562 (780)
Q Consensus 529 ~~~-----------------------~~----~~-------------------~t~~~GT~~Y~APE~l~~~~~t~ksDV 562 (780)
... .. .. ....+||+.|||||++++..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 110 00 00 011469999999999999999999999
Q ss_pred HhHHHHHHHHHhCCCCCCCCCcccc-chhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCC
Q 048425 563 YSYGVVLLELLSGRKPVDMSQPQGQ-ENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPF 641 (780)
Q Consensus 563 ySfGVvLlELlTGr~P~~~~~~~~~-~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs 641 (780)
||+|||+||||.|.+||....+... ..++.|-..+.... + .+...+..+|+.+|+. ||++|--
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-------~--------~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-------E--------VDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-------c--------CcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999999999988776532 34555532221111 1 1111467789999998 9999986
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=317.23 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=200.6
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
++|+..+.||+|+||.||+|... ++..|++|.+........+.|.+|++++++++|+||+++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888899999999999999975 58999999997665555678999999999999999999999999989999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++++|..++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++++||+|||++........
T Consensus 92 ~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 99999888753 3456899999999999999999999987 99999999999999999999999999876433221
Q ss_pred cceeccccCccccCchhhc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 534 HISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~-----~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
......++..|+|||++. ...++.++|||||||++|||++|+.|+....+. ..+..+. .. .
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~----~~-------~ 231 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIA----KS-------E 231 (292)
T ss_pred -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HHHHHHh----cC-------C
Confidence 123345888999999884 345688999999999999999999998643321 1111110 00 0
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+.+. .+......+.+++.+||+.+|++||+++||++
T Consensus 232 ~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 232 PPTLS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CccCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 01100 01122346788999999999999999999865
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=312.50 Aligned_cols=249 Identities=25% Similarity=0.394 Sum_probs=193.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-----cchHHHHHHHHHhhhcCCCceeeeeeeeeec--cee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-----NGDREFIAEVEMLSRLHHRNLVKLIGICIEG--RTR 446 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-----~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~ 446 (780)
.+|...+.||+|+||.||+|... +|..||+|++..... ...+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999874 689999999865422 1234688999999999999999999988653 567
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
++++||+++++|.+++.. ...+++...+.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999853 346899999999999999999999887 9999999999999999999999999998
Q ss_pred cccCCCc--cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccc
Q 048425 527 EATEGSQ--HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 527 ~~~~~~~--~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
....... .......++..|+|||++.+..++.++|||||||++|||++|+.||....... ... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~--~~~----~~~------ 222 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA--AIF----KIA------ 222 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH--HHH----HHh------
Confidence 6543211 11123458899999999999899999999999999999999999996432110 000 000
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.....+.+ +......+..++ .|+..+|++||+|+||++
T Consensus 223 ~~~~~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 223 TQPTNPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred cCCCCCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00011111 111123344455 688899999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.82 Aligned_cols=248 Identities=26% Similarity=0.411 Sum_probs=202.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
..|+..+.||+|+||.||+|... ++..||+|.+.... ......|.+|++++++++|+||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34667788999999999999975 68899999987543 23346789999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++|+|.+++.. .++++.+...++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999999842 36889999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
. ......++..|+|||++.+..++.++|||||||++|||+||+.|+....+...... .....
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-----------------~~~~~ 217 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-----------------IPKNN 217 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-----------------hhcCC
Confidence 2 12334688899999999988999999999999999999999999864432211000 00000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
...........+.+++..||+.+|++||++.|+++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 111222345678899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=356.75 Aligned_cols=266 Identities=22% Similarity=0.310 Sum_probs=208.8
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc---chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN---GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...++||+|+||.||+|... +|+.||||++...... ..++|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999875 6899999999754322 2357999999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccc
Q 048425 451 ELVHNGSVESHLHGVDK-------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~-------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFG 523 (780)
||+++|+|.+++..... ....+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 1235678889999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCC-----------------ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccc
Q 048425 524 LAREATEGS-----------------QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQG 586 (780)
Q Consensus 524 LA~~~~~~~-----------------~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~ 586 (780)
+++...... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998762110 001123569999999999999999999999999999999999999996532111
Q ss_pred cchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHhhcCCC
Q 048425 587 QENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRP-FMGEVVQALKLIYNDTDE 658 (780)
Q Consensus 587 ~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RP-sm~EVv~~L~~i~~~~~~ 658 (780)
+. +. ..+.++.-.. ...+....+.+++.+|++.||++|| +++++.+.|+........
T Consensus 239 ---i~-~~----------~~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~ 296 (932)
T PRK13184 239 ---IS-YR----------DVILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE 296 (932)
T ss_pred ---hh-hh----------hhccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcc
Confidence 10 00 0001110000 0012234678899999999999995 678888888887765443
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=333.18 Aligned_cols=203 Identities=27% Similarity=0.395 Sum_probs=176.3
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|+..+.||+|+||+||++... +|+.||||+++... ......+.+|++++.+++|+||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999875 68999999997542 223456888999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++. ....+++.....++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 81 E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999985 3456899999999999999999999998 99999999999999999999999999875432
Q ss_pred CCc----------------------------------cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCC
Q 048425 531 GSQ----------------------------------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGR 576 (780)
Q Consensus 531 ~~~----------------------------------~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr 576 (780)
... .......||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0112357999999999999999999999999999999999999
Q ss_pred CCCCCCCc
Q 048425 577 KPVDMSQP 584 (780)
Q Consensus 577 ~P~~~~~~ 584 (780)
.||....+
T Consensus 234 ~Pf~~~~~ 241 (360)
T cd05627 234 PPFCSETP 241 (360)
T ss_pred CCCCCCCH
Confidence 99976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=308.76 Aligned_cols=251 Identities=30% Similarity=0.512 Sum_probs=200.6
Q ss_pred cccceeecccCceEEEEEEEeC-----CcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 377 FSSKRILGEGGFGCVYHGVMDN-----GTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~~-----g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
|+..+.||.|+||.||++...+ +..||+|+++..... ..+.+.+|++++.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456889999999999999753 488999999765443 4568999999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++++|.+++... ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++....
T Consensus 81 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKN--RPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhh--hhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 999999999999642 1122899999999999999999999998 99999999999999999999999999987765
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
..........++..|+|||.+.+..++.++||||+|++++||++ |+.|+..... ..+..... . .. ..
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~---~-~~---~~-- 223 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLK---K-GY---RL-- 223 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHh---c-CC---CC--
Confidence 43222222337789999999988899999999999999999999 7888764221 11111110 0 00 00
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
.........+.+++.+|++.+|++||++.|+++.|
T Consensus 224 -----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 -----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00111335688899999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=328.28 Aligned_cols=256 Identities=27% Similarity=0.373 Sum_probs=204.4
Q ss_pred HHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--------------cchHHHHHHHHHhhhcCCCceeee
Q 048425 372 KATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--------------NGDREFIAEVEMLSRLHHRNLVKL 436 (780)
Q Consensus 372 ~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--------------~~~~~f~~Ei~iL~~L~HpNIV~L 436 (780)
+..++|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+...+||.+|++++|+|||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34588999999999999999999965 789999999865421 112468899999999999999999
Q ss_pred eeeeeec--ceeEEEEeecCCCChhhhcccccCCCCC-CCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC
Q 048425 437 IGICIEG--RTRCLVYELVHNGSVESHLHGVDKNRGP-LDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED 513 (780)
Q Consensus 437 ~g~~~~~--~~~~LV~Ey~~~GSL~~~L~~~~~~~~~-L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~ 513 (780)
+++..+. +..|||+|||..|.+... ....+ |+..+.++++.++..||+|||.++ ||||||||+|+||++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS 245 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence 9998764 578999999999987554 23344 999999999999999999999998 999999999999999
Q ss_pred CCCCeeecccccccccCCCc----cceeccccCccccCchhhccCC----CCchhhHHhHHHHHHHHHhCCCCCCCCCcc
Q 048425 514 DFTPKVSDFGLAREATEGSQ----HISTRVMGTFGYVAPEYAMTGH----LLVKSDVYSYGVVLLELLSGRKPVDMSQPQ 585 (780)
Q Consensus 514 ~~~vKLsDFGLA~~~~~~~~----~~~t~~~GT~~Y~APE~l~~~~----~t~ksDVySfGVvLlELlTGr~P~~~~~~~ 585 (780)
+|++||+|||.+..+..+.. ..-.+.+||+.|+|||...++. ...+.||||+||.||-|+.|+.||.....
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~- 324 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE- 324 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-
Confidence 99999999999987743321 1123467999999999987743 24688999999999999999999975321
Q ss_pred ccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048425 586 GQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651 (780)
Q Consensus 586 ~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~ 651 (780)
.. ..+.+++..|.-....++-+.+.+|++++|++||++|.+..+|......
T Consensus 325 -----~~----------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 325 -----LE----------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred -----HH----------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 11 1223333333222223456678899999999999999999999876543
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.52 Aligned_cols=259 Identities=27% Similarity=0.379 Sum_probs=204.6
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeec--ceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEG--RTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LV~ 450 (780)
++|...+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++|+||++++++|.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999985 688999999875433 3346799999999999999999999998654 3679999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++++|.+++.........+++.....++.|++.||+|||+.+ ++|+||+++||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999988654445567899999999999999999999988 99999999999999999999999999876543
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCc--cccchhhhhccccccccccccccc
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQP--QGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~--~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.|++.... .....+..|..... ...+.
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 229 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP-----NPELK 229 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC-----chhhc
Confidence 221 234578899999999999999999999999999999999999975532 11112222211100 00010
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+. . .........+.+++.+|++.+|.+||++.||++
T Consensus 230 ~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 230 DE-P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cC-C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 00 0 001123457889999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=348.53 Aligned_cols=259 Identities=23% Similarity=0.308 Sum_probs=209.9
Q ss_pred hcCcccceeecccCceEEEEEEEeCC-cEEEEEEeeccCCcchHHHHHHHHHhhhcC-CCceeeeee-eeee------cc
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDNG-TEVAVKLLTRNNQNGDREFIAEVEMLSRLH-HRNLVKLIG-ICIE------GR 444 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~g-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g-~~~~------~~ 444 (780)
..+.++.+.|.+|||+.||.+.+..+ .+||+|++-..+..+.+...+||++|++|. |+|||.+++ .... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 35667889999999999999998766 999999997777777889999999999996 999999999 3221 13
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccc
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGL 524 (780)
+.+|.||||++|+|-|++..... ..|+..++++|+.++++|+++||.. .|||||||||-+||||+.+++.||||||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 67899999999999999975333 3499999999999999999999987 58999999999999999999999999999
Q ss_pred cccccCCCccc--------eeccccCccccCchhhc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhh
Q 048425 525 AREATEGSQHI--------STRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTW 593 (780)
Q Consensus 525 A~~~~~~~~~~--------~t~~~GT~~Y~APE~l~---~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~w 593 (780)
|.......... .-...-|+.|+|||.+. +...++|+|||+|||+||-|+....||+....
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--------- 263 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--------- 263 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---------
Confidence 97543221100 01124588999999764 66889999999999999999999999975421
Q ss_pred cccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 594 ARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 594 a~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
..|++....-........+|..||..||+.||.+||++-+|++.+.++.+.
T Consensus 264 -----------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 264 -----------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -----------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 112222111111135567899999999999999999999999999888764
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.48 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=201.6
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
+|...+.||+|+||.||+|... ++..|++|.++..... ..+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777899999999999999875 7899999999766543 456799999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++++|.+++.. ...+++..+..++.+++.||+|||+.+ |+|+||+++||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999853 345889999999999999999999998 9999999999999999999999999998775443
Q ss_pred cccee---ccccCccccCchhhccCC---CCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 533 QHIST---RVMGTFGYVAPEYAMTGH---LLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 533 ~~~~t---~~~GT~~Y~APE~l~~~~---~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
..... ...++..|+|||++.+.. .+.++||||||+++|||++|+.||....... ...... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~~~~~~---~~------- 221 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--QIMFHV---GA------- 221 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--HHHHHH---hc-------
Confidence 32211 356788999999998766 8899999999999999999999996432110 000000 00
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
...+.+... ......+.+++.+|++.+|++||++.|++.
T Consensus 222 ~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 GHKPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 001111111 111345678999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=328.45 Aligned_cols=241 Identities=23% Similarity=0.300 Sum_probs=190.2
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHH-HhhhcCCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVE-MLSRLHHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~-iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
+.||+|+||+||+++.. +++.||+|++.... .....++..|.. +++.++|+||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 67889999987542 122334555544 56788999999999999999999999999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
|+|.+++. ....+.......++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~ 152 (325)
T cd05602 81 GELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-T 152 (325)
T ss_pred CcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-C
Confidence 99999985 3446788888899999999999999998 99999999999999999999999999986433221 2
Q ss_pred eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCC
Q 048425 536 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGS 615 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~ 615 (780)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... +.. ..+ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~---i~~----------~~~--~ 214 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDN---ILN----------KPL--Q 214 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHHH---HHh----------CCc--C
Confidence 34467999999999999999999999999999999999999999753321 11111 111 000 0
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 616 YDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 616 ~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
........+.+++..|++.+|.+||++.+.+.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 11122346788999999999999999876443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=329.10 Aligned_cols=263 Identities=25% Similarity=0.331 Sum_probs=196.6
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecc------
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGR------ 444 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------ 444 (780)
.++|...+.||+|+||.||++... +|..||||++.... ......+.+|+.+++.++|+||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 478999999999999999999875 68999999986542 233457889999999999999999999986543
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccc
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGL 524 (780)
..++||||+++ +|.+.++ ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999975 5666553 24788999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-hh------------
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LV------------ 591 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-Lv------------ 591 (780)
++...... ......||..|+|||.+.+..++.++|||||||++|||+||+.||.......... +.
T Consensus 170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred ccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 98654322 2234568999999999999999999999999999999999999997543211000 00
Q ss_pred ---hhcccccccc-----cccccccCCccCC---CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 592 ---TWARPLLTTR-----EGLEQLVDPSLAG---SYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 592 ---~wa~~ll~~~-----~~l~~lvDp~L~~---~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.......... ....++....... .........+.+++.+|++.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000 0000000000000 0011123467899999999999999999999763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=314.48 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=196.0
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHH-hhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEM-LSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~i-L~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
++|+..+.||+|+||.||+++.. +|+.||+|+++.... ....++..|+++ ++.++|+||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47888999999999999999976 699999999876532 234456667775 566799999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED-SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~-~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
|++ |+|.+++.........+++..+++++.|++.||+|||+. + ++||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 788888865444456799999999999999999999986 5 99999999999999999999999999987643
Q ss_pred CCccceeccccCccccCchhhcc----CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~----~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
.. ..+...|+..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... .+.+.... .
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~----~------- 222 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQVV----E------- 222 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHHHH----h-------
Confidence 22 1233568899999998864 45688999999999999999999998632110 01111100 0
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
-..+.+.. ......+.+++..|++.+|++||++.+|++
T Consensus 223 ~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 223 EPSPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred cCCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111100 112246889999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.08 Aligned_cols=264 Identities=23% Similarity=0.325 Sum_probs=199.1
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|...+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888899999999999999875 688999999865432 2345688999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
++ ++|.+++.. ....+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 589888853 3456899999999999999999999988 9999999999999999999999999998654322
Q ss_pred ccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchh-hhhc--------cccccccc
Q 048425 533 QHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENL-VTWA--------RPLLTTRE 602 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~L-v~wa--------~~ll~~~~ 602 (780)
.. .....++..|+|||.+.+ ..++.++|||||||++|||+||+.||........... .... ...... .
T Consensus 159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 236 (301)
T cd07873 159 KT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN-E 236 (301)
T ss_pred Cc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc-c
Confidence 11 123457889999998865 4578899999999999999999999975443211100 0000 000000 0
Q ss_pred ccccccCCccCCC----CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 603 GLEQLVDPSLAGS----YDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 603 ~l~~lvDp~L~~~----~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.....-.+..... ........+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000110000 01112345788999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=312.55 Aligned_cols=256 Identities=25% Similarity=0.438 Sum_probs=199.6
Q ss_pred cccceeecccCceEEEEEEEe----CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecc------
Q 048425 377 FSSKRILGEGGFGCVYHGVMD----NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGR------ 444 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~----~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------ 444 (780)
|...+.||+|+||.||+|.+. ++..||||++..... ...+++.+|++++++++|+||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999864 368899999865432 23457899999999999999999999986542
Q ss_pred eeEEEEeecCCCChhhhccccc--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecc
Q 048425 445 TRCLVYELVHNGSVESHLHGVD--KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDF 522 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~--~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDF 522 (780)
..++++||+++|+|.+++.... .....+++...++++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2378999999999998875321 22335889999999999999999999987 999999999999999999999999
Q ss_pred cccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccc
Q 048425 523 GLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTT 600 (780)
Q Consensus 523 GLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~ 600 (780)
|+++........ ......++..|++||.+.++.++.++||||||+++|||++ |+.|+..... ..+..+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~---- 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLIK---- 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHHc----
Confidence 999876433211 1223345678999999999999999999999999999999 8888864322 122221110
Q ss_pred ccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 601 REGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 601 ~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
.... .........+.+++.+|++.+|++||++.||++.|+.+
T Consensus 231 ~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 01112335789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.38 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=194.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-----cchHHHHHHHHHhhhcCCCceeeeeeeeeec--cee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-----NGDREFIAEVEMLSRLHHRNLVKLIGICIEG--RTR 446 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-----~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~ 446 (780)
++|+..+.||+|+||.||+|... +|..||||.+..... ...+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57888999999999999999875 689999998864321 1234688899999999999999999988764 457
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
++||||+++++|.+++. ....+++...++++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999985 2345889999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCc--cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccc
Q 048425 527 EATEGSQ--HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 527 ~~~~~~~--~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
....... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||....... .... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~----~~------ 222 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA--AIFK----IA------ 222 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH--HHHH----Hh------
Confidence 6542211 11233468899999999998889999999999999999999999986432110 0000 00
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.....+ ..+......+..++..|+. +|++||+++||++
T Consensus 223 ~~~~~~----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 223 TQPTNP----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred cCCCCC----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 000011 1122333467778888885 8999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=315.67 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=202.9
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
.++|...+.||+|+||.||+|... ++..||+|+++.......+.|.+|++++++++|+||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467888899999999999999975 6899999999766555567899999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++++|.+++.. ....+++..+.+++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 999999999853 3456999999999999999999999998 9999999999999999999999999987654322
Q ss_pred ccceeccccCccccCchhhc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 533 QHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~-----~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
.. .....||..|+|||.+. ...++.++||||||+++|||++|+.||...... ..+..+ ...
T Consensus 158 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~~~~----~~~------- 223 (280)
T cd06611 158 QK-RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVLLKI----LKS------- 223 (280)
T ss_pred cc-cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHHHHH----hcC-------
Confidence 21 23356899999999875 345678999999999999999999999654321 111111 000
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
..+.+. .+......+.+++..|++.+|.+||++.+|++.
T Consensus 224 ~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 224 EPPTLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCCCcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 001110 011122467889999999999999999999653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=314.85 Aligned_cols=260 Identities=27% Similarity=0.410 Sum_probs=204.7
Q ss_pred cchHHHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeeee
Q 048425 365 FALSDLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICIE 442 (780)
Q Consensus 365 f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~ 442 (780)
.++.++..+.+.|+..+.||+|+||.||+|... +++.+|+|++.... ....++..|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 466777778899999999999999999999974 68899999986543 2345788999999998 79999999999853
Q ss_pred ------cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC
Q 048425 443 ------GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT 516 (780)
Q Consensus 443 ------~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~ 516 (780)
.+..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCC
Confidence 45779999999999999998642 2346888999999999999999999998 999999999999999999
Q ss_pred CeeecccccccccCCCccceeccccCccccCchhhc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhh
Q 048425 517 PKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV 591 (780)
Q Consensus 517 vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~-----~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv 591 (780)
+||+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+.......
T Consensus 160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~ 238 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238 (282)
T ss_pred EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence 99999999886543221 123356899999999875 356788999999999999999999999643321111000
Q ss_pred hhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 592 TWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 592 ~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.....+.+. .......+.+++.+||+.||.+||++.|+++
T Consensus 239 -------------~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 -------------PRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -------------hhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000011111 0112346889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=307.49 Aligned_cols=256 Identities=27% Similarity=0.430 Sum_probs=205.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|+..+.||.|+||+||+|... ++..+|+|++..... ...+.+.+|+++++.++|+||+++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47888999999999999999964 688999999865432 2456799999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++++|.+++.... ....+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999996421 1256899999999999999999999988 9999999999999999999999999998765433
Q ss_pred cc---ceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 533 QH---ISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 533 ~~---~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
.. ......|+..|+|||++... ..+.++|||||||++|||++|+.||....+. ..+...... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~~-----------~ 223 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLTLQN-----------D 223 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHHhcC-----------C
Confidence 22 22345689999999998877 7899999999999999999999999754321 111111110 0
Q ss_pred CCccCCCCC-hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 609 DPSLAGSYD-FDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 609 Dp~L~~~~~-~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+.+..... ......+.+++..|++.||++||++.||++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111111110 122356789999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=313.85 Aligned_cols=265 Identities=23% Similarity=0.301 Sum_probs=201.8
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
+|...+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999975 78999999987654 23346799999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+ +++|.+++.. ....+++.++++++.||+.||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 9999999863 2357999999999999999999999988 9999999999999999999999999998775543
Q ss_pred ccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-hhhhc-------ccccccccc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LVTWA-------RPLLTTREG 603 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-Lv~wa-------~~ll~~~~~ 603 (780)
........|+..|+|||++.+. .++.++||||+|++++||+||+.++.......... ..... ++.......
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 2223345689999999988654 46899999999999999999987775433211100 00000 000000000
Q ss_pred cccccCCccC----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 604 LEQLVDPSLA----GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 604 l~~lvDp~L~----~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
...+..+.-. .+...+....+.+++.+|++.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000000 0000122367899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=333.15 Aligned_cols=261 Identities=28% Similarity=0.459 Sum_probs=217.8
Q ss_pred HHHHhcCcccceeecccCceEEEEEEEe---CCc--EEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeeec
Q 048425 370 LEKATEKFSSKRILGEGGFGCVYHGVMD---NGT--EVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEG 443 (780)
Q Consensus 370 l~~at~~f~~~~~LG~G~fG~VYkg~l~---~g~--~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~ 443 (780)
++...+.....++||+|.||.||+|+.. .|+ .||||..+.+. .+..+.|++|..+|+.++|||||+|+|+|.+
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 3444556677789999999999999963 233 48999988754 4445679999999999999999999999986
Q ss_pred ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccc
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFG 523 (780)
...++|||.++-|.|..||. .++..|+......++.||..+|+|||+.. +|||||..+|||+...--+||+|||
T Consensus 463 ~P~WivmEL~~~GELr~yLq---~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQ---QNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred cceeEEEecccchhHHHHHH---hccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccc
Confidence 56789999999999999996 45678999999999999999999999987 9999999999999999999999999
Q ss_pred ccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccc
Q 048425 524 LAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 524 LA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
|++...+......++..-.+.|||||.+.-++++.++|||-|||.+||++. |.+||.+-...+ ++ ..++.++
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD---VI----~~iEnGe 609 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD---VI----GHIENGE 609 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc---eE----EEecCCC
Confidence 999998877665566666778999999999999999999999999999987 999997543211 10 1122221
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
. + ..+..+...+..|+.+||..+|.+||.+.|+...|.+++.
T Consensus 610 R---l-------P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 610 R---L-------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred C---C-------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1 1 2334566788999999999999999999999999988876
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=340.67 Aligned_cols=246 Identities=24% Similarity=0.377 Sum_probs=205.7
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
-|...+.||+|+-|.|-.|++. +|+.+|||++.+.. ......+.+||-||+.|.|||++.|++++.+..++|||.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 4566788999999999999974 89999999996652 2223457899999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++|-|.++|- .+++|...+..+++.||+.|+.|+|..+ |+|||+||+|+|||..+++||+|||||..-.++
T Consensus 93 yv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 93 YVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred ecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999994 5678999999999999999999999998 999999999999999999999999999876654
Q ss_pred CccceeccccCccccCchhhccCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t-~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
. .-.+.+|.+.|.|||++++.+|. .++||||+|||||.||||+.||+.... ..|...+ ..+..++
T Consensus 166 k--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LLlKV------~~G~f~M--- 231 (786)
T KOG0588|consen 166 K--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLLLKV------QRGVFEM--- 231 (786)
T ss_pred c--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHHHHH------HcCcccC---
Confidence 3 33557899999999999999995 799999999999999999999984321 1111111 1111111
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
+.....+..+|+.+|+..||++|-|++||.+.
T Consensus 232 ------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 232 ------PSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ------CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 12233567889999999999999999999775
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=318.96 Aligned_cols=250 Identities=22% Similarity=0.285 Sum_probs=200.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc---chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN---GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|+..+.||+|+||.||++... +++.||+|.+...... ..+.+.+|++++++++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888899999999999999976 5899999999765432 3456899999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+.+++|.+++.. .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999863 23457999999999999999999999988 99999999999999999999999999876532
Q ss_pred CCcc----------------------------ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 048425 531 GSQH----------------------------ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMS 582 (780)
Q Consensus 531 ~~~~----------------------------~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~ 582 (780)
.... ......||..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 112346889999999999989999999999999999999999999654
Q ss_pred CccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHH
Q 048425 583 QPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEV 645 (780)
Q Consensus 583 ~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EV 645 (780)
... ..+. .+.+....-.........+.+++.+|++.+|++||++...
T Consensus 236 ~~~--~~~~--------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~ 282 (316)
T cd05574 236 NRD--ETFS--------------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRG 282 (316)
T ss_pred chH--HHHH--------------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhh
Confidence 321 1111 1111111000111134678999999999999999994433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.03 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=198.2
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc----------chHHHHHHHHHhhhcCCCceeeeeeeeeecc
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN----------GDREFIAEVEMLSRLHHRNLVKLIGICIEGR 444 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~----------~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 444 (780)
+|...+.||+|+||.||+|... +|+.||+|.++..... ..+.+.+|++++++++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999864 6899999988542111 1235788999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccc
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGL 524 (780)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999953 357899999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCcc-ceeccccCccccCchhhccCC--CCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccc
Q 048425 525 AREATEGSQH-ISTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTR 601 (780)
Q Consensus 525 A~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~--~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~ 601 (780)
++........ ......|+..|+|||.+.... ++.++||||||+++|||++|+.|+...... ..+... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~----~~~- 227 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFKL----GNK- 227 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHHHHh----hcc-
Confidence 9865432211 123456889999999987654 789999999999999999999998643211 111110 000
Q ss_pred cccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 602 EGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 602 ~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.....++.. ...+....+.+++..|++.+|++||++.||++
T Consensus 228 -~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 228 -RSAPPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred -ccCCcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 001111111 11123357888999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=311.74 Aligned_cols=256 Identities=30% Similarity=0.459 Sum_probs=202.7
Q ss_pred HHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeeeecc-----
Q 048425 372 KATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGR----- 444 (780)
Q Consensus 372 ~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~----- 444 (780)
.++++|+..+.||+|+||.||+|... +++.+++|++..... ..++|.+|+++++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35689999999999999999999985 678999999865543 346799999999999 7999999999997644
Q ss_pred -eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccc
Q 048425 445 -TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 445 -~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFG 523 (780)
..++||||+++++|.+++.........+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 479999999999999998754434568999999999999999999999988 9999999999999999999999999
Q ss_pred ccccccCCCccceeccccCccccCchhhcc-----CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccc
Q 048425 524 LAREATEGSQHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLL 598 (780)
Q Consensus 524 LA~~~~~~~~~~~t~~~GT~~Y~APE~l~~-----~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll 598 (780)
++......... .....|+..|+|||++.. ..++.++|||||||+++||++|+.||....+. ..+....
T Consensus 159 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~---- 231 (275)
T cd06608 159 VSAQLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFKIP---- 231 (275)
T ss_pred cceecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHHhh----
Confidence 99765433221 233458899999998754 34678999999999999999999999643221 1111110
Q ss_pred ccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 599 TTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 599 ~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
. -..+.+. ........+.+++.+|+..||++||++.|+++
T Consensus 232 ~-------~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 R-------NPPPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred c-------cCCCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 0001111 11123357889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=340.75 Aligned_cols=194 Identities=25% Similarity=0.335 Sum_probs=168.4
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
..+|...+.||+|+||.||++... .++.||||... ...+.+|+++|++++|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346999999999999999999976 57889999642 23467899999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+ .++|.+++.. ....++|.+++.|+.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 242 ~-~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 Y-RSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred c-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 9 4788888852 3347999999999999999999999998 9999999999999999999999999998764332
Q ss_pred c-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCC
Q 048425 533 Q-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVD 580 (780)
Q Consensus 533 ~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~ 580 (780)
. .......||..|+|||++.+..++.++|||||||+||||++|..++.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 1 12234679999999999999999999999999999999999887653
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=307.41 Aligned_cols=252 Identities=24% Similarity=0.360 Sum_probs=207.6
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|+..+.||+|++|.||++... +|+.|+||++..... ...++|.+|++++.+++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888899999999999999986 599999999876544 3456899999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE-DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~-~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
+++++|.+++.. ...+++..+++++.|+++||+|||+ .+ ++||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999953 3678999999999999999999999 87 999999999999999999999999999877543
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
... .....++..|+|||.+.+..++.++||||||+++|||+||+.|+..........+..+.. ....+.
T Consensus 154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----------~~~~~~ 222 (264)
T cd06623 154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----------DGPPPS 222 (264)
T ss_pred CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----------cCCCCC
Confidence 322 124568899999999999999999999999999999999999997554211112222111 000111
Q ss_pred cCCCCChh-hHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 612 LAGSYDFD-DMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 612 L~~~~~~e-e~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.+.. ....+.+++.+|++.+|++||++.|+++.
T Consensus 223 ----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 ----LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ----CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1112 34578999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.05 Aligned_cols=249 Identities=21% Similarity=0.326 Sum_probs=202.1
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
+|+..+.||+|+||.||++... +|+.||+|++.... ....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999865 68999999987542 22345799999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++++|.+++.. .....+++.++++++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999863 22346889999999999999999999987 9999999999999999999999999998764432
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
.. .....|+..|+|||++.++..+.++|||||||+++||++|+.|+...... . ......... . +
T Consensus 156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~---~~~~~~~~~------~-~-- 219 (256)
T cd08218 156 EL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---N---LVLKIIRGS------Y-P-- 219 (256)
T ss_pred hh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH---H---HHHHHhcCC------C-C--
Confidence 21 22345888999999999999999999999999999999999998643221 1 111111100 0 0
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.........+.+++.+|++.+|.+||+|.||++
T Consensus 220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 --PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred --CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 011222356889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.07 Aligned_cols=197 Identities=21% Similarity=0.248 Sum_probs=165.3
Q ss_pred ceeeccc--CceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 380 KRILGEG--GFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 380 ~~~LG~G--~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
.++||+| +|++||++... +|+.||||+++.... ...+.+.+|+++++.++||||++++++|..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4789999 78999999875 789999999975532 223467789999999999999999999999999999999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+|+|.+++... ....+++..+++++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+.........
T Consensus 83 ~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 83 YGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999998532 2345899999999999999999999988 999999999999999999999999876543221110
Q ss_pred ------ceeccccCccccCchhhcc--CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 048425 535 ------ISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLSGRKPVDM 581 (780)
Q Consensus 535 ------~~t~~~GT~~Y~APE~l~~--~~~t~ksDVySfGVvLlELlTGr~P~~~ 581 (780)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 1122356788999999876 4688999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.96 Aligned_cols=262 Identities=23% Similarity=0.316 Sum_probs=196.1
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
+|+..+.||+|+||.||+|... +|+.||+|+++.... .....+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777899999999999999975 789999999865432 2235688899999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
++ ++|.+++.. ....+++...+.++.||++||+|||+.+ |+||||||+||+++.++++||+|||+++......
T Consensus 81 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 578887752 3456999999999999999999999998 9999999999999999999999999998664332
Q ss_pred ccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccc--c---ccccc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTT--R---EGLEQ 606 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~--~---~~l~~ 606 (780)
.. .....++..|+|||++.+. .++.++|||||||++|||+||+.|+....... ..+ ......... . ..+..
T Consensus 154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQL-KRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHH-HHHHHHhCCCChHHhHHhhh
Confidence 21 2234578899999988765 46899999999999999999999864322111 110 000000000 0 00000
Q ss_pred ccCC----ccCCC-----CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 607 LVDP----SLAGS-----YDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 607 lvDp----~L~~~-----~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+.+. ..... ........+.+++.+|++.||.+|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0010 00000 00112356789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.62 Aligned_cols=264 Identities=23% Similarity=0.281 Sum_probs=199.2
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc-----chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN-----GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~-----~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
+|...+.||+|+||.||+|... +|+.||||.++..... ....+..|++++++++|+||+++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999975 6899999999765432 234578899999999999999999999998999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+ +|+|.+++.. ....+++..+++++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 9999999963 2247999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc-hhhhhcccc----cccccc
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE-NLVTWARPL----LTTREG 603 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~-~Lv~wa~~l----l~~~~~ 603 (780)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|..+|......... ......... +.....
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence 43222 223356788999998865 46789999999999999999997777644321100 000000000 000000
Q ss_pred cccccCCccCCCC-----ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 604 LEQLVDPSLAGSY-----DFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 604 l~~lvDp~L~~~~-----~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+............ .......+.+++.+|++.+|++||++.||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000000000011 1122457889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=306.40 Aligned_cols=248 Identities=21% Similarity=0.355 Sum_probs=200.5
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
+|+..+.||+|+||.||++... ++..+|||++.... ....+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788899999999999999874 78899999986543 22346799999999999999999999999988999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC-CCCeeecccccccccCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD-FTPKVSDFGLAREATEG 531 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~-~~vKLsDFGLA~~~~~~ 531 (780)
+++++|.+++.. .....+++..+++++.+++.||+|||+.+ |+||||||+||+++++ +.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999964 22446899999999999999999999987 9999999999999865 46899999999876543
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
.. .....|+..|+|||.+.+...+.++||||||+++|||++|+.|++..... ...... ... ....
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~---~~~--~~~~----- 220 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLKI---MSG--TFAP----- 220 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHHH---Hhc--CCCC-----
Confidence 22 23356889999999999888999999999999999999999998654321 111111 000 0000
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 612 L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
........+.+++..||+.+|++||++.|+++
T Consensus 221 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 ----ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ----CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=311.77 Aligned_cols=199 Identities=29% Similarity=0.398 Sum_probs=180.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|+..+.||.|+||+|...+.+ +|..+|+|+|++..- .+.+...+|..+|+.+.||.+++|.+.|.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46777799999999999999976 788999999977643 23345788999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|.|..+|+ +.++++.....-+|.+|+.||+|||+.+ |++||+||+|||||.+|.+||.|||+|+....
T Consensus 124 eyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 9999999999995 4567999999999999999999999998 99999999999999999999999999998765
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCc
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQP 584 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~ 584 (780)
. ....+||+.|+|||.+....+..++|.|+|||++|||+.|..||...++
T Consensus 197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 3 3568999999999999999999999999999999999999999976654
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=317.64 Aligned_cols=197 Identities=24% Similarity=0.357 Sum_probs=161.7
Q ss_pred eeecccCceEEEEEEEe---CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeee--cceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMD---NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIE--GRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~---~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~LV~Ey~~~ 455 (780)
++||+|+||+||+|... +++.||+|.+.... ....+.+|++++++++|+||+++++++.. +...++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 67999999999999864 46789999986542 23567899999999999999999998854 356789999986
Q ss_pred CChhhhccccc-----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE----cCCCCCeeecccccc
Q 048425 456 GSVESHLHGVD-----KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL----EDDFTPKVSDFGLAR 526 (780)
Q Consensus 456 GSL~~~L~~~~-----~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL----d~~~~vKLsDFGLA~ 526 (780)
++|.+++.... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 57877764211 12336899999999999999999999998 9999999999999 456789999999998
Q ss_pred cccCCCcc--ceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 048425 527 EATEGSQH--ISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQ 583 (780)
Q Consensus 527 ~~~~~~~~--~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~ 583 (780)
........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 76543221 1234678999999999877 458899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=312.45 Aligned_cols=265 Identities=24% Similarity=0.347 Sum_probs=197.3
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|+..+.||+|++|.||+|... +++.||||.+...... ....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67888899999999999999976 7899999998754332 234678899999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++ +|.+++.. ....+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 984 89998863 3347899999999999999999999988 9999999999999999999999999987643221
Q ss_pred ccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCcc-ccchhhhhc-cc--------cccc-
Q 048425 533 QHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQ-GQENLVTWA-RP--------LLTT- 600 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~-~~~~Lv~wa-~~--------ll~~- 600 (780)
. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||...... .+....... .. ....
T Consensus 158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 1 1122346889999998875 45789999999999999999999999654311 000000000 00 0000
Q ss_pred --cc-ccccccCCccCCCC-ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 601 --RE-GLEQLVDPSLAGSY-DFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 601 --~~-~l~~lvDp~L~~~~-~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.. .........+.... .......+.+++..|++.+|++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 00000000000000 0111256788999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=319.30 Aligned_cols=247 Identities=25% Similarity=0.396 Sum_probs=199.2
Q ss_pred ccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCC
Q 048425 378 SSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNG 456 (780)
Q Consensus 378 ~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~G 456 (780)
.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+..++..++||||++++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 33467999999999999875 68899999987655555567999999999999999999999999999999999999999
Q ss_pred ChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccce
Q 048425 457 SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIS 536 (780)
Q Consensus 457 SL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~ 536 (780)
+|.+++. ...+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++......... .
T Consensus 105 ~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~ 175 (292)
T cd06658 105 ALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-R 175 (292)
T ss_pred cHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-C
Confidence 9999874 235899999999999999999999997 999999999999999999999999999765432221 2
Q ss_pred eccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCC
Q 048425 537 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSY 616 (780)
Q Consensus 537 t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~ 616 (780)
....|+..|+|||++.+..++.++|||||||++|||++|+.||....+... +.. +.....+.+...
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~-----------~~~~~~~~~~~~- 241 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--MRR-----------IRDNLPPRVKDS- 241 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-----------HHhcCCCccccc-
Confidence 334689999999999988999999999999999999999999865332111 000 011111111111
Q ss_pred ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 617 DFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 617 ~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
......+..++..|++.+|++||+++|+++.
T Consensus 242 -~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 -HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1122367789999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.98 Aligned_cols=252 Identities=24% Similarity=0.408 Sum_probs=200.5
Q ss_pred CcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCc------chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 376 KFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQN------GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
+|+..+.||+|++|.||+|.. .+++.||+|.+...... ..+.+.+|++++++++|+||+++++++.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999986 47899999998654311 23578999999999999999999999999999999
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC-CCeeeccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF-TPKVSDFGLARE 527 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~-~vKLsDFGLA~~ 527 (780)
||||+++++|.+++. ...++++..+.+++.|++.||+|||+.+ ++||||||+||+++.++ .+||+|||++..
T Consensus 81 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999985 2357899999999999999999999998 99999999999998776 599999999987
Q ss_pred ccCCCcc---ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccc
Q 048425 528 ATEGSQH---ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 528 ~~~~~~~---~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
....... ......|+..|+|||.+.+..++.++||||+|++++||++|+.||.............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------------ 221 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF------------ 221 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH------------
Confidence 6543211 1223568899999999988889999999999999999999999986433211111100
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+..........+......+.+++.+|++.+|.+||++.|+++
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 222 -KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000000011122223357888999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=314.55 Aligned_cols=196 Identities=24% Similarity=0.359 Sum_probs=160.8
Q ss_pred eeecccCceEEEEEEEe---CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeee--cceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMD---NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIE--GRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~---~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~LV~Ey~~~ 455 (780)
+.||+|+||+||+|... ++..||+|.++... ....+.+|++++++++|+||+++++++.. +...++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 67999999999999965 45789999986543 33568899999999999999999999854 4567899999875
Q ss_pred CChhhhccccc-----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE----cCCCCCeeecccccc
Q 048425 456 GSVESHLHGVD-----KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL----EDDFTPKVSDFGLAR 526 (780)
Q Consensus 456 GSL~~~L~~~~-----~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL----d~~~~vKLsDFGLA~ 526 (780)
+|.+++.... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+ ++++++||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 7777764211 12346889999999999999999999998 9999999999999 567799999999998
Q ss_pred cccCCCcc--ceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 048425 527 EATEGSQH--ISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMS 582 (780)
Q Consensus 527 ~~~~~~~~--~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~ 582 (780)
........ ......||..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76543221 1234568999999999876 45789999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=326.67 Aligned_cols=263 Identities=23% Similarity=0.316 Sum_probs=197.0
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeec------c
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEG------R 444 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~ 444 (780)
.++|...+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++|+||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 478999999999999999999865 68899999987543 22345788999999999999999999987543 3
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccc
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGL 524 (780)
..++||||+++ +|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 56999999965 6776663 24889999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchh-hh--------hcc
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENL-VT--------WAR 595 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~L-v~--------wa~ 595 (780)
++...... ......||..|+|||++.+..++.++|||||||+||||++|+.||........... .. +..
T Consensus 173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 98764322 22345689999999999999999999999999999999999999975432211000 00 000
Q ss_pred -------cccccccc-----cccccCCccC---CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 596 -------PLLTTREG-----LEQLVDPSLA---GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 596 -------~ll~~~~~-----l~~lvDp~L~---~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
........ ...+....+. ..........+.+++.+|++.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 0000000000 00111123467899999999999999999998763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.68 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=202.6
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|+..+.||+|+||.||++... +++.||+|++..... ...+++.+|++++++++|+||+++++++..++..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777789999999999999986 689999999876543 3446799999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE-DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~-~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
+++++|.+++.. ....++.....+++.|++.||+|||+ .+ ++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKE---VQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 999999999863 22678999999999999999999999 76 999999999999999999999999998766432
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
... ...|+..|+|||++.+..++.++||||||+++|||++|+.|+...... .............. ..+.
T Consensus 155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~-------~~~~ 223 (265)
T cd06605 155 LAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNE-------PPPR 223 (265)
T ss_pred Hhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcC-------CCCC
Confidence 211 256889999999999999999999999999999999999998643211 11111111111110 0011
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 612 L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+... .....+.+++..|+..+|++||++.|++.
T Consensus 224 ~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 224 LPSG---KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CChh---hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1111 13346789999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=316.69 Aligned_cols=255 Identities=23% Similarity=0.348 Sum_probs=201.7
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||.||++... .++.||+|.+..... ...+.+.+|+++++.++|+||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999975 578999999876532 23356889999999999999999999999989999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++++|.+++. ....+++..+..++.+++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLK----NIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999994 3356899999999999999999999987 99999999999999999999999999874211
Q ss_pred CC--------------ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccc
Q 048425 531 GS--------------QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARP 596 (780)
Q Consensus 531 ~~--------------~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ 596 (780)
.. ........|+..|+|||++.+..++.++||||||+++|||++|+.||....+. .+.. .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~~~---~ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFG---Q 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---H
Confidence 10 00112345788999999999889999999999999999999999999643321 1110 0
Q ss_pred ccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048425 597 LLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651 (780)
Q Consensus 597 ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~ 651 (780)
... .....+.... .....+.+++.+|++.+|++||++.++.+.|+.
T Consensus 228 ~~~-----~~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VIS-----DDIEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHh-----cccCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 000 0011111111 123467899999999999999998777666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=311.73 Aligned_cols=264 Identities=22% Similarity=0.314 Sum_probs=197.5
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
+|+..+.||+|++|.||+|... +|+.||||+++.... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5788899999999999999875 689999999865432 2335789999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+. ++|.+++.. .....+++..++.++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 689888864 23457899999999999999999999987 9999999999999999999999999998664322
Q ss_pred ccceeccccCccccCchhhccCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCcccc-chhhhhcccc-------ccc---
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ-ENLVTWARPL-------LTT--- 600 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~-~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~-~~Lv~wa~~l-------l~~--- 600 (780)
. ......++..|+|||++.+.. ++.++|||||||++|||+||+.||........ ..+..+.... ...
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 1 123335788999999887644 58899999999999999999999865432110 0011110000 000
Q ss_pred -ccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 601 -REGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 601 -~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
...........+.. ........+.+++.+|++.||++||+++|+++
T Consensus 234 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000000 00011235678999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=329.80 Aligned_cols=261 Identities=22% Similarity=0.303 Sum_probs=198.3
Q ss_pred hcCcccceeecccCceEEEEEEEe---CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD---NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~---~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
..+|...+.||+|+||.||++... .+..||||.+... +.+.+|++++++++|+||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357999999999999999999753 3578999988543 24568999999999999999999999989999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+. ++|.+++. ....++|..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 166 e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9985 68888883 3467999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc-hhhhhccccc-------cc-
Q 048425 531 GSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE-NLVTWARPLL-------TT- 600 (780)
Q Consensus 531 ~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~-~Lv~wa~~ll-------~~- 600 (780)
.... ......||..|+|||++.+..++.++|||||||+||||++|+.||......... .+....+.+. ..
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 3222 223467999999999999999999999999999999999999999654432211 1110000000 00
Q ss_pred c----cccccccCCccCCCCC-------hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 601 R----EGLEQLVDPSLAGSYD-------FDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 601 ~----~~l~~lvDp~L~~~~~-------~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
. ..+.+. .......+. ......+.+++.+|++.+|++||++.|++..
T Consensus 318 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQY-AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhh-cccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 000000 000000000 0112356789999999999999999999764
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=306.71 Aligned_cols=248 Identities=26% Similarity=0.348 Sum_probs=207.1
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|+..+.||+|.||.||.|+.+ ++-.||+|++-+.. .+...++.+|+++-+.|+||||+++++|+.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 67888899999999999999975 67889999986653 334567999999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||.++|+|...|.+ .....++......++.|+|.||.|+|..+ ||||||||+|+|++.++..||+|||.+...+.
T Consensus 102 Eya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 102 EYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 99999999999964 34557888889999999999999999987 99999999999999999999999999877653
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
+. ....+||..|++||...+...+.+.|+|++||+.||++.|..||..... .....- +.. + ++.+|
T Consensus 177 ~k---R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---~etYkr---I~k----~-~~~~p 242 (281)
T KOG0580|consen 177 NK---RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---SETYKR---IRK----V-DLKFP 242 (281)
T ss_pred CC---ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---HHHHHH---HHH----c-cccCC
Confidence 32 2457899999999999999999999999999999999999999975431 111110 000 1 11122
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
........+++..|+..+|.+|....||+..
T Consensus 243 -------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 -------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2223467889999999999999999999763
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=299.77 Aligned_cols=249 Identities=27% Similarity=0.452 Sum_probs=204.4
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
+|+..+.||+|++|.||++... ++..+++|++........+++.+|++++++++|+||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677899999999999999986 789999999977655556789999999999999999999999999999999999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+++|.+++.. ....+++..+..++.+++.||+|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 9999999863 2257999999999999999999999987 99999999999999999999999999987765432
Q ss_pred ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCC
Q 048425 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAG 614 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~ 614 (780)
.....|+..|++||++.+...+.++||||||++++||++|+.|+........ +..... .....+.+
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~------~~~~~~~~----- 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA--LFKIAT------NGPPGLRN----- 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHh------cCCCCcCc-----
Confidence 2345688999999999988899999999999999999999999865322110 000000 00011111
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 615 SYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 615 ~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.......+.+++.+|++.+|++||++.|+++
T Consensus 220 --~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 --PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred --ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0111356889999999999999999999865
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=312.37 Aligned_cols=267 Identities=24% Similarity=0.339 Sum_probs=197.9
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcc-hHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNG-DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++++|...+.||+|+||.||+|... +|..||+|++....... ...+.+|++++++++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999864 68999999986554332 346789999999999999999999999989999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+. ++|.+++.. ....+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 83 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9995 677776642 3346888999999999999999999987 99999999999999999999999999986533
Q ss_pred CCccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcc---c-------ccc
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWAR---P-------LLT 599 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~---~-------ll~ 599 (780)
.... .....++..|+|||++.+. .++.++|||||||++|||++|+.||+........-...|.. + +..
T Consensus 156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 156 PSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 2211 1233578899999988754 57889999999999999999999997543211100000100 0 000
Q ss_pred cccccccccCCccCCCC-----ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 600 TREGLEQLVDPSLAGSY-----DFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 600 ~~~~l~~lvDp~L~~~~-----~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
................. .......+.+++.+|++.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000000000 0112356778999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=308.31 Aligned_cols=248 Identities=25% Similarity=0.431 Sum_probs=200.2
Q ss_pred CcccceeecccCceEEEEEEE-eCCcEEEEEEeeccC-CcchHHHHHHHHHhhhcC---CCceeeeeeeeeecceeEEEE
Q 048425 376 KFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNN-QNGDREFIAEVEMLSRLH---HRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~LV~ 450 (780)
.|+..+.||+|+||.||+|.. .+|+.||+|.++... .....++.+|++++++++ |+|++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467778999999999999997 478999999986543 334467889999999997 999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++++|.+++.. ..+++...+.++.+++.||.|||+.+ |+||||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998842 37899999999999999999999998 99999999999999999999999999987755
Q ss_pred CCccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
.... .....|+..|+|||++.++ .++.++|||||||++|||++|+.||....... ...+. .....
T Consensus 154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~~----------~~~~~ 219 (277)
T cd06917 154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR---AMMLI----------PKSKP 219 (277)
T ss_pred Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh---hhhcc----------ccCCC
Confidence 4322 2334689999999988754 46889999999999999999999997543211 11110 00011
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
+.+... .....+.+++.+|++.+|++||++.|+++.
T Consensus 220 ~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 220 PRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 111111 133568899999999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=309.79 Aligned_cols=264 Identities=24% Similarity=0.319 Sum_probs=199.8
Q ss_pred cccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeec--ceeEEEEe
Q 048425 377 FSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEG--RTRCLVYE 451 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LV~E 451 (780)
|...+.||+|+||.||+|... +|+.+|+|++.... ....+.+.+|++++++++|+|++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999976 58999999998763 33346788999999999999999999999887 78999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++ +|.+++.. ....+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 88888853 2357999999999999999999999987 999999999999999999999999999877654
Q ss_pred CccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc-hhhhhcccccc-cccccccc-
Q 048425 532 SQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE-NLVTWARPLLT-TREGLEQL- 607 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~-~Lv~wa~~ll~-~~~~l~~l- 607 (780)
.....+...++..|+|||.+.+ ..++.++||||||+++|||+||+.||......... .+......... .......+
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 3222334457889999997765 46789999999999999999999999754432111 01110000000 00000000
Q ss_pred ----------cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 608 ----------VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 608 ----------vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
....+...+...+...+.+++..|++.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000011112457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=308.52 Aligned_cols=247 Identities=27% Similarity=0.437 Sum_probs=200.0
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
-|+..+.||+|+||.||+|... ++..||||.+..... ...+.|.+|++++++++|+||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3566789999999999999864 788999999864432 23457899999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++++|.+++. ...+++.....++.+++.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 85 ~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 9999999985 246899999999999999999999988 99999999999999999999999999986644321
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
......|+..|+|||++.+...+.++|||||||++|||++|+.|+....+. ..... +... -.+.+
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~---~~~~-------~~~~~- 221 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM---KVLFL---IPKN-------NPPTL- 221 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH---HHHHH---HhcC-------CCCCC-
Confidence 123346888999999999888999999999999999999999998643221 11110 0000 00111
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.......+.+++.+|++.+|.+||++.++++.
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 ---EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11223567889999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=304.76 Aligned_cols=249 Identities=20% Similarity=0.353 Sum_probs=200.9
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
+|...+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|++++++++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5778899999999999999976 68899999986542 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC-CCeeecccccccccCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF-TPKVSDFGLAREATEG 531 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~-~vKLsDFGLA~~~~~~ 531 (780)
+++++|.+++.. .....+++..+++++.|++.||+|||+.+ ++|+||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999864 23346899999999999999999999987 99999999999999885 4699999999876543
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
.. ......|+..|+|||++.+..++.++||||||+++|||++|+.|+..... ..+....... .+.+
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~------~~~~- 221 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQG------YFAP- 221 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhcc------cCCC-
Confidence 22 22334589999999999988999999999999999999999999864321 1111111110 0111
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 612 L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
........+.+++.+|++.+|++||++.||++
T Consensus 222 ----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 ----ISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 01122346889999999999999999999965
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.01 Aligned_cols=261 Identities=25% Similarity=0.338 Sum_probs=196.3
Q ss_pred HHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeec----
Q 048425 371 EKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEG---- 443 (780)
Q Consensus 371 ~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~---- 443 (780)
....++|...+.||+|+||.||+|... ++..||||++..... ...+.+.+|++++++++|+||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 345688999999999999999999864 788999999865422 2335688999999999999999999987543
Q ss_pred --ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeec
Q 048425 444 --RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSD 521 (780)
Q Consensus 444 --~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsD 521 (780)
...++++|++ +++|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcC
Confidence 3568999988 788988774 246999999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccc
Q 048425 522 FGLAREATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTT 600 (780)
Q Consensus 522 FGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~ 600 (780)
||+++...... ....||..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+..+....-..
T Consensus 162 fg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~ 235 (343)
T cd07878 162 FGLARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEVVGTP 235 (343)
T ss_pred CccceecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCC
Confidence 99998764422 33468999999999877 578899999999999999999999996543211 111110000000
Q ss_pred -cc---------------ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 601 -RE---------------GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 601 -~~---------------~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+ .+.......+...+ ......+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 00000000000000 011234679999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.03 Aligned_cols=253 Identities=23% Similarity=0.396 Sum_probs=198.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|+..+.||+|+||.||++... +|..||+|.++.... .....|.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778899999999999999986 789999999865422 2345789999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++++|..++... .....+++..+..++.+++.||.|||+.. +|+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 9999999988642 12347899999999999999999999742 39999999999999999999999999997664322
Q ss_pred ccceeccccCccccCchhhccC------CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~------~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
.....|+..|+|||++.+. .++.++|||||||++|||++|+.||...... .... .+..
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~----------~~~~ 221 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFA----------QLSA 221 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHH----------HHHH
Confidence 2234588899999988554 3478999999999999999999999643211 1110 0111
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+.+... .....+....+.+++.+|++.+|++||++.+++.
T Consensus 222 ~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 222 IVDGDP-PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HhhcCC-CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 111000 0111223456788999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=316.38 Aligned_cols=245 Identities=23% Similarity=0.364 Sum_probs=198.9
Q ss_pred ceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCCh
Q 048425 380 KRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSV 458 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL 458 (780)
...||+|+||.||++... +++.||+|.+........+.+.+|+.++..++|+||+++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999875 6899999999766555567789999999999999999999999999999999999999999
Q ss_pred hhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccceec
Q 048425 459 ESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR 538 (780)
Q Consensus 459 ~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~ 538 (780)
.+++. ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++......... ...
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~ 176 (297)
T cd06659 106 TDIVS-----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKS 176 (297)
T ss_pred HHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc-ccc
Confidence 98874 245899999999999999999999988 999999999999999999999999999765433221 233
Q ss_pred cccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCCh
Q 048425 539 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDF 618 (780)
Q Consensus 539 ~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ 618 (780)
..|+..|+|||++.+..++.++|||||||++|||++|+.||....+... +. .... ...+.... ..
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~-~~~~----------~~~~~~~~--~~ 241 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--MK-RLRD----------SPPPKLKN--AH 241 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH-HHhc----------cCCCCccc--cC
Confidence 5689999999999998999999999999999999999999975432111 11 1000 00000000 01
Q ss_pred hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 619 DDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 619 ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.....+.+++..|++.+|++||+++||++.
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 122457889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=299.02 Aligned_cols=250 Identities=26% Similarity=0.375 Sum_probs=204.2
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeec--ceeEEEE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEG--RTRCLVY 450 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LV~ 450 (780)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+.+. +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999986 789999999876543 3456799999999999999999999999988 8899999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++++|.+++.. ...+++..++.++.++++||+|||+.+ ++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999853 238999999999999999999999987 99999999999999999999999999988765
Q ss_pred CCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 531 GSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 531 ~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
.... ......++..|++||.+.+...+.++||||||++++||++|+.||...... ...+ .... .
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~----~~~~----------~ 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-MAAL----YKIG----------S 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-HHHH----Hhcc----------c
Confidence 4321 123456888999999999888999999999999999999999999754310 0000 0000 0
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.......+......+.+++.+|++.+|++||++.|+++
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 00001112222457889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=310.96 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=203.6
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
++|...+.||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|+||++++++|..++..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67888899999999999999864 68899999987655555677999999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++++|.+++.. ..+++.++..++.+++.||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999852 35889999999999999999999998 99999999999999999999999999876654322
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
. .....|+..|+|||++..+.++.++|||||||++|||++|+.||....+... +..+ ..... +..
T Consensus 171 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~~----~~~~~-------~~~- 235 (293)
T cd06647 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLI----ATNGT-------PEL- 235 (293)
T ss_pred c-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eeeh----hcCCC-------CCC-
Confidence 2 2234688899999999888899999999999999999999999975433211 1100 00000 000
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.........+.+++.+||+.+|++||++.+++..
T Consensus 236 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223467889999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.34 Aligned_cols=246 Identities=22% Similarity=0.396 Sum_probs=208.9
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcchH---HHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDR---EFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~~~---~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
.+|++.+.||+|.||+|-++.. ..|+.||||.++++...+++ .+.+||+||+.|+||||+.++.+|.+.+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 5677888999999999999985 68999999999877554443 4788999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||..+|.|+||+. .++.|+..+...++.||..|+.|+|++. ++|||||.+|||||+|+++||+||||+..+..
T Consensus 133 EYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999994 5678999999999999999999999997 99999999999999999999999999988765
Q ss_pred CCccceeccccCccccCchhhccCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t-~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
.. .-+.++|++-|.+||++.+.+|. +..|-||+||+||-|+.|..||++..- ..++. . +-
T Consensus 206 ~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvr---Q----------Is- 266 (668)
T KOG0611|consen 206 KK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVR---Q----------IS- 266 (668)
T ss_pred cc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHH---H----------hh-
Confidence 43 34678999999999999998885 789999999999999999999986431 22221 1 11
Q ss_pred CccCCCC-ChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 610 PSLAGSY-DFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 610 p~L~~~~-~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
.+.| ..+......-|++||+..||++|-|+.+|...-
T Consensus 267 ---~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 267 ---RGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ---cccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1111 122334566799999999999999999997654
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=323.50 Aligned_cols=236 Identities=22% Similarity=0.271 Sum_probs=184.6
Q ss_pred ecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhc---CCCceeeeeeeeeecceeEEEEeecCC
Q 048425 383 LGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRL---HHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 383 LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
||+|+||+||+|... +|+.||||++..... .....+..|..++.+. +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 689999999865422 1223456677777765 699999999999999999999999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~ 152 (330)
T cd05586 81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T 152 (330)
T ss_pred ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence 99999884 3457899999999999999999999998 99999999999999999999999999976433222 2
Q ss_pred eeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCC
Q 048425 536 STRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAG 614 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~ 614 (780)
.....||..|+|||++.+. .++.++|||||||++|||+||+.||....... +. ..+.... ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~---~~---~~i~~~~--------~~~~~ 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ---MY---RNIAFGK--------VRFPK 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH---HH---HHHHcCC--------CCCCC
Confidence 2345799999999998765 47899999999999999999999996543211 10 0000000 00100
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHH
Q 048425 615 SYDFDDMAKVAAIASMCVHPEVTHRPFMG 643 (780)
Q Consensus 615 ~~~~ee~~~l~~La~~Cl~~dP~~RPsm~ 643 (780)
......+.+++.+|++.+|++||++.
T Consensus 219 ---~~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 219 ---NVLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred ---ccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 01124567899999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=310.91 Aligned_cols=243 Identities=24% Similarity=0.365 Sum_probs=199.2
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|+..+.||+|+||.||++... +++.||+|++..... ...+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999975 689999999875432 23456889999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999853 357899999999999999999999987 99999999999999999999999999987654
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
. .....|++.|+|||.+.+...+.++||||||+++|||++|+.||...... .... .+...
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~-------------~~~~~ 213 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYE-------------KILEG 213 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHH-------------HHhcC
Confidence 3 23456899999999999888899999999999999999999998654311 1110 00000
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRP-----FMGEVV 646 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv 646 (780)
.. ..+......+.+++.+|++.+|.+|+ +++|++
T Consensus 214 ~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 214 KV--RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred Cc--cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 00 01111235678999999999999999 555554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=308.75 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=206.1
Q ss_pred HHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 372 KATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 372 ~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
..+++|+..+.||+|++|.||+|..+ ++..|++|+++.... ..+.+.+|++++++++|+||+++++++..++..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45677888899999999999999986 689999999976544 5667899999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++++|.+++... ...+++..++.++.+++.||+|||+.+ |+|+||||+||+++.++++||+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999999642 247999999999999999999999987 99999999999999999999999999876543
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
... ......++..|++||++.+..++.++|||||||++|||++|+.|+....+.. ....+.. .....+.+
T Consensus 169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~~~~~~~------~~~~~~~~- 238 (286)
T cd06614 169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--ALFLITT------KGIPPLKN- 238 (286)
T ss_pred chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh------cCCCCCcc-
Confidence 321 1233457889999999998889999999999999999999999986433211 1111000 00000000
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.......+.+++.+|++.+|.+||++.+|++.
T Consensus 239 ------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 239 ------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ------hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01123468899999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=302.91 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=204.3
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
+|+..+.||+|+||.||+++.. +++.+|+|.+..... ....++.+|++++++++|+||+++++++.++...++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999865 788999999876432 2345788999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++++|.+++.........+++..++.++.+++.||+|||+.+ ++||||+|+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999998654344567999999999999999999999998 9999999999999999999999999998776542
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
.....|+..|++||++.+..++.++|+||||+++|||++|+.||+..... .+.... .. ...
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~---~~--~~~-------- 218 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRYKV---QR--GKY-------- 218 (256)
T ss_pred ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH---hc--CCC--------
Confidence 22345788999999999999999999999999999999999999754321 111100 00 000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..........+.+++.+|++.+|++||++.|+++
T Consensus 219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 -PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111223356899999999999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=307.95 Aligned_cols=261 Identities=23% Similarity=0.304 Sum_probs=197.1
Q ss_pred cccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 377 FSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
|+..+.||+|++|.||+|... +|..||+|++..... ...+.+.+|++++++++|+||+++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999875 799999999875432 23357889999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
+ ++|.+++... ....+++..+++++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 4 7899998632 2246899999999999999999999987 99999999999999999999999999976543221
Q ss_pred cceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccc-----------
Q 048425 534 HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTR----------- 601 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~----------- 601 (780)
. .....++..|+|||++.+. .++.++||||||+++|||++|+.||....... .+....+......
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhch
Confidence 1 1223468899999987664 56899999999999999999999986543211 1111110000000
Q ss_pred ---cccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 602 ---EGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 602 ---~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
........... ..........+.+++.+|++.+|++||+++|+++
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 232 DYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000000 0011122356889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=308.97 Aligned_cols=265 Identities=22% Similarity=0.295 Sum_probs=199.5
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeec--ceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEG--RTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LV 449 (780)
++|+..+.||+|+||.||+|... +++.+|+|.++..... ....+.+|++++.+++|+||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 56788899999999999999986 6889999999754322 234578899999999999999999999877 789999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||++ ++|.+++.. ....+++..+++++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 85 ~e~~~-~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 589888863 2346999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc-hhhhhcc-----------c
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE-NLVTWAR-----------P 596 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~-~Lv~wa~-----------~ 596 (780)
..... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||......... .+..... .
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 43221 2334578899999988764 4689999999999999999999999754322110 0100000 0
Q ss_pred ccccc-cccccccCCccCCCCChh-hHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 597 LLTTR-EGLEQLVDPSLAGSYDFD-DMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 597 ll~~~-~~l~~lvDp~L~~~~~~e-e~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+.... ..........+...+... ....+.+++..|++.+|++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000 000111111111112211 2456789999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=311.39 Aligned_cols=268 Identities=21% Similarity=0.295 Sum_probs=198.3
Q ss_pred CcccceeecccCceEEEEEEEe---CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeec--ceeE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD---NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEG--RTRC 447 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~---~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~ 447 (780)
.|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++|+||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4777889999999999999975 47899999997643 33346788999999999999999999999988 7899
Q ss_pred EEEeecCCCChhhhcccccCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC----CCCCeeecc
Q 048425 448 LVYELVHNGSVESHLHGVDKN-RGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED----DFTPKVSDF 522 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~-~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~----~~~vKLsDF 522 (780)
+||||+++ +|.+++...... ...++....+.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 666666432222 247899999999999999999999998 999999999999999 999999999
Q ss_pred cccccccCCCc--cceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCcccc-------chhhh
Q 048425 523 GLAREATEGSQ--HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ-------ENLVT 592 (780)
Q Consensus 523 GLA~~~~~~~~--~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~-------~~Lv~ 592 (780)
|+++....... .......+|..|+|||++.+. .++.++|||||||+++||++|+.||........ ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987644322 112345688999999988764 578999999999999999999999975543220 00100
Q ss_pred hcccccc----------cccccccccCCccCCCCC---------h--hhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 593 WARPLLT----------TREGLEQLVDPSLAGSYD---------F--DDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 593 wa~~ll~----------~~~~l~~lvDp~L~~~~~---------~--ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
....+-. .........+......+. . .....+.+++.+|++.||++||++.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 000000000000000011 0 22346889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.55 Aligned_cols=266 Identities=24% Similarity=0.354 Sum_probs=199.4
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
+|+..+.||+|++|.||+|+.. +|+.||||+++..... ....+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999985 6899999998765433 3456788999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++ +|.+++.... ....+++..+++++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 8888875422 2356899999999999999999999988 99999999999999999999999999986543222
Q ss_pred cceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc-hhhhhc-cccccccccccccc--
Q 048425 534 HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE-NLVTWA-RPLLTTREGLEQLV-- 608 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~-~Lv~wa-~~ll~~~~~l~~lv-- 608 (780)
. .....++..|++||.+.+. .++.++|||||||++|||++|+.||......+.. ...... .+.....+.+....
T Consensus 156 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 T-FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred c-cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 1 1234578899999988664 5689999999999999999999999754422110 011100 00000000000000
Q ss_pred CCccC-------CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 609 DPSLA-------GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 609 Dp~L~-------~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..... ..........+.+++..|++.+|.+||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 0000112346789999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=309.19 Aligned_cols=248 Identities=22% Similarity=0.360 Sum_probs=201.0
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
+|...+.||+|++|.||++... +++.|++|+++.......+.+.+|+.++++++|+||+++++++..++..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3455589999999999999864 788999999876555555678999999999999999999999999999999999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.........
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence 9999999853 46899999999999999999999998 999999999999999999999999998765443221
Q ss_pred ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCC
Q 048425 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAG 614 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~ 614 (780)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||....+.. ....... ...+.+..
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~------~~~~~~~-------~~~~~~~~ 237 (285)
T cd06648 172 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ------AMKRIRD-------NLPPKLKN 237 (285)
T ss_pred -cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHHHh-------cCCCCCcc
Confidence 233468999999999998889999999999999999999999986533211 1111000 00111111
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 615 SYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 615 ~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.......+.+++.+|++.+|++||++.|+++
T Consensus 238 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 --LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1112357899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.38 Aligned_cols=246 Identities=30% Similarity=0.429 Sum_probs=196.3
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc---chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN---GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
+.|...+.||+|+||.||+|... +|+.||+|.+...... ..+++.+|+++++.++|+||++++++|.+++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999975 6899999998654332 2356889999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||++.....
T Consensus 95 e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 677777642 3346999999999999999999999987 99999999999999999999999999976543
Q ss_pred CCccceeccccCccccCchhhc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 531 GSQHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~---~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
. ....|+..|+|||++. .+.++.++||||||+++|||+||+.|+........ ... ....
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~---~~~---~~~~------- 229 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYH---IAQN------- 229 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH---HHH---HhcC-------
Confidence 2 2345788999999874 45688999999999999999999999865432111 000 0000
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
..+.+. .......+.+++.+||+.+|++||+|.+|+..
T Consensus 230 ~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 DSPTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 001110 11223468899999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.15 Aligned_cols=268 Identities=24% Similarity=0.306 Sum_probs=200.0
Q ss_pred HHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecc----
Q 048425 372 KATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGR---- 444 (780)
Q Consensus 372 ~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~---- 444 (780)
.+.++|+..+.||+|+||.||+|... +|+.||||+++.... .....+.+|++++++++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45688999999999999999999986 689999999976532 23356788999999999999999999987654
Q ss_pred ------eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCe
Q 048425 445 ------TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPK 518 (780)
Q Consensus 445 ------~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vK 518 (780)
..++|+||+++ +|.+.+.. ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999976 67776642 3457999999999999999999999997 99999999999999999999
Q ss_pred eecccccccccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc-hhhhhccc
Q 048425 519 VSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE-NLVTWARP 596 (780)
Q Consensus 519 LsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~-~Lv~wa~~ 596 (780)
|+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... .+......
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999998775543322233456788999998765 45689999999999999999999999754321110 01110000
Q ss_pred -ccccccccccc-----cC------CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 597 -LLTTREGLEQL-----VD------PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 597 -ll~~~~~l~~l-----vD------p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.......+.+. .+ ..+..... .....+.+++..|++.+|.+||++.+|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000000 00 00000000 12357889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=308.86 Aligned_cols=266 Identities=20% Similarity=0.261 Sum_probs=196.0
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhc-CCCceeeeeeeeeecce-----
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRT----- 445 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~----- 445 (780)
++|+..+.||+|+||.||+|... +|+.||||.++.... .....+.+|+++++++ +|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999975 689999999865432 2345788999999999 46999999999887655
Q ss_pred eEEEEeecCCCChhhhcccccCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC-CCCCeeeccc
Q 048425 446 RCLVYELVHNGSVESHLHGVDKN-RGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED-DFTPKVSDFG 523 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~~-~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~-~~~vKLsDFG 523 (780)
.++||||+++ +|.+++...... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 898888643322 457899999999999999999999998 999999999999998 8999999999
Q ss_pred ccccccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccc-c
Q 048425 524 LAREATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTT-R 601 (780)
Q Consensus 524 LA~~~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~-~ 601 (780)
+++........ .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||....... .+......+... .
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHhCCCCh
Confidence 99865432111 122356888999998865 457899999999999999999999986533211 110000000000 0
Q ss_pred ccccc---ccC----CccC----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 602 EGLEQ---LVD----PSLA----GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 602 ~~l~~---lvD----p~L~----~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..... +.+ +... ..........+.+++..|++.+|.+||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 000 0000 0000112356789999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=333.48 Aligned_cols=251 Identities=27% Similarity=0.410 Sum_probs=206.9
Q ss_pred cccceeecccCceEEEEEEEe--CCc--EEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 377 FSSKRILGEGGFGCVYHGVMD--NGT--EVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~--~g~--~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
....++||+|.||.|++|.|+ +|+ .||||.++..... ...+|++|+.+|-+|+|+|+++|||+..+ ...+||+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 344578999999999999986 454 5899999877655 45789999999999999999999999987 77899999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
.++.|||.+.|+. ..+..|-...+..++.|||.||.||..+. +|||||..+|+||.....+||+||||.+.+..+
T Consensus 191 LaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 9999999999985 35667888899999999999999999987 999999999999999999999999999998766
Q ss_pred Cccc--eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 532 SQHI--STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 532 ~~~~--~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
..+. .....-.+.|+|||.+..++++.++|||+|||.||||+| |..||-+..... +.+.+
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-----------------IL~~i 328 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-----------------ILKNI 328 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-----------------HHHhc
Confidence 5432 122334668999999999999999999999999999999 788886543211 11122
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
|..-.-..+..+.+.+.+++..||..+|++||++..|++.+-
T Consensus 329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 211111224456788999999999999999999999986543
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.06 Aligned_cols=251 Identities=25% Similarity=0.415 Sum_probs=206.0
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
+|...+.||.|+||.||++... ++..|++|++..... ...+++.+|++++++++|+|++++++.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5778899999999999999975 689999999976543 3456789999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++++|.+++.........+++..+.+++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999754333578999999999999999999999997 9999999999999999999999999998765543
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
.......|+..|+|||...+..++.++||||||+++++|++|+.|++..... .+.. ..... .. +
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~---~~~~~------~~-~-- 221 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELAL---KILKG------QY-P-- 221 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHHH---HHhcC------CC-C--
Confidence 1223456888999999999999999999999999999999999998654321 1111 00000 00 0
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..+......+.+++.+|+..+|++||++.|+++
T Consensus 222 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 --PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111122356889999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=309.09 Aligned_cols=265 Identities=22% Similarity=0.278 Sum_probs=200.8
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcc--hHHHHHHHHHhhhcCCCceeeeeeeeeec--ceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNG--DREFIAEVEMLSRLHHRNLVKLIGICIEG--RTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LV 449 (780)
++|...+.|++|.||.||+|+.+ +++.||+|+++.+.... .-.-++||.+|.+++|||||.+..+.... +..+||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45666799999999999999975 78999999997654221 12468999999999999999999987643 578999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
||||+. +|...++. -..++...+..-+..|+++|++|||... |+|||||++|+|+++.|.+||+|||||+.+.
T Consensus 156 Me~~Eh-DLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 999976 78888863 3468899999999999999999999998 9999999999999999999999999999987
Q ss_pred CCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhc-----ccccccccc
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWA-----RPLLTTREG 603 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa-----~~ll~~~~~ 603 (780)
.... ..|..+-|.+|.|||.+.+ ..|+...|+||+|||+.||++++.-|.+...-++.+.+--. ..++..-..
T Consensus 229 sp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 229 SPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred CCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 6533 3466778999999999887 46889999999999999999999888766544332211000 011111000
Q ss_pred cc--------cccCCccCCCCChh-hHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 604 LE--------QLVDPSLAGSYDFD-DMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 604 l~--------~lvDp~L~~~~~~e-e~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+. .-.-..+.+.+... ..+.-.++....+..||++|-|++|.++
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00 00011111111111 1245567888899999999999998754
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=316.93 Aligned_cols=261 Identities=25% Similarity=0.348 Sum_probs=200.0
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecc-----eeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGR-----TRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~~L 448 (780)
-.|...+++|.|.||.||+|.+. +++.||||+.-.+... -.+|+++|++++|||||+|+-+|.... ...|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 34666799999999999999975 5789999998654432 236899999999999999998886532 2368
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC-CCCeeeccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD-FTPKVSDFGLARE 527 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~-~~vKLsDFGLA~~ 527 (780)
|||||+. +|.+.++.....+..++...+.-+..||.+||+|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999986 899988765556778888888889999999999999987 9999999999999966 9999999999999
Q ss_pred ccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccc-cccc-
Q 048425 528 ATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTT-REGL- 604 (780)
Q Consensus 528 ~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~-~~~l- 604 (780)
...+....+ ...|.-|+|||.+.+ ..|+.+.||||.|||+.||+-|+.-|.+....+ +|+..++-+-.. ++.+
T Consensus 176 L~~~epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 176 LVKGEPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eccCCCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHHHHHhCCCCHHHHh
Confidence 877655433 346778999998876 578999999999999999999999887755433 333322211100 0001
Q ss_pred ------ccccCCccCCC-----CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 605 ------EQLVDPSLAGS-----YDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 605 ------~~lvDp~L~~~-----~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+.-.+.+... +........++++.++++.+|.+|.+..|++.
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11111222211 12233457889999999999999999999875
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.92 Aligned_cols=258 Identities=23% Similarity=0.300 Sum_probs=194.2
Q ss_pred cccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcC-CCceeeeeeeeeec--ceeEEEEe
Q 048425 377 FSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLH-HRNLVKLIGICIEG--RTRCLVYE 451 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~--~~~~LV~E 451 (780)
|+..+.||+|+||.||+|... +++.||+|+++.... .......+|+.++.++. |+||+++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 556789999999999999865 689999999876432 22335567999999985 99999999999987 88899999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|++ |+|.+++.. ....++|.+++.++.|++.||+|||+.+ ++||||||+||++++ +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 588888753 2357899999999999999999999998 999999999999999 99999999999876443
Q ss_pred CccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccc-ccccccc-
Q 048425 532 SQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTR-EGLEQLV- 608 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~-~~l~~lv- 608 (780)
.. .....++..|+|||++.. +.++.++|||||||++|||++|+.||....+.+ .+.+........ ..+.+..
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhc
Confidence 22 133457889999997654 567899999999999999999999997544321 111111111000 0000000
Q ss_pred --------CCccCC----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 609 --------DPSLAG----SYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 609 --------Dp~L~~----~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+.... .........+.+++.+|++.+|++||+++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000 000123467899999999999999999999865
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=308.80 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=195.3
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcC-CCceeeeeeeeeecceeEEEEee
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLH-HRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
+|...+.||+|+||.||++... +|+.||+|.+..... .....+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4555678999999999999875 689999999875433 33457899999999996 99999999999988899999999
Q ss_pred cCCCChhhhcccc-cCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 453 VHNGSVESHLHGV-DKNRGPLDWEARMKIALGAARGLAYLHED-SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 453 ~~~GSL~~~L~~~-~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~-~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
+. ++|.++.... ......+++....+++.+++.||+|||+. + |+||||||+||++++++.+||+|||+++....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 86 4555443211 12346799999999999999999999975 5 99999999999999999999999999986644
Q ss_pred CCccceeccccCccccCchhhccC---CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTG---HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~---~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
... .....|+..|+|||++.+. .++.++|||||||++|||++|+.||..... ...-...... .
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-------~ 226 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-------G 226 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-------C
Confidence 322 1334688999999998776 689999999999999999999999864321 1000000000 0
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
..+.+...........+.+++.+|++.+|++||+++||++.
T Consensus 227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112222222344578899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=304.18 Aligned_cols=246 Identities=24% Similarity=0.322 Sum_probs=201.7
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
+|+..+.||.|+||.||++... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788899999999999999976 689999999975432 335689999999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++++|.+++.. ...+++.....++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999853 357899999999999999999999987 999999999999999999999999999876543
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
. ......|+..|+|||++.+..++.++||||||+++|+|++|+.|+..........+.. ....
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~----------- 216 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA----KQET----------- 216 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH----Hhcc-----------
Confidence 2 1234568889999999998889999999999999999999999997654321111111 0000
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCH--HHH
Q 048425 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFM--GEV 645 (780)
Q Consensus 612 L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm--~EV 645 (780)
.....+......+.+++.+|++.+|.+||++ +|+
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l 252 (258)
T cd05578 217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDL 252 (258)
T ss_pred ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHH
Confidence 0011112223678899999999999999999 554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=311.40 Aligned_cols=249 Identities=29% Similarity=0.416 Sum_probs=197.5
Q ss_pred cccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc---chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 377 FSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN---GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
|...+.||+|+||.||+|+.. +|..||+|++...... ..+++.+|++++++++|+|++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667789999999999999964 6899999998754322 234688999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
++ |+|.+.+. ....+++|.++..++.+++.||.|||+.+ |+||||+|+||++++++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CC-CCHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 96 57777764 23456999999999999999999999988 999999999999999999999999998765432
Q ss_pred ccceeccccCccccCchhhc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 533 QHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~---~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
....|+..|+|||++. .+.++.++|||||||++|||++|+.|+...... ..+..+..
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~-------------- 238 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQ-------------- 238 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHh--------------
Confidence 2345888999999874 467889999999999999999999998643211 11111110
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIY 653 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~ 653 (780)
..............+.+++.+|++.+|.+||++.||++.+..+.
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 239 NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 00000001122346889999999999999999999988665443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=337.54 Aligned_cols=253 Identities=28% Similarity=0.446 Sum_probs=208.4
Q ss_pred cceeecccCceEEEEEEE-eCCc----EEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 379 SKRILGEGGFGCVYHGVM-DNGT----EVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 379 ~~~~LG~G~fG~VYkg~l-~~g~----~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
..++||.|+||+||||.+ .+|+ +||+|++.... .+...+|++|+.+|.+++|+|+++|+|+|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 347899999999999986 3444 58999986654 344578999999999999999999999998755 8899999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
|+.|+|.+|++. .+..+.-+..+.|..|||+||.|||++. ++||||..+||||.+-..+||.|||+++......
T Consensus 779 mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 779 MPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred cccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 999999999974 6678999999999999999999999887 9999999999999999999999999999887655
Q ss_pred ccceec-cccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 533 QHISTR-VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 533 ~~~~t~-~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
...... ..-.+.|||-|.+....++.++|||||||.+|||+| |..|++.....+.. .+++.++.+. .
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-------dlle~geRLs---q- 921 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-------DLLEKGERLS---Q- 921 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-------HHHhccccCC---C-
Confidence 443322 223457999999999999999999999999999999 99999765432222 2233332222 1
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
+.-....+..++.+||..|+..||+++++...+.+...+
T Consensus 922 ------PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 922 ------PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ------CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 223345788999999999999999999999998877654
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=350.14 Aligned_cols=259 Identities=22% Similarity=0.358 Sum_probs=201.0
Q ss_pred HHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeec--c
Q 048425 370 LEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEG--R 444 (780)
Q Consensus 370 l~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~ 444 (780)
.....++|.+.+.||+|+||+||++... ++..||+|.+..... .....|..|+.++++|+|+|||++++++... .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3344578999999999999999999975 577899999865432 2345789999999999999999999988653 5
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC----CcEEecccCCcceEEcCC------
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSN----PRVIHRDFKASNVLLEDD------ 514 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~----p~IvHrDIKpsNILLd~~------ 514 (780)
..+|||||+++|+|.++|.........+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.+
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 6899999999999999997543445679999999999999999999998542 349999999999999643
Q ss_pred -----------CCCeeecccccccccCCCccceeccccCccccCchhhcc--CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 048425 515 -----------FTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLSGRKPVDM 581 (780)
Q Consensus 515 -----------~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~--~~~t~ksDVySfGVvLlELlTGr~P~~~ 581 (780)
+.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||+||||+||+.||..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 348999999998764332 2234579999999999864 4588999999999999999999999964
Q ss_pred CCccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 582 SQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 582 ~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.... ..+. ..+ ... .+..+ ......+.+|+..||+.+|.+||++.|++.
T Consensus 246 ~~~~--~qli---~~l-k~~------p~lpi-----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ANNF--SQLI---SEL-KRG------PDLPI-----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcH--HHHH---HHH-hcC------CCCCc-----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 3211 1111 110 000 00000 012346889999999999999999999984
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.05 Aligned_cols=237 Identities=24% Similarity=0.312 Sum_probs=192.6
Q ss_pred ecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCCh
Q 048425 383 LGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSV 458 (780)
Q Consensus 383 LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL 458 (780)
||+|++|.||+++.. +++.||+|++..... ...+.+.+|++++++++|+||+++++++.+++..++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999985 489999999875432 2346799999999999999999999999999999999999999999
Q ss_pred hhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccceec
Q 048425 459 ESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR 538 (780)
Q Consensus 459 ~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~ 538 (780)
.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++...... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 999953 345899999999999999999999987 9999999999999999999999999998775532 1233
Q ss_pred cccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCCh
Q 048425 539 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDF 618 (780)
Q Consensus 539 ~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ 618 (780)
..|+..|++||.+.+..++.++||||||+++|||++|+.|+....... .... ..+.+......++.
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~----------~~~~~~~~~~~~~~ 217 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIY----------NDILKGNGKLEFPN 217 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHH----------HHHhccCCCCCCCc
Confidence 468899999999988889999999999999999999999997543210 1111 11111011111222
Q ss_pred hhHHHHHHHHHHccccCCCCCCCH
Q 048425 619 DDMAKVAAIASMCVHPEVTHRPFM 642 (780)
Q Consensus 619 ee~~~l~~La~~Cl~~dP~~RPsm 642 (780)
.....+.+++..||+.+|++||++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~ 241 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGN 241 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCC
Confidence 224578999999999999999993
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=302.37 Aligned_cols=245 Identities=24% Similarity=0.388 Sum_probs=197.0
Q ss_pred ecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCCh
Q 048425 383 LGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSV 458 (780)
Q Consensus 383 LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL 458 (780)
||+|+||.||+++.. +|+.+++|.+..... ...+.+.+|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 499999999865533 3446789999999999999999999999999999999999999999
Q ss_pred hhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc-----
Q 048425 459 ESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ----- 533 (780)
Q Consensus 459 ~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~----- 533 (780)
.+++.. ...+++..+++++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999963 237899999999999999999999988 99999999999999999999999999986543321
Q ss_pred --cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCc
Q 048425 534 --HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 534 --~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
.......++..|++||.......+.++||||||+++|||++|+.||....+.. +... ..... . .
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~---~~~~~--~----~-- 219 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---IFQN---ILNGK--I----E-- 219 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HhcCC--c----C--
Confidence 12234567889999999998889999999999999999999999997543221 1111 00000 0 0
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 612 L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
... .......+.+++.+|++.+|++||++.+|.+.|+
T Consensus 220 ~~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 WPE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCc--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 000 0012357789999999999999999977766554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=304.25 Aligned_cols=265 Identities=21% Similarity=0.292 Sum_probs=195.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
++|+..+.||+|++|.||+|... +|+.||+|.+..... ...+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999975 789999999865432 233578899999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC-CCCCeeecccccccccC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED-DFTPKVSDFGLAREATE 530 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~-~~~vKLsDFGLA~~~~~ 530 (780)
|++ ++|.+++.. .....+++.....++.||+.||+|||+.+ |+||||||+||++++ ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 578777742 22334688888999999999999999987 999999999999985 56799999999986543
Q ss_pred CCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-hhhhc-ccc---ccccccc
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LVTWA-RPL---LTTREGL 604 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-Lv~wa-~~l---l~~~~~l 604 (780)
... ..+...++..|+|||++.+ ..++.++|||||||++|||+||+.||......+... ...+. .+. +.....+
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 221 1233457889999998866 457899999999999999999999997543221100 00000 000 0000000
Q ss_pred ccc-------cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 605 EQL-------VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 605 ~~l-------vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
... ....+. .........+.+++.+|++.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 235 PDYKSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000000 001122346789999999999999999999975
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=307.01 Aligned_cols=263 Identities=22% Similarity=0.309 Sum_probs=195.2
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecc-------
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGR------- 444 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------- 444 (780)
++|+..+.||+|+||.||+|... +++.||||.+...... ....+.+|++++++++|+||++++++|....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 57888999999999999999975 6899999998654322 2345678999999999999999999987654
Q ss_pred -eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccc
Q 048425 445 -TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 445 -~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFG 523 (780)
..++||||+.+ +|.+++.. ....+++.+.++++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 34999999964 78887752 3346899999999999999999999997 9999999999999999999999999
Q ss_pred ccccccCCCcc---ceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccc---
Q 048425 524 LAREATEGSQH---ISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARP--- 596 (780)
Q Consensus 524 LA~~~~~~~~~---~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~--- 596 (780)
++......... ......++..|+|||++.+. .++.++||||||+++|||+||+.|+....+............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99876433211 12334578899999988764 468899999999999999999999976543221111111100
Q ss_pred --ccccccc---ccc---------ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 597 --LLTTREG---LEQ---------LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 597 --ll~~~~~---l~~---------lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
....... ... .+...+.. ......+.+++.+|++.||++||+++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~---~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKP---YVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhccc---ccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000000 000 00000000 001235678999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=325.23 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=210.2
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecce-eEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRT-RCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~-~~LV~ 450 (780)
++|...++||+|+||.++..+.+ ++..+++|.+.-.... ..+...+|+.++++++|||||.+++.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57788899999999999988765 6789999998665432 23467899999999999999999999999888 89999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
+|++||+|.+.|.. .+...++...+.+++.|++.|++|||++. |+|||||+.||+++.+..+||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~--~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKE--QKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHH--HhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999975 33567899999999999999999999876 99999999999999999999999999999876
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
... ....+.||+-||.||.+.+.+|..|+|||||||++|||++-+.+|...... .|+. . ......+|
T Consensus 159 ~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~---k------i~~~~~~P 225 (426)
T KOG0589|consen 159 EDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELIL---K------INRGLYSP 225 (426)
T ss_pred chh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHH---H------HhhccCCC
Confidence 542 334578999999999999999999999999999999999999999765432 1211 1 11112222
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.+......+..++..|++.+|+.||++.+++..
T Consensus 226 -----lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 -----LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -----CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 222334578899999999999999999999886
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=306.93 Aligned_cols=267 Identities=24% Similarity=0.315 Sum_probs=201.5
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCc-eeeeeeeeeecc------
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRN-LVKLIGICIEGR------ 444 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpN-IV~L~g~~~~~~------ 444 (780)
.+|...++||+|.||+||+|+.. +|+.||+|++.-...+ ......+|+.+|++++|+| ||+|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 45666678999999999999975 7899999998765442 2345689999999999999 999999998877
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccc
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGL 524 (780)
..+|||||+ .-+|..++....+....++-..+..+..||++||+|||+.+ |+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 788999999 45899998754332245777889999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccc----cc
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL----LT 599 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~l----l~ 599 (780)
|+...-... ..+..++|.+|.|||++.+. .|+...||||+||++.||++++.-|.+....++ +....+-+ ..
T Consensus 167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q--l~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ--LFRIFRLLGTPNEK 243 (323)
T ss_pred HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH--HHHHHHHcCCCCcc
Confidence 997653322 24556789999999999886 789999999999999999999888876554322 11111000 00
Q ss_pred cccccccccCCc--cCC-----CCCh---hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 600 TREGLEQLVDPS--LAG-----SYDF---DDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 600 ~~~~l~~lvDp~--L~~-----~~~~---ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
....+..+.+-. ... .... .......+++.+|++.+|.+|.+++..++.
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000111111110 000 0000 001367899999999999999999988764
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=299.18 Aligned_cols=249 Identities=21% Similarity=0.318 Sum_probs=196.3
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC-----CcchHHHHHHHHHhhhcCCCceeeeeeeeeec--cee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN-----QNGDREFIAEVEMLSRLHHRNLVKLIGICIEG--RTR 446 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~ 446 (780)
.+|...+.||+|+||.||+|... +|..||+|.+.... ......|.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57888999999999999999875 68999999875321 12235788999999999999999999998764 457
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
++|+||+++++|.+++. ....+++....+++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999985 2345889999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCc--cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccc
Q 048425 527 EATEGSQ--HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 527 ~~~~~~~--~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
....... ...+...|+..|+|||++.+..++.++|||||||+++||++|+.||...... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~------------ 220 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AAIFK------------ 220 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HHHHH------------
Confidence 6532111 1113356899999999999888999999999999999999999998643211 11111
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+.........+......+.+++.+|++ +|.+||+..+++.
T Consensus 221 --~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 221 --IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 110001111222333568899999999 5799999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=303.45 Aligned_cols=242 Identities=25% Similarity=0.357 Sum_probs=187.5
Q ss_pred eecccCceEEEEEEEe-CCcEEEEEEeeccCCc---chHHHHHHHHHhhh---cCCCceeeeeeeeeecceeEEEEeecC
Q 048425 382 ILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN---GDREFIAEVEMLSR---LHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 382 ~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~---L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
+||+|+||.||++... +|+.+|+|.+...... ....+.+|..++.. .+|+||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999874 6899999998654321 22335555544444 479999999999998899999999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 81 ~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 999999885 3456999999999999999999999998 99999999999999999999999999976543221
Q ss_pred ceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 535 ISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
....||..|+|||.+.+ ..++.++|||||||+++||++|+.||..........+... ....+..+
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-----------~~~~~~~~- 218 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-----------TLTVNVEL- 218 (279)
T ss_pred --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-----------hhcCCcCC-
Confidence 23468999999998864 5578999999999999999999999975432211111110 00011111
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRP-----FMGEVVQA 648 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv~~ 648 (780)
+......+.+++..|++.||++|| +++|+++.
T Consensus 219 ---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 ---PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 122235678899999999999999 58888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=294.47 Aligned_cols=247 Identities=28% Similarity=0.469 Sum_probs=202.3
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
+|+..+.||+|++|.||++... +++.|++|.+..... ...+.+.+|++++++++|+|++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999875 678999999976654 3446799999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999853 367999999999999999999999988 9999999999999999999999999998776543
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
.. .....++..|+|||+..+...+.++|||++|+++|||++|+.|+...... ..+ |.. .. . ..+.
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~--~~~--~~~--~~--~-----~~~~- 218 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM--AAL--FRI--VQ--D-----DHPP- 218 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH--HHH--HHH--hc--c-----CCCC-
Confidence 22 23356889999999998888899999999999999999999998643211 111 100 00 0 0011
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+......+.+++.+|++.+|++||++.|++.
T Consensus 219 ---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 ---LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11122357789999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=304.01 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=196.0
Q ss_pred CcccceeecccCceEEEEEEE----eCCcEEEEEEeeccCC----cchHHHHHHHHHhhhc-CCCceeeeeeeeeeccee
Q 048425 376 KFSSKRILGEGGFGCVYHGVM----DNGTEVAVKLLTRNNQ----NGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTR 446 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l----~~g~~VAVK~l~~~~~----~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~ 446 (780)
+|+..+.||+|+||.||++.. .+|..||+|+++.... ...+.+.+|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 3789999999975422 2345688999999999 699999999999988889
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
++||||+++++|.+++. ....+++.....++.|+++||+|||+.+ ++||||||+|||+++++++||+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999985 2356889999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCCccceeccccCccccCchhhccC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccc
Q 048425 527 EATEGSQHISTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 527 ~~~~~~~~~~t~~~GT~~Y~APE~l~~~--~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
..............|+..|+|||++... .++.++||||||+++|||++|+.|+...... .....+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~--- 228 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE--- 228 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccC---
Confidence 7654332222345689999999998753 4678999999999999999999998643221 11111111111110
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHH
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRP-----FMGEVV 646 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv 646 (780)
+ .++......+.+++.+|++.+|++|| +++++.
T Consensus 229 -----~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 229 -----P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred -----C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 1 11122335678999999999999997 555553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=304.51 Aligned_cols=256 Identities=23% Similarity=0.293 Sum_probs=201.1
Q ss_pred CcccceeecccCceEEEEEEE----eCCcEEEEEEeeccC----CcchHHHHHHHHHhhhc-CCCceeeeeeeeeeccee
Q 048425 376 KFSSKRILGEGGFGCVYHGVM----DNGTEVAVKLLTRNN----QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTR 446 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~ 446 (780)
+|+..+.||+|++|.||++.. .+++.||||++++.. ....+.+.+|++++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467789999999999999975 357889999987542 22335688999999999 699999999999988899
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
++||||+++|+|.+++.. ...+++.....++.|+++||+|||+.+ ++||||||+||++++++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999852 356899999999999999999999987 9999999999999999999999999998
Q ss_pred cccCCCccceeccccCccccCchhhccCC--CCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccc
Q 048425 527 EATEGSQHISTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 527 ~~~~~~~~~~t~~~GT~~Y~APE~l~~~~--~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
..............|+..|+|||.+.+.. .+.++||||||+++|||++|+.||....... ............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~---- 227 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS---- 227 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc----
Confidence 76543322223356889999999987765 7889999999999999999999986432111 011111111110
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
++.. .......+.+++.+|++.+|++|||+.+|.+.|+..
T Consensus 228 ----~~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 ----KPPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ----CCCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0111 111224578899999999999999999998877643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=298.72 Aligned_cols=260 Identities=25% Similarity=0.319 Sum_probs=195.3
Q ss_pred cccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhc---CCCceeeeeeeeeecce-----
Q 048425 377 FSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRL---HHRNLVKLIGICIEGRT----- 445 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~~~~----- 445 (780)
|+..+.||+|+||.||+|... +++.||+|+++..... ....+.+|++++.++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999986 5899999999754322 234577788877766 59999999999988776
Q ss_pred eEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccc
Q 048425 446 RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA 525 (780)
.+++|||+. ++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999997 4898888532 2236999999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccc------
Q 048425 526 REATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLT------ 599 (780)
Q Consensus 526 ~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~------ 599 (780)
........ .....++..|+|||++.+..++.++|||||||++|||++|+.||....... .+..+......
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEW 230 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhc
Confidence 87654322 123457889999999999999999999999999999999999987543221 11111100000
Q ss_pred ------cccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 600 ------TREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 600 ------~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
............. .....+....+.+++.+||+.||.+||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000000 0001122356789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=305.72 Aligned_cols=266 Identities=25% Similarity=0.312 Sum_probs=197.2
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeec--ceeEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEG--RTRCL 448 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~L 448 (780)
.++|+..+.||+|+||.||+|... +|+.||+|+++..... ....+.+|++++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 367889999999999999999975 6899999998754322 234567899999999999999999998754 46799
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||+. ++|.+++.. ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++...
T Consensus 86 v~e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 478888753 2357999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-hhhhcc-------cccc
Q 048425 529 TEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LVTWAR-------PLLT 599 (780)
Q Consensus 529 ~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-Lv~wa~-------~ll~ 599 (780)
..... ..+...++..|+|||.+.+ ..++.++|||||||++|||++|+.||....+..... +..+.. +...
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 159 GLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 54321 1223346788999998865 567899999999999999999999997544322111 111100 0000
Q ss_pred ccccccccc-CCccCCCCC---hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 600 TREGLEQLV-DPSLAGSYD---FDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 600 ~~~~l~~lv-Dp~L~~~~~---~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
......... ......... ......+.+++..|++.||++||+++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 000000000 011345678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=313.61 Aligned_cols=263 Identities=24% Similarity=0.343 Sum_probs=196.9
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecc-----ee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGR-----TR 446 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~ 446 (780)
+++|...+.||+|+||.||+|... +|+.||||+++.... .....+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 478999999999999999999864 789999999865332 23456889999999999999999999876543 57
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
++|+||+.+ +|.+.+. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 84 ~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 999999974 7777764 246999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCcc--ceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccc--c
Q 048425 527 EATEGSQH--ISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTT--R 601 (780)
Q Consensus 527 ~~~~~~~~--~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~--~ 601 (780)
........ ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ..+....+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCH
Confidence 76433221 1233568999999998755 5688999999999999999999999965332110 0000000000 0
Q ss_pred cccccccCCcc---------CCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 602 EGLEQLVDPSL---------AGSYD-----FDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 602 ~~l~~lvDp~L---------~~~~~-----~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
+.+..+.+... ..... ......+.+++.+|++.+|++||++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00111110000 00000 0123468899999999999999999999775
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=304.48 Aligned_cols=266 Identities=23% Similarity=0.300 Sum_probs=196.0
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecc------
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGR------ 444 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------ 444 (780)
.++|+..+.||+|+||.||+|... +++.||||++...... ....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999975 6899999998654322 2346789999999999999999999876543
Q ss_pred --eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecc
Q 048425 445 --TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDF 522 (780)
Q Consensus 445 --~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDF 522 (780)
..++|+||+.+ +|...+.. ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 45999999965 67766652 3457999999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCc----------cceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchh-
Q 048425 523 GLAREATEGSQ----------HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENL- 590 (780)
Q Consensus 523 GLA~~~~~~~~----------~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~L- 590 (780)
|+++....... ...+...|+..|+|||++.+. .++.++|||||||++|||++|+.||...........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99986543221 112334678899999987654 578999999999999999999999975443211111
Q ss_pred hhhcccc----ccccccccccc--------CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 591 VTWARPL----LTTREGLEQLV--------DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 591 v~wa~~l----l~~~~~l~~lv--------Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
....... +.....+.... .+.+...+ ......+.+++.+|++.+|++||++.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000 00000001100 01110000 111256889999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=300.71 Aligned_cols=263 Identities=22% Similarity=0.285 Sum_probs=199.6
Q ss_pred cccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 377 FSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
|...+.||+|++|.||++... +|+.+++|+++..... ....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456688999999999999875 7899999998765433 3467889999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++ +|.+++.. ....+++..++.++.+++.||+|||+.+ |+|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 88888753 3357999999999999999999999998 9999999999999999999999999998776543
Q ss_pred cceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-hhhh-ccccccccccccc----
Q 048425 534 HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LVTW-ARPLLTTREGLEQ---- 606 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-Lv~w-a~~ll~~~~~l~~---- 606 (780)
.......++..|+|||.+.+. ..+.++||||||+++|+|+||+.||......+... .... ..+.......+..
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 122334578899999998876 78999999999999999999999986543221100 0000 0000000000000
Q ss_pred ----ccCCccC--CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 607 ----LVDPSLA--GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 607 ----lvDp~L~--~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..+.... .....+....+.+++..|++.+|.+||+++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000 0001123457889999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=304.76 Aligned_cols=251 Identities=26% Similarity=0.438 Sum_probs=194.4
Q ss_pred cCcccceeecccCceEEEEEEEeC-CcEEEEEEeeccCC-cchHHHHHHHHHhhhcC-CCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDN-GTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLH-HRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~-g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~E 451 (780)
++|...+.||+|+||.||+|..++ ++.||||+++.... ....++..|++++.+.. |+||++++++|.++...++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567788999999999999999864 89999999976533 23456777888777775 9999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED-SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~-~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
|+. ++|.+++.. ....+++..+.+++.+++.||+|||+. + |+||||+|+||++++++.+||+|||++.....
T Consensus 95 ~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 95 LMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred ccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 985 467766642 234799999999999999999999974 5 99999999999999999999999999987644
Q ss_pred CCccceeccccCccccCchhhccCC----CCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGH----LLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~----~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
.... ....++..|+|||++.+.. ++.++||||||+++|||++|+.||...... .+.+..+ .... .
T Consensus 168 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~----~~~~--~-- 236 (296)
T cd06618 168 SKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKI----LQEE--P-- 236 (296)
T ss_pred CCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHH----hcCC--C--
Confidence 3221 2335788999999987554 789999999999999999999998642211 1111111 1000 0
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
+.+. ........+.+++.+|++.+|++||++.++++.
T Consensus 237 ---~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 ---PSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ---CCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 001223568899999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=312.27 Aligned_cols=267 Identities=24% Similarity=0.323 Sum_probs=198.5
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeecc--CCcchHHHHHHHHHhhhc-CCCceeeeeeeeeec--cee
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRN--NQNGDREFIAEVEMLSRL-HHRNLVKLIGICIEG--RTR 446 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~--~~~ 446 (780)
..++|...+.||+|+||.||+|... +|+.+|||++... .......+.+|+.+++++ +|+||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3577888899999999999999975 6889999988543 222345678899999999 999999999998653 367
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
++||||++ ++|.+++.. . .++|..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~-~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----N-ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc----C-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 589888842 2 7899999999999999999999987 9999999999999999999999999998
Q ss_pred cccCCCc----cceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-hhhhccccccc
Q 048425 527 EATEGSQ----HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LVTWARPLLTT 600 (780)
Q Consensus 527 ~~~~~~~----~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-Lv~wa~~ll~~ 600 (780)
....... .......||..|+|||++.+ ..++.++||||||+++|||+||+.||....+..... +..+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 7654322 12234568999999998765 467899999999999999999999996543321110 00000000000
Q ss_pred ------ccccccccC----CccC--CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 601 ------REGLEQLVD----PSLA--GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 601 ------~~~l~~lvD----p~L~--~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
......+++ .... .....+....+.+++.+|++.+|++||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000110 0000 00001123578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=300.88 Aligned_cols=263 Identities=23% Similarity=0.312 Sum_probs=197.3
Q ss_pred cccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcC-CCceeeeeeeeeecceeEEEEeec
Q 048425 377 FSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLH-HRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
|...+.||+|+||+||+|... +++.|+||++...... ......+|++.+++++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 556789999999999999986 5789999998655332 2334567999999999 999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
+|+|.+++... ....++|..++.++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 88999988642 2357899999999999999999999987 99999999999999999999999999987654322
Q ss_pred cceeccccCccccCchhhc-cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-hhhhcccc----cccccccccc
Q 048425 534 HISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LVTWARPL----LTTREGLEQL 607 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~-~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-Lv~wa~~l----l~~~~~l~~l 607 (780)
.+...|+..|+|||++. +..++.++||||||++++||++|+.||......+... ...+.... +.....+...
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 23345888999999875 4567899999999999999999999986543221110 00000000 0000000000
Q ss_pred cCCccCC-------CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 608 VDPSLAG-------SYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 608 vDp~L~~-------~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+..+.. .........+.+++.+|++.+|++||+++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 1100000 000111357889999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=329.93 Aligned_cols=272 Identities=19% Similarity=0.212 Sum_probs=190.1
Q ss_pred HHhcCcccceeecccCceEEEEEEEeC--CcEEEEEEe--------------ec---cCCcchHHHHHHHHHhhhcCCCc
Q 048425 372 KATEKFSSKRILGEGGFGCVYHGVMDN--GTEVAVKLL--------------TR---NNQNGDREFIAEVEMLSRLHHRN 432 (780)
Q Consensus 372 ~at~~f~~~~~LG~G~fG~VYkg~l~~--g~~VAVK~l--------------~~---~~~~~~~~f~~Ei~iL~~L~HpN 432 (780)
...++|...+.||+|+||+||++.++. +..+++|.+ .+ ........|.+|+++|++++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999987642 222222211 00 11122356889999999999999
Q ss_pred eeeeeeeeeecceeEEEEeecCCCChhhhccccc-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE
Q 048425 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVD-KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL 511 (780)
Q Consensus 433 IV~L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~-~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL 511 (780)
|+++++++...+..++|+|++. ++|.+++.... ............+|+.||+.||+|||+.+ ||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999984 57777764321 11223445667889999999999999998 9999999999999
Q ss_pred cCCCCCeeecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCC-CCCCCccccchh
Q 048425 512 EDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP-VDMSQPQGQENL 590 (780)
Q Consensus 512 d~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P-~~~~~~~~~~~L 590 (780)
++++.+||+|||+++.+............||..|+|||++.+..++.++|||||||+||||++|+.+ +..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999987755433333456799999999999999999999999999999999998754 432221111122
Q ss_pred hhhccccccccc-------ccccccCC-ccCC---CCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 591 VTWARPLLTTRE-------GLEQLVDP-SLAG---SYD-----FDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 591 v~wa~~ll~~~~-------~l~~lvDp-~L~~---~~~-----~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
......+....+ .+...++. .+.. ... ......+.+++.+|++.||++||++.|++.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 111111000000 00000000 0000 000 011234667889999999999999999975
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=311.46 Aligned_cols=264 Identities=23% Similarity=0.321 Sum_probs=198.5
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeec------
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEG------ 443 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------ 443 (780)
..++|+..+.||+|+||.||+|... +|+.||||++.... .....++.+|++++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3478999999999999999999875 78999999986532 22335678899999999999999999988643
Q ss_pred ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccc
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFG 523 (780)
...++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 34699999995 588887742 2889999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc-hhhh--------hc
Q 048425 524 LAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE-NLVT--------WA 594 (780)
Q Consensus 524 LA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~-~Lv~--------wa 594 (780)
+++....... .....|+..|+|||.+.+..++.++|||||||++|||++|+.||......... .+.. +.
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9987644322 23345888999999999999999999999999999999999999654321100 0000 00
Q ss_pred -------ccccccc-----cccccccCCccC----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 595 -------RPLLTTR-----EGLEQLVDPSLA----GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 595 -------~~ll~~~-----~~l~~lvDp~L~----~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
....... ..+.++....+. ..........+.+++.+|++.||++||++.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 001111111110 00011234567899999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.89 Aligned_cols=240 Identities=26% Similarity=0.372 Sum_probs=190.5
Q ss_pred ecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCCh
Q 048425 383 LGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSV 458 (780)
Q Consensus 383 LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL 458 (780)
||+|+||+||++... +|+.||+|.+.... ......+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 68999999986542 22344678899999999999999999999998999999999999999
Q ss_pred hhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccceec
Q 048425 459 ESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR 538 (780)
Q Consensus 459 ~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~ 538 (780)
.+++... ....+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++........ ...
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~ 153 (277)
T cd05577 81 KYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKG 153 (277)
T ss_pred HHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccc
Confidence 9999642 2246899999999999999999999998 99999999999999999999999999987644221 223
Q ss_pred cccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCcccc-chhhhhcccccccccccccccCCccCCCCC
Q 048425 539 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ-ENLVTWARPLLTTREGLEQLVDPSLAGSYD 617 (780)
Q Consensus 539 ~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~-~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~ 617 (780)
..++..|+|||++.++.++.++|||||||+++||++|+.||........ ..+.. ..... . ....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~--------~----~~~~ 218 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR---RTLEM--------A----VEYP 218 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh---ccccc--------c----ccCC
Confidence 4578899999999988899999999999999999999999965432111 00000 00000 0 0111
Q ss_pred hhhHHHHHHHHHHccccCCCCCCCHHH
Q 048425 618 FDDMAKVAAIASMCVHPEVTHRPFMGE 644 (780)
Q Consensus 618 ~ee~~~l~~La~~Cl~~dP~~RPsm~E 644 (780)
......+.+++.+||+.+|++||+..|
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCc
Confidence 122346789999999999999995444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=304.21 Aligned_cols=243 Identities=23% Similarity=0.366 Sum_probs=196.5
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCChh
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVE 459 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL~ 459 (780)
..||+|+||.||++... +|..||||.+..........+.+|+.++++++|+||+++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999875 78999999986554445567999999999999999999999999999999999999999999
Q ss_pred hhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccceecc
Q 048425 460 SHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRV 539 (780)
Q Consensus 460 ~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~~ 539 (780)
+++. ...+++.....++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........ .....
T Consensus 106 ~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 106 DIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 9874 235899999999999999999999987 99999999999999999999999999876644321 12335
Q ss_pred ccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCChh
Q 048425 540 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFD 619 (780)
Q Consensus 540 ~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~e 619 (780)
.|+..|+|||++.+..++.++|||||||++|||++|+.||...... ....... ....+.+.. ...
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~----------~~~~~~~~~--~~~ 241 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIR----------DNLPPKLKN--LHK 241 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----------hhCCcccCC--ccc
Confidence 6889999999998888999999999999999999999998643221 1111110 001111110 011
Q ss_pred hHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 620 DMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 620 e~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
....+.+++.+|++.+|.+||++.|+++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 2245778999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=299.77 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=201.2
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcC-CCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLH-HRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV 449 (780)
++|...+.||+|+||.||+|... +|..||+|++.... ....+.+.+|++++++++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999975 78999999986532 223467889999999998 99999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++++|.+++.. ...+++..++.|+.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999953 347999999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCc-------------------cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchh
Q 048425 530 EGSQ-------------------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENL 590 (780)
Q Consensus 530 ~~~~-------------------~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~L 590 (780)
.... .......|+..|+|||.......+.++||||||++++|+++|+.|+...... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~ 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LT 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HH
Confidence 4321 1122346788999999999888999999999999999999999999754311 10
Q ss_pred hhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCH----HHHH
Q 048425 591 VTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFM----GEVV 646 (780)
Q Consensus 591 v~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm----~EVv 646 (780)
.. .+.+ ............+.+++.+|++.+|.+||++ ++++
T Consensus 231 ~~-------------~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 231 FQ-------------KILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred HH-------------HHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 00 0000 0011112223568899999999999999999 6664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=310.38 Aligned_cols=267 Identities=22% Similarity=0.354 Sum_probs=199.5
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeee----ccee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIE----GRTR 446 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~ 446 (780)
.++|+..+.||+|+||.||+|... +|..||+|++..... ...+.+.+|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 378899999999999999999875 699999999876432 334568889999999999999999998763 3467
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
++||||+. |+|.+++. ....+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 84 ~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 68988885 3345999999999999999999999987 9999999999999999999999999998
Q ss_pred cccCCCcc---ceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhc-c-c---c
Q 048425 527 EATEGSQH---ISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWA-R-P---L 597 (780)
Q Consensus 527 ~~~~~~~~---~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa-~-~---l 597 (780)
........ ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.............-. . + .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 76433211 1234568999999998865 46889999999999999999999999654322111100000 0 0 0
Q ss_pred cc--cccccccccCC-ccCCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 598 LT--TREGLEQLVDP-SLAGSYD-----FDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 598 l~--~~~~l~~lvDp-~L~~~~~-----~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.. ..+.+....+. ....... ......+.+++..|++.+|++||++++++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 00001111100 0000111 1224678999999999999999999998764
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=313.70 Aligned_cols=250 Identities=28% Similarity=0.313 Sum_probs=207.8
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcc---hHHHHHHHHHhhhcC-CCceeeeeeeeeecceeEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNG---DREFIAEVEMLSRLH-HRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~L 448 (780)
.+.|...+.||.|.||.||+++.+ +|+.+|+|.+.+..... .....+|+.+|+++. |||||.+++++.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456778899999999999999987 59999999997765433 357899999999998 9999999999999999999
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC----CCCeeecccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD----FTPKVSDFGL 524 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~----~~vKLsDFGL 524 (780)
|||++.+|.|.+.+... .++......++.|++.+++|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999642 3999999999999999999999998 9999999999999633 5799999999
Q ss_pred cccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccc
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
+..... ......++||+.|+|||.+....++..+||||.||++|.|++|..||.......... .+....
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~--- 254 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGD--- 254 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCC---
Confidence 998876 334467889999999999999999999999999999999999999997654322111 001100
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
......+-........+++..|+..||.+|+++.++++
T Consensus 255 -----~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 255 -----FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -----CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 01111112233457788999999999999999999977
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.62 Aligned_cols=244 Identities=23% Similarity=0.294 Sum_probs=189.5
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccCCc---chHHHHHHHHHh-hhcCCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN---GDREFIAEVEML-SRLHHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL-~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
+.||+|+||.||+|... +|+.||||++...... ....+..|..++ ...+|+||+++++++.+++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999874 6899999998654321 223345555544 455899999999999999999999999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
++|.+++. ....+++..+.+++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999985 3356899999999999999999999987 99999999999999999999999999876543
Q ss_pred eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCC
Q 048425 536 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGS 615 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~ 615 (780)
.....|+..|+|||.+.+..++.++||||||+++|||++|..||....... +.. ........ ... .
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~---~~~~~~~~----~~~----~ 215 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VFD---NILSRRIN----WPE----E 215 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHH---HHHhcccC----CCC----c
Confidence 123458889999999988888999999999999999999999996543211 100 00000000 000 0
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 616 YDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 616 ~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
........+.+++.+|++.+|++||++.++.+.|.
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 11122356889999999999999998876655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.33 Aligned_cols=270 Identities=22% Similarity=0.310 Sum_probs=200.9
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeec-----ce
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEG-----RT 445 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~ 445 (780)
.++|...+.||+|+||+||+|... +|+.||||.++... ......+.+|+++++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467889999999999999999864 68999999986532 22345678899999999999999999988654 24
Q ss_pred eEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccc
Q 048425 446 RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA 525 (780)
.++||||+. ++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 68888874 3457999999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-hhhhccc-------
Q 048425 526 REATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LVTWARP------- 596 (780)
Q Consensus 526 ~~~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-Lv~wa~~------- 596 (780)
+...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||.......... .......
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 8765432 12233457889999998865 468899999999999999999999996543211000 0000000
Q ss_pred ccccc---ccc---ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHh
Q 048425 597 LLTTR---EGL---EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA--LKLIY 653 (780)
Q Consensus 597 ll~~~---~~l---~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~--L~~i~ 653 (780)
..... +.+ ....++.... ...+....+.+++.+|++.+|++||+++|+++. ++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 00000 000 0000010000 011234567899999999999999999999876 55443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.87 Aligned_cols=272 Identities=22% Similarity=0.352 Sum_probs=198.6
Q ss_pred chHHHHHH----hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeee
Q 048425 366 ALSDLEKA----TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIG 438 (780)
Q Consensus 366 ~~~el~~a----t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g 438 (780)
..+|+.++ .++|...+.||+|+||.||+|+.. +|+.||||+++... ......+.+|++++++++|+||+++++
T Consensus 2 ~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~ 81 (342)
T cd07879 2 YREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81 (342)
T ss_pred chhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhh
Confidence 34455544 378999999999999999999964 78999999987542 222356889999999999999999999
Q ss_pred eeeec------ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc
Q 048425 439 ICIEG------RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE 512 (780)
Q Consensus 439 ~~~~~------~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd 512 (780)
++... ...++|+||+.. +|..++ ...+++..+..++.|++.||+|||+.+ |+||||||+||+++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~ 151 (342)
T cd07879 82 VFTSAVSGDEFQDFYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVN 151 (342)
T ss_pred eecccccCCCCceEEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC
Confidence 98654 245899999964 666654 235899999999999999999999998 99999999999999
Q ss_pred CCCCCeeecccccccccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhh
Q 048425 513 DDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV 591 (780)
Q Consensus 513 ~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv 591 (780)
+++.+||+|||+++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............
T Consensus 152 ~~~~~kL~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~ 227 (342)
T cd07879 152 EDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 227 (342)
T ss_pred CCCCEEEeeCCCCcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999998653321 23457889999999876 46889999999999999999999999754321110000
Q ss_pred hhcccc--------ccc---cccc---ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHH
Q 048425 592 TWARPL--------LTT---REGL---EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA--LKLI 652 (780)
Q Consensus 592 ~wa~~l--------l~~---~~~l---~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~--L~~i 652 (780)
...... ... .... .......+...+ ......+.+++.+|++.||++||+++|++.. ++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 228 LKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000000 000 0000 000000000000 0122457899999999999999999999853 5544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=294.41 Aligned_cols=249 Identities=21% Similarity=0.265 Sum_probs=191.6
Q ss_pred HHHHHHhcCcccceee--cccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeeeec
Q 048425 368 SDLEKATEKFSSKRIL--GEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICIEG 443 (780)
Q Consensus 368 ~el~~at~~f~~~~~L--G~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~ 443 (780)
.+.....++|...+.+ |+|+||.||++... ++..+|+|.+........ |+.....+ +|+||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444455677776666 99999999999864 788899999865432211 22222222 799999999999999
Q ss_pred ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC-CCeeecc
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF-TPKVSDF 522 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~-~vKLsDF 522 (780)
+..++||||+++|+|.+++.. ...++|.++..++.|+++||+|||+.+ ++||||||+||+++.++ .++|+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecC
Confidence 999999999999999999953 348999999999999999999999998 99999999999999998 9999999
Q ss_pred cccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccc
Q 048425 523 GLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 523 GLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
|+++..... ....|+..|+|||++.+..++.++||||||+++|||++|+.||....... .+...|....
T Consensus 155 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~----- 223 (267)
T PHA03390 155 GLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ----- 223 (267)
T ss_pred ccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-----
Confidence 999866432 22358899999999999999999999999999999999999997433211 1112221111
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPF-MGEVVQ 647 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs-m~EVv~ 647 (780)
.... .........+.+++..|++.+|.+||+ ++|+++
T Consensus 224 ------~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 ------QKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ------cccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000 001122346788999999999999996 688753
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=295.60 Aligned_cols=250 Identities=23% Similarity=0.351 Sum_probs=196.6
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC-----CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN-----QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
+|...+.||+|+||.||++... .+..+++|.++... .....++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4677899999999999999875 34556666665321 22334577899999999999999999999998999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++++|.+++.........+++..++.++.|++.||+|||+.+ ++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999998754445568999999999999999999999988 999999999999976 469999999998764
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
.... ......|+..|+|||++.+..++.++||||||+++|+|++|+.|+..... ......... -..
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~~-------~~~ 222 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIVE-------GPT 222 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHc-------CCC
Confidence 4322 22345688899999999888889999999999999999999999864321 111101000 001
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+. .+......+.+++.+|++.+|++||++.|+++
T Consensus 223 ~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 PS----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CC----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11 12223357889999999999999999999965
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.62 Aligned_cols=247 Identities=30% Similarity=0.415 Sum_probs=194.8
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
+.|...+.||+|+||.||+|+.. ++..||+|.+..... ...+++.+|+++++.++|+|++++++++..+...++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666788999999999999975 678899999864322 22356889999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+. |+|.+++.. ....+++..+..++.+++.||.|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 95 e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 688777742 3456899999999999999999999987 99999999999999999999999999876543
Q ss_pred CCccceeccccCccccCchhhc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 531 GSQHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~---~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
. ....|+..|+|||++. .+.++.++|||||||++|||++|+.|+...... ..+..+...
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~----------- 229 (308)
T cd06634 168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQN----------- 229 (308)
T ss_pred c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHHHHhhc-----------
Confidence 2 2345888999999875 356788999999999999999999998543211 111111100
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
..+... .......+.+++.+||+.+|++||++.+|++.-
T Consensus 230 ~~~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 230 ESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CCCCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 001110 112235678999999999999999999997653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=295.55 Aligned_cols=241 Identities=24% Similarity=0.354 Sum_probs=187.6
Q ss_pred eecccCceEEEEEEEe-CCcEEEEEEeeccCCc---chHHHHHHHHH---hhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 382 ILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN---GDREFIAEVEM---LSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 382 ~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~i---L~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
+||+|+||.||++... +|+.||+|.+...... ....+..|..+ ++..+|+||+.+++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 6889999998654321 22234555444 444579999999999999999999999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+|+|.+++. ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 81 g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 999999884 3457999999999999999999999987 99999999999999999999999999976543221
Q ss_pred ceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 535 ISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
....|+..|+|||++.++ .++.++|||||||++|||++|+.||............ . .....+..+.
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~----------~~~~~~~~~~ 219 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-R----------MTLTMAVELP 219 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-H----------HhhccCCCCC
Confidence 234689999999998755 6889999999999999999999999754322111110 0 0000111111
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRP-----FMGEVVQ 647 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv~ 647 (780)
. .....+.+++.+|+..+|.+|| ++.|+++
T Consensus 220 ~----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 220 D----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred C----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1 1235788999999999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=304.17 Aligned_cols=266 Identities=21% Similarity=0.286 Sum_probs=195.3
Q ss_pred eeeccc--CceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEG--GFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G--~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
..||+| +||+||++... +|+.||||++...... ..+.+.+|+.+++.++|+||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457777 89999999874 7999999998754322 235688999999999999999999999999999999999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 9999998642 2345899999999999999999999987 9999999999999999999999998664432211110
Q ss_pred ------eeccccCccccCchhhccC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccc---------cc
Q 048425 536 ------STRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARP---------LL 598 (780)
Q Consensus 536 ------~t~~~GT~~Y~APE~l~~~--~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~---------ll 598 (780)
.....++..|+|||++.++ .++.++|||||||++|||++|+.||....... .+...... ..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCcccccc
Confidence 1112356679999998764 47899999999999999999999996543211 11110000 00
Q ss_pred ccc----------------------cccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHh
Q 048425 599 TTR----------------------EGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA--LKLIY 653 (780)
Q Consensus 599 ~~~----------------------~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~--L~~i~ 653 (780)
... .....+.+..+...........+.+++.+|++.||++|||++|+++. ++.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 000 00001111112112222345678999999999999999999999753 44443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=300.88 Aligned_cols=260 Identities=20% Similarity=0.238 Sum_probs=192.6
Q ss_pred eeecccCceEEEEEEEeCCcEEEEEEeecc--CCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCCh
Q 048425 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRN--NQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSV 458 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL 458 (780)
+.+|.|+++.||++.. +|+.||||+++.. .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4455666666666655 7899999998765 233446799999999999999999999999999999999999999999
Q ss_pred hhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc-----
Q 048425 459 ESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ----- 533 (780)
Q Consensus 459 ~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~----- 533 (780)
.+++... ....+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.+........
T Consensus 87 ~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 87 EDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999642 2346889999999999999999999998 99999999999999999999999999876543211
Q ss_pred -cceeccccCccccCchhhcc--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhc----cccccc------
Q 048425 534 -HISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWA----RPLLTT------ 600 (780)
Q Consensus 534 -~~~t~~~GT~~Y~APE~l~~--~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa----~~ll~~------ 600 (780)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||....... .+.... ...+..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhh
Confidence 11233457888999999876 357899999999999999999999997543211 111100 000000
Q ss_pred cccccc----ccCCccCC----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 601 REGLEQ----LVDPSLAG----SYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 601 ~~~l~~----lvDp~L~~----~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
...+.. ..++.... .........+.+++.+||+.||++||+++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 01111000 1111223567889999999999999999999774
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=333.95 Aligned_cols=266 Identities=26% Similarity=0.441 Sum_probs=210.8
Q ss_pred HHHHhcCcccceeecccCceEEEEEEEe----C----CcEEEEEEeeccCCc-chHHHHHHHHHhhhc-CCCceeeeeee
Q 048425 370 LEKATEKFSSKRILGEGGFGCVYHGVMD----N----GTEVAVKLLTRNNQN-GDREFIAEVEMLSRL-HHRNLVKLIGI 439 (780)
Q Consensus 370 l~~at~~f~~~~~LG~G~fG~VYkg~l~----~----g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~L~g~ 439 (780)
++...++....+.||+|.||.|++|... . ...||||.++..... ..+.+..|+++|+.+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 4444555566679999999999999854 1 356999999876544 446799999999998 69999999999
Q ss_pred eeecceeEEEEeecCCCChhhhccccc---C-------CC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCc
Q 048425 440 CIEGRTRCLVYELVHNGSVESHLHGVD---K-------NR--GPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKAS 507 (780)
Q Consensus 440 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~---~-------~~--~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKps 507 (780)
|.+++..++|.||+..|+|.++|+..+ . .. ..|+..+.+.++.|||.||+||++.. +|||||..+
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999899999999999999999997544 0 01 24899999999999999999999987 999999999
Q ss_pred ceEEcCCCCCeeecccccccccCCCccceecccc--CccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCc
Q 048425 508 NVLLEDDFTPKVSDFGLAREATEGSQHISTRVMG--TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQP 584 (780)
Q Consensus 508 NILLd~~~~vKLsDFGLA~~~~~~~~~~~t~~~G--T~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~ 584 (780)
|||+.++..+||+|||+|+............-.| ...|||||.+....++.|+|||||||+||||+| |..|+....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~- 526 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP- 526 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-
Confidence 9999999999999999999765544333222223 345999999999999999999999999999999 888885411
Q ss_pred cccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 585 QGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 585 ~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
...++..+ ++.+..++ .+..+..++.++++.||+.+|++||++.|+++.++..+.
T Consensus 527 -~~~~l~~~----l~~G~r~~----------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 -PTEELLEF----LKEGNRME----------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred -cHHHHHHH----HhcCCCCC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 11222222 22222111 122334678899999999999999999999999998654
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=305.14 Aligned_cols=266 Identities=25% Similarity=0.350 Sum_probs=202.3
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeec--cCCcchHHHHHHHHHhhhcCCCceeeeeeeeee-----cc
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTR--NNQNGDREFIAEVEMLSRLHHRNLVKLIGICIE-----GR 444 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~--~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-----~~ 444 (780)
....|...+.||+|+||.|+++... +|+.||||++.. ......++-.+|+++|+.++|+||+.+++.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666789999999999999975 789999999873 334445678899999999999999999999865 35
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccc
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGL 524 (780)
..++|+|+| .-+|...+ +.+..|+.....-+..|+++||.|+|+.+ |+|||+||+|+|++.+...||+||||
T Consensus 100 DvYiV~elM-etDL~~ii----k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQII----KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHH----HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 679999999 55777777 44556999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCC-ccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccc
Q 048425 525 AREATEGS-QHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 525 A~~~~~~~-~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
|+...... ....|..+-|.+|.|||.+.+ ..|+.+.||||.||+|.||++|+.-|-+...-.+..+..-.-... ..+
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP-~~e 250 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP-SEE 250 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC-CHH
Confidence 99886431 112356678999999998764 689999999999999999999999887665444333322211111 001
Q ss_pred ccccccC----------CccCCCCCh-----hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 603 GLEQLVD----------PSLAGSYDF-----DDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 603 ~l~~lvD----------p~L~~~~~~-----ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.+..+-. +.. ...+. ..-...++|..+++..||.+|+|++|.++.
T Consensus 251 ~l~~i~s~~ar~yi~slp~~-p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQI-PKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhccHHHHHHHHhCCCC-CCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111110 000 00010 122467899999999999999999998763
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=306.59 Aligned_cols=270 Identities=23% Similarity=0.320 Sum_probs=203.8
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecc-----eeE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGR-----TRC 447 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~~ 447 (780)
+|...+.||.|+||.||+|+.. +|..||||++.... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999975 58999999987654 334467999999999999999999999988765 789
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+||||++ ++|.+++. ....+++..++.++.+++.||+|||+.+ |+||||||+|||+++++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999998 58888885 3348999999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCc--cceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-hhhhcccccc----
Q 048425 528 ATEGSQ--HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LVTWARPLLT---- 599 (780)
Q Consensus 528 ~~~~~~--~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-Lv~wa~~ll~---- 599 (780)
...... .......+|..|+|||++.+. .++.++||||||+++|||++|+.||.......... +..+......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 755431 112344688899999999887 88999999999999999999999997554321110 0110000000
Q ss_pred --cccccccccCC-ccCCC-----CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHh
Q 048425 600 --TREGLEQLVDP-SLAGS-----YDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA--LKLIY 653 (780)
Q Consensus 600 --~~~~l~~lvDp-~L~~~-----~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~--L~~i~ 653 (780)
........+.. ..... ...+....+.+++.+||+.+|++||+++++++. ++.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00000000000 00000 001123567899999999999999999999874 44443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=301.39 Aligned_cols=243 Identities=29% Similarity=0.451 Sum_probs=192.2
Q ss_pred cccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc---chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 377 FSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN---GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
|...+.||+|+||+||+|+.. +|+.|++|++...... ..+.+.+|++++++++|+|++++++++.+++..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999874 6889999998654332 234688999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+. |+|.+++. ....++++.+++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~---~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~- 174 (313)
T cd06633 103 CL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA- 174 (313)
T ss_pred CC-CCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence 96 57777774 23457999999999999999999999998 999999999999999999999999998654321
Q ss_pred ccceeccccCccccCchhhc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 533 QHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~---~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
....|+..|+|||++. .+.++.++|||||||++|||++|+.|+........ ..+. ... ..
T Consensus 175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~---~~~~---~~~--~~----- 237 (313)
T cd06633 175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHI---AQN--DS----- 237 (313)
T ss_pred ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHH---Hhc--CC-----
Confidence 2346889999999974 46688999999999999999999999865432111 1100 000 00
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+... .......+.+++.+|++.+|++||++.+++.
T Consensus 238 ~~~~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 238 PTLQ---SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1110 1111235788999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=300.13 Aligned_cols=257 Identities=18% Similarity=0.249 Sum_probs=183.3
Q ss_pred cCcccceeecccCceEEEEEEEeC----CcEEEEEEeeccCCcch-----------HHHHHHHHHhhhcCCCceeeeeee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDN----GTEVAVKLLTRNNQNGD-----------REFIAEVEMLSRLHHRNLVKLIGI 439 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~----g~~VAVK~l~~~~~~~~-----------~~f~~Ei~iL~~L~HpNIV~L~g~ 439 (780)
++|...++||+|+||+||+|...+ +..+|+|+......... .....+...+..++|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578899999999999999999754 34667775433222111 112233445566789999999997
Q ss_pred eeecc----eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC
Q 048425 440 CIEGR----TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF 515 (780)
Q Consensus 440 ~~~~~----~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~ 515 (780)
+.... ..++++|++.. ++.+.+. .....++..+..|+.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFK----RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHH----hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 66543 33667776643 5555553 2234578889999999999999999987 99999999999999999
Q ss_pred CCeeecccccccccCCCcc------ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch
Q 048425 516 TPKVSDFGLAREATEGSQH------ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN 589 (780)
Q Consensus 516 ~vKLsDFGLA~~~~~~~~~------~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~ 589 (780)
.+||+|||+|+........ ......||+.|+|||+..+..++.++|||||||+||||++|+.||....... .
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~ 241 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--N 241 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--H
Confidence 9999999999876432211 1123469999999999999999999999999999999999999997542211 1
Q ss_pred hhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 590 LVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 590 Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
+..-.. .+.+..+....+. .......+.+++..|++.+|++||++.++++.|
T Consensus 242 ~~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAK-----CDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhH-----HHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111000 0001111111110 011235688999999999999999999998876
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=294.31 Aligned_cols=262 Identities=26% Similarity=0.350 Sum_probs=198.2
Q ss_pred cccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 377 FSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
|+..+.||+|++|.||+|+.. +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999976 58999999997653 333467889999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
+ ++|.+++.. ....+++..+++++.+++.||+|||+.+ |+||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDK---RPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 589999963 2257999999999999999999999998 99999999999999999999999999987654322
Q ss_pred cceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc-hhhhhcccc-------cc----c
Q 048425 534 HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE-NLVTWARPL-------LT----T 600 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~-~Lv~wa~~l-------l~----~ 600 (780)
. .....++..|+|||.+.+. .++.++|||||||++|||++|+.||......+.. .+....... .. .
T Consensus 154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 T-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred c-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 1 2233467789999998776 8899999999999999999999998654321110 000000000 00 0
Q ss_pred ccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 601 REGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 601 ~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
............. .........+.+++..|++.+|++||++.+|+.
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000000 000011356899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=302.99 Aligned_cols=264 Identities=21% Similarity=0.265 Sum_probs=194.8
Q ss_pred cCcc-cceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcc--------------hHHHHHHHHHhhhcCCCceeeeee
Q 048425 375 EKFS-SKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNG--------------DREFIAEVEMLSRLHHRNLVKLIG 438 (780)
Q Consensus 375 ~~f~-~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~--------------~~~f~~Ei~iL~~L~HpNIV~L~g 438 (780)
++|. ..+.||+|+||+||+|... +|+.||||.++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 3477999999999999975 68999999986543221 125789999999999999999999
Q ss_pred eeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCe
Q 048425 439 ICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPK 518 (780)
Q Consensus 439 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vK 518 (780)
++..++..++||||+. |+|.+++. ....+++.....++.|++.||+|||+.+ |+|||||++||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 9999999999999996 68988884 3456899999999999999999999988 99999999999999999999
Q ss_pred eecccccccccCCC-------------ccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCc
Q 048425 519 VSDFGLAREATEGS-------------QHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQP 584 (780)
Q Consensus 519 LsDFGLA~~~~~~~-------------~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~ 584 (780)
|+|||+++...... ........++..|+|||++.+. .++.++|||||||++|||+||+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999998764111 0111223468889999998764 468999999999999999999999975543
Q ss_pred cccc-hhhhhcccccc----cccc------cccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 585 QGQE-NLVTWARPLLT----TREG------LEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 585 ~~~~-~Lv~wa~~ll~----~~~~------l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+.. .+......... .... ......+.+.. ........+.+++..|++.+|++||+++|++.
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 2110 01110000000 0000 00000000000 00112356789999999999999999999975
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=302.72 Aligned_cols=263 Identities=23% Similarity=0.298 Sum_probs=192.3
Q ss_pred CcccceeecccCceEEEEEEEe-C--CcEEEEEEeeccCC--cchHHHHHHHHHhhhc-CCCceeeeeeeeeec----ce
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-N--GTEVAVKLLTRNNQ--NGDREFIAEVEMLSRL-HHRNLVKLIGICIEG----RT 445 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~--g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~----~~ 445 (780)
+|...+.||+|+||.||++... . +..||+|++..... ...+.+.+|++++.++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999975 3 77899999865322 2245788999999999 599999999976432 35
Q ss_pred eEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccc
Q 048425 446 RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA 525 (780)
.++++||+. ++|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 678888885 68988884 3457999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCcc---ceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-hhh--------
Q 048425 526 REATEGSQH---ISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LVT-------- 592 (780)
Q Consensus 526 ~~~~~~~~~---~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-Lv~-------- 592 (780)
+........ ......||..|+|||++.+ ..++.++|||||||++|||++|+.||.......... ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 876533221 1233568999999998765 468899999999999999999999987543211000 000
Q ss_pred hccccccccc-----ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 593 WARPLLTTRE-----GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 593 wa~~ll~~~~-----~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+...+..... .........+. .........+.+++.+|++.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 00000000000 000112356889999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=306.47 Aligned_cols=272 Identities=23% Similarity=0.332 Sum_probs=202.9
Q ss_pred cccchHHHHHHhcCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeee
Q 048425 363 KTFALSDLEKATEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGI 439 (780)
Q Consensus 363 ~~f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~ 439 (780)
+.....++..++++|...+.||+|+||.||+|.. .+|+.||+|+++.... ...+.+.+|++++++++|+||++++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 4455677888999999999999999999999986 4789999999875432 234568899999999999999999998
Q ss_pred eeec------ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC
Q 048425 440 CIEG------RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED 513 (780)
Q Consensus 440 ~~~~------~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~ 513 (780)
+... ...+++++++ +++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~ 155 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE 155 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcC
Confidence 8643 3357888876 789988774 235899999999999999999999998 999999999999999
Q ss_pred CCCCeeecccccccccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc-hhh
Q 048425 514 DFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE-NLV 591 (780)
Q Consensus 514 ~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~-~Lv 591 (780)
++.+||+|||+++..... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||......... .+.
T Consensus 156 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (345)
T cd07877 156 DCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231 (345)
T ss_pred CCCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999999865432 233468899999998876 56789999999999999999999998643321110 010
Q ss_pred hhcc-------cccccc---c---ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 592 TWAR-------PLLTTR---E---GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 592 ~wa~-------~ll~~~---~---~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.+.. ..+... . .+......... .........+.+++..|++.+|.+||++.|++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 1000 000000 0 00000000000 0000123467899999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=301.12 Aligned_cols=265 Identities=24% Similarity=0.329 Sum_probs=199.1
Q ss_pred HHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeee-cc
Q 048425 369 DLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIE-GR 444 (780)
Q Consensus 369 el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~ 444 (780)
++..++++|+..+.||+|+||.||++... +|+.||||++.... ....+.+.+|++++++++||||+++++++.. +.
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 44557889999999999999999999865 78999999886532 2234678899999999999999999999865 45
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccc
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGL 524 (780)
..++|+||+ +++|.+++. ...+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 84 ~~~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred cEEEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccc
Confidence 788999998 568988874 235788888999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc-hhhhh--------c
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE-NLVTW--------A 594 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~-~Lv~w--------a 594 (780)
+....... ....++..|+|||++.+ ..++.++||||||+++|||+||+.||......... .+.++ .
T Consensus 155 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 155 ARIQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred ccccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 97643321 23357889999998766 56899999999999999999999999654321110 01111 1
Q ss_pred ccccccccccccccCCccCCCCCh-----hhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 595 RPLLTTREGLEQLVDPSLAGSYDF-----DDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 595 ~~ll~~~~~l~~lvDp~L~~~~~~-----ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
...... ...+.+.+-......+. .....+.+++.+|++.+|++||+++|++.
T Consensus 231 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 231 NTICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred Hhccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 00000000000011111 12357889999999999999999998854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=320.66 Aligned_cols=242 Identities=24% Similarity=0.415 Sum_probs=192.4
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeecc--C--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecce--eEEEEeec
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRN--N--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRT--RCLVYELV 453 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~--~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~--~~LV~Ey~ 453 (780)
.+||+|.|-+||||.+. +|.+||--.++.. . ....+.|..|+.+|+.|+|+||++++.+..+... ..+|+|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 67999999999999875 6778875544322 1 2233679999999999999999999999887654 68899999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC-CCCCeeecccccccccCCC
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED-DFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~-~~~vKLsDFGLA~~~~~~~ 532 (780)
..|+|..|+. +-+.++.+...+|+.||++||.|||++ +|||||||||.+||+|+. .|.|||+|+|||.......
T Consensus 126 TSGtLr~Y~k----k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 126 TSGTLREYRK----KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred cCCcHHHHHH----HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999984 455788999999999999999999998 699999999999999985 5899999999999876543
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
. ..+.||+.|||||.+. ..|.+..||||||+.++||+|+..||..-.... .+...+..-.. ...+..+-||
T Consensus 201 a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A--QIYKKV~SGiK-P~sl~kV~dP-- 271 (632)
T KOG0584|consen 201 A---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA--QIYKKVTSGIK-PAALSKVKDP-- 271 (632)
T ss_pred c---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH--HHHHHHHcCCC-HHHhhccCCH--
Confidence 2 3478999999999877 889999999999999999999999996433221 11111111000 1122323233
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
++.+++..|+.. ..+||++.|++.
T Consensus 272 ----------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 272 ----------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 577899999999 899999999865
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=303.30 Aligned_cols=264 Identities=23% Similarity=0.345 Sum_probs=195.1
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeec----------
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEG---------- 443 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~---------- 443 (780)
.+|...+.||+|+||.||+|... +|..||+|.+........+.+.+|++++++++|+||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67889999999999999999875 6899999998776666667899999999999999999999876543
Q ss_pred ----ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc-CCCCCe
Q 048425 444 ----RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE-DDFTPK 518 (780)
Q Consensus 444 ----~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd-~~~~vK 518 (780)
...++||||++ ++|.+++. ...+++.....++.||+.||+|||+.+ |+||||||+||+++ +++.+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35689999997 58888774 236899999999999999999999998 99999999999997 556789
Q ss_pred eecccccccccCCCcc--ceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcc
Q 048425 519 VSDFGLAREATEGSQH--ISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWAR 595 (780)
Q Consensus 519 LsDFGLA~~~~~~~~~--~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~ 595 (780)
|+|||+++........ ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||....+...........
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999865432111 1123457889999998754 567889999999999999999999997544321111100000
Q ss_pred ccccc--cccc----ccccC-CccCCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 596 PLLTT--REGL----EQLVD-PSLAGSYD-----FDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 596 ~ll~~--~~~l----~~lvD-p~L~~~~~-----~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+.... .... ..... ........ ......+.+++..|++.+|++||+++|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000 0000 00000 00000000 012246789999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=302.69 Aligned_cols=263 Identities=21% Similarity=0.339 Sum_probs=196.6
Q ss_pred HHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecc---
Q 048425 371 EKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGR--- 444 (780)
Q Consensus 371 ~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~--- 444 (780)
....++|...+.||+|+||.||++... +|..||||++...... ....+.+|++++++++|+||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 345678999999999999999999864 7899999998654322 2346889999999999999999999987543
Q ss_pred ---eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeec
Q 048425 445 ---TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSD 521 (780)
Q Consensus 445 ---~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsD 521 (780)
..++||||+ +++|.+++. ...+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 358999999 778988874 246899999999999999999999988 99999999999999999999999
Q ss_pred ccccccccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc-hhhh-------
Q 048425 522 FGLAREATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE-NLVT------- 592 (780)
Q Consensus 522 FGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~-~Lv~------- 592 (780)
||++....... ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......... ....
T Consensus 162 fg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 162 FGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99998654322 23457889999998876 46889999999999999999999999754321100 0000
Q ss_pred -hcccccccc--c---ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 593 -WARPLLTTR--E---GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 593 -wa~~ll~~~--~---~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
|...+.... . .+...-...+ ..........+.+++.+|++.||++||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 0 0000000000 0000122345789999999999999999999974
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=291.08 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=203.7
Q ss_pred HHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--c--ch----HHHHHHHHHhhhc-CCCceeeeeeeee
Q 048425 372 KATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--N--GD----REFIAEVEMLSRL-HHRNLVKLIGICI 441 (780)
Q Consensus 372 ~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~--~~----~~f~~Ei~iL~~L-~HpNIV~L~g~~~ 441 (780)
...++|...++||.|..++|-+...+ +|.+.|+|++..... . .. ++-.+|+++|+++ -||||+++.+++.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34567888899999999999998875 788999999854321 1 12 2346799999998 6999999999999
Q ss_pred ecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeec
Q 048425 442 EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSD 521 (780)
Q Consensus 442 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsD 521 (780)
.+...++|+|.|+.|.|.|+|. ....++.+...+|..|+.+|++|||..+ ||||||||+|||+|++.++||+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred CcchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 9999999999999999999994 5567999999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCccceeccccCccccCchhhcc------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcc
Q 048425 522 FGLAREATEGSQHISTRVMGTFGYVAPEYAMT------GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWAR 595 (780)
Q Consensus 522 FGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~------~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~ 595 (780)
||+|..+..+... ...+||++|+|||.+.. ..|+...|+|++||++|-|+.|..||-... +++. .+
T Consensus 167 FGFa~~l~~GekL--relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----QmlM-LR 238 (411)
T KOG0599|consen 167 FGFACQLEPGEKL--RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----QMLM-LR 238 (411)
T ss_pred cceeeccCCchhH--HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----HHHH-HH
Confidence 9999998876543 56899999999998753 367889999999999999999999985321 1110 01
Q ss_pred cccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 596 PLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 596 ~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
-+...+ -++-.|.. .+......+|+.+|++.||.+|-|.+|++..
T Consensus 239 ~ImeGk---yqF~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 239 MIMEGK---YQFRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHhcc---cccCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 111110 11111111 1233567899999999999999999999863
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=298.38 Aligned_cols=252 Identities=24% Similarity=0.297 Sum_probs=204.8
Q ss_pred cCcccceeecccCceEEEEEEEeC-CcEEEEEEeeccCCc---chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDN-GTEVAVKLLTRNNQN---GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~-g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
+.|+..+.||.|.-|+||++.+++ +..+|+|++.+.... .....+.|-+||+.++||.++.||+.+..++..||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456667889999999999999864 588999999876433 3345778999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
|||+||+|..+++. +....++.....-+|..|.-||+|||..| ||.|||||+||||-+||++.|+||.|+.....
T Consensus 157 eyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999999874 55678999999999999999999999999 99999999999999999999999999864311
Q ss_pred C---------------------------------Cc----------------------cceeccccCccccCchhhccCC
Q 048425 531 G---------------------------------SQ----------------------HISTRVMGTFGYVAPEYAMTGH 555 (780)
Q Consensus 531 ~---------------------------------~~----------------------~~~t~~~GT~~Y~APE~l~~~~ 555 (780)
. .. ..+..++||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 00 0012257999999999999999
Q ss_pred CCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccC
Q 048425 556 LLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPE 635 (780)
Q Consensus 556 ~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~d 635 (780)
-+.++|.|+|||+||||+.|..||.+.... +.+..++-..+.-....+....+.+|++..|.+|
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~----------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNK----------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCch----------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 999999999999999999999999865422 1222333322221112244567889999999999
Q ss_pred CCCCCC----HHHHHH
Q 048425 636 VTHRPF----MGEVVQ 647 (780)
Q Consensus 636 P~~RPs----m~EVv~ 647 (780)
|++|.- +.||.+
T Consensus 376 P~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhhccccchHHhhc
Confidence 999998 666644
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=315.58 Aligned_cols=244 Identities=27% Similarity=0.440 Sum_probs=199.8
Q ss_pred eeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCChh
Q 048425 381 RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVE 459 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL~ 459 (780)
-+||+|.||+||-|+.. +...+|||-+........+-+..||.+.++++|+|||+.+|.|.+++..-+.||-++||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 46999999999999975 56679999986665556667889999999999999999999999999999999999999999
Q ss_pred hhcccccCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc-CCCCCeeecccccccccCCCccce
Q 048425 460 SHLHGVDKNRGPL--DWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE-DDFTPKVSDFGLAREATEGSQHIS 536 (780)
Q Consensus 460 ~~L~~~~~~~~~L--~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd-~~~~vKLsDFGLA~~~~~~~~~~~ 536 (780)
++|. .+-++| +....-....||++||.|||++. |||||||-+|||++ -.|.+||+|||-++.+..- +...
T Consensus 661 sLLr---skWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~T 733 (1226)
T KOG4279|consen 661 SLLR---SKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCT 733 (1226)
T ss_pred HHHH---hccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-Cccc
Confidence 9996 345566 67778888999999999999997 99999999999996 5789999999999877532 3345
Q ss_pred eccccCccccCchhhccC--CCCchhhHHhHHHHHHHHHhCCCCCCCCC-ccccchhhhhcccccccccccccccCCccC
Q 048425 537 TRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVLLELLSGRKPVDMSQ-PQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 537 t~~~GT~~Y~APE~l~~~--~~t~ksDVySfGVvLlELlTGr~P~~~~~-~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
..+.||..|||||++..| .|..++|||||||.+.||.||++||..-. |+.. . .+ -++.. +.
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA----M-----Fk--VGmyK-vH---- 797 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA----M-----FK--VGMYK-VH---- 797 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh----h-----hh--hccee-cC----
Confidence 667899999999999876 57899999999999999999999995322 1110 0 00 01111 12
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
...+.+..++...++.+|+.++|.+||++.++++
T Consensus 798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 2334555678889999999999999999999865
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=297.35 Aligned_cols=267 Identities=25% Similarity=0.372 Sum_probs=216.8
Q ss_pred hHHHHHHhcCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeee
Q 048425 367 LSDLEKATEKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGI 439 (780)
Q Consensus 367 ~~el~~at~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~ 439 (780)
.+|+.....+++...++-+|.||.||+|.+. +.+.|-||.++....+ +...|+.|.-++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4566666778999999999999999999764 3456888888765443 34678999999999999999999999
Q ss_pred eeec-ceeEEEEeecCCCChhhhccccc----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC
Q 048425 440 CIEG-RTRCLVYELVHNGSVESHLHGVD----KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD 514 (780)
Q Consensus 440 ~~~~-~~~~LV~Ey~~~GSL~~~L~~~~----~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~ 514 (780)
+.+. ...+.+|.++.-|+|..+|...+ +....++..+...+|.|++.|++|||+.+ |||.||..+|+++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 9765 56688999999999999997221 23346788889999999999999999998 9999999999999999
Q ss_pred CCCeeecccccccccCCCccc-eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhh
Q 048425 515 FTPKVSDFGLAREATEGSQHI-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVT 592 (780)
Q Consensus 515 ~~vKLsDFGLA~~~~~~~~~~-~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~ 592 (780)
.++||+|-.|++.+.....+. .........||+||.+.+..|+.++|||||||+||||+| |+.|+-.-.|.+.+.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~--- 509 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH--- 509 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH---
Confidence 999999999999876654432 333445678999999999999999999999999999999 999986555443221
Q ss_pred hcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 048425 593 WARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIY 653 (780)
Q Consensus 593 wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~ 653 (780)
++.++.++.+ +.++..++..++.-||...|++||++++++.-|.+..
T Consensus 510 ----ylkdGyRlaQ----------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 510 ----YLKDGYRLAQ----------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred ----HHhccceecC----------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 2333332322 3456678899999999999999999999999997653
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=283.55 Aligned_cols=236 Identities=28% Similarity=0.339 Sum_probs=193.3
Q ss_pred ecccCceEEEEEEEe-CCcEEEEEEeeccCCc---chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCCh
Q 048425 383 LGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN---GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSV 458 (780)
Q Consensus 383 LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL 458 (780)
||+|+||.||++... +++.+|+|++...... ....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999976 5899999998765332 345789999999999999999999999999999999999999999
Q ss_pred hhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccceec
Q 048425 459 ESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR 538 (780)
Q Consensus 459 ~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~ 538 (780)
.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........ ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNT 152 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccC
Confidence 999853 346899999999999999999999987 99999999999999999999999999987654321 2234
Q ss_pred cccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCCh
Q 048425 539 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDF 618 (780)
Q Consensus 539 ~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ 618 (780)
..++..|++||...+...+.++|+||||+++|||++|+.||..... ..+.... .. .. ...+.
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~---~~----------~~--~~~~~ 214 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKI---LK----------DP--LRFPE 214 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH---hc----------CC--CCCCC
Confidence 5688899999999988889999999999999999999999965432 1111111 00 00 01111
Q ss_pred hhHHHHHHHHHHccccCCCCCCCHHH
Q 048425 619 DDMAKVAAIASMCVHPEVTHRPFMGE 644 (780)
Q Consensus 619 ee~~~l~~La~~Cl~~dP~~RPsm~E 644 (780)
.....+.+++..|+..+|++||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 22357789999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=313.01 Aligned_cols=200 Identities=27% Similarity=0.371 Sum_probs=171.0
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcC-C-----CceeeeeeeeeecceeEE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH-H-----RNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-H-----pNIV~L~g~~~~~~~~~L 448 (780)
+|.+.++||+|.||.|-|+... +++.||||+++... .-.++-..|+.+|..|+ | -|+|++++|+...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7888999999999999999864 79999999996543 33456678999999997 4 489999999999999999
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC--CCCeeecccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD--FTPKVSDFGLAR 526 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~--~~vKLsDFGLA~ 526 (780)
|+|.+ .-+|+++|.. .+...|+......|+.||+.||.+||+.+ |||+||||+||||.+- ..+||+|||.+.
T Consensus 266 VfELL-~~NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 266 VFELL-STNLYELLKN--NKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eehhh-hhhHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 99998 5699999975 34456999999999999999999999998 9999999999999754 479999999998
Q ss_pred cccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccc
Q 048425 527 EATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQG 586 (780)
Q Consensus 527 ~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~ 586 (780)
...... . ...-+.-|+|||++.+.+|+.+.||||||||+.||+||..-|-+....+
T Consensus 340 ~~~q~v---y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 340 FESQRV---Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred ccCCcc---e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 765432 1 3345667999999999999999999999999999999987776665443
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=304.16 Aligned_cols=263 Identities=22% Similarity=0.348 Sum_probs=197.4
Q ss_pred HHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecce---
Q 048425 372 KATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRT--- 445 (780)
Q Consensus 372 ~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~--- 445 (780)
...++|...+.||+|+||.||+|... ++..||||++.... ....+.+.+|+.++++++|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999985 68899999986532 2233567889999999999999999998766554
Q ss_pred ---eEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecc
Q 048425 446 ---RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDF 522 (780)
Q Consensus 446 ---~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDF 522 (780)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccc
Confidence 79999998 6799998852 46999999999999999999999988 999999999999999999999999
Q ss_pred cccccccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc-hhhhhcccc---
Q 048425 523 GLAREATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE-NLVTWARPL--- 597 (780)
Q Consensus 523 GLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~-~Lv~wa~~l--- 597 (780)
|++...... .....++..|+|||.+.+ ..++.++|||||||++|||+||+.||......... .+.+.....
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 163 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 999876443 233457889999998865 46789999999999999999999999654322110 000100000
Q ss_pred -ccc--ccccccccCCcc---CCCCC---hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 598 -LTT--REGLEQLVDPSL---AGSYD---FDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 598 -l~~--~~~l~~lvDp~L---~~~~~---~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
... .+.....+.... ...+. ......+.+++.+|++.+|++|||+.||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000 000000000000 00000 012457889999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=300.78 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=209.2
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcc--hHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNG--DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
.-|..++.||+|.|..|-++++- +|+.||||++.+...+. ...+.+|+..|+.++|||||+||++......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 44666688999999999998853 89999999997765433 3568899999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc-CCCCCeeecccccccccC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE-DDFTPKVSDFGLAREATE 530 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd-~~~~vKLsDFGLA~~~~~ 530 (780)
.=.+|+|++||- +....++.....+++.||..|+.|+|+.. +|||||||+||.+- .-|-+||.|||++..+..
T Consensus 98 LGD~GDl~DyIm---KHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIM---KHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHH---hhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999995 55667999999999999999999999998 99999999999875 568899999999988877
Q ss_pred CCccceeccccCccccCchhhccCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t-~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
+... +..+|...|-|||++.+..|+ ++.||||+||+||-|++|+.||+..... +.+..++|
T Consensus 172 G~kL--~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS----------------ETLTmImD 233 (864)
T KOG4717|consen 172 GKKL--TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS----------------ETLTMIMD 233 (864)
T ss_pred cchh--hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch----------------hhhhhhhc
Confidence 6543 567899999999999999886 7899999999999999999999754322 23333444
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
-.. ..+.-...++.+|+..|+..||++|-+.+||+..
T Consensus 234 CKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 234 CKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 322 2333445688999999999999999999998753
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=311.05 Aligned_cols=244 Identities=30% Similarity=0.440 Sum_probs=199.1
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcch---HHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGD---REFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~---~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
-|...+.||.|+||.||.++.. +.+.||||++.-...+.. .+++.|+..|.+++|||++.+.|+|..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3666788999999999999965 778899999976554443 578999999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|| -||-.|+|. -.+.+|-..++..|..|.+.||+|||+.+ .||||||+.||||++.|.|||+|||.|......
T Consensus 107 YC-lGSAsDlle---VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 107 YC-LGSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HH-hccHHHHHH---HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 99 457777774 24567889999999999999999999998 999999999999999999999999999876542
Q ss_pred CccceeccccCccccCchhhc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 532 SQHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~---~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
..++||+.|||||++. .|.|+-|+||||+|+...||.-.++|+...+. ...|...+. --
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--MSALYHIAQ-----------Ne 241 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQ-----------NE 241 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--HHHHHHHHh-----------cC
Confidence 4578999999999885 57999999999999999999999999754321 111222111 11
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.|.|. ..+-...+++++..|++.-|.+|||.+++++
T Consensus 242 sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 242 SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 22232 2233457889999999999999999987754
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=290.64 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=198.8
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeecc--CCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRN--NQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
+++|++.+.||+|.|+.||+.... +|+.+|+|+++.. ...+.+++.+|+.|-+.|+|||||+|.+.+.+....+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 367778889999999999998764 7899999987533 3446678999999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC---CCCCeeeccccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED---DFTPKVSDFGLARE 527 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~---~~~vKLsDFGLA~~ 527 (780)
|+|.+++|..-+- .+...+....-..+.||+++|.|+|.++ |||||+||.|+||.. .--+||+|||+|..
T Consensus 90 e~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999977663 2245666777788999999999999998 999999999999953 34589999999999
Q ss_pred ccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 528 ATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 528 ~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
...+ ......+||++|||||++...+|+..+|||+.||+||-|+.|+.||.... +..+.+- +.... - -
T Consensus 163 l~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~---~~rlye~---I~~g~---y-d 230 (355)
T KOG0033|consen 163 VNDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYEQ---IKAGA---Y-D 230 (355)
T ss_pred eCCc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc---HHHHHHH---Hhccc---c-C
Confidence 8743 33455679999999999999999999999999999999999999997532 1222110 00000 0 0
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+++ .+-....+...+|+.+|+..||.+|.|+.|.++
T Consensus 231 ~~~----~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 YPS----PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CCC----cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 011 011122345678999999999999999988754
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=294.54 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=206.8
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
-|.+...||+|.||.|||+.++ .|..||||.+..+ .+.+++..|+.+|++.+.+++|++||.+.....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4666788999999999999976 7999999998543 456889999999999999999999999999999999999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
.|++.+.++ ..+.+|+..++..|+...++||+|||... -||||||+.||||+.+|.+||+|||.|-.+.+....
T Consensus 112 AGSiSDI~R---~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 112 AGSISDIMR---ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred CCcHHHHHH---HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 999999996 45678999999999999999999999886 799999999999999999999999999877654322
Q ss_pred ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCC
Q 048425 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAG 614 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~ 614 (780)
...+.||+-|||||++..-.|..++||||+|+...||.-|+.|+..-.|... +.. +..-..|..+
T Consensus 186 -RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---------IFM----IPT~PPPTF~- 250 (502)
T KOG0574|consen 186 -RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---------IFM----IPTKPPPTFK- 250 (502)
T ss_pred -hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---------eEe----ccCCCCCCCC-
Confidence 3457899999999999999999999999999999999999999965443211 100 0111111111
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 615 SYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 615 ~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+.+-...+-++++.|+-.+|++|-|+.++++
T Consensus 251 -KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 251 -KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred -ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 12233457889999999999999999988865
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=319.17 Aligned_cols=145 Identities=32% Similarity=0.419 Sum_probs=131.0
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc---chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN---GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|.+.+.||+|+||+||+|... +++.||||+++..... ....+.+|++++..++|+||+++++++...+..+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67889999999999999999976 6899999999764322 2356889999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
||+++++|.+++.. ...+++...++|+.||+.||+|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999853 346889999999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=298.38 Aligned_cols=249 Identities=25% Similarity=0.373 Sum_probs=202.7
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
.+.|+.-++||+||||.||-.+.. +|+.+|.|.+.+.. ..++.-.++|-.||.+++.+.||.|--.|...+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356888899999999999998865 79999999986543 34555678999999999999999998889999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
+..|.||+|.-+|... .+..++....+-.|.+|+-||++||+.. ||.||+||+|||||+.|+++|+|.|||..+.
T Consensus 264 LtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999742 3467999999999999999999999998 9999999999999999999999999999998
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
++... ...+||.||||||+++++.|+...|.||+||+||||+.|+.||...... +.| +.++..+-
T Consensus 339 ~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-----vk~--------eEvdrr~~ 403 (591)
T KOG0986|consen 339 EGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-----VKR--------EEVDRRTL 403 (591)
T ss_pred CCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-----hhH--------HHHHHHHh
Confidence 87554 2337999999999999999999999999999999999999999643322 111 01111110
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMG 643 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~ 643 (780)
.. ...|+..-.+....+...-++.||++|.--.
T Consensus 404 ~~-~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 404 ED-PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cc-hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 00 1233333345566777788899999997543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=271.42 Aligned_cols=237 Identities=29% Similarity=0.409 Sum_probs=193.8
Q ss_pred CceEEEEEEEe-CCcEEEEEEeeccCCcc-hHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCChhhhccc
Q 048425 387 GFGCVYHGVMD-NGTEVAVKLLTRNNQNG-DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHG 464 (780)
Q Consensus 387 ~fG~VYkg~l~-~g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~ 464 (780)
+||.||+|... +|+.+|+|++....... .+.|.+|++.+++++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 58999999997765544 67899999999999999999999999998999999999999999999853
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccceeccccCcc
Q 048425 465 VDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFG 544 (780)
Q Consensus 465 ~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~ 544 (780)
...+++..++.++.+++++|+|||+.+ ++|+||+|+||++++++.++|+|||++....... ......++..
T Consensus 81 ----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 ----RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred ----ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 223899999999999999999999987 9999999999999999999999999998876542 2234568889
Q ss_pred ccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCCh-hhHHH
Q 048425 545 YVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDF-DDMAK 623 (780)
Q Consensus 545 Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~-ee~~~ 623 (780)
|++||.+....++.++|||+||++++||++|+.|+.... ....+..+... ......... .....
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~~~~~~~-------------~~~~~~~~~~~~~~~ 216 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLELFKKIGK-------------PKPPFPPPEWKISPE 216 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHhc-------------cCCCCccccccCCHH
Confidence 999999998889999999999999999999999986521 11122221110 000000000 03357
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 048425 624 VAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 624 l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+.+++.+|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 889999999999999999999975
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=323.14 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=189.6
Q ss_pred HHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeee------
Q 048425 371 EKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIE------ 442 (780)
Q Consensus 371 ~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~------ 442 (780)
.+-..+|+..++||+||||.|||++.+ ||+.+|||++.... ...-....+|+.+|++|+|||||+++....+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345578888899999999999999987 99999999986553 2223568899999999999999998732210
Q ss_pred --------------------------------------------------------------------------------
Q 048425 443 -------------------------------------------------------------------------------- 442 (780)
Q Consensus 443 -------------------------------------------------------------------------------- 442 (780)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------c--------ceeEEEEeecCCCChhhhcccccCCCCCC-CHHHHHHHHHHHHHHH
Q 048425 443 -------------------------G--------RTRCLVYELVHNGSVESHLHGVDKNRGPL-DWEARMKIALGAARGL 488 (780)
Q Consensus 443 -------------------------~--------~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L-~~~~rl~Ia~qIA~gL 488 (780)
+ ..+||-||||+.-+|.++++.. ... .-...++++.+|+.||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N----~~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN----HFNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc----ccchhhHHHHHHHHHHHHHH
Confidence 0 1135678888888877777532 111 3567899999999999
Q ss_pred HHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc------C----------CC-ccceeccccCccccCchhh
Q 048425 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT------E----------GS-QHISTRVMGTFGYVAPEYA 551 (780)
Q Consensus 489 ~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~------~----------~~-~~~~t~~~GT~~Y~APE~l 551 (780)
+|+|+++ ||||||||.||+||++..|||+|||+|.... + +. ....|..+||.-|+|||++
T Consensus 711 aYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 9999998 9999999999999999999999999998721 0 01 1123567899999999998
Q ss_pred ccC---CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCC--CCChhhHHHHHH
Q 048425 552 MTG---HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAG--SYDFDDMAKVAA 626 (780)
Q Consensus 552 ~~~---~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~--~~~~ee~~~l~~ 626 (780)
.+. +|+.|+|+||+||||+||+. ||..... ... .+..+-+..+.. ++..+++..=..
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra~-------------iL~~LR~g~iP~~~~f~~~~~~~e~s 849 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME--RAS-------------ILTNLRKGSIPEPADFFDPEHPEEAS 849 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchHH--HHH-------------HHHhcccCCCCCCcccccccchHHHH
Confidence 765 59999999999999999985 4543221 111 111122222222 234455566688
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 048425 627 IASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 627 La~~Cl~~dP~~RPsm~EVv~ 647 (780)
++.+++++||.+|||+.|++.
T Consensus 850 lI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 850 LIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHhcCCCccCCCHHHHhh
Confidence 999999999999999998864
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=308.17 Aligned_cols=271 Identities=26% Similarity=0.380 Sum_probs=204.6
Q ss_pred cccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeec------ceeEE
Q 048425 377 FSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEG------RTRCL 448 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~~~~L 448 (780)
+...+.||+|+||.||+|+.+ .|+.||||..+.... ...+...+|+++|++++|+|||++.+.-.+. +...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 344578999999999999964 899999999977543 3345688999999999999999999985543 35689
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc--CCC--CCeeecccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE--DDF--TPKVSDFGL 524 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd--~~~--~vKLsDFGL 524 (780)
|||||.+|||...|... .+...|+..+.+.+..++..||.|||+++ |+||||||.||++- ++| .-||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999865 34457999999999999999999999988 99999999999993 444 369999999
Q ss_pred cccccCCCccceeccccCccccCchhhc-cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccc-cc
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTT-RE 602 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~-~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~-~~ 602 (780)
|+...++. ..+.++||..|++||.+. .+.|+...|.|||||++||.+||..||..........-+.|. .... ..
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~--~~tkkp~ 246 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH--IITKKPS 246 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh--hhccCCC
Confidence 99998865 456789999999999998 488999999999999999999999999765432211112222 1111 11
Q ss_pred ccccccCCccCC------------CCChhhHHHHHHHHHHccccCCCCCC--CHHHHHHHHHHHhhc
Q 048425 603 GLEQLVDPSLAG------------SYDFDDMAKVAAIASMCVHPEVTHRP--FMGEVVQALKLIYND 655 (780)
Q Consensus 603 ~l~~lvDp~L~~------------~~~~ee~~~l~~La~~Cl~~dP~~RP--sm~EVv~~L~~i~~~ 655 (780)
.+....++...+ ........++.......+..+|++|= ...+.-..+..|++.
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 111111111111 11223345666666777777888887 666666666666654
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=300.65 Aligned_cols=250 Identities=21% Similarity=0.322 Sum_probs=201.3
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeecc--CCcchHHHHHHHHHhhhcC-CCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRN--NQNGDREFIAEVEMLSRLH-HRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~E 451 (780)
..|++.+.||+||.++|||+...+.+.+|+|++... +.+...-|.+|+++|.+|+ |.+||.|++|-..++.+|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 457778999999999999999888888999886543 3344567999999999994 9999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|= +.+|..+|.. +.....+| .+..+..|++.++.++|+.+ |||.||||.|+|+-. |.+||+|||+|.....+
T Consensus 441 ~G-d~DL~kiL~k--~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 441 CG-DIDLNKILKK--KKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred cc-cccHHHHHHh--ccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 85 6789999963 33344556 77788899999999999998 999999999999965 58999999999988766
Q ss_pred Cccc-eeccccCccccCchhhccC-----------CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccc
Q 048425 532 SQHI-STRVMGTFGYVAPEYAMTG-----------HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLT 599 (780)
Q Consensus 532 ~~~~-~t~~~GT~~Y~APE~l~~~-----------~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~ 599 (780)
...+ ....+||+.||+||.+... +.+.++||||+||+||+|+.|+.||..- .+ .|
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n--~~------ 579 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----IN--QI------ 579 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HH--HH------
Confidence 5443 3456899999999988643 3567999999999999999999999521 11 11
Q ss_pred cccccccccCCccCCCCCh-hhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 600 TREGLEQLVDPSLAGSYDF-DDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 600 ~~~~l~~lvDp~L~~~~~~-ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..+..+.||.-.-+|+. .....++++++.||+.||++||++.|+++
T Consensus 580 --aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 --AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 23556667654434432 22234899999999999999999999975
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=302.55 Aligned_cols=246 Identities=25% Similarity=0.382 Sum_probs=204.4
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcch--HHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGD--REFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~--~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
...|.+...||+|.|++|..|+.. +|..||||.+++...... +.+.+|+++|..++|||||+++.+......+++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467888999999999999999965 799999999977654333 45889999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+.+|.++++|. +.+.+.......++.|+.++++|||+++ |||||||.+||||+.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~----~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLV----KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHH----hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 9999999999995 3445556888889999999999999998 99999999999999999999999999998875
Q ss_pred CCccceeccccCccccCchhhccCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~-t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
+. .....+|++.|.|||++.+.++ .+++|+||+||+||-|+.|..||++..-. ++-+
T Consensus 208 ~~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--------------------~Lr~ 265 (596)
T KOG0586|consen 208 GL--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--------------------ELRP 265 (596)
T ss_pred cc--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc--------------------cccc
Confidence 43 3456789999999999998877 48999999999999999999999854321 1111
Q ss_pred CccCCCCC--hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 610 PSLAGSYD--FDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 610 p~L~~~~~--~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
+.+.+.+- .-....+.+++++.+-.+|.+|++++++.+.
T Consensus 266 rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 266 RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 12222111 1112356778889999999999999988764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=276.46 Aligned_cols=222 Identities=20% Similarity=0.179 Sum_probs=177.4
Q ss_pred cCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCChhhhccc
Q 048425 386 GGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHG 464 (780)
Q Consensus 386 G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~ 464 (780)
|.||+||++... +|+.||+|++.... ++.+|...+....|+||+++++++.+++..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999875 78999999986543 234455556666799999999999999999999999999999999853
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccceeccccCcc
Q 048425 465 VDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFG 544 (780)
Q Consensus 465 ~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~ 544 (780)
...+++.....++.|++.||+|||+.+ |+||||||+||++++++.++++|||++....... ....++..
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~ 147 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENM 147 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcc
Confidence 345899999999999999999999988 9999999999999999999999999887654321 22346778
Q ss_pred ccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCChhhHHHH
Q 048425 545 YVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKV 624 (780)
Q Consensus 545 Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l 624 (780)
|+|||...++.++.++||||+|+++|||++|+.|++...... .. .....+.. .....+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~------~~~~~~~~----~~~~~~ 205 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT------HTTLNIPE----WVSEEA 205 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc------ccccCCcc----cCCHHH
Confidence 999999988889999999999999999999998865321100 00 00000111 122467
Q ss_pred HHHHHHccccCCCCCCCHHHH
Q 048425 625 AAIASMCVHPEVTHRPFMGEV 645 (780)
Q Consensus 625 ~~La~~Cl~~dP~~RPsm~EV 645 (780)
.+++.+|++.||++||++.+.
T Consensus 206 ~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHHHccCCHHHhcCCCcc
Confidence 889999999999999998544
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=301.08 Aligned_cols=260 Identities=21% Similarity=0.282 Sum_probs=182.7
Q ss_pred hcCcccceeecccCceEEEEEEE-----------------eCCcEEEEEEeeccCCcchHH--------------HHHHH
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVM-----------------DNGTEVAVKLLTRNNQNGDRE--------------FIAEV 422 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l-----------------~~g~~VAVK~l~~~~~~~~~~--------------f~~Ei 422 (780)
.++|...++||+|+||+||+|.+ .+++.||||+++.......++ +..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 57899999999999999999974 245689999987544332233 34577
Q ss_pred HHhhhcCCCce-----eeeeeeeee--------cceeEEEEeecCCCChhhhcccccC--------------------CC
Q 048425 423 EMLSRLHHRNL-----VKLIGICIE--------GRTRCLVYELVHNGSVESHLHGVDK--------------------NR 469 (780)
Q Consensus 423 ~iL~~L~HpNI-----V~L~g~~~~--------~~~~~LV~Ey~~~GSL~~~L~~~~~--------------------~~ 469 (780)
.++.+++|.|+ +++++||.. .+..+|||||+++|+|.++|++... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77888876654 778888753 3567999999999999999974211 11
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccceeccccCccccCch
Q 048425 470 GPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549 (780)
Q Consensus 470 ~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE 549 (780)
..++|..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..............+|+.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 24678889999999999999999987 999999999999999999999999999766443322222234588999999
Q ss_pred hhccCCC----------------------CchhhHHhHHHHHHHHHhCCC-CCCCCCccc------cchhhhhccccccc
Q 048425 550 YAMTGHL----------------------LVKSDVYSYGVVLLELLSGRK-PVDMSQPQG------QENLVTWARPLLTT 600 (780)
Q Consensus 550 ~l~~~~~----------------------t~ksDVySfGVvLlELlTGr~-P~~~~~~~~------~~~Lv~wa~~ll~~ 600 (780)
.+..... ..+.||||+||+++||++|.. |+....... ..++..|-. ...
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~ 458 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKG 458 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hcc
Confidence 8754321 235799999999999999875 554211100 011112210 000
Q ss_pred ccccccccCCccCCCCChhhHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 048425 601 REGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEV---THRPFMGEVVQ 647 (780)
Q Consensus 601 ~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP---~~RPsm~EVv~ 647 (780)
...+-.. .........+++..++..+| .+|+|++|+++
T Consensus 459 -----~~~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 -----QKYDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred -----cCCCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0001000 11122456788888888755 78999999864
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-33 Score=327.35 Aligned_cols=249 Identities=27% Similarity=0.379 Sum_probs=193.8
Q ss_pred hcCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
+-++...+.||.|.||.||-|.. ++|+..|||-++... ........+|+.++..|+|||+|+.+|+-...+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 44666778999999999999985 589999999876543 233456889999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
|||++|+|.+.+. ..+-.+......+..|++.|++|||+.+ ||||||||.||+|+.+|-+|++|||.|.....
T Consensus 1314 EyC~~GsLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 9999999999984 2334555556667889999999999999 99999999999999999999999999998765
Q ss_pred CCccc---eeccccCccccCchhhccCC---CCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccc
Q 048425 531 GSQHI---STRVMGTFGYVAPEYAMTGH---LLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 531 ~~~~~---~t~~~GT~~Y~APE~l~~~~---~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
..... -...+||+.|||||++.+.+ -.-+.||||+|||++||+||++||..-.. .|+.-+--
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V----- 1454 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHV----- 1454 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHH-----
Confidence 53222 13468999999999997643 35689999999999999999999953221 22211100
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHH
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEV 645 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EV 645 (780)
..--.|.+ +......=.+++..|++.||++|-++.|+
T Consensus 1455 ~~gh~Pq~----P~~ls~~g~dFle~Cl~~dP~~Rw~~~ql 1491 (1509)
T KOG4645|consen 1455 AAGHKPQI----PERLSSEGRDFLEHCLEQDPKMRWTASQL 1491 (1509)
T ss_pred hccCCCCC----chhhhHhHHHHHHHHHhcCchhhhHHHHH
Confidence 00011222 22223345689999999999999666654
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=276.57 Aligned_cols=246 Identities=26% Similarity=0.447 Sum_probs=192.7
Q ss_pred ceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcC-CCceeeeeeeeeecceeEEEEeecCCC
Q 048425 380 KRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLH-HRNLVKLIGICIEGRTRCLVYELVHNG 456 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~Ey~~~G 456 (780)
...||.|..|.|+|.... .|..+|||.+.+... +..+.++..++++..-+ +|+||+.+|||..+....+.||.|. .
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence 356999999999999975 689999999977644 33456788888887765 9999999999999888899999984 3
Q ss_pred ChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccce
Q 048425 457 SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIS 536 (780)
Q Consensus 457 SL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~ 536 (780)
.++.+|. .-..++++.-.-++...+.+||.||.++. .|||||+||+|||+|+.|++||+|||++-.+.+...+
T Consensus 176 C~ekLlk---rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-- 248 (391)
T KOG0983|consen 176 CAEKLLK---RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-- 248 (391)
T ss_pred HHHHHHH---HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence 4555554 23456888888899999999999998875 5999999999999999999999999999888765443
Q ss_pred eccccCccccCchhhcc---CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 537 TRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 537 t~~~GT~~Y~APE~l~~---~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
++.+|-+.|||||.+.- .+|+.++||||||+.|+||.||+.||.....+ .+-+.. +++ +. .|.|.
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe~ltk----vln------~e-PP~L~ 316 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FEVLTK----VLN------EE-PPLLP 316 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HHHHHH----HHh------cC-CCCCC
Confidence 66789999999998863 47889999999999999999999999764321 111111 111 01 13332
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+.. .....+.++...|+++|+.+||...++++
T Consensus 317 ~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 317 GHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ccc--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 211 12356889999999999999999988754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=310.44 Aligned_cols=261 Identities=19% Similarity=0.238 Sum_probs=173.0
Q ss_pred HhcCcccceeecccCceEEEEEEEe-C----CcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeee------ee
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-N----GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGI------CI 441 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~----g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~------~~ 441 (780)
..++|...+.||+|+||.||+|++. + +..||||+++.... .+.+..| .+.+..+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5689999999999999999999975 4 68999998754321 1112211 1222222233222221 24
Q ss_pred ecceeEEEEeecCCCChhhhcccccC----------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccC
Q 048425 442 EGRTRCLVYELVHNGSVESHLHGVDK----------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFK 505 (780)
Q Consensus 442 ~~~~~~LV~Ey~~~GSL~~~L~~~~~----------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIK 505 (780)
.+...+|||||+++++|.++++.... .........+..|+.|++.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 56688999999999999999864210 0001123345679999999999999987 9999999
Q ss_pred CcceEEcC-CCCCeeecccccccccCCCccceeccccCccccCchhhccC----------------------CCCchhhH
Q 048425 506 ASNVLLED-DFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG----------------------HLLVKSDV 562 (780)
Q Consensus 506 psNILLd~-~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~----------------------~~t~ksDV 562 (780)
|+|||+++ ++.+||+|||+|+..............||+.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 58999999999987655544445567899999999965322 23456799
Q ss_pred HhHHHHHHHHHhCCCCCCCCCcc-------ccchhhhhcccccccccccccccCCccCCCCC--hhhHHHHHHHHHHccc
Q 048425 563 YSYGVVLLELLSGRKPVDMSQPQ-------GQENLVTWARPLLTTREGLEQLVDPSLAGSYD--FDDMAKVAAIASMCVH 633 (780)
Q Consensus 563 ySfGVvLlELlTGr~P~~~~~~~-------~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~--~ee~~~l~~La~~Cl~ 633 (780)
|||||+||||+++..+.+..... ...++..|...... ...+.+...++ ........+|+.+|++
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP-------RASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc-------ccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 99999999999987765432110 00112222111100 00000000000 0011234589999999
Q ss_pred cCCCCCCCHHHHHH
Q 048425 634 PEVTHRPFMGEVVQ 647 (780)
Q Consensus 634 ~dP~~RPsm~EVv~ 647 (780)
.||++|||+.|+++
T Consensus 436 ~dP~kR~ta~e~L~ 449 (566)
T PLN03225 436 FKGRQRISAKAALA 449 (566)
T ss_pred CCcccCCCHHHHhC
Confidence 99999999999975
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=302.01 Aligned_cols=249 Identities=23% Similarity=0.373 Sum_probs=197.7
Q ss_pred cccceeecccCceEEEEEEEeC-CcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCC
Q 048425 377 FSSKRILGEGGFGCVYHGVMDN-GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~~-g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
|.+...||.|+||+|||++.++ +...|-|++...+....++|+-||+||+..+||+||+|++.|..++.+++..|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 3445679999999999999864 445677888766666678899999999999999999999999989999999999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
|-.+..+-. -...|+..++.-++.+++.||.|||++. |||||||+.|||++-+|.++|+|||.+-...... ..
T Consensus 114 GAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-qk 186 (1187)
T KOG0579|consen 114 GAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-QK 186 (1187)
T ss_pred chHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHH-hh
Confidence 999888754 3457999999999999999999999997 9999999999999999999999999886543221 12
Q ss_pred eeccccCccccCchhhc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 536 STRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~-----~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
...+.||+.|||||+.+ ..+|+.|+||||||+.|.||..+..|...-.+. .-+...+ .. .-..++.|
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM--RVllKia----KS--ePPTLlqP 258 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIA----KS--EPPTLLQP 258 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH--HHHHHHh----hc--CCCcccCc
Confidence 24578999999999875 468899999999999999999999987543321 0111110 00 01111111
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..-...+.++...|+..||+.||++.++++
T Consensus 259 -------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 259 -------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -------chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 122346788999999999999999998864
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=277.27 Aligned_cols=242 Identities=24% Similarity=0.330 Sum_probs=195.7
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchH---HHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDR---EFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~---~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
.++|...++||+|.||+|-..+-+ .|+.+|+|+++++..-... .-+.|-.+|+..+||.+..|.-.+...+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 367888899999999999998865 7999999999887543333 357789999999999999998888999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||..+|.|.-+|. ....++.....-.-..|..||.|||+++ ||.||||.+|.|||.||++||+||||++.-.
T Consensus 247 MeyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999999985 3556888888888899999999999988 9999999999999999999999999998754
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
.... ....++||+.|+|||++....|..+.|.|.+|||+|||++|+.||....- +.|... ++-
T Consensus 320 ~~g~-t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeL-------------Il~ 382 (516)
T KOG0690|consen 320 KYGD-TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFEL-------------ILM 382 (516)
T ss_pred cccc-eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHH-------------HHh
Confidence 4322 34568999999999999999999999999999999999999999964321 112111 111
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCC
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPF 641 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs 641 (780)
..+ .++.....+...|....+..||++|.-
T Consensus 383 ed~--kFPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 383 EDL--KFPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred hhc--cCCccCCHHHHHHHHHHhhcChHhhcC
Confidence 111 112222234556777888999999964
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=279.48 Aligned_cols=260 Identities=25% Similarity=0.367 Sum_probs=198.7
Q ss_pred ccccchHHHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhc-CCCceeeeee
Q 048425 362 VKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRL-HHRNLVKLIG 438 (780)
Q Consensus 362 ~~~f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~g 438 (780)
...|+-++|+.. ..||.|.||+|+|-.++ .|+.+|||+++.... ..+++|+.|.+...+- +.||||+++|
T Consensus 58 ~~~F~~~~Lqdl-------g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 58 LHTFTSDNLQDL-------GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccchHHHH-------HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 345666666554 56999999999999876 799999999977654 3456788999876665 7999999999
Q ss_pred eeeecceeEEEEeecCCCChhhhccc-ccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCC
Q 048425 439 ICIEGRTRCLVYELVHNGSVESHLHG-VDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP 517 (780)
Q Consensus 439 ~~~~~~~~~LV~Ey~~~GSL~~~L~~-~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~v 517 (780)
.+..++..++.||.|. -||+.+-.. ....+..+++.-.-+|+....+||.||.+.- +||||||||+|||||..|.+
T Consensus 131 a~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 131 ALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCE
Confidence 9999999999999994 455443321 1124457888888899999999999998765 69999999999999999999
Q ss_pred eeecccccccccCCCccceeccccCccccCchhhcc--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcc
Q 048425 518 KVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWAR 595 (780)
Q Consensus 518 KLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~--~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~ 595 (780)
||||||++-.+.+.- ..+.-+|-..|||||.+.. ..|+.+|||||+|+.|+|+.||+.|+..... +.+
T Consensus 208 KLCDFGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfe--- 277 (361)
T KOG1006|consen 208 KLCDFGICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFE--- 277 (361)
T ss_pred eeecccchHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHH---
Confidence 999999998765532 2345568889999998864 3489999999999999999999999864321 111
Q ss_pred ccccccccccccc--C-CccCCCC-ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 596 PLLTTREGLEQLV--D-PSLAGSY-DFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 596 ~ll~~~~~l~~lv--D-p~L~~~~-~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.+.+++ | |.+..+. ..+....|..++..|+.+|-.+||...++.+.
T Consensus 278 -------ql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 278 -------QLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -------HHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111111 1 1111111 12344678999999999999999999988664
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=294.01 Aligned_cols=260 Identities=28% Similarity=0.425 Sum_probs=210.5
Q ss_pred chHHHHHHhcCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeeee-
Q 048425 366 ALSDLEKATEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICIE- 442 (780)
Q Consensus 366 ~~~el~~at~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~- 442 (780)
.++.+-..++.|.+.+.||+|.+|.|||++. ++|+.+|||++.... +.+++...|.++|+.+ +|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3444445567889999999999999999985 489999999986654 3567788899999988 79999999999864
Q ss_pred ----cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCe
Q 048425 443 ----GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPK 518 (780)
Q Consensus 443 ----~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vK 518 (780)
+++++||||||.+||..|++.+.. ...+.|..+..|+..+++||.+||... ++|||||-.|||+++++.+|
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 578999999999999999998654 678999999999999999999999887 99999999999999999999
Q ss_pred eecccccccccCCCccceeccccCccccCchhhccC-----CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhh
Q 048425 519 VSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG-----HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTW 593 (780)
Q Consensus 519 LsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~-----~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~w 593 (780)
|.|||++......... .....||+.|||||++... .|+..+|+||+|++..||--|..|+....|.-
T Consensus 164 LvDFGvSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr------- 235 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR------- 235 (953)
T ss_pred Eeeeeeeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-------
Confidence 9999999887654332 2345799999999998643 56788999999999999999999987655421
Q ss_pred cccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 594 ARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 594 a~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+... .-+|...-.-+..-..++.+++..|+..|-++||++.++++
T Consensus 236 --aLF~I------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 236 --ALFLI------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --hhccC------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11110 11121111123344578899999999999999999988764
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=270.69 Aligned_cols=265 Identities=24% Similarity=0.376 Sum_probs=203.6
Q ss_pred chHHHHHHhcCcccceeecccCceEEEEEE-EeCCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeeeec
Q 048425 366 ALSDLEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICIEG 443 (780)
Q Consensus 366 ~~~el~~at~~f~~~~~LG~G~fG~VYkg~-l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~ 443 (780)
+++|+-+.|+ ++||+|+++.|--++ +.+|.++|||++.+..........+|++++.+. .|+||+.|++||.++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3567777775 789999999998877 568999999999888777777899999999998 499999999999999
Q ss_pred ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC---Ceee
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT---PKVS 520 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~---vKLs 520 (780)
...|||||-|.+|+|..+|+ ++..++..+.-++..+||.||.|||.++ |.|||+||+|||..+... +||+
T Consensus 149 ~~FYLVfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeee
Confidence 99999999999999999996 4567999999999999999999999999 999999999999976554 7999
Q ss_pred cccccccccCCCc------cceeccccCccccCchhhc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch
Q 048425 521 DFGLAREATEGSQ------HISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN 589 (780)
Q Consensus 521 DFGLA~~~~~~~~------~~~t~~~GT~~Y~APE~l~-----~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~ 589 (780)
||.|......... ..-...+|+..|||||+.. ...|+.+.|.||+|||||-|++|..||.+....+
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d--- 298 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD--- 298 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc---
Confidence 9999865432211 1112357889999999763 2467889999999999999999999998766432
Q ss_pred hhhhcccccc--cccccccccCCccCCCCChhhH----HHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 590 LVTWARPLLT--TREGLEQLVDPSLAGSYDFDDM----AKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 590 Lv~wa~~ll~--~~~~l~~lvDp~L~~~~~~ee~----~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..|-+.-.- ..+.+.+-+... .-+++.++. .+..+++...+-.++.+|.++.+|+.
T Consensus 299 -CGWdrGe~Cr~CQ~~LFesIQEG-kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 299 -CGWDRGEVCRVCQNKLFESIQEG-KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred -CCccCCCccHHHHHHHHHHHhcc-CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 233322110 011111111110 112333333 34456677777799999999888765
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=270.46 Aligned_cols=204 Identities=25% Similarity=0.356 Sum_probs=169.5
Q ss_pred cCcccceeecccCceEEEEEEEeC-----CcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeee-ccee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDN-----GTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIE-GRTR 446 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~-----g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~~ 446 (780)
..|+....||+|.||.||||.-++ ...+|+|.++..... ......+|+.+++.++|+||+.|..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 457778899999999999997432 236999999765332 22467899999999999999999999887 7788
Q ss_pred EEEEeecCCCChhhhccccc-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC----CCCeeec
Q 048425 447 CLVYELVHNGSVESHLHGVD-KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD----FTPKVSD 521 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~-~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~----~~vKLsD 521 (780)
+|++||.+. +|...++..+ .....++-.....|+.||+.|+.|||++- |+||||||.||||..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999976 6777775322 23357888899999999999999999998 9999999999999877 8999999
Q ss_pred ccccccccCCCcc--ceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 048425 522 FGLAREATEGSQH--ISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMS 582 (780)
Q Consensus 522 FGLA~~~~~~~~~--~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~ 582 (780)
||+++.+...-.. ....++-|++|.|||.+.+ ..||.+.|||+.||++.||+|-+.-|...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9999988654332 2356778999999999887 57899999999999999999988777543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=277.98 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=194.6
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCC--c-----chHHHHHHHHHhhhcCCCceeeeeeeee-ecce
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQ--N-----GDREFIAEVEMLSRLHHRNLVKLIGICI-EGRT 445 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~--~-----~~~~f~~Ei~iL~~L~HpNIV~L~g~~~-~~~~ 445 (780)
++|-.+++||+|||+.|||+.. ...+.||||+-..+.. + -.+...+|.+|.+.|+||.||++|+|+. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 3566678999999999999984 4678899998533221 1 1234678999999999999999999985 4567
Q ss_pred eEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC---CCCCeeecc
Q 048425 446 RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED---DFTPKVSDF 522 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~---~~~vKLsDF 522 (780)
.|-|+|||++.+|+-|| +....++.++...|+.||..||.||.+. .|||||-||||.||||.+ -|.+||.||
T Consensus 543 FCTVLEYceGNDLDFYL----KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYL----KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ceeeeeecCCCchhHHH----HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 89999999999999999 4556799999999999999999999887 588999999999999954 478999999
Q ss_pred cccccccCCCc------cceeccccCccccCchhhccC----CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhh
Q 048425 523 GLAREATEGSQ------HISTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVT 592 (780)
Q Consensus 523 GLA~~~~~~~~------~~~t~~~GT~~Y~APE~l~~~----~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~ 592 (780)
||++.+.+... .......||.+|++||.+.-+ +.+.|.||||.||++|..+.|++||..... +.++..
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdILq 695 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDILQ 695 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHHh
Confidence 99999875432 234567899999999988654 568899999999999999999999976543 233322
Q ss_pred hcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHH
Q 048425 593 WARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEV 645 (780)
Q Consensus 593 wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EV 645 (780)
.. .+++..+ +.--..| ....+...++++|++..-++|-...++
T Consensus 696 eN-TIlkAtE-VqFP~KP--------vVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 696 EN-TILKATE-VQFPPKP--------VVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred hh-chhccee-ccCCCCC--------ccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 11 1111111 1100111 112355679999999998888766554
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=275.00 Aligned_cols=241 Identities=25% Similarity=0.337 Sum_probs=192.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc---chHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN---GDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV 449 (780)
.+|....+||+|+||+|.+|.-+ +.+.+|||+|+++..- +.+--+.|-++|+.. +-|.++.|..++..-+.+++|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888899999999999999875 4567999999876422 222345677777765 578899999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+.+|+|--++. .-+.+......-+|..||-||-+||+++ ||.||||..|||||.+|++||+|||+++.-.
T Consensus 429 MEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999998885 3456777788889999999999999999 9999999999999999999999999998754
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
-+. ......+||+.|+|||++...+|....|.|||||+||||+.|+.||++.... .+ ...+.+
T Consensus 502 ~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~---el-------------F~aI~e 564 (683)
T KOG0696|consen 502 FDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---EL-------------FQAIME 564 (683)
T ss_pred cCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH---HH-------------HHHHHH
Confidence 332 2345689999999999999999999999999999999999999999875422 11 122222
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCC
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPF 641 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs 641 (780)
... .|+.....+...+...-+...|.+|.-
T Consensus 565 hnv--syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 565 HNV--SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence 221 334444456667778888899998854
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-30 Score=287.65 Aligned_cols=240 Identities=24% Similarity=0.323 Sum_probs=191.6
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEE
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
.++.|.....+|.|+|+.|-++... +++..+||++.+... +-.+|+.++.+. +|+||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3567778888999999999998864 788999999976522 233577777666 7999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE-cCCCCCeeeccccccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL-EDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL-d~~~~vKLsDFGLA~~~~ 529 (780)
|++.++-|.+.+.. ..... .++..|+.+|+.++.|||.++ |||||+||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~----~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS----KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHh----cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999888777642 22233 778889999999999999998 9999999999999 589999999999999876
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
.. ...-+-|..|.|||++....+++++|+||||++||||++|+.|+...... .++.. .+-
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~-------------~i~- 527 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT-------------RIQ- 527 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH-------------hhc-
Confidence 64 12224578899999999999999999999999999999999999754321 11111 111
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+.+.........+|+.+|++.||.+||+|+++..
T Consensus 528 ---~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 528 ---MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---CCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 11222333346678999999999999999999854
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=240.87 Aligned_cols=210 Identities=34% Similarity=0.585 Sum_probs=184.0
Q ss_pred ecccCceEEEEEEEeC-CcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCChhh
Q 048425 383 LGEGGFGCVYHGVMDN-GTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVES 460 (780)
Q Consensus 383 LG~G~fG~VYkg~l~~-g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL~~ 460 (780)
||+|.+|.||++...+ |+.+++|++...... ..+.+.+|++.+++++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999998765432 34679999999999999999999999998889999999999999999
Q ss_pred hcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC-CCCCeeecccccccccCCCccceecc
Q 048425 461 HLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED-DFTPKVSDFGLAREATEGSQHISTRV 539 (780)
Q Consensus 461 ~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~-~~~vKLsDFGLA~~~~~~~~~~~t~~ 539 (780)
++... ...+++..++.++.+++++|+|||+.+ ++|+||++.||++++ ++.++|+|||.+........ .....
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKEN---EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 98531 146899999999999999999999997 999999999999999 89999999999987755421 12334
Q ss_pred ccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCCh
Q 048425 540 MGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDF 618 (780)
Q Consensus 540 ~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ 618 (780)
.+...|++||..... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578889999999887 888999999999999999
Q ss_pred hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 619 DDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 619 ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 467889999999999999999999764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=299.43 Aligned_cols=259 Identities=22% Similarity=0.283 Sum_probs=206.0
Q ss_pred hHHHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeee
Q 048425 367 LSDLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIE 442 (780)
Q Consensus 367 ~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~ 442 (780)
..++.--.++|.+.++||+|+||.|...+.+ .++.+|+|++++.. .....-|..|-++|..-+.+=|+.|.-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4455566789999999999999999999986 68899999998743 3334568999999999999999999999999
Q ss_pred cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecc
Q 048425 443 GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDF 522 (780)
Q Consensus 443 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDF 522 (780)
.+.+|||||||+||+|-.+|.. ..+++......++..|.-||.-||+.| +|||||||+|||||..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 9999999999999999999953 337888888889999999999999999 999999999999999999999999
Q ss_pred cccccccCCCccceeccccCccccCchhhcc-----CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccc
Q 048425 523 GLAREATEGSQHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL 597 (780)
Q Consensus 523 GLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~-----~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~l 597 (780)
|.+-.+..+..-.+...+|||.|.+||++.. +.|...+|.||+||.+|||+.|..||.. ++++.--..+
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~KI 293 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYGKI 293 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHHHH
Confidence 9999888666656666789999999998852 6788999999999999999999999964 4454433333
Q ss_pred cccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 048425 598 LTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPF---MGEVVQ 647 (780)
Q Consensus 598 l~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs---m~EVv~ 647 (780)
+.-.+.+. +.|. .+......+|+..-+. +|+.|.. ++++..
T Consensus 294 m~hk~~l~-FP~~-------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 294 MNHKESLS-FPDE-------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred hchhhhcC-CCcc-------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 33322211 1111 1122344555555443 5667776 766644
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=276.21 Aligned_cols=243 Identities=27% Similarity=0.369 Sum_probs=192.9
Q ss_pred ceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCC
Q 048425 380 KRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNG 456 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~G 456 (780)
.++||.|.||+||-|+.+ +|+.||||++.+.. ..++..+.+|+.||+.++||.||.|.-.|+..+..++|||-+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999975 89999999997653 345567899999999999999999999999999999999999766
Q ss_pred ChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC---CCCeeecccccccccCCCc
Q 048425 457 SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD---FTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 457 SL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~---~~vKLsDFGLA~~~~~~~~ 533 (780)
-|+-.|. .+.++|+......++.||+.||.|||.++ |+|+||||+||||.+. -.+||+|||+|+...+..-
T Consensus 649 MLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 649 MLEMILS---SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred HHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 6666664 46678998888889999999999999998 9999999999999643 4799999999999877543
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
...++||+.|+|||++.++.|...-|+||.||++|--++|..||+....- .+-+.-+.- +..+.-
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNAaF----------MyPp~P- 787 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNAAF----------MYPPNP- 787 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhhcccc----------ccCCCc-
Confidence 35678999999999999999999999999999999999999999743211 111111100 001100
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVV 646 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv 646 (780)
-.+.....++++...++..-++|=+...-+
T Consensus 788 ---W~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 788 ---WSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ---hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 112223556777777777777887776543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=240.88 Aligned_cols=263 Identities=22% Similarity=0.303 Sum_probs=191.6
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
+|...++||+|.||+||||+.. +++.||+|+++-++.+ -....++||-+++.++|+|||+++++...++..-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4555678999999999999965 6889999998765432 235688999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+. .+|..+.. .-++.++......++.|+.+||.|+|+.+ +.|||+||.|.|++.+|+.|++|||+++.+.-..
T Consensus 83 cd-qdlkkyfd---slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CD-QDLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hh-HHHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 94 47777764 34667999999999999999999999998 9999999999999999999999999999876543
Q ss_pred ccceeccccCccccCchhhccCC-CCchhhHHhHHHHHHHHHhCCCC-CCCCCccccchhhhhccccccc--cccccccc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLSGRKP-VDMSQPQGQENLVTWARPLLTT--REGLEQLV 608 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~-~t~ksDVySfGVvLlELlTGr~P-~~~~~~~~~~~Lv~wa~~ll~~--~~~l~~lv 608 (780)
... ...+-|.+|.+|.++.+.+ |+...|+||-||++.||.....| |.+..-.++..-+-|......+ ...+..+.
T Consensus 156 rcy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 156 RCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred Eee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 322 2334689999999988765 57889999999999999985444 4433322221112222111111 12233344
Q ss_pred CCccCCCCChh----h-----HHHHHHHHHHccccCCCCCCCHHHHH
Q 048425 609 DPSLAGSYDFD----D-----MAKVAAIASMCVHPEVTHRPFMGEVV 646 (780)
Q Consensus 609 Dp~L~~~~~~e----e-----~~~l~~La~~Cl~~dP~~RPsm~EVv 646 (780)
|-..-..|+.. + ..+=.++....+.-+|.+|.++++.+
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaal 281 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAAL 281 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHh
Confidence 43322222210 0 11224555556666788888877654
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-29 Score=257.95 Aligned_cols=249 Identities=24% Similarity=0.304 Sum_probs=192.9
Q ss_pred HhcCccc-ceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeeee----cce
Q 048425 373 ATEKFSS-KRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICIE----GRT 445 (780)
Q Consensus 373 at~~f~~-~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~----~~~ 445 (780)
.|++|++ .++||-|-.|+|-....+ +|+.+|+|+|... ....+|+++--+. .|+|||.++++|.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 3556654 368999999999998875 7899999998533 2345788876665 69999999999864 356
Q ss_pred eEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC---CCCCeeecc
Q 048425 446 RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED---DFTPKVSDF 522 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~---~~~vKLsDF 522 (780)
+++|||+|+||.|...+.+ +....++..+.-+|..||+.|+.|||+.+ |.||||||+|+|... |-.+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 6899999999999999864 45567999999999999999999999998 999999999999964 457899999
Q ss_pred cccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccc
Q 048425 523 GLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 523 GLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
|+|+...+.. .....+-|+.|.|||++...+|+...|+||+||++|-|++|..||....... + .+-++.+
T Consensus 209 GFAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---i----spgMk~r- 278 (400)
T KOG0604|consen 209 GFAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---I----SPGMKRR- 278 (400)
T ss_pred ccccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---C----ChhHHhH-
Confidence 9999866422 2234567999999999999999999999999999999999999997543211 0 0001110
Q ss_pred ccccccCCccCCCCChhh----HHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 603 GLEQLVDPSLAGSYDFDD----MAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee----~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+... .-+++.+| .+...++++..+..+|.+|.|+.|++.
T Consensus 279 ----I~~g--qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 279 ----IRTG--QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ----hhcc--CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 0000 01223233 345567888889999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=241.86 Aligned_cols=199 Identities=35% Similarity=0.473 Sum_probs=173.3
Q ss_pred cccceeecccCceEEEEEEEeC-CcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 377 FSSKRILGEGGFGCVYHGVMDN-GTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~~-g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
|...+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999874 899999999776554 56789999999999999999999999998899999999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+++|.+++... ...+++.....++.+++++|.|||+.+ ++|+||+++||++++++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 99999998632 112899999999999999999999987 999999999999999999999999999887654311
Q ss_pred ceeccccCccccCchhh-ccCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 048425 535 ISTRVMGTFGYVAPEYA-MTGHLLVKSDVYSYGVVLLELLSGRKPVDM 581 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l-~~~~~t~ksDVySfGVvLlELlTGr~P~~~ 581 (780)
......++..|++||.. ....++.++|||+||++++||++|+.||+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334678889999998 667788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=282.65 Aligned_cols=247 Identities=28% Similarity=0.373 Sum_probs=188.6
Q ss_pred CcccceeecccCceE-EEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEEeec
Q 048425 376 KFSSKRILGEGGFGC-VYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~-VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
-|...+++|.|.-|+ ||+|.. +|+.||||++-.+. ..-..+||..|+.- +|+|||++++.-.+....|++.|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 356668899999875 799999 68999999984332 23457899999988 6999999999888888999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC-----CCCCeeecccccccc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED-----DFTPKVSDFGLAREA 528 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~-----~~~vKLsDFGLA~~~ 528 (780)
..+|.+++...........-...+.+..|++.||++||+.+ ||||||||.||||+. ..+++|+|||+++..
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 56999999752111111221445778899999999999987 999999999999975 257999999999998
Q ss_pred cCCCccc--eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhC-CCCCCCCCccccchhhhhcccccccccccc
Q 048425 529 TEGSQHI--STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSG-RKPVDMSQPQGQENLVTWARPLLTTREGLE 605 (780)
Q Consensus 529 ~~~~~~~--~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTG-r~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~ 605 (780)
..+.... .....||-||+|||.+....-+.++||||+|||+|+.++| ..||...... +.++ +.....+.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~NI-------l~~~~~L~ 733 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QANI-------LTGNYTLV 733 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhhh-------hcCcccee
Confidence 7664332 2456799999999999999889999999999999999995 8899643321 1121 11111122
Q ss_pred cccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 606 QLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 606 ~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+. . ..++ ...+|+.+|++.+|..||++.+|+.
T Consensus 734 ~L~-----~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 HLE-----P--LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eec-----c--CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 110 0 0111 5678999999999999999999963
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=269.87 Aligned_cols=211 Identities=26% Similarity=0.383 Sum_probs=175.9
Q ss_pred CcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 376 KFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
-|...+.||-|+||+|.++.- ++...+|+|.|++.+. ......++|-+||..-+.+=||+|+-.|.+++.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 366678899999999999874 4567799999977642 334457889999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc--
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT-- 529 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~-- 529 (780)
|++||++-.+|- ..+-+.+.....++..+..|+++.|+.| +|||||||+|||||.||++||.||||+.-+.
T Consensus 710 YIPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 710 YIPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ccCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 999999999985 3456778877888889999999999999 9999999999999999999999999996431
Q ss_pred -------CCCc-----------------c---------------ceeccccCccccCchhhccCCCCchhhHHhHHHHHH
Q 048425 530 -------EGSQ-----------------H---------------ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLL 570 (780)
Q Consensus 530 -------~~~~-----------------~---------------~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLl 570 (780)
++.. . .....+||..|+|||++....++.-+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 1100 0 011257999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCccccc-hhhhh
Q 048425 571 ELLSGRKPVDMSQPQGQE-NLVTW 593 (780)
Q Consensus 571 ELlTGr~P~~~~~~~~~~-~Lv~w 593 (780)
||+.|+.||....+.+.+ .+..|
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeeh
Confidence 999999999877665433 33344
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=245.20 Aligned_cols=203 Identities=27% Similarity=0.382 Sum_probs=169.5
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC-CcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN-QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
++......||+|++|.|-+-++. +|+..|||++...- .+..+..++|+++..+. .+|.+|.++|........++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 44444577999999999888764 89999999987653 33446788899987765 79999999999988899999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
.| .-||+.+-....+....+++...-+||..+.+||.|||++- .+||||+||+|||++.+|++|+||||.+-.+.+.
T Consensus 126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 99 45787776655567788999999999999999999999975 5999999999999999999999999999877654
Q ss_pred CccceeccccCccccCchhhcc----CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 048425 532 SQHISTRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVLLELLSGRKPVDMS 582 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~----~~~t~ksDVySfGVvLlELlTGr~P~~~~ 582 (780)
... +--.|-..|||||.+.. ..|+.|+||||+|+.+.||.+++.|++..
T Consensus 203 iAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 203 IAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 221 22357888999998753 37889999999999999999999999753
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=256.54 Aligned_cols=265 Identities=24% Similarity=0.358 Sum_probs=192.7
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC-Cc-chHHHHHHHHHhhhcCCCceeeeeeeeeec--------c
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN-QN-GDREFIAEVEMLSRLHHRNLVKLIGICIEG--------R 444 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~-~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--------~ 444 (780)
.|....+||+|.||.||+|+.+ .|+.||+|++-.+. .. -....++|+++|..++|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3445578999999999999976 57788998753322 22 224568899999999999999999998642 3
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccc
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGL 524 (780)
..+|||++++. +|.-.|. .....++..++.++..++..||.|+|... |+|||+|+.|+|++.++.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 46999999975 6777774 23467999999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCcc---ceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhh--------h
Q 048425 525 AREATEGSQH---ISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV--------T 592 (780)
Q Consensus 525 A~~~~~~~~~---~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv--------~ 592 (780)
++.+...... ..+..+-|.+|++||.+.+ +.++.+.|||.-|||+.||+|+..-+.......+..++ .
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 9877543322 2344556999999998876 57889999999999999999998777655433322111 1
Q ss_pred hccccccccccccccc-CCccCCCCC--hhhH------HHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 593 WARPLLTTREGLEQLV-DPSLAGSYD--FDDM------AKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 593 wa~~ll~~~~~l~~lv-Dp~L~~~~~--~ee~------~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
-+|+....-.-.+.+- .|...+.+. .+.+ ...++|+...+..||.+|+...+++.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 1222222211111110 111111111 1111 24678888999999999999998854
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=261.96 Aligned_cols=263 Identities=21% Similarity=0.286 Sum_probs=198.6
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCC--C----ceeeeeeeeeeccee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHH--R----NLVKLIGICIEGRTR 446 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H--p----NIV~L~g~~~~~~~~ 446 (780)
+++|.+...+|+|.||.|-+.... .+..||||+++.-.. -.+.-+-|+++|.+|++ | -+|.+.+++.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 688999999999999999998764 578999999865432 23445679999999942 2 388888999989999
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC-------------
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED------------- 513 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~------------- 513 (780)
|+|+|.+ |-|+.++|.. ++..+++...+..|+.|++++++|||+.. ++|.||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred EEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 9999988 6699999964 35567889999999999999999999998 999999999999831
Q ss_pred -------CCCCeeecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccc
Q 048425 514 -------DFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQG 586 (780)
Q Consensus 514 -------~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~ 586 (780)
+..+||+|||.|..-.+.. +.++.|..|.|||++++-.++..+||||+||||.||.||..-|......+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3468999999998765433 45678899999999999999999999999999999999999887654221
Q ss_pred cchhhhhc-cc-------------ccccc----------cccccccCCcc----CCCCChhhHHHHHHHHHHccccCCCC
Q 048425 587 QENLVTWA-RP-------------LLTTR----------EGLEQLVDPSL----AGSYDFDDMAKVAAIASMCVHPEVTH 638 (780)
Q Consensus 587 ~~~Lv~wa-~~-------------ll~~~----------~~l~~lvDp~L----~~~~~~ee~~~l~~La~~Cl~~dP~~ 638 (780)
.-.+.+-+ .+ +...+ ..+....++.. .-.....+..++.+|+..++..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 11010000 00 00000 00011111100 00123456678999999999999999
Q ss_pred CCCHHHHHH
Q 048425 639 RPFMGEVVQ 647 (780)
Q Consensus 639 RPsm~EVv~ 647 (780)
|+|+.|++.
T Consensus 397 RiTl~EAL~ 405 (415)
T KOG0671|consen 397 RITLREALS 405 (415)
T ss_pred cccHHHHhc
Confidence 999999864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-29 Score=270.30 Aligned_cols=241 Identities=23% Similarity=0.345 Sum_probs=198.3
Q ss_pred CcccceeecccCceEEEEEEEeCCc-EEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 376 KFSSKRILGEGGFGCVYHGVMDNGT-EVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~~g~-~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
++.....||-||||.|=+...+... .+|+|++++.. ..+++....|-.+|...+.+.||+||-.|.+....|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4445567999999999998875433 38999887653 3344567889999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
-|-+|.|...|. .++.++......++..+.+|++|||..+ ||.|||||+|.+||.+|-+||.|||+|+....+
T Consensus 501 aClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 501 ACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999994 5678899898999999999999999998 999999999999999999999999999998775
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
.. .-.++||+.|.|||++.+...+.++|.||+|+++|||+||+.||....+....+++ ++ .++.+--
T Consensus 574 ~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------Lk---Gid~i~~-- 640 (732)
T KOG0614|consen 574 RK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------LK---GIDKIEF-- 640 (732)
T ss_pred Cc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------Hh---hhhhhhc--
Confidence 43 24689999999999999999999999999999999999999999877654333322 11 1222211
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCC
Q 048425 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPF 641 (780)
Q Consensus 612 L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs 641 (780)
+........++++..+..+|.+|.-
T Consensus 641 -----Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 641 -----PRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -----ccccchhHHHHHHHHHhcCcHhhhc
Confidence 2222345677888888999999976
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=248.66 Aligned_cols=250 Identities=21% Similarity=0.315 Sum_probs=195.8
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcch---HHHHHHHHHhhhc-CCCceeeeeeeeeecceeE
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGD---REFIAEVEMLSRL-HHRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~---~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~ 447 (780)
..++|...++||+|+|.+|..+.++ +.+.+|+|+++++.-... .=.+.|-.+..+- +||.+|.|..++..+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3478999999999999999999975 678899999987643322 2345677777665 8999999999999999999
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+|.||+++|+|--++. ...+|+.....-....|.-||.|||+.+ ||.||||..|||+|..|++||.|||+++.
T Consensus 328 fvieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 9999999999988874 4557888888888899999999999999 99999999999999999999999999997
Q ss_pred ccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCcccc-chhhhhccccccccccccc
Q 048425 528 ATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ-ENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 528 ~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~-~~Lv~wa~~ll~~~~~l~~ 606 (780)
-..... ....++||+.|.|||.+.+..|....|.|++||+++||+.|+.||+....... ++--++. .+.
T Consensus 401 ~l~~gd-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl---------fqv 470 (593)
T KOG0695|consen 401 GLGPGD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL---------FQV 470 (593)
T ss_pred CCCCCc-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH---------HHH
Confidence 654332 34568999999999999999999999999999999999999999985432211 1111111 111
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCC
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPF 641 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs 641 (780)
++...++ .+.....+...+.+.-+++||++|.-
T Consensus 471 ilekqir--iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 471 ILEKQIR--IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred Hhhhccc--ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 1222221 11222245567778889999998853
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-27 Score=240.98 Aligned_cols=263 Identities=25% Similarity=0.347 Sum_probs=194.1
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeec-----ceeE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEG-----RTRC 447 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~~~ 447 (780)
+.+..+-||-|.||.||..... +|+.||.|++-..- -...+.+.+|+++|.-++|.|++..++..... .+.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3445688999999999998865 89999999885432 22346788999999999999999998876543 3567
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+++|.|. .+|...+ -....|+-....-+..||++||.|||+.+ |.||||||.|.|++.|...||+|||+|+.
T Consensus 134 V~TELmQ-SDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHH-hhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 8888884 3555554 45667888888888999999999999998 99999999999999999999999999997
Q ss_pred ccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccc-----
Q 048425 528 ATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTR----- 601 (780)
Q Consensus 528 ~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~----- 601 (780)
-......-.+..+-|..|.|||.+++ +.|+.+.||||.||++.||+..+.-|....|..+.+++.- ++...
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd---LLGTPs~EaM 282 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID---LLGTPSQEAM 282 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH---HhCCCcHHHH
Confidence 65544444455567889999999997 5789999999999999999999988887766554443321 11100
Q ss_pred ------c---ccc-cccCCccCCCCC----hhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 602 ------E---GLE-QLVDPSLAGSYD----FDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 602 ------~---~l~-~lvDp~L~~~~~----~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
. .++ ..-.|.+..-|. ...-.+-+.+...++..||++|-+.++.+..+
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0 000 000111111111 11223455677778999999999988876654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=252.71 Aligned_cols=196 Identities=24% Similarity=0.387 Sum_probs=168.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cch-----HHHHHHHHHhhhcC---CCceeeeeeeeee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGD-----REFIAEVEMLSRLH---HRNLVKLIGICIE 442 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~-----~~f~~Ei~iL~~L~---HpNIV~L~g~~~~ 442 (780)
.+|+..+.+|+|+||.|+.++++ +..+|+||.+.++.- .+. -..-.||.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46888999999999999999986 566799998866531 111 12456999999997 9999999999999
Q ss_pred cceeEEEEeec-CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeec
Q 048425 443 GRTRCLVYELV-HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSD 521 (780)
Q Consensus 443 ~~~~~LV~Ey~-~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsD 521 (780)
++..+|+||-. ++-+|.+++. ....+++.+..-|+.||+.|+++||+++ |||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 99999999976 4568888884 4567999999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCccceeccccCccccCchhhccCCCC-chhhHHhHHHHHHHHHhCCCCCC
Q 048425 522 FGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLSGRKPVD 580 (780)
Q Consensus 522 FGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t-~ksDVySfGVvLlELlTGr~P~~ 580 (780)
||.|.....+.- ..++||.+|.|||++.+.+|- ..-|||++|++||-++....||.
T Consensus 714 fgsaa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999987765543 456799999999999998875 56799999999999998888874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-26 Score=276.31 Aligned_cols=196 Identities=20% Similarity=0.272 Sum_probs=141.7
Q ss_pred hhcCC-Cceeeeeeee-------eecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 048425 426 SRLHH-RNLVKLIGIC-------IEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNP 497 (780)
Q Consensus 426 ~~L~H-pNIV~L~g~~-------~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p 497 (780)
+.++| .||++++++| .+.+..++++||+ +++|.++|.. ....+++.+++.++.||++||+|||+.+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g-- 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG-- 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 34555 6888888887 2334567888987 6699999963 3456999999999999999999999998
Q ss_pred cEEecccCCcceEEcC-------------------CCCCeeecccccccccCCCc---------------cceeccccCc
Q 048425 498 RVIHRDFKASNVLLED-------------------DFTPKVSDFGLAREATEGSQ---------------HISTRVMGTF 543 (780)
Q Consensus 498 ~IvHrDIKpsNILLd~-------------------~~~vKLsDFGLA~~~~~~~~---------------~~~t~~~GT~ 543 (780)
|+||||||+||||+. ++.+||+|||+++....... .......||+
T Consensus 101 -IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 101 -IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred -eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 999999999999954 45677777777764321000 0011246899
Q ss_pred cccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCChhhHHH
Q 048425 544 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAK 623 (780)
Q Consensus 544 ~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~ 623 (780)
.|||||++.+..++.++|||||||+||||++|..|+.... ..+..+. .....+.. ......
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~----------~~~~~~~~-----~~~~~~ 240 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLR----------HRVLPPQI-----LLNWPK 240 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHH----------HhhcChhh-----hhcCHH
Confidence 9999999999999999999999999999999988764211 0000000 00111111 111234
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 048425 624 VAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 624 l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
...++.+||+.+|.+||+|.||++
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhh
Confidence 567888999999999999999975
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=237.30 Aligned_cols=132 Identities=26% Similarity=0.431 Sum_probs=111.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcC-----C---Cceeeeeeeeee---
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH-----H---RNLVKLIGICIE--- 442 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-----H---pNIV~L~g~~~~--- 442 (780)
.+|...++||-|.|++||++... +.+.||+|+.+... .-.+..+.||++|++++ | .+||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 67888999999999999999864 67889999986543 33456788999999983 2 469999999864
Q ss_pred -cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc
Q 048425 443 -GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE 512 (780)
Q Consensus 443 -~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd 512 (780)
+.+.|||+|++ |-+|..+|.. .....++...+.+|+.||+.||.|||.++ .|||.||||+|||+.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 56889999998 6688888853 34557899999999999999999999998 699999999999993
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=223.83 Aligned_cols=258 Identities=20% Similarity=0.316 Sum_probs=193.2
Q ss_pred hcCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcchHHHHHHHHHhhhcC-CCceeeeeeeeeec--ceeEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH-HRNLVKLIGICIEG--RTRCLV 449 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~--~~~~LV 449 (780)
.++|++.+.+|+|.++.||.|.. .+.+.++||+++.. ..+.+.+|+++|..|. |+||++|++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46788899999999999999984 57889999999754 3467889999999997 99999999998765 466899
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC-CCCeeecccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD-FTPKVSDFGLAREA 528 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~-~~vKLsDFGLA~~~ 528 (780)
+||+.|.+...+. ..|+...+.....++++||.|+|+.| |.|||+||.|+++|.. -..+|+|+|||..+
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999998766554 35777888889999999999999999 9999999999999954 57999999999987
Q ss_pred cCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccc-----c
Q 048425 529 TEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTR-----E 602 (780)
Q Consensus 529 ~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~-----~ 602 (780)
..+... .-+ +.+.-|.-||.+.. ..++..-|+|||||+|.+|+..+.||-.... ..++|+..++-+-.+. .
T Consensus 184 Hp~~eY-nVR-VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKEY-NVR-VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCcee-eee-eehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHHHH
Confidence 665432 222 24556789998865 4567788999999999999999999864332 2344555443221110 0
Q ss_pred ccccccCCccCC---CCC------------h-hhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 603 GLEQLVDPSLAG---SYD------------F-DDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 603 ~l~~lvDp~L~~---~~~------------~-ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
...--+||.... ... . -...+.++++...+..|-.+|||++|.+.
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 001112222211 000 0 00246788899999999999999998764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=228.37 Aligned_cols=257 Identities=20% Similarity=0.350 Sum_probs=190.7
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeee-eeecceeEEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGI-CIEGRTRCLVY 450 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~-~~~~~~~~LV~ 450 (780)
.+.|.+.+.||+|.||.+-++.++ ..+.+++|.+.+. ....++|.+|...--.| .|.||+.-|++ |...+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 367888899999999999999986 5778999988654 34568899998876666 69999998877 45557788999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc--CCCCCeeecccccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE--DDFTPKVSDFGLAREA 528 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd--~~~~vKLsDFGLA~~~ 528 (780)
||++.|+|.+.+. ...+......+++.|++.||.|+|+++ +||||||.+||||- +..++||+|||+.+..
T Consensus 102 E~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999999999874 245778888999999999999999998 99999999999993 4458999999999865
Q ss_pred cCCCccceeccccCccccCchhhcc---C--CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccc
Q 048425 529 TEGSQHISTRVMGTFGYVAPEYAMT---G--HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREG 603 (780)
Q Consensus 529 ~~~~~~~~t~~~GT~~Y~APE~l~~---~--~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~ 603 (780)
...-. .+.-+..|.+||.... + ...+.+|||.||++++.++||+.||+.....+ .....|..-.-+....
T Consensus 174 g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~~~~w~~rk~~~ 248 (378)
T KOG1345|consen 174 GTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWEWEQWLKRKNPA 248 (378)
T ss_pred Cceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHHHHHHhcccCcc
Confidence 44222 2223556999997653 2 33578999999999999999999997433222 2233332211111111
Q ss_pred cccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 048425 604 LEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIY 653 (780)
Q Consensus 604 l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~ 653 (780)
+...+. .+ ..+..++.++-+.+++++|-...++.++.+...
T Consensus 249 ~P~~F~-----~f----s~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 249 LPKKFN-----PF----SEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred Cchhhc-----cc----CHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 111111 11 246677888889999999987777777765443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=252.93 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=202.5
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
.++|.....+|.|.+|.|||++.. .++..|||+++-+......-..+|+-+++..+|+|||.++|-+...+..+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 468889999999999999999975 7899999999887776677788999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+.+|+|++.-| ..++++..+...++....+||+|||+.+ =+|||||-.|||+++.+.+|++|||.+-.+...-
T Consensus 94 cgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 94 CGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred cCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence 99999999876 3568999999999999999999999998 7999999999999999999999999987665422
Q ss_pred ccceeccccCccccCchhh---ccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 533 QHISTRVMGTFGYVAPEYA---MTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l---~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
.....+.||+.|||||+. ..+.|..++|||+.|+...|+---+.|...-.+.....+.. . ..++
T Consensus 167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT--------k----S~~q 233 (829)
T KOG0576|consen 167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT--------K----SGFQ 233 (829)
T ss_pred -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh--------c----cCCC
Confidence 123456799999999976 46788999999999999999987777654333321111110 0 1111
Q ss_pred C-ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHH
Q 048425 610 P-SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVV 646 (780)
Q Consensus 610 p-~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv 646 (780)
| .++. ...--..+-++++.|+..+|++||+++.++
T Consensus 234 pp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 234 PPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 1 1111 112234677899999999999999987654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.8e-25 Score=215.05 Aligned_cols=169 Identities=22% Similarity=0.186 Sum_probs=127.5
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
|||.++++. ....++|.+++.|+.|+++||+|||+.+ ||+|||+++++.+|+ ||+++......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc---
Confidence 789999863 3457999999999999999999999885 999999999999999 99998765422
Q ss_pred eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCC
Q 048425 536 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGS 615 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~ 615 (780)
..||+.|||||++.+..++.|+|||||||++|||+||+.||....... ..+..+...... . ++.- ..
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~-------~-~~~~-~~ 130 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPA-------D-DPRD-RS 130 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhcc-------C-Cccc-cc
Confidence 258999999999999999999999999999999999999986432211 111111111000 0 0000 00
Q ss_pred CChhhH--HHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 616 YDFDDM--AKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 616 ~~~ee~--~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
...... ..+.+++.+|++.+|++||++.|+++.+..+..
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 011111 268999999999999999999999999876643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=228.09 Aligned_cols=255 Identities=24% Similarity=0.348 Sum_probs=190.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeecc--CCcchHHHHHHHHHhhhcCCCceeeeeeeeeec------ce
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRN--NQNGDREFIAEVEMLSRLHHRNLVKLIGICIEG------RT 445 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~~ 445 (780)
.+|.....+|.|.- .|.-+... .++.||+|++... .....+...+|..++..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34555677888888 56555543 6889999988654 233346678899999999999999999998643 35
Q ss_pred eEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccc
Q 048425 446 RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA 525 (780)
.++||||| .++|...++ ..++=.....|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|
T Consensus 96 ~y~v~e~m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhh-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 68999999 567877775 24677888899999999999999998 999999999999999999999999999
Q ss_pred ccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcc----------
Q 048425 526 REATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWAR---------- 595 (780)
Q Consensus 526 ~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~---------- 595 (780)
+..... ...+..+.|.-|.|||.+.+..+.+++||||.||++.||++|+.-|.+.. .+-.|.+
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCCH
Confidence 876554 34466778899999999998889999999999999999999998876332 2222221
Q ss_pred -----------cccccccc-----cccc-cCCccCCCC--ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 596 -----------PLLTTREG-----LEQL-VDPSLAGSY--DFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 596 -----------~ll~~~~~-----l~~l-vDp~L~~~~--~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
........ ..++ .|....... +.-......+++..|+-.+|++|-+++++++
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 11111100 1111 111111111 1122345678999999999999999999865
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-24 Score=231.80 Aligned_cols=199 Identities=28% Similarity=0.371 Sum_probs=166.6
Q ss_pred HHhcCcccceeecccCceEEEEEEEe----CCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeeeeccee
Q 048425 372 KATEKFSSKRILGEGGFGCVYHGVMD----NGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTR 446 (780)
Q Consensus 372 ~at~~f~~~~~LG~G~fG~VYkg~l~----~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~ 446 (780)
...+.|...++||+|.|++||++.+. ..+.||+|.+...+ ......+|+++|.++ -+.||+++.+++..++..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 34567889999999999999999864 36789999986543 345688999999999 599999999999999999
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC-CCCCeeeccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED-DFTPKVSDFGLA 525 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~-~~~vKLsDFGLA 525 (780)
++|+||++.-...+++. .++..++...+..+.+||+++|.+| ||||||||+|+|.+. .+.-.|.|||||
T Consensus 111 ~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred EEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 99999999998888874 3678899999999999999999999 999999999999974 577899999999
Q ss_pred ccccCC-------------------C------------------------ccceeccccCccccCchhhcc-CCCCchhh
Q 048425 526 REATEG-------------------S------------------------QHISTRVMGTFGYVAPEYAMT-GHLLVKSD 561 (780)
Q Consensus 526 ~~~~~~-------------------~------------------------~~~~t~~~GT~~Y~APE~l~~-~~~t~ksD 561 (780)
...... . .......+||+||.|||++.. ...+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 832100 0 000112469999999998864 56789999
Q ss_pred HHhHHHHHHHHHhCCCCCCCC
Q 048425 562 VYSYGVVLLELLSGRKPVDMS 582 (780)
Q Consensus 562 VySfGVvLlELlTGr~P~~~~ 582 (780)
|||-||+++-+++++.||-..
T Consensus 261 iws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred eeeccceeehhhccccccccC
Confidence 999999999999999998543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=238.03 Aligned_cols=204 Identities=25% Similarity=0.304 Sum_probs=169.8
Q ss_pred HHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcC------CCceeeeeeeeeec
Q 048425 371 EKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH------HRNLVKLIGICIEG 443 (780)
Q Consensus 371 ~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~------HpNIV~L~g~~~~~ 443 (780)
+.....|.+....|+|-|++|.+|... .|..||||++..+.. -.+.=+.|+++|++|+ --|+++|+-.|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 334578888889999999999999865 588999999966532 3345568999999995 35789999999999
Q ss_pred ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC-CCCeeecc
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD-FTPKVSDF 522 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~-~~vKLsDF 522 (780)
+++|||||-+ ..+|.+.|... ..+..|....+..++.|+.-||..|-..+ |+|.||||.||||++. ..+|||||
T Consensus 507 nHLClVFE~L-slNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccC
Confidence 9999999977 56899998754 34456888999999999999999998887 9999999999999876 46899999
Q ss_pred cccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 048425 523 GLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQ 583 (780)
Q Consensus 523 GLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~ 583 (780)
|.|....++.. +...-+.-|.|||++.+-.|+...|+||.||.||||.||+.-|.+..
T Consensus 582 GSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 582 GSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred ccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 99988766532 22223446999999999999999999999999999999998886543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.1e-22 Score=203.32 Aligned_cols=260 Identities=29% Similarity=0.420 Sum_probs=197.3
Q ss_pred cccceeecccCceEEEEEEEeCCcEEEEEEeeccCCc---chHHHHHHHHHhhhcCCC-ceeeeeeeeeecceeEEEEee
Q 048425 377 FSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQN---GDREFIAEVEMLSRLHHR-NLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~Hp-NIV~L~g~~~~~~~~~LV~Ey 452 (780)
|...+.||.|+||.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +|+++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566789999999999999986 88999998766443 357899999999999988 799999999776778999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC-CCeeecccccccccCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF-TPKVSDFGLAREATEG 531 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~-~vKLsDFGLA~~~~~~ 531 (780)
+.++++.+++...... ..+.......++.+++.++.|+|+.+ ++|||+||+||+++... .++++|||+++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999766421111 36889999999999999999999998 99999999999999988 7999999999866543
Q ss_pred Ccc-----ceeccccCccccCchhhcc---CCCCchhhHHhHHHHHHHHHhCCCCCCCCCcc-ccchhhhhccccccccc
Q 048425 532 SQH-----ISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQ-GQENLVTWARPLLTTRE 602 (780)
Q Consensus 532 ~~~-----~~t~~~GT~~Y~APE~l~~---~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~-~~~~Lv~wa~~ll~~~~ 602 (780)
... ......||..|+|||.+.+ .......|+|++|++++++++|..|+...... ...............
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-- 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-- 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence 322 2356789999999999987 67889999999999999999999997544321 001111111000000
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223567889999999999999999887664
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=224.72 Aligned_cols=164 Identities=21% Similarity=0.199 Sum_probs=129.5
Q ss_pred HhcCcccceeecccCceEEEEEEEe--CCcEEEEEEeeccC-----CcchHHHHHHHHHhhhcCCCceee-eeeeeeecc
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD--NGTEVAVKLLTRNN-----QNGDREFIAEVEMLSRLHHRNLVK-LIGICIEGR 444 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~--~g~~VAVK~l~~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~-L~g~~~~~~ 444 (780)
..++|...+.||+|+||+||+|... +++.||||++.... ....+.|.+|+++|++++|+|+++ ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 3478999999999999999999875 57888999875331 112456899999999999999985 4432 4
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEeccc-CCcceEEcCCCCCeeeccc
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDF-KASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDI-KpsNILLd~~~~vKLsDFG 523 (780)
..+|||||+++++|... . .. . ...++.++++||+|||+.+ |+|||| ||+|||++.++++||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~~-~---~~-~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-R---PH-G------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHHh-C---cc-c------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 57999999999999632 1 11 1 1467889999999999998 999999 9999999999999999999
Q ss_pred ccccccCCCcc-------ceeccccCccccCchhhccC
Q 048425 524 LAREATEGSQH-------ISTRVMGTFGYVAPEYAMTG 554 (780)
Q Consensus 524 LA~~~~~~~~~-------~~t~~~GT~~Y~APE~l~~~ 554 (780)
+|+.+...... .-+...+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99977543211 11457789999999988654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-21 Score=210.74 Aligned_cols=262 Identities=23% Similarity=0.284 Sum_probs=196.4
Q ss_pred CcccceeecccCceEEEEEEEeCC--cEEEEEEeeccCCcchHHHHHHHHHhhhcCC----Cceeeeeeee-eecceeEE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMDNG--TEVAVKLLTRNNQNGDREFIAEVEMLSRLHH----RNLVKLIGIC-IEGRTRCL 448 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~~g--~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H----pNIV~L~g~~-~~~~~~~L 448 (780)
+|.+.+.||+|+||.||++..... ..+|+|............+..|+.++..+.. .++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 789999999999999999997643 4789998766544333378889999998873 6889999888 46778899
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC-----CCCeeeccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD-----FTPKVSDFG 523 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~-----~~vKLsDFG 523 (780)
||+.+ +.+|.++.... ....++..+.++|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~--~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRN--PPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhC--CCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99987 88999977432 2568999999999999999999999999 9999999999999754 468999999
Q ss_pred ccc--cccCCCc----c--c-eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhc
Q 048425 524 LAR--EATEGSQ----H--I-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWA 594 (780)
Q Consensus 524 LA~--~~~~~~~----~--~-~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa 594 (780)
+++ .+..... . . .....||..|.++....+...+.+.|+||++.++.|++.|..||...........
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~---- 248 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK---- 248 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH----
Confidence 999 4322111 0 1 1235699999999999999999999999999999999999999965432211100
Q ss_pred ccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 595 RPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 595 ~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
+.+.................+.++...+-..+...+|....+...|+......
T Consensus 249 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 249 ---------FEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ---------HHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 00000000000011122344555666666689999999999999988876554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.6e-23 Score=211.12 Aligned_cols=245 Identities=20% Similarity=0.335 Sum_probs=188.7
Q ss_pred eeecccCceEEEEEEEeCCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCCh
Q 048425 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSV 458 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL 458 (780)
.+|.+...|..|+|+++ |..+++|+++... ....++|..|.-.|+-+.||||+.++|.|....+..++..||+.|||
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 45889999999999995 5667778875433 33447899999999999999999999999999999999999999999
Q ss_pred hhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeee--cccccccccCCCccce
Q 048425 459 ESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVS--DFGLAREATEGSQHIS 536 (780)
Q Consensus 459 ~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLs--DFGLA~~~~~~~~~~~ 536 (780)
+..||+ ...-..+-.+..++|+++|+|++|||+.. |-|.---+.+..|++|++.+++|+ |--++.. +
T Consensus 275 ynvlhe--~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq--e------ 343 (448)
T KOG0195|consen 275 YNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--E------ 343 (448)
T ss_pred HHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee--c------
Confidence 999996 44556788999999999999999999985 444455699999999999998885 2221111 1
Q ss_pred eccccCccccCchhhccCCCC---chhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 537 TRVMGTFGYVAPEYAMTGHLL---VKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 537 t~~~GT~~Y~APE~l~~~~~t---~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
....-.+.||+||.++..+.+ .++|+|||.++||||.|...||..-.+.+-.- + +.-..++
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-----------k-----ialeglr 407 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-----------K-----IALEGLR 407 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-----------h-----hhhcccc
Confidence 111235689999999876554 57899999999999999999996544322110 0 1111122
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIY 653 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~ 653 (780)
...+......+.+++.-|...||.+||.+..|+-.|++..
T Consensus 408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 2233334457888999999999999999999999998753
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.4e-20 Score=187.12 Aligned_cols=138 Identities=21% Similarity=0.258 Sum_probs=108.6
Q ss_pred eeecccCceEEEEEEEeCCcEEEEEEeeccCCc--c-------hHHH-----------------HHHHHHhhhcCCCcee
Q 048425 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQN--G-------DREF-----------------IAEVEMLSRLHHRNLV 434 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~--~-------~~~f-----------------~~Ei~iL~~L~HpNIV 434 (780)
..||+|+||.||+|...+|+.||||+++..... . ...| ..|++.+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 679999999999999888999999999764221 1 1122 3499999999887764
Q ss_pred eeeeeeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCcEEecccCCcceEEcC
Q 048425 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL-HEDSNPRVIHRDFKASNVLLED 513 (780)
Q Consensus 435 ~L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yL-H~~~~p~IvHrDIKpsNILLd~ 513 (780)
....+.. ...+|||||++++++...+. ....+++....+++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 4333222 23489999999887765432 234789999999999999999999 6777 99999999999998
Q ss_pred CCCCeeecccccccc
Q 048425 514 DFTPKVSDFGLAREA 528 (780)
Q Consensus 514 ~~~vKLsDFGLA~~~ 528 (780)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=190.20 Aligned_cols=258 Identities=21% Similarity=0.313 Sum_probs=195.5
Q ss_pred cCcccceeecccCceEEEEEE-EeCCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~-l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
-+|.+.++||+|.||..+.|+ +-+++.||||.-... ...-++..|....+.| ..++|...+-|-.++....||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 367888999999999999998 458999999974332 2334667788888887 578999999888888899999998
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC-----CCCeeeccccccc
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD-----FTPKVSDFGLARE 527 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~-----~~vKLsDFGLA~~ 527 (780)
+ +-||+|++. -....++.++...||.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|+.
T Consensus 106 L-GPSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 106 L-GPSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred h-CcCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 8 789988875 24567999999999999999999999998 9999999999999643 3578999999998
Q ss_pred ccCCCc--cc----eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccc
Q 048425 528 ATEGSQ--HI----STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTR 601 (780)
Q Consensus 528 ~~~~~~--~~----~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~ 601 (780)
+.+... ++ .....||.+||+-....++..+.+.|.-|+|-|+++.|-|..||.+-......
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK------------- 245 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK------------- 245 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH-------------
Confidence 865432 22 23467999999999999999999999999999999999999999764322111
Q ss_pred cccccccCC-------ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCCC
Q 048425 602 EGLEQLVDP-------SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDE 658 (780)
Q Consensus 602 ~~l~~lvDp-------~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~~ 658 (780)
+..+.+-|. .|...+ .+++...+..++ ..+-.+-|..+-+...+..++....+
T Consensus 246 ~kYeKIGe~Kr~T~i~~Lc~g~-P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 246 EKYEKIGETKRSTPIEVLCEGF-PEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred HHHHHhccccccCCHHHHHhcC-HHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 111111111 111112 233344444443 46677889988888877777765543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.7e-20 Score=186.81 Aligned_cols=271 Identities=21% Similarity=0.297 Sum_probs=204.4
Q ss_pred chHHHHHHhcCcccceeecccCceEEEEEE-EeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCC-Cceeeeeeeeeec
Q 048425 366 ALSDLEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHH-RNLVKLIGICIEG 443 (780)
Q Consensus 366 ~~~el~~at~~f~~~~~LG~G~fG~VYkg~-l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H-pNIV~L~g~~~~~ 443 (780)
+++++..+ ++|...+.||.|+||.+|.|. ..+|++||||.-.... ...++.-|.++...|++ ..|..+.-|..++
T Consensus 7 s~~~~iv~-gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 7 SLEELIVG-GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred chhhheec-cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence 34444444 689999999999999999998 4689999999864433 23457788999998864 5688888888888
Q ss_pred ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC---CCCeee
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD---FTPKVS 520 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~---~~vKLs 520 (780)
+...||||.+ +-||++++.- ....++.++.+-+|.|++.-++|+|..+ +|||||||+|+|..-+ ..+.++
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred ccceeeeecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEE
Confidence 8999999988 8899998853 3456889999999999999999999998 9999999999999754 457899
Q ss_pred cccccccccCCCc--cc----eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhc
Q 048425 521 DFGLAREATEGSQ--HI----STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWA 594 (780)
Q Consensus 521 DFGLA~~~~~~~~--~~----~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa 594 (780)
|||||+.+.+... ++ .....||.+|.+-....+...+...|+-|+|.||..+.-|..||+.-......+-.+.
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk- 235 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK- 235 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH-
Confidence 9999998865432 22 2456899999988877777888999999999999999999999987554332221111
Q ss_pred ccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 595 RPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 595 ~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
+.+. .+...+ ..|...+ +.++...+.-|-..--++-|.-.-+-+.+..+....
T Consensus 236 --I~Ek--K~s~~i-e~LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 236 --ISEK--KMSTPI-EVLCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred --HHHh--hcCCCH-HHHhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 0100 011000 1112222 356777888898888889999888877777666543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-20 Score=221.61 Aligned_cols=248 Identities=21% Similarity=0.225 Sum_probs=186.6
Q ss_pred cceeecccCceEEEEEEEe-CCcEEEEEEeecc--CCcchH----HHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 379 SKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRN--NQNGDR----EFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 379 ~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~--~~~~~~----~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
..+++|.|.+|.|+..... ..+..+.|..... .....+ .+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4588999999977776643 3333444432210 111222 25567778888999999998888887776666799
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++ +|...+. ....++-.++..+..|+.+|++|||..| |.|||+|++|++++.++.+||+|||.+..+...
T Consensus 402 ~~~~-Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHh----cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 9999984 3357888899999999999999999999 999999999999999999999999999876543
Q ss_pred Cc---cceeccccCccccCchhhccCCCCc-hhhHHhHHHHHHHHHhCCCCCCCCCccccch----hhhhcccccccccc
Q 048425 532 SQ---HISTRVMGTFGYVAPEYAMTGHLLV-KSDVYSYGVVLLELLSGRKPVDMSQPQGQEN----LVTWARPLLTTREG 603 (780)
Q Consensus 532 ~~---~~~t~~~GT~~Y~APE~l~~~~~t~-ksDVySfGVvLlELlTGr~P~~~~~~~~~~~----Lv~wa~~ll~~~~~ 603 (780)
.. .....++|+..|+|||.+....|.+ ..||||.|+++..|++|+.||......++.. ...|...
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~------- 546 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNI------- 546 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccccc-------
Confidence 22 4556788999999999999998875 6799999999999999999998766543321 0010000
Q ss_pred cccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 604 LEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 604 l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..-..........+...++.++++.+|.+|-+|++|++
T Consensus 547 ------~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 ------FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ------ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000111233457788999999999999999999965
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.4e-19 Score=180.05 Aligned_cols=141 Identities=21% Similarity=0.228 Sum_probs=111.9
Q ss_pred ceeecccCceEEEEEEEeCCcEEEEEEeeccCCcc--------------------------hHHHHHHHHHhhhcCCCce
Q 048425 380 KRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNG--------------------------DREFIAEVEMLSRLHHRNL 433 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~--------------------------~~~f~~Ei~iL~~L~HpNI 433 (780)
...||+|+||.||+|...+|+.||||+++...... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 36799999999999998889999999987653210 1123578999999999987
Q ss_pred eeeeeeeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCcEEecccCCcceEEc
Q 048425 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE-DSNPRVIHRDFKASNVLLE 512 (780)
Q Consensus 434 V~L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~-~~~p~IvHrDIKpsNILLd 512 (780)
.....+... ..+|||||++++++...+. ....++..+..+++.+++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence 554444332 3489999999886543321 12457788899999999999999999 87 99999999999999
Q ss_pred CCCCCeeecccccccccC
Q 048425 513 DDFTPKVSDFGLAREATE 530 (780)
Q Consensus 513 ~~~~vKLsDFGLA~~~~~ 530 (780)
+++++|+|||++.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 88999999999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.5e-20 Score=189.22 Aligned_cols=171 Identities=11% Similarity=0.132 Sum_probs=135.7
Q ss_pred HhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHH---------HHHHHHHhhhcCCCceeeeeeeeeec
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDRE---------FIAEVEMLSRLHHRNLVKLIGICIEG 443 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~---------f~~Ei~iL~~L~HpNIV~L~g~~~~~ 443 (780)
..++|...++||.|+||.||.... ++..+|||.+........+. |.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468899999999999999999655 67789999997654333322 68899999999999999999886533
Q ss_pred --------ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC
Q 048425 444 --------RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF 515 (780)
Q Consensus 444 --------~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~ 515 (780)
...+|||||++|.+|.++.. ++. ....+++.+|..||+.+ ++|||+||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 35789999999999988741 222 24568999999999998 99999999999999988
Q ss_pred CCeeecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHH
Q 048425 516 TPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL 573 (780)
Q Consensus 516 ~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELl 573 (780)
++|+|||......+.... ..+.+...+..++|+|+|||.+.-+.
T Consensus 173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988765432111 11455556778999999999987765
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-20 Score=219.19 Aligned_cols=247 Identities=21% Similarity=0.246 Sum_probs=184.6
Q ss_pred CcccceeecccCceEEEEEEEeCCcEEEEEEeeccC-CcchHHHHHHHHHhh--hcCCCceeeeeeeeeecceeEEEEee
Q 048425 376 KFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNN-QNGDREFIAEVEMLS--RLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~--~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++...+.||.+.|=+|.+|+.++|. |+||++-+.. .-..+.|.++++-++ .+++||.+++.-+-...+-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666788999999999999998888 8999875544 445567766665554 45899999998887777777899999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc--cC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA--TE 530 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~--~~ 530 (780)
+.+ +|+|.| ..+.-|...+..-|+.|++.||..+|+.+ |+|||||.+||||+.-.-+.|+||.--+.. ++
T Consensus 103 vkh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 855 777777 45667888899999999999999999998 999999999999999999999999877643 22
Q ss_pred CCcccee----ccccCccccCchhhccC-----------CCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhc
Q 048425 531 GSQHIST----RVMGTFGYVAPEYAMTG-----------HLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWA 594 (780)
Q Consensus 531 ~~~~~~t----~~~GT~~Y~APE~l~~~-----------~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa 594 (780)
+.....+ ....-..|.|||.+... .++++.||||.|||+.||++ |+.+|+.. +|..+-
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr 248 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYR 248 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHh
Confidence 2111111 11123369999977541 26789999999999999998 78888643 233221
Q ss_pred cc-ccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 595 RP-LLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 595 ~~-ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
+. .......++++-|. .+.+++..|++.||.+|-++++.++.-
T Consensus 249 ~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 249 SGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred ccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhh
Confidence 11 01111123333332 467899999999999999999998873
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.1e-19 Score=201.72 Aligned_cols=218 Identities=24% Similarity=0.398 Sum_probs=165.6
Q ss_pred hhhcCCCceeeeeeeeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEeccc
Q 048425 425 LSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDF 504 (780)
Q Consensus 425 L~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDI 504 (780)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+. .....++|.....+..+|++||+|||+.. -..|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~---~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILS---NEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHh---ccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeee
Confidence 467899999999999999999999999999999999996 35668999999999999999999999764 2299999
Q ss_pred CCcceEEcCCCCCeeecccccccccCCC-ccceeccccCccccCchhhccC-------CCCchhhHHhHHHHHHHHHhCC
Q 048425 505 KASNVLLEDDFTPKVSDFGLAREATEGS-QHISTRVMGTFGYVAPEYAMTG-------HLLVKSDVYSYGVVLLELLSGR 576 (780)
Q Consensus 505 KpsNILLd~~~~vKLsDFGLA~~~~~~~-~~~~t~~~GT~~Y~APE~l~~~-------~~t~ksDVySfGVvLlELlTGr 576 (780)
+++|+++|..+.+||+|||+.....+.. ........-..-|.|||.+... ..+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999998775311 1111112234469999988763 1477899999999999999999
Q ss_pred CCCCCCCcccc-chhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 577 KPVDMSQPQGQ-ENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 577 ~P~~~~~~~~~-~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
.||+....... ..++.++.. .-...+.|.+.... +....+..++..||..+|++||++++|-..++.+...
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred CccccccccCChHHHHHHHHh------cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99976432221 223332211 11222333332111 3334789999999999999999999998888776553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.8e-18 Score=172.66 Aligned_cols=184 Identities=17% Similarity=0.104 Sum_probs=139.7
Q ss_pred cceeecccCceEEEEEEEeCCcEEEEEEeeccCCcc----hHHHHHHHHHhhhcC-CCceeeeeeeeeecceeEEEEeec
Q 048425 379 SKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNG----DREFIAEVEMLSRLH-HRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 379 ~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~----~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
....|++|+||+||.+.- .+.+++.+.+.....-. ...|.+|+++|++|+ |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997655 67888888775543311 125889999999995 5889999886 3468999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEeccc-CCcceEEcCCCCCeeecccccccccCCC
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDF-KASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDI-KpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
.+.+|...+. . ....++.+++.+|+++|+.+ |+|||| ||+|||+++++.++|+|||+|.......
T Consensus 81 ~G~~L~~~~~----~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPP----R-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhh----h-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 9999875431 1 11357789999999999998 999999 7999999999999999999998655433
Q ss_pred cc----c--------eeccccCccccCchhhcc-CCCC-chhhHHhHHHHHHHHHhCCCCCCC
Q 048425 533 QH----I--------STRVMGTFGYVAPEYAMT-GHLL-VKSDVYSYGVVLLELLSGRKPVDM 581 (780)
Q Consensus 533 ~~----~--------~t~~~GT~~Y~APE~l~~-~~~t-~ksDVySfGVvLlELlTGr~P~~~ 581 (780)
.. . ......++.|++|+...- ...+ ...+.++-|.-+|.++|++.+.-.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 10 0 111236778888874432 1223 567999999999999999987643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=177.80 Aligned_cols=234 Identities=22% Similarity=0.368 Sum_probs=150.7
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcC----------CCceeeeeeeee
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLH----------HRNLVKLIGICI 441 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~----------HpNIV~L~g~~~ 441 (780)
.+...+.||.|+++.||.++.. +|+++|||+...... ...+++.+|.-.+..+. |-.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4456689999999999999986 589999999754432 23356777766555532 212222222211
Q ss_pred ---------ecc--------eeEEEEeecCCCChhhhcccc---cCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEe
Q 048425 442 ---------EGR--------TRCLVYELVHNGSVESHLHGV---DKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIH 501 (780)
Q Consensus 442 ---------~~~--------~~~LV~Ey~~~GSL~~~L~~~---~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvH 501 (780)
.+. +.+++|+-+ .++|.+.+... ......+....++.+..|+.+.+++||..+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 235677766 56887775421 112223556677888899999999999999 999
Q ss_pred cccCCcceEEcCCCCCeeecccccccccCCCccceeccccCccccCchhhccC--------CCCchhhHHhHHHHHHHHH
Q 048425 502 RDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG--------HLLVKSDVYSYGVVLLELL 573 (780)
Q Consensus 502 rDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~--------~~t~ksDVySfGVvLlELl 573 (780)
+|||++|++++.+|.++|+||+......+... . ...+..|.+||..... .++.+.|.|++|+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE---G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee---c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999987776544211 1 2345779999976442 5788999999999999999
Q ss_pred hCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCC
Q 048425 574 SGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHR 639 (780)
Q Consensus 574 TGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~R 639 (780)
+|+.||+...+.... .| .+ .... +..+.+..|+...++.||++|
T Consensus 245 C~~lPf~~~~~~~~~---~~-----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADP---EW-----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTS---GG-----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccc---cc-----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999865432211 11 11 1222 455788899999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-17 Score=170.53 Aligned_cols=136 Identities=15% Similarity=0.243 Sum_probs=106.8
Q ss_pred ccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhc-----CCCceeeeeeeeeecc---e-eE
Q 048425 378 SSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-----HHRNLVKLIGICIEGR---T-RC 447 (780)
Q Consensus 378 ~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-----~HpNIV~L~g~~~~~~---~-~~ 447 (780)
+..++||+|+||.||. .. ++.. +||++........+++.+|+++++.+ +|+||++++|++.++. . ..
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 4457899999999996 43 4444 79988765555567899999999999 5799999999998763 2 33
Q ss_pred EEEee--cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCcEEecccCCcceEEcC----CCCCeee
Q 048425 448 LVYEL--VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGL-AYLHEDSNPRVIHRDFKASNVLLED----DFTPKVS 520 (780)
Q Consensus 448 LV~Ey--~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL-~yLH~~~~p~IvHrDIKpsNILLd~----~~~vKLs 520 (780)
+|+|| +++|+|.+++.. ..++.. ..++.+++.++ +|||+.+ |+||||||+|||++. +++++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 568999999942 235554 35677888777 9999998 999999999999973 3489999
Q ss_pred cccccc
Q 048425 521 DFGLAR 526 (780)
Q Consensus 521 DFGLA~ 526 (780)
||+.+.
T Consensus 152 Dg~G~~ 157 (210)
T PRK10345 152 DNIGES 157 (210)
T ss_pred ECCCCc
Confidence 955443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=198.44 Aligned_cols=200 Identities=23% Similarity=0.261 Sum_probs=159.7
Q ss_pred HHHHHHhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcC---CCceeeeeeeeeecc
Q 048425 368 SDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH---HRNLVKLIGICIEGR 444 (780)
Q Consensus 368 ~el~~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~ 444 (780)
.+++...+.|.+.+.||+|+||+||+|...+|+.||+|+-+....-. |.=-.+++.||+ -+.|..+.....-.+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 34555667888999999999999999999899999999976655421 111223344444 233444444455567
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc-------CCCCC
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE-------DDFTP 517 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd-------~~~~v 517 (780)
.-+||+||.+-|+|.+++. ..+.++|...+.++.++++.++.||..+ |||+||||+|.||. ++.-+
T Consensus 768 ~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred cceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccce
Confidence 7899999999999999995 5678999999999999999999999998 99999999999993 33468
Q ss_pred eeecccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCC
Q 048425 518 KVSDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRK 577 (780)
Q Consensus 518 KLsDFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~ 577 (780)
+|+|||.+..+.--.. .....+++|-++-.+|...++.++...|-|.+.-+++-||.|+.
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999999976542221 23356678999999999999999999999999999999999974
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.7e-18 Score=196.06 Aligned_cols=225 Identities=25% Similarity=0.306 Sum_probs=176.7
Q ss_pred eecccCceEEEEEE----EeCCcEEEEEEeeccCCcc--hHHHHHHHHHhhhcC-CCceeeeeeeeeecceeEEEEeecC
Q 048425 382 ILGEGGFGCVYHGV----MDNGTEVAVKLLTRNNQNG--DREFIAEVEMLSRLH-HRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 382 ~LG~G~fG~VYkg~----l~~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
.+|+|.||.|+... .+.|..+|+|.+++..... ......|..++..++ |+.+|++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999754 3457789999987653221 124566888888887 9999999999998999999999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+|.|...+. ....++..........+|-+++++|+.+ |++||+|++||+++.+|++|+.|||+++...+....
T Consensus 81 gg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 999988884 4556677777777788899999999998 999999999999999999999999999987664332
Q ss_pred ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCC
Q 048425 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAG 614 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~ 614 (780)
+||..|||||++. ......|.||||++.+||+||-.||.. . .+..+.... -
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~-------------~~~~Il~~~--~ 204 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------D-------------TMKRILKAE--L 204 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------H-------------HHHHHhhhc--c
Confidence 7999999999988 457789999999999999999999864 0 011111111 1
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCH
Q 048425 615 SYDFDDMAKVAAIASMCVHPEVTHRPFM 642 (780)
Q Consensus 615 ~~~~ee~~~l~~La~~Cl~~dP~~RPsm 642 (780)
..+.+.......+....+..+|.+|--.
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 2233444556677778888888888765
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.4e-17 Score=165.84 Aligned_cols=134 Identities=18% Similarity=0.265 Sum_probs=114.1
Q ss_pred eeecccCceEEEEEEEeCCcEEEEEEeeccCCcc--------hHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNG--------DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~--------~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
+.||+|++|.||+|.. +|..|+||+........ ...+.+|++++..++|+||.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 67889999865432211 13578899999999999998888887777888999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+++++|.+++.. ..+ .+..++.+++.+|.+||+.+ ++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~-------~~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINS-------NGM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHh-------ccH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999852 112 88899999999999999998 99999999999999 78999999998865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.5e-17 Score=162.80 Aligned_cols=131 Identities=18% Similarity=0.301 Sum_probs=107.8
Q ss_pred eecccCceEEEEEEEeCCcEEEEEEeeccCCc--------chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 382 ILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQN--------GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 382 ~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~--------~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
+||+|+||.||+|.+ +|..|++|+....... ....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 6788999986543211 1245778999999999887666666666667779999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
++++|.+++... .. .++.+++.+|++||+.+ ++|||++|.||+++ ++.+++.|||+++..
T Consensus 80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999987421 10 78999999999999998 99999999999999 889999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.6e-17 Score=168.29 Aligned_cols=144 Identities=19% Similarity=0.191 Sum_probs=112.5
Q ss_pred CcccceeecccCceEEEEEE--EeCCcEEEEEEeeccCCc------------------------chHHHHHHHHHhhhcC
Q 048425 376 KFSSKRILGEGGFGCVYHGV--MDNGTEVAVKLLTRNNQN------------------------GDREFIAEVEMLSRLH 429 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~--l~~g~~VAVK~l~~~~~~------------------------~~~~f~~Ei~iL~~L~ 429 (780)
-|...+.||+|+||.||+|. ..+|+.||||+++..... ....+..|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 568999999998754211 0123568999999997
Q ss_pred CCc--eeeeeeeeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCc
Q 048425 430 HRN--LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKAS 507 (780)
Q Consensus 430 HpN--IV~L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKps 507 (780)
+.+ +.+++++ ...++||||+++++|...+. ....+...+...++.|++.+|+|||+.+ .|+||||||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence 533 3444443 23589999999988877652 2234566677899999999999999886 4999999999
Q ss_pred ceEEcCCCCCeeecccccccccC
Q 048425 508 NVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 508 NILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++ +++++|+|||++.....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccCC
Confidence 99999 88999999999875443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.5e-17 Score=189.07 Aligned_cols=140 Identities=16% Similarity=0.253 Sum_probs=114.0
Q ss_pred HHhcCcccceeecccCceEEEEEEEeCCcEEEEEEe-eccCC-------cchHHHHHHHHHhhhcCCCceeeeeeeeeec
Q 048425 372 KATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLL-TRNNQ-------NGDREFIAEVEMLSRLHHRNLVKLIGICIEG 443 (780)
Q Consensus 372 ~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l-~~~~~-------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~ 443 (780)
.....|...++||+|+||+||+|.+.+. .+++|+. .+... ...+.+.+|++++.+++|++++..+.++...
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 3345556779999999999999987544 4444432 22111 1124688999999999999999988888877
Q ss_pred ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccc
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFG 523 (780)
+..++||||+++++|.+++. ...+++.+++++|+|||+.+ |+||||||+|||+ +++.++|+|||
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCc
Confidence 78899999999999999873 35789999999999999998 9999999999999 67799999999
Q ss_pred ccccc
Q 048425 524 LAREA 528 (780)
Q Consensus 524 LA~~~ 528 (780)
+++..
T Consensus 473 la~~~ 477 (535)
T PRK09605 473 LGKYS 477 (535)
T ss_pred ccccC
Confidence 99764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.6e-17 Score=162.80 Aligned_cols=146 Identities=18% Similarity=0.149 Sum_probs=114.1
Q ss_pred HHHHHHhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCc----------------------chHHHHHHHHHh
Q 048425 368 SDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQN----------------------GDREFIAEVEML 425 (780)
Q Consensus 368 ~el~~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~----------------------~~~~f~~Ei~iL 425 (780)
.++.+....|...+.||+|+||.||++..++|+.||||++...... ....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444544457778999999999999999888999999987543210 012367789999
Q ss_pred hhcCCCc--eeeeeeeeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecc
Q 048425 426 SRLHHRN--LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRD 503 (780)
Q Consensus 426 ~~L~HpN--IV~L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrD 503 (780)
..+.|.+ +...++. ...++||||+++++|.+.... ....+++.+++.++.++|+.+ |+|||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~D 150 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGD 150 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence 9998874 4444442 355899999999998765420 234678899999999999987 99999
Q ss_pred cCCcceEEcCCCCCeeecccccccccC
Q 048425 504 FKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 504 IKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
|||+||++++++.++|+|||++.....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.6e-17 Score=182.40 Aligned_cols=174 Identities=24% Similarity=0.355 Sum_probs=130.5
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccc
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGL 524 (780)
..++.|+++.-.+|++||.+. ......+|...+.++.|++.|++| ++ .+|||+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 467999999999999999653 345678899999999999999999 55 89999999999999999999999999
Q ss_pred cccccCCC-----ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccc
Q 048425 525 AREATEGS-----QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLL 598 (780)
Q Consensus 525 A~~~~~~~-----~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll 598 (780)
........ ....+...||..||+||.+.+..|+.|+||||+|++|+||++ =...++...
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~--------------- 467 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA--------------- 467 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH---------------
Confidence 98776554 223356789999999999999999999999999999999997 222221000
Q ss_pred ccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHH
Q 048425 599 TTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEV 645 (780)
Q Consensus 599 ~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EV 645 (780)
...+.....++|...-+++ .=..+..+++...|.+||++.++
T Consensus 468 t~~d~r~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 468 TLTDIRDGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hhhhhhcCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHH
Confidence 0000011122222222222 22467889999999999954443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.1e-15 Score=142.11 Aligned_cols=136 Identities=21% Similarity=0.197 Sum_probs=116.1
Q ss_pred cceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCC--CceeeeeeeeeecceeEEEEeecCCC
Q 048425 379 SKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHH--RNLVKLIGICIEGRTRCLVYELVHNG 456 (780)
Q Consensus 379 ~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~~~~~LV~Ey~~~G 456 (780)
..+.||+|.++.||++...+ ..++||....... ...+.+|+.++..++| .+++++++++..++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999854 7899999865433 5679999999999976 58999999988778899999999987
Q ss_pred ChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 457 SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 457 SL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
.+..+ ++.....++.+++.+|++||......++|+|++++||++++++.+++.|||.+...
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 76543 56777889999999999999875556999999999999999899999999988753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.9e-15 Score=147.90 Aligned_cols=137 Identities=23% Similarity=0.266 Sum_probs=99.6
Q ss_pred ceeecccCceEEEEEEEeCCcEEEEEEeeccCCcc--hHHH----------------------HHHHHHhhhcCCCc--e
Q 048425 380 KRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNG--DREF----------------------IAEVEMLSRLHHRN--L 433 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~--~~~f----------------------~~Ei~iL~~L~HpN--I 433 (780)
.+.||+|+||+||+|...+|+.||||+++...... ...+ ..|.+.+.++++.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 36799999999999998889999999986543211 1111 34666666664433 4
Q ss_pred eeeeeeeeecceeEEEEeecCCCChhhh-cccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCcEEecccCCcceEE
Q 048425 434 VKLIGICIEGRTRCLVYELVHNGSVESH-LHGVDKNRGPLDWEARMKIALGAARGLAYLHE-DSNPRVIHRDFKASNVLL 511 (780)
Q Consensus 434 V~L~g~~~~~~~~~LV~Ey~~~GSL~~~-L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~-~~~p~IvHrDIKpsNILL 511 (780)
.+.+++ ...++||||++++.+... +... ... .+..+++.+++.++.++|. .+ |+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence 444443 245899999999654322 2110 011 5678899999999999998 76 9999999999999
Q ss_pred cCCCCCeeecccccccccC
Q 048425 512 EDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 512 d~~~~vKLsDFGLA~~~~~ 530 (780)
+ ++.++|+|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 89999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.2e-15 Score=175.88 Aligned_cols=209 Identities=24% Similarity=0.349 Sum_probs=142.3
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
.+|...++|-.|++|.||..+++ ..+.+|+|+- +... ..+. ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~l-----ilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL-----ILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhccc-ccch-----hhhc--cccccCCccee-------------------
Confidence 67889999999999999999876 4567888542 2211 1111 22222333333
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC-
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS- 532 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~- 532 (780)
|+-...+ +.-++++... +.+++|||+.+ |+|||+||+|.+|+.=|++|+.|||+.+......
T Consensus 136 --gDc~tll----k~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 --GDCATLL----KNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred --chhhhhc----ccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 3333333 2333443322 67899999998 9999999999999999999999999998642210
Q ss_pred -------------ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccc
Q 048425 533 -------------QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLT 599 (780)
Q Consensus 533 -------------~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~ 599 (780)
......++||+.|.|||++....|..-+|.|++|+++||.+-|..||....+++-.. ..+....
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg--~visd~i- 275 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG--QVISDDI- 275 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh--hhhhhhc-
Confidence 112345799999999999999999999999999999999999999998876542110 0011100
Q ss_pred cccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 048425 600 TREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFM 642 (780)
Q Consensus 600 ~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm 642 (780)
.+.++ +.....+..+++.+.++.+|..|---
T Consensus 276 --~wpE~----------dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 276 --EWPEE----------DEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred --ccccc----------CcCCCHHHHHHHHHHHHhChHhhccc
Confidence 11111 12223456778888889999998543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.1e-14 Score=147.91 Aligned_cols=135 Identities=21% Similarity=0.272 Sum_probs=106.1
Q ss_pred eeec-ccCceEEEEEEEeCCcEEEEEEeeccC-------------CcchHHHHHHHHHhhhcCCCce--eeeeeeeeecc
Q 048425 381 RILG-EGGFGCVYHGVMDNGTEVAVKLLTRNN-------------QNGDREFIAEVEMLSRLHHRNL--VKLIGICIEGR 444 (780)
Q Consensus 381 ~~LG-~G~fG~VYkg~l~~g~~VAVK~l~~~~-------------~~~~~~f~~Ei~iL~~L~HpNI--V~L~g~~~~~~ 444 (780)
..|| .||.|+||+... ++..++||+..... ......+.+|++++.+++|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 6798 899999999888 47789999885421 1123467889999999998875 77777754432
Q ss_pred e----eEEEEeecCC-CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCee
Q 048425 445 T----RCLVYELVHN-GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKV 519 (780)
Q Consensus 445 ~----~~LV~Ey~~~-GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKL 519 (780)
. .++|+||+++ .+|.+++.. ..++.. .+.+++.+|.+||+.+ |+||||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 2 2599999997 689888742 234443 3568899999999998 999999999999999999999
Q ss_pred ecccccccc
Q 048425 520 SDFGLAREA 528 (780)
Q Consensus 520 sDFGLA~~~ 528 (780)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.6e-13 Score=148.10 Aligned_cols=198 Identities=22% Similarity=0.256 Sum_probs=135.1
Q ss_pred CCCceeeeeeeeee---------------------------cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHH
Q 048425 429 HHRNLVKLIGICIE---------------------------GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIA 481 (780)
Q Consensus 429 ~HpNIV~L~g~~~~---------------------------~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia 481 (780)
+|||||++.++|.+ +...++||.-. ..+|.++|.. ...+...+.-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc-----CCCchHHHHHHH
Confidence 59999999988753 23457887765 3478888742 235556667788
Q ss_pred HHHHHHHHHHhhCCCCcEEecccCCcceEE--cCCC--CCeeecccccccccCCCc---cc--eeccccCccccCchhhc
Q 048425 482 LGAARGLAYLHEDSNPRVIHRDFKASNVLL--EDDF--TPKVSDFGLAREATEGSQ---HI--STRVMGTFGYVAPEYAM 552 (780)
Q Consensus 482 ~qIA~gL~yLH~~~~p~IvHrDIKpsNILL--d~~~--~vKLsDFGLA~~~~~~~~---~~--~t~~~GT~~Y~APE~l~ 552 (780)
.|+++|..|||+++ |.|||+|++|||| |+|. ...|+|||.+-.-....- .. .....|...-||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999998 9999999999999 4554 357899998754322111 11 12234677899999876
Q ss_pred cC--CC----CchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHH
Q 048425 553 TG--HL----LVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAA 626 (780)
Q Consensus 553 ~~--~~----t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~ 626 (780)
.. +. ..|+|.|+.|-+.||+++...||..... . + +..+ ..++---|.+ +......+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe---m-~-------L~~r-~Yqe~qLPal----p~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE---M-L-------LDTR-TYQESQLPAL----PSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch---h-e-------echh-hhhhhhCCCC----cccCChHHHH
Confidence 43 22 4799999999999999999999965211 1 1 1000 0111111112 1222345778
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHH
Q 048425 627 IASMCVHPEVTHRPFMGEVVQALKL 651 (780)
Q Consensus 627 La~~Cl~~dP~~RPsm~EVv~~L~~ 651 (780)
++...++.||.+|++..-....|..
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHHH
Confidence 9999999999999998766666654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=7.8e-15 Score=172.32 Aligned_cols=254 Identities=23% Similarity=0.310 Sum_probs=185.8
Q ss_pred CcccceeecccCceEEEEEEEeC--CcEEEEEEeeccC--CcchHHHHHHHHHhhhcC-CCceeeeeeeeeecceeEEEE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMDN--GTEVAVKLLTRNN--QNGDREFIAEVEMLSRLH-HRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~~--g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~ 450 (780)
.|...+.||+|.|+.|-.....+ ...+|+|.+.... .........|..+-..+. |.|++.+++...+.+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 34455679999999998877643 3456666665443 112233445777777776 999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCcEEecccCCcceEEcCCC-CCeeecccccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH-EDSNPRVIHRDFKASNVLLEDDF-TPKVSDFGLAREA 528 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH-~~~~p~IvHrDIKpsNILLd~~~-~vKLsDFGLA~~~ 528 (780)
+|..++++.+-+.. ......+-...-....|+..++.|+| ..+ +.||||||+|.+++..+ ..|++|||+|..+
T Consensus 101 ~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 101 SYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred Cccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999988831 22224555566678899999999999 777 99999999999999999 9999999999988
Q ss_pred cC--CCccceecccc-CccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccc
Q 048425 529 TE--GSQHISTRVMG-TFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 529 ~~--~~~~~~t~~~G-T~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
.. +........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...... .....|...- ...
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~----~~~ 250 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK----GRF 250 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc----ccc
Confidence 66 33334455678 9999999988874 45678999999999999999999998655432 2222332111 000
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.... -........++...++..+|..|.+.+++..
T Consensus 251 ~~~~--------~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 251 TQLP--------WNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccCc--------cccCChhhhhcccccccCCchhccccccccc
Confidence 0000 0111234567778888899999999988743
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.1e-13 Score=152.85 Aligned_cols=142 Identities=22% Similarity=0.229 Sum_probs=102.0
Q ss_pred ceeecccCceEEEEEEEeCCcEEEEEEeeccCCcc----------------------------------------hHHHH
Q 048425 380 KRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNG----------------------------------------DREFI 419 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~----------------------------------------~~~f~ 419 (780)
.+.||.|++|.||+|++.+|+.||||+.+...... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999986542100 01255
Q ss_pred HHHHHhhhcC----CCceeeeeeeee-ecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHH-HHHHHhh
Q 048425 420 AEVEMLSRLH----HRNLVKLIGICI-EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAAR-GLAYLHE 493 (780)
Q Consensus 420 ~Ei~iL~~L~----HpNIV~L~g~~~-~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~-gL~yLH~ 493 (780)
+|+..+.++. |.+-+.+-.++. .....+|||||++|++|.+.+... .... .+.+++..+++ .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCC---CHHHHHHHHHHHHHHHHHh
Confidence 5666666552 333333333332 234679999999999998876421 1112 24567777766 4688898
Q ss_pred CCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 494 ~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
.+ ++|+|+||.||+++++++++++|||++.....
T Consensus 276 ~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 87 99999999999999999999999999977653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.5e-12 Score=136.55 Aligned_cols=204 Identities=20% Similarity=0.238 Sum_probs=143.4
Q ss_pred HHHhhhcCCCceeeeeeeeeec-----ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 048425 422 VEMLSRLHHRNLVKLIGICIEG-----RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSN 496 (780)
Q Consensus 422 i~iL~~L~HpNIV~L~g~~~~~-----~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~ 496 (780)
..-|-++.|-|||++..|..+. ....++.|||..|+|..+|.+..+....+......+++.||..||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 3445566799999999997653 345899999999999999988777777888889999999999999999986 7
Q ss_pred CcEEecccCCcceEEcCCCCCeeeccccccccc---CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHH
Q 048425 497 PRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT---EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL 573 (780)
Q Consensus 497 p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~---~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELl 573 (780)
|+|+|+++..+-|++..++-+||.--.-..... ...........|-++|.+||+-.....+..+|||+||+-.+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 999999999999999999888874321111000 00001112334678899999988888889999999999999998
Q ss_pred hCCCC-CCCCCccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 574 SGRKP-VDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 574 TGr~P-~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
-|..- .+...... .-...++. +..+-++ .-..++..|++.+|..||+|.+++.
T Consensus 277 ilEiq~tnseS~~~--~ee~ia~~-------i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVE--VEENIANV-------IIGLENG------------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceee--hhhhhhhh-------eeeccCc------------cccCcCcccccCCCCCCcchhhhhc
Confidence 77642 22111100 00000000 0101011 1124567899999999999998754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.1e-11 Score=121.31 Aligned_cols=131 Identities=18% Similarity=0.079 Sum_probs=97.9
Q ss_pred ceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCcee-eeeeeeeecceeEEEEeecCCCCh
Q 048425 380 KRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV-KLIGICIEGRTRCLVYELVHNGSV 458 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV-~L~g~~~~~~~~~LV~Ey~~~GSL 458 (780)
.+.|+.|.++.||+.... |..|++|....... ....+..|++++..+.+.+++ +++++. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 367899999999999874 78899998754432 223567899999998765544 445443 3345899999999887
Q ss_pred hhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 459 ESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS--NPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 459 ~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~--~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
.+.- . ....++.+++++|+.||..+ ...++|+|+++.||+++ ++.++++|||.+..
T Consensus 79 ~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5431 0 11345678999999999886 23469999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.22 E-value=7e-12 Score=145.22 Aligned_cols=147 Identities=17% Similarity=0.222 Sum_probs=95.4
Q ss_pred hcCcccceeecccCceEEEEEEEeC-CcEEEEEEeeccCCc--------------------------c--------h---
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDN-GTEVAVKLLTRNNQN--------------------------G--------D--- 415 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~-g~~VAVK~l~~~~~~--------------------------~--------~--- 415 (780)
..+|+. +.||.|++|.||+|++++ |+.||||+++..-.. . .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345766 789999999999999987 999999998654210 0 0
Q ss_pred ---HHHHHHHHHhhhcC----CCceeeeeeeeee-cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHH
Q 048425 416 ---REFIAEVEMLSRLH----HRNLVKLIGICIE-GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARG 487 (780)
Q Consensus 416 ---~~f~~Ei~iL~~L~----HpNIV~L~g~~~~-~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~g 487 (780)
-+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.+.-.- .. ...+. .+++...++.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~--~g~d~---~~la~~~v~~ 271 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RA--AGTDM---KLLAERGVEV 271 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-Hh--cCCCH---HHHHHHHHHH
Confidence 12444554444442 3333443333332 3567899999999999774210 01 11221 2222222221
Q ss_pred -HHHHhhCCCCcEEecccCCcceEEcCCC----CCeeecccccccccC
Q 048425 488 -LAYLHEDSNPRVIHRDFKASNVLLEDDF----TPKVSDFGLAREATE 530 (780)
Q Consensus 488 -L~yLH~~~~p~IvHrDIKpsNILLd~~~----~vKLsDFGLA~~~~~ 530 (780)
+..+...+ ++|+|+||.||+++.++ ++++.|||++.....
T Consensus 272 ~~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 272 FFTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33344566 99999999999999888 999999999987754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.6e-11 Score=138.11 Aligned_cols=248 Identities=21% Similarity=0.256 Sum_probs=177.0
Q ss_pred cCcccceeecc--cCceEEEEEEE--e-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcC-CCceeeeeeeeeeccee
Q 048425 375 EKFSSKRILGE--GGFGCVYHGVM--D-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLH-HRNLVKLIGICIEGRTR 446 (780)
Q Consensus 375 ~~f~~~~~LG~--G~fG~VYkg~l--~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~ 446 (780)
..|.....+|. |.+|.||++.. . ++..+|+|+-+.... .....=.+|+....+++ |+|.++.......++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34556688999 99999999987 3 678899998544322 22223346777777774 99999988888888888
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCcEEecccCCcceEEcCC-CCCeeec
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAAR----GLAYLHEDSNPRVIHRDFKASNVLLEDD-FTPKVSD 521 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~----gL~yLH~~~~p~IvHrDIKpsNILLd~~-~~vKLsD 521 (780)
++-+|++. .+|..+.+.. ...++....+.+..+... ||.++|... ++|-|+|+.||++.++ ...++.|
T Consensus 194 fiqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 99999884 7888888753 233555666666666666 999999987 9999999999999999 8899999
Q ss_pred ccccccccCCCcc----ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccc
Q 048425 522 FGLAREATEGSQH----ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL 597 (780)
Q Consensus 522 FGLA~~~~~~~~~----~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~l 597 (780)
||+...+.++... ...+..|...|++||.. ++-++.+.|+|++|.+.+|-.+|-....... ...|..
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~------~~~W~~-- 337 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGK------NSSWSQ-- 337 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCC------CCCccc--
Confidence 9999988765421 22344677889999955 5567899999999999999999866543211 111211
Q ss_pred cccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 598 LTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 598 l~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
++... +..++...-..++......+++.++..|++..++..
T Consensus 338 ------~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 ------LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ------ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111 111222122234445888899999999998876643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.2e-10 Score=116.48 Aligned_cols=142 Identities=24% Similarity=0.290 Sum_probs=112.5
Q ss_pred eeecccCceEEEEEEEeCCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCC--Cceeeeeeeeeecc---eeEEEEeecC
Q 048425 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHH--RNLVKLIGICIEGR---TRCLVYELVH 454 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~~---~~~LV~Ey~~ 454 (780)
+.|+.|..+.||+....+|..+++|....... .....+..|+++++.+++ .++.+++.++.+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987778999999755432 134578899999999975 34677788776542 5689999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------------
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS--------------------------------------- 495 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~--------------------------------------- 495 (780)
+.++.+.+.. ..++..++..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988776531 35778888889999999999998531
Q ss_pred --------------CCcEEecccCCcceEEcC--CCCCeeeccccccc
Q 048425 496 --------------NPRVIHRDFKASNVLLED--DFTPKVSDFGLARE 527 (780)
Q Consensus 496 --------------~p~IvHrDIKpsNILLd~--~~~vKLsDFGLA~~ 527 (780)
...++|+|+++.||++++ ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.7e-10 Score=129.84 Aligned_cols=248 Identities=20% Similarity=0.192 Sum_probs=176.0
Q ss_pred HHhcCcccceeecccCceEEEEEEEe--CCcEEEEEEeeccCCcchHH--HHHHHHHhhhc-CCCceeeeeeeeeeccee
Q 048425 372 KATEKFSSKRILGEGGFGCVYHGVMD--NGTEVAVKLLTRNNQNGDRE--FIAEVEMLSRL-HHRNLVKLIGICIEGRTR 446 (780)
Q Consensus 372 ~at~~f~~~~~LG~G~fG~VYkg~l~--~g~~VAVK~l~~~~~~~~~~--f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~ 446 (780)
.-+.+|.....||.|.|+.||+...+ ++..+++|.+.........+ -+.|+.+...+ .|.++++.......-+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34578899999999999999997643 68899999987664433322 24566666666 488888877777667777
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC-CCCeeeccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD-FTPKVSDFGLA 525 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~-~~vKLsDFGLA 525 (780)
++=-||+.++++...+ .....++...++++..+++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+
T Consensus 342 ~ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cCchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccc
Confidence 8999999999987766 23446778889999999999999999887 9999999999999886 88999999998
Q ss_pred ccccCCCccceeccccCcccc--CchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccc
Q 048425 526 REATEGSQHISTRVMGTFGYV--APEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREG 603 (780)
Q Consensus 526 ~~~~~~~~~~~t~~~GT~~Y~--APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~ 603 (780)
..+.-.. .....+-+++ +++......+-.+.|+||||.-+.|.++|..-.. +.+.|..-.- +
T Consensus 415 t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~--------~~~~~~~i~~--~-- 478 (524)
T KOG0601|consen 415 TRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE--------SGVQSLTIRS--G-- 478 (524)
T ss_pred cccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCc--------ccccceeeec--c--
Confidence 7532110 1111223344 5555556677899999999999999999865321 1122211100 0
Q ss_pred cccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048425 604 LEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651 (780)
Q Consensus 604 l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~ 651 (780)
.-+.+ ... ...+..++..+...++..||.+.+.....+.
T Consensus 479 ----~~p~~----~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 479 ----DTPNL----PGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ----cccCC----Cch-HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 00111 111 1455667788889999999998887665443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.2e-09 Score=109.60 Aligned_cols=136 Identities=20% Similarity=0.219 Sum_probs=98.0
Q ss_pred eeecccCceEEEEEEEeC-------CcEEEEEEeeccC----------------------CcchHHHH----HHHHHhhh
Q 048425 381 RILGEGGFGCVYHGVMDN-------GTEVAVKLLTRNN----------------------QNGDREFI----AEVEMLSR 427 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~-------g~~VAVK~l~~~~----------------------~~~~~~f~----~Ei~iL~~ 427 (780)
..||.|--+.||.|...+ +..+|||+.+... ....+.+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998643 4799999864221 00112233 79999999
Q ss_pred cCC--CceeeeeeeeeecceeEEEEeecCCCChhh-hcccccCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCcEEecc
Q 048425 428 LHH--RNLVKLIGICIEGRTRCLVYELVHNGSVES-HLHGVDKNRGPLDWEARMKIALGAARGLAYL-HEDSNPRVIHRD 503 (780)
Q Consensus 428 L~H--pNIV~L~g~~~~~~~~~LV~Ey~~~GSL~~-~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yL-H~~~~p~IvHrD 503 (780)
+.. -++..++++ ...+|||||+.+..+.. .|. ...++..+..++..+++.+|.+| |+.+ |||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 853 456666654 45689999997654322 121 12344456677889999999999 7777 99999
Q ss_pred cCCcceEEcCCCCCeeeccccccccc
Q 048425 504 FKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 504 IKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|++.|||+++ +.+.|+|||.+....
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999974 689999999886553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.95 E-value=6.7e-09 Score=119.80 Aligned_cols=166 Identities=21% Similarity=0.247 Sum_probs=124.4
Q ss_pred EeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCChhhhcccccCCCCCCCHH
Q 048425 396 MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWE 475 (780)
Q Consensus 396 l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~ 475 (780)
..++.+|.|+..+...........+-++.|+.++||||++++.....+...|||+|-+. -|..+|.. +.-.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence 34788999998877665344557788899999999999999999999999999999874 35555532 2233
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccceeccccCccccCchhhccCC
Q 048425 476 ARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGH 555 (780)
Q Consensus 476 ~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~ 555 (780)
...-.+.||+.||-|||+.+ .++|++|.-.-|+|++.|+-||++|.++........ ......--..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 44456789999999999877 499999999999999999999999998876543321 001111122466666443322
Q ss_pred CCchhhHHhHHHHHHHHHhC
Q 048425 556 LLVKSDVYSYGVVLLELLSG 575 (780)
Q Consensus 556 ~t~ksDVySfGVvLlELlTG 575 (780)
-..|.|-||++++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.3e-08 Score=114.18 Aligned_cols=170 Identities=16% Similarity=0.215 Sum_probs=133.2
Q ss_pred ceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeee----ecceeEEEEeecCC-CChhhh
Q 048425 388 FGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICI----EGRTRCLVYELVHN-GSVESH 461 (780)
Q Consensus 388 fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~----~~~~~~LV~Ey~~~-GSL~~~ 461 (780)
-.+.||+... ||..|++|+++....+.......-+++++++.|.|||++.+++. .+..++|||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3578999865 89999999996665555445566789999999999999999876 24577999999986 677766
Q ss_pred cccccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 462 LHGVDK-----------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 462 L~~~~~-----------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
-..... .+...+...+|.++.|++.||.++|+.| +.-+-|.+++||++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 543211 2335777899999999999999999998 88899999999999999999999888776654
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P 578 (780)
+.. |.+.. -.+-|.=.||.+++.|.||...
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 331 11111 3467888999999999999654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=3e-08 Score=99.29 Aligned_cols=131 Identities=18% Similarity=0.241 Sum_probs=98.2
Q ss_pred eeecccCceEEEEEEEeCCcEEEEEEeeccCCcc--------hHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNG--------DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~--------~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
..|++|+-+.+|.+.+. |..+++|.=.+..... ...-.+|+.++.+++--.|...+=|..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35889999999999774 4456666432221111 12357799999998655555555556667788899999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+++-.|.+.|... +..++..+-+-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999998531 3556667777778899998 99999999999998875 99999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=7e-08 Score=96.42 Aligned_cols=144 Identities=21% Similarity=0.300 Sum_probs=103.7
Q ss_pred cceeecccCceEEEEEEEeCCcEEEEEE-eeccC-------CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 379 SKRILGEGGFGCVYHGVMDNGTEVAVKL-LTRNN-------QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 379 ~~~~LG~G~fG~VYkg~l~~g~~VAVK~-l~~~~-------~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
...+|-+|+-+.|+++.+ .|+...||. ..+.- .-..+..++|+++|.+++--.|.-..=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999988 577777774 22211 112245788999999986545544444566666778999
Q ss_pred eecCC-CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC---CCeeecccccc
Q 048425 451 ELVHN-GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF---TPKVSDFGLAR 526 (780)
Q Consensus 451 Ey~~~-GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~---~vKLsDFGLA~ 526 (780)
||+++ .++.+++..... ..-.-.....++..|-+.+.-||.++ |||+||..+||+|..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence 99977 478888754221 12222333677888888899999998 99999999999997654 45899999986
Q ss_pred cc
Q 048425 527 EA 528 (780)
Q Consensus 527 ~~ 528 (780)
..
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 43
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=1e-07 Score=102.13 Aligned_cols=141 Identities=18% Similarity=0.087 Sum_probs=102.4
Q ss_pred eeecccCceEEEEEEEeCCcEEEEEEeeccCC-----------cchHHHHHHHHHhhhcCCCc--eeeeeeeeee-----
Q 048425 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQ-----------NGDREFIAEVEMLSRLHHRN--LVKLIGICIE----- 442 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~-----------~~~~~f~~Ei~iL~~L~HpN--IV~L~g~~~~----- 442 (780)
+.+-+-....|++..+ +|+.+.||+...... .....+.+|...+.++...+ ...++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4555555556778766 678999997643221 11124789999998885433 3444556543
Q ss_pred cceeEEEEeecCCC-ChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC-------C
Q 048425 443 GRTRCLVYELVHNG-SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED-------D 514 (780)
Q Consensus 443 ~~~~~LV~Ey~~~G-SL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~-------~ 514 (780)
....+||+|++++- +|.+++.... ....+...+..++.+++..+.-||..+ |+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCC
Confidence 23468999999986 8988874211 234556677899999999999999998 999999999999975 4
Q ss_pred CCCeeeccccccc
Q 048425 515 FTPKVSDFGLARE 527 (780)
Q Consensus 515 ~~vKLsDFGLA~~ 527 (780)
+.+.|+||+.++.
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6889999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.69 E-value=8.9e-08 Score=97.27 Aligned_cols=126 Identities=23% Similarity=0.292 Sum_probs=82.7
Q ss_pred EEEEEEEeCCcEEEEEEeeccC--------------C--------cc----hHHHHHHHHHhhhcCCC--ceeeeeeeee
Q 048425 390 CVYHGVMDNGTEVAVKLLTRNN--------------Q--------NG----DREFIAEVEMLSRLHHR--NLVKLIGICI 441 (780)
Q Consensus 390 ~VYkg~l~~g~~VAVK~l~~~~--------------~--------~~----~~~f~~Ei~iL~~L~Hp--NIV~L~g~~~ 441 (780)
.||.|...+|..+|||+.+... . .. .....+|.+.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899999899999999864321 0 00 12357799999999765 56666655
Q ss_pred ecceeEEEEeecC--CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHH-HhhCCCCcEEecccCCcceEEcCCCCCe
Q 048425 442 EGRTRCLVYELVH--NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY-LHEDSNPRVIHRDFKASNVLLEDDFTPK 518 (780)
Q Consensus 442 ~~~~~~LV~Ey~~--~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~y-LH~~~~p~IvHrDIKpsNILLd~~~~vK 518 (780)
...+|||||++ +..+..+... .++......++.+++..+.. +|..+ |+|+|+.+.|||++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEE
Confidence 34579999998 5444443321 11134456677777776655 46777 9999999999999988 999
Q ss_pred eeccccccccc
Q 048425 519 VSDFGLAREAT 529 (780)
Q Consensus 519 LsDFGLA~~~~ 529 (780)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=9e-09 Score=123.12 Aligned_cols=248 Identities=21% Similarity=0.213 Sum_probs=159.1
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
.+.|.+.+-+-.|.++.++.+.-. .|...+.|...... ....+....+-.++-..++|-++...--+.-.....||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 356666677889999999877632 34333444332221 11111222222232223456666554444456778999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
++|..+++|...||.. +..+..-....+..+...++|||... +.|||+++.|+|...++..+++|||+.....
T Consensus 883 ~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 9999999999999743 23343333344555667899999876 8999999999999999999999998443221
Q ss_pred CC----------------------------C--ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCC
Q 048425 530 EG----------------------------S--QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPV 579 (780)
Q Consensus 530 ~~----------------------------~--~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~ 579 (780)
.- . ......+.||..|.+||...+..-...+|.|++|+.++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0 01123467999999999999999999999999999999999999999
Q ss_pred CCCCccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHH
Q 048425 580 DMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMG 643 (780)
Q Consensus 580 ~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~ 643 (780)
+...++... +.+.... -+.. ....+......+++..-+..+|.+|-.|.
T Consensus 1036 na~tpq~~f------~ni~~~~-------~~~p--~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIF------ENILNRD-------IPWP--EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhh------hccccCC-------CCCC--CCccccChhhhhhhhhhhccCchhccCcc
Confidence 876654221 1111100 0000 01112223455666667778888887665
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.2e-06 Score=94.63 Aligned_cols=264 Identities=17% Similarity=0.165 Sum_probs=154.9
Q ss_pred cceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeee----e--ee-cceeEEEE
Q 048425 379 SKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGI----C--IE-GRTRCLVY 450 (780)
Q Consensus 379 ~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~----~--~~-~~~~~LV~ 450 (780)
..+.||+|+-+.+|--- .-...+-|+..........+ .++.|... .||-+-.=+.+ . -+ +...-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45779999999999532 11223446665544322222 23333333 34432221111 0 01 12245666
Q ss_pred eecCCCCh-hhhcc--cccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 451 ELVHNGSV-ESHLH--GVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 451 Ey~~~GSL-~~~L~--~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
..+.+..- .+++. ..++.....+|...++++..+|.+.+-||+.| .+-+|+.++|+|+.+++.+.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 66655421 12221 11233456899999999999999999999998 88999999999999999999987554333
Q ss_pred ccCCCccceeccccCccccCchhhc-----cCCCCchhhHHhHHHHHHHHHhC-CCCCCCCCccccc---hhhhhccccc
Q 048425 528 ATEGSQHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLSG-RKPVDMSQPQGQE---NLVTWARPLL 598 (780)
Q Consensus 528 ~~~~~~~~~t~~~GT~~Y~APE~l~-----~~~~t~ksDVySfGVvLlELlTG-r~P~~~~~~~~~~---~Lv~wa~~ll 598 (780)
...+..+ --.+|...|.+||... +-..+...|-|.+||++++|+.| +.||.+-...... .-.+.+....
T Consensus 167 ~~ng~~~--~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 167 NANGTLH--LCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred ccCCceE--ecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 3222222 2345888999999654 33557889999999999999986 8898653311100 0001111110
Q ss_pred cc--ccccccccCCccCCCCChhh-HHHHHHHHHHccccC--CCCCCCHHHHHHHHHHHhhc
Q 048425 599 TT--REGLEQLVDPSLAGSYDFDD-MAKVAAIASMCVHPE--VTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 599 ~~--~~~l~~lvDp~L~~~~~~ee-~~~l~~La~~Cl~~d--P~~RPsm~EVv~~L~~i~~~ 655 (780)
.. +........ ....+.+. ...+..+..+|+... +.-||+.+-.+..|..+...
T Consensus 245 ~ya~~~~~g~~p~---P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 245 AYASDQRRGLKPP---PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred eechhccCCCCCC---CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 00 000000000 01222222 235667788887653 66899999999998877654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.1e-06 Score=93.04 Aligned_cols=134 Identities=22% Similarity=0.205 Sum_probs=95.4
Q ss_pred ccceeecccCceEEEEEEEeCCcEEEEEEeeccC----------C--------c----chHHHHHHHHHhhhcCCC--ce
Q 048425 378 SSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNN----------Q--------N----GDREFIAEVEMLSRLHHR--NL 433 (780)
Q Consensus 378 ~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~----------~--------~----~~~~f~~Ei~iL~~L~Hp--NI 433 (780)
.+.+.||.|--+.||.|...+|.++|||.=+... . . ......+|.++|.+|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 3458899999999999999999999999632211 0 0 112357899999998655 67
Q ss_pred eeeeeeeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC
Q 048425 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED 513 (780)
Q Consensus 434 V~L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~ 513 (780)
.+.+++ +.-.+||||+++--|...- ++-...-.|+..|+.-+.-+-..| |||+|+..-||++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 777765 4568999999886554321 122233344444444444444566 999999999999999
Q ss_pred CCCCeeeccccccc
Q 048425 514 DFTPKVSDFGLARE 527 (780)
Q Consensus 514 ~~~vKLsDFGLA~~ 527 (780)
||.+.++||-.+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999976643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.2e-06 Score=90.04 Aligned_cols=125 Identities=21% Similarity=0.174 Sum_probs=91.8
Q ss_pred CCcEEEEEEeecc-CC------cchHHHHHHHHHhhhcC--CCceeeeeeeeeecc----eeEEEEeecCCC-Chhhhcc
Q 048425 398 NGTEVAVKLLTRN-NQ------NGDREFIAEVEMLSRLH--HRNLVKLIGICIEGR----TRCLVYELVHNG-SVESHLH 463 (780)
Q Consensus 398 ~g~~VAVK~l~~~-~~------~~~~~f~~Ei~iL~~L~--HpNIV~L~g~~~~~~----~~~LV~Ey~~~G-SL~~~L~ 463 (780)
.++.+.+|.+... .. -....+.+|...+.++. .-...+.+++..... ..+||+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 3556666654221 11 23346788888888875 334556666665432 348999999984 7999885
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC---CCeeeccccccccc
Q 048425 464 GVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF---TPKVSDFGLAREAT 529 (780)
Q Consensus 464 ~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~---~vKLsDFGLA~~~~ 529 (780)
.. ..++...+..++.++++.++-||+.+ |+|+|+++.|||++.+. ++.++||+-++...
T Consensus 111 ~~----~~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 111 QW----EQLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred hh----cccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 31 12666778899999999999999999 99999999999999887 89999999877543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.34 E-value=5.3e-06 Score=85.59 Aligned_cols=139 Identities=17% Similarity=0.152 Sum_probs=104.2
Q ss_pred ecccCceEEEEEEEeCCcEEEEEEeeccC------CcchHHHHHHHHHhhhcCC--Cceeeeeeeeeec-----ceeEEE
Q 048425 383 LGEGGFGCVYHGVMDNGTEVAVKLLTRNN------QNGDREFIAEVEMLSRLHH--RNLVKLIGICIEG-----RTRCLV 449 (780)
Q Consensus 383 LG~G~fG~VYkg~l~~g~~VAVK~l~~~~------~~~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~-----~~~~LV 449 (780)
-|+||-+.|++-.+ +|..+-+|+-...- ..+...|.+|+..|.++.. -.+.+++ ++... -..+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46689999999776 45679999864111 3456789999999999853 2345555 33211 235899
Q ss_pred EeecCC-CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC--Ceeecccccc
Q 048425 450 YELVHN-GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT--PKVSDFGLAR 526 (780)
Q Consensus 450 ~Ey~~~-GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~--vKLsDFGLA~ 526 (780)
+|-+++ -+|.+++.. ....+.+...+..++.+++..++-||+.+ +.|+|+.+.|||++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~--~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQ--HAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhc--CCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998764 588888743 22345677888999999999999999998 999999999999986666 9999998665
Q ss_pred cc
Q 048425 527 EA 528 (780)
Q Consensus 527 ~~ 528 (780)
..
T Consensus 179 ~~ 180 (216)
T PRK09902 179 RR 180 (216)
T ss_pred hh
Confidence 43
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.5e-07 Score=106.27 Aligned_cols=150 Identities=19% Similarity=0.347 Sum_probs=101.6
Q ss_pred HHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc--------ceeccccCccccCchhhcc
Q 048425 482 LGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH--------ISTRVMGTFGYVAPEYAMT 553 (780)
Q Consensus 482 ~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~--------~~t~~~GT~~Y~APE~l~~ 553 (780)
.+++.||.|+|... ++||++|.|++|.++.++..||+.|+.+......... ...-..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34559999999764 7999999999999999999999999988765442111 1111223456999999999
Q ss_pred CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccc
Q 048425 554 GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVH 633 (780)
Q Consensus 554 ~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~ 633 (780)
...+.++|+||+||++|-+..|+++.-..... ...+... ....+-.. -.+..+...++.+-+.+.+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~----~~~~~~~--------~~~~~~~~-~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGG----LLSYSFS--------RNLLNAGA-FGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCC----cchhhhh--------hccccccc-ccccccCcHHHHHHHHHHhc
Confidence 88899999999999999999666554322110 0000000 00001111 11223445577778888899
Q ss_pred cCCCCCCCHHHHH
Q 048425 634 PEVTHRPFMGEVV 646 (780)
Q Consensus 634 ~dP~~RPsm~EVv 646 (780)
.++.-||++.++.
T Consensus 251 ~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 251 GDSAVRPTLDLLL 263 (700)
T ss_pred CCcccCcchhhhh
Confidence 9999999877664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.1e-05 Score=84.28 Aligned_cols=139 Identities=18% Similarity=0.234 Sum_probs=86.5
Q ss_pred eeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCc--eeeeeeeeeecceeEEEEeecCCCC-
Q 048425 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN--LVKLIGICIEGRTRCLVYELVHNGS- 457 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~L~g~~~~~~~~~LV~Ey~~~GS- 457 (780)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.++++...+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 67999999999984 25567788875432 3345688999999986443 4677888777777889999998863
Q ss_pred hhhh---------------------cccccCCCCCCCHHHHHH-HHH----------HHHH-HHHHHhhC-CCCcEEecc
Q 048425 458 VESH---------------------LHGVDKNRGPLDWEARMK-IAL----------GAAR-GLAYLHED-SNPRVIHRD 503 (780)
Q Consensus 458 L~~~---------------------L~~~~~~~~~L~~~~rl~-Ia~----------qIA~-gL~yLH~~-~~p~IvHrD 503 (780)
+... ||...... .....+.. +.. .+.. ...+|... ..+.++|+|
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 2111 22211111 11111100 000 0111 12222211 234578999
Q ss_pred cCCcceEEcCCCCCeeeccccccc
Q 048425 504 FKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 504 IKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+.+.||++++++ +.|+||+.+..
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999988 99999997753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.25 E-value=3.4e-06 Score=97.76 Aligned_cols=147 Identities=21% Similarity=0.257 Sum_probs=96.7
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCc--------------------------c----hH--------
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQN--------------------------G----DR-------- 416 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~--------------------------~----~~-------- 416 (780)
..|+. +-|+.++-|.||+|++++|+.||||+.+.+-.. . .+
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34442 679999999999999999999999997543110 0 01
Q ss_pred --HHHHHHHHhhhcC----CCceeeeeeeeee-cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHH-H
Q 048425 417 --EFIAEVEMLSRLH----HRNLVKLIGICIE-GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARG-L 488 (780)
Q Consensus 417 --~f~~Ei~iL~~L~----HpNIV~L~g~~~~-~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~g-L 488 (780)
+|.+|..-+.+++ ...-+.+=.+|.+ .....|+|||++|-.+.+...- +...++ +..|+..++++ +
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d---~k~ia~~~~~~f~ 278 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL---KSAGID---RKELAELLVRAFL 278 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH---HhcCCC---HHHHHHHHHHHHH
Confidence 1344444444442 2222233333332 4677999999999888887421 113344 33444444443 3
Q ss_pred HHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 489 ~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
..+-..+ +.|.|..|.||+++.+++..+.|||+.....+.
T Consensus 279 ~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 279 RQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 3343455 999999999999999999999999999876543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.4e-05 Score=79.68 Aligned_cols=145 Identities=19% Similarity=0.204 Sum_probs=86.3
Q ss_pred ceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCC--ceeeeeeeeeec---ceeEEEEeecC
Q 048425 380 KRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHR--NLVKLIGICIEG---RTRCLVYELVH 454 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp--NIV~L~g~~~~~---~~~~LV~Ey~~ 454 (780)
.+.|+.|..+.||+....+ ..+++|..... .....+.+|.+++..+... .+.+++.++... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3679999999999998876 68999986443 3456788899999888533 356777655333 34589999999
Q ss_pred CCChhh----------------h---cccccCCCCCCCHHHH---------HHH------------HHHHHH-HHHHHhh
Q 048425 455 NGSVES----------------H---LHGVDKNRGPLDWEAR---------MKI------------ALGAAR-GLAYLHE 493 (780)
Q Consensus 455 ~GSL~~----------------~---L~~~~~~~~~L~~~~r---------l~I------------a~qIA~-gL~yLH~ 493 (780)
+..+.. . ||........+.+... ... ...+.+ .++.+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 1 1211111111222110 000 011222 2333332
Q ss_pred ----CCCCcEEecccCCcceEEc-CCCCCeeeccccccc
Q 048425 494 ----DSNPRVIHRDFKASNVLLE-DDFTPKVSDFGLARE 527 (780)
Q Consensus 494 ----~~~p~IvHrDIKpsNILLd-~~~~vKLsDFGLA~~ 527 (780)
.....++|+|+.+.|||++ +++.+.|.||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2345699999999999999 666668999987653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.6e-05 Score=80.88 Aligned_cols=105 Identities=27% Similarity=0.202 Sum_probs=83.2
Q ss_pred HHHHHHhhhcCC-CceeeeeeeeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 048425 419 IAEVEMLSRLHH-RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNP 497 (780)
Q Consensus 419 ~~Ei~iL~~L~H-pNIV~L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p 497 (780)
..|.-++..+++ +++.+++|+| ..++|.||...+++...- .....-...+|..|.+||.++++.+.+|++...-
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358888888876 6999999999 347899999887664320 0001123468999999999999999999986544
Q ss_pred cEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 498 RVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 498 ~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
.+.-.|++++|+-+++++++|+.|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 5889999999999999999999999877544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.04 E-value=3.2e-05 Score=80.92 Aligned_cols=141 Identities=19% Similarity=0.174 Sum_probs=87.0
Q ss_pred eecccCc-eEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcC-CCceeeeeeeeeecceeEEEEeecCCCChh
Q 048425 382 ILGEGGF-GCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH-HRNLVKLIGICIEGRTRCLVYELVHNGSVE 459 (780)
Q Consensus 382 ~LG~G~f-G~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL~ 459 (780)
.|-.|.. ..||+...+ +..+.||+..... ..+..+|++++..+. +--+.+++++...++..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3555555 789998764 4788888875432 345678999988883 445667788776666679999999998776
Q ss_pred hhc-------------------ccccCCCCCCC--HHHHHHHHH--------------------HHHHHHHHHhh----C
Q 048425 460 SHL-------------------HGVDKNRGPLD--WEARMKIAL--------------------GAARGLAYLHE----D 494 (780)
Q Consensus 460 ~~L-------------------~~~~~~~~~L~--~~~rl~Ia~--------------------qIA~gL~yLH~----~ 494 (780)
... |.......++. +..++.... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 22111111111 001111000 01111222211 1
Q ss_pred CCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 495 ~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
..+.++|+|+.+.|||++++..+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 24569999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.93 E-value=6.7e-05 Score=77.90 Aligned_cols=138 Identities=13% Similarity=0.138 Sum_probs=93.2
Q ss_pred HhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHH---------HHHHHHhhhcC---CCceeeeeeee
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREF---------IAEVEMLSRLH---HRNLVKLIGIC 440 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f---------~~Ei~iL~~L~---HpNIV~L~g~~ 440 (780)
..++|...+++-......|.+-.. +|..+++|..+......++.| .+++..+.+++ .-.+..++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 346788888888877777776655 678999998866544333333 23444444443 22333333332
Q ss_pred e-----ecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC
Q 048425 441 I-----EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF 515 (780)
Q Consensus 441 ~-----~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~ 515 (780)
. .....+|+|||++|..|.+... ++. .++..+..++.-||+.| +.|+|..|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence 2 1245579999999988876542 221 35566778899999999 99999999999999664
Q ss_pred CCeeeccccccc
Q 048425 516 TPKVSDFGLARE 527 (780)
Q Consensus 516 ~vKLsDFGLA~~ 527 (780)
+++.||+..+.
T Consensus 173 -i~iID~~~k~~ 183 (229)
T PF06176_consen 173 -IRIIDTQGKRM 183 (229)
T ss_pred -EEEEECccccc
Confidence 99999986654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.91 E-value=1.5e-06 Score=100.20 Aligned_cols=189 Identities=17% Similarity=0.133 Sum_probs=136.4
Q ss_pred hcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCc-eeeeeeeeeecceeEEEEee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN-LVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN-IV~L~g~~~~~~~~~LV~Ey 452 (780)
+.-+..-+-+++|.++++||.+-.-.+...++.+... ....-++++|.+++||| .+..++-+..++..++++++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 3333444668999999999987543344446655332 34456899999999999 66667667767788899999
Q ss_pred cCCC-ChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 453 VHNG-SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 453 ~~~G-SL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
+..+ +-..... .....+..-+...+...-+++|+|||+.. =+||| ||+..+ ...|..||+.+..+...
T Consensus 316 ~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 316 CSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 9877 2222111 12223444445566677788999999874 48998 888776 58899999999877664
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCC
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVD 580 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~ 580 (780)
. ......+|+.++|||....+.+..+-|+|+.|+--.++--|-.|-.
T Consensus 385 ~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 385 M--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred c--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 3 2344678999999999999999999999999987777776766643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00014 Score=76.61 Aligned_cols=155 Identities=21% Similarity=0.257 Sum_probs=101.4
Q ss_pred cccchHHHHHHhcCcccceeec---ccCceEEEEEEEeCCcEEEEEEeeccCCc-------------------chHH---
Q 048425 363 KTFALSDLEKATEKFSSKRILG---EGGFGCVYHGVMDNGTEVAVKLLTRNNQN-------------------GDRE--- 417 (780)
Q Consensus 363 ~~f~~~el~~at~~f~~~~~LG---~G~fG~VYkg~l~~g~~VAVK~l~~~~~~-------------------~~~~--- 417 (780)
...+++.|....++..+..+.| .|--+.||+|.-.++..+|||+.+..... ..++
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 3456677777777766666655 56667899999888999999998543211 1111
Q ss_pred --HHHHHHHhhhcC--CCceeeeeeeeeecceeEEEEeecCCC-ChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 048425 418 --FIAEVEMLSRLH--HRNLVKLIGICIEGRTRCLVYELVHNG-SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492 (780)
Q Consensus 418 --f~~Ei~iL~~L~--HpNIV~L~g~~~~~~~~~LV~Ey~~~G-SL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH 492 (780)
-.+|+.-|.++. +-.+.+-+++. ...|||||+... .-.-.|. ..++...+...+..++.+.+.-|-
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~ 183 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLY 183 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHH
Confidence 134666666653 33444555543 457999999654 1111121 112223355666677777777777
Q ss_pred hCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 493 ~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
..+ .+||+||..=|||+. ++.+.|+|||.|....
T Consensus 184 ~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 184 KEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred Hhc--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 633 399999999999999 7899999999886553
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.87 E-value=4.4e-05 Score=88.63 Aligned_cols=163 Identities=17% Similarity=0.171 Sum_probs=103.8
Q ss_pred eccccccccchHHHHHH------------hcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCc-----------
Q 048425 357 TCILSVKTFALSDLEKA------------TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQN----------- 413 (780)
Q Consensus 357 ~~~~~~~~f~~~el~~a------------t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~----------- 413 (780)
.+...++.|+++|+.+. ...|+ .+-||.-..|.||+|++++|+.||||+-+..-..
T Consensus 132 ~LqD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~ 210 (538)
T KOG1235|consen 132 ELQDQAPPFPWEEAFKIFEEELGAPIEDIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRL 210 (538)
T ss_pred HHhccCCCCCHHHHHHHHHHHhCCCHHHHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHH
Confidence 33445677787776433 33443 3679999999999999999999999986432110
Q ss_pred --------------------------chHHHHHHHHHhhhc----CCCc------eeeeeeeeeecceeEEEEeecCCCC
Q 048425 414 --------------------------GDREFIAEVEMLSRL----HHRN------LVKLIGICIEGRTRCLVYELVHNGS 457 (780)
Q Consensus 414 --------------------------~~~~f~~Ei~iL~~L----~HpN------IV~L~g~~~~~~~~~LV~Ey~~~GS 457 (780)
.+-+|.+|.+-..+. .|-+ |.+++-.+ ...+.|+||||+|..
T Consensus 211 ~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~ 288 (538)
T KOG1235|consen 211 LAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIK 288 (538)
T ss_pred HHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCcc
Confidence 011355565544443 3545 33333222 257799999999998
Q ss_pred hhhhcccccCCCCCCCHHHHHHHHHHHHHHHHH-HhhCCCCcEEecccCCcceEEcC----CCCCeeecccccccccCC
Q 048425 458 VESHLHGVDKNRGPLDWEARMKIALGAARGLAY-LHEDSNPRVIHRDFKASNVLLED----DFTPKVSDFGLAREATEG 531 (780)
Q Consensus 458 L~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~y-LH~~~~p~IvHrDIKpsNILLd~----~~~vKLsDFGLA~~~~~~ 531 (780)
+.|.-. -.+..++-.. |+..+.++... |-..| ++|.|=.|.||++.. ++++.+-|||+.......
T Consensus 289 i~Dl~~---i~~~gi~~~~---i~~~l~~~~~~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 289 INDLDA---IDKRGISPHD---ILNKLVEAYLEQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CCCHHH---HHHcCCCHHH---HHHHHHHHHHHHHHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 877642 1223344443 33333333221 22234 999999999999983 678999999999876543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00031 Score=76.46 Aligned_cols=79 Identities=15% Similarity=0.116 Sum_probs=58.6
Q ss_pred cccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCC---Cceeeeeeeeeec---ceeEEEE
Q 048425 377 FSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHH---RNLVKLIGICIEG---RTRCLVY 450 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H---pNIV~L~g~~~~~---~~~~LV~ 450 (780)
....+.||+|..+.||+-...++ .+.+|..+. ......|.+|.+.|+.|.- -.+.+++++|..+ +..+|||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 34457899999999999876555 466777432 1133578999999998853 3688888887643 5579999
Q ss_pred eecCCCCh
Q 048425 451 ELVHNGSV 458 (780)
Q Consensus 451 Ey~~~GSL 458 (780)
|+++++++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00019 Score=88.50 Aligned_cols=149 Identities=15% Similarity=0.236 Sum_probs=93.2
Q ss_pred ceeecccCceEEEEEEEeCC---cEEEEEEeeccCC-cchHHHHHHHHHhhhcC-CCce--eeeeeeeeec---ceeEEE
Q 048425 380 KRILGEGGFGCVYHGVMDNG---TEVAVKLLTRNNQ-NGDREFIAEVEMLSRLH-HRNL--VKLIGICIEG---RTRCLV 449 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~~g---~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~-HpNI--V~L~g~~~~~---~~~~LV 449 (780)
.+.|+.|.+..+|+-...++ ..+++|+...... .....+.+|+++|+.+. |.++ .+++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 57789999999999877554 3677777543321 23357889999999995 6664 7888888764 356899
Q ss_pred EeecCCCChhhh-----------------------cccccCC-------CCCCCHHH--HHHH---------------HH
Q 048425 450 YELVHNGSVESH-----------------------LHGVDKN-------RGPLDWEA--RMKI---------------AL 482 (780)
Q Consensus 450 ~Ey~~~GSL~~~-----------------------L~~~~~~-------~~~L~~~~--rl~I---------------a~ 482 (780)
|||+++..+.+. ||..... ..+.++.. .-++ .-
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999988654321 2221111 01111111 1110 01
Q ss_pred HHHHHHHHHhhCC--------CCcEEecccCCcceEEcCC-CC-Ceeecccccccc
Q 048425 483 GAARGLAYLHEDS--------NPRVIHRDFKASNVLLEDD-FT-PKVSDFGLAREA 528 (780)
Q Consensus 483 qIA~gL~yLH~~~--------~p~IvHrDIKpsNILLd~~-~~-vKLsDFGLA~~~ 528 (780)
.+.+.+++|..+- .+.+||+|+++.|||++.+ .+ .-|.||.++..-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 2333456664421 1359999999999999853 34 468999988653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.0002 Score=73.55 Aligned_cols=129 Identities=18% Similarity=0.295 Sum_probs=92.3
Q ss_pred cceeecccCceEEEEEEEeCCcEEEEEEeeccC----------------CcchHHHHHHHHHhhhcC------CCceeee
Q 048425 379 SKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNN----------------QNGDREFIAEVEMLSRLH------HRNLVKL 436 (780)
Q Consensus 379 ~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~----------------~~~~~~f~~Ei~iL~~L~------HpNIV~L 436 (780)
....||+|+.-.||. +++.....||++.... ....+++.+|+.-..++. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346899999999996 5667778999987665 223466777777766665 8899999
Q ss_pred eeeeeecceeEEEEeecCC--C----ChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceE
Q 048425 437 IGICIEGRTRCLVYELVHN--G----SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVL 510 (780)
Q Consensus 437 ~g~~~~~~~~~LV~Ey~~~--G----SL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNIL 510 (780)
+|+...+....+|+|.+.+ | +|.+++. .+.++. ...+.+.++ .+||-+.. |+.+|++|.||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEE
Confidence 9999999999999998854 3 4666663 233554 333333333 45666665 999999999999
Q ss_pred EcCC--C--CCeeec
Q 048425 511 LEDD--F--TPKVSD 521 (780)
Q Consensus 511 Ld~~--~--~vKLsD 521 (780)
+..+ + .+.|+|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 9643 2 456665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00015 Score=75.66 Aligned_cols=141 Identities=23% Similarity=0.316 Sum_probs=79.0
Q ss_pred eeecccCce-EEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCC---ceeeeeeeeeecc---eeEEEEeec
Q 048425 381 RILGEGGFG-CVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHR---NLVKLIGICIEGR---TRCLVYELV 453 (780)
Q Consensus 381 ~~LG~G~fG-~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp---NIV~L~g~~~~~~---~~~LV~Ey~ 453 (780)
+.|+.||.. .||+. +..+++|..... .....+.+|++++..+... .+.+.++.....+ ..+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 568888876 48974 245777765432 2345788999999887532 3444454443322 347899999
Q ss_pred CCCChhhh------------------cccccCCCCCC-------------CHHHHH--HHH-------HHHHHH-HHH-H
Q 048425 454 HNGSVESH------------------LHGVDKNRGPL-------------DWEARM--KIA-------LGAARG-LAY-L 491 (780)
Q Consensus 454 ~~GSL~~~------------------L~~~~~~~~~L-------------~~~~rl--~Ia-------~qIA~g-L~y-L 491 (780)
+|.++.+. ||......... .|.... .+. .+.+.. ++. +
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 99777432 23221111000 121111 000 011111 111 1
Q ss_pred hh--CCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 492 HE--DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 492 H~--~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+. ...+.++|+|+.+.|||++++...-|.||+.+..
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 1234599999999999998775567999997753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00038 Score=71.55 Aligned_cols=125 Identities=26% Similarity=0.377 Sum_probs=91.0
Q ss_pred cCcccceeecccCc-eEEEEEEEeCCcEEEEEEeeccC----------C-----------cchHHHHHHHHHhhhcC---
Q 048425 375 EKFSSKRILGEGGF-GCVYHGVMDNGTEVAVKLLTRNN----------Q-----------NGDREFIAEVEMLSRLH--- 429 (780)
Q Consensus 375 ~~f~~~~~LG~G~f-G~VYkg~l~~g~~VAVK~l~~~~----------~-----------~~~~~f~~Ei~iL~~L~--- 429 (780)
.+|+..+.||.|.- |.|||..+ +|..+|+|..+... . .-...|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78888999999999 99999999 68899999942210 0 01134888999888884
Q ss_pred CCce--eeeeeeeeec------------------ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048425 430 HRNL--VKLIGICIEG------------------RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLA 489 (780)
Q Consensus 430 HpNI--V~L~g~~~~~------------------~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~ 489 (780)
+.++ |+++||..-. ..+.||.||++... .+. .+-+.++.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHH
Confidence 4456 9999997321 12367888776532 122 233556677788
Q ss_pred HHhhCCCCcEEecccCCcceEEcCCCCCeeeccccc
Q 048425 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525 (780)
Q Consensus 490 yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA 525 (780)
.+|..+ |+-+|+|+.|.. .-||+|||.+
T Consensus 179 ~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 899998 999999999986 4589999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00071 Score=71.52 Aligned_cols=139 Identities=19% Similarity=0.129 Sum_probs=81.5
Q ss_pred ecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCce-eeeeeeeeecceeEEEEeecCCCChhhh
Q 048425 383 LGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL-VKLIGICIEGRTRCLVYELVHNGSVESH 461 (780)
Q Consensus 383 LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LV~Ey~~~GSL~~~ 461 (780)
+..|-.+.+|+... +|..+++|+.......-.-...+|.++++.+....+ .++++++. ..+||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 55677789998874 677888987644322211235789999988864333 34444432 3689999998776432
Q ss_pred -----------------cccccCCCCCCCHHHHH-HHHHH---------HHHHHHHHhhC-----CCCcEEecccCCcce
Q 048425 462 -----------------LHGVDKNRGPLDWEARM-KIALG---------AARGLAYLHED-----SNPRVIHRDFKASNV 509 (780)
Q Consensus 462 -----------------L~~~~~~~~~L~~~~rl-~Ia~q---------IA~gL~yLH~~-----~~p~IvHrDIKpsNI 509 (780)
||.......+++...++ +...+ +.+-+..+-.. ..+.++|+|+.+.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 23322222233332221 11101 11112222111 123589999999999
Q ss_pred EEcCCCCCeeeccccccc
Q 048425 510 LLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 510 LLd~~~~vKLsDFGLA~~ 527 (780)
++++++ +.|+||..|..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 79999987754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00078 Score=69.92 Aligned_cols=142 Identities=17% Similarity=0.146 Sum_probs=82.5
Q ss_pred eeecccCceEEEEEEEeC--CcEEEEEEeeccCCcchHHHHHHHHHhhhcCC-CceeeeeeeeeecceeEEEEeecCCCC
Q 048425 381 RILGEGGFGCVYHGVMDN--GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHH-RNLVKLIGICIEGRTRCLVYELVHNGS 457 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~--g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H-pNIV~L~g~~~~~~~~~LV~Ey~~~GS 457 (780)
+.|..|-...+|+....+ +..|++|+...... ..-+-.+|+.++..+.. .-..++++.+. ..+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567788888999987764 67899997654322 11223478888888843 33444554432 248999999877
Q ss_pred hhhh-----------------cccccCCC-------CCCC-HHHHHHHHH----------------------HHH---HH
Q 048425 458 VESH-----------------LHGVDKNR-------GPLD-WEARMKIAL----------------------GAA---RG 487 (780)
Q Consensus 458 L~~~-----------------L~~~~~~~-------~~L~-~~~rl~Ia~----------------------qIA---~g 487 (780)
+... ||...... .... |..+..+.. .+. ..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 12211111 1111 222111111 111 11
Q ss_pred H-HHHhhC-CCCcEEecccCCcceEEcC-CCCCeeeccccccc
Q 048425 488 L-AYLHED-SNPRVIHRDFKASNVLLED-DFTPKVSDFGLARE 527 (780)
Q Consensus 488 L-~yLH~~-~~p~IvHrDIKpsNILLd~-~~~vKLsDFGLA~~ 527 (780)
| +.+-.. ....++|+|+.+.|||+++ +..+.|+||..|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1 112111 2346999999999999998 57899999987753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00048 Score=69.16 Aligned_cols=127 Identities=21% Similarity=0.230 Sum_probs=85.8
Q ss_pred cceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceee-eeeeeeecceeEEEEeecCCCC
Q 048425 379 SKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVK-LIGICIEGRTRCLVYELVHNGS 457 (780)
Q Consensus 379 ~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~-L~g~~~~~~~~~LV~Ey~~~GS 457 (780)
..+.|++|++|.||+|.+. |..+|+|+-+.++ ....+..|+++|..+.--++.+ ++.| ++..+.|||+.|-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCcc
Confidence 3477999999999999995 5688999865543 3567889999999887666544 4443 23345699998888
Q ss_pred hhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccC-Cc-ceEEcCCCCCeeeccccccc
Q 048425 458 VESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFK-AS-NVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 458 L~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIK-ps-NILLd~~~~vKLsDFGLA~~ 527 (780)
|.++-.+ .+-...+ .+++.---|-..+ |-|+.|. |. ||++.+ ..+.|+||.-|..
T Consensus 99 L~~~~~~-------~~rk~l~----~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIG-------GDRKHLL----RVLEKAYKLDRLG---IEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhc-------ccHHHHH----HHHHHHHHHHHhc---cchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 8776532 1223333 3333323344445 8888887 44 555554 4999999998873
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00092 Score=71.95 Aligned_cols=144 Identities=22% Similarity=0.182 Sum_probs=87.2
Q ss_pred ceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCc--eeeeeeee------eecceeEEEEe
Q 048425 380 KRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN--LVKLIGIC------IEGRTRCLVYE 451 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~L~g~~------~~~~~~~LV~E 451 (780)
.+.|..|....+|+...++ ..+++|+... ....+...|++++..+.+.+ +.+++... ..++..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4667788888999987644 4688888754 23445667888888875332 44544421 22345589999
Q ss_pred ecCCCChhh----h----------cccccC-------CCCCCCHHHHHH----------HHHHHHHHHHHHhhC----CC
Q 048425 452 LVHNGSVES----H----------LHGVDK-------NRGPLDWEARMK----------IALGAARGLAYLHED----SN 496 (780)
Q Consensus 452 y~~~GSL~~----~----------L~~~~~-------~~~~L~~~~rl~----------Ia~qIA~gL~yLH~~----~~ 496 (780)
|++|..+.. . ||.... ......|..... ....+...+.++.+. ..
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877643 0 121100 011234433211 111233445555431 12
Q ss_pred CcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 497 PRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 497 p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
..++|+|+.+.|||++++..+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3599999999999999987778999987753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0025 Score=72.23 Aligned_cols=75 Identities=19% Similarity=0.108 Sum_probs=54.7
Q ss_pred eeecccCceEEEEEEEeCC-cEEEEEEeecc-----C--CcchHHHHHHHHHhhhcC---CCceeeeeeeeeecceeEEE
Q 048425 381 RILGEGGFGCVYHGVMDNG-TEVAVKLLTRN-----N--QNGDREFIAEVEMLSRLH---HRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~g-~~VAVK~l~~~-----~--~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~LV 449 (780)
+.||.|.+..||+....+| +.|+||.-... . ....+.+..|.+.|..+. -.++.+++.+. .+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence 6799999999999998877 48999984321 1 123456777888888763 24577777773 3567899
Q ss_pred EeecCCCC
Q 048425 450 YELVHNGS 457 (780)
Q Consensus 450 ~Ey~~~GS 457 (780)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0052 Score=66.84 Aligned_cols=144 Identities=22% Similarity=0.242 Sum_probs=82.9
Q ss_pred ceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCC--ceeeeeeee------eecceeEEEEe
Q 048425 380 KRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHR--NLVKLIGIC------IEGRTRCLVYE 451 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp--NIV~L~g~~------~~~~~~~LV~E 451 (780)
.+.++.|....+|+...++| .+++|+.+... ...+...|++++..|... ++.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 35577777789999876555 57788764421 234455677777777422 234444422 12345689999
Q ss_pred ecCCCChhhh--------------cccccCC----C----CCCCHHHHHH------------HHHHHHHHHHHHhh----
Q 048425 452 LVHNGSVESH--------------LHGVDKN----R----GPLDWEARMK------------IALGAARGLAYLHE---- 493 (780)
Q Consensus 452 y~~~GSL~~~--------------L~~~~~~----~----~~L~~~~rl~------------Ia~qIA~gL~yLH~---- 493 (780)
|++|..+... +|..... . ..-.|..... ....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9988654211 1211110 0 0112322111 01123345555543
Q ss_pred CCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 494 ~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
.....++|+|+.+.||++++++...|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123469999999999999998777899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0051 Score=67.08 Aligned_cols=157 Identities=18% Similarity=0.187 Sum_probs=83.3
Q ss_pred chHHHHHHhcCccc-----ceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCc--eeeeee
Q 048425 366 ALSDLEKATEKFSS-----KRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN--LVKLIG 438 (780)
Q Consensus 366 ~~~el~~at~~f~~-----~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~L~g 438 (780)
+.+++....+.|.. .+.|+.|....+|+...++| .+++|+... ...++...|++++..|...+ +.+.+.
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCccee
Confidence 34444444444533 34566777789999877655 688888752 12233444556665553211 333332
Q ss_pred e------eeecceeEEEEeecCCCChhhh--------------cccccC-------CCCCCCH-HHHHHHH---------
Q 048425 439 I------CIEGRTRCLVYELVHNGSVESH--------------LHGVDK-------NRGPLDW-EARMKIA--------- 481 (780)
Q Consensus 439 ~------~~~~~~~~LV~Ey~~~GSL~~~--------------L~~~~~-------~~~~L~~-~~rl~Ia--------- 481 (780)
. ....+..++++||++|..+... ||.... ....+.| .....-.
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 1 1223456899999998754210 121111 0111223 2221111
Q ss_pred ----HHHHHHHHHHhhC----CCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 482 ----LGAARGLAYLHED----SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 482 ----~qIA~gL~yLH~~----~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
..+...++.+... -...+||+|+.+.|||++++...-|+||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111222333211 12359999999999999976556899999775
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.005 Score=66.90 Aligned_cols=143 Identities=24% Similarity=0.299 Sum_probs=74.9
Q ss_pred cccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcC---CCceeeeeeeeeecceeEEEEeec
Q 048425 377 FSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH---HRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
.+..+.|+.|....+|+.. .++..+.||+-. ......|..|.+-|+.|. --.+.+.+++....+..+||+||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445779989999999976 578899999875 223456888988888883 456788888887777779999999
Q ss_pred CCCCh--h---------hhccc-cc-----------------CCCCCCCHHH-----HHHHHHHH--------------H
Q 048425 454 HNGSV--E---------SHLHG-VD-----------------KNRGPLDWEA-----RMKIALGA--------------A 485 (780)
Q Consensus 454 ~~GSL--~---------~~L~~-~~-----------------~~~~~L~~~~-----rl~Ia~qI--------------A 485 (780)
+.+.. . ..||. .. .+.-.-+|.+ |+.-..+. .
T Consensus 95 ~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~ 174 (288)
T PF03881_consen 95 EMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLV 174 (288)
T ss_dssp ------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHH
Confidence 87711 0 11232 00 0011233432 22211111 1
Q ss_pred HHH-HHHhhC-CCCcEEecccCCcceEEcCCCCCeeeccc
Q 048425 486 RGL-AYLHED-SNPRVIHRDFKASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 486 ~gL-~yLH~~-~~p~IvHrDIKpsNILLd~~~~vKLsDFG 523 (780)
+.+ ..|+.. -.|.++|+||-+.|++.+.++++.|.|=.
T Consensus 175 ~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 175 ERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 111 223322 25789999999999999999989988744
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0065 Score=65.70 Aligned_cols=141 Identities=22% Similarity=0.268 Sum_probs=83.9
Q ss_pred eeecccCceEEEEEEEeC-------CcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCc-eeeeeeeeeecceeEEEEee
Q 048425 381 RILGEGGFGCVYHGVMDN-------GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN-LVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~-------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN-IV~L~g~~~~~~~~~LV~Ey 452 (780)
+.|..|-...+|+....+ ++.+++|+...... ...+..+|.+++..+.... ..++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667677999988755 57899998755432 2234567888888885333 3455555532 368999
Q ss_pred cCCCChhhh-----------------cccccCCC-------CCCCHHHHHH--------------------------HHH
Q 048425 453 VHNGSVESH-----------------LHGVDKNR-------GPLDWEARMK--------------------------IAL 482 (780)
Q Consensus 453 ~~~GSL~~~-----------------L~~~~~~~-------~~L~~~~rl~--------------------------Ia~ 482 (780)
++|..+... ||...... .+.-|....+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776431 12211110 0111111111 011
Q ss_pred HHHHHHHHHhh------CCCCcEEecccCCcceEEcCC----CCCeeecccccc
Q 048425 483 GAARGLAYLHE------DSNPRVIHRDFKASNVLLEDD----FTPKVSDFGLAR 526 (780)
Q Consensus 483 qIA~gL~yLH~------~~~p~IvHrDIKpsNILLd~~----~~vKLsDFGLA~ 526 (780)
.+.+-+..|-. .....++|+|+.+.|||++++ +.++++||..|.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22222334432 134568999999999999985 889999998774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0089 Score=64.48 Aligned_cols=33 Identities=18% Similarity=0.435 Sum_probs=26.7
Q ss_pred CCcEEecccCCcceEEcCCCC-Ceeecccccccc
Q 048425 496 NPRVIHRDFKASNVLLEDDFT-PKVSDFGLAREA 528 (780)
Q Consensus 496 ~p~IvHrDIKpsNILLd~~~~-vKLsDFGLA~~~ 528 (780)
.+.++|+|+++.|||++++++ .-|.||+.+...
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 345899999999999998655 469999987643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0038 Score=77.13 Aligned_cols=195 Identities=22% Similarity=0.219 Sum_probs=131.4
Q ss_pred HHHHHHhhhcCCCceeeeeeeeeecceeE----EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhC
Q 048425 419 IAEVEMLSRLHHRNLVKLIGICIEGRTRC----LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494 (780)
Q Consensus 419 ~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~----LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~ 494 (780)
.-|.+.+..+.|+|++.+++|-.+....- +..|++..-++...+. ....++....+.+..++..||+|+|+.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 44677788889999999999977654333 3346777777777663 455788888888999999999999988
Q ss_pred CCCcEEecccCCc---ceEEcCCCCCeee--cccccccccCCCccceeccccCccccCchhhccCCCC--chhhHHhHHH
Q 048425 495 SNPRVIHRDFKAS---NVLLEDDFTPKVS--DFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLL--VKSDVYSYGV 567 (780)
Q Consensus 495 ~~p~IvHrDIKps---NILLd~~~~vKLs--DFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t--~ksDVySfGV 567 (780)
. ..|.-+..+ +-..+.++.+.++ ||+..+.......... ..-+..|.++|.......+ ...|+|.+|.
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHH
Confidence 5 555555444 5555666777777 9998887765432211 1234457788877665554 3479999999
Q ss_pred HHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 568 VLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 568 vLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
++..+..|..+-.... ....+.+... . ..+......|+..++++|+...+++.
T Consensus 381 l~~~~~~~~~i~~~~~-------------------~~~~~l~~~~----~----~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSA-------------------VPVSLLDVLS----T----SELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHhhhhhcCccccccc-------------------chhhhhcccc----c----hhhhhhhhhhcchhhhhccchhhhhh
Confidence 9999998865432110 0111111111 0 13556677899999999999999876
Q ss_pred HH
Q 048425 648 AL 649 (780)
Q Consensus 648 ~L 649 (780)
..
T Consensus 434 ~~ 435 (1351)
T KOG1035|consen 434 HP 435 (1351)
T ss_pred ch
Confidence 54
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.035 Score=61.78 Aligned_cols=142 Identities=16% Similarity=0.209 Sum_probs=81.9
Q ss_pred eeecccCceEEEEEEEeC-----CcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCce-eeeeeeeeecceeEEEEeecC
Q 048425 381 RILGEGGFGCVYHGVMDN-----GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL-VKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~-----g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LV~Ey~~ 454 (780)
+.|-.|-.-.+|+....+ ++.|++|+......... +-.+|..++..+...++ .++++++..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345457777899987532 36789998755432221 23678888888854443 3556655332 5899998
Q ss_pred CCChhhh-----------------cccccCCCC--CCCHHHHHHHHHH-----------------HHHHHHHH----hh-
Q 048425 455 NGSVESH-----------------LHGVDKNRG--PLDWEARMKIALG-----------------AARGLAYL----HE- 493 (780)
Q Consensus 455 ~GSL~~~-----------------L~~~~~~~~--~L~~~~rl~Ia~q-----------------IA~gL~yL----H~- 493 (780)
+.+|... +|....... ..-|.+..++..+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7776421 232211111 1223333232211 11112222 22
Q ss_pred CCCCcEEecccCCcceEEcC-CCCCeeeccccccc
Q 048425 494 DSNPRVIHRDFKASNVLLED-DFTPKVSDFGLARE 527 (780)
Q Consensus 494 ~~~p~IvHrDIKpsNILLd~-~~~vKLsDFGLA~~ 527 (780)
.....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22346899999999999986 47899999987753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.045 Score=60.27 Aligned_cols=148 Identities=20% Similarity=0.289 Sum_probs=82.4
Q ss_pred eeecccCceEEEEEEEeCCcEEEEEEee-ccCCcchHHHHHHHHHhhhcCC--Cceeeeeeeeeecc--eeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMDNGTEVAVKLLT-RNNQNGDREFIAEVEMLSRLHH--RNLVKLIGICIEGR--TRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~g~~VAVK~l~-~~~~~~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~~--~~~LV~Ey~~~ 455 (780)
+.+-.|..-.+|.... +++.+++.+-. ...........+|.++|+.+.- --+...+++|.++. ..+.||+|+++
T Consensus 31 ~~~~~G~sn~t~~~~~-~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG 109 (321)
T COG3173 31 EEISGGWSNDTFRLGD-TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG 109 (321)
T ss_pred eeccCCcccceEEEec-CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence 4443333334454443 37788887221 1112223456678888887742 33555677787766 55899999988
Q ss_pred CChhhhccc---------------------ccCC-------------CCCCCHHHHHHHHH--------HHHHHHHHHhh
Q 048425 456 GSVESHLHG---------------------VDKN-------------RGPLDWEARMKIAL--------GAARGLAYLHE 493 (780)
Q Consensus 456 GSL~~~L~~---------------------~~~~-------------~~~L~~~~rl~Ia~--------qIA~gL~yLH~ 493 (780)
..+.+.+.. .... ++--.|...++.+. ...+-..+|+.
T Consensus 110 e~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~ 189 (321)
T COG3173 110 EVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA 189 (321)
T ss_pred eeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence 544333321 1000 00111222221000 11122334433
Q ss_pred C-----CCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 494 D-----SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 494 ~-----~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
. +.+.++|+|+.+.||+++++.-+-|.||+++..-.
T Consensus 190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 2 23579999999999999998889999999987543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.0026 Score=80.08 Aligned_cols=160 Identities=11% Similarity=-0.026 Sum_probs=112.1
Q ss_pred HHHHHHhhhcCCCceeeeeeeeee--cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-
Q 048425 419 IAEVEMLSRLHHRNLVKLIGICIE--GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS- 495 (780)
Q Consensus 419 ~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~- 495 (780)
..|.+.++...|+++.....-... ..+.+.+++|+..|.+.+.|-...++...++..-+...-.+......-.|...
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 334445555678887766554332 34568899999999999998654444445554443333333244444444432
Q ss_pred -CCcEEecccCCcceEEcCCCCCeeecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh
Q 048425 496 -NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS 574 (780)
Q Consensus 496 -~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT 574 (780)
..-.+|+++|+-|.+|..+.++|++++|+.+....... ......+++-|+.|+....-+++.++|+|..|+.+|++.-
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCchHh-hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 23478999999999999999999999999994332211 1233457788999998888899999999999999999988
Q ss_pred CCCCC
Q 048425 575 GRKPV 579 (780)
Q Consensus 575 Gr~P~ 579 (780)
|..++
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 87665
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.064 Score=57.93 Aligned_cols=29 Identities=31% Similarity=0.449 Sum_probs=25.0
Q ss_pred CcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 497 PRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 497 p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
..++|+|+.+.||++++ +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45899999999999988 578899998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.17 Score=57.52 Aligned_cols=73 Identities=11% Similarity=0.087 Sum_probs=49.8
Q ss_pred ceeecccCceEEEEEEEeCCcEEEEEEeecc----CC---cchHHHHHHHHHhhhcC---CCceeeeeeeeeecceeEEE
Q 048425 380 KRILGEGGFGCVYHGVMDNGTEVAVKLLTRN----NQ---NGDREFIAEVEMLSRLH---HRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~----~~---~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~LV 449 (780)
.+.||.|....||+... ++..++||+-... .. .....-..|++.|+.+. -.++.+++.+|. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46799999999999776 4556999985411 11 12223334566666553 357888999887 456889
Q ss_pred EeecCC
Q 048425 450 YELVHN 455 (780)
Q Consensus 450 ~Ey~~~ 455 (780)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.078 Score=58.62 Aligned_cols=141 Identities=17% Similarity=0.258 Sum_probs=79.7
Q ss_pred eeecccCceEEEEEEEeC----CcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCce-eeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMDN----GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL-VKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~----g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
+.|..|=...+|+....+ +..|++|+....... .-+-.+|..+++.+..-++ .++++++..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 445556677889876543 237889987554322 2234578888888865444 4566665322 58999977
Q ss_pred CChhh-----------------hcccccCC--CCCCCHHHHHHHHHHH----------------------HHHHH----H
Q 048425 456 GSVES-----------------HLHGVDKN--RGPLDWEARMKIALGA----------------------ARGLA----Y 490 (780)
Q Consensus 456 GSL~~-----------------~L~~~~~~--~~~L~~~~rl~Ia~qI----------------------A~gL~----y 490 (780)
.+|.. .||..... ..+--|....++..++ ..-+. +
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 66532 12322111 1111233322222111 11111 1
Q ss_pred HhhCC-CCcEEecccCCcceEEcC-CCCCeeecccccc
Q 048425 491 LHEDS-NPRVIHRDFKASNVLLED-DFTPKVSDFGLAR 526 (780)
Q Consensus 491 LH~~~-~p~IvHrDIKpsNILLd~-~~~vKLsDFGLA~ 526 (780)
+...+ ...++|.|+.+.|||+++ ++.++++||..|-
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 21112 235789999999999975 5789999998774
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.13 Score=57.70 Aligned_cols=73 Identities=16% Similarity=0.131 Sum_probs=47.8
Q ss_pred eecccCceEEEEEEEeCC-cEEEEEEeecc------C-CcchHHHHHHHHHhhhcC--CC-ceeeeeeeeeecceeEEEE
Q 048425 382 ILGEGGFGCVYHGVMDNG-TEVAVKLLTRN------N-QNGDREFIAEVEMLSRLH--HR-NLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 382 ~LG~G~fG~VYkg~l~~g-~~VAVK~l~~~------~-~~~~~~f~~Ei~iL~~L~--Hp-NIV~L~g~~~~~~~~~LV~ 450 (780)
.||.|....||++..++| +.|+||.-... + .-..+...-|.+.|.... -| .+.+++.| +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 489999999999998755 58999974221 1 222344456777776653 34 34455544 445667999
Q ss_pred eecCCC
Q 048425 451 ELVHNG 456 (780)
Q Consensus 451 Ey~~~G 456 (780)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.46 Score=52.39 Aligned_cols=94 Identities=16% Similarity=0.150 Sum_probs=55.1
Q ss_pred ccchHHHHHHhcCcccc---e-eecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCC--ceeeee
Q 048425 364 TFALSDLEKATEKFSSK---R-ILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHR--NLVKLI 437 (780)
Q Consensus 364 ~f~~~el~~at~~f~~~---~-~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp--NIV~L~ 437 (780)
.++.+.+..+.+.+... + ..=.+.-..||+...++|..+++|+.+.. .....+...|++.+..|.-. .++..+
T Consensus 10 ~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~ 88 (325)
T PRK11768 10 TLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPL 88 (325)
T ss_pred CCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCc
Confidence 44555566555554332 1 22234556899988878889999987533 23455677788887776321 122211
Q ss_pred ---e--eeeecceeEEEEeecCCCCh
Q 048425 438 ---G--ICIEGRTRCLVYELVHNGSV 458 (780)
Q Consensus 438 ---g--~~~~~~~~~LV~Ey~~~GSL 458 (780)
| +...++..+.++++++|...
T Consensus 89 ~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 89 AFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 2 11223456789999987654
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.12 Score=57.73 Aligned_cols=139 Identities=20% Similarity=0.265 Sum_probs=92.8
Q ss_pred eeecccCceEEEEEEEeCCcEEEEEEeeccC---------------------CcchHH-----HHHHHHHhhhcCCCcee
Q 048425 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRNN---------------------QNGDRE-----FIAEVEMLSRLHHRNLV 434 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~---------------------~~~~~~-----f~~Ei~iL~~L~HpNIV 434 (780)
-.|..|--+.||.+.-.+|..+|||+.+-.- ....+. ...|+.-|.+|+.-.|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 3577888899999999999999999874320 000011 23467777777644332
Q ss_pred eeeeeeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC
Q 048425 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD 514 (780)
Q Consensus 435 ~L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~ 514 (780)
-.--... ....|||+|+.... |- ...-....++......+-.++++-|.-|.+.| ++||.||.--|+|+-+
T Consensus 230 ~PePIlL--k~hVLVM~FlGrdg---w~-aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd- 300 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGRDG---WA-APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD- 300 (520)
T ss_pred CCCceee--ecceEeeeeccCCC---Cc-CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-
Confidence 1111111 23479999995321 11 11112345777778888889999999998887 6999999999999965
Q ss_pred CCCeeecccccccc
Q 048425 515 FTPKVSDFGLAREA 528 (780)
Q Consensus 515 ~~vKLsDFGLA~~~ 528 (780)
|.+.|+|.+.+-..
T Consensus 301 G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEH 314 (520)
T ss_pred CEEEEEEccccccC
Confidence 58899998876543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.03 E-value=0.022 Score=62.32 Aligned_cols=145 Identities=21% Similarity=0.222 Sum_probs=94.3
Q ss_pred cchHHHHHHhc---CcccceeecccCceEEEEEEEeCCcEEEEEEeecc----------C--------Ccch----HHHH
Q 048425 365 FALSDLEKATE---KFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRN----------N--------QNGD----REFI 419 (780)
Q Consensus 365 f~~~el~~at~---~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~----------~--------~~~~----~~f~ 419 (780)
+.|-.|+..++ -++..+.||-|--+-||.+...+|++.++|.-+-. . ..+. -...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 44444444333 24567999999999999999999999999952111 0 0011 1245
Q ss_pred HHHHHhhhcCC--CceeeeeeeeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 048425 420 AEVEMLSRLHH--RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNP 497 (780)
Q Consensus 420 ~Ei~iL~~L~H--pNIV~L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p 497 (780)
+|...|+.|.. --+.+.+++ +.-++|||++.+-.|...-+ ..+..++..-+.++ +.-|-..|
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-------v~d~~~ly~~lm~~---Iv~la~~G-- 222 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH-------VEDPPTLYDDLMGL---IVRLANHG-- 222 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee-------cCChHHHHHHHHHH---HHHHHHcC--
Confidence 67777777742 234455554 34589999998877755432 22333333333333 23344556
Q ss_pred cEEecccCCcceEEcCCCCCeeecccccc
Q 048425 498 RVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 498 ~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
+||+|..-=||+++++..++++||-...
T Consensus 223 -lIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 223 -LIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred -ceecccchheeEEecCCCEEEeechHhh
Confidence 9999999999999999999999997554
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.91 E-value=0.027 Score=67.69 Aligned_cols=44 Identities=11% Similarity=0.104 Sum_probs=28.6
Q ss_pred cCCchhhhhhccccccccccCcccc--cCceeEEeccCCCCCCCCC
Q 048425 210 KFDNTTAVLTYDRLWHKKVPLNLTL--FGIYEVIYISYPGIPSSPP 253 (780)
Q Consensus 210 ~~~~~~~~~~~~n~~~g~vp~~~~~--fg~~~~~~~~~~~l~~~pp 253 (780)
.+.+++.|++++|.++|.+|..... .....+.+.+|+++|+.|.
T Consensus 488 ~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~ 533 (623)
T PLN03150 488 QLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533 (623)
T ss_pred cCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence 4567778888888888888865421 2223455777787887543
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.085 Score=54.09 Aligned_cols=124 Identities=20% Similarity=0.209 Sum_probs=60.4
Q ss_pred CcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCc-eeeeeeeeeecceeEEEEeecCCCChhhh----------------
Q 048425 399 GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN-LVKLIGICIEGRTRCLVYELVHNGSVESH---------------- 461 (780)
Q Consensus 399 g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN-IV~L~g~~~~~~~~~LV~Ey~~~GSL~~~---------------- 461 (780)
.+.|+||+..... ...-.-..|..+++.+..-+ -.++++++.+ .+|+||+++.+|..-
T Consensus 2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 4678888876653 23345567888888885433 3556665433 267899976654221
Q ss_pred -cccccC---CCCCCCHHHHHHH----------------------HHHHHHHHHHHh----hCCC-CcEEecccCCcceE
Q 048425 462 -LHGVDK---NRGPLDWEARMKI----------------------ALGAARGLAYLH----EDSN-PRVIHRDFKASNVL 510 (780)
Q Consensus 462 -L~~~~~---~~~~L~~~~rl~I----------------------a~qIA~gL~yLH----~~~~-p~IvHrDIKpsNIL 510 (780)
||.... ....--|....++ ...+..-+..+. .... ..++|+|+.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 121111 1111112222222 011111122221 1111 24789999999999
Q ss_pred E-cCCCCCeeeccccccc
Q 048425 511 L-EDDFTPKVSDFGLARE 527 (780)
Q Consensus 511 L-d~~~~vKLsDFGLA~~ 527 (780)
+ +.++.++++||..|..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8889999999988754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.68 E-value=0.38 Score=53.42 Aligned_cols=142 Identities=23% Similarity=0.297 Sum_probs=83.5
Q ss_pred eeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCc------eeeeeeee----eecceeEEEE
Q 048425 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN------LVKLIGIC----IEGRTRCLVY 450 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN------IV~L~g~~----~~~~~~~LV~ 450 (780)
+.|.+ .-..+|+....+|.. ++|+.... ....+...|++.|..+.-.. +..+-|-. ..+...+-++
T Consensus 32 ~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 32 RGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred ccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 34444 556889988877777 88877654 34556677788887773211 22222221 1112667899
Q ss_pred eecCCCChhh-h--------------ccc----c----cCCCCCCCHHH-------------HHHHHHHHHHHHHHHhhC
Q 048425 451 ELVHNGSVES-H--------------LHG----V----DKNRGPLDWEA-------------RMKIALGAARGLAYLHED 494 (780)
Q Consensus 451 Ey~~~GSL~~-~--------------L~~----~----~~~~~~L~~~~-------------rl~Ia~qIA~gL~yLH~~ 494 (780)
+|++|..+.. . ||. . ........|.. .......+...+..+.+.
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999988873 1 111 1 01112345541 011223333444444432
Q ss_pred -------CCCcEEecccCCcceEEcCCCC-Ceeecccccc
Q 048425 495 -------SNPRVIHRDFKASNVLLEDDFT-PKVSDFGLAR 526 (780)
Q Consensus 495 -------~~p~IvHrDIKpsNILLd~~~~-vKLsDFGLA~ 526 (780)
+...+||+|+.+.||+++++.. +.+.|||-+.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1123899999999999999885 8899998664
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.49 E-value=0.47 Score=60.26 Aligned_cols=160 Identities=18% Similarity=0.228 Sum_probs=86.5
Q ss_pred ccchHHHHH-HhcCccc---ceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhc-------CCCc
Q 048425 364 TFALSDLEK-ATEKFSS---KRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-------HHRN 432 (780)
Q Consensus 364 ~f~~~el~~-at~~f~~---~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-------~HpN 432 (780)
.++.++++. +.+.|.. .+.|+ |..-.+|+....+|..+++|+.+.... ..+...|...|..| .-|.
T Consensus 10 ~~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~ 86 (1013)
T PRK06148 10 EFTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPR 86 (1013)
T ss_pred CCCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCe
Confidence 344444432 2333433 24564 456888998888888999999876432 23334455555544 2334
Q ss_pred eeeee-ee----eee-cc--eeEEEEeecCCCChhhhc-----------------cc----c--cCCCCCCCHHH-----
Q 048425 433 LVKLI-GI----CIE-GR--TRCLVYELVHNGSVESHL-----------------HG----V--DKNRGPLDWEA----- 476 (780)
Q Consensus 433 IV~L~-g~----~~~-~~--~~~LV~Ey~~~GSL~~~L-----------------~~----~--~~~~~~L~~~~----- 476 (780)
+++-. |- ... ++ ..+-+++|++|..|.+.. |. . ......+.|..
T Consensus 87 ~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~ 166 (1013)
T PRK06148 87 LIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGR 166 (1013)
T ss_pred eeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchh
Confidence 44322 11 111 11 356789999998776511 10 0 00112344432
Q ss_pred ------------HHHHHHHHHHHHH-----HHhhCCCCcEEecccCCcceEEcCCC--CCe-eeccccccc
Q 048425 477 ------------RMKIALGAARGLA-----YLHEDSNPRVIHRDFKASNVLLEDDF--TPK-VSDFGLARE 527 (780)
Q Consensus 477 ------------rl~Ia~qIA~gL~-----yLH~~~~p~IvHrDIKpsNILLd~~~--~vK-LsDFGLA~~ 527 (780)
...++.++.+.++ .|.+ -...+||+|+.+.|||++.+. ++. |+|||-+..
T Consensus 167 l~~~l~~i~d~~~r~~l~~~~~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 167 ARDRLHFIDDPEDRALVERFLARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred hhhhhhhcCCHHHHHHHHHHHHHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 1122222222221 1211 123499999999999999875 555 999998764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.04 E-value=0.23 Score=52.04 Aligned_cols=138 Identities=17% Similarity=0.183 Sum_probs=87.0
Q ss_pred EEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHH
Q 048425 402 VAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKI 480 (780)
Q Consensus 402 VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~I 480 (780)
..+|++...... ...-|..+..++++++ .|++|..- ++-..-++.|+|-.-. ....-.|
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~----------------i~~~N~i 147 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK----------------INFSNFI 147 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc----------------cchhHHH
Confidence 345555433333 4456888999999886 47777732 3345568888873211 1111122
Q ss_pred HHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccceeccccCccccCchhhccCCCCchh
Q 048425 481 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKS 560 (780)
Q Consensus 481 a~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ks 560 (780)
..+ .+.|.-.|+. ++..+|+|..|+||+-|.+|.+||.|=+..-.- +.-|.--| ....|.++
T Consensus 148 ~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~-------------~V~~vN~~---Y~~lT~~a 209 (308)
T PF07387_consen 148 TAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN-------------QVNMVNIE---YESLTQEA 209 (308)
T ss_pred HHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhhh-------------eeeEEeee---ccccChHH
Confidence 222 3667888865 346999999999999999999999996633210 11122212 23457888
Q ss_pred hHHhHHHHHHHHHhCCC
Q 048425 561 DVYSYGVVLLELLSGRK 577 (780)
Q Consensus 561 DVySfGVvLlELlTGr~ 577 (780)
.+=+|=.-++++.....
T Consensus 210 E~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 210 EVKVFVKSCLKLVEKQR 226 (308)
T ss_pred HHHHHHHHHHHHHHHHh
Confidence 88888888888877543
|
The function of this family is unknown. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.85 E-value=0.32 Score=53.05 Aligned_cols=30 Identities=17% Similarity=0.192 Sum_probs=27.2
Q ss_pred cEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 498 RVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 498 ~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
.++|+|+.+.|||+++++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 599999999999999999999999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=93.67 E-value=0.069 Score=50.61 Aligned_cols=40 Identities=15% Similarity=0.122 Sum_probs=24.0
Q ss_pred CCCCCCCccceeehhHHHHHHHHHHHHHHHHHHhhhcccc
Q 048425 276 GNKNQRMNFRTIAIIALSAFVLLLVFVGAISILIKWRKAR 315 (780)
Q Consensus 276 ~~~~~~~s~~~i~ii~v~~~vlllvli~~il~~~~~Rk~r 315 (780)
.+-.++.+...|++|++|++++++.++++++|+++|+++|
T Consensus 55 ~ql~h~fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk 94 (122)
T PF01102_consen 55 SQLVHRFSEPAIIGIIFGVMAGVIGIILLISYCIRRLRKK 94 (122)
T ss_dssp -SSSSSSS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred cccccCccccceeehhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence 3445667777888888877777666666665555555443
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=93.44 E-value=0.3 Score=55.44 Aligned_cols=75 Identities=16% Similarity=0.199 Sum_probs=49.9
Q ss_pred ceeecccCceEEEEEEEeC-CcEEEEEEeecc---C---CcchHHHHHHHHHhhhcC--CC-ceeeeeeeeeecceeEEE
Q 048425 380 KRILGEGGFGCVYHGVMDN-GTEVAVKLLTRN---N---QNGDREFIAEVEMLSRLH--HR-NLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~~-g~~VAVK~l~~~---~---~~~~~~f~~Ei~iL~~L~--Hp-NIV~L~g~~~~~~~~~LV 449 (780)
.+.||.|.-..||++.+.+ +..|+||.-... . .-..++..-|.+.|+... -| .+.+++.| +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4679999999999999853 567999974221 1 223345566778877663 34 35556544 44566899
Q ss_pred EeecCCC
Q 048425 450 YELVHNG 456 (780)
Q Consensus 450 ~Ey~~~G 456 (780)
||+++..
T Consensus 112 MEdL~~~ 118 (409)
T PRK12396 112 MEDLSDH 118 (409)
T ss_pred HHhCccc
Confidence 9998653
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.15 E-value=0.14 Score=57.00 Aligned_cols=85 Identities=16% Similarity=0.161 Sum_probs=61.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccceeccccCccccCchh
Q 048425 471 PLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550 (780)
Q Consensus 471 ~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~ 550 (780)
.-.|.+.+.|+.+.+..++-+..+- +.-|||+.-.||||+ +|++-|+||-+++....+...... ..--|-.
T Consensus 317 ~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl~~~q~~isy~------rldhp~l 387 (488)
T COG5072 317 ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRLSYSQGIISYN------RLDHPDL 387 (488)
T ss_pred cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeecccCCceeecc------ccCchhh
Confidence 3579999999999888887776653 689999999999999 999999999999965443322111 1234544
Q ss_pred hccCCCCchhhHHhH
Q 048425 551 AMTGHLLVKSDVYSY 565 (780)
Q Consensus 551 l~~~~~t~ksDVySf 565 (780)
+. |.-+.+-|||-+
T Consensus 388 F~-G~dd~QFeIYrl 401 (488)
T COG5072 388 FN-GVDDYQFEIYRL 401 (488)
T ss_pred hc-CccceeeeHHHH
Confidence 54 333667777763
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.99 E-value=0.79 Score=51.97 Aligned_cols=74 Identities=18% Similarity=0.197 Sum_probs=44.3
Q ss_pred eeecccCceEEEEEEEeCC--cE-----EEEEEeeccCCcchHHHHHHHHHhhhcCCCce-eeeeeeeeecceeEEEEee
Q 048425 381 RILGEGGFGCVYHGVMDNG--TE-----VAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL-VKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~g--~~-----VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LV~Ey 452 (780)
+.|..|-...+|+....++ .. |.++... ......-+-.+|+++++.+...++ .++++.+. ..+|+||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence 4555577889999876543 22 3333321 111111233578999999965544 45555553 2599999
Q ss_pred cCCCChh
Q 048425 453 VHNGSVE 459 (780)
Q Consensus 453 ~~~GSL~ 459 (780)
+++-+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9988764
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=92.18 E-value=1.4 Score=47.34 Aligned_cols=71 Identities=18% Similarity=0.135 Sum_probs=43.8
Q ss_pred cccCceEEEEEEEeC-----C----cEEEEEEeeccCC-----cchHHHHHHHHHhhhcC---------C----Cceeee
Q 048425 384 GEGGFGCVYHGVMDN-----G----TEVAVKLLTRNNQ-----NGDREFIAEVEMLSRLH---------H----RNLVKL 436 (780)
Q Consensus 384 G~G~fG~VYkg~l~~-----g----~~VAVK~l~~~~~-----~~~~~f~~Ei~iL~~L~---------H----pNIV~L 436 (780)
|+|-.|.+|+....- + ..+.||....... ....-|.+|+.+.+.+- . ....++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 677889999887521 2 3488998752211 11245788888777651 1 234555
Q ss_pred eeeeeecceeEEEEeecC
Q 048425 437 IGICIEGRTRCLVYELVH 454 (780)
Q Consensus 437 ~g~~~~~~~~~LV~Ey~~ 454 (780)
+....+....+||||-+.
T Consensus 82 ~~~~~~~~~~~lvlEDL~ 99 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDLS 99 (294)
T ss_pred EEeccCCCceeeehhhhh
Confidence 655544456789998764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 780 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-64 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-62 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-55 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-55 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-43 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-43 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-43 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-42 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-26 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-24 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-24 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-24 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-24 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-23 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-23 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-22 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-22 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-22 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-22 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-22 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-22 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-22 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-22 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-22 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-22 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-22 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-22 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-22 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-22 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-22 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-22 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-21 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-20 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-20 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-20 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-20 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-20 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-20 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-20 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-20 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-20 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-20 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-20 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-19 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-19 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-18 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-18 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-17 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-16 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-13 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-04 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 7e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 517 bits (1334), Expect = e-180
Identities = 129/293 (44%), Positives = 189/293 (64%), Gaps = 4/293 (1%)
Query: 361 SVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNN-QNGDREFI 419
+K F+L +L+ A++ FS+K ILG GGFG VY G + +GT VAVK L Q G+ +F
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75
Query: 420 AEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMK 479
EVEM+S HRNL++L G C+ R LVY + NGSV S L +++ PLDW R +
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 480 IALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRV 539
IALG+ARGLAYLH+ +P++IHRD KA+N+LL+++F V DFGLA+ H++T V
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 195
Query: 540 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE--NLVTWARPL 597
GT G++APEY TG K+DV+ YGV+LLEL++G++ D+++ + L+ W + L
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 598 LTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650
L ++ LE LVD L G+Y +++ ++ +A +C RP M EVV+ L+
Sbjct: 256 LKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 510 bits (1317), Expect = e-177
Identities = 126/312 (40%), Positives = 181/312 (58%), Gaps = 5/312 (1%)
Query: 340 SSSIASSTSVSLMSTMATCILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNG 399
S A+++ +S+ L DLE+AT F K ++G G FG VY GV+ +G
Sbjct: 4 KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 400 TEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVE 459
+VA+K T + G EF E+E LS H +LV LIG C E L+Y+ + NG+++
Sbjct: 64 AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 460 SHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKV 519
HL+G D + WE R++I +GAARGL YLH + +IHRD K+ N+LL+++F PK+
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI 180
Query: 520 SDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
+DFG++++ TE Q H+ST V GT GY+ PEY + G L KSDVYS+GVVL E+L R
Sbjct: 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
Query: 579 VDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTH 638
+ S P+ NL WA + LEQ+VDP+LA + + K A C+
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQ-LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSED 299
Query: 639 RPFMGEVVQALK 650
RP MG+V+ L+
Sbjct: 300 RPSMGDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 492 bits (1268), Expect = e-170
Identities = 105/303 (34%), Positives = 171/303 (56%), Gaps = 20/303 (6%)
Query: 361 SVKTFALSDLEKATEKFSSKR------ILGEGGFGCVYHGVMDNGTEVAVKLL----TRN 410
+F+ +L+ T F + +GEGGFG VY G ++ T VAVK L
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDIT 69
Query: 411 NQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRG 470
+ ++F E++++++ H NLV+L+G +G CLVY + NGS+ L +D
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TP 128
Query: 471 PLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530
PL W R KIA GAA G+ +LHE+ IHRD K++N+LL++ FT K+SDFGLAR + +
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 531 GSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN 589
+Q +++R++GT Y+APE + G + KSD+YS+GVVLLE+++G VD + +
Sbjct: 186 FAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQL 242
Query: 590 LVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649
L+ + + +E +D + D + + ++AS C+H + RP + +V Q L
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
Query: 650 KLI 652
+ +
Sbjct: 302 QEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 8e-92
Identities = 75/315 (23%), Positives = 120/315 (38%), Gaps = 29/315 (9%)
Query: 365 FALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEM 424
+L + + G FGCV+ + VAVK+ ++ + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 425 LSRLHHRNLVKLIGICIEGRT----RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKI 480
L + H N+++ IG G + L+ GS+ L + W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHI 126
Query: 481 ALGAARGLAYLHED-------SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533
A ARGLAYLHED P + HRD K+ NVLL+++ T ++DFGLA + G
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 534 HI-STRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLSGRKPVDMSQPQGQ 587
+ +GT Y+APE ++ D+Y+ G+VL EL S D +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 588 ENLVTWARPLLTTRE----GLEQLVDPSLAGSYDFDD-MAKVAAIASMCVHPEVTHRPFM 642
+ + + + P L + MA + C + R
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 643 GEVVQALKLIYNDTD 657
G V + + + T+
Sbjct: 307 GCVGERITQMQRLTN 321
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 2e-68
Identities = 83/284 (29%), Positives = 133/284 (46%), Gaps = 34/284 (11%)
Query: 380 KRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGD--REFIAEVEMLSRLHHRNLVKLI 437
K +G G FG V+ +G++VAVK+L + + + EF+ EV ++ RL H N+V +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 438 GICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNP 497
G + +V E + GS+ LH R LD R+ +A A+G+ YLH NP
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNP 158
Query: 498 RVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLL 557
++HR+ K+ N+L++ +T KV DFGL+R S GT ++APE
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRDEPSN 217
Query: 558 VKSDVYSYGVVLLELLSGRKP-VDMSQPQ-----GQENLVTWARPLLTTREGLEQLVDPS 611
KSDVYS+GV+L EL + ++P +++ Q G + R + ++P
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK----RLEIPRN------LNPQ 267
Query: 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655
+ AAI C E RP ++ L+ +
Sbjct: 268 V------------AAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 9e-67
Identities = 75/301 (24%), Positives = 133/301 (44%), Gaps = 55/301 (18%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGD-------REFIAEVEMLS 426
+ ++ +G+GGFG V+ G + + + VA+K L + G+ +EF EV ++S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 427 RLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAAR 486
L+H N+VKL G+ +V E V G + L P+ W ++++ L A
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIAL 133
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLL-----EDDFTPKVSDFGLAREATEGSQHISTRVMG 541
G+ Y+ + NP ++HRD ++ N+ L KV+DFGL+++ S H + ++G
Sbjct: 134 GIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLG 188
Query: 542 TFGYVAPEYAMTGHLLV--KSDVYSYGVVLLELLSGRKP-VDMSQPQ-------GQENLV 591
F ++APE K+D YS+ ++L +L+G P + S + +E L
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL- 247
Query: 592 TWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651
RP + P L + +C + RP +V+ L
Sbjct: 248 ---RPTIPED------CPPRL------------RNVIELCWSGDPKKRPHFSYIVKELSE 286
Query: 652 I 652
+
Sbjct: 287 L 287
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 2e-66
Identities = 68/330 (20%), Positives = 122/330 (36%), Gaps = 44/330 (13%)
Query: 365 FALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEM 424
A S+ + ++G G +G VY G + + VAVK+ + N + FI E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNI 58
Query: 425 --LSRLHHRNLVKLIGICIEG-----RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEAR 477
+ + H N+ + I LV E NGS+ +L DW +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSS 113
Query: 478 MKIALGAARGLAYLHED------SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR----- 526
++A RGLAYLH + P + HRD + NVL+++D T +SDFGL+
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 527 --EATEGSQHISTRVMGTFGYVAPEYAM-------TGHLLVKSDVYSYGVVLLELLSGRK 577
+ + +GT Y+APE L + D+Y+ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 578 PVDMSQPQGQENLV-TWARPLLTTREGLEQLVD-----PSLAGSYDFDD--MAKVAAIAS 629
+ + + + T E ++ LV P ++ + + +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 630 MCVHPEVTHRPFMGEVVQALKLIYNDTDET 659
C + R + + + +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERN 323
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 4e-65
Identities = 61/291 (20%), Positives = 115/291 (39%), Gaps = 51/291 (17%)
Query: 380 KRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGD--REFIAEVEMLSRLHHRNLVKLI 437
L E G ++ G G ++ VK+L + + R+F E L H N++ ++
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 438 GICIE--GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS 495
G C L+ + GS+ + LH + +D +K AL ARG+A+LH
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAFLH-TL 130
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE------ 549
P + + +V++++D T ++S + S M +VAPE
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKP 184
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLSGRKP-VDMSQPQ-----GQENLVTWARPLLTTREG 603
+D++S+ V+L EL++ P D+S + E L RP +
Sbjct: 185 EDTNRR---SADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL----RPTIPPG-- 235
Query: 604 LEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654
+ P + + + +C++ + RP +V L+ + +
Sbjct: 236 ----ISPHV------------SKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 7e-65
Identities = 81/303 (26%), Positives = 136/303 (44%), Gaps = 28/303 (9%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
++ + ++G G FG V +VA+K + +++ + FI E+ LSR++H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
KL G C+ CLV E GS+ + LHG + M L ++G+AYLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 495 SNPRVIHRDFKASNVLL-EDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT 553
+IHRD K N+LL K+ DFG A + Q T G+ ++APE
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPEVFEG 177
Query: 554 GHLLVKSDVYSYGVVLLELLSGRKP-VDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612
+ K DV+S+G++L E+++ RKP ++ P + + WA G P L
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---IMWA-----VHNGTR----PPL 225
Query: 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDETCGDCCSPKDSSVP 672
+ + ++ + C + + RP M E+V+ + + P S+P
Sbjct: 226 IKNLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLP 281
Query: 673 DSD 675
+
Sbjct: 282 PGE 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 3e-62
Identities = 76/286 (26%), Positives = 119/286 (41%), Gaps = 39/286 (13%)
Query: 380 KRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGD----REFIAEVEMLSRLHHRNLVK 435
+ I+G GGFG VY G EVAVK + E ++ + L H N++
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 436 LIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS 495
L G+C++ CLV E G + L G + + + A+ ARG+ YLH+++
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 496 NPRVIHRDFKASNVLLEDDFTP--------KVSDFGLAREATEGSQHISTRVMGTFGYVA 547
+IHRD K+SN+L+ K++DFGLARE + G + ++A
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMA 182
Query: 548 PEYAMTGHLLVKSDVYSYGVVLLELLSGRKP-VDMSQPQGQENLVTWARPLLTTREGLEQ 606
PE SDV+SYGV+L ELL+G P + V + +
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-----VAYGVAMNKLA----- 232
Query: 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652
+ + A + C +P+ RP ++ L I
Sbjct: 233 ---LPIPSTCP----EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 9e-61
Identities = 68/323 (21%), Positives = 116/323 (35%), Gaps = 44/323 (13%)
Query: 380 KRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIG 438
+LG+G FG + G + +K L R ++ R F+ EV+++ L H N++K IG
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 439 ICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPR 498
+ + + + E + G++ + W R+ A A G+AYLH +
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHSMN--- 128
Query: 499 VIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS-------------QHISTRVMGTFGY 545
+IHRD + N L+ ++ V+DFGLAR + + V+G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 546 VAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP---VDMSQPQGQENLVTWARPLLTTRE 602
+APE K DV+S+G+VL E++ N+ +
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP--- 245
Query: 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDETCGD 662
PS I C + RP ++ L+ + G
Sbjct: 246 ---PNCPPSF------------FPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA---GH 287
Query: 663 CCSPKDSSVPDSDFKGELVPSDS 685
D F +S
Sbjct: 288 LPLGPQLEQLDRGFWETYRRGES 310
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 2e-59
Identities = 62/294 (21%), Positives = 108/294 (36%), Gaps = 52/294 (17%)
Query: 380 KRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGD--REFIAEVEMLSRLHHRNLVKLI 437
++G+G FG VYHG EVA++L+ N D + F EV + H N+V +
Sbjct: 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 438 GICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNP 497
G C+ ++ L ++ S + + LD +IA +G+ YLH
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLH---AK 149
Query: 498 RVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM----GTFGYVAPEYAMT 553
++H+D K+ NV D+ ++DFGL + + G ++APE
Sbjct: 150 GILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 554 GHLLV---------KSDVYSYGVVLLELLSGRKP-VDMSQPQGQENLVTWA-----RPLL 598
SDV++ G + EL + P + W +P L
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-----IIWQMGTGMKPNL 263
Query: 599 TTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652
+ + + + I C E RP +++ L+ +
Sbjct: 264 SQIG-----MGKEI------------SDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 3e-59
Identities = 69/293 (23%), Positives = 126/293 (43%), Gaps = 39/293 (13%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGD--REFIAEVEMLSRLHHRN 432
+ + + +G G FG VY G +VAVK+L + F EV +L + H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
++ +G + +V + S+ HLH + + + + IA ARG+ YLH
Sbjct: 82 ILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLH 137
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR-EATEGSQHISTRVMGTFGYVAPE-- 549
+IHRD K++N+ L +D T K+ DFGLA ++ H ++ G+ ++APE
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 550 -YAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWA------RPLLTTRE 602
+ +SDVY++G+VL EL++G+ P + Q + P L+
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLSPDLSK-- 249
Query: 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655
+ + + + C+ + RP ++ ++ + +
Sbjct: 250 -VRSNCPKRM------------KRLMAECLKKKRDERPSFPRILAEIEELARE 289
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 3e-57
Identities = 66/305 (21%), Positives = 127/305 (41%), Gaps = 41/305 (13%)
Query: 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEM--LSRLHHRNLVKLIG 438
+ +G+G +G V+ G G +VAVK+ + + E E+ + H N++ I
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98
Query: 439 ICIEGRTR----CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
I+G L+ + NGS+ +L LD ++ +K+A + GL +LH +
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 495 -----SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI---STRVMGTFGYV 546
P + HRD K+ N+L++ + T ++D GLA + + + +GT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 547 APE------YAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQP--QGQENLVTWARPLL 598
PE + +D+YS+G++L E+ + + +LV P
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV----PSD 269
Query: 599 TTREGLEQLVD-----PSLAGSYDFDD-MAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652
+ E + ++V PS + D+ + ++ + + C R V + L +
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
Query: 653 YNDTD 657
D
Sbjct: 330 SESQD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-56
Identities = 63/298 (21%), Positives = 125/298 (41%), Gaps = 41/298 (13%)
Query: 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEM--LSRLHHRNLVKLIG 438
+G+G +G V+ G G VAVK+ + + ++ + E E+ L H N++ I
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIA 69
Query: 439 ICIEGRTR----CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+ R L+ GS+ +L LD + ++I L A GLA+LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 495 -----SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI---STRVMGTFGYV 546
P + HRD K+ N+L++ + ++D GLA ++ + + + +GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 547 APE------YAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ--ENLVTWARPLL 598
APE + D++++G+VL E+ + + ++V P
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV----PND 240
Query: 599 TTREGLEQLVD-----PSLAGSYDFDD-MAKVAAIASMCVHPEVTHRPFMGEVVQALK 650
+ E + ++V P++ + D + +A + C + + R + + L
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-54
Identities = 70/305 (22%), Positives = 128/305 (41%), Gaps = 43/305 (14%)
Query: 382 ILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEM--LSRLHHRNLVKLIGI 439
+G+G FG V+ G G EVAVK+ + +R + E E+ L H N++ I
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 440 CIEGRTR----CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED- 494
+ LV + +GS+ +L+ R + E +K+AL A GLA+LH +
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 495 ----SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI---STRVMGTFGYVA 547
P + HRD K+ N+L++ + T ++D GLA + I +GT Y+A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 548 PEYAMTGHLLV-------KSDVYSYGVVLLELLSGRKPVDMSQPQGQ--ENLVTWARPLL 598
PE + + + ++D+Y+ G+V E+ + + +LV P
Sbjct: 220 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV----PSD 274
Query: 599 TTREGLEQLVD-----PSLAGSYDFDD-MAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652
+ E + ++V P++ + + + +A I C + R + + L +
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
Query: 653 YNDTD 657
Sbjct: 335 SQQEG 339
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-47
Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRN 432
E +G G FG V+ G + + T VAVK + +F+ E +L + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
+V+LIG+C + + +V ELV G + L L + +++ AA G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYV-----A 547
IHRD A N L+ + K+SDFG++RE +G + G V A
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGL-RQVPVKWTA 283
Query: 548 PEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
PE G +SDV+S+G++L E S G P
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASP 315
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 68/238 (28%), Positives = 103/238 (43%), Gaps = 18/238 (7%)
Query: 380 KRILGEGGFGCVYHGVMD-----NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
LG+G FG V D G VAVK L + + R+F E+++L LH +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 435 KLIGICIEGRTR--CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
K G+ + LV E + +G + L ++R LD + + +G+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLG 144
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF--GYVAPEY 550
R +HRD A N+L+E + K++DFGLA+ + R G + APE
Sbjct: 145 SR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 551 AMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607
+SDV+S+GVVL EL + K S ++ R + LE L
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELL 257
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 5e-44
Identities = 67/212 (31%), Positives = 108/212 (50%), Gaps = 22/212 (10%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
+ + + +G G FG V+ G N +VA+K + R + +FI E E++ +L H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+L G+C+E CLV E + +G + +L RG E + + L G+AYL E+
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYL-EE 122
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR-------EATEGSQHISTRVMGTFGYVA 547
+ VIHRD A N L+ ++ KVSDFG+ R ++ G++ + +
Sbjct: 123 AC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK-FPVKWA------S 173
Query: 548 PEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
PE KSDV+S+GV++ E+ S G+ P
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-44
Identities = 69/239 (28%), Positives = 110/239 (46%), Gaps = 19/239 (7%)
Query: 380 KRILGEGGFGCVYHGVMD-----NGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRNL 433
R LGEG FG V D G +VAVK L + + E+E+L L+H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 434 VKLIGICIEGRTR--CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
VK GIC E L+ E + +GS++ +L KN+ ++ + ++K A+ +G+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP---KNKNKINLKQQLKYAVQICKGMDYL 142
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF--GYVAPE 549
+ +HRD A NVL+E + K+ DFGL + ++ + + + APE
Sbjct: 143 GSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607
M + SDV+S+GV L ELL+ S ++ +T + L
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSD--SSPMALFLKMIGPTHGQMTVTRLVNTL 256
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-44
Identities = 66/237 (27%), Positives = 105/237 (44%), Gaps = 15/237 (6%)
Query: 380 KRILGEGGFGCVYHGVMD-----NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
+ LG+G FG V D G VAVK L + + R+F E+E+L L H N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 435 KLIGICIEGRTR--CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
K G+C R L+ E + GS+ +L K++ +D ++ +G+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF--GYVAPEY 550
R IHRD N+L+E++ K+ DFGL + + + + G + APE
Sbjct: 132 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 551 AMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607
V SDV+S+GVVL EL + + + + + + +E L
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-44
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
E+ + + LG G FG V G +VAVK++ + + EF E + + +L H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
K G+C + +V E + NG + ++L + L+ +++ G+A+L E
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLR---SHGKGLEPSQLLEMCYDVCEGMAFL-ES 122
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR-------EATEGSQHISTRVMGTFGYVA 547
IHRD A N L++ D KVSDFG+ R ++ G++ + A
Sbjct: 123 HQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK-FPVKWS------A 173
Query: 548 PEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
PE KSDV+++G+++ E+ S G+ P
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 8e-44
Identities = 70/228 (30%), Positives = 113/228 (49%), Gaps = 18/228 (7%)
Query: 355 MATCILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNG 414
M + + F S ++ + +G+G FG V G G +VAVK + +
Sbjct: 1 MGGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-- 57
Query: 415 DREFIAEVEMLSRLHHRNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLD 473
+ F+AE ++++L H NLV+L+G+ +E + +V E + GS+ +L + R L
Sbjct: 58 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLG 115
Query: 474 WEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533
+ +K +L + YL E +N +HRD A NVL+ +D KVSDFGL +EA+
Sbjct: 116 GDCLLKFSLDVCEAMEYL-EGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172
Query: 534 --HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
+ + APE KSDV+S+G++L E+ S GR P
Sbjct: 173 TGKLPVKWT------APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
+ + + LG G FG V +G +VA+K++ + + EFI E +++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+L G+C + R ++ E + NG + ++L + R + +++ + YL E
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYL-ES 138
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR-------EATEGSQHISTRVMGTFGYVA 547
+HRD A N L+ D KVSDFGL+R ++ GS+ R
Sbjct: 139 KQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK-FPVRWS------P 189
Query: 548 PEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
PE M KSD++++GV++ E+ S G+ P
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-43
Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 15/237 (6%)
Query: 380 KRILGEGGFGCVYHGVMD-----NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
+ LG+G FG V D G VAVK L + + R+F E+E+L L H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 435 KLIGICIEGRTR--CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
K G+C R L+ E + GS+ +L K++ +D ++ +G+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLG 162
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF--GYVAPEY 550
R IHRD N+L+E++ K+ DFGL + + ++ + G + APE
Sbjct: 163 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219
Query: 551 AMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607
V SDV+S+GVVL EL + + + + + + +E L
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 380 KRILGEGGFGCVYHGVM----DNGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRNLV 434
++I+G G G V +G + VA+K L R +F++E ++ + H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+L G+ GR +V E + NGS+++ L + G + + G G+ YL D
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYL-SD 169
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGY--VAPEYAM 552
+HRD A NVL++ + KVSDFGL+R + T G APE
Sbjct: 170 LG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 553 TGHLLVKSDVYSYGVVLLELLS-GRKP 578
SDV+S+GVV+ E+L+ G +P
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-42
Identities = 69/222 (31%), Positives = 111/222 (50%), Gaps = 18/222 (8%)
Query: 361 SVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIA 420
+ F S ++ + +G+G FG V G G +VAVK + + + F+A
Sbjct: 179 AQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLA 235
Query: 421 EVEMLSRLHHRNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK 479
E ++++L H NLV+L+G+ +E + +V E + GS+ +L + R L + +K
Sbjct: 236 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLK 293
Query: 480 IALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH--IST 537
+L + YL E +N +HRD A NVL+ +D KVSDFGL +EA+ +
Sbjct: 294 FSLDVCEAMEYL-EGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 350
Query: 538 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
+ APE KSDV+S+G++L E+ S GR P
Sbjct: 351 KWT------APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 380 KRILGEGGFGCVYHGV---MDNGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRNLVK 435
LG G FG V GV +VA+K+L + + D E + E +++ +L + +V+
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 436 LIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS 495
LIG+C + LV E+ G + L R + ++ + G+ YL
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF--GYVAPEYAMT 553
+HRD A NVLL + K+SDFGL++ + + R G + + APE
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 554 GHLLVKSDVYSYGVVLLELLS-GRKP 578
+SDV+SYGV + E LS G+KP
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 5e-42
Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNG-TEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL 433
+ K LG G +G VY GV VAVK L + + EF+ E ++ + H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
V+L+G+C ++ E + G++ +L + NR + + +A + + YL E
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYL-E 128
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR-------EATEGSQHISTRVMGTFGYV 546
N IHRD A N L+ ++ KV+DFGL+R A G++ +
Sbjct: 129 KKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK-FPIKWT------ 179
Query: 547 APEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
APE +KSDV+++GV+L E+ + G P
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-42
Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 381 RILGEGGFGCVYHGVMDNG-----TEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRNLV 434
++LG G FG VY G+ VA+K L E + E +++ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+L+GIC+ T L+ +L+ G + ++ +++ + + + + A+G+ YL +
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRV-------MGTFGYVA 547
R++HRD A NVL++ K++DFGLA+ + M A
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM------A 187
Query: 548 PEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
E + +SDV+SYGV + EL++ G KP
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 6e-42
Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 15/213 (7%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTE-----VAVKLLTRNNQNGDR-EFIAEVEMLSRL 428
+ ++++G G FG VY G++ + VA+K L R +F+ E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 429 HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGL 488
H N+++L G+ + + ++ E + NG+++ L + G + + G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGM 160
Query: 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGY--V 546
YL + N +HRD A N+L+ + KVSDFGL+R + + T G
Sbjct: 161 KYL-ANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217
Query: 547 APEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
APE SDV+S+G+V+ E+++ G +P
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-41
Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 8/228 (3%)
Query: 353 STMATCILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDN-GTEVAVKLLTRNN 411
+ + E + K LG G +G VY GV VAVK L +
Sbjct: 198 PKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT 257
Query: 412 QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGP 471
+ EF+ E ++ + H NLV+L+G+C ++ E + G++ +L + NR
Sbjct: 258 MEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQE 314
Query: 472 LDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531
+ + +A + + YL + IHR+ A N L+ ++ KV+DFGL+R T
Sbjct: 315 VSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371
Query: 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
+ + APE +KSDV+++GV+L E+ + G P
Sbjct: 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 380 KRILGEGGFGCVYHGVM----DNGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRNLV 434
+++G G FG V G + VA+K L R +F+ E ++ + H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+L G+ + + +V E + NGS++S L K+ + + G A G+ YL D
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYL-SD 165
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGY--VAPEYAM 552
+HRD A N+L+ + KVSDFGL R + + T G +PE
Sbjct: 166 MG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 553 TGHLLVKSDVYSYGVVLLELLS-GRKP 578
SDV+SYG+VL E++S G +P
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 5e-41
Identities = 67/208 (32%), Positives = 109/208 (52%), Gaps = 14/208 (6%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
E LG G FG V+ G + T+VAVK L + + + D F+AE ++ +L H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLV 71
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+L + + ++ E + NGS+ L + L + +A A G+A++ E+
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFI-EE 127
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGT---FGYVAPEYA 551
N IHRD +A+N+L+ D + K++DFGLAR + T G + APE
Sbjct: 128 RN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAI 182
Query: 552 MTGHLLVKSDVYSYGVVLLELLS-GRKP 578
G +KSDV+S+G++L E+++ GR P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-41
Identities = 76/239 (31%), Positives = 106/239 (44%), Gaps = 21/239 (8%)
Query: 380 KRILGEGGFGCVYHGVMDN-----GTEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRNL 433
R LGEG FG V D G VAVK L + R + E+++L L+H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 434 VKLIGICIEGRTR--CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
+K G C + LV E V GS+ +L ++ + + A G+AYL
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHS--IGLAQLLLFAQQICEGMAYL 150
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF--GYVAPE 549
H IHRD A NVLL++D K+ DFGLA+ EG ++ R G + APE
Sbjct: 151 HAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 207
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607
SDV+S+GV L ELL+ S P L+ A+ +T E L
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSS--QSPPTKFLELIGIAQGQMTVLRLTELL 264
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 67/220 (30%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 375 EKFSSKRILGEGGFGCVYHGVM----DNGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRLH 429
S R++G+G FG VYHG N + A+K L+R + F+ E ++ L+
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 430 HRNLVKLIGICIEGRTRCL-VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGL 488
H N++ LIGI + + + +G + + + + + L ARG+
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGM 137
Query: 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR-----EATEGSQHISTRV---- 539
YL + + +HRD A N +L++ FT KV+DFGLAR E QH R+
Sbjct: 138 EYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKW 194
Query: 540 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
A E T KSDV+S+GV+L ELL+ G P
Sbjct: 195 T------ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-41
Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 29/222 (13%)
Query: 375 EKFSSKRILGEGGFGCVYHGV--------MDNGTEVAVKLLTRNNQNGDREFIAEVEMLS 426
E LG+G F ++ GV + TEV +K+L + ++N F M+S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 427 RLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAAR 486
+L H++LV G+C+ G LV E V GS++++L KN+ ++ ++++A A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK---KNKNCINILWKLEVAKQLAA 124
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDFTP--------KVSDFGLAREATEGSQHISTR 538
+ +L E++ +IH + A N+LL + K+SD G++ + R
Sbjct: 125 AMHFL-EENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-VLPKDILQER 180
Query: 539 VMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLS-GRKP 578
+ PE L + +D +S+G L E+ S G KP
Sbjct: 181 IPWV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 7e-41
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 22/211 (10%)
Query: 381 RILGEGGFGCVYHGVMDNG----TEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRNLVK 435
++G G FGCVYHG + + AVK L R G+ +F+ E ++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 436 LIGICIEGR-TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
L+GIC+ + +V + +G + + + + + L A+G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYL--- 144
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFG------YVAP 548
++ + +HRD A N +L++ FT KV+DFGLAR+ + V G ++A
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE---YYSVHNKTGAKLPVKWMAL 201
Query: 549 EYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
E T KSDV+S+GV+L EL++ G P
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 9e-41
Identities = 64/209 (30%), Positives = 90/209 (43%), Gaps = 17/209 (8%)
Query: 380 KRILGEGGFGCVYHGV----MDNGTEVAVKLL---TRNNQNGDREFIAEVEMLSRLHHRN 432
LG+G FG V G VAVK L + +FI EV + L HRN
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
L++L G+ + +V EL GS+ L K++G + A+ A G+ YL
Sbjct: 83 LIRLYGVVLT-PPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYL- 137
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGY--VAPEY 550
E IHRD A N+LL K+ DFGL R + H + + APE
Sbjct: 138 ESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 551 AMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
T SD + +GV L E+ + G++P
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 381 RILGEGGFGCVYHGVMDNG---TEVAVKLL--TRNNQNGDREFIAEVEMLSRLHHRNLVK 435
+ LG G FG V G VAVK+L N+ E +AE ++ +L + +V+
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 436 LIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS 495
+IGIC E + LV E+ G + +L + + + +++ + G+ YL E+S
Sbjct: 83 MIGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYL-EES 136
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF--GYVAPEYAMT 553
N +HRD A NVLL K+SDFGL++ + + G + + APE
Sbjct: 137 N--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 554 GHLLVKSDVYSYGVVLLELLS-GRKP 578
KSDV+S+GV++ E S G+KP
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-40
Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 8/205 (3%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
E + LG+G FG V+ G + T VA+K L + + F+ E +++ +L H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLV 242
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+L + E +V E + GS+ L + L + +A A G+AY+ E
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYV-ER 298
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG 554
N +HRD +A+N+L+ ++ KV+DFGLAR + + APE A+ G
Sbjct: 299 MN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 555 HLLVKSDVYSYGVVLLELLS-GRKP 578
+KSDV+S+G++L EL + GR P
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVP 381
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-40
Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 27/217 (12%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNG----TEVAVKLLTRNNQNGDR-EFIAEVEMLSRLH 429
E RILGEG FG VY GV N VAVK ++ ++ +F++E ++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLA 489
H ++VKLIGI E T ++ EL G + +L +N+ L + +L + +A
Sbjct: 72 HPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLE---RNKNSLKVLTLVLYSLQICKAMA 127
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE-------ATEGSQHISTRVMGT 542
YL E N +HRD N+L+ K+ DFGL+R ++ + + M
Sbjct: 128 YL-ESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR-LPIKWM-- 181
Query: 543 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
+PE SDV+ + V + E+LS G++P
Sbjct: 182 ----SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-40
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 380 KRILGEGGFGCVYHGVM-----DNGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRNL 433
++LG G FG V+ GV V +K++ + + + L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
V+L+G+C + LV + + GS+ H+ ++RG L + + + A+G+ YL E
Sbjct: 78 VRLLGLCPG-SSLQLVTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGMYYLEE 133
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGT---FGYVAPEY 550
++HR+ A NVLL+ +V+DFG+A + + ++A E
Sbjct: 134 H---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKTPIKWMALES 188
Query: 551 AMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
G +SDV+SYGV + EL++ G +P
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-40
Identities = 60/234 (25%), Positives = 110/234 (47%), Gaps = 31/234 (13%)
Query: 367 LSDLEKATEKFSSKRILGEGGFGCVYHGVMDNG----TEVAVKLLTRNNQNGDR--EFIA 420
L D+ ++F+ R+LG+G FG V + +VAVK+L + EF+
Sbjct: 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 421 EVEMLSRLHHRNLVKLIGICIEGRTR------CLVYELVHNGSVESHL--HGVDKNRGPL 472
E + H ++ KL+G+ + R + ++ + +G + + L + +N L
Sbjct: 75 EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 473 DWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532
+ ++ + A G+ YL S+ IHRD A N +L +D T V+DFGL+R+ G
Sbjct: 135 PLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 533 ---QHISTRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
Q ++++ + A E V SDV+++GV + E+++ G+ P
Sbjct: 192 YYRQGCASKLPVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-40
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 13/210 (6%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNG----TEVAVKLLTRNNQNGDR-EFIAEVEMLSRLH 429
E+ R +GEG FG V+ G+ + VA+K + R +F+ E + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLA 489
H ++VKLIG+ E ++ EL G + S L + LD + + A + LA
Sbjct: 75 HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALA 130
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549
YL + R +HRD A NVL+ + K+ DFGL+R + + + +++ ++APE
Sbjct: 131 YL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 187
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
SDV+ +GV + E+L G KP
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-40
Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 26/218 (11%)
Query: 380 KRILGEGGFGCVYHGVMDNG------TEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRN 432
R LG+G FG VY GV T VA+K + +R EF+ E ++ + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHL------HGVDKNRGPLDWEARMKIALGAAR 486
+V+L+G+ +G+ ++ EL+ G ++S+L + P +++A A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYV 546
G+AYL + + +HRD A N ++ +DFT K+ DFG+ R+ E + G G +
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLL 202
Query: 547 -----APEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
+PE G SDV+S+GVVL E+ + +P
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-39
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 8/205 (3%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
E ++ LG G FG V+ + T+VAVK + + + + F+AE ++ L H LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLV 246
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
KL + + ++ E + GS+ L + + A G+A++ E
Sbjct: 247 KLHAVVTKEPI-YIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFI-EQ 302
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG 554
N IHRD +A+N+L+ K++DFGLAR + + APE G
Sbjct: 303 RN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 360
Query: 555 HLLVKSDVYSYGVVLLELLS-GRKP 578
+KSDV+S+G++L+E+++ GR P
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-39
Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 32/291 (10%)
Query: 312 RKARKPSSAVG---PAFASSINKRSGIGSILSSSIASSTSVSLMSTMATCILSVKTFALS 368
R+ S A G P + ++ I + +S + S +L A + +
Sbjct: 14 HGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNP 73
Query: 369 DLEKATEKF---------SSKRILGEGGFGCVYHGVMDNG----TEVAVKLLTRNNQNGD 415
+L +A + ++G G FGCVYHG + + AVK L R G+
Sbjct: 74 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 133
Query: 416 R-EFIAEVEMLSRLHHRNLVKLIGICIEGRT-RCLVYELVHNGSVESHLHGVDKNRGPLD 473
+F+ E ++ H N++ L+GIC+ +V + +G + + +
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPT 190
Query: 474 WEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533
+ + L A+G+ +L ++ + +HRD A N +L++ FT KV+DFGLAR+ +
Sbjct: 191 VKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247
Query: 534 HISTRVMGTFGYV-----APEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
T + A E T KSDV+S+GV+L EL++ G P
Sbjct: 248 DSVHN--KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 62/234 (26%), Positives = 107/234 (45%), Gaps = 30/234 (12%)
Query: 366 ALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNG----TEVAVKLLTRNNQNGD--REFI 419
L D+ +ILGEG FG V G + +VAVK + +N + EF+
Sbjct: 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL 84
Query: 420 AEVEMLSRLHHRNLVKLIGICIEGRTRC-----LVYELVHNGSVESHL--HGVDKNRGPL 472
+E + H N+++L+G+CIE ++ ++ + G + ++L ++ +
Sbjct: 85 SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144
Query: 473 DWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532
+ +K + A G+ YL SN +HRD A N +L DD T V+DFGL+++ G
Sbjct: 145 PLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201
Query: 533 ---QHISTRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
Q ++ + A E KSDV+++GV + E+ + G P
Sbjct: 202 YYRQGRIAKMPVKWI------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 56/214 (26%), Positives = 104/214 (48%), Gaps = 19/214 (8%)
Query: 375 EKFSSKRILGEGGFGCVYHGVM-----DNGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRL 428
+F ++LG G FG VY G+ VA+K L E + E +++ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 429 HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGL 488
+ ++ +L+GIC+ T L+ +L+ G + ++ +++ + + + + A+G+
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGM 130
Query: 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGT---FGY 545
YL + R++HRD A NVL++ K++DFGLA+ + G +
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKW 185
Query: 546 VAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
+A E + +SDV+SYGV + EL++ G KP
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-39
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 15/214 (7%)
Query: 380 KRILGEGGFGCVYHGV--MDNG-TEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRNLVK 435
LG G FG V GV M +VA+K+L + + D E + E +++ +L + +V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 436 LIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS 495
LIG+C + LV E+ G + L R + ++ + G+ YL E+
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYL-EEK 455
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGY--VAPEYAMT 553
N +HR+ A NVLL + K+SDFGL++ + + R G + APE
Sbjct: 456 N--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 554 GHLLVKSDVYSYGVVLLELLS-GRKP-VDMSQPQ 585
+SDV+SYGV + E LS G+KP M P+
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 6e-39
Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 8/205 (3%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
E + LG+G FG V+ G + T VA+K L + + F+ E +++ +L H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLV 325
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+L + E +V E + GS+ L + L + +A A G+AY+ E
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYV-ER 381
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG 554
N +HRD +A+N+L+ ++ KV+DFGLAR + + APE A+ G
Sbjct: 382 MN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 439
Query: 555 HLLVKSDVYSYGVVLLELLS-GRKP 578
+KSDV+S+G++L EL + GR P
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVP 464
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-39
Identities = 83/356 (23%), Positives = 140/356 (39%), Gaps = 29/356 (8%)
Query: 229 PLNLTLFGIYEVIYISYPGIPSSPPYESSTESGPSVSVGSLPISANFGNKNQRMNFRTIA 288
P +L F + I S +G L ++A + M
Sbjct: 260 PTHLADFNQVQTIQYSNSEDKDRKGMLQLKIAGAP---EPLTVTAPSLTIAENM------ 310
Query: 289 IIALSAFVLLLVFVGAISILIKWRKARKPSSAVGPAFASSINKRSGIGSILSSSIASSTS 348
A + GA I R ++ A+ + N++ G+ S S +
Sbjct: 311 --ADLIDGYCRLVNGATQSFI-IRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDY 367
Query: 349 VSLMSTMATCILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNG----TEVAV 404
++ T + D E E+ R +GEG FG V+ G+ + VA+
Sbjct: 368 AEIIDEEDTYTMPSTR----DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAI 423
Query: 405 KLLTRNNQNGDR-EFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLH 463
K + R +F+ E + + H ++VKLIG+ E ++ EL G + S L
Sbjct: 424 KTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ 482
Query: 464 GVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 523
+ LD + + A + LAYL + R +HRD A NVL+ + K+ DFG
Sbjct: 483 ---VRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFG 536
Query: 524 LAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
L+R + + + +++ ++APE SDV+ +GV + E+L G KP
Sbjct: 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-38
Identities = 73/269 (27%), Positives = 117/269 (43%), Gaps = 35/269 (13%)
Query: 336 GSILSSSIASSTSVSLMSTMATCILSVKTFALSDL-EKATEKFSSKRILGEGGFGCVYHG 394
G++ S S S T I + + F+ + + K LGEG FG V+
Sbjct: 1 GAMGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLA 60
Query: 395 VMDNG------TEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448
N VAVK L +++ ++F E E+L+ L H+++V+ G+C EGR +
Sbjct: 61 ECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120
Query: 449 VYELVHNGSVESHL-----------HGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNP 497
V+E + +G + L G D GPL + +A A G+ YL +
Sbjct: 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGL 177
Query: 498 RVIHRDFKASNVLLEDDFTPKVSDFGLARE-------ATEGSQHISTRVMGTFGYVAPEY 550
+HRD N L+ K+ DFG++R+ G + R M PE
Sbjct: 178 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM------PPES 231
Query: 551 AMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
+ +SDV+S+GVVL E+ + G++P
Sbjct: 232 ILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 35/225 (15%)
Query: 380 KRILGEGGFGCVYHGVMDNG------TEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL 433
KR LGEG FG V+ N VAVK L ++F E E+L+ L H ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHL------------HGVDKNRGPLDWEARMKIA 481
VK G+C +G +V+E + +G + L + +G L + IA
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 482 LGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE-------ATEGSQH 534
A G+ YL ++ +HRD N L+ + K+ DFG++R+ G
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
+ R M PE M +SDV+S+GV+L E+ + G++P
Sbjct: 197 LPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 381 RILGEGGFGCVYHGVMDN--GTEVAVKLLTRNNQNGDREFIA----EVEMLSRLHHRNLV 434
LG GG VY D +VA+K + E + EV S+L H+N+V
Sbjct: 17 DKLGGGGMSTVYLAE-DTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+I + E LV E + ++ ++ + GPL + + G+ + H+
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG 554
R++HRD K N+L++ + T K+ DFG+A+ +E S + V+GT Y +PE A
Sbjct: 131 ---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 555 HLLVKSDVYSYGVVLLELLSGRKP 578
+D+YS G+VL E+L G P
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 65/218 (29%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 380 KRILGEGGFGCVYHGVMDNG------TEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRN 432
R LG G FG VY G + +VAVK L D +F+ E ++S+ +H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLH---GVDKNRGPLDWEARMKIALGAARGLA 489
+V+ IG+ ++ R ++ EL+ G ++S L L + +A A G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 490 YLHEDSNPRVIHRDFKASNVLLE---DDFTPKVSDFGLAREATEGSQHISTRVMGTFGYV 546
YL IHRD A N LL K+ DFG+AR+ S G +
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----SYYRKGGCAML 207
Query: 547 -----APEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
PE M G K+D +S+GV+L E+ S G P
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 27/233 (11%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL 433
+ + + LGEGGF V + +G A+K + + Q E E +M +H N+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 434 VKLIGICIEGRTR----CLVYELVHNGSVESHLHGVDKNRGPLDWEAR-MKIALGAARGL 488
++L+ C+ R L+ G++ + + + L E + + + LG RGL
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT-EDQILWLLLGICRGL 147
Query: 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM-------- 540
+H HRD K +N+LL D+ P + D G +A + +
Sbjct: 148 EAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 541 GTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ 587
T Y APE + + ++DV+S G VL ++ G P DM +G
Sbjct: 205 CTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 65/226 (28%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 380 KRILGEGGFGCVYHGVMDNG------TEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRN 432
LGE FG VY G + VA+K L + R EF E + +RL H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHL------------HGVDKNRGPLDWEARMKI 480
+V L+G+ + + +++ +G + L + L+ + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 481 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE-------ATEGSQ 533
A G+ YL S+ V+H+D NVL+ D K+SD GL RE G+
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
+ R M APE M G + SD++SYGVVL E+ S G +P
Sbjct: 191 LLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 380 KRILGEGGFGCVYHGVMDNG---TEVAVKLLTRNNQNGDR-EFIAEVEMLSRL-HHRNLV 434
+ ++GEG FG V + + A+K + D +F E+E+L +L HH N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHL------------HGVDKNRGPLDWEARMKIAL 482
L+G C L E +G++ L + L + + A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 483 GAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRV--- 539
ARG+ YL S + IHRD A N+L+ +++ K++DFGL+R + R+
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 206
Query: 540 -MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
M A E SDV+SYGV+L E++S G P
Sbjct: 207 WM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 61/268 (22%), Positives = 101/268 (37%), Gaps = 34/268 (12%)
Query: 382 ILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGD--REFIAEVEMLSRLHHRNLVKLIG 438
+G G F VY G+ + EVA L + F E EML L H N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 439 ICIEGRTR----CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
LV EL+ +G+++++L K + + +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHT- 147
Query: 495 SNPRVIHRDFKASNVLLE-DDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT 553
P +IHRD K N+ + + K+ D GL AT + V+GT ++APE
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGL---ATLKRASFAKAVIGTPEFMAPEMYEE 204
Query: 554 GHLLVKSDVYSYGVVLLELLSGRKP-VDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612
+ DVY++G+ +LE+ + P + VT +++ P +
Sbjct: 205 KYDE-SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----PASFDKVAIPEV 259
Query: 613 AGSYDFDDMAKVAAIASMCVHPEVTHRP 640
+ C+ R
Sbjct: 260 K---EI---------IEGCIRQNKDERY 275
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 64/223 (28%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNG------TEVAVKLLTRNNQNGDR-EFIAEVEMLSR 427
+ + R LG G FG VY G + +VAVK L D +F+ E ++S+
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 428 LHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLH---GVDKNRGPLDWEARMKIALGA 484
+H+N+V+ IG+ ++ R ++ EL+ G ++S L L + +A
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 485 ARGLAYLHEDSNPRVIHRDFKASNVLLE---DDFTPKVSDFGLAREATEGSQHISTRVMG 541
A G YL IHRD A N LL K+ DFG+AR+ G
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----GYYRKG 243
Query: 542 TFGYV-----APEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
+ PE M G K+D +S+GV+L E+ S G P
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 35/225 (15%)
Query: 380 KRILGEGGFGCVYHGVM------DNGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRL-HHR 431
+ LG G FG V D +VAVK+L ++ ++E++++S L H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHL----------HGVDKNRGPLDWEARMKIA 481
N+V L+G C G ++ E G + + L + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 482 LGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIST---- 537
A+G+A+L ++ IHRD A NVLL + K+ DFGLAR+ S +I
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 538 ---RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
+ M APE V+SDV+SYG++L E+ S G P
Sbjct: 228 LPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 59/234 (25%), Positives = 102/234 (43%), Gaps = 39/234 (16%)
Query: 375 EKFSSKRILGEGGFGCVYHGV--------MDNGTEVAVKLLTRNNQNGDR-EFIAEVEML 425
+K + + LGEG FG V VAVK+L + D + ++E+EM+
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 426 SRL-HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHL------------HGVDKNRGPL 472
+ H+N++ L+G C + ++ E G++ +L +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 473 DWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532
++ + ARG+ YL ++ + IHRD A NVL+ ++ K++DFGLAR+
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 533 QHISTRV-------MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
+ T M APE +SDV+S+GV++ E+ + G P
Sbjct: 212 YYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 40/232 (17%)
Query: 380 KRILGEGGFGCVYHGVMDNG------TEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRN 432
R +GEG FG V+ T VAVK+L + +F E +++ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHL--------------------HGVDKNRGPL 472
+VKL+G+C G+ CL++E + G + L PL
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 473 DWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532
++ IA A G+AYL S + +HRD N L+ ++ K++DFGL+R
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 533 QHISTRVMGTFGYV-----APEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
+ + PE +SDV++YGVVL E+ S G +P
Sbjct: 229 YY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-35
Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 44/234 (18%)
Query: 380 KRILGEGGFGCVYHGVM------DNGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRLHHRN 432
+ LGEG FG V T VAVK+L N + + ++E +L +++H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHL--------------------HGVDKNRGPL 472
++KL G C + L+ E GS+ L + L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 473 DWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532
+ A ++G+ YL + +++HRD A N+L+ + K+SDFGL+R+ E
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 533 QHIST-------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
++ + M A E +SDV+S+GV+L E+++ G P
Sbjct: 205 SYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 381 RILGEGGFGCVYHGVMDN--GTEVAVKLLTRNNQNGDREFIA----EVEMLSRLHHRNLV 434
ILG GG V+ D +VAVK+L R + D F E + + L+H +V
Sbjct: 18 EILGFGGMSEVHLAR-DLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 435 KL--IGICIEGRTRC--LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY 490
+ G +V E V ++ +H GP+ + +++ A + L +
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNF 131
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI--STRVMGTFGYVAP 548
H++ +IHRD K +N+++ KV DFG+AR + + + V+GT Y++P
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 549 EYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
E A + +SDVYS G VL E+L+G P
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 18/213 (8%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRN--NQNGDRE-FIAEVEMLSRLHH 430
++ R LG+GGF + D A K++ ++ + RE E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 431 RNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLD-WEARMKIALGAARGL 488
+++V G E +V EL S+ K R L EAR G
Sbjct: 75 QHVVGFHG-FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEAR-YYLRQIVLGC 128
Query: 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAP 548
YLH + RVIHRD K N+ L +D K+ DFGLA + + + GT Y+AP
Sbjct: 129 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAP 184
Query: 549 EYAM-TGHLLVKSDVYSYGVVLLELLSGRKPVD 580
E GH + DV+S G ++ LL G+ P +
Sbjct: 185 EVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFE 216
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 63/211 (29%), Positives = 92/211 (43%), Gaps = 18/211 (8%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRN--NQNGDRE-FIAEVEMLSRLHH 430
++ R LG+GGF + D A K++ ++ + RE E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 431 RNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLD-WEARMKIALGAARGL 488
+++V G E +V EL S+ K R L EAR G
Sbjct: 101 QHVVGFHG-FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEAR-YYLRQIVLGC 154
Query: 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAP 548
YLH + RVIHRD K N+ L +D K+ DFGLA + + + GT Y+AP
Sbjct: 155 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAP 210
Query: 549 EYAM-TGHLLVKSDVYSYGVVLLELLSGRKP 578
E GH + DV+S G ++ LL G+ P
Sbjct: 211 EVLSKKGHSF-EVDVWSIGCIMYTLLVGKPP 240
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 67/234 (28%), Positives = 103/234 (44%), Gaps = 39/234 (16%)
Query: 375 EKFSSKRILGEGGFGCVYHGV------MDNGTEVAVKLLTRNNQNGDR-EFIAEVEMLSR 427
+ S + LG G FG V D VAVK+L + +R ++E+++LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 428 L-HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHL--------------HGVDKNRGPL 472
L +H N+V L+G C G ++ E G + + L ++ + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 473 DWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532
D E + + A+G+A+L ++ IHRD A N+LL K+ DFGLAR+ S
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 533 QHIST-------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
++ + M APE +SDV+SYG+ L EL S G P
Sbjct: 200 NYVVKGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 64/234 (27%), Positives = 106/234 (45%), Gaps = 39/234 (16%)
Query: 375 EKFSSKRILGEGGFGCVYHGV--------MDNGTEVAVKLLTRNNQNGDR-EFIAEVEML 425
++ + LGEG FG V + T+VAVK+L + D + I+E+EM+
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 426 SRL-HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHL------------HGVDKNRGPL 472
+ H+N++ L+G C + ++ E G++ +L + L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 473 DWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532
+ + A ARG+ YL ++ + IHRD A NVL+ +D K++DFGLAR+
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 533 QHIST-------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
+ T + M APE +SDV+S+GV+L E+ + G P
Sbjct: 246 YYKKTTNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 38/228 (16%)
Query: 380 KRILGEGGFGCVYHGVMDN------GTEVAVKLLTRNNQNGDR-EFIAEVEMLSRL-HHR 431
+ LG G FG V VAVK+L + + ++E+++L + HH
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 432 NLVKLIGIC-IEGRTRCLVYELVHNGSVESHL------------HGVDKNRGPLDWEARM 478
N+V L+G C G ++ E G++ ++L D + L E +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 479 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIST- 537
+ A+G+ +L ++ + IHRD A N+LL + K+ DFGLAR+ + ++
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 538 ------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
+ M APE ++SDV+S+GV+L E+ S G P
Sbjct: 209 DARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-34
Identities = 49/242 (20%), Positives = 89/242 (36%), Gaps = 30/242 (12%)
Query: 381 RILGEGGFGCVYHGVMD---NGTEVAVK-LLTRNNQNGDREFIAEVEMLSRLHHRNLVKL 436
+ GG G +Y + D NG V +K L+ + +AE + L+ + H ++V++
Sbjct: 86 GCIAHGGLGWIYLAL-DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 437 IGICIEGRTRC-----LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
+V E V S++ L + L L+YL
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPALSYL 198
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA 551
H +++ D K N++L ++ K+ D G + GT G+ APE
Sbjct: 199 HSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-----LYGTPGFQAPEIV 249
Query: 552 MTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611
V +D+Y+ G L L + G + P+L T + +L+ +
Sbjct: 250 -RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG----LPEDDPVLKTYDSYGRLLRRA 304
Query: 612 LA 613
+
Sbjct: 305 ID 306
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-34
Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 39/229 (17%)
Query: 380 KRILGEGGFGCVYHGV--------MDNGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRL-H 429
+ LGEG FG V VAVK+L + D + ++E+EM+ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHL------------HGVDKNRGPLDWEAR 477
H+N++ L+G C + ++ E G++ +L + ++
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 478 MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS---QH 534
+ ARG+ YL ++ + IHRD A NVL+ ++ K++DFGLAR+ +
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 535 ISTRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
+ R+ M APE +SDV+S+GV++ E+ + G P
Sbjct: 263 TNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 380 KRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIG 438
+ +LG+G +G VY G + N +A+K + + + E+ + L H+N+V+ +G
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 439 ICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPL-DWEARMKI----ALGAARGLAYLHE 493
E + E V GS+ + L GPL D E + L GL YLH+
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLR---SKWGPLKDNEQTIGFYTKQIL---EGLKYLHD 140
Query: 494 DSNPRVIHRDFKASNVLL-EDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE--- 549
+ +++HRD K NVL+ K+SDFG ++ + T GT Y+APE
Sbjct: 141 N---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIID 196
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLSGRKP-VDMSQPQ 585
G+ +D++S G ++E+ +G+ P ++ +PQ
Sbjct: 197 KGPRGYGK-AADIWSLGCTIIEMATGKPPFYELGEPQ 232
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-34
Identities = 53/204 (25%), Positives = 81/204 (39%), Gaps = 15/204 (7%)
Query: 381 RILGEGGFGCVYHGVMDN--GTEVAVKLLTRNNQNGDREFIA----EVEMLSRLHHRNLV 434
R++G GG G VY D VA+KL+ + D F E RL ++V
Sbjct: 40 RLVGRGGMGDVYEAE-DTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+ + L++ + + L + +GPL + I L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG 554
HRD K N+L+ D + DFG+A T+ +GT Y+APE
Sbjct: 154 ---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 555 HLLVKSDVYSYGVVLLELLSGRKP 578
H ++D+Y+ VL E L+G P
Sbjct: 211 HATYRADIYALTCVLYECLTGSPP 234
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 55/234 (23%), Positives = 93/234 (39%), Gaps = 25/234 (10%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA-EVEMLSRLHHRN 432
+ ILG+G V+ G G A+K+ + + E E+L +L+H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 433 LVKLIGICIEGRTR---CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLA 489
+VKL I E T L+ E GS+ + L G + E + G+
Sbjct: 69 IVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMN 126
Query: 490 YLHEDSNPRVIHRDFKASNVLL----EDDFTPKVSDFGLAREATEGSQHISTRVMGTFGY 545
+L E+ ++HR+ K N++ + K++DFG ARE + Q + GT Y
Sbjct: 127 HLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSLY-GTEEY 181
Query: 546 VAPEYAMTGHLLV--------KSDVYSYGVVLLELLSGRKP-VDMSQPQGQENL 590
+ P+ L D++S GV +G P P+ + +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 381 RILGEGGFGCVYHGV-MDNGTEVAVKLLTRNN--QNGDREFIA-EVEMLSRLHHRNLVKL 436
+LG+G F VY + G EVA+K++ + + G + + EV++ +L H ++++L
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 437 IGICIEGRTRC-LVYELVHNGSVESHLHGVDKNRGPLD-WEARMKIALGAARGLAYLHED 494
E LV E+ HNG + +L P EAR + G+ YLH
Sbjct: 77 YN-YFEDSNYVYLVLEMCHNGEMNRYLK---NRVKPFSENEARHFMH-QIITGMLYLHSH 131
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM-T 553
++HRD SN+LL + K++DFGLA + + T + GT Y++PE A +
Sbjct: 132 ---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRS 187
Query: 554 GHLLVKSDVYSYGVVLLELLSGRKP 578
H L +SDV+S G + LL GR P
Sbjct: 188 AHGL-ESDVWSLGCMFYTLLIGRPP 211
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 48/213 (22%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGD--REFIAEVEMLSRLHHR 431
EK+ + +GEG FG ++G + +K + + + E EV +L+ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
N+V+ E + +V + G + ++ + + + + L ++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRIN--AQKGVLFQEDQILDWFVQICLALKHV 141
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE-- 549
H+ +++HRD K+ N+ L D T ++ DFG+AR + + GT Y++PE
Sbjct: 142 HD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEIC 197
Query: 550 ----YAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
Y KSD+++ G VL EL + +
Sbjct: 198 ENKPYNN------KSDIWALGCVLYELCTLKHA 224
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVK---LLTRNNQNGDREFIAEVEMLSRLHH 430
F ++ +G G F VY + +G VA+K + + + I E+++L +L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY 490
N++K IE +V EL G + + K + + K + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE- 549
+H RV+HRD K +NV + K+ D GL R + + + V GT Y++PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 550 -----YAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
Y KSD++S G +L E+ + + P
Sbjct: 208 IHENGYNF------KSDIWSLGCLLYEMAALQSP 235
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 47/220 (21%), Positives = 87/220 (39%), Gaps = 25/220 (11%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGD--REFIAEVEMLSRL--HH 430
+S + +G GG V+ + + A+K + + + E+ L++L H
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY 490
+++L I + +V E N + S L K + +D R +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHT 123
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR-VMGTFGYVAPE 549
+H+ ++H D K +N L+ D K+ DFG+A + + + +GT Y+ PE
Sbjct: 124 IHQH---GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 550 ------YAMTGHLLV-----KSDVYSYGVVLLELLSGRKP 578
+ KSDV+S G +L + G+ P
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 57/218 (26%), Positives = 88/218 (40%), Gaps = 20/218 (9%)
Query: 368 SDLEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLS 426
+ + + + +G G FG V+ G + AVK + + E+ +
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACA 105
Query: 427 RLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAAR 486
L +V L G EG + EL+ GS+ + K G L + + A
Sbjct: 106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALE 161
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDFTP-KVSDFGLAREATEGSQHISTR----VMG 541
GL YLH R++H D KA NVLL D + + DFG A S + G
Sbjct: 162 GLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 542 TFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLSGRKP 578
T ++APE M K D++S ++L +L+G P
Sbjct: 219 TETHMAPEVVMGKPCDA-KVDIWSSCCMMLHMLNGCHP 255
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 44/234 (18%)
Query: 380 KRILGEGGFGCVYHGV------MDNGTEVAVKLLTRNNQNGDR-EFIAEVEMLSRL-HHR 431
++LG G FG V + +VAVK+L + +R ++E++M+++L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHL-------------------HGVDKNRGPL 472
N+V L+G C L++E G + ++L +++ L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 473 DWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532
+E + A A+G+ +L +HRD A NVL+ K+ DFGLAR+ S
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 533 QHIST-------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKP 578
++ + M APE G +KSDV+SYG++L E+ S G P
Sbjct: 227 NYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 55/234 (23%), Positives = 93/234 (39%), Gaps = 25/234 (10%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA-EVEMLSRLHHRN 432
+ ILG+G V+ G G A+K+ + + E E+L +L+H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 433 LVKLIGICIEGRTR---CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLA 489
+VKL I E T L+ E GS+ + L G + E + G+
Sbjct: 69 IVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMN 126
Query: 490 YLHEDSNPRVIHRDFKASNVLL----EDDFTPKVSDFGLAREATEGSQHISTRVMGTFGY 545
+L E+ ++HR+ K N++ + K++DFG ARE + Q + GT Y
Sbjct: 127 HLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSLY-GTEEY 181
Query: 546 VAPEYAMTGHLLV--------KSDVYSYGVVLLELLSGRKP-VDMSQPQGQENL 590
+ P+ L D++S GV +G P P+ + +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 46/220 (20%), Positives = 86/220 (39%), Gaps = 25/220 (11%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGD--REFIAEVEMLSRLHHRN 432
+S + +G GG V+ + + A+K + + + E+ L++L +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 433 L--VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY 490
++L I + +V E N + S L K + +D R +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHT 142
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR-VMGTFGYVAPE 549
+H+ ++H D K +N L+ D K+ DFG+A + + + +GT Y+ PE
Sbjct: 143 IHQH---GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 550 ------YAMTGHLLV-----KSDVYSYGVVLLELLSGRKP 578
+ KSDV+S G +L + G+ P
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 28/221 (12%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL 433
F ++G GGFG V+ +G +K + NN+ +RE V+ L++L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNI 66
Query: 434 VKLIG----------------ICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEAR 477
V G + + + E G++E + + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLA 124
Query: 478 MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIST 537
+++ +G+ Y+H ++I+RD K SN+ L D K+ DFGL + T
Sbjct: 125 LELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--T 179
Query: 538 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
R GT Y++PE + + D+Y+ G++L ELL
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-32
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 380 KRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA-EVEMLSRLHHRNLVKLI 437
K LG GGFG V + D G +VA+K + +RE E++++ +L+H N+V
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 438 GI------CIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIA-LGAARGLAY 490
+ L E G + +L+ + G + R ++ + +A L Y
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA--LRY 136
Query: 491 LHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVA 547
LHE+ R+IHRD K N++L K+ D G A+E +G + V GT Y+A
Sbjct: 137 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTEFV-GTLQYLA 191
Query: 548 PEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVD 580
PE V D +S+G + E ++G +P
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 20/217 (9%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQN-GDREFI-AEVEMLSRLHHR 431
E + +G G +G +G + K L + +++ + +EV +L L H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 432 NLVKLIGICIEGRTR--CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLA 489
N+V+ I+ +V E G + S + K R LD E +++ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 490 YLHE--DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVA 547
H D V+HRD K +NV L+ K+ DFGLAR + T V GT Y++
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 548 PE------YAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
PE Y KSD++S G +L EL + P
Sbjct: 185 PEQMNRMSYNE------KSDIWSLGCLLYELCALMPP 215
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 52/231 (22%), Positives = 93/231 (40%), Gaps = 37/231 (16%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN 432
F +LG+G FG V + A+K + + ++EV +L+ L+H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 433 LVKLIGICIEGRTR-------------CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK 479
+V+ +E R + E NG++ +H + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH---SENLNQQRDEYWR 120
Query: 480 IALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR------------- 526
+ L+Y+H +IHRD K N+ +++ K+ DFGLA+
Sbjct: 121 LFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 527 -EATEGSQHISTRVMGTFGYVAPE-YAMTGHLLVKSDVYSYGVVLLELLSG 575
S ++++ + GT YVA E TGH K D+YS G++ E++
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-31
Identities = 44/214 (20%), Positives = 83/214 (38%), Gaps = 25/214 (11%)
Query: 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGD--REFIAEVEMLSRLHHRNL--VKL 436
+ +G GG V+ + + A+K + + + E+ L++L + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 437 IGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSN 496
I + +V E N + S L K + +D R + +H+
Sbjct: 122 YDYEITDQYIYMVMECG-NIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH-- 174
Query: 497 PRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR-VMGTFGYVAPE------ 549
++H D K +N L+ D K+ DFG+A + + + +G Y+ PE
Sbjct: 175 -GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 550 YAMTGHLLV-----KSDVYSYGVVLLELLSGRKP 578
+ KSDV+S G +L + G+ P
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-31
Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 23/215 (10%)
Query: 376 KFSSKRILGEGGFGCVYHGVMDNGTEVAVK-LLTRNNQNGDREFIAEVEMLSRL-HHRNL 433
F K +LG G G + + M + +VAVK +L DR EV++L H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR----EVQLLRESDEHPNV 80
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
++ + + + + EL +++ ++ K+ L E + GLA+LH
Sbjct: 81 IRYFCTEKDRQFQYIAIELC-AATLQEYV--EQKDFAHLGLEPI-TLLQQTTSGLAHLHS 136
Query: 494 DSNPRVIHRDFKASNVLLED-----DFTPKVSDFGLAREATEGSQHISTR--VMGTFGYV 546
++HRD K N+L+ +SDFGL ++ G S R V GT G++
Sbjct: 137 L---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 547 APEY---AMTGHLLVKSDVYSYGVVLLELLSGRKP 578
APE + D++S G V ++S
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 32/255 (12%), Positives = 62/255 (24%), Gaps = 41/255 (16%)
Query: 368 SDLEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLT---RNNQNGDREFIAEVE 423
S L + K L G V+ ++ + A+K+ T N+++
Sbjct: 55 SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATF 114
Query: 424 MLSRLHHRNLVKLIGIC--------------------------IEGRTRCLVYELVH--N 455
+RL + + L+
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDL 174
Query: 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF 515
+ S L V RG A + R A L ++H F N+ + D
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDG 231
Query: 516 TPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLV--KSDVYSYGVVLLELL 573
+ D + Y E+ + + G+ + +
Sbjct: 232 RLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
Query: 574 SGRKPVDMSQPQGQE 588
P + P +
Sbjct: 288 CLFLPFGLVTPGIKG 302
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 54/224 (24%), Positives = 86/224 (38%), Gaps = 29/224 (12%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDRE-FIAEVEMLSRLHHRN 432
F + LG GGFG V+ + A+K + N+ RE + EV+ L++L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 433 LVKLIGICIEGRTR------------CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKI 480
+V+ +E T + +L ++ + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENL-KDWMNGRCTIEERERSVCLHI 123
Query: 481 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE-----------AT 529
L A + +LH ++HRD K SN+ D KV DFGL
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL 573
+ T +GT Y++PE K D++S G++L ELL
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 66/212 (31%), Positives = 92/212 (43%), Gaps = 22/212 (10%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNN--QNGDREFI-AEVEMLSRLHH 430
E F R LG+G FG VY + +A+K+L + + G + EVE+ S L H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 431 RNLVKLIGICIEGRTRC-LVYELVHNGSVESHLHGVDKNRGPLD-WEARMKIALGAARGL 488
N+++L G TR L+ E G+V L + D I A L
Sbjct: 69 PNILRLYG-YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITE-LANAL 122
Query: 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM-GTFGYVA 547
+Y H RVIHRD K N+LL K++DFG + A + GT Y+
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTDLCGTLDYLP 175
Query: 548 PEYAMT-GHLLVKSDVYSYGVVLLELLSGRKP 578
PE H K D++S GV+ E L G+ P
Sbjct: 176 PEMIEGRMHDE-KVDLWSLGVLCYEFLVGKPP 206
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-29
Identities = 69/270 (25%), Positives = 113/270 (41%), Gaps = 42/270 (15%)
Query: 360 LSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNG--DR 416
+ F S +E + + LG G +G V E A+K++ + + + +
Sbjct: 22 ATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNS 81
Query: 417 EFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLD-WE 475
+ + EV +L L H N++KL + R LV E G + + +R + +
Sbjct: 82 KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI----IHRMKFNEVD 137
Query: 476 AR--MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREATE 530
A +K L + YLH+ + ++HRD K N+LL E D K+ DFGL+
Sbjct: 138 AAVIIKQVLSG---VTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191
Query: 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENL 590
+ + R+ GT Y+APE + K DV+S GV+L LL+G P
Sbjct: 192 Q-KKMKERL-GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPF----------- 237
Query: 591 VTWARPLLTTREGLEQLVDPSLAGSYDFDD 620
+ T + + + V G Y FD
Sbjct: 238 --GGQ----TDQEILRKV---EKGKYTFDS 258
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 25/226 (11%)
Query: 376 KFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNL 433
+ +R+L EGGF VY + +G E A+K L N + +R I EV + +L H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 434 VKLIGICI-------EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAAR 486
V+ G+ L+ + G + L + ++RGPL + +KI R
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM-ESRGPLSCDTVLKIFYQTCR 147
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM------ 540
+ ++H P +IHRD K N+LL + T K+ DFG A + + +
Sbjct: 148 AVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 541 -----GTFGYVAPE-YAMTGHLLV--KSDVYSYGVVLLELLSGRKP 578
T Y PE + + + K D+++ G +L L + P
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 44/227 (19%), Positives = 85/227 (37%), Gaps = 41/227 (18%)
Query: 381 RILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIA-----------------EVE 423
R L +G F + + A+K ++ R+F E++
Sbjct: 37 RTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 424 MLSRLHHRNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIAL 482
+++ + + + GI I ++YE + N S+ + LD I +
Sbjct: 96 IITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFD----EYFFVLDKNYTCFIPI 150
Query: 483 GAAR--------GLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534
+ +Y+H + + HRD K SN+L++ + K+SDFG + +
Sbjct: 151 QVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--K 206
Query: 535 ISTRVMGTFGYVAPEYAMTGHLLV---KSDVYSYGVVLLELLSGRKP 578
I GT+ ++ PE + K D++S G+ L + P
Sbjct: 207 IKG-SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-29
Identities = 69/278 (24%), Positives = 117/278 (42%), Gaps = 43/278 (15%)
Query: 353 STMATCILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNN 411
S M + F ++++ +R+LG+G FG V G E AVK++++
Sbjct: 4 SMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ 63
Query: 412 QNG--DREFIA-EVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKN 468
D+E + EV++L +L H N++KL + LV E+ G + + +
Sbjct: 64 VKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI----IS 119
Query: 469 RGPLD-WEAR--MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDF 522
R +A ++ L + Y+H++ ++HRD K N+LL D ++ DF
Sbjct: 120 RKRFSEVDAARIIRQVLSG---ITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDF 173
Query: 523 GLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMS 582
GL+ + + ++ GT Y+APE + G K DV+S GV+L LLSG P
Sbjct: 174 GLSTHFEAS-KKMKDKI-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPF--- 227
Query: 583 QPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDD 620
+ + V G Y F+
Sbjct: 228 ----------NGA----NEYDILKKV---EKGKYTFEL 248
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 26/236 (11%), Positives = 63/236 (26%), Gaps = 41/236 (17%)
Query: 381 RILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDRE---------------------- 417
+LG+ + G V + +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 418 ------FIAEVEMLSRLHHRNLVKLI--GICIEGRTRCLVYELVH--NGSVESHLHGVDK 467
FI +++ + ++++ + +R +Y + + L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 468 NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527
L AR+++ L R LA LH ++H + +++L+ ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 528 ATEGSQHISTRVMGTFGYVAPE-----YAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
+ R A + D ++ G+ + + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 52/209 (24%), Positives = 79/209 (37%), Gaps = 16/209 (7%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGD--REFIAEVEMLSRL-HH 430
+ F LG G +G V+ ++G AVK + +AEV ++ H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEAR-MKIALGAARGLA 489
V+L EG L EL S++ H L EA+ LA
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCE---AWGASLP-EAQVWGYLRDTLLALA 171
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549
+LH ++H D K +N+ L K+ DFGL E G Y+APE
Sbjct: 172 HLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPE 226
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
+ +DV+S G+ +LE+ +
Sbjct: 227 LLQGSYGT-AADVFSLGLTILEVACNMEL 254
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 71/256 (27%), Positives = 110/256 (42%), Gaps = 42/256 (16%)
Query: 374 TEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVK-LLTRNNQNGDRE-FIAEVEMLSRLHH 430
E+++ +LG+G FG V E AVK + + +N D + EVE+L +L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLD-WEAR--MKIALGAARG 487
N++KL I + + +V EL G + + R +A +K
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEI----IKRKRFSEHDAARIIKQVFSG--- 133
Query: 488 LAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREATEGSQHISTRVMGTFG 544
+ Y+H+ ++HRD K N+LL E D K+ DFGL+ + + R+ GT
Sbjct: 134 ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAY 188
Query: 545 YVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604
Y+APE + G K DV+S GV+L LLSG P + + +
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPF-------------YGK----NEYDI 230
Query: 605 EQLVDPSLAGSYDFDD 620
+ V G Y FD
Sbjct: 231 LKRV---ETGKYAFDL 243
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-28
Identities = 35/231 (15%), Positives = 71/231 (30%), Gaps = 24/231 (10%)
Query: 368 SDLEKATEKFSSKRILGEGGFGCVYHGV------MDNGTEVAVKLLTRNNQNGDREFIAE 421
++ + ++ +LGEG F VY N + +K+ N
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 422 VEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHL-HGVDKNRGPLDWEARMKI 480
+E L +K + LV EL G++ + + + + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 481 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP-----------KVSDFGLAREAT 529
A+ + +H+ +IH D K N +L + F + D G + +
Sbjct: 178 AMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 530 --EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
+ + T G+ E + D + + +L G
Sbjct: 235 LFPKGTIFTAKC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 63/255 (24%), Positives = 98/255 (38%), Gaps = 37/255 (14%)
Query: 374 TEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIA-EVEMLSRLHHR 431
+ F KR LG G FG V+ +G E +K + ++ E I E+E+L L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLD-WEAR--MKIALGAARGL 488
N++K+ + + +V E G + + L MK + A L
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---L 137
Query: 489 AYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREATEGSQHISTRVMGTFGY 545
AY H V+H+D K N+L K+ DFGLA +H + GT Y
Sbjct: 138 AYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAA-GTALY 192
Query: 546 VAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLE 605
+APE + K D++S GVV+ LL+G P + E ++
Sbjct: 193 MAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPF-------------TGT----SLEEVQ 234
Query: 606 QLVDPSLAGSYDFDD 620
Q ++
Sbjct: 235 QKA---TYKEPNYAV 246
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNN--QNGDREFIA-EVEMLSRLHH 430
+ F R LG+G FG VY N +A+K+L ++ + G + E+E+ S L H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 431 RNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLD-WEARMKIALGAARGL 488
N++++ R R L+ E G + L + G D + + A L
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEE-LADAL 127
Query: 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAP 548
Y HE +VIHRD K N+L+ K++DFG + A + GT Y+ P
Sbjct: 128 HYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPP 181
Query: 549 EYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
E K D++ GV+ E L G P
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 33/301 (10%), Positives = 83/301 (27%), Gaps = 52/301 (17%)
Query: 322 GPAFASSINKRSGIGSILSSSIASSTSVSLMSTMATCILSVKTFALSDLEKATEKFSSKR 381
G + R ++ ++S ++ + + + S+L +
Sbjct: 20 GDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGT 79
Query: 382 ILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDRE----------------------- 417
+LG+ + G V + +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 418 -----FIAEVEMLSRLHHRNLVKLIGIC--IEGRTRCLVYELVH--NGSVESHLHGVDKN 468
FI +++ + ++++ + +R +Y + + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 469 RGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528
L AR+++ L R LA LH ++H + +++L+ ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 529 TEGSQHISTRVMGTFGYVAPEYAMTGHLLV-----------KSDVYSYGVVLLELLSGRK 577
+ G+ PE + D ++ G+V+ +
Sbjct: 257 GA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 578 P 578
P
Sbjct: 312 P 312
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-28
Identities = 69/275 (25%), Positives = 104/275 (37%), Gaps = 57/275 (20%)
Query: 370 LEKATEKFSSK----RILGEGGFGCVYHGVM-DNGTEVAVK------------LLTRNNQ 412
+ K K R LG G +G V + +E A+K N
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 413 NGDREFIA-EVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGP 471
E I E+ +L L H N++KL + + + LV E G + + NR
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI----INRHK 142
Query: 472 LD-WEAR--MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLA 525
D +A MK L + YLH+ ++HRD K N+LL K+ DFGL+
Sbjct: 143 FDECDAANIMKQILSG---ICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLS 196
Query: 526 REATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQ 585
++ + R+ GT Y+APE + K DV+S GV++ LL G P
Sbjct: 197 SFFSKD-YKLRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPF------ 247
Query: 586 GQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDD 620
+ + + + V G Y FD
Sbjct: 248 -------GGQ----NDQDIIKKV---EKGKYYFDF 268
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-28
Identities = 57/233 (24%), Positives = 91/233 (39%), Gaps = 38/233 (16%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVK-LLTRNNQNGDREFIAEVEMLSRL-HHRN 432
S++ILG G G V G VAVK +L E+++L+ H N
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM----EIKLLTESDDHPN 70
Query: 433 LVKLIGICIEGRTRCLVYELVHNGS----VESHLHGVDKNRGPLDWEARMKIALGAARGL 488
+++ R + EL N + VES + + ++ + A G+
Sbjct: 71 VIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGV 128
Query: 489 AYLHEDSNPRVIHRDFKASNVLL-------------EDDFTPKVSDFGLAREATEGSQHI 535
A+LH ++IHRD K N+L+ ++ +SDFGL ++ G
Sbjct: 129 AHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 536 STRVM---GTFGYVAPEYAMTGHLLV-------KSDVYSYGVVLLELLSGRKP 578
T + GT G+ APE + L D++S G V +LS K
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 61/215 (28%), Positives = 89/215 (41%), Gaps = 33/215 (15%)
Query: 381 RILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA-EVEMLSRLHHRNLVKLIG 438
+ LGEG +G V V VAVK++ E I E+ + L+H N+VK G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 439 ICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK----IALGAARGLAYLHE 493
L E G + + P +A+ +A G+ YLH
Sbjct: 73 H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEP-DAQRFFHQLMA-----GVVYLH- 122
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ--HISTRVMGTFGYVAPE-- 549
+ HRD K N+LL++ K+SDFGLA ++ ++ GT YVAPE
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL 179
Query: 550 ----YAMTGHLLVKSDVYSYGVVLLELLSGRKPVD 580
+ DV+S G+VL +L+G P D
Sbjct: 180 KRREFH--AE---PVDVWSCGIVLTAMLAGELPWD 209
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 63/282 (22%), Positives = 111/282 (39%), Gaps = 18/282 (6%)
Query: 352 MSTMATCILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRN 410
+ T V D EK +E LG G G V+ +G +A KL+
Sbjct: 17 LEAFLTQKQKVGELKDDDFEKISE-------LGAGNGGVVFKVSHKPSGLVMARKLIHLE 69
Query: 411 NQNGDREFIA-EVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNR 469
+ R I E+++L + +V G + E + GS++ L K
Sbjct: 70 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKA 125
Query: 470 GPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529
G + + K+++ +GL YL E ++HRD K SN+L+ K+ DFG++ +
Sbjct: 126 GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183
Query: 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN 589
+ ++ +GT Y++PE H V+SD++S G+ L+E+ GR P+ + E
Sbjct: 184 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240
Query: 590 LVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMC 631
+ + D +A +
Sbjct: 241 MFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLD 282
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 62/259 (23%), Positives = 101/259 (38%), Gaps = 44/259 (16%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH 429
+ ++ + +G G +G V V A K + + F E+E++ L
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDK--NRGPLD-WEAR--MKIALGA 484
H N+++L + LV EL G + ++ ++ +A MK L A
Sbjct: 65 HPNIIRLYETFEDNTDIYLVMELCTGGEL------FERVVHKRVFRESDAARIMKDVLSA 118
Query: 485 ARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREATEGSQHISTRVMG 541
+AY H+ V HRD K N L D K+ DFGLA G + + T+V G
Sbjct: 119 ---VAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKV-G 170
Query: 542 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTR 601
T YV+P+ + G + D +S GV++ LL G P A T
Sbjct: 171 TPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPF-------------SAP----TD 212
Query: 602 EGLEQLVDPSLAGSYDFDD 620
+ + G++ F +
Sbjct: 213 SEVMLKI---REGTFTFPE 228
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN 432
E + LG+G FG VY + G A K++ ++ ++I E+E+L+ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
+VKL+G ++ E G+V++ + + L + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAI---MLELDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM 552
R+IHRD KA NVL+ + +++DFG++ + + Q + +GT ++APE M
Sbjct: 135 SK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVM 190
Query: 553 TGHLL-----VKSDVYSYGVVLLELLSGRKP 578
+ K+D++S G+ L+E+ P
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 26/215 (12%)
Query: 381 RILGEGGFGCVYHGV-MDNGTEVAVKLLTR----NNQNGDREFIAEVEMLSRLHHRNLVK 435
+LGEG +G V + + AVK+L + NG+ E+++L RL H+N+++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 436 LIGICIEGRTR---CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK----IALGAARGL 488
L+ + + + +V E G E L V + R P +A I GL
Sbjct: 71 LVDV-LYNEEKQKMYMVMEYCVCGMQEM-LDSVPEKRFP-VCQAHGYFCQLID-----GL 122
Query: 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ-HISTRVMGTFGYVA 547
YLH ++H+D K N+LL T K+S G+A + G+ +
Sbjct: 123 EYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 548 PEYAMTGHLLV--KSDVYSYGVVLLELLSGRKPVD 580
PE A K D++S GV L + +G P +
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 65/263 (24%), Positives = 100/263 (38%), Gaps = 58/263 (22%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN 432
+ F +LG G F V+ G A+K + ++ D E+ +L ++ H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDW----------EAR--MKI 480
+V L I LV +LV G + D +A ++
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGEL-------------FDRILERGVYTEKDASLVIQQ 114
Query: 481 ALGAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREATEGSQHIST 537
L A + YLHE+ ++HRD K N+L E++ ++DFGL++ G +ST
Sbjct: 115 VLSA---VKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MST 166
Query: 538 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL 597
GT GYVAPE D +S GV+ LL G P
Sbjct: 167 AC-GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY----------------- 208
Query: 598 LTTREGLEQLVDPSLAGSYDFDD 620
E +L + G Y+F+
Sbjct: 209 ---EETESKLFEKIKEGYYEFES 228
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 61/215 (28%), Positives = 89/215 (41%), Gaps = 33/215 (15%)
Query: 381 RILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA-EVEMLSRLHHRNLVKLIG 438
+ LGEG +G V V VAVK++ E I E+ + L+H N+VK G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 439 ICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK----IALGAARGLAYLHE 493
L E G + + P +A+ +A G+ YLH
Sbjct: 73 H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEP-DAQRFFHQLMA-----GVVYLH- 122
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ--HISTRVMGTFGYVAPE-- 549
+ HRD K N+LL++ K+SDFGLA ++ ++ GT YVAPE
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL 179
Query: 550 ----YAMTGHLLVKSDVYSYGVVLLELLSGRKPVD 580
+ DV+S G+VL +L+G P D
Sbjct: 180 KRREFH--AE---PVDVWSCGIVLTAMLAGELPWD 209
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 70/263 (26%), Positives = 110/263 (41%), Gaps = 56/263 (21%)
Query: 374 TEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDRE--FIAEVEMLSRLHH 430
E+++ +LG+G FG V E AVK++ + + + EVE+L +L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDK--NRGPLD-WEAR--MKIALGAA 485
N++KL I + + +V EL G + D+ R +A +K
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL------FDEIIKRKRFSEHDAARIIKQVFSG- 133
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREATEGSQHISTRVMGT 542
+ Y+H+ + ++HRD K N+LL E D K+ DFGL+ + + R+ GT
Sbjct: 134 --ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GT 186
Query: 543 FGYVAPE-----YAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL 597
Y+APE Y K DV+S GV+L LLSG P + +
Sbjct: 187 AYYIAPEVLRGTYDE------KCDVWSAGVILYILLSGTPPF-------------YGK-- 225
Query: 598 LTTREGLEQLVDPSLAGSYDFDD 620
+ + V G Y FD
Sbjct: 226 --NEYDILKRV---ETGKYAFDL 243
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 57/262 (21%), Positives = 104/262 (39%), Gaps = 53/262 (20%)
Query: 374 TEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHR 431
T+ + K +G G + + E AVK++ ++ ++ E +E+L R H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHP 76
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLD-WEAR--MKIALGAARGL 488
N++ L + +G+ +V EL+ G + + + EA + +
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKT---V 129
Query: 489 AYLHEDSNPRVIHRDFKASNVLL----EDDFTPKVSDFGLAREATEGSQHISTRVMGTFG 544
YLH V+HRD K SN+L + + ++ DFG A++ + + T T
Sbjct: 130 EYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTAN 185
Query: 545 YVAPEYAMTGHLLVKS------DVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLL 598
+VAPE +L + D++S GV+L +L+G P P
Sbjct: 186 FVAPE------VLERQGYDAACDIWSLGVLLYTMLTGYTPF-------------ANGPDD 226
Query: 599 TTREGLEQLVDPSLAGSYDFDD 620
T E L ++ +G +
Sbjct: 227 TPEEILARI----GSGKFSLSG 244
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 43/231 (18%), Positives = 79/231 (34%), Gaps = 36/231 (15%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGD--REFIAEVEMLSRL-H 429
T +F +G G FG V+ V +G A+K + + + EV + L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLA 489
H ++V+ E + E + GS+ + + + L RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 490 YLHEDSNPRVIHRDFKASNVLL-------------------EDDFTPKVSDFGLAREATE 530
Y+H ++H D K SN+ + + K+ D G +
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS- 185
Query: 531 GSQHISTRVM-GTFGYVAPEYAM--TGHLLVKSDVYSYGVVLLELLSGRKP 578
S +V G ++A E HL K+D+++ + ++
Sbjct: 186 -----SPQVEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPL 230
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 63/276 (22%), Positives = 106/276 (38%), Gaps = 70/276 (25%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVK--------LLTRNNQNGDREFIA-EVE 423
E + K ILG G V + E AVK + RE EV+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 424 MLSRL-HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDW-------- 474
+L ++ H N+++L LV++L+ G + D+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-------------FDYLTEKVTLS 122
Query: 475 --EAR--MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530
E R M+ L + LH+ ++HRD K N+LL+DD K++DFG + +
Sbjct: 123 EKETRKIMRALLEV---ICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
Query: 531 GSQHISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQP 584
G + + GT Y+APE + D++S GV++ LL+G P
Sbjct: 177 G-EKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF----- 229
Query: 585 QGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDD 620
W R + + +++ ++G+Y F
Sbjct: 230 --------WHR----KQMLMLRMI---MSGNYQFGS 250
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 71/261 (27%), Positives = 105/261 (40%), Gaps = 34/261 (13%)
Query: 379 SKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKL 436
+ +LGEG V + + E AVK++ + + EVEML + HRN+++L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 437 IGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLD-WEAR--MKIALGAARGLAYLHE 493
I E LV+E + GS+ SH+H R + EA ++ A L +LH
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIH----KRRHFNELEASVVVQDVASA---LDFLH- 128
Query: 494 DSNPRVIHRDFKASNVLLE---DDFTPKVSDFGLAREATEGSQH--ISTRVM----GTFG 544
N + HRD K N+L E K+ DF L IST + G+
Sbjct: 129 --NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 545 YVAPEYAMTGHLLVKS-----DVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLT 599
Y+APE D++S GV+L LLSG P G +
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV--GRCGSDCGWDRGEACPA 244
Query: 600 TREGLEQLVDPSLAGSYDFDD 620
+ L + + G Y+F D
Sbjct: 245 CQNMLFESI---QEGKYEFPD 262
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFI-AEVEMLSRLHHR 431
E F+ +G+G FG V+ G+ VA+K++ + E I E+ +LS+
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
+ K G ++ ++ E + GS L GPLD I +GL YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYL 135
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA 551
H + + IHRD KA+NVLL + K++DFG+A + T+ +T +GT ++APE
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVI 191
Query: 552 MTGHLLVKSDVYSYGVVLLELLSGRKP 578
K+D++S G+ +EL G P
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 63/267 (23%), Positives = 109/267 (40%), Gaps = 47/267 (17%)
Query: 368 SDLEKATEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLS 426
S + + + LGEG F V + AVK++++ + ++ E+ L
Sbjct: 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALK 60
Query: 427 RL-HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLD-WEAR--MKIAL 482
H N+VKL + + LV EL++ G + + K + EA M+ +
Sbjct: 61 LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERI----KKKKHFSETEASYIMRKLV 116
Query: 483 GAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREATEGSQHISTRV 539
A ++++H+ V+HRD K N+L D+ K+ DFG AR +Q + T
Sbjct: 117 SA---VSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170
Query: 540 MGTFGYVAPEYAMTGHLLVKS------DVYSYGVVLLELLSGRKPVDMSQPQGQENLVTW 593
T Y APE LL ++ D++S GV+L +LSG+ P
Sbjct: 171 -FTLHYAAPE------LLNQNGYDESCDLWSLGVILYTMLSGQVPF-------------Q 210
Query: 594 ARPLLTTREGLEQLVDPSLAGSYDFDD 620
+ T +++ G + F+
Sbjct: 211 SHDRSLTCTSAVEIMKKIKKGDFSFEG 237
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-26
Identities = 66/271 (24%), Positives = 102/271 (37%), Gaps = 70/271 (25%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVK-LLTRNNQNGDREFIA-EVEMLSRLHH 430
TE++ LG+G F V V + G E A + T+ D + + E + L H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDW----------EAR--M 478
N+V+L E L+++LV G + + +A +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGEL-------------FEDIVAREYYSEADASHCI 116
Query: 479 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREATEGSQHI 535
+ L A + + H+ V+HR+ K N+LL K++DFGLA E Q
Sbjct: 117 QQILEA---VLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170
Query: 536 STRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN 589
GT GY++PE Y D+++ GV+L LL G P
Sbjct: 171 FGFA-GTPGYLSPEVLRKDPYGK------PVDLWACGVILYILLVGYPP----------- 212
Query: 590 LVTWARPLLTTREGLEQLVDPSLAGSYDFDD 620
W + L Q + AG+YDF
Sbjct: 213 --FWDE----DQHRLYQQI---KAGAYDFPS 234
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 10/206 (4%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN 432
E F LGEG +G VY + + G VA+K + ++ +E I E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPH 85
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
+VK G + +V E GSV + L + I +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM 552
R IHRD KA N+LL + K++DFG+A + T+ +T + GT ++APE
Sbjct: 143 FM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQ 198
Query: 553 TGHLLVKSDVYSYGVVLLELLSGRKP 578
+D++S G+ +E+ G+ P
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 62/271 (22%), Positives = 100/271 (36%), Gaps = 64/271 (23%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVK-----LLTRNNQNGDREFIAEVEMLSR 427
+ + ++G+G F V + + G + AVK T + + E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 428 LHHRNLVKLIGICIEGRTRCLVYELVHNGS-----VESHLHGVDKNRGPLDW-----EAR 477
L H ++V+L+ +V+E + V+ R + A
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVK---------RADAGFVYSEAVAS 133
Query: 478 --MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREATEGS 532
M+ L A L Y H++ +IHRD K VLL E+ K+ FG+A + E
Sbjct: 134 HYMRQILEA---LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187
Query: 533 QHISTRVMGTFGYVAPE---YAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN 589
RV GT ++APE G DV+ GV+L LLSG P
Sbjct: 188 LVAGGRV-GTPHFMAPEVVKREPYGK---PVDVWGCGVILFILLSGCLP----------- 232
Query: 590 LVTWARPLLTTREGLEQLVDPSLAGSYDFDD 620
+ T+E L + + + G Y +
Sbjct: 233 --FYG-----TKERLFEGI---IKGKYKMNP 253
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 10/206 (4%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN 432
+K++ +G+G G VY + + G EVA++ + Q I E+ ++ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
+V + + G +V E + GS+ + +D + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH 133
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM 552
+ +VIHRD K+ N+LL D + K++DFG + T ST V GT ++APE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVT 189
Query: 553 TGHLLVKSDVYSYGVVLLELLSGRKP 578
K D++S G++ +E++ G P
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 19/221 (8%)
Query: 365 FALSDLEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFI-AEV 422
DLE E LG G +G V + +G +AVK + + +++ + ++
Sbjct: 4 VKADDLEPIME-------LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL 56
Query: 423 EM-LSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIA 481
++ + + V G + EL+ + S++ V + + KIA
Sbjct: 57 DISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIA 115
Query: 482 LGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMG 541
+ + L +LH S VIHRD K SNVL+ K+ DFG++ + G
Sbjct: 116 VSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK--DIDAG 171
Query: 542 TFGYVAPE----YAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
Y+APE VKSD++S G+ ++EL R P
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 67/240 (27%), Positives = 103/240 (42%), Gaps = 21/240 (8%)
Query: 352 MSTMATCILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRN 410
M++ + S+ LS L F ++G G +G VY G + G A+K++
Sbjct: 2 MASDSP-ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 411 NQNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRC------LVYELVHNGSVESHLH 463
+ E E+ ML + HHRN+ G I+ LV E GSV +
Sbjct: 61 GDE-EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 464 GVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 523
L E I RGL++LH+ +VIHRD K NVLL ++ K+ DFG
Sbjct: 120 NT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 524 LAREATEGSQHISTRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLSGRKP 578
++ + +T +GT ++APE KSD++S G+ +E+ G P
Sbjct: 175 VSAQLDRTVGRRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 10/206 (4%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN 432
S +GEG G V +G +VAVK++ Q EV ++ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
+V++ + G ++ E + G++ + + L+ E + + LAYLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLH 158
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM 552
VIHRD K+ ++LL D K+SDFG + ++ + V GT ++APE
Sbjct: 159 AQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVIS 214
Query: 553 TGHLLVKSDVYSYGVVLLELLSGRKP 578
+ D++S G++++E++ G P
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 29/222 (13%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVK------LLTRNNQNGDRE--FIAEVEM 424
+++ + LG G G V +VA++ + + D E+E+
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 425 LSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEAR--MKIAL 482
L +L+H ++K+ + +V EL+ G + + V R + L
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV--VGNKRLKEA-TCKLYFYQML 249
Query: 483 GAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREATEGSQHISTRV 539
A + YLHE+ +IHRD K NVLL E+D K++DFG ++ E + T
Sbjct: 250 LA---VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLC 302
Query: 540 MGTFGYVAPE---YAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
GT Y+APE T D +S GV+L LSG P
Sbjct: 303 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 67/214 (31%), Positives = 99/214 (46%), Gaps = 33/214 (15%)
Query: 381 RILGEGGFGCVYHGV-MDNGTEVAVKLLTRNN-QNGDREFIA-EVEMLSRLHHRNLVKLI 437
+ +G+G F V + G EVA+K++ + + + EV ++ L+H N+VKL
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 438 GICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLD-WEARMK---IALGAARGLAYLH 492
+ IE L+ E G V +L G + EAR K I + Y H
Sbjct: 81 EV-IETEKTLYLIMEYASGGEVFDYL----VAHGRMKEKEARSKFRQIV----SAVQYCH 131
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE--- 549
+ R++HRD KA N+LL+ D K++DFG + E T G + G Y APE
Sbjct: 132 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFC-GAPPYAAPELFQ 186
Query: 550 ---YAMTGHLLVKSDVYSYGVVLLELLSGRKPVD 580
Y G + DV+S GV+L L+SG P D
Sbjct: 187 GKKYD--GP---EVDVWSLGVILYTLVSGSLPFD 215
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 60/232 (25%), Positives = 96/232 (41%), Gaps = 43/232 (18%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRN--------NQNGDREFIAE 421
+ +++ + LG G G V +VA+K++++ + E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 422 VEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGS-----VESHLHGVDKNRGPLD-WE 475
+E+L +L+H ++K+ + +V EL+ G V L
Sbjct: 66 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVG---------NKRLKEAT 115
Query: 476 AR--MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREATE 530
+ L A + YLHE+ +IHRD K NVLL E+D K++DFG ++ E
Sbjct: 116 CKLYFYQMLLA---VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 531 GSQHISTRVMGTFGYVAPE----YAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
S + T GT Y+APE G+ D +S GV+L LSG P
Sbjct: 170 TSL-MRTLC-GTPTYLAPEVLVSVGTAGYNR-AVDCWSLGVILFICLSGYPP 218
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 72/341 (21%), Positives = 123/341 (36%), Gaps = 73/341 (21%)
Query: 312 RKARKPSSAVGPAFASSINKRSGIGSILSSSIASSTSVSLMSTMATCILSVKTFALSDLE 371
R + AF S+ + L + T S+
Sbjct: 27 RHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDW 86
Query: 372 KATEKFSSK----RILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA------ 420
A ++F K ++G G V V G E AVK++ + E +
Sbjct: 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146
Query: 421 --EVEMLSRLH-HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDW--- 474
E +L ++ H +++ LI LV++L+ G E L D+
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG--E--L---------FDYLTE 193
Query: 475 -------EAR--MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525
E R M+ L A +++LH + ++HRD K N+LL+D+ ++SDFG +
Sbjct: 194 KVALSEKETRSIMRSLLEA---VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFS 247
Query: 526 REATEGSQHISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLSGRKPV 579
G + + GT GY+APE + D+++ GV+L LL+G P
Sbjct: 248 CHLEPG-EKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305
Query: 580 DMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDD 620
W R + + +++ + G Y F
Sbjct: 306 -------------WHR----RQILMLRMI---MEGQYQFSS 326
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 53/255 (20%), Positives = 91/255 (35%), Gaps = 35/255 (13%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH 429
+ + LG G FG V+ V G K + E+ ++++LH
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 106
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEAR--MKIALGAARG 487
H L+ L + L+ E + G E ++ + E M+ A G
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGG--ELFDRIAAEDYKMSEAEVINYMRQACE---G 161
Query: 488 LAYLHEDSNPRVIHRDFKASNVLLE--DDFTPKVSDFGLAREATEGSQHISTRVMGTFGY 545
L ++HE ++H D K N++ E + K+ DFGLA + T +
Sbjct: 162 LKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEF 216
Query: 546 VAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLE 605
APE + +D+++ GV+ LLSG P E L+
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF-------------AGE---DDLETLQ 260
Query: 606 QLVDPSLAGSYDFDD 620
+ ++FD+
Sbjct: 261 NV----KRCDWEFDE 271
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 45/219 (20%), Positives = 72/219 (32%), Gaps = 20/219 (9%)
Query: 374 TEKFSSKRILGEG--GFGCVYHGV-MDNGTEVAVKL--LTRNNQNGDREFIAEVEMLSRL 428
+ ++G+G V G V V+ L + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 429 HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGL 488
+H N+V I +V + GS L ++ A I G + L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFM-DGMNELAIAYILQGVLKAL 141
Query: 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYV-- 546
Y+H +HR KAS++L+ D +S Q V
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 547 ----APEYAMTGHLL---VKSDVYSYGVVLLELLSGRKP 578
+PE + +L KSD+YS G+ EL +G P
Sbjct: 199 LPWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 66/215 (30%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 381 RILGEGGFGCVYHGV-MDNGTEVAVKLLTRN--NQNGDREFIA-EVEMLSRLHHRNLVKL 436
LG G FG V G G +VAVK+L R I E++ L H +++KL
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 437 IGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK----IALGAARGLAYL 491
+ I T +V E V G + ++ R EAR ++ + Y
Sbjct: 77 YQV-ISTPTDFFMVMEYVSGGELFDYI--CKHGRVEEM-EARRLFQQILS-----AVDYC 127
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE-- 549
H V+HRD K NVLL+ K++DFGL+ ++G + + T G+ Y APE
Sbjct: 128 HRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSC-GSPNYAAPEVI 182
Query: 550 ----YAMTGHLLVKSDVYSYGVVLLELLSGRKPVD 580
YA G + D++S GV+L LL G P D
Sbjct: 183 SGRLYA--GP---EVDIWSCGVILYALLCGTLPFD 212
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 53/239 (22%)
Query: 380 KRILGEGGFGCVYHGV-MDNGTEVAVKLLTR-------------------------NNQN 413
K +G+G +G V ++ T A+K+L++
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 414 GDREFIA-EVEMLSRLHHRNLVKLIGICIEGRTR---CLVYELVHNGSVESHLHGVDK-N 468
G E + E+ +L +L H N+VKL+ + ++ +V+ELV+ G V ++
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEV-LDDPNEDHLYMVFELVNQGPV------MEVPT 130
Query: 469 RGPLD-WEARMK---IALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524
PL +AR + G + YLH ++IHRD K SN+L+ +D K++DFG+
Sbjct: 131 LKPLSEDQARFYFQDLIKG----IEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 525 AREATEGSQHISTRVMGTFGYVAPEYAMTGHLLV---KSDVYSYGVVLLELLSGRKPVD 580
+ E +S V GT ++APE + DV++ GV L + G+ P
Sbjct: 184 SNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 36/215 (16%)
Query: 381 RILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA-EVEMLSRLHHRNLVKLIG 438
+ +G G FG VAVK + R + + E+ L H N+V+
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN--VQREIINHRSLRHPNIVRFKE 83
Query: 439 ICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK----IALGAARGLAYLHE 493
+ I T ++ E G + + + R D EAR ++ G++Y H
Sbjct: 84 V-ILTPTHLAIIMEYASGGELYERI--CNAGRFSED-EARFFFQQLLS-----GVSYCH- 133
Query: 494 DSNPRVIHRDFKASNVLLEDDFTP--KVSDFGLAREATEGSQHISTRVMGTFGYVAPE-- 549
+ ++ HRD K N LL+ P K+ DFG ++ + SQ + V GT Y+APE
Sbjct: 134 --SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTV-GTPAYIAPEVL 189
Query: 550 ----YAMTGHLLVKSDVYSYGVVLLELLSGRKPVD 580
Y G +DV+S GV L +L G P +
Sbjct: 190 LRQEYD--GK---IADVWSCGVTLYVMLVGAYPFE 219
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 75/263 (28%), Positives = 109/263 (41%), Gaps = 50/263 (19%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKL-----LTRNNQNGDREFIA-EVEMLS 426
+ + LG G F V G E A K L+ + + RE I EV +L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 427 RLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDK--NRGPL-DWEAR--MKIA 481
+ H N++ L I L+ ELV G E L D + L + EA +K
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGG--E--LF--DFLAEKESLTEDEATQFLKQI 117
Query: 482 LGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP----KVSDFGLAREATEGSQHIST 537
L G+ YLH R+ H D K N++L D P K+ DFG+A + G++
Sbjct: 118 LD---GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--K 169
Query: 538 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL 597
+ GT +VAPE L +++D++S GV+ LLSG P
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-------------LGE-- 214
Query: 598 LTTREGLEQLVDPSLAGSYDFDD 620
T +E L + A +YDFD+
Sbjct: 215 -TKQETLTNI----SAVNYDFDE 232
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 58/227 (25%), Positives = 90/227 (39%), Gaps = 36/227 (15%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVK-----LLTRNNQNGDREFIA-EVE 423
E + + + LG G F V G + A K + + RE I EV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 424 MLSRLHHRNLVKLIGICIEGRTRCLVYELVHNG------SVESHLHGVDKNRGPLDWEAR 477
+L + H N++ L + L+ ELV G + + L + A
Sbjct: 67 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE---------AT 117
Query: 478 --MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL----EDDFTPKVSDFGLAREATEG 531
+K L + YLH + H D K N++L K+ DFGLA + G
Sbjct: 118 EFLKQILNG---VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
++ + GT +VAPE L +++D++S GV+ LLSG P
Sbjct: 172 NEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 66/267 (24%), Positives = 104/267 (38%), Gaps = 63/267 (23%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVK-LLTRNNQNGDRE-FIAEVEMLSRLHH 430
++ + K LG+G F V V G E A K + T+ D + E + +L H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGS-----VESHLHGVDKNRGPLD-WEAR--MKIAL 482
N+V+L E LV++LV G V R +A ++ L
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA---------REFYSEADASHCIQQIL 115
Query: 483 GAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREATEGSQHISTRV 539
+ +AY H + ++HR+ K N+LL K++DFGLA E + +
Sbjct: 116 ES---IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFA 168
Query: 540 MGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTW 593
GT GY++PE Y+ D+++ GV+L LL G P W
Sbjct: 169 -GTPGYLSPEVLKKDPYSK------PVDIWACGVILYILLVGYPPF-------------W 208
Query: 594 ARPLLTTREGLEQLVDPSLAGSYDFDD 620
+ L + AG+YD+
Sbjct: 209 DE----DQHRLYAQI---KAGAYDYPS 228
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 73/267 (27%), Positives = 105/267 (39%), Gaps = 52/267 (19%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKL-----LTRNNQNGDREFIA-EVE 423
+K + + LG G F V G E A K + + RE I EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 424 MLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKN----RGPLDWEAR-- 477
+L ++ H N++ L + L+ ELV G E K EA
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGG--ELFDFLAQKESLSEE-----EATSF 120
Query: 478 MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP----KVSDFGLAREATEGSQ 533
+K L G+ YLH + H D K N++L D P K+ DFGLA E +G +
Sbjct: 121 IKQILD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTW 593
+ GT +VAPE L +++D++S GV+ LLSG P
Sbjct: 175 F--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-------------L 219
Query: 594 ARPLLTTREGLEQLVDPSLAGSYDFDD 620
T +E L + + SYDFD+
Sbjct: 220 GD---TKQETLANI----TSVSYDFDE 239
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 15/208 (7%)
Query: 376 KFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
S ILG G FG V+ G ++A K++ E E+ ++++L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEAR--MKIALGAARGLAYLH 492
+L LV E V G E +D++ + + MK G+ ++H
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGG--ELFDRIIDESYNLTELDTILFMKQICE---GIRHMH 204
Query: 493 EDSNPRVIHRDFKASNVLL--EDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
+ ++H D K N+L D K+ DFGLAR + + GT ++APE
Sbjct: 205 QM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNF-GTPEFLAPEV 259
Query: 551 AMTGHLLVKSDVYSYGVVLLELLSGRKP 578
+ +D++S GV+ LLSG P
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 48/256 (18%), Positives = 92/256 (35%), Gaps = 38/256 (14%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA-EVEMLSRL 428
++ EK+ LG G FG V+ V + K + D+ + E+ +L+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIA 58
Query: 429 HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEAR--MKIALGAAR 486
HRN++ L +++E + + + E +
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGL--DIFERINTSAFELNEREIVSYVHQVCE--- 113
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDFTP--KVSDFGLAREATEGSQHISTRVMGTFG 544
L +LH + + H D + N++ + + K+ +FG AR+ G +
Sbjct: 114 ALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPE 168
Query: 545 YVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604
Y APE + +D++S G ++ LLSG P A T + +
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF-------------LAE----TNQQI 211
Query: 605 EQLVDPSLAGSYDFDD 620
+ + + Y FD+
Sbjct: 212 IENI---MNAEYTFDE 224
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 69/276 (25%), Positives = 110/276 (39%), Gaps = 63/276 (22%)
Query: 365 FALSDLEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVK-LLTRNNQNGDREFIA-E 421
F ++ K ++ + K LG+G F V V G E A K + T+ D + + E
Sbjct: 19 FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE 78
Query: 422 VEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGS-----VESHLHGVDKNRGPLD-WE 475
+ +L H N+V+L E LV++LV G V R +
Sbjct: 79 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA---------REFYSEAD 129
Query: 476 AR--MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREATE 530
A ++ L + +AY H + ++HR+ K N+LL K++DFGLA E +
Sbjct: 130 ASHCIQQILES---IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
Query: 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVLLELLSGRKPVDMSQP 584
+ GT GY++PE +L K D+++ GV+L LL G P
Sbjct: 184 S-EAWHGFA-GTPGYLSPE------VLKKDPYSKPVDIWACGVILYILLVGYPPF----- 230
Query: 585 QGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDD 620
W + L + AG+YD+
Sbjct: 231 --------WDE----DQHRLYAQI---KAGAYDYPS 251
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 50/230 (21%), Positives = 88/230 (38%), Gaps = 21/230 (9%)
Query: 360 LSVKTFALSDLEKATEKFS-SKRILGEGGFGCVYHGV-MDNGTEVAVKLL-TRNNQNGDR 416
L + +E + + + LG G F V + G E A K L R R
Sbjct: 13 LGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR 72
Query: 417 EFIA-EVEMLSRL-HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLD- 473
I E+ +L ++ L + L+ E G E + + +
Sbjct: 73 AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG--EIFSLCLPELAEMVSE 130
Query: 474 WEAR--MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREA 528
+ +K L G+ YLH++ ++H D K N+LL K+ DFG++R+
Sbjct: 131 NDVIRLIKQILE---GVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184
Query: 529 TEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
+ + GT Y+APE + +D+++ G++ LL+ P
Sbjct: 185 GHA-CELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 74/267 (27%), Positives = 105/267 (39%), Gaps = 52/267 (19%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKL-----LTRNNQNGDREFI-AEVE 423
+K + + LG G F V G E A K + + RE I EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 424 MLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKN----RGPLDWEAR-- 477
+L ++ H N++ L + L+ ELV G E K EA
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGG--ELFDFLAQKESLSEE-----EATSF 120
Query: 478 MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP----KVSDFGLAREATEGSQ 533
+K L G+ YLH + H D K N++L D P K+ DFGLA E +G +
Sbjct: 121 IKQILD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTW 593
+ GT +VAPE L +++D++S GV+ LLSG P
Sbjct: 175 F--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-------------L 219
Query: 594 ARPLLTTREGLEQLVDPSLAGSYDFDD 620
T +E L + A SYDFD+
Sbjct: 220 GD---TKQETLANI----TAVSYDFDE 239
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 65/269 (24%), Positives = 101/269 (37%), Gaps = 58/269 (21%)
Query: 368 SDLEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLS 426
S+ + ++ F + LG G VY A+K+L + E+ +L
Sbjct: 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--TEIGVLL 103
Query: 427 RLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDW----------EA 476
RL H N++KL I LV ELV G + D +A
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGEL-------------FDRIVEKGYYSERDA 150
Query: 477 R--MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREATEG 531
+K L A +AYLHE+ ++HRD K N+L D K++DFGL++
Sbjct: 151 ADAVKQILEA---VAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204
Query: 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV 591
+ T GT GY APE + D++S G++ LL G +P
Sbjct: 205 -VLMKTVC-GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF------------ 250
Query: 592 TWARPLLTTREGLEQLVDPSLAGSYDFDD 620
+ + + + + L Y F
Sbjct: 251 -YDE---RGDQFMFRRI---LNCEYYFIS 272
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 14/215 (6%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA-EVEMLSRLHHRN 432
+ + + ++G G V +VA+K + + + E++ +S+ HH N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSV----ESHLHGVDKNRGPLDWEARMKIALGAARGL 488
+V + LV +L+ GSV + + + G LD I GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF-G--- 544
YLH++ IHRD KA N+LL +D + +++DFG++ G +V TF G
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 545 YVAPEYAMTGHLL-VKSDVYSYGVVLLELLSGRKP 578
++APE K+D++S+G+ +EL +G P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 53/253 (20%), Positives = 94/253 (37%), Gaps = 31/253 (12%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH 429
+ + + LG G FG V+ G A K + +++ E++ +S L
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 212
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLA 489
H LV L + ++YE + G + V + + ++ +GL
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQVCKGLC 269
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTP--KVSDFGLAREATEGSQHISTRVMGTFGYVA 547
++HE++ +H D K N++ + K+ DFGL Q + GT + A
Sbjct: 270 HMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTT-GTAEFAA 324
Query: 548 PEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607
PE A + +D++S GV+ LLSG P E L +
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF-------------GGE---NDDETLRNV 368
Query: 608 VDPSLAGSYDFDD 620
+ ++ DD
Sbjct: 369 ----KSCDWNMDD 377
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 65/215 (30%), Positives = 96/215 (44%), Gaps = 34/215 (15%)
Query: 381 RILGEGGFGCVYHGV-MDNGTEVAVKLLTRN--NQNGDREFIA-EVEMLSRLHHRNLVKL 436
LG G FG V G G +VAVK+L R I E++ L H +++KL
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 437 IGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK----IALGAARGLAYL 491
+ I + +V E V G + ++ R E+R ++ G+ Y
Sbjct: 82 YQV-ISTPSDIFMVMEYVSGGELFDYI--CKNGRLDEK-ESRRLFQQILS-----GVDYC 132
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE-- 549
H V+HRD K NVLL+ K++DFGL+ ++G + + T G+ Y APE
Sbjct: 133 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSC-GSPNYAAPEVI 187
Query: 550 ----YAMTGHLLVKSDVYSYGVVLLELLSGRKPVD 580
YA G + D++S GV+L LL G P D
Sbjct: 188 SGRLYA--G---PEVDIWSSGVILYALLCGTLPFD 217
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 62/263 (23%), Positives = 93/263 (35%), Gaps = 64/263 (24%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTR----NNQNGDREFIA-EVEM 424
+ +K+ K +G+G +G V + A+K++ + D E I EV +
Sbjct: 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRL 81
Query: 425 LSRLHHRNLVKLIGICIEGRTRCLVYELVHNG------SVESHLHGVDKNRGPLDWEARM 478
+ +LHH N+ +L + + + CLV EL H G +V + +
Sbjct: 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 479 KIALG-----------------------AAR-------GLAYLHEDSNPRVIHRDFKASN 508
+ L YLH + HRD K N
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPEN 198
Query: 509 VLLE--DDFTPKVSDFGLARE---ATEGSQHISTRVMGTFGYVAPE--------YAMTGH 555
L F K+ DFGL++E G + T GT +VAPE Y
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP--- 255
Query: 556 LLVKSDVYSYGVVLLELLSGRKP 578
K D +S GV+L LL G P
Sbjct: 256 ---KCDAWSAGVLLHLLLMGAVP 275
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 35/215 (16%)
Query: 381 RILGEGGFGCVYHGV-MDNGTEVAVKLLTRN--NQNGDREFIA-EVEMLSRLHHRNLVKL 436
LGEG FG V +VA+K ++R ++ + E+ L L H +++KL
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 437 IGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK----IALGAARGLAYL 491
+ I T +V E G + ++ V+K R D E R I + Y
Sbjct: 75 YDV-ITTPTDIVMVIEYA-GGELFDYI--VEKKRMTED-EGRRFFQQIIC-----AIEYC 124
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE-- 549
H +++HRD K N+LL+D+ K++DFGL+ T+G + T G+ Y APE
Sbjct: 125 H---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSC-GSPNYAAPEVI 179
Query: 550 ----YAMTGHLLVKSDVYSYGVVLLELLSGRKPVD 580
YA G + DV+S G+VL +L GR P D
Sbjct: 180 NGKLYA--GP---EVDVWSCGIVLYVMLVGRLPFD 209
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 20/223 (8%)
Query: 364 TFALSDLEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFI-AE 421
F DL+ E +G G +G V V +G +AVK + +++ + +
Sbjct: 18 DFTAEDLKDLGE-------IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD 70
Query: 422 VEMLSRL-HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNR-GPLDWEARMK 479
++++ R +V+ G + EL+ + S + V + E K
Sbjct: 71 LDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK 129
Query: 480 IALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRV 539
I L + L +L E+ +IHRD K SN+LL+ K+ DFG++ + + TR
Sbjct: 130 ITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRD 185
Query: 540 MGTFGYVAPEYAMTGHLL----VKSDVYSYGVVLLELLSGRKP 578
G Y+APE V+SDV+S G+ L EL +GR P
Sbjct: 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 7e-23
Identities = 65/226 (28%), Positives = 96/226 (42%), Gaps = 40/226 (17%)
Query: 376 KFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA--------EVEMLS 426
K+S+ LG G FG V+ V + EV VK + + D E+ +LS
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 427 RLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVD-----KNRGPLD-WEARMKI 480
R+ H N++K++ I E + ++LV +E H G+D LD A I
Sbjct: 85 RVEHANIIKVLDI-FENQGF---FQLV----MEKHGSGLDLFAFIDRHPRLDEPLAS-YI 135
Query: 481 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM 540
+ YL +IHRD K N+++ +DFT K+ DFG A G + T
Sbjct: 136 FRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFC- 190
Query: 541 GTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLSGRKPVD 580
GT Y APE Y G + +++S GV L L+ P
Sbjct: 191 GTIEYCAPEVLMGNPYR--GP---ELEMWSLGVTLYTLVFEENPFC 231
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-23
Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEV--AVKLLTRN---NQNGDREFIAEVEMLSRLH 429
+ F R+LG GGFG V+ T A K L + + G + + E ++L+++H
Sbjct: 185 DWFLDFRVLGRGGFGEVF-ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 430 HRNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK-----IALG 483
R +V L E +T CLV +++ G + H++ VD++ E R I G
Sbjct: 244 SRFIVSLAY-AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSG 301
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF 543
L +LH+ +I+RD K NVLL+DD ++SD GLA E G GT
Sbjct: 302 ----LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTP 353
Query: 544 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
G++APE + G S D ++ GV L E+++ R P
Sbjct: 354 GFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVK---LLTRNNQNGDREFIAEVEMLSRLH 429
+ FS R +G G FG VY + N VA+K + + ++ I EV L +L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLA 489
H N ++ G + T LV E GS ++ ++ PL + GA +GLA
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYC-LGSA---SDLLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549
YLH +IHRD KA N+LL + K+ DFG A + +GT ++APE
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPE 220
Query: 550 YAMTGHLL---VKSDVYSYGVVLLELLSGRKP 578
+ K DV+S G+ +EL + P
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 53/235 (22%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH 429
K ++F +R+ G+G FG V G G VA+K + ++ + +RE + ++ L+ LH
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLH 77
Query: 430 HRNLVKLIGICIEGRTR-------CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIAL 482
H N+V+L R +V E V LH R ++A
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRC------CRNYYRRQVAP 126
Query: 483 GAA----------RGLAYLHEDSNPRVIHRDFKASNVLL-EDDFTPKVSDFGLAREATEG 531
R + LH S V HRD K NVL+ E D T K+ DFG A++ +
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS 185
Query: 532 SQHIS---TRVMGTFGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLSGR 576
+++ +R Y APE L+ + D++S G + E++ G
Sbjct: 186 EPNVAYICSRY-----YRAPE------LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA--EVEMLSRLHHR 431
EK+ + ++GEG +G V D G VA+K ++ + + IA E+++L +L H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGV-DKNRGPLDWEARMKIALGAARGLAY 490
NLV L+ +C + + LV+E V + + + LD++ K G+ +
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFV-----DHTILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
H S+ +IHRD K N+L+ K+ DFG AR + V T Y APE
Sbjct: 140 CH--SH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPE- 194
Query: 551 AMTGHLLVKSDVYSYGV-------VLLELLSGR 576
LLV Y V ++ E+ G
Sbjct: 195 -----LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 8e-22
Identities = 61/213 (28%), Positives = 88/213 (41%), Gaps = 26/213 (12%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA--EVEMLSRLHHR 431
EK+ +GEG +G V+ D G VA+K + + + IA E+ ML +L H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGV-DKNRGPLDWEARMKIALGAARGLAY 490
NLV L+ + R LV+E + + D+ + + I + + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYC-----DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
H+ IHRD K N+L+ K+ DFG AR T S + V T Y +PE
Sbjct: 118 CHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPE- 172
Query: 551 AMTGHLLVKSDVYSYGV-------VLLELLSGR 576
LLV Y V V ELLSG
Sbjct: 173 -----LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 57/254 (22%), Positives = 98/254 (38%), Gaps = 44/254 (17%)
Query: 379 SKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKL 436
SK++LG G G V G + A+KLL + + EV+ + ++V +
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCI 87
Query: 437 IGICIEGRTRC----LVYELVHNGSVESHLHGVDKNRGPLD-WEAR--MKIALGAARGLA 489
+ + ++ E + G + S + ++ EA M+ A +
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRI--QERGDQAFTEREAAEIMRDIGTA---IQ 142
Query: 490 YLHEDSNPRVIHRDFKASNVLLED---DFTPKVSDFGLAREATEGSQHISTRVMGTFGYV 546
+LH + + HRD K N+L D K++DFG A+E T+ + + T T YV
Sbjct: 143 FLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYV 196
Query: 547 APEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606
APE D++S GV++ LL G P ++ T +
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF-------------YSN---TGQAISPG 240
Query: 607 LVDPSLAGSYDFDD 620
+ G Y F +
Sbjct: 241 MKRRIRLGQYGFPN 254
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 23/223 (10%)
Query: 364 TFALSDLEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA-E 421
++DLE E +G G G V+ G +AVK + R+ + + I +
Sbjct: 21 QAEINDLENLGE-------MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD 73
Query: 422 VEMLSRLH-HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKI 480
++++ + H +V+ G I + EL+ + + +GP+ K+
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCA----EKLKKRMQGPIPERILGKM 129
Query: 481 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM 540
+ + L YL E VIHRD K SN+LL++ K+ DFG++ + R
Sbjct: 130 TVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSA 185
Query: 541 GTFGYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLSGRKP 578
G Y+APE +++DV+S G+ L+EL +G+ P
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 61/260 (23%), Positives = 100/260 (38%), Gaps = 57/260 (21%)
Query: 380 KRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIA-EVEMLSRL-HHRNLVKL 436
++LG G G V + A+K+L D EVE+ R ++V++
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWRASQCPHIVRI 120
Query: 437 IGICIEGRTRC----LVYELVHNGSVESHLHGVDKNRGPLD-WEAR--MKIALGAARGLA 489
+ + +V E + G + S + D+ EA MK A +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEA---IQ 175
Query: 490 YLHEDSNPRVIHRDFKASNVLLED---DFTPKVSDFGLAREATEGSQHISTRVMGTFGYV 546
YLH + + HRD K N+L + K++DFG A+E T ++T T YV
Sbjct: 176 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPC-YTPYYV 230
Query: 547 APEYAMTGHLLVKS------DVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTT 600
APE +L D++S GV++ LL G P ++ L
Sbjct: 231 APE------VLGPEKYDKSCDMWSLGVIMYILLCGYPPF-------------YSNHGLAI 271
Query: 601 REGLEQLVDPSLAGSYDFDD 620
G++ + G Y+F +
Sbjct: 272 SPGMKTRI---RMGQYEFPN 288
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-20
Identities = 69/214 (32%), Positives = 107/214 (50%), Gaps = 27/214 (12%)
Query: 377 FSSKRILGEGGFGCVYHG-VMDNGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRN 432
F R+LG+GGFG V V G A K L + + G+ + E ++L +++ R
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 433 LVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK-----IALGAAR 486
+V L E + CLV L++ G ++ H++ + + P EAR I G
Sbjct: 246 VVSLAY-AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARAVFYAAEICCG--- 298
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYV 546
L LH + R+++RD K N+LL+D ++SD GLA EG Q I RV GT GY+
Sbjct: 299 -LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRV-GTVGYM 352
Query: 547 APE-YAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
APE + S D ++ G +L E+++G+ P
Sbjct: 353 APEVVKNERY--TFSPDWWALGCLLYEMIAGQSP 384
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 91.0 bits (227), Expect = 3e-20
Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 26/215 (12%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVK-LLTRNNQNG-DREFIAEVEMLSRLHHR 431
+K+ +GEG +G V+ + VA+K + ++ G + E+ +L L H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGV-DKNRGPLDWEARMKIALGAARGLAY 490
N+V+L + + LV+E + L D G LD E +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFC-----DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
H V+HRD K N+L+ + K+++FGLAR + S V+ T Y P+
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPD- 171
Query: 551 AMTGHLLVKSDVYSYGV-------VLLELLSGRKP 578
+L + +YS + + EL + +P
Sbjct: 172 -----VLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 60/263 (22%), Positives = 105/263 (39%), Gaps = 30/263 (11%)
Query: 335 IGSILSSSIASSTSVSLMSTMATC--ILSVKTFALSDLEKATEKFSSKRILGEGGFGCVY 392
+GS SS V S MA C + + K + E ++ +LG GGFG VY
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVY 60
Query: 393 HGV-MDNGTEVAVKLLTRN--NQNGDREFIA----EVEMLSRLHHR--NLVKLIGICIEG 443
G+ + + VA+K + ++ + G+ EV +L ++ +++L+ E
Sbjct: 61 SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FER 119
Query: 444 RTR-CLVYELVHN-GSVESHLHGVDKNRGPLD-WEARMKIALGAARGLAYLHEDSNPRVI 500
L+ E + + RG L AR + + H V+
Sbjct: 120 PDSFVLILERPEPVQDLFDFI----TERGALQEELAR-SFFWQVLEAVRHCHNC---GVL 171
Query: 501 HRDFKASNVLL-EDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLV- 558
HRD K N+L+ + K+ DFG + + GT Y PE+ + H
Sbjct: 172 HRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFD-GTRVYSPPEW-IRYHRYHG 227
Query: 559 -KSDVYSYGVVLLELLSGRKPVD 580
+ V+S G++L +++ G P +
Sbjct: 228 RSAAVWSLGILLYDMVCGDIPFE 250
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVK-LLTRNNQNG-DREFIAEVEMLSRLHHRN 432
EK+ +GEG +G VY G VA+K + G I E+ +L LHH N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGV-DKNRGPLDWEARMKIALGAARGLAYL 491
+V LI + R LV+E + E L V D+N+ L RG+A+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFM-----EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA 551
H+ R++HRD K N+L+ D K++DFGLAR + + V+ T Y AP+
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPD-- 189
Query: 552 MTGHLLVKSDVYSYGV-------VLLELLSGR 576
+L+ S YS V + E+++G+
Sbjct: 190 ----VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-20
Identities = 64/244 (26%), Positives = 100/244 (40%), Gaps = 59/244 (24%)
Query: 362 VKTFALSDLEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA 420
V T ++ +++G G FG VY D+G VA+K + + D+ F
Sbjct: 41 VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKN 95
Query: 421 -EVEMLSRLHHRNLVKLIGICIEGRTRC------LVYELVHNGSVESHLHGVDKNRGPLD 473
E++++ +L H N+V+L + LV + V ++ V
Sbjct: 96 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRV------AR 144
Query: 474 WEARMKIALGAA----------RGLAYLHEDSNPRVIHRDFKASNVLL-EDDFTPKVSDF 522
+R K L R LAY+H + + HRD K N+LL D K+ DF
Sbjct: 145 HYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDF 201
Query: 523 GLAREATEGSQHIS---TRVMGTFGYVAPEYAMTGHLLVKS-------DVYSYGVVLLEL 572
G A++ G ++S +R Y APE L+ + DV+S G VL EL
Sbjct: 202 GSAKQLVRGEPNVSYICSRY-----YRAPE------LIFGATDYTSSIDVWSAGCVLAEL 250
Query: 573 LSGR 576
L G+
Sbjct: 251 LLGQ 254
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 4e-20
Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 377 FSSKRILGEGGFGCVYHG-VMDNGTEVAVKLLTRN---NQNGDREFIAEVEMLSRLH--- 429
FS RI+G GGFG VY D G A+K L + + G+ + E MLS +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 430 HRNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK-----IALG 483
+V + + + +L++ G + HL G EA M+ I LG
Sbjct: 251 CPFIVCMSY-AFHTPDKLSFILDLMNGGDLHYHLS----QHGVFS-EADMRFYAAEIILG 304
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF 543
L ++H V++RD K +N+LL++ ++SD GLA + ++ H V GT
Sbjct: 305 ----LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTH 354
Query: 544 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
GY+APE G S D +S G +L +LL G P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 375 EKFSSKRILGEGGFGCVYHG-VMDNGTEVAVKLLTRNNQNG-DREFIAEVEMLSRLHHRN 432
E + LGEG + VY G VA+K + ++ G I EV +L L H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGV-DKNRGPLDWEARMKIALGAARGLAYL 491
+V L I ++ LV+E + + L D ++ RGLAY
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYL-----DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA 551
H +V+HRD K N+L+ + K++DFGLAR + ++ V+ T Y P+
Sbjct: 117 HR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPD-- 170
Query: 552 MTGHLLVKSDVYSYGV-------VLLELLSGR 576
+L+ S YS + + E+ +GR
Sbjct: 171 ----ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 8e-20
Identities = 56/246 (22%), Positives = 99/246 (40%), Gaps = 58/246 (23%)
Query: 359 ILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREF 418
++ V E+ +++ +++G G FG V+ + EVA+K + + D+ F
Sbjct: 24 VIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRF 78
Query: 419 IA-EVEMLSRLHHRNLVKLIGICIEGRTRC------LVYELVHNGSVESHLHGVDKNRGP 471
E++++ + H N+V L + LV E V ++
Sbjct: 79 KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY-----VPETVYRA------ 127
Query: 472 LDWEARMKIALGAA----------RGLAYLHEDSNPRVIHRDFKASNVLL-EDDFTPKVS 520
A++K + R LAY+H + + HRD K N+LL K+
Sbjct: 128 SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLI 184
Query: 521 DFGLAREATEGSQHIS---TRVMGTFGYVAPEYAMTGHLLVKS-------DVYSYGVVLL 570
DFG A+ G ++S +R Y APE L+ + D++S G V+
Sbjct: 185 DFGSAKILIAGEPNVSYICSRY-----YRAPE------LIFGATNYTTNIDIWSTGCVMA 233
Query: 571 ELLSGR 576
EL+ G+
Sbjct: 234 ELMQGQ 239
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-20
Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 36/225 (16%)
Query: 374 TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIA-----------EV 422
++ +R + G +G V GV G VA+K + +G I E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 423 EMLSRLHHRNLVKLIGICIEGRTRC-----LVYELVHNGSVESHLHGVDK-NRGPLDWEA 476
+L+ HH N++ L I + LV EL+ + L V R +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVIS-PQ 134
Query: 477 RMK-IALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ-- 533
++ GL LH ++ V+HRD N+LL D+ + DF LARE T +
Sbjct: 135 HIQYFMYHILLGLHVLH-EAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKT 191
Query: 534 -HISTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLSGR 576
+++ R Y APE M K D++S G V+ E+ + +
Sbjct: 192 HYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDRE-----FIAEVEMLSRLH 429
EK+ +GEG +G VY + G A+K + + E I E+ +L L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALK---KIRLEKEDEGIPSTTIREISILKELK 58
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGV-DKNRGPLDWEARMKIALGAARGL 488
H N+VKL + + LV+E + + L + D G L+ L G+
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHL-----DQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAP 548
AY H+ RV+HRD K N+L+ + K++DFGLAR + + ++ T Y AP
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAP 169
Query: 549 EYAMTGHLLVKSDVYSYGV-------VLLELLSGR 576
+ +L+ S YS + + E+++G
Sbjct: 170 D------VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 50/221 (22%), Positives = 87/221 (39%), Gaps = 38/221 (17%)
Query: 381 RILGEGGFGCVYHGV-MDNGTEVAVKLLTRN--NQNGDREFIA----EVEMLSRLH---- 429
+LG+GGFG V+ G + + +VA+K++ RN EV +L ++
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 430 HRNLVKLIGICIEGRTR-CLVYELVHNGS-----VESHLHGVDKNRGPLD-WEARMKIAL 482
H +++L+ E + LV E + GPL +R
Sbjct: 97 HPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEK--------GPLGEGPSR-CFFG 146
Query: 483 GAARGLAYLHEDSNPRVIHRDFKASNVLL-EDDFTPKVSDFGLAREATEGSQHISTRVMG 541
+ + H V+HRD K N+L+ K+ DFG + G
Sbjct: 147 QVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---G 200
Query: 542 TFGYVAPEYAMTGHLLV--KSDVYSYGVVLLELLSGRKPVD 580
T Y PE+ ++ H + V+S G++L +++ G P +
Sbjct: 201 TRVYSPPEW-ISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 27/201 (13%), Positives = 53/201 (26%), Gaps = 43/201 (21%)
Query: 383 LGEGGFGCVYHGVMDN--GTEVAVKLLTRNNQNGD---REFIAEVEMLSRLHHRNLVKLI 437
G + + D +VA+ + D +E ++ LSR+ + +++
Sbjct: 39 HGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 438 GICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNP 497
+ +V E + GS++ ++ A H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA------DTSPSPVGAIRAMQSLAAAADAAHRAG-- 149
Query: 498 RVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLL 557
V S V + D ++ +A
Sbjct: 150 -VALSIDHPSRVRVSIDGDVVLAYPATMPDANP--------------------------- 181
Query: 558 VKSDVYSYGVVLLELLSGRKP 578
+ D+ G L LL R P
Sbjct: 182 -QDDIRGIGASLYALLVNRWP 201
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-19
Identities = 57/214 (26%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTR---NNQNGDREFIAEVEMLSRLH 429
+++ + + +G G G V VA+K L+R N + R + E+ ++ ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 82
Query: 430 HRNLVKLIGICIEGRTRC------LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIAL- 482
H+N++ L+ + ++ +V EL+ +++L V + LD RM L
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQV--IQMELD-HERMSYLLY 134
Query: 483 GAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGT 542
G+ +LH + +IHRD K SN++++ D T K+ DFGLAR A G+ + T + T
Sbjct: 135 QMLCGIKHLH-SAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVT 189
Query: 543 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGR 576
Y APE + D++S G ++ E++ G
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 373 ATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNG-DREFIAEVEMLSRLHH 430
++ +F LG G + VY G+ G VA+K + +++ G I E+ ++ L H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHL--HGVDKNRGPLDWEARMKIALGAARGL 488
N+V+L + LV+E + N ++ ++ V L+ +GL
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAP 548
A+ HE+ +++HRD K N+L+ K+ DFGLAR S+ V+ T Y AP
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAP 177
Query: 549 EYAMTGHLLVKSDVYSYGV-------VLLELLSGR 576
+ +L+ S YS + +L E+++G+
Sbjct: 178 D------VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 4e-19
Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTR---NNQNGDREFIAEVEMLSRLH 429
+++ + + +G G G V VA+K L+R N + R + E+ ++ ++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 119
Query: 430 HRNLVKLIGICIEGRTRC------LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALG 483
H+N++ L+ + +T LV EL+ +++L V + LD E +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQV--IQMELDHERMSYLLYQ 172
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF 543
G+ +LH + +IHRD K SN++++ D T K+ DFGLAR T G+ + T + T
Sbjct: 173 MLCGIKHLH-SAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 227
Query: 544 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGR 576
Y APE + D++S G ++ E++ +
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 5e-19
Identities = 34/174 (19%), Positives = 63/174 (36%), Gaps = 15/174 (8%)
Query: 411 NQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRG 470
+ + ++ + +N V + + +L ++ +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENL-KDWMNRRCSLE 159
Query: 471 PLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE--- 527
+ + I + A + +LH ++HRD K SN+ D KV DFGL
Sbjct: 160 DREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216
Query: 528 --------ATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL 573
+ T +GT Y++PE + K D++S G++L ELL
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 20/96 (20%), Positives = 37/96 (38%), Gaps = 2/96 (2%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA-EVEMLSRLHHRN 432
F + +G GGFG V+ + A+K + N+ RE + EV+ L++L H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKN 468
+V+ +E E+ + +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSS 101
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 1e-18
Identities = 59/223 (26%), Positives = 105/223 (47%), Gaps = 31/223 (13%)
Query: 369 DLEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA-----EV 422
D++ +++ LGEG F VY + VA+K + +++ ++ I E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 423 EMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGV-DKNRGPLDWEARMK-I 480
++L L H N++ L+ LV++ + E+ L + N L + +K
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-----ETDLEVIIKDNSLVLT-PSHIKAY 117
Query: 481 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM 540
L +GL YLH+ ++HRD K +N+LL+++ K++DFGLA+ ++ + +V+
Sbjct: 118 MLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV 174
Query: 541 GTFGYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLSGR 576
T Y APE LL + +Y GV +L ELL
Sbjct: 175 -TRWYRAPE------LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTR---NNQNGDREFIAEVEMLSRLH 429
+ + +G G +G V V G +VA+K L R + R + E+ +L +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMR 82
Query: 430 HRNLVKLIGICIEGRTRC------LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALG 483
H N++ L+ + T LV + + L + K+ L + +
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHE-KLGEDRIQFLVYQ 136
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA-TEGSQHISTRVMGT 542
+GL Y+H +IHRD K N+ + +D K+ DFGLAR+A +E + ++ TR
Sbjct: 137 MLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW--- 190
Query: 543 FGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLSGR 576
Y APE + ++ D++S G ++ E+++G+
Sbjct: 191 --YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 62/258 (24%), Positives = 100/258 (38%), Gaps = 45/258 (17%)
Query: 339 LSSSIASSTSVSLMSTMATCILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVM-D 397
+ + A + A + D F +ILGEG F V
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPRKKRPED-------FKFGKILGEGSFSTVVLARELA 53
Query: 398 NGTEVAVKLL-----TRNNQNGDREFI-AEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451
E A+K+L + N+ ++ E +++SRL H VKL +
Sbjct: 54 TSREYAIKILEKRHIIKENK---VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 110
Query: 452 LVHNGSVESHLHGVDKNRGPLDWEARMK-----IALGAARGLAYLHEDSNPRVIHRDFKA 506
NG + ++ + G D E + I L YLH +IHRD K
Sbjct: 111 YAKNGELLKYI----RKIGSFD-ETCTRFYTAEIVSA----LEYLHGKG---IIHRDLKP 158
Query: 507 SNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM-GTFGYVAPEYAMTGHLLVK-----S 560
N+LL +D +++DFG A+ + S+ GT YV+PE L K S
Sbjct: 159 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL-----LTEKSACKSS 213
Query: 561 DVYSYGVVLLELLSGRKP 578
D+++ G ++ +L++G P
Sbjct: 214 DLWALGCIIYQLVAGLPP 231
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 52/215 (24%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTR---NNQNGDREFIAEVEMLSRLH 429
+ + S +G G +G V + +G +VA+K L+R + R + E+ +L +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQ 81
Query: 430 HRNLVKLIGICIEGRTRC------LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALG 483
H N++ L+ + + LV + ++ L + E +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGL--KFSEEKIQYLVYQ 134
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG-SQHISTRVMGT 542
+GL Y+H + V+HRD K N+ + +D K+ DFGLAR A + ++ TR
Sbjct: 135 MLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW--- 188
Query: 543 FGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLSGR 576
Y APE ++ ++ D++S G ++ E+L+G+
Sbjct: 189 --YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 7e-18
Identities = 50/252 (19%), Positives = 91/252 (36%), Gaps = 49/252 (19%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA-----EVEMLSR 427
+++ + ++G G +G V VA+K + R ++ E+ +L+R
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED---LIDCKRILREIAILNR 108
Query: 428 LHHRNLVKLIGICIEGRTRC-----LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIAL 482
L+H ++VK++ I I +V E+ +S + + L +
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLTELHIKTLLY 163
Query: 483 GAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGT 542
G+ Y+H S ++HRD K +N L+ D + KV DFGLAR S +
Sbjct: 164 NLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 543 FGYVAPEYA----------MTGH----------LLVKSDVYSYGV-------VLLELLSG 575
+TGH L++ + Y+ + + ELL+
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280
Query: 576 RKPVDMSQPQGQ 587
K
Sbjct: 281 IKENVAYHADRG 292
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 9e-18
Identities = 56/239 (23%), Positives = 92/239 (38%), Gaps = 46/239 (19%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIA-----EVEMLSR 427
+ + K ++G G +G VY + VA+K + R ++ E+ +L+R
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED---LIDCKRILREITILNR 81
Query: 428 LHHRNLVKLIGICIEGRTRC-----LVYELVHNGSVESHLHGVDKNRGPLDWEARMK-IA 481
L +++L + I +V E+ +S L + K L E +K I
Sbjct: 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLT-EEHIKTIL 135
Query: 482 LGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMG 541
G ++HE S +IHRD K +N LL D + KV DFGLAR +
Sbjct: 136 YNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 542 TFGYVAPEYA-----MTGH----------LLVKS-------DVYSYGVVLLELLSGRKP 578
P +T H L++ D++S G + ELL+ +
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 53/220 (24%), Positives = 82/220 (37%), Gaps = 36/220 (16%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDRE-----FIAEVEMLSRL 428
+++ LGEG +G VY + VA+K R + E I EV +L L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIK---RIRLEHEEEGVPGTAIREVSLLKEL 90
Query: 429 HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGL 488
HRN+++L + L++E E+ L + G+
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTP-----KVSDFGLAREATEGSQHISTRVMGTF 543
+ H R +HRD K N+LL K+ DFGLAR + + ++ T
Sbjct: 146 NFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TL 201
Query: 544 GYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLSGR 576
Y PE +L+ S YS V + E+L
Sbjct: 202 WYRPPE------ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 52/256 (20%), Positives = 101/256 (39%), Gaps = 67/256 (26%)
Query: 370 LEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL 428
LE +++K+S + LG G FG V +++G A+K + ++ + +RE ++++ L
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVL 57
Query: 429 HHRNLVKLIGI---CIEGRTRCLVYELVHNGSVESHLHGVDKNRGP-------------- 471
H N++KL+ + + HN + + ++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 472 ----------LDWEARMKIALGAA----------RGLAYLHEDSNPRVIHRDFKASNVLL 511
L R ++ R + ++H + + HRD K N+L+
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLV 174
Query: 512 -EDDFTPKVSDFGLAREATEGSQHIS---TRVMGTFGYVAPEYAMTGHLLVKS------- 560
D T K+ DFG A++ ++ +R Y APE L++ +
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPE------LMLGATEYTPSI 223
Query: 561 DVYSYGVVLLELLSGR 576
D++S G V EL+ G+
Sbjct: 224 DLWSIGCVFGELILGK 239
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 60/225 (26%), Positives = 92/225 (40%), Gaps = 36/225 (16%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLT--RNNQNGDREFIAEVEMLSRLHH 430
+ F K +LGEG +G V G VA+K + R E+++L H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKH 68
Query: 431 RNLVKLIGICIEGRTRC-----LVYELVHNGSVESHLHGVDKNRGPLDWEARMKI----A 481
N++ + I ++ EL+ ++ LH V + L + ++
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQ-MLS-DDHIQYFIYQT 121
Query: 482 LGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMG 541
L R + LH + VIHRD K SN+L+ + KV DFGLAR E + S
Sbjct: 122 L---RAVKVLH--GS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 542 TF---GYV------APEYAMTGHLLVKS-DVYSYGVVLLELLSGR 576
+V APE +T ++ DV+S G +L EL R
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGD---REFIAEVEMLSRLH 429
E++ + +G G +G V G VAVK L+R Q+ R + E+ +L +
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 86
Query: 430 HRNLVKLIGICIEGRTRC------LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALG 483
H N++ L+ + R+ LV L+ + L+ + K + L + +
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQ-KLTDDHVQFLIYQ 140
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG-SQHISTRVMGT 542
RGL Y+H + +IHRD K SN+ + +D K+ DFGLAR + + +++TR
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW--- 194
Query: 543 FGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLSGR 576
Y APE + ++ D++S G ++ ELL+GR
Sbjct: 195 --YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLT--RNNQNGDREFIAEVEMLSRLHH 430
++++ +GEG +G V N VA+K ++ + R E+++L R H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 84
Query: 431 RNLVKLIGICIEGRTRC-----LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAA 485
N++ + I +V +L+ E+ L+ + K + L +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQ-HLSNDHICYFLYQIL 138
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGY 545
RGL Y+H +N V+HRD K SN+LL K+ DFGLAR A H T + T Y
Sbjct: 139 RGLKYIH-SAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADP--DHDHTGFL-T-EY 191
Query: 546 V------APEYAMTGHLLVKS-DVYSYGVVLLELLSGR 576
V APE + KS D++S G +L E+LS R
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 38/227 (16%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLT-RNNQNGDREFIAEVEMLSRLHHR 431
++ + LG GG G V+ V D VA+K + + Q+ E++++ RL H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHD 68
Query: 432 NLVKLIGICIEGRTRC--------------LVYELVHNGSVESHLHGVDKNRGPLDWEAR 477
N+VK+ I ++ +V E + E+ L V + GPL E
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQ-GPLLEEHA 122
Query: 478 MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL-EDDFTPKVSDFGLAREATEGSQHIS 536
RGL Y+H + V+HRD K +N+ + +D K+ DFGLAR +
Sbjct: 123 RLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLAR--IMDPHYSH 177
Query: 537 TRVMGTFGYV------APEYAMTGHLLVKS-DVYSYGVVLLELLSGR 576
+ + + +P ++ + K+ D+++ G + E+L+G+
Sbjct: 178 KGHL-S-EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 7e-17
Identities = 51/223 (22%), Positives = 94/223 (42%), Gaps = 45/223 (20%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHR 431
+ + R LG G + V+ + + N +V VK+L ++ E+++L L
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNR--GPL-DWEAR--MKIALGAAR 486
N++ L I + +R V H++ D + L D++ R M L +
Sbjct: 92 NIITLADIVKDPVSRTPAL-------VFEHVNNTDFKQLYQTLTDYDIRFYMYEIL---K 141
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLL-EDDFTPKVSDFGLAREATEGSQ---HISTRVMGT 542
L Y H S ++HRD K NV++ + ++ D+GLA G + +++R
Sbjct: 142 ALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY--- 195
Query: 543 FGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLSGRKP 578
+ PE LLV D++S G +L ++ ++P
Sbjct: 196 --FKGPE------LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 9e-17
Identities = 49/217 (22%), Positives = 87/217 (40%), Gaps = 35/217 (16%)
Query: 383 LGEGGFGCVYHGV---MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGI 439
+G G +G VY + + A+K + E+ +L L H N++ L +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTGISMSACREIALLRELKHPNVISLQKV 86
Query: 440 CIEGRTRC--LVYE-LVH--NGSVESHLHGVDKNRG-PLDWEARMKIALGAARGLAYLHE 493
+ R L+++ H ++ H + L + G+ YLH
Sbjct: 87 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH- 145
Query: 494 DSNPRVIHRDFKASNVLLEDDFTP----KVSDFGLAREATEGSQ---HISTRVMGTFGYV 546
+N V+HRD K +N+L+ + K++D G AR + + V+ TF Y
Sbjct: 146 -AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYR 202
Query: 547 APEYAMTGHLLVKS-------DVYSYGVVLLELLSGR 576
APE LL+ + D+++ G + ELL+
Sbjct: 203 APE------LLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 46/229 (20%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVK-LLTRNNQNGDREF----IAEVEMLSRL 428
K+ +G+G FG V+ G +VA+K +L N + G F + E+++L L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLL 73
Query: 429 HHRNLVKLIGICIEGRTRC--------LVYELVHNGSVESHLHGV-DKNRGPLDWEARMK 479
H N+V LI IC + LV++ E L G+ + +K
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-----EHDLAGLLSNVLVKFT-LSEIK 127
Query: 480 -IALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE----ATEGSQH 534
+ GL Y+H + +++HRD KA+NVL+ D K++DFGLAR
Sbjct: 128 RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLSGR 576
+ RV+ T Y PE LL+ Y + ++ E+ +
Sbjct: 185 YTNRVV-TLWYRPPE------LLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 34/218 (15%)
Query: 377 FSSKRILGEGGFGCVYHGVM--DNGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHR 431
F R +G+G FG V V D A+K + + +N R E++++ L H
Sbjct: 17 FEILRAIGKGSFGKV-CIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP 75
Query: 432 NLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK-----IALGAA 485
LV L + +V +L+ G + HL + E +K + +
Sbjct: 76 FLVNLWY-SFQDEEDMFMVVDLLLGGDLRYHL----QQNVHFK-EETVKLFICELVMA-- 127
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGY 545
L YL R+IHRD K N+LL++ ++DF +A +Q + + GT Y
Sbjct: 128 --LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPY 180
Query: 546 VAPE----YAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
+APE G+ + D +S GV ELL GR+P
Sbjct: 181 MAPEMFSSRKGAGYS--FAVDWWSLGVTAYELLRGRRP 216
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 56/268 (20%), Positives = 94/268 (35%), Gaps = 84/268 (31%)
Query: 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRN 432
+ + ++LG G G V + A+K+L + EVE+ R +
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPH 72
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGV----------DK--NRGPLDW---EAR 477
+V+++ VYE ++ G L V + +RG + EA
Sbjct: 73 IVRIVD----------VYENLYAG--RKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120
Query: 478 --MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREATEGS 532
MK A + YLH + + HRD K N+L + K++DFG A+E T
Sbjct: 121 EIMKSIGEA---IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK 174
Query: 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVT 592
Y D++S GV++ LL G P
Sbjct: 175 -----------------YDK------SCDMWSLGVIMYILLCGYPPF------------- 198
Query: 593 WARPLLTTREGLEQLVDPSLAGSYDFDD 620
++ L G++ + G Y+F +
Sbjct: 199 YSNHGLAISPGMKTRI---RMGQYEFPN 223
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 6e-16
Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 17/129 (13%)
Query: 458 VESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP 517
VE D + L E + + A+G+ +L ++ + IHRD A N+LL +
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVV 232
Query: 518 KVSDFGLAREATEGSQHIST-------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLL 570
K+ DFGLAR+ + ++ + M APE ++SDV+S+GV+L
Sbjct: 233 KICDFGLARDIYKDPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLW 286
Query: 571 ELLS-GRKP 578
E+ S G P
Sbjct: 287 EIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 31/161 (19%), Positives = 57/161 (35%), Gaps = 20/161 (12%)
Query: 375 EKFSSKRILGEGGFGCVYHGV------MDNGTEVAVKLLTRNNQNGDR-EFIAEVEMLSR 427
++ + LG G FG V VAVK+L + + ++E+++L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 428 L-HHRNLVKLIGICI-EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAA 485
+ HH N+V L+G C G ++ E G++ ++L R +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-----------SKRNEFVPYKT 130
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526
+G + I D K + + S F +
Sbjct: 131 KGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 65/227 (28%), Positives = 98/227 (43%), Gaps = 38/227 (16%)
Query: 372 KATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVK-LLTRNNQNGDREF----IAEVEML 425
AT ++ +G G +G VY +G VA+K + N G + EV +L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 426 SRLH---HRNLVKLIGICIEGRTRC-----LVYELVHNGSVESHLHGV--DKNRGPLDWE 475
RL H N+V+L+ +C RT LV+E V + L L E
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-----DQDLRTYLDKAPPPGLPAE 120
Query: 476 ARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535
+ RGL +LH + ++HRD K N+L+ T K++DFGLAR Q
Sbjct: 121 TIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMA 175
Query: 536 STRVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVLLELLSGR 576
T V+ T Y APE +L++S D++S G + E+ +
Sbjct: 176 LTPVVVTLWYRAPE------VLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 66/226 (29%), Positives = 104/226 (46%), Gaps = 38/226 (16%)
Query: 372 KATEKFSSKRILGEGGFGCVYHG--VMDNGTEVAVK-LLTRNNQNGD-----REFIAEVE 423
+A +++ +GEG +G V+ + + G VA+K + + + G RE +A +
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLR 66
Query: 424 MLSRLHHRNLVKLIGICIEGRTRC-----LVYELVHNGSVESHLHGV-DKNRGPLDWEAR 477
L H N+V+L +C RT LV+E V + L DK P
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-----DQDLTTYLDKVPEPGVPTET 121
Query: 478 MK-IALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIS 536
+K + RGL +LH S+ RV+HRD K N+L+ K++DFGLAR Q
Sbjct: 122 IKDMMFQLLRGLDFLH--SH-RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMAL 176
Query: 537 TRVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVLLELLSGR 576
T V+ T Y APE +L++S D++S G + E+ +
Sbjct: 177 TSVVVTLWYRAPE------VLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 40/232 (17%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTR---NNQNGDREFIAEVEMLSRLH 429
K+ + LG+G +G V+ + G VAVK + N+ + R F E+ +L+ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELS 66
Query: 430 -HRNLVKLIGICI--EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMK-IALGAA 485
H N+V L+ + R LV++ +E+ LH V + L+ + +
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDY-----METDLHAVIRAN-ILE-PVHKQYVVYQLI 119
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF-- 543
+ + YLH ++HRD K SN+LL + KV+DFGL+R + + +
Sbjct: 120 KVIKYLH-SGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 544 ------------GYV------APEYAMTGHLLVKS-DVYSYGVVLLELLSGR 576
YV APE + K D++S G +L E+L G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 49/226 (21%), Positives = 90/226 (39%), Gaps = 48/226 (21%)
Query: 381 RILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH---------- 429
R LG G F V+ M N T VA+K++ R ++ E+++L R++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 430 -HRNLVKLIG----ICIEGRTRCLVYELVHNGSVESHLHGVDK--NRGPLDWEARMKIAL 482
+++KL+ G +V+E++ +L + K + +I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLG-----ENLLALIKKYEHRGIPLIYVKQISK 138
Query: 483 GAARGLAYLHEDSNPRVIHRDFKASNVLLED------DFTPKVSDFGLAREATEGSQHIS 536
GL Y+H +IH D K NVL+E K++D G A +H +
Sbjct: 139 QLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG---NACWYDEHYT 193
Query: 537 TRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLSGR 576
+ Y +PE + +D++S ++ EL++G
Sbjct: 194 NSIQTRE-YRSPEVLLGAPWGC------GADIWSTACLIFELITGD 232
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 45/216 (20%), Positives = 85/216 (39%), Gaps = 25/216 (11%)
Query: 377 FSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNN--QNGDRE-FIAEVEMLSRLHHRN 432
F +++G G FG V + + A+K+L + + + F E ++L +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMK-----IALGAARG 487
+ L + LV + G + + L K L E + + +
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLL---SKFEDRLP-EEMARFYLAEMVIA---- 187
Query: 488 LAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVA 547
+ +H+ +HRD K N+L++ + +++DFG + E S+ +GT Y++
Sbjct: 188 IDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 548 PEYAMTGHLLVKS-----DVYSYGVVLLELLSGRKP 578
PE D +S GV + E+L G P
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 33/225 (14%)
Query: 375 EKFSSKRILGEGGFGCVYHGVM--DNGTEVAVKLLTRNN--QNGDREFI-AEVEMLSRLH 429
++F + LG G FG V V ++G A+K+L + + E E +L ++
Sbjct: 41 DQFDRIKTLGTGSFGRV-MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMK-----IALGA 484
LVKL + +V E V G + SHL + G E + I L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFS-EPHARFYAAQIVLT- 153
Query: 485 ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM-GTF 543
YLH +I+RD K N+L++ +V+DFG A+ T + GT
Sbjct: 154 ---FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTP 202
Query: 544 GYVAPEYAMT-GHLLVKS-DVYSYGVVLLELLSGRKPVDMSQPQG 586
+APE ++ G+ K+ D ++ GV++ E+ +G P QP
Sbjct: 203 EALAPEIILSKGY--NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 49/215 (22%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 377 FSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNN--QNGDRE-FIAEVEMLSRLHHRN 432
F +++G G F V M G A+K++ + + + G+ F E ++L R
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 433 LVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIA-LGAARGLAY 490
+ +L + LV E G + + L + R P + AR +A + A +
Sbjct: 123 ITQLHF-AFQDENYLYLVMEYYVGGDLLTLLSKFGE-RIPAEM-ARFYLAEIVMA--IDS 177
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
+H +HRD K N+LL+ +++DFG + S +GT Y++PE
Sbjct: 178 VHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 551 AMTGHLLVKSDVY-------SYGVVLLELLSGRKP 578
+ Y + GV E+ G+ P
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.5 bits (169), Expect = 8e-13
Identities = 39/253 (15%), Positives = 70/253 (27%), Gaps = 67/253 (26%)
Query: 373 ATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLL--------TRNNQNGDREFIAEVEM 424
TEK +GEG FG V+ + + T VA+K++ ++Q E + E+ +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 425 LSRLH---------HRNLVKLIGICI------------------------------EGRT 445
L + L + +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 446 RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFK 505
+V E G + I LA + R HRD
Sbjct: 137 LFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLH 189
Query: 506 ASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAP--EYAMTGHLLVKSDVY 563
NVLL+ K+ + +T + + G +Y ++ V+
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSST----------IPSCGLQVSIIDYTLSRLERDGIVVF 239
Query: 564 SYGVVLLELLSGR 576
+ +L +G
Sbjct: 240 CDVSMDEDLFTGD 252
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-13
Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 25/215 (11%)
Query: 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNN--QNGDREFI-AEVEMLSRLHH 430
+F ++LG+G FG V G A+K+L + + E +L H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 431 RNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK-----IALGA 484
L L + R C V E + G + HL E R + I
Sbjct: 208 PFLTALKY-SFQTHDRLCFVMEYANGGELFFHLS----RERVFS-EDRARFYGAEIVSA- 260
Query: 485 ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFG 544
L YLH + N V++RD K N++L+ D K++DFGL +E + + T GT
Sbjct: 261 ---LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPE 314
Query: 545 YVAPEYAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
Y+APE + + ++ D + GVV+ E++ GR P
Sbjct: 315 YLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 34/223 (15%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH 429
EK +++ ++G+G FG V VA+K++ +N + + EV +L ++
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMN 108
Query: 430 HR------NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRG--PLDWEARMKIA 481
+V L + CLV+E++ +L+ + +N + K A
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-----YNLYDLLRNTNFRGVSLNLTRKFA 163
Query: 482 LGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP--KVSDFGLAREATEGSQHISTRV 539
L +L +IH D K N+LL + K+ DFG + + Q I +
Sbjct: 164 QQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYI 219
Query: 540 MGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLSGR 576
F Y +PE Y + D++S G +L+E+ +G
Sbjct: 220 QSRF-YRSPEVLLGMPYDL------AIDMWSLGCILVEMHTGE 255
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 60/234 (25%), Positives = 108/234 (46%), Gaps = 31/234 (13%)
Query: 360 LSVKTFALSDLEKAT-EKFSSKRILGEGGFGCVY----HGVMDNGTEVAVKLLTRNN--Q 412
+++ EKA +F ++LG+G FG V+ D A+K+L +
Sbjct: 8 IAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV 67
Query: 413 NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGP 471
E ++L ++H +VKL + + L+ + + G + + L
Sbjct: 68 RDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS----KEVM 122
Query: 472 LDWEARMK-----IALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526
E +K +AL L +LH +I+RD K N+LL+++ K++DFGL++
Sbjct: 123 FT-EEDVKFYLAELALA----LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK 174
Query: 527 EATEGSQHISTRVMGTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
E+ + + + GT Y+APE GH +S D +S+GV++ E+L+G P
Sbjct: 175 ESIDHEKKAYS-FCGTVEYMAPEVVNRRGH--TQSADWWSFGVLMFEMLTGTLP 225
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 49/222 (22%), Positives = 82/222 (36%), Gaps = 34/222 (15%)
Query: 376 KFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHH-RNL 433
F + +G G FG + G + VA+KL ++ E +L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGI 67
Query: 434 VKLIGICIEGRTRCLVYELVHNG-SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
++ G+ +V EL+ G S+E D + + IA+ + Y+H
Sbjct: 68 PQVYYFGPCGKYNAMVLELL--GPSLEDLF---DLCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVS-----DFGLARE--ATEGSQHISTR----VMG 541
+ +I+RD K N L+ DF LA+E E +HI R + G
Sbjct: 123 SKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179
Query: 542 TFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLSGRKP 578
T Y + HL + D+ + G + + L G P
Sbjct: 180 T-----ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 18/211 (8%)
Query: 377 FSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNN--QNGDRE-FIAEVEMLSRLHHRN 432
+ +++G G FG V A+KLL++ + D F E ++++ +
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIA-LGAARGLAYL 491
+V+L + R +V E + G + + + P W AR A + A L +
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKW-ARFYTAEVVLA--LDAI 184
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA 551
H IHRD K N+LL+ K++DFG + + +GT Y++PE
Sbjct: 185 HSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 241
Query: 552 MTGHLLVK----SDVYSYGVVLLELLSGRKP 578
+ D +S GV L E+L G P
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 42/246 (17%), Positives = 88/246 (35%), Gaps = 48/246 (19%)
Query: 367 LSDLEKATEKFSSKRILGEGGFGCVYHGV---------MDNGTEVAVKLLTRNNQNGDR- 416
L+D ++ K G +Y + ++KL ++ + +
Sbjct: 36 LTDKSG--RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQ 93
Query: 417 ---EFIAEVEMLSRLHHRNLVKLIGI-------CIEGRTRCLVYELVHNG-SVESHLHGV 465
+ A+ +++ L+ I + + R LV + G S++S L
Sbjct: 94 NFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALD-- 149
Query: 466 DKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKV--SDFG 523
+ L + +++A L +LHE+ +H + A N+ ++ + +V + +G
Sbjct: 150 VSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYG 206
Query: 524 LAREATEGSQHISTR------VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLEL 572
A +H++ G E+ M H +SD+ S G +L+
Sbjct: 207 FAFRYCPSGKHVAYVEGSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKW 261
Query: 573 LSGRKP 578
L G P
Sbjct: 262 LYGFLP 267
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 9e-12
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 35/216 (16%)
Query: 377 FSSKRILGEGGFGCVY---HGVMDNGTEVAVKLLTRNN--QNGDREFI-AEVEMLSRLHH 430
F R LG G FG V+ NG A+K+L + + E E MLS + H
Sbjct: 8 FQILRTLGTGSFGRVHLIRS--RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMK-----IALGAA 485
++++ G + + ++ + + G + S L + K + L
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL----RKSQRFP-NPVAKFYAAEVCLA-- 118
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM-GTFG 544
L YLH +I+RD K N+LL+ + K++DFG A+ + T + GT
Sbjct: 119 --LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPD 168
Query: 545 YVAPE-YAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
Y+APE + + KS D +S+G+++ E+L+G P
Sbjct: 169 YIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGYTP 202
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 54/221 (24%), Positives = 89/221 (40%), Gaps = 32/221 (14%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHH-RN 432
++ R +G G FG +Y G + G EVA+KL ++ + E ++ +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 66
Query: 433 LVKLIGICIEGRTRCLVYELVHNG-SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
+ + EG +V EL+ G S+E + + + +A + Y+
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL--GPSLEDLF---NFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 492 HEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLARE--ATEGSQHISTR----VMGT 542
H + IHRD K N L+ + + DFGLA++ QHI R + GT
Sbjct: 122 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 543 FGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLSGRKP 578
YA + HL + + D+ S G VL+ G P
Sbjct: 179 -----ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 47/238 (19%), Positives = 87/238 (36%), Gaps = 48/238 (20%)
Query: 376 KFSSKRILGEGGFGCVYHGVMDNGT------EVAVKLLTRNNQNGDREF-----IAEVEM 424
+ +G+GGFGC+Y M++ VK+ +N E A+ E
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 425 LSRLHHRNLVKLIGIC----------IEGRTRCLVYELVHNG-SVESHLHGVDKNRGPLD 473
+ + +K +G+ R ++ + G ++ + N
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIY---EANAKRFS 150
Query: 474 WEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKV--SDFGLARE--AT 529
+ ++++L L Y+HE +H D KASN+LL +V D+GLA
Sbjct: 151 RKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207
Query: 530 EGSQHISTR----VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLSGRKP 578
+ + GT E+ + H V + D+ G +++ L+G P
Sbjct: 208 GVHKAYAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 8e-11
Identities = 58/220 (26%), Positives = 88/220 (40%), Gaps = 36/220 (16%)
Query: 375 EKFSSKRILGEGGFGCVYHGVM-----DNGTEVAVKLLTRNN--QNGDREFI-AEVEMLS 426
F ++LG+G FG V+ G A+K+L + + E +L
Sbjct: 5 NDFDYLKLLGKGTFG----KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 427 RLHHRNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK-----I 480
H L L + R C V E + G + HL E R + I
Sbjct: 61 NTRHPFLTALKY-AFQTHDRLCFVMEYANGGELFFHLS----RERVFT-EERARFYGAEI 114
Query: 481 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVM 540
L YLH V++RD K N++L+ D K++DFGL +E + T
Sbjct: 115 VSA----LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FC 166
Query: 541 GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
GT Y+APE + ++ D + GVV+ E++ GR P
Sbjct: 167 GTPEYLAPEVLEDNDY--GRAVDWWGLGVVMYEMMCGRLP 204
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 52/221 (23%)
Query: 381 RILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHR------NL 433
+++G+G FG V VA+K++ RN + R+ E+ +L L + N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 434 VKLIG-------ICIEGRTRCLVYELVHNGSVESHLHGVDKNRG--PLDWEARMKIALGA 484
+ ++ IC+ +EL+ +L+ + K K A
Sbjct: 162 IHMLENFTFRNHICM-------TFELLS-----MNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 485 ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP--KVSDFGLAREATEG-SQHISTRVMG 541
+ L LH+ R+IH D K N+LL+ KV DFG + + +I +R
Sbjct: 210 LQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR--- 263
Query: 542 TFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLSGR 576
F Y APE Y M D++S G +L ELL+G
Sbjct: 264 -F-YRAPEVILGARYGM------PIDMWSLGCILAELLTGY 296
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 35/228 (15%)
Query: 371 EKAT-EKFSSKRILGEGGFGCVY----HGVMDNGTEVAVKLLTRNN---QNGDREFI-AE 421
EK E F ++LG G +G V+ D G A+K+L + + E E
Sbjct: 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 108
Query: 422 VEMLSRL-HHRNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK 479
++L + LV L + T+ L+ + ++ G + +HL R E ++
Sbjct: 109 RQVLEHIRQSPFLVTLHY-AFQTETKLHLILDYINGGELFTHL----SQRERFT-EHEVQ 162
Query: 480 -----IALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534
I L L +LH+ +I+RD K N+LL+ + ++DFGL++E
Sbjct: 163 IYVGEIVL----ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215
Query: 535 ISTRVMGTFGYVAPE---YAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
+ GT Y+AP+ +GH K+ D +S GV++ ELL+G P
Sbjct: 216 RAYDFCGTIEYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGASP 261
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 52/223 (23%), Positives = 83/223 (37%), Gaps = 34/223 (15%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHH-RN 432
+ R +GEG FG ++ G + N +VA+K R + + E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 67
Query: 433 LVKLIGICIEGRTRCLVYELVHNG-SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
+ + EG LV +L+ G S+E L D + A + +
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLL--GPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPK-----VSDFGLAREATEGS--QHISTR----VM 540
HE S +++RD K N L+ + V DFG+ + + QHI R +
Sbjct: 123 HEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 179
Query: 541 GTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLSGRKP 578
GT Y + HL + D+ + G V + L G P
Sbjct: 180 GT-----ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 4e-10
Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 33/225 (14%)
Query: 371 EKAT-EKFSSKRILGEGGFGCVY----HGVMDNGTEVAVKLLTRNN---QNGDREFI-AE 421
EK E F R+LG+GG+G V+ + G A+K+L + D AE
Sbjct: 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 422 VEMLSRLHHRNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK- 479
+L + H +V LI + + L+ E + G + L G E
Sbjct: 72 RNILEEVKHPFIVDLIY-AFQTGGKLYLILEYLSGGELFMQLE----REGIFM-EDTACF 125
Query: 480 ----IALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535
I++ L +LH+ +I+RD K N++L K++DFGL +E+
Sbjct: 126 YLAEISMA----LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT 178
Query: 536 STRVMGTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
T GT Y+APE +GH ++ D +S G ++ ++L+G P
Sbjct: 179 HT-FCGTIEYMAPEILMRSGH--NRAVDWWSLGALMYDMLTGAPP 220
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 62.0 bits (150), Expect = 5e-10
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNN--QNGDREFI-AEVEMLSR-LH 429
F+ +LG+G FG V AVK+L ++ Q+ D E E +L+
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 430 HRNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKI-ALGAARG 487
L +L C + R V E V+ G + H+ V + + E A A G
Sbjct: 401 PPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-----EPHAVFYAAEIAIG 454
Query: 488 LAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVA 547
L +L +I+RD K NV+L+ + K++DFG+ +E T GT Y+A
Sbjct: 455 LFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIA 510
Query: 548 PEYAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
PE + KS D +++GV+L E+L+G+ P
Sbjct: 511 PE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 32/221 (14%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL 433
KF R +G G FG +Y G + EVA+KL ++ + + E ++ L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTG 64
Query: 434 V-KLIGICIEGRTRCLVYELVHNG-SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
+ + +EG LV +L+ G S+E + L + + +A + ++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL--GPSLEDLF---NFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPK---VSDFGLARE--ATEGSQHISTR----VMGT 542
H S +HRD K N L+ + DFGLA++ T QHI R + GT
Sbjct: 120 HSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
Query: 543 FGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLSGRKP 578
YA + HL + + D+ S G VL+ L G P
Sbjct: 177 -----ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 8e-10
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNN--QNGDREFI-AEVEMLSR-LH 429
E F ++LG+G FG V+ A+K L ++ + D E E +LS
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 430 HRNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK-----IALG 483
H L + + + V E ++ G + H+ + D +R I LG
Sbjct: 77 HPFLTHMFC-TFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFD-LSRATFYAAEIILG 130
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF 543
L +LH +++RD K N+LL+ D K++DFG+ +E G +T GT
Sbjct: 131 ----LQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTP 182
Query: 544 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
Y+APE + G S D +S+GV+L E+L G+ P
Sbjct: 183 DYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 35/220 (15%)
Query: 375 EKFSSKRILGEGGFGCVYHGVM-----DNGTEVAVKLLTRNN--QNGDREFI-AEVEMLS 426
+ F R++G G + V+ A+K++ + + D +++ E +
Sbjct: 9 QDFDLLRVIGRGSYA----KVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64
Query: 427 R-LHHRNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK----- 479
+ +H LV L C + +R V E V+ G + H+ + L E +
Sbjct: 65 QASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLP-EEHARFYSAE 118
Query: 480 IALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRV 539
I+L L YLHE +I+RD K NVLL+ + K++D+G+ +E ST
Sbjct: 119 ISLA----LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-F 170
Query: 540 MGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
GT Y+APE + G S D ++ GV++ E+++GR P
Sbjct: 171 CGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 49/236 (20%), Positives = 87/236 (36%), Gaps = 47/236 (19%)
Query: 376 KFSSKRILGEGGFGCVYHGV-MDNGTEVA---VKLLTRNNQNGDREF-----IAEVEMLS 426
++ + +G GGFG +Y + + A VK+ + N E +A+ + +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 427 RLHHRNLVKLIGI----------CIEGRTRCLVYELVHNG-SVESHLHGVDKNRGPLDWE 475
+ R + +GI R +V E + G ++ G
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS----GQNGTFKKS 151
Query: 476 ARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKV--SDFGLAREATEGSQ 533
+++ + L Y+HE+ +H D KA+N+LL +V +D+GL+
Sbjct: 152 TVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208
Query: 534 HI------STRVMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLSGRKP 578
H GT E+ + H V +SDV G +L L G+ P
Sbjct: 209 HKQYQENPRKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 29/217 (13%)
Query: 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNN--QNGDREFI-AEVEMLSR-LH 429
F+ +LG+G FG V AVK+L ++ Q+ D E E +L+
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 430 HRNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK-----IALG 483
L +L C + R V E V+ G + H+ V + + E IA+G
Sbjct: 80 PPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-----EPHAVFYAAEIAIG 133
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF 543
L +L +I+RD K NV+L+ + K++DFG+ +E T GT
Sbjct: 134 ----LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTP 185
Query: 544 GYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
Y+APE A + KS D +++GV+L E+L+G+ P
Sbjct: 186 DYIAPEIIAYQPY--GKSVDWWAFGVLLYEMLAGQAP 220
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 27/216 (12%)
Query: 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREF---IAEVEMLSR-LH 429
+ F R++G G + V + A++++ + N D + E + + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 430 HRNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK-----IALG 483
H LV L C + +R V E V+ G + H+ + L E + I+L
Sbjct: 112 HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLP-EEHARFYSAEISLA 165
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF 543
L YLHE +I+RD K NVLL+ + K++D+G+ +E ST GT
Sbjct: 166 ----LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTP 217
Query: 544 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
Y+APE + G S D ++ GV++ E+++GR P
Sbjct: 218 NYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 49/267 (18%), Positives = 85/267 (31%), Gaps = 76/267 (28%)
Query: 374 TEKFSSKRILGEGGFGCVYHGVMDNGTE--VAVKLLTRNNQNGDREFIAEVEMLSRLH-- 429
++ R LG G F V+ D + VA+K++ + E+ +L +
Sbjct: 36 NGRYHVIRKLGWGHFSTVW-LSWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRNS 93
Query: 430 ------HRNLVKLIGI-CIEGRT---RCLVYELVHNGSVESHLHGVDKNR-GPLDWEARM 478
+V+L+ I G C+V+E++ L + K+ L
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLG----HHLLKWIIKSNYQGLPLPCVK 149
Query: 479 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE-------------------------- 512
KI +GL YLH +IH D K N+LL
Sbjct: 150 KIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 513 -----------------------DDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549
+ K++D G A +H + + T Y + E
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLG---NACWVHKHFTEDIQ-TRQYRSLE 263
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLSGR 576
+ +D++S + EL +G
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGD 290
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 8e-09
Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 37/221 (16%)
Query: 375 EKFSSKRILGEGGFGCVYHGVM-----DNGTEVAVKLLTRNN--QNGDREFI-AEVEMLS 426
+ F R+LG+G FG VM + G AVK+L ++ Q+ D E E +LS
Sbjct: 23 DNFEFIRVLGKGSFG----KVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 427 R-LHHRNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK----- 479
+H L +L C + R V E V+ G + H+ D EAR +
Sbjct: 79 LARNHPFLTQLFC-CFQTPDRLFFVMEFVNGGDLMFHIQ----KSRRFD-EARARFYAAE 132
Query: 480 IALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRV 539
I L +LH+ +I+RD K NVLL+ + K++DFG+ +E +T
Sbjct: 133 IIS----ALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC 185
Query: 540 MGTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
GT Y+APE + + D ++ GV+L E+L G P
Sbjct: 186 -GTPDYIAPEILQEMLY--GPAVDWWAMGVLLYEMLCGHAP 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 31/218 (14%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEV--AVKLLTRNN--QNGDREFI-AEVEMLSR-L 428
F +++G+G FG V EV AVK+L + + + + I +E +L + +
Sbjct: 38 SDFHFLKVIGKGSFGKVLL-ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV 96
Query: 429 HHRNLVKLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK-----IAL 482
H LV L + + V + ++ G + HL E R + IA
Sbjct: 97 KHPFLVGLHF-SFQTADKLYFVLDYINGGELFYHLQ----RERCFL-EPRARFYAAEIAS 150
Query: 483 GAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGT 542
L YLH + +++RD K N+LL+ ++DFGL +E E + ST GT
Sbjct: 151 A----LGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGT 202
Query: 543 FGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
Y+APE + ++ D + G VL E+L G P
Sbjct: 203 PEYLAPEVLHKQPY--DRTVDWWCLGAVLYEMLYGLPP 238
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 60/280 (21%), Positives = 98/280 (35%), Gaps = 91/280 (32%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL---- 428
F R +G+G FG V +DN AVK++ RN + R E ++L ++
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTRSAKIEADILKKIQNDD 92
Query: 429 -HHRNLVKLIG-------ICIEGRTRCLVYELVHNGSVESHLHGVDKNRG--PLDWEARM 478
++ N+VK G +C+ ++E + L+ + E
Sbjct: 93 INNNNIVKYHGKFMYYDHMCL-------IFEPLG-----PSLYEIITRNNYNGFHIEDIK 140
Query: 479 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP--------------------- 517
+ + L YL + + H D K N+LL+D +
Sbjct: 141 LYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 518 ----KVSDFGLAREATEGSQHISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGV 567
K+ DFG AT S + + + Y APE + + SD++S+G
Sbjct: 198 STGIKLIDFG---CATFKSDYHGSIINTRQ-YRAPEVILNLGWDV------SSDMWSFGC 247
Query: 568 VLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607
VL EL +G L T E +E L
Sbjct: 248 VLAELYTG-------------------SLLFRTHEHMEHL 268
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 57/276 (20%), Positives = 87/276 (31%), Gaps = 87/276 (31%)
Query: 374 TEKFSSKRILGEGGFGCVY--HGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHR 431
E++ LGEG FG V ++VA+K++ RN E+ +L ++ +
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RNVGKYREAARLEINVLKKIKEK 76
Query: 432 ------NLVKLIG-------ICIEGRTRCLVYELVHNGSVESHLHGVDKNRG--PLDWEA 476
V + +CI +EL+ + K P
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCI-------AFELLG-----KNTFEFLKENNFQPYPLPH 124
Query: 477 RMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP------------------- 517
+A L +LHE ++ H D K N+L +
Sbjct: 125 VRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
Query: 518 KVSDFGLAREATEGSQHISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLE 571
+V+DFG AT +H +T V Y PE +A DV+S G +L E
Sbjct: 182 RVADFG---SATFDHEHHTTIVATRH-YRPPEVILELGWAQ------PCDVWSIGCILFE 231
Query: 572 LLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607
G L T E E L
Sbjct: 232 YYRG-------------------FTLFQTHENREHL 248
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 61/281 (21%), Positives = 96/281 (34%), Gaps = 97/281 (34%)
Query: 374 TEKFSSKRILGEGGFGCVYHGVMD---NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHH 430
+ ++ LGEG FG V +D G VAVK++ +N +E+++L L+
Sbjct: 13 SARYEIVDTLGEGAFGKVVE-CIDHKAGGRHVAVKIV-KNVDRYCEAARSEIQVLEHLNT 70
Query: 431 R------NLVKLIG-------ICIEGRTRCLVYELVHNGSVESHLHGVDKNRG--PLDWE 475
V+++ ICI V+EL+ + K G P +
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICI-------VFELLG-----LSTYDFIKENGFLPFRLD 118
Query: 476 ARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP------------------ 517
K+A + + +LH ++ H D K N+L
Sbjct: 119 HIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 518 -KVSDFGLAREATEGSQH----ISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYG 566
KV DFG AT +H +STR Y APE ++ DV+S G
Sbjct: 176 IKVVDFG---SATYDDEHHSTLVSTRH-----YRAPEVILALGWSQ------PCDVWSIG 221
Query: 567 VVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607
+L+E G + T + E L
Sbjct: 222 CILIEYYLG-------------------FTVFPTHDSKEHL 243
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 9e-07
Identities = 94/680 (13%), Positives = 181/680 (26%), Gaps = 216/680 (31%)
Query: 105 HHHHHSKPHAVTPASSVRPGCDQICVEPLTATPYGSPCGCVFPMKVRLLLDVAPYSVFP- 163
HHHHH H + I + VF D P
Sbjct: 1 HHHHH---HMDFETGEHQYQYKDI-LS-------------VFEDAFVDNFDCKDVQDMPK 43
Query: 164 -VMNELEIE-------IAAGTYL--------QQSQVKIMGASADSQNQGKTVVDINLVPL 207
++++ EI+ +GT Q+ V+ N + I
Sbjct: 44 SILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR 103
Query: 208 GEKFDNTTAVLTYDRLWHKKVPLNLTLFGIYEVIYISYPGIPSSPPYES------STESG 261
+ DRL++ F Y V PY
Sbjct: 104 QPSMMTRMYIEQRDRLYNDNQV-----FAKYNV--------SRLQPYLKLRQALLELRPA 150
Query: 262 PSVSV----GSLPISANFGNKNQRMNFRTIAIIALSAFVLLLVFVGAISILIKW---RKA 314
+V + G G K +A+ ++ + I W +
Sbjct: 151 KNVLIDGVLG-------SG-KT------WVALDVCLSYKVQCKMDFKIF----WLNLKNC 192
Query: 315 RKPSS----------AVGPAFASSINKRSGIGSILSSSIASSTSVSLMSTM-ATCILSVK 363
P + + P + S + S I + SI + L S C+L V
Sbjct: 193 NSPETVLEMLQKLLYQIDPNWTSRSDHSSNI-KLRIHSIQAELRRLLKSKPYENCLL-V- 249
Query: 364 TFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLL--TRNNQNGD------ 415
L ++ + + C K+L TR Q D
Sbjct: 250 ---LLNV-------QNAKAWNAFNLSC--------------KILLTTRFKQVTDFLSAAT 285
Query: 416 REFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWE 475
I+ L + L+ ++ R + L E V + P
Sbjct: 286 TTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPRE-VLTTN-------------PR--- 328
Query: 476 ARMKIALGAAR---GLA----YLHEDSNPRVIHRDFKAS-NVLLEDDFTPKVSDFGLARE 527
++++ A GLA + H + + + ++S NVL ++ +
Sbjct: 329 ---RLSIIAESIRDGLATWDNWKHVNCDK--LTTIIESSLNVLEPAEYRKMFDRLSVFPP 383
Query: 528 ATEGSQHISTRVMGTFGYVAPEY---AMTGHL----LVKSDVYSYGVVLLELLSGRKPVD 580
+ HI T ++ + + + L LV+ + + + ++
Sbjct: 384 SA----HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY-----LE 434
Query: 581 MSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAA---IASMCVHPEVT 637
+ EN R ++ + ++D DD+ S H
Sbjct: 435 LKVK--LENEYALHRSIVDHYNIPK---------TFDSDDLIPPYLDQYFYSHIGH---- 479
Query: 638 H--RPFMGEVVQALKLIYNDTDETCGDCCSPKDSSVPDSDF-KGELVPSDSSWWNAGALT 694
H E + ++++ D F + ++ ++W +G++
Sbjct: 480 HLKNIEHPERMTLFRMVFLDF------------------RFLEQKIRHDSTAWNASGSIL 521
Query: 695 PRLT----YGQASSFITMEH 710
L Y +I
Sbjct: 522 NTLQQLKFYKP---YICDND 538
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 780 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.95 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.56 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.34 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.33 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.3 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.26 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.07 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.96 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.95 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.78 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.73 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.53 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.3 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.21 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.18 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.04 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.96 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.92 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.57 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.4 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.07 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.94 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.59 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 93.08 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 93.07 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 91.69 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.75 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 87.12 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=470.80 Aligned_cols=261 Identities=27% Similarity=0.453 Sum_probs=209.7
Q ss_pred cCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
++|...+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 57888899999999999999864 478899999987666666789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhcccccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCC
Q 048425 449 VYELVHNGSVESHLHGVDK-----------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP 517 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~-----------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~v 517 (780)
|||||++|+|.++|+.... ...+++|.++++|+.|||+||+|||+.+ ||||||||+||||++++++
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999975322 2357999999999999999999999987 9999999999999999999
Q ss_pred eeecccccccccCCC-ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcc
Q 048425 518 KVSDFGLAREATEGS-QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWAR 595 (780)
Q Consensus 518 KLsDFGLA~~~~~~~-~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~ 595 (780)
||+|||+|+...... ....+...||+.|||||++.+..++.|+|||||||+||||+| |+.||...... .+...+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~i- 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAIDCI- 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHHHHH-
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHHHHH-
Confidence 999999999765433 223456789999999999999999999999999999999999 89999754321 121111
Q ss_pred cccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 596 PLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 596 ~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
.. ... + ..+......+.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 274 --~~-g~~------~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 --TQ-GRE------L----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp --HH-TCC------C----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --Hc-CCC------C----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 11 100 1 11222345788999999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-54 Score=464.13 Aligned_cols=262 Identities=26% Similarity=0.421 Sum_probs=216.2
Q ss_pred cCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
++|...+.||+|+||+||+|++. +|..||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57888899999999999999864 478899999987666666789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhccccc---------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCee
Q 048425 449 VYELVHNGSVESHLHGVD---------KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKV 519 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~---------~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKL 519 (780)
|||||++|+|.++|+... .....++|.++++|+.|||+||+|||+.+ ||||||||+||||++++++||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997432 23457999999999999999999999987 999999999999999999999
Q ss_pred ecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccc
Q 048425 520 SDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPL 597 (780)
Q Consensus 520 sDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~l 597 (780)
+|||+|+........ ......||+.|||||++.++.++.|+|||||||+||||+| |+.||...... .+...+
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~i--- 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIECI--- 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHH---
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---
Confidence 999999876543322 2334579999999999999999999999999999999999 89999754321 122111
Q ss_pred cccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 598 LTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 598 l~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
.. +.. ...+......+.+|+.+||+.||++||||+||++.|+.+....
T Consensus 244 ~~-~~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 244 TQ-GRV----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp HH-TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred Hc-CCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 10 100 0112233457889999999999999999999999999887643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=461.60 Aligned_cols=258 Identities=28% Similarity=0.403 Sum_probs=211.4
Q ss_pred cCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 447 (780)
++++..+.||+|+||+||+|.+. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34556689999999999999862 568899999976543 34578999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhcccccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC
Q 048425 448 LVYELVHNGSVESHLHGVDK------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF 515 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~ 515 (780)
||||||++|+|.++|+.... ....++|.++++|+.|||+||+|||+.+ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999964321 1346999999999999999999999998 99999999999999999
Q ss_pred CCeeecccccccccCCC-ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhh
Q 048425 516 TPKVSDFGLAREATEGS-QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTW 593 (780)
Q Consensus 516 ~vKLsDFGLA~~~~~~~-~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~w 593 (780)
++||+|||+|+...... ....+...||+.|||||++.++.++.|+|||||||+||||+| |+.||..... ..+...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~~~ 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVEM 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHHHH
Confidence 99999999999765432 223455679999999999999999999999999999999999 8999975432 222222
Q ss_pred cccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 594 ARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 594 a~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
+. .+.. ...+.+....+.+|+.+||+.||++||+|+||++.|+..
T Consensus 260 i~----~~~~----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 IR----NRQV----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HH----TTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HH----cCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11 1110 112233446788999999999999999999999999854
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=452.56 Aligned_cols=262 Identities=27% Similarity=0.464 Sum_probs=206.8
Q ss_pred hcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
.++|...+.||+|+||+||+|++++ .||||+++.... ...++|.+|+++|++++|||||+++|+|.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 4677888999999999999998743 599999875433 234679999999999999999999999865 56899999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
||++|+|.++|+. ....++|.++++|+.|||+||+|||+.+ ||||||||+||||++++++||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 112 WCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred cCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999999973 4567999999999999999999999987 999999999999999999999999999876543
Q ss_pred C-ccceeccccCccccCchhhcc---CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 532 S-QHISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 532 ~-~~~~t~~~GT~~Y~APE~l~~---~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
. ....+..+||+.|||||++.+ +.++.|+|||||||+||||+||+.||....... .+... ... ..
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--~~~~~----~~~-----~~ 254 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--QIIFM----VGR-----GY 254 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHH----HHT-----TC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--HHHHH----Hhc-----CC
Confidence 2 223355689999999999864 468999999999999999999999997543211 11111 100 11
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
..|.+. ....+....+.+|+.+||+.||++||||.||++.|+.+....
T Consensus 255 ~~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 255 ASPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp CCCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred CCCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 112111 122234467889999999999999999999999999887543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=442.92 Aligned_cols=273 Identities=24% Similarity=0.333 Sum_probs=204.6
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecc----eeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGR----TRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~----~~~LV~ 450 (780)
++|.+.+.||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|+|.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4677889999999999999998 689999999965421 1223345666677899999999999998754 579999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCcEEecccCCcceEEcCCCCCeeeccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED-----SNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~-----~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA 525 (780)
|||++|+|.++|+. ..++|..+++|+.|+|+||+|||+. ..++||||||||+|||||+++++||+|||+|
T Consensus 81 Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999963 3699999999999999999999987 2456999999999999999999999999999
Q ss_pred ccccCCCcc---ceeccccCccccCchhhccC------CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccc
Q 048425 526 REATEGSQH---ISTRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARP 596 (780)
Q Consensus 526 ~~~~~~~~~---~~t~~~GT~~Y~APE~l~~~------~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ 596 (780)
+........ .....+||+.|||||++.+. .++.|+|||||||+||||+||+.|+....... .....+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~-~p~~~~~~~ 234 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ-LPYYDLVPS 234 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC-CTTTTTSCS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccc-ccchhcccc
Confidence 987654322 12346799999999998764 46789999999999999999998875432211 001111000
Q ss_pred ccccccc----cccccCCccCCCC-ChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 597 LLTTREG----LEQLVDPSLAGSY-DFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 597 ll~~~~~----l~~lvDp~L~~~~-~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
....... .....+|.+.... +.+....+.+|+.+||+.||++||||.||++.|+++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 0000001 1111223222211 234567889999999999999999999999999998754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=451.50 Aligned_cols=272 Identities=25% Similarity=0.397 Sum_probs=220.2
Q ss_pred cchHHHHHHhcCcccceeecccCceEEEEEEEeC------CcEEEEEEeeccCCc-chHHHHHHHHHhhhcCC-Cceeee
Q 048425 365 FALSDLEKATEKFSSKRILGEGGFGCVYHGVMDN------GTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHH-RNLVKL 436 (780)
Q Consensus 365 f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~~------g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~H-pNIV~L 436 (780)
+..++++...++|+..+.||+|+||+||+|.+.. ++.||||+++..... ..++|.+|+++|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4455666677899999999999999999998653 367999999765443 34679999999999965 899999
Q ss_pred eeeeeec-ceeEEEEeecCCCChhhhcccccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecc
Q 048425 437 IGICIEG-RTRCLVYELVHNGSVESHLHGVDK------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRD 503 (780)
Q Consensus 437 ~g~~~~~-~~~~LV~Ey~~~GSL~~~L~~~~~------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrD 503 (780)
+|+|.+. +..+||||||++|+|.++|+.... ....++|.+++.|+.|||+||+|||+.+ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999764 568999999999999999975322 1356999999999999999999999998 99999
Q ss_pred cCCcceEEcCCCCCeeecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCC
Q 048425 504 FKASNVLLEDDFTPKVSDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDM 581 (780)
Q Consensus 504 IKpsNILLd~~~~vKLsDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~ 581 (780)
|||+||||++++++||+|||+|+........ ..+...||+.|||||++.++.++.|+|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999977554333 3345679999999999999999999999999999999998 9999975
Q ss_pred CCccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 582 SQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 582 ~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
.... +.+... +..+. .+ ..+......+.+++..||+.||++||||.||++.|+.+++.
T Consensus 291 ~~~~--~~~~~~----i~~g~------~~----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 291 VKID--EEFCRR----LKEGT------RM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCCS--HHHHHH----HHHTC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHH--HHHHHH----HHcCC------CC----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 4321 111111 11111 01 11222335688999999999999999999999999988764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=439.90 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=202.5
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
++|+..+.||+|+||+||+|+.. +|+.||||+++..... ..+.|.+|+++|++++|||||++++++.+++..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999975 7999999999765432 34579999999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
||++|+|.++|.. .....+++.+.+.|+.||+.||+|||+.+ ||||||||+||||++++++||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999963 33456899999999999999999999998 999999999999999999999999999876542
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
. ...+..+||+.|||||++.+..|+.++|||||||+||||+||+.||...... .+. ..+.... . +.
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~---~~i~~~~------~-~~ 244 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK---NLV---LKIISGS------F-PP 244 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH---HHHHHTC------C-CC
T ss_pred c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHH---HHHHcCC------C-CC
Confidence 2 1234567999999999999999999999999999999999999999754321 111 1111110 0 01
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 612 L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+ .......+.+|+.+||+.||++|||++|+++
T Consensus 245 ~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 V----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1122346789999999999999999999976
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=435.30 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=209.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
+.|+..+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..+||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56888999999999999999975 79999999998776666678999999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++|+|.+++.. ..+++.++..|+.||+.||+|||+++ ||||||||+||||++++++||+|||+|+.......
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 99999999852 36999999999999999999999998 99999999999999999999999999998755432
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
..+..+||+.|||||++.+..|+.++|||||||+||||++|+.||....+.. +...+ . .-..+.+.
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i---~-------~~~~~~~~ 291 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMI---R-------DNLPPRLK 291 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHH---H-------HSSCCCCS
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHH---H-------cCCCCCCC
Confidence 2345789999999999999999999999999999999999999997543221 11111 0 00111111
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
........+.+|+.+||+.||++|||+.|+++
T Consensus 292 --~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp --CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11122356789999999999999999998854
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=433.05 Aligned_cols=257 Identities=23% Similarity=0.246 Sum_probs=208.8
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
.+.|...+.||+|+||+||+|+.. +|+.||||+++.... +.+|++++++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888899999999999999975 799999999976432 24699999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC-CCeeecccccccccCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF-TPKVSDFGLAREATEG 531 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~-~vKLsDFGLA~~~~~~ 531 (780)
|++|+|.++|.. .+.+++.+...++.||+.||+|||+.+ ||||||||+||||+.++ ++||+|||+|+.....
T Consensus 132 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999953 457999999999999999999999998 99999999999999987 6999999999977543
Q ss_pred Ccc----ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 532 SQH----ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 532 ~~~----~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
... ....++||+.|||||++.+..++.++|||||||+||||+||+.||....... +.. .+........
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~---~i~~~~~~~~-- 276 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCL---KIASEPPPIR-- 276 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHH---HHHHSCCGGG--
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHH---HHHcCCCCch--
Confidence 211 1234679999999999999999999999999999999999999997544321 111 1111110011
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
..+......+.+++.+||+.||++|||+.|+++.|...+....
T Consensus 277 -------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 277 -------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp -------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred -------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 1112223567889999999999999999999999988776543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=424.81 Aligned_cols=246 Identities=25% Similarity=0.388 Sum_probs=196.0
Q ss_pred ccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeee----cceeEEEE
Q 048425 378 SSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIE----GRTRCLVY 450 (780)
Q Consensus 378 ~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~~LV~ 450 (780)
...+.||+|+||+||+|... ++..||||++..... ...+.|.+|+++|++++|||||+++++|.+ ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45578999999999999975 689999999976532 234579999999999999999999999865 34579999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC-CCCCeeeccccccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED-DFTPKVSDFGLAREAT 529 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~-~~~vKLsDFGLA~~~~ 529 (780)
|||++|+|.++|.. ...+++..+..|+.||+.||+|||+++ ++||||||||+||||++ ++++||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999953 457999999999999999999999874 56999999999999984 8999999999998654
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
.. .....+||+.|||||++. ++++.++|||||||+||||+||+.||...... ..+...+ ... ...
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~~~i---~~~------~~~ 248 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRV---TSG------VKP 248 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHH---TTT------CCC
T ss_pred CC---ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHHHHH---HcC------CCC
Confidence 32 234578999999999876 46999999999999999999999999643221 1111111 100 000
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+.+ +......+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 ASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011 1111235788999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=426.31 Aligned_cols=248 Identities=25% Similarity=0.357 Sum_probs=208.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeecc---CCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRN---NQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|+..+.||+|+||+||+|+.. +|+.||||++++. .....+.+.+|+++|++++|||||++++++.+++..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 7999999999754 2344577999999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.++|. ..+.+++.+...++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~----~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999995 3457999999999999999999999998 99999999999999999999999999998754
Q ss_pred CC-ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 531 GS-QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 531 ~~-~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
.. .......+||+.|||||++.+..++.++||||+||+||||+||+.||...... .+.. .+....
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~---~i~~~~-------- 250 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---LIFA---KIIKLE-------- 250 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHTC--------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHcCC--------
Confidence 33 22345678999999999999999999999999999999999999999754321 1111 111110
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.. ++......+.+++.+|++.||++|||++|+..
T Consensus 251 ~~----~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 251 YD----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp CC----CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred CC----CCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 01 11122346789999999999999999998743
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=436.96 Aligned_cols=249 Identities=22% Similarity=0.338 Sum_probs=209.6
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
+.|+..+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..+||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 79999999998776666778999999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++|+|.+++.. ..+++.++..|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.......
T Consensus 231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 99999999852 35999999999999999999999998 99999999999999999999999999998755432
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
..+..+||+.|||||++.+..|+.++|||||||+||||++|+.||....+.. +...+ . .-..+.+.
T Consensus 303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i---~-------~~~~~~~~ 368 (423)
T 4fie_A 303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMI---R-------DNLPPRLK 368 (423)
T ss_dssp -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHH---H-------HSCCCCCS
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHH---H-------cCCCCCCc
Confidence 2345789999999999999999999999999999999999999997543221 11111 0 00111111
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
. .......+.+|+.+||+.||++|||+.|+++
T Consensus 369 ~--~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 N--LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp C--TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c--cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 1122346789999999999999999999854
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=411.68 Aligned_cols=245 Identities=23% Similarity=0.340 Sum_probs=190.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|+..+.||+|+||+||+|+.. +|+.||||++++.. ....+.|.+|+++|++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999974 79999999997643 233467999999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+ +|+|.++|. ..+.+++.+...++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHH----HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 689999985 3457999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccceeccccCccccCchhhccCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~-t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
.. .....+||+.|||||++.+..+ +.++||||+||+||||+||+.||...... .+. ..+....
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~---~~i~~~~-------- 228 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLF---KNISNGV-------- 228 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHTC--------
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHH---HHHHcCC--------
Confidence 32 2345689999999999998876 57999999999999999999999754321 111 1111110
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..+ +......+.+++.+|++.||++|||++|+++
T Consensus 229 ~~~----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 229 YTL----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCC----CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 011 1112246788999999999999999999976
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=409.23 Aligned_cols=291 Identities=42% Similarity=0.708 Sum_probs=250.8
Q ss_pred cccchHHHHHHhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeee
Q 048425 363 KTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIE 442 (780)
Q Consensus 363 ~~f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~ 442 (780)
..+.+.++..++++|...+.||+|+||+||+|.+.+|+.||||++........+.|.+|++++++++||||++++++|.+
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 45667778889999999999999999999999988899999999887766667889999999999999999999999999
Q ss_pred cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecc
Q 048425 443 GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDF 522 (780)
Q Consensus 443 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDF 522 (780)
++..++||||+++|+|.+++.........++|..+++++.|++.||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeec
Confidence 99999999999999999999764444457999999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCC-ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccc
Q 048425 523 GLAREATEGS-QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTR 601 (780)
Q Consensus 523 GLA~~~~~~~-~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~ 601 (780)
|+++...... ........||..|+|||.+.++.++.++||||||+++|||+||+.||....+.....+..|...... .
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~ 262 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-N 262 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-T
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-c
Confidence 9998754322 2223445699999999999999999999999999999999999999987766665666666544332 2
Q ss_pred cccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 602 EGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 602 ~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
..+..++++.+......+....+.+++.+||+.||++||++.||++.|+.+....+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 34566777777777778888999999999999999999999999999999876543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=419.18 Aligned_cols=242 Identities=23% Similarity=0.298 Sum_probs=193.5
Q ss_pred cCcccceeecccCceEEEEEEEe----CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD----NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~----~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
++|+..+.||+|+||+||+|+.. +++.||||++++... .....+.+|+++|++++|||||++++++.+++..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999862 478999999976432 233468899999999999999999999999999999
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||+++|+|.++|.. ...+++.+...++.||+.||+|||+.+ |+||||||+|||+++++++||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999953 457999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 529 TEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 529 ~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
..... .....+||+.|||||.+.+..++.++|||||||+||||+||+.||....... +.. .+....
T Consensus 177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~---~i~~~~------- 242 (304)
T 3ubd_A 177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMT---MILKAK------- 242 (304)
T ss_dssp ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHCC-------
T ss_pred cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHH---HHHcCC-------
Confidence 44332 2345689999999999999999999999999999999999999997543221 111 111110
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFM 642 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm 642 (780)
. .++......+.+++.+||+.||++|||+
T Consensus 243 -~----~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 243 -L----GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp -C----CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred -C----CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 0 1111223467899999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=405.82 Aligned_cols=290 Identities=44% Similarity=0.776 Sum_probs=250.4
Q ss_pred cccccchHHHHHHhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeee
Q 048425 361 SVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGI 439 (780)
Q Consensus 361 ~~~~f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~ 439 (780)
..+.|+++++..++++|+..+.||+|+||+||+|...+|+.||||++...... ....|.+|++++++++|+||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 45779999999999999999999999999999999888999999999765432 33479999999999999999999999
Q ss_pred eeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCee
Q 048425 440 CIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKV 519 (780)
Q Consensus 440 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKL 519 (780)
|.+.+..++||||+++|+|.+++.........++|..++.|+.|++.||+|||+...++|+||||||+|||+++++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999999999865556667999999999999999999999993334999999999999999999999
Q ss_pred ecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCC--ccccchhhhhcccc
Q 048425 520 SDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQ--PQGQENLVTWARPL 597 (780)
Q Consensus 520 sDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~--~~~~~~Lv~wa~~l 597 (780)
+|||+++..............||+.|+|||.+.++.++.++||||||+++|||+||+.||+... ......+.+|....
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999999876555555556679999999999999999999999999999999999999996321 11233456666665
Q ss_pred cccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048425 598 LTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651 (780)
Q Consensus 598 l~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~ 651 (780)
... ..+..+.+..+...+..+....+.+++.+|++.||++|||+.||++.|+.
T Consensus 256 ~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 256 LKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TSS-CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhc-hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 544 34677778888888888889999999999999999999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=408.68 Aligned_cols=247 Identities=24% Similarity=0.401 Sum_probs=187.5
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecc--------
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGR-------- 444 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-------- 444 (780)
++|+..+.||+|+||+||+|+.. +|+.||||+++..... ..+.|.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 57899999999999999999975 7999999999765433 3357999999999999999999999987644
Q ss_pred ----eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeee
Q 048425 445 ----TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVS 520 (780)
Q Consensus 445 ----~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLs 520 (780)
..++||||+++|+|.+++... ......++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTC-CSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhc-CCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 368999999999999999642 12234677888999999999999999998 9999999999999999999999
Q ss_pred cccccccccCCCcc-----------ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch
Q 048425 521 DFGLAREATEGSQH-----------ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN 589 (780)
Q Consensus 521 DFGLA~~~~~~~~~-----------~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~ 589 (780)
|||+|+........ ..+..+||+.|||||++.+..++.++|||||||+||||++ ||.... +.
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~ 233 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ER 233 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HH
Confidence 99999977543211 1234579999999999999999999999999999999997 664211 10
Q ss_pred hhhhcccccccccccccccCCccCCCCC---hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 590 LVTWARPLLTTREGLEQLVDPSLAGSYD---FDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 590 Lv~wa~~ll~~~~~l~~lvDp~L~~~~~---~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
... +..+.+ ..++ .+......+++.+||+.||++|||+.|+++
T Consensus 234 ~~~-----------~~~~~~----~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRT-----------LTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHH-----------HHHHHT----TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH-----------HHHHhc----CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 000000 0111 112234567999999999999999999865
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=400.94 Aligned_cols=265 Identities=22% Similarity=0.348 Sum_probs=200.2
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeee------cce
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIE------GRT 445 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~------~~~ 445 (780)
++|...+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 7999999999755332 23568899999999999999999998754 357
Q ss_pred eEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccc
Q 048425 446 RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA 525 (780)
.+||||||+ |+|.++|. ....+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 899999995 78999985 4568999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCC---ccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhh-hcc-c---
Q 048425 526 REATEGS---QHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVT-WAR-P--- 596 (780)
Q Consensus 526 ~~~~~~~---~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~-wa~-~--- 596 (780)
+.+.... ....+..+||+.|||||++.+. .++.++||||+||++|||++|+.||.......+...+. ... +
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 8764332 2233557899999999998875 56899999999999999999999997654332211110 000 0
Q ss_pred cccc--ccccccccCCcc-CCCCCh-----hhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 597 LLTT--REGLEQLVDPSL-AGSYDF-----DDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 597 ll~~--~~~l~~lvDp~L-~~~~~~-----ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.... .......+.... ....+. .....+.+|+.+||+.||++|||+.|+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 000000000000 000011 11246788999999999999999998854
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=375.79 Aligned_cols=285 Identities=36% Similarity=0.648 Sum_probs=234.4
Q ss_pred cccccchHHHHHHhcCcccc------eeecccCceEEEEEEEeCCcEEEEEEeeccC----CcchHHHHHHHHHhhhcCC
Q 048425 361 SVKTFALSDLEKATEKFSSK------RILGEGGFGCVYHGVMDNGTEVAVKLLTRNN----QNGDREFIAEVEMLSRLHH 430 (780)
Q Consensus 361 ~~~~f~~~el~~at~~f~~~------~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L~H 430 (780)
....|+++++.+++++|... +.||+|+||.||+|.. +++.||||++.... ....+.|.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34679999999999999988 8999999999999987 68999999986532 2234679999999999999
Q ss_pred CceeeeeeeeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceE
Q 048425 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVL 510 (780)
Q Consensus 431 pNIV~L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNIL 510 (780)
|||+++++++.+++..++||||+++|+|.+++... .....++|..+++++.|++.||+|||+.+ |+||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 99999999999999999999999999999999643 23457999999999999999999999998 999999999999
Q ss_pred EcCCCCCeeecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch
Q 048425 511 LEDDFTPKVSDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN 589 (780)
Q Consensus 511 Ld~~~~vKLsDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~ 589 (780)
+++++.+||+|||+++........ ......||..|+|||.+.+ .++.++||||||+++|||++|+.||+..... ..
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~ 242 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP--QL 242 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS--SB
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch--HH
Confidence 999999999999999876543322 2334579999999998764 5899999999999999999999999764322 22
Q ss_pred hhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 590 LVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 590 Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
+..+..........+...+++.+. .........+.+++..||+.+|++||++.||++.|+++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 243 LLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp TTHHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 222222222223334555555543 3455667889999999999999999999999999998753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=379.59 Aligned_cols=261 Identities=24% Similarity=0.389 Sum_probs=214.3
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
++|...+.||+|+||+||+|... +|+.||+|++........+.|.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 67888999999999999999975 68999999987666666678999999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++|+|.+++.. ....++|.+++.|+.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 90 ~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 90 KGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp TTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred CCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999963 3457999999999999999999999998 99999999999999999999999999987644322
Q ss_pred cc-------------eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccc
Q 048425 534 HI-------------STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTT 600 (780)
Q Consensus 534 ~~-------------~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~ 600 (780)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|..|+....+......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~---------- 233 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG---------- 233 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS----------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh----------
Confidence 11 1145799999999999999999999999999999999999998865433211100
Q ss_pred ccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 601 REGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 601 ~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
.......+...... ....+.+++.+|++.||++||++.|+++.|+.+....
T Consensus 234 -~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 234 -LNVRGFLDRYCPPN----CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp -BCHHHHHHHTCCTT----CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -hhhhccccccCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00111111111111 1235788999999999999999999999999887653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=390.87 Aligned_cols=199 Identities=25% Similarity=0.347 Sum_probs=171.9
Q ss_pred HHhcCcccceeecccCceEEEEEEEe----CCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeeeeccee
Q 048425 372 KATEKFSSKRILGEGGFGCVYHGVMD----NGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTR 446 (780)
Q Consensus 372 ~at~~f~~~~~LG~G~fG~VYkg~l~----~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~ 446 (780)
...++|+..+.||+|+||+||+|+.+ .++.||||++.... ....+.+|+++|..+ +|||||++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34678999999999999999999864 46789999986543 356788999999998 699999999999999999
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC-CCCeeeccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD-FTPKVSDFGLA 525 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~-~~vKLsDFGLA 525 (780)
+|||||+++|+|.+++. .+++.+...++.|++.||+|||+.+ |+||||||+|||++.+ +.+||+|||+|
T Consensus 96 ~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 99999999999999983 4899999999999999999999998 9999999999999877 79999999999
Q ss_pred ccccCCCc---------------------------cceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCC
Q 048425 526 REATEGSQ---------------------------HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRK 577 (780)
Q Consensus 526 ~~~~~~~~---------------------------~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~ 577 (780)
+....... ...+..+||+.|||||++.+. .++.++||||+||++|||+||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 86543211 112335799999999999875 58999999999999999999999
Q ss_pred CCCCC
Q 048425 578 PVDMS 582 (780)
Q Consensus 578 P~~~~ 582 (780)
||...
T Consensus 246 Pf~~~ 250 (361)
T 4f9c_A 246 PFYKA 250 (361)
T ss_dssp SSSCC
T ss_pred CCCCC
Confidence 99643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=412.22 Aligned_cols=251 Identities=20% Similarity=0.305 Sum_probs=208.3
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
++|.+.+.||+|+||+||+|... +|+.||||++........+.+.+|+++|+.++|||||++++++.+++..+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 68999999999999999999975 79999999998766555677999999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC--CCCeeecccccccccCC
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD--FTPKVSDFGLAREATEG 531 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~--~~vKLsDFGLA~~~~~~ 531 (780)
++|+|.++|. .....+++.+...++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 237 ~gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 237 SGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred CCCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999985 34457999999999999999999999998 9999999999999854 89999999999987654
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
. .....+||+.|||||++.+..++.++||||+||+||||++|+.||....... +... +...... +++.
T Consensus 311 ~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~---~~~~---i~~~~~~----~~~~ 378 (573)
T 3uto_A 311 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLRN---VKSCDWN----MDDS 378 (573)
T ss_dssp S--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHH---HHTTCCC----CCSG
T ss_pred C--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHH---HHhCCCC----CCcc
Confidence 3 2345679999999999999999999999999999999999999997544321 1110 1110000 0111
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 612 L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..... ...+.+|+.+||+.||++||++.|+++
T Consensus 379 ~~~~~----s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 379 AFSGI----SEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111 245778999999999999999999865
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=381.03 Aligned_cols=274 Identities=27% Similarity=0.373 Sum_probs=209.8
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecc----eeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGR----TRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~----~~~LV~ 450 (780)
++|+..+.||+|+||+||+|+. .++.||||++.... .....+..|+.++++++||||+++++++.++. ..++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 6888999999999999999987 48999999996543 23345677999999999999999999998754 369999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-------CCCcEEecccCCcceEEcCCCCCeeeccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED-------SNPRVIHRDFKASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~-------~~p~IvHrDIKpsNILLd~~~~vKLsDFG 523 (780)
||+++|+|.+++.. ..++|..+++|+.|++.||+|||+. ..++|+||||||+|||+++++++||+|||
T Consensus 102 e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 102 AFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 99999999999953 3599999999999999999999988 01139999999999999999999999999
Q ss_pred ccccccCCCcc-ceeccccCccccCchhhccC-----CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccc
Q 048425 524 LAREATEGSQH-ISTRVMGTFGYVAPEYAMTG-----HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL 597 (780)
Q Consensus 524 LA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~-----~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~l 597 (780)
+++........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||..................
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 99876544322 22345799999999998863 4567899999999999999999999765433221111111000
Q ss_pred cccccccccccCCccCCCC-----ChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 598 LTTREGLEQLVDPSLAGSY-----DFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 598 l~~~~~l~~lvDp~L~~~~-----~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
.........+......... .......+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0000001111111111111 123456799999999999999999999999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=378.27 Aligned_cols=261 Identities=25% Similarity=0.443 Sum_probs=211.6
Q ss_pred cCcccceeecccCceEEEEEEEe----CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD----NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~----~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
++|...+.||+|+||+||+|.+. .+..||||+++.... ...+.|.+|++++++++|+||+++++++.+++..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 67888999999999999999974 455699999976533 3346799999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++|+|.+++.. ....+++..++.|+.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 129 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 129 TEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999953 3457999999999999999999999998 9999999999999999999999999999775
Q ss_pred CCCcc--ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccc
Q 048425 530 EGSQH--ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 530 ~~~~~--~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
..... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+......
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~~---------- 269 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVISSVEE---------- 269 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHHHT----------
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHc----------
Confidence 44322 2233456888999999999999999999999999999999 99999654321 11111000
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCCC
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDE 658 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~~ 658 (780)
......+......+.+++..||+.||++||++.||++.|+.+....+.
T Consensus 270 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 270 ----GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred ----CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 000111223345788999999999999999999999999999876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=366.09 Aligned_cols=257 Identities=30% Similarity=0.460 Sum_probs=214.3
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
++|+..+.||+|+||+||+|...++..||||++.... ...++|.+|++++++++||||+++++++.+++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 6788899999999999999999889999999997653 345789999999999999999999999999999999999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 89 ~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 89 HGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 9999999963 4457999999999999999999999998 999999999999999999999999999876543322
Q ss_pred ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
......||..|+|||.+.+..++.++||||||+++|||++ |+.||....... +.... ... ...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---~~~~~---~~~-------~~~--- 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDI---STG-------FRL--- 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH---HTT-------CCC---
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHH---hcC-------ccC---
Confidence 2334557888999999999999999999999999999999 999997543221 11110 000 000
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
..+......+.+++..|++.+|++||++.|+++.|+++.+.
T Consensus 227 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 227 -YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11111235688999999999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=384.21 Aligned_cols=263 Identities=25% Similarity=0.408 Sum_probs=213.9
Q ss_pred hcCcccceeecccCceEEEEEEEe--------CCcEEEEEEeeccCCc-chHHHHHHHHHhhhc-CCCceeeeeeeeeec
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD--------NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRL-HHRNLVKLIGICIEG 443 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~--------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~ 443 (780)
.++|...+.||+|+||+||+|... ++..||||+++..... ..++|.+|+++++++ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 368889999999999999999863 3567999999765332 345799999999999 899999999999999
Q ss_pred ceeEEEEeecCCCChhhhcccccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDK------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL 511 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL 511 (780)
+..++||||+++|+|.+++..... ....+++.++++++.||+.||+|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999975321 1246899999999999999999999998 9999999999999
Q ss_pred cCCCCCeeecccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccch
Q 048425 512 EDDFTPKVSDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQEN 589 (780)
Q Consensus 512 d~~~~vKLsDFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~ 589 (780)
++++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 9999999999999987654322 12234567889999999999999999999999999999999 99999754321 1
Q ss_pred hhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 590 LVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 590 Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
+.... ... .....+......+.+++.+||+.+|++||++.|+++.|+.+....
T Consensus 314 ~~~~~----~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 314 LFKLL----KEG----------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHHHH----HTT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHH----hcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 11110 000 001112233457889999999999999999999999999987643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=387.29 Aligned_cols=260 Identities=26% Similarity=0.441 Sum_probs=201.8
Q ss_pred cCcccceeecccCceEEEEEEEe----CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD----NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~----~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
++|...+.||+|+||.||+|++. ++..||||+++.... ...++|.+|++++++++||||++++++|.+++..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57889999999999999999875 577899999976532 2346799999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++|+|.++++. ....+++.+++.|+.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 125 ~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 125 TEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999963 3457999999999999999999999998 9999999999999999999999999998775
Q ss_pred CCCccc--eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccc
Q 048425 530 EGSQHI--STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 530 ~~~~~~--~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
...... .....+|..|+|||++.++.++.++|||||||++|||++ |+.||...... .+...+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~~i------------ 263 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIKAV------------ 263 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHHHH------------
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH------------
Confidence 433221 122345778999999999999999999999999999998 99999654321 111111
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
+..............+.+++.+||+.||++||++.||++.|+.+.....
T Consensus 264 --~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 264 --DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp --HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred --HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 0001111122334678899999999999999999999999999986543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=371.39 Aligned_cols=262 Identities=22% Similarity=0.340 Sum_probs=217.3
Q ss_pred ccccchHHHHHHhcC----------cccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCC
Q 048425 362 VKTFALSDLEKATEK----------FSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHH 430 (780)
Q Consensus 362 ~~~f~~~el~~at~~----------f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H 430 (780)
...|++++++.+++. |...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 456899999998875 777789999999999999986 799999999987776677889999999999999
Q ss_pred CceeeeeeeeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceE
Q 048425 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVL 510 (780)
Q Consensus 431 pNIV~L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNIL 510 (780)
+||+++++++..++..++||||+++|+|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEE
Confidence 999999999999999999999999999999985 246999999999999999999999998 999999999999
Q ss_pred EcCCCCCeeecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchh
Q 048425 511 LEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENL 590 (780)
Q Consensus 511 Ld~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~L 590 (780)
++.++++||+|||+++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... .
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~ 249 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---A 249 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H
T ss_pred ECCCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence 999999999999999876543222 244679999999999999999999999999999999999999997543211 1
Q ss_pred hhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 591 VTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 591 v~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.... .....+.+. ........+.+++.+||+.||++||++.|+++
T Consensus 250 ~~~~----------~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 250 MKRL----------RDSPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHH----------HHSSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHH----------hcCCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1110 111111111 01122346889999999999999999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=372.11 Aligned_cols=266 Identities=30% Similarity=0.456 Sum_probs=206.0
Q ss_pred HHHHhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecceeE
Q 048425 370 LEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 370 l~~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 447 (780)
+....++|+..+.||+|+||+||+|.. +|+.||||++...... ..++|.+|++++++++|+||+++++++.+.+..+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 333457899999999999999999987 6899999998765432 2357999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+||||+++|+|.+++... .....+++..++.++.|++.||+|||+.+ ++|+||||||+|||+++++.+||+|||+++.
T Consensus 111 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEEECCTTCBHHHHHHST-THHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEEecCCCCcHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999999632 11224999999999999999999999885 4599999999999999999999999999986
Q ss_pred ccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 528 ATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 528 ~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
...... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||....... ....... . .
T Consensus 189 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~~~~---~------~ 255 (309)
T 3p86_A 189 KASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVAAVGF---K------C 255 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHHHHHH---S------C
T ss_pred cccccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh---c------C
Confidence 543321 2234579999999999999999999999999999999999999997543321 1111000 0 0
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
... ..+......+.+++.+||+.+|++||++.||++.|+.+...
T Consensus 256 ~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 256 KRL----EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 001 11122235688999999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=362.37 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=213.4
Q ss_pred hcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
.++|+..+.||+|+||.||+|...++..||||+++.... ..+++.+|++++.+++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 468889999999999999999998888999999976543 4578999999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 86 ~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 86 SNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp TTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 99999999963 2346999999999999999999999998 99999999999999999999999999987765443
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
.......+|..|+|||.+.+..++.++||||||+++|||+| |+.||+....... ... .... .....+
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~----~~~~----~~~~~~-- 227 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV--VLK----VSQG----HRLYRP-- 227 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HHH----HHTT----CCCCCC--
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH--HHH----HHcC----CCCCCC--
Confidence 33344557788999999999999999999999999999999 9999975432211 000 0000 000111
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
......+.+++..|++.+|++||++.|+++.|+.+.+
T Consensus 228 -----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 228 -----HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp -----TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred -----CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1122468899999999999999999999999988754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=372.28 Aligned_cols=272 Identities=25% Similarity=0.378 Sum_probs=208.9
Q ss_pred cCcccceeecccCceEEEEEEE-----eCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeec--ceeE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-----DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEG--RTRC 447 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~ 447 (780)
++|+..+.||+|+||+||+|.+ .+|+.||||++........+.|.+|++++++++|+||++++++|... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 6788999999999999999984 26889999999876655567899999999999999999999998654 4579
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+||||+++|+|.+++.. ....+++..+++++.|++.||+|||+.+ |+||||||+|||+++++++||+|||+++.
T Consensus 90 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 99999999999999963 2346999999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCc--cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccc---c
Q 048425 528 ATEGSQ--HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTR---E 602 (780)
Q Consensus 528 ~~~~~~--~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~---~ 602 (780)
...... .......||..|+|||.+.+..++.++||||||+++|||+||..|+...... ...+........ .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMIVF 239 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccchhHH
Confidence 754332 1223445788899999999999999999999999999999999988642211 000000000000 0
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
.+.+.+........+......+.+++.+||+.||++||++.||++.|+.+.+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 001111111111122334467889999999999999999999999999987653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=364.98 Aligned_cols=258 Identities=25% Similarity=0.408 Sum_probs=211.2
Q ss_pred hcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
.++|...+.||+|+||.||+|...++..||||+++... ...++|.+|++++.+++|+||+++++++.+++..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 46888999999999999999999888899999997653 34578999999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++++||+|||+++.......
T Consensus 102 ~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 102 ANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp TTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred CCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999999963 2446999999999999999999999998 99999999999999999999999999987654322
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
.......+|..|+|||.+.+..++.++||||||+++|||+| |+.||....... .... +. .....
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---~~~~---~~-------~~~~~-- 240 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEH---IA-------QGLRL-- 240 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHH---HH-------TTCCC--
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---HHHH---Hh-------cccCC--
Confidence 22233457888999999999999999999999999999999 999997543221 1110 00 00000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
..+......+.+++.+||+.+|++||++.|+++.|+.+.+.
T Consensus 241 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 241 --YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp --CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 11111235688999999999999999999999999988754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=367.12 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=209.0
Q ss_pred hcCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
.++|+..+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 36899999999999999999986 47899999999877666778899999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999853 25899999999999999999999998 9999999999999999999999999998765443
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
.. .....||+.|+|||.+.+..++.++|||||||++|||+||+.||....+..... .. .... .+.+
T Consensus 171 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~~----~~~~-------~~~~ 236 (297)
T 3fxz_A 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY--LI----ATNG-------TPEL 236 (297)
T ss_dssp CC-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HH----HHHC-------SCCC
T ss_pred cc-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HH----HhCC-------CCCC
Confidence 32 344579999999999999999999999999999999999999997543221110 00 0000 0000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.........+.+++.+||+.||++||++.|+++
T Consensus 237 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 --QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111223356889999999999999999999865
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=379.45 Aligned_cols=273 Identities=25% Similarity=0.402 Sum_probs=217.7
Q ss_pred ccchHHHHHHhcCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCCc-chHHHHHHHHHhhhc-CCCceee
Q 048425 364 TFALSDLEKATEKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRL-HHRNLVK 435 (780)
Q Consensus 364 ~f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~ 435 (780)
.+...+++...++|...+.||+|+||.||+|.+. +++.||||+++..... ..+.|.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 4556667777899999999999999999999842 4678999999765432 335799999999999 8999999
Q ss_pred eeeeeeecce-eEEEEeecCCCChhhhcccccCC----------------------------------------------
Q 048425 436 LIGICIEGRT-RCLVYELVHNGSVESHLHGVDKN---------------------------------------------- 468 (780)
Q Consensus 436 L~g~~~~~~~-~~LV~Ey~~~GSL~~~L~~~~~~---------------------------------------------- 468 (780)
++++|.+.+. .++||||+++|+|.++++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 89999999999999999753221
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 469 ----------------RGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 469 ----------------~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
...+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 122899999999999999999999998 9999999999999999999999999998765433
Q ss_pred c-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 533 Q-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 533 ~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
. .......||..|+|||++.+..++.++|||||||++|||+| |+.||....... .+... .... ...
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~----~~~~------~~~ 315 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRR----LKEG------TRM 315 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHH----HHHT------CCC
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHH----HHcC------CCC
Confidence 2 22345678999999999999999999999999999999999 999997543211 11110 0000 001
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
.........+.+++..||+.||++||++.||++.|+.+.+.
T Consensus 316 ----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 316 ----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 11112234688999999999999999999999999988753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=407.52 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=199.5
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHH---HHHhhhcCCCceeeeeeeeeecceeE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAE---VEMLSRLHHRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~E---i~iL~~L~HpNIV~L~g~~~~~~~~~ 447 (780)
++|...++||+|+||+||+|+.. +|+.||||++++.. ......+.+| +.+++.++|||||++++++.+.+..+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 68999999999999999999975 79999999997542 2233334444 66777789999999999999999999
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
|||||++||+|.++|. ..+.+++.....++.||+.||+|||+.+ ||||||||+||||+++|++||+|||+|+.
T Consensus 269 lVmEy~~GGdL~~~l~----~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEECCCCSCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999995 3457999999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 528 ATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 528 ~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
..... ....+||+.|||||++.. ..|+.++||||+||+||||++|+.||..........+... ....
T Consensus 342 ~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~---i~~~------ 409 (689)
T 3v5w_A 342 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTM------ 409 (689)
T ss_dssp CSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH---HHHC------
T ss_pred cCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---hcCC------
Confidence 75533 234689999999999975 5799999999999999999999999975332221111110 0000
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPF-----MGEVVQ 647 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs-----m~EVv~ 647 (780)
... ++......+.+|+..||+.||++|++ ++||.+
T Consensus 410 --~~~----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 410 --AVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --CCC----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --CCC----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 011 11122346789999999999999998 566644
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=396.43 Aligned_cols=263 Identities=24% Similarity=0.383 Sum_probs=215.0
Q ss_pred HHHHHhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 369 DLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 369 el~~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
+++...++|...+.||+|+||+||+|.++++..||||+++... ...++|.+|+++|++++||||+++++++. .+..++
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 3444567899999999999999999999888999999997654 45678999999999999999999999986 567899
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||+++|+|.++|+.. ....+++..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 260 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 99999999999999642 2236889999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 529 TEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 529 ~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
............+|..|+|||.+..+.++.++|||||||+||||+| |+.||...... .+...+ ....
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i----~~~~----- 402 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL----ERGY----- 402 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH----HHTC-----
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCC-----
Confidence 5432222233456789999999999999999999999999999999 99999754321 111111 0000
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
. ...+......+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 403 -~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 403 -R----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -C----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 0 011122345788999999999999999999999999987654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=384.62 Aligned_cols=258 Identities=28% Similarity=0.411 Sum_probs=210.6
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
.++|...+.||+|+||.||+|.+. +|+.||||+++..... ..++|.+|++++++++||||++++++|.+++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467888999999999999999986 7899999998754322 23468999999999999999999999999899999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++|+|.+++.. ....+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999963 3346899999999999999999999998 999999999999999999999999999875443
Q ss_pred Cccce-eccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 532 SQHIS-TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 532 ~~~~~-t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
..... ....++..|+|||.+.++.++.++|||||||++|||+| |+.||...... .+...+ ....
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~~~----~~~~------- 332 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTREFV----EKGG------- 332 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHHHH----HTTC-------
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCC-------
Confidence 21111 12235778999999999999999999999999999999 99998654321 111111 0000
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
....+......+.+++.+||+.||++||++.||++.|+.+..
T Consensus 333 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 333 ---RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 001112233568899999999999999999999999998865
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=373.38 Aligned_cols=268 Identities=26% Similarity=0.457 Sum_probs=214.2
Q ss_pred HHHHhcCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeee
Q 048425 370 LEKATEKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIE 442 (780)
Q Consensus 370 l~~at~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~ 442 (780)
+....++|...+.||+|+||.||+|... +++.||||+++..... ..+.|.+|++++++++||||++++++|.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445689999999999999999999985 3478999999765432 34679999999999999999999999999
Q ss_pred cceeEEEEeecCCCChhhhcccccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEec
Q 048425 443 GRTRCLVYELVHNGSVESHLHGVDKN--------------------RGPLDWEARMKIALGAARGLAYLHEDSNPRVIHR 502 (780)
Q Consensus 443 ~~~~~LV~Ey~~~GSL~~~L~~~~~~--------------------~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHr 502 (780)
++..++||||+++|+|.+++...... ...+++.+++.|+.||++||+|||+.+ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 99999999999999999999753211 257999999999999999999999998 9999
Q ss_pred ccCCcceEEcCCCCCeeecccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCC
Q 048425 503 DFKASNVLLEDDFTPKVSDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVD 580 (780)
Q Consensus 503 DIKpsNILLd~~~~vKLsDFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~ 580 (780)
||||+|||+++++.+||+|||+++....... .......||..|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999987643321 12234568999999999999999999999999999999999 999997
Q ss_pred CCCccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 581 MSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 581 ~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
..... .+.... . +... ...+......+.+++.+||+.||++||++.||++.|+.+.....
T Consensus 279 ~~~~~---~~~~~~---~----------~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 279 GMAHE---EVIYYV---R----------DGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TSCHH---HHHHHH---H----------TTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCChH---HHHHHH---h----------CCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 54321 111110 0 0000 01112233578899999999999999999999999998876543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=395.08 Aligned_cols=259 Identities=26% Similarity=0.406 Sum_probs=215.1
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
..++|...+.||+|+||.||+|.+. ++..||||+++... ...++|.+|+++|++++||||++++++|.+.+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 3467889999999999999999986 48899999997654 346789999999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++|+|.++|.. .....+++..++.|+.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 297 ~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 297 FMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred ccCCCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999999964 23456999999999999999999999998 999999999999999999999999999977544
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
.........+|..|+|||.+.++.++.++|||||||+||||+| |+.||...... .+.... ..
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~~--------------~~ 434 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL--------------EK 434 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH--------------HT
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH--------------Hc
Confidence 3322334456789999999999999999999999999999999 99998754321 111111 00
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
......+......+.+|+.+||+.||++||++.||++.|+.+..
T Consensus 435 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 435 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 11111122334578899999999999999999999999997754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=361.60 Aligned_cols=260 Identities=23% Similarity=0.395 Sum_probs=202.4
Q ss_pred hcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhh--cCCCceeeeeeeeeec----ceeE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSR--LHHRNLVKLIGICIEG----RTRC 447 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~--L~HpNIV~L~g~~~~~----~~~~ 447 (780)
.++|...+.||+|+||+||+|.. +|+.||||++... ..+.+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 47899999999999999999988 7899999998643 34567778777777 7999999999997653 4578
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCcEEecccCCcceEEcCCCCCee
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH--------EDSNPRVIHRDFKASNVLLEDDFTPKV 519 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH--------~~~~p~IvHrDIKpsNILLd~~~~vKL 519 (780)
+||||+++|+|.+++. ...+++..+++|+.|++.||+||| +.+ |+||||||+|||++.++++||
T Consensus 83 lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 9999999999999994 246999999999999999999999 665 999999999999999999999
Q ss_pred ecccccccccCCCccc---eeccccCccccCchhhccC------CCCchhhHHhHHHHHHHHHhC----------CCCCC
Q 048425 520 SDFGLAREATEGSQHI---STRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVLLELLSG----------RKPVD 580 (780)
Q Consensus 520 sDFGLA~~~~~~~~~~---~t~~~GT~~Y~APE~l~~~------~~t~ksDVySfGVvLlELlTG----------r~P~~ 580 (780)
+|||+++......... .....||+.|+|||.+.+. .++.++|||||||++|||+|| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999998765543321 2334799999999999876 455799999999999999999 77775
Q ss_pred CCCccccchhhhhcccccccccccccccCCccCC-CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 581 MSQPQGQENLVTWARPLLTTREGLEQLVDPSLAG-SYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 581 ~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~-~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
...+.... .... ....... ...+.+.. .........+.+++.+||+.||++|||+.||++.|+.|
T Consensus 235 ~~~~~~~~-~~~~-~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPS-FEDM-RKVVCVD-----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCC-HHHH-HHHHTTS-----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcc-hhhh-hHHHhcc-----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 43322111 0000 0000000 00111111 11234567899999999999999999999999999876
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=371.19 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=204.1
Q ss_pred cCcccceeecccCceEEEEEEEe-CCc----EEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGT----EVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~----~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
++|+..+.||+|+||+||+|.+. +|+ .||+|.++... ....++|.+|++++++++||||++++++|.++ ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 67889999999999999999964 444 36888875443 34557899999999999999999999999875 4789
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
|+||+++|+|.+++.. ....+++..++.|+.|++.||+|||+.+ |+||||||+|||+++++++||+|||+++..
T Consensus 94 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 9999999999999963 3467999999999999999999999998 999999999999999999999999999877
Q ss_pred cCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccc
Q 048425 529 TEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 529 ~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
...... ......||..|+|||++.+..++.++|||||||++|||+| |+.||+............
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-------------- 233 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------------- 233 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH--------------
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH--------------
Confidence 544322 2234557889999999999999999999999999999999 999997644321111110
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
..............+.+++.+||+.+|++||++.||++.|+.+..+
T Consensus 234 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 234 ---KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ---cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 0001111223345788999999999999999999999999988764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=365.64 Aligned_cols=262 Identities=24% Similarity=0.379 Sum_probs=207.2
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcc---hHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNG---DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|+..+.||+|+||.||+|... +++.||||++....... .+.|.+|++++++++||||+++++++.+++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 67899999999999999999965 78999999986554332 357899999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++.. ..++++..++.++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 91 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 91 EYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp ECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999953 347999999999999999999999998 99999999999999999999999999987755
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
..........||+.|+|||.+.+..++.++||||||+++|||+||+.||........ .... .... ..
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~----~~~~--~~----- 230 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKH----IQDS--VP----- 230 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--HHHH----HSSC--CC-----
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHH----hhcc--CC-----
Confidence 443334456799999999999999999999999999999999999999975432110 0000 0000 00
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHhhcC
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRP-FMGEVVQALKLIYNDT 656 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RP-sm~EVv~~L~~i~~~~ 656 (780)
........+....+.+++.+|++.||++|| +++++.+.|+.+....
T Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 000011112235788999999999999998 8999999998776543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=355.78 Aligned_cols=256 Identities=30% Similarity=0.460 Sum_probs=212.9
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
++|...+.||+|+||.||+|...++..||||++..... ..+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 67888999999999999999998889999999976543 45789999999999999999999999999999999999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+++|.+++.. ....+++..+++++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 87 ~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 87 HGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 9999999963 3457899999999999999999999998 999999999999999999999999999876443222
Q ss_pred ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
......||..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+... +... ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~---i~~~-------~~~--- 224 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVED---ISTG-------FRL--- 224 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH---HHTT-------CCC---
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHHH---HhcC-------CcC---
Confidence 2234457889999999999999999999999999999999 89998754321 11111 0000 000
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
..+......+.+++.+|++.+|++||++.|+++.|+.+.+
T Consensus 225 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 225 -YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0111223568899999999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=356.42 Aligned_cols=253 Identities=30% Similarity=0.494 Sum_probs=197.3
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCC----cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQ----NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~----~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|+..+.||+|+||.||+|.. .|+.||||+++.... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 6788999999999999999997 589999999865432 23467999999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC--------CCCCeeecc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED--------DFTPKVSDF 522 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~--------~~~vKLsDF 522 (780)
||+++++|.+++. ...+++..++.++.|++.||+|||+.+..+|+||||||+|||+++ ++.+||+||
T Consensus 86 e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 86 EFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp ECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999984 346999999999999999999999987666999999999999986 678999999
Q ss_pred cccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccc
Q 048425 523 GLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 523 GLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
|+++....... ....||..|+|||.+.+..++.++||||||+++|||++|+.||......... .
T Consensus 161 g~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~----------- 224 (271)
T 3dtc_A 161 GLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA--Y----------- 224 (271)
T ss_dssp CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH--H-----------
T ss_pred Ccccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--H-----------
Confidence 99987654322 2456999999999999999999999999999999999999999754321110 0
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
..................+.+++.+|++.||++||++.|+++.|+.|
T Consensus 225 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 225 ---GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ---HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ---hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00001111111223335788999999999999999999999999754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=379.83 Aligned_cols=265 Identities=27% Similarity=0.436 Sum_probs=213.4
Q ss_pred hcCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeeeccee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTR 446 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 446 (780)
.++|...+.||+|+||+||+|.+. ++..||||+++... .....+|.+|+.++++++|+||+++++++.++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367889999999999999999853 46789999996543 23345799999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhcccccC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC---CCeee
Q 048425 447 CLVYELVHNGSVESHLHGVDK---NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF---TPKVS 520 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~---~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~---~vKLs 520 (780)
++||||+++|+|.+++..... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999975332 2346999999999999999999999998 99999999999999554 59999
Q ss_pred cccccccccCCC-ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccc
Q 048425 521 DFGLAREATEGS-QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLL 598 (780)
Q Consensus 521 DFGLA~~~~~~~-~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll 598 (780)
|||+++...... ........||+.|+|||.+.++.++.++|||||||++|||+| |+.||...... .+...+.
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~~~i~--- 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFVT--- 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHH---
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---
Confidence 999998653322 222344568999999999999999999999999999999998 99999754321 1111110
Q ss_pred ccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCCC
Q 048425 599 TTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDE 658 (780)
Q Consensus 599 ~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~~ 658 (780)
. .. ...........+.+++.+||+.+|++||++.||++.|+.+....+.
T Consensus 301 ~-~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~ 349 (367)
T 3l9p_A 301 S-GG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349 (367)
T ss_dssp T-TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred c-CC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence 0 00 0011122335688999999999999999999999999998876543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=363.41 Aligned_cols=263 Identities=26% Similarity=0.410 Sum_probs=213.7
Q ss_pred HhcCcccceeecccCceEEEEEEE------eCCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecce
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVM------DNGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRT 445 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 445 (780)
..++|...+.||+|+||.||+|.. .++..||||+++.... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 357899999999999999999986 2457899999976533 234678999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhcccccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccC
Q 048425 446 RCLVYELVHNGSVESHLHGVDK--------------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFK 505 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~--------------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIK 505 (780)
.++||||+++|+|.+++..... ....+++.++++++.|++.||+|||+.+ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999975322 1235899999999999999999999998 9999999
Q ss_pred CcceEEcCCCCCeeecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCC
Q 048425 506 ASNVLLEDDFTPKVSDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQ 583 (780)
Q Consensus 506 psNILLd~~~~vKLsDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~ 583 (780)
|+|||+++++.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876543322 1233457889999999999999999999999999999999 999997544
Q ss_pred ccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 584 PQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 584 ~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
... +..... .. .. ..........+.+++.+|++.||++||++.||++.|+.+...
T Consensus 258 ~~~---~~~~~~----~~------~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PER---LFNLLK----TG------HR----MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGG---HHHHHH----TT------CC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHH---HHHHhh----cC------Cc----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 321 111110 00 00 111122335788999999999999999999999999988753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=376.30 Aligned_cols=264 Identities=27% Similarity=0.406 Sum_probs=215.0
Q ss_pred hcCcccceeecccCceEEEEEEEe--------CCcEEEEEEeeccCCc-chHHHHHHHHHhhhc-CCCceeeeeeeeeec
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD--------NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRL-HHRNLVKLIGICIEG 443 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~--------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~ 443 (780)
.++|...+.||+|+||+||+|... ++..||||+++..... ..+++.+|+++++++ +||||++++++|.++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 478899999999999999999863 2457999999765432 336799999999999 999999999999999
Q ss_pred ceeEEEEeecCCCChhhhcccccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDK------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL 511 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL 511 (780)
+..++||||+++|+|.+++..... ....+++..+++|+.||+.||+|||+.+ |+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999975321 1246999999999999999999999998 9999999999999
Q ss_pred cCCCCCeeecccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccch
Q 048425 512 EDDFTPKVSDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQEN 589 (780)
Q Consensus 512 d~~~~vKLsDFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~ 589 (780)
++++.+||+|||+++....... .......||..|+|||++.+..++.++|||||||++|||+| |+.||...... .
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---~ 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---H
Confidence 9999999999999987654322 22334567889999999999999999999999999999999 99999654321 1
Q ss_pred hhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 590 LVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 590 Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
+...... . ............+.+++.+||+.+|++||++.||++.|+.+.....
T Consensus 302 ~~~~~~~----~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 302 LFKLLKE----G----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp HHHHHHT----T----------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HHHHHHc----C----------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1111100 0 0011112233578899999999999999999999999999987654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=361.82 Aligned_cols=263 Identities=27% Similarity=0.406 Sum_probs=218.7
Q ss_pred HHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 371 EKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 371 ~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
+...++|+..+.||+|+||.||+|... ++..||||++.... ...+.|.+|++++++++|+||+++++++.+++..++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 345678999999999999999999986 58899999996543 3457899999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++++|.+++.. .....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EECCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEcCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999964 23456999999999999999999999998 9999999999999999999999999998876
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
...........+|..|+|||.+.+..++.++||||||+++|||++ |+.||....... +.... ....
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~~----------~~~~ 229 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELL----------EKDY 229 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH----------HTTC
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----------hccC
Confidence 554444445567889999999999999999999999999999999 999987543221 11110 0000
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
. ..........+.+++..|++.||++||++.||++.|+.+....
T Consensus 230 ~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 230 R----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C----CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1 1111223357889999999999999999999999999887643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=358.94 Aligned_cols=264 Identities=26% Similarity=0.416 Sum_probs=214.8
Q ss_pred HHHHhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 370 LEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 370 l~~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
++...++|...+.||+|+||.||+|...++..||||+++... ...+.|.+|++++++++|+||+++++++.+ +..++|
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 85 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence 333457899999999999999999998888899999997653 346789999999999999999999999864 568999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++++|.+++... ....+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 9999999999999631 1236999999999999999999999998 9999999999999999999999999998776
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
...........+|..|+|||.+.++.++.++||||||+++|||++ |+.||...... .+.... ... .
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~---~~~-------~ 227 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNL---ERG-------Y 227 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH---HTT-------C
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHHH---hcc-------c
Confidence 543333334557889999999999999999999999999999999 89998654321 111110 000 0
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
.. .........+.+++..|++.+|++||++.++++.|+.+.....
T Consensus 228 ~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 228 RM----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CC----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 01 1112223578899999999999999999999999999886543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=367.51 Aligned_cols=267 Identities=27% Similarity=0.433 Sum_probs=211.4
Q ss_pred HHhcCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccC-CcchHHHHHHHHHhhhc-CCCceeeeeeeeeec
Q 048425 372 KATEKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNN-QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEG 443 (780)
Q Consensus 372 ~at~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~ 443 (780)
...++|...+.||+|+||.||+|... ++..||||+++... ....+.+.+|++++.++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 34588999999999999999999962 45689999997543 23446799999999999 899999999999999
Q ss_pred ceeEEEEeecCCCChhhhcccccCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEeccc
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDKN-------------------RGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDF 504 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~~-------------------~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDI 504 (780)
+..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||+.+ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 9999999999999999999743211 134899999999999999999999998 999999
Q ss_pred CCcceEEcCCCCCeeecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCC
Q 048425 505 KASNVLLEDDFTPKVSDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMS 582 (780)
Q Consensus 505 KpsNILLd~~~~vKLsDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~ 582 (780)
||+|||++.++.+||+|||+++........ ......||+.|+|||.+.++.++.++||||||+++|||+| |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999999876544322 2334568889999999999999999999999999999998 99999754
Q ss_pred CccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 583 QPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 583 ~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
... ..+...... ......+......+.+++..||+.||++||++.||++.|+.+.....
T Consensus 279 ~~~--~~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 279 PVD--ANFYKLIQN--------------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCS--HHHHHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CcH--HHHHHHHhc--------------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 321 111111100 00111122233578899999999999999999999999998876544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=386.68 Aligned_cols=260 Identities=27% Similarity=0.420 Sum_probs=207.8
Q ss_pred HhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
..++|...+.||+|+||.||+|.++++..||||+++... ...++|.+|+++|++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 457788999999999999999999888889999997654 346789999999999999999999999876 678999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++|+|.++|... ....+++..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 260 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 260 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 9999999999632 2346899999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
........+|..|+|||.+.++.++.++|||||||+||||+| |+.||...... .+...+ ...
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i----~~~---------- 397 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQV----ERG---------- 397 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH----HTT----------
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcC----------
Confidence 322334457889999999999999999999999999999999 99999654321 111110 000
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 612 L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
.....+......+.+++.+||+.||++||++++|++.|+.+....
T Consensus 398 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 398 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 000112233457889999999999999999999999999887543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=361.67 Aligned_cols=264 Identities=27% Similarity=0.432 Sum_probs=214.2
Q ss_pred hcCcccceeecccCceEEEEEEE------eCCcEEEEEEeeccCC-cchHHHHHHHHHhhhc-CCCceeeeeeeeeecce
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVM------DNGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRT 445 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~ 445 (780)
.++|...+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++.+++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46888999999999999999985 2567899999976543 2346799999999999 99999999999999999
Q ss_pred eEEEEeecCCCChhhhcccccC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE
Q 048425 446 RCLVYELVHNGSVESHLHGVDK--------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL 511 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~--------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL 511 (780)
.++||||+++|+|.+++..... ....+++..+++++.|++.||+|||+.+ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999974321 1235999999999999999999999998 9999999999999
Q ss_pred cCCCCCeeecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccch
Q 048425 512 EDDFTPKVSDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQEN 589 (780)
Q Consensus 512 d~~~~vKLsDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~ 589 (780)
++++.+||+|||+++........ ......||..|+|||.+.+..++.++||||||+++|||+| |+.||....... .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~ 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--H
Confidence 99999999999999877654332 2234567889999999999999999999999999999999 999987543211 1
Q ss_pred hhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 590 LVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 590 Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
+.... ...... .........+.+++.+|++.||++||++.||++.|+++....
T Consensus 257 ~~~~~----------~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 257 FYKMI----------KEGFRM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHH----------HHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHh----------ccCCCC----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 11110 000011 111222357889999999999999999999999999887654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=369.26 Aligned_cols=247 Identities=25% Similarity=0.383 Sum_probs=205.5
Q ss_pred hcCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
.++|...+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 36899999999999999999997 4899999999976533 23456889999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999953 356999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccceeccccCccccCchhhccCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t-~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
... .....||+.|+|||.+.+..++ .++|||||||++|||++|+.||+...... +.. .+....
T Consensus 167 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~---~i~~~~-------- 230 (328)
T 3fe3_A 167 GGK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRE---RVLRGK-------- 230 (328)
T ss_dssp SCG--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHCC--------
T ss_pred CCc--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHHhCC--------
Confidence 332 3456799999999999988875 79999999999999999999997543221 111 111100
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
. ..+......+.+++.+|++.||++|||++|+++
T Consensus 231 --~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 231 --Y--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp --C--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred --C--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 111122346788999999999999999999865
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=381.61 Aligned_cols=254 Identities=29% Similarity=0.455 Sum_probs=208.7
Q ss_pred HhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecc-eeEEEEe
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGR-TRCLVYE 451 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-~~~LV~E 451 (780)
..++|...+.||+|+||.||+|.+ +|+.||||+++... ..+.|.+|+++|++++|+||++++++|.+.+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 356788999999999999999988 47899999997643 4578999999999999999999999987765 7899999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++|+|.+++.. .....+++..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp CCTTCBHHHHHHH--HCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 9999999999974 23345899999999999999999999998 999999999999999999999999999865332
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
. ....+|..|+|||.+.+..++.++|||||||+||||+| |+.||....... +...+ ..+
T Consensus 343 ~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i----~~~--------- 402 (450)
T 1k9a_A 343 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----EKG--------- 402 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHHH----HTT---------
T ss_pred c----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcC---------
Confidence 1 22357889999999999999999999999999999999 999997543221 11110 000
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
.....+......+.+++..||+.||++||++.||++.|+.+...
T Consensus 403 -~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 403 -YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 00111223345788999999999999999999999999998753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=357.91 Aligned_cols=258 Identities=25% Similarity=0.378 Sum_probs=198.3
Q ss_pred hcCcccceeecccCceEEEEEEEe----CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD----NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~----~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
.++|...+.||+|+||.||+|... .+..||||+++..... ..+.|.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 368889999999999999999874 2557999998764332 3457999999999999999999999985 467899
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 93 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 9999999999999963 3457999999999999999999999998 999999999999999999999999999877
Q ss_pred cCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 529 TEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 529 ~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... +.... .. ..
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~i---~~-~~----- 234 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI---EN-GE----- 234 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH---HT-TC-----
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHHH---Hc-CC-----
Confidence 6543333344567889999999999999999999999999999997 999997543221 11111 00 00
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
.. ..+......+.+++..|++.||++||++.|+++.|+.+.+.
T Consensus 235 -~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 235 -RL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp -CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00 11122335788999999999999999999999999988753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=366.38 Aligned_cols=268 Identities=24% Similarity=0.419 Sum_probs=199.1
Q ss_pred HHHHHhcCcccceeecccCceEEEEEEEeC-C---cEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeee
Q 048425 369 DLEKATEKFSSKRILGEGGFGCVYHGVMDN-G---TEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIE 442 (780)
Q Consensus 369 el~~at~~f~~~~~LG~G~fG~VYkg~l~~-g---~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~ 442 (780)
++....++|...+.||+|+||+||+|.... + ..||||+++... ....+.|.+|++++++++|+||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 333445789999999999999999998753 3 279999997653 3345679999999999999999999999987
Q ss_pred ccee------EEEEeecCCCChhhhccccc--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC
Q 048425 443 GRTR------CLVYELVHNGSVESHLHGVD--KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD 514 (780)
Q Consensus 443 ~~~~------~LV~Ey~~~GSL~~~L~~~~--~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~ 514 (780)
.+.. ++||||+++|+|.+++.... .....+++..+++|+.|++.||+|||+.+ |+||||||+|||++++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCC
Confidence 7655 99999999999999996432 22336999999999999999999999998 9999999999999999
Q ss_pred CCCeeecccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhh
Q 048425 515 FTPKVSDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVT 592 (780)
Q Consensus 515 ~~vKLsDFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~ 592 (780)
+.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... +..
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~ 250 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYN 250 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHH
Confidence 9999999999987654332 12234457889999999999999999999999999999999 899997543221 111
Q ss_pred hcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 593 WARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 593 wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
. +.... ...........+.+++.+|++.||++||++.|+++.|+++.+..
T Consensus 251 ~---~~~~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 251 Y---LIGGN-----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp H---HHTTC-----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred H---HhcCC-----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 0 00000 00112223357889999999999999999999999999998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=352.09 Aligned_cols=254 Identities=22% Similarity=0.331 Sum_probs=205.5
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeec--ceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEG--RTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LV~ 450 (780)
++|...+.||+|+||.||+|+. +|+.||||+++.... ...+.|.+|++++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 6788899999999999999998 589999999976542 2345799999999999999999999999877 6789999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++.. .....+++..++.++.|++.||+|||+.+ ++|+||||||+|||+++++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999974 23346999999999999999999999874 4599999999999999999999999998765332
Q ss_pred CCccceeccccCccccCchhhccCCCCc---hhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLV---KSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~---ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
....||+.|+|||.+.+...+. ++||||||+++|||+||+.||........ ... .. ..-
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~----~~------~~~ 227 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI--GMK----VA------LEG 227 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH--HHH----HH------HSC
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH--HHH----HH------hcC
Confidence 2346899999999998765544 89999999999999999999975432111 000 00 000
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
..+. .+......+.+++..||+.||++||++.|+++.|+.+.+
T Consensus 228 ~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 228 LRPT----IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111 122233568899999999999999999999999998753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=366.46 Aligned_cols=244 Identities=23% Similarity=0.265 Sum_probs=194.0
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|+..++||+|+||+||+|... +|+.||||++...... ...++..|+..+.++ +|+||++++++|.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 68999999999999999999986 7999999998654332 223566676666665 8999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+ +++|.+++.. ....++|..+++|+.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 137 e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 7799998863 3457999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
.. ......||++|+|||++.+ .++.++|||||||++|||++|+.++... ......... ...+
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~~~~~~~~~----------~~~~ 271 (311)
T 3p1a_A 210 AG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----EGWQQLRQG----------YLPP 271 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----HHHHHHTTT----------CCCH
T ss_pred CC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHhcc----------CCCc
Confidence 32 2344569999999998875 7899999999999999999997766421 111111000 0011
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+. ......+.+++.+|++.||++||++.|+++
T Consensus 272 ~~~----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 EFT----AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111 112357889999999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=356.27 Aligned_cols=264 Identities=17% Similarity=0.205 Sum_probs=213.1
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|...+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|++++.++ +|+|++++++++.++...++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 6789999999999999999996 478999999986543 334688999999999 899999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC-----Ceeeccccccc
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT-----PKVSDFGLARE 527 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~-----vKLsDFGLA~~ 527 (780)
+ +++|.+++.. ....+++..+++|+.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 88 ~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 88 L-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp C-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9 9999999963 3456999999999999999999999998 999999999999987776 99999999987
Q ss_pred ccCCCcc------ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccc
Q 048425 528 ATEGSQH------ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTR 601 (780)
Q Consensus 528 ~~~~~~~------~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~ 601 (780)
....... ......||..|+|||.+.+..++.++||||||+++|||++|+.||................ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~---~~~ 237 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG---EKK 237 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH---HHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH---hhc
Confidence 7543221 2345679999999999999999999999999999999999999997644322221111110 000
Q ss_pred cccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 602 EGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 602 ~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
.....+.+.. .....+.+++..|++.||++||++++|++.|+.+.....
T Consensus 238 ---~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 238 ---QSTPLRELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp ---HHSCHHHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ---cCccHHHHHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 0000001111 123578899999999999999999999999999987543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=363.99 Aligned_cols=251 Identities=25% Similarity=0.362 Sum_probs=203.0
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|+..+.||+|+||+||+|... +|+.||||++..... ...+.+.+|+.+++.++|+||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 68999999999999999999976 789999999865433 2335689999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++|+|.+++. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 87 ~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 87 CSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999995 3456999999999999999999999998 9999999999999999999999999998764332
Q ss_pred -ccceeccccCccccCchhhccCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 533 -QHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 533 -~~~~t~~~GT~~Y~APE~l~~~~~-t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
........||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .....|..... ...+
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~--------~~~~ 230 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKT--------YLNP 230 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHHTTCT--------TSTT
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhcccc--------cCCc
Confidence 222345679999999999988776 779999999999999999999997543221 11112211100 0000
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.......+.+++.+|++.||++||++.|+++
T Consensus 231 ------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 231 ------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1122346788999999999999999998854
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=360.94 Aligned_cols=269 Identities=26% Similarity=0.389 Sum_probs=208.7
Q ss_pred cCcccceeecccCceEEEEEEE-----eCCcEEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeeec--cee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-----DNGTEVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEG--RTR 446 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-----~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~ 446 (780)
++|+..+.||+|+||.||+|.+ .+|+.||||+++... ....+.+.+|++++++++|+||+++++++.+. +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5588889999999999999984 368999999997543 33457899999999999999999999999876 567
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 101 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 999999999999999953 3456999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCc--cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccc--cc
Q 048425 527 EATEGSQ--HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTT--RE 602 (780)
Q Consensus 527 ~~~~~~~--~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~--~~ 602 (780)
....... .......||..|+|||.+.+..++.++||||||+++|||+||+.|+..... .......+.... ..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMTVT 250 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccCHH
Confidence 7765432 223445688899999999999999999999999999999999988642210 000000000000 00
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIY 653 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~ 653 (780)
.+...+........+......+.+++.+||+.||++||++.|+++.|+.++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 011111111111122333467889999999999999999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=354.67 Aligned_cols=254 Identities=27% Similarity=0.530 Sum_probs=203.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcch-------HHHHHHHHHhhhcCCCceeeeeeeeeeccee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGD-------REFIAEVEMLSRLHHRNLVKLIGICIEGRTR 446 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~-------~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 446 (780)
++|...+.||+|+||+||+|... +++.||||++........ +.|.+|++++++++|+||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 67889999999999999999974 789999999865443221 67899999999999999999999986544
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC-----Ceeec
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT-----PKVSD 521 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~-----vKLsD 521 (780)
++||||+++|+|.+++. .....+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHh---cccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 79999999999999886 34557999999999999999999999885 45999999999999988776 99999
Q ss_pred ccccccccCCCccceeccccCccccCchhh--ccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccc
Q 048425 522 FGLAREATEGSQHISTRVMGTFGYVAPEYA--MTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLT 599 (780)
Q Consensus 522 FGLA~~~~~~~~~~~t~~~GT~~Y~APE~l--~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~ 599 (780)
||+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||......... ....
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~------ 241 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-FINM------ 241 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-HHHH------
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-HHHH------
Confidence 999985443 23446799999999998 4556789999999999999999999999754322111 0110
Q ss_pred cccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 600 TREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 600 ~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
+................+.+++..||+.||++||++.||++.|+++
T Consensus 242 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 242 -------IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -------HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -------HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0000111112223345788999999999999999999999999753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=356.71 Aligned_cols=272 Identities=20% Similarity=0.273 Sum_probs=211.2
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeeecc--eeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGR--TRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~--~~~LV~ 450 (780)
++|...++||+|+||+||+|... +|+.||||+++... ....+.+.+|++++++++|+||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 67889999999999999999986 58999999997643 334567899999999999999999999988765 679999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE----cCCCCCeeecccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL----EDDFTPKVSDFGLAR 526 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL----d~~~~vKLsDFGLA~ 526 (780)
||+++|+|.+++... .....+++..++.|+.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 89 EFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp ECCTTCBHHHHHHSG-GGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred eCCCCCCHHHHHHHh-ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999753 22334999999999999999999999998 9999999999999 788889999999998
Q ss_pred cccCCCccceeccccCccccCchhhc--------cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCcccc-chhh-hhccc
Q 048425 527 EATEGSQHISTRVMGTFGYVAPEYAM--------TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ-ENLV-TWARP 596 (780)
Q Consensus 527 ~~~~~~~~~~t~~~GT~~Y~APE~l~--------~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~-~~Lv-~wa~~ 596 (780)
....... .....||..|+|||++. +..++.++|||||||++|||+||+.||........ ..+. .....
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 7755432 23456999999999886 57889999999999999999999999964332211 1111 10000
Q ss_pred cccc-ccccccc------cCCc--cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 597 LLTT-REGLEQL------VDPS--LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 597 ll~~-~~~l~~l------vDp~--L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
.... ...+... .++. ............+.+++..|++.||++||+++|+++...+.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 0000 0000000 0011 11233456667889999999999999999999998887653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=365.91 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=205.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcE----EEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTE----VAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~----VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
++|...+.||+|+||+||+|... +|+. ||+|.+.... ....+.+.+|+.++++++|+||++++++|. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57888999999999999999964 4543 7888875443 233456889999999999999999999986 467899
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++++||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 9999999999999963 3457999999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccc
Q 048425 529 TEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 529 ~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
...... ......||..|+|||.+.++.++.++||||||+++|||+| |+.||.............. .. .
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-------~~---~ 235 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK-------GE---R 235 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT-------TC---B
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc-------CC---C
Confidence 554322 2345668889999999999999999999999999999999 9999976443221111110 00 0
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
... +......+.+++..||+.||++||++.||++.|+.+....
T Consensus 236 ~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 236 LAQ-------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp CCC-------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred CCC-------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 000 1111224678999999999999999999999999887643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=368.64 Aligned_cols=275 Identities=25% Similarity=0.367 Sum_probs=213.0
Q ss_pred cCcccceeecccCceEEEEEEE-----eCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeee--ecceeE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-----DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICI--EGRTRC 447 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~--~~~~~~ 447 (780)
++|+..+.||+|+||.||++.+ .+++.||||++........+.|.+|++++++++|+||+++++++. +.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6788999999999999999984 368899999998766555677999999999999999999999987 445689
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+||||+++++|.+++.. ....+++..++.|+.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 103 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 99999999999999963 2346999999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCcc--ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccc
Q 048425 528 ATEGSQH--ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLE 605 (780)
Q Consensus 528 ~~~~~~~--~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~ 605 (780)
....... ......||..|+|||.+.+..++.++||||||+++|||++|+.|+........ ....+.... .....+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~-~~~~~~~ 254 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-RMMGCERDV-PALSRLL 254 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHCC----C-CHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhh-hhccccccc-ccHHHHH
Confidence 7543322 22345688899999999999999999999999999999999999864221100 000000000 0001111
Q ss_pred cccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 606 QLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 606 ~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
+.+........+......+.+++.+|++.||++||++.||++.|+.+.....
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 1111222222233445678999999999999999999999999998876544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=365.17 Aligned_cols=263 Identities=17% Similarity=0.219 Sum_probs=212.3
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|...+.||+|+||+||+|.. .+|+.||||++..... .+.+.+|+++++++ +|+||+++++++..++..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 6789999999999999999996 4789999999875432 34688999999999 999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC-----Ceeeccccccc
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT-----PKVSDFGLARE 527 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~-----vKLsDFGLA~~ 527 (780)
+ +++|.+++.. ....+++..++.|+.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 87 L-GPSLEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp C-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred C-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9 9999999963 2457999999999999999999999998 999999999999998887 99999999997
Q ss_pred ccCCCcc------ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccc
Q 048425 528 ATEGSQH------ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTR 601 (780)
Q Consensus 528 ~~~~~~~------~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~ 601 (780)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.............. +....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~---i~~~~ 236 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK---IGDTK 236 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH---HHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH---HHhhh
Confidence 6543221 12456799999999999999999999999999999999999999976543221111111 10000
Q ss_pred cccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 602 EGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 602 ~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
.......+.. ... .+.+++..|++.+|.+||++.+|++.|+.+.....
T Consensus 237 ---~~~~~~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 237 ---RATPIEVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp ---HHSCHHHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ---ccCCHHHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 0000000111 112 78899999999999999999999999998876543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=355.99 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=196.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--------------------------chHHHHHHHHHhhh
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--------------------------GDREFIAEVEMLSR 427 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--------------------------~~~~f~~Ei~iL~~ 427 (780)
++|...+.||+|+||.||+|... +|+.||||++...... ..+.|.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 67889999999999999999875 6899999998654311 13568999999999
Q ss_pred cCCCceeeeeeeeee--cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccC
Q 048425 428 LHHRNLVKLIGICIE--GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFK 505 (780)
Q Consensus 428 L~HpNIV~L~g~~~~--~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIK 505 (780)
++||||+++++++.+ ++..++||||+++++|.+++. ...+++..++.++.|++.||+|||+.+ |+|||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 999999999999986 567899999999999988763 347999999999999999999999998 9999999
Q ss_pred CcceEEcCCCCCeeecccccccccCCCccceeccccCccccCchhhccCC---CCchhhHHhHHHHHHHHHhCCCCCCCC
Q 048425 506 ASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGH---LLVKSDVYSYGVVLLELLSGRKPVDMS 582 (780)
Q Consensus 506 psNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~---~t~ksDVySfGVvLlELlTGr~P~~~~ 582 (780)
|+|||++.++++||+|||+++....... ......||+.|+|||.+.+.. .+.++|||||||++|||++|+.||...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999987654322 234457999999999988765 378999999999999999999999653
Q ss_pred CccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 583 QPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 583 ~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
... .+.. .+.... . .. + ........+.+++.+||+.||++||++.|+++
T Consensus 244 ~~~---~~~~---~~~~~~--~-~~--~-----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RIM---CLHS---KIKSQA--L-EF--P-----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SHH---HHHH---HHHHCC--C-CC--C-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cHH---HHHH---HHhccc--C-CC--C-----CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 211 1111 000000 0 00 0 01122356889999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=360.17 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=201.6
Q ss_pred hcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
.++|+..+.||+|+||+||+|...+|+.||||+++..... ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 3789999999999999999999988999999999654322 23678999999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|++ |+|.+++. .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FME-KDLKKVLD---ENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCS-EEHHHHHH---TCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCC-CCHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 998 47888875 34456999999999999999999999998 999999999999999999999999999876543
Q ss_pred CccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-hhhhccc-c---cccccccc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LVTWARP-L---LTTREGLE 605 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-Lv~wa~~-l---l~~~~~l~ 605 (780)
.. ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... +...... . +.....+.
T Consensus 173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 173 VR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred cc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 22 2234568999999999876 568999999999999999999999997654332111 1000000 0 00000000
Q ss_pred cccCCccC--CCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 606 QLVDPSLA--GSYD-----FDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 606 ~lvDp~L~--~~~~-----~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
...+.... .... ......+.+++.+|++.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000 0000 112246789999999999999999999865
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=370.98 Aligned_cols=270 Identities=19% Similarity=0.272 Sum_probs=209.4
Q ss_pred hcCcccceeecccCceEEEEEEEeC------CcEEEEEEeeccCCcc-----------hHHHHHHHHHhhhcCCCceeee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDN------GTEVAVKLLTRNNQNG-----------DREFIAEVEMLSRLHHRNLVKL 436 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~------g~~VAVK~l~~~~~~~-----------~~~f~~Ei~iL~~L~HpNIV~L 436 (780)
.++|...+.||+|+||.||+|.+.+ ++.||||++....... ...+..|+..+..++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4689999999999999999998864 4789999987653211 1224456667778889999999
Q ss_pred eeeeeec----ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc
Q 048425 437 IGICIEG----RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE 512 (780)
Q Consensus 437 ~g~~~~~----~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd 512 (780)
++++... ...+|||||+ +++|.+++.. ....+++..++.|+.||+.||+|||+.+ |+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 9998875 4579999999 9999999963 3467999999999999999999999998 99999999999999
Q ss_pred --CCCCCeeecccccccccCCCcc------ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCc
Q 048425 513 --DDFTPKVSDFGLAREATEGSQH------ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQP 584 (780)
Q Consensus 513 --~~~~vKLsDFGLA~~~~~~~~~------~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~ 584 (780)
+++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+||||+||+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999876543211 11335599999999999999999999999999999999999999974322
Q ss_pred cccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 585 QGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 585 ~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
. .....+..... ...+..++++.+.. ......+.+++..|++.+|++||++.+|++.|+.+.....
T Consensus 267 ~--~~~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 267 D--PKYVRDSKIRY--RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp C--HHHHHHHHHHH--HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred C--HHHHHHHHHHh--hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 1 11111111111 12233344433321 1223568899999999999999999999999999987644
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=384.07 Aligned_cols=264 Identities=19% Similarity=0.244 Sum_probs=213.4
Q ss_pred cchHHHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeee
Q 048425 365 FALSDLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGIC 440 (780)
Q Consensus 365 f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~ 440 (780)
+.+.+++..+++|+..++||+|+||+||+|+.. +|+.||||++++.. ......+.+|++++..++|+||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 456677777899999999999999999999986 57899999997532 22234589999999999999999999999
Q ss_pred eecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeee
Q 048425 441 IEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVS 520 (780)
Q Consensus 441 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLs 520 (780)
.+++..+|||||+++|+|.++|.. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEc
Confidence 999999999999999999999963 3467999999999999999999999998 9999999999999999999999
Q ss_pred cccccccccCCCccceeccccCccccCchhhc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcc
Q 048425 521 DFGLAREATEGSQHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWAR 595 (780)
Q Consensus 521 DFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~-----~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~ 595 (780)
|||+++..........+..+||+.|+|||++. .+.++.++|||||||++|||++|+.||......... .
T Consensus 218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~------~ 291 (437)
T 4aw2_A 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------G 291 (437)
T ss_dssp CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------H
T ss_pred chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH------H
Confidence 99999877655444445578999999999987 567899999999999999999999999754322111 0
Q ss_pred cccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 048425 596 PLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTH--RPFMGEVVQ 647 (780)
Q Consensus 596 ~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~--RPsm~EVv~ 647 (780)
.++.... .+.-+.... .....+.+++.+|++.+|++ ||+++|+++
T Consensus 292 ~i~~~~~---~~~~p~~~~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 292 KIMNHKE---RFQFPTQVT----DVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHTHHH---HCCCCSSCC----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhhhccc---cccCCcccc----cCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1111100 011111101 12246788999999888888 999999865
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=353.70 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=206.1
Q ss_pred hcCcccceeecccCceEEEEEEEeC----CcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDN----GTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~----g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
.++|...+.||+|+||+||+|...+ +..||||+++.... ...+.|.+|++++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4788899999999999999998653 33699999976532 334679999999999999999999999865 45689
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 90 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 9999999999999963 3456999999999999999999999998 999999999999999999999999999877
Q ss_pred cCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 529 TEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 529 ~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
............+|..|+|||.+.+..++.++||||||+++|||+| |+.||....... +.... ....
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~----~~~~----- 231 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVL----EKGD----- 231 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHH----HHTC-----
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHH----hcCC-----
Confidence 5543333344567889999999999999999999999999999998 999997543221 11110 0000
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
.. .........+.+++.+|++.||++||++.|+++.|+.+...
T Consensus 232 -~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 232 -RL----PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp -CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CC----CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 00 01112235688999999999999999999999999988754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=359.38 Aligned_cols=253 Identities=26% Similarity=0.443 Sum_probs=204.2
Q ss_pred cCcccceeecccCceEEEEEEEe-CC-------cEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeeccee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NG-------TEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTR 446 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g-------~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 446 (780)
++|...+.||+|+||+||+|... ++ ..||+|++........+.|.+|++++++++|+||+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 67889999999999999999875 33 57999999777666678899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC--------Ce
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT--------PK 518 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~--------vK 518 (780)
++||||+++|+|.+++.. ....+++..+++++.|++.||+|||+.+ |+||||||+|||++.++. +|
T Consensus 88 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp EEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999963 3345999999999999999999999998 999999999999998887 99
Q ss_pred eecccccccccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccc
Q 048425 519 VSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL 597 (780)
Q Consensus 519 LsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~l 597 (780)
|+|||++...... ....||..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... ......
T Consensus 162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~~~~---- 230 (289)
T 4fvq_A 162 LSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRKLQF---- 230 (289)
T ss_dssp ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHH----
T ss_pred eccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--HHHHHH----
Confidence 9999999765332 23458999999999987 77899999999999999999965554322111 111100
Q ss_pred cccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 598 LTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 598 l~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
.... ..+.. .....+.+++..||+.||++||++.|+++.|+.+....
T Consensus 231 ~~~~--------~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 231 YEDR--------HQLPA----PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp HHTT--------CCCCC----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred hhcc--------CCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 0000 00001 11234778999999999999999999999999887643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=357.89 Aligned_cols=265 Identities=24% Similarity=0.362 Sum_probs=203.0
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||.||+|... +|+.||||+++.... ...+++.+|++++++++|+||+++++++.+++..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 57899999999999999999974 789999999975432 23457899999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++.........+++..+++++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999999754445677999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
... ......||..|+|||.+.+..++.++||||||+++|||++|+.||...... ...+...+.. ...+
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~-------~~~~ 256 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQ-------CDYP 256 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHHHT-------TCSC
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHhhc-------ccCC
Confidence 322 123456899999999999999999999999999999999999999643211 1111111000 0001
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
.+. .......+.+++.+||+.||++||++.||++.|+++.....
T Consensus 257 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 257 PLP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp CCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 110 11223468899999999999999999999999999976543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=395.26 Aligned_cols=261 Identities=27% Similarity=0.415 Sum_probs=213.4
Q ss_pred HHhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 372 KATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 372 ~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
...++|...+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++|+||++++++|.+ +..+||||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3457888999999999999999999888889999997654 346789999999999999999999999876 67899999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++|+|.++|... ....+++.++++|+.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.....
T Consensus 342 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred hhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 99999999999632 2346899999999999999999999998 999999999999999999999999999876542
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
.........+|..|+|||.+.++.++.++|||||||+||||+| |+.||...... .+...+ ...
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~~i----~~~--------- 480 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQV----ERG--------- 480 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHHHH----HTT---------
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcC---------
Confidence 2222233457889999999999999999999999999999999 99999654321 111111 000
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
............+.+|+.+||+.||++||++++|++.|+.+....
T Consensus 481 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 481 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 000111223457889999999999999999999999999876543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=357.61 Aligned_cols=259 Identities=30% Similarity=0.490 Sum_probs=200.7
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
++|...+.||+|+||+||+|.. .++.||||++... ...+.|.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 5788889999999999999988 5789999998643 34567999999999999999999999987 45799999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC-CeeecccccccccCCCc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT-PKVSDFGLAREATEGSQ 533 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~-vKLsDFGLA~~~~~~~~ 533 (780)
+|+|.+++... .....+++..+++++.|+++||+|||+.+..+|+||||||+|||+++++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 83 GGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999642 12235789999999999999999999942223999999999999998887 799999999865432
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
.....||..|+|||.+.+..++.++||||||+++|||+||+.||+...... ....|.. .. -..+.+.
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~--~~-------~~~~~~~ 226 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRIMWAV--HN-------GTRPPLI 226 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH--HHHHHHH--HT-------TCCCCCB
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH--HHHHHHH--hc-------CCCCCcc
Confidence 123469999999999999999999999999999999999999997533211 1111110 00 0011111
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCCC
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDE 658 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~~ 658 (780)
. .....+.+++.+|++.||++||++.||++.|+.+......
T Consensus 227 ~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 227 K----NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred c----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 1 2234688999999999999999999999999998765543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=361.27 Aligned_cols=264 Identities=25% Similarity=0.415 Sum_probs=212.1
Q ss_pred hcCcccceeecccCceEEEEEEE--------eCCcEEEEEEeeccCC-cchHHHHHHHHHhhhc-CCCceeeeeeeeeec
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVM--------DNGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRL-HHRNLVKLIGICIEG 443 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l--------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~ 443 (780)
.++|...+.||+|+||.||+|.. .++..||||+++.... ...+.+.+|+++++++ +||||++++++|.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 47899999999999999999986 3567899999976533 2345789999999999 899999999999999
Q ss_pred ceeEEEEeecCCCChhhhcccccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDK------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL 511 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL 511 (780)
+..++||||+++|+|.+++..... ....+++..+++++.||+.||+|||+.+ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999975321 1235899999999999999999999998 9999999999999
Q ss_pred cCCCCCeeecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccch
Q 048425 512 EDDFTPKVSDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQEN 589 (780)
Q Consensus 512 d~~~~vKLsDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~ 589 (780)
+.++.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||+++|||+| |+.||...... .
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~ 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---H
Confidence 99999999999999876543321 2234457889999999999999999999999999999999 99999754321 1
Q ss_pred hhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 590 LVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 590 Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
+..... .. ... .........+.+++.+||+.+|++||++.||++.|+.+.....
T Consensus 268 ~~~~~~----~~------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 268 LFKLLK----EG------HRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHHHH----HT------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHh----cC------CCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 111110 00 000 1112233568899999999999999999999999999986543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=360.93 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=205.1
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc------chHHHHHHHHHhhhcCCCceeeeeeeeeeccee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN------GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTR 446 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 446 (780)
.++|...+.||+|+||.||++... +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+++..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 367889999999999999999975 6899999999765322 356799999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC----CCeeecc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF----TPKVSDF 522 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~----~vKLsDF 522 (780)
++||||+++|+|.+++. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999995 3457999999999999999999999998 99999999999999887 8999999
Q ss_pred cccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccc
Q 048425 523 GLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 523 GLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ +... .....
T Consensus 163 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~----~~~~~ 234 (326)
T 2y0a_A 163 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LANV----SAVNY 234 (326)
T ss_dssp TTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHHH----HHTCC
T ss_pred CCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHHH----HhcCC
Confidence 99987754322 2345799999999999999999999999999999999999999975432111 1000 00000
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
. ...... ......+.+++..|++.||++|||+.|+++
T Consensus 235 ~----~~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 E----FEDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C----CCHHHH----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C----cCcccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 000000 112246789999999999999999999965
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=355.52 Aligned_cols=267 Identities=24% Similarity=0.382 Sum_probs=203.9
Q ss_pred HHHhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhc--CCCceeeeeeeeeec----c
Q 048425 371 EKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL--HHRNLVKLIGICIEG----R 444 (780)
Q Consensus 371 ~~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L--~HpNIV~L~g~~~~~----~ 444 (780)
....++|...+.||+|+||.||+|.. +|+.||||++... ....+..|.+++..+ +|+||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 34457899999999999999999988 4899999998643 234556666666654 999999999999887 6
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCcEEecccCCcceEEcCCCCCee
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS-----NPRVIHRDFKASNVLLEDDFTPKV 519 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~-----~p~IvHrDIKpsNILLd~~~~vKL 519 (780)
..++||||+++|+|.+++.. ..+++..+++++.|++.||+|||+.+ .++|+||||||+|||++.++++||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 78999999999999999953 36999999999999999999999881 123999999999999999999999
Q ss_pred ecccccccccCCCccc---eeccccCccccCchhhccCCCCch------hhHHhHHHHHHHHHhC----------CCCCC
Q 048425 520 SDFGLAREATEGSQHI---STRVMGTFGYVAPEYAMTGHLLVK------SDVYSYGVVLLELLSG----------RKPVD 580 (780)
Q Consensus 520 sDFGLA~~~~~~~~~~---~t~~~GT~~Y~APE~l~~~~~t~k------sDVySfGVvLlELlTG----------r~P~~ 580 (780)
+|||+++......... .....||..|+|||.+.+...+.+ +|||||||++|||+|| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999998765433221 124579999999999988766654 9999999999999999 44443
Q ss_pred CCCccccchhhhhcccccccccccccccCCccCCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 581 MSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYD-----FDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 581 ~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~-----~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
...+.... ...+ ...+....+....+ .+....+.+++.+||+.||++||++.||++.|+.+.+.
T Consensus 264 ~~~~~~~~-~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 264 DLVPSDPS-YEDM----------REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TTSCSSCC-HHHH----------HHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hhcCCCCc-hhhh----------HHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 32211110 0000 00001111111111 25567899999999999999999999999999999876
Q ss_pred CC
Q 048425 656 TD 657 (780)
Q Consensus 656 ~~ 657 (780)
.+
T Consensus 333 ~~ 334 (337)
T 3mdy_A 333 QD 334 (337)
T ss_dssp TT
T ss_pred cc
Confidence 54
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=353.03 Aligned_cols=263 Identities=25% Similarity=0.350 Sum_probs=200.5
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|...+.||+|+||+||+|...+|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57889999999999999999998899999999865432 2346789999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++ +|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 975 89888853 3467999999999999999999999998 9999999999999999999999999998765332
Q ss_pred ccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccc----ccccccccc-
Q 048425 533 QHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL----LTTREGLEQ- 606 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~l----l~~~~~l~~- 606 (780)
. ......||+.|+|||.+.+. .++.++|||||||++|||+||+.||........ +....+.. ........+
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGS
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHHCCCChhhchhhhcc
Confidence 2 22345689999999998764 589999999999999999999999976432211 11100000 000000000
Q ss_pred -ccCCccCC-------CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 607 -LVDPSLAG-------SYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 607 -lvDp~L~~-------~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..++.... .........+.+++.+|++.||++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 01111100 011122356789999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=359.01 Aligned_cols=251 Identities=22% Similarity=0.369 Sum_probs=198.2
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecce------
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRT------ 445 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~------ 445 (780)
.++|+..+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 468999999999999999999986 7999999999765433 44679999999999999999999999866432
Q ss_pred ---------------------------------------------------eEEEEeecCCCChhhhcccccCCCCCCCH
Q 048425 446 ---------------------------------------------------RCLVYELVHNGSVESHLHGVDKNRGPLDW 474 (780)
Q Consensus 446 ---------------------------------------------------~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~ 474 (780)
.++||||+++|+|.+++... ......++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-CSLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC-CSGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc-cCccchhh
Confidence 79999999999999999743 23345678
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc-----------cceeccccCc
Q 048425 475 EARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ-----------HISTRVMGTF 543 (780)
Q Consensus 475 ~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~-----------~~~t~~~GT~ 543 (780)
..+++++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 889999999999999999998 99999999999999999999999999987755421 1123457999
Q ss_pred cccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCChhhHHH
Q 048425 544 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAK 623 (780)
Q Consensus 544 ~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~ 623 (780)
.|+|||.+.+..++.++|||||||++|||++|..|+.. ...... ........ .........
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~-------------~~~~~~~~-~~~~~~~~~ 301 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIIT-------------DVRNLKFP-LLFTQKYPQ 301 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHH-------------HHHTTCCC-HHHHHHCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHH-------------HhhccCCC-cccccCChh
Confidence 99999999999999999999999999999998765421 011100 00000000 001122345
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 048425 624 VAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 624 l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+.+++.+||+.||++||++.|+++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCCCCcCCCHHHHhh
Confidence 688999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=358.80 Aligned_cols=272 Identities=25% Similarity=0.409 Sum_probs=216.2
Q ss_pred cchHHHHHHhcCcccceeecccCceEEEEEEE------eCCcEEEEEEeeccCCc-chHHHHHHHHHhhhc-CCCceeee
Q 048425 365 FALSDLEKATEKFSSKRILGEGGFGCVYHGVM------DNGTEVAVKLLTRNNQN-GDREFIAEVEMLSRL-HHRNLVKL 436 (780)
Q Consensus 365 f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l------~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~L 436 (780)
+...++....++|...+.||+|+||+||+|.. .+++.||||+++..... ..+.+.+|++++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44455555678999999999999999999985 25688999999765432 335799999999999 79999999
Q ss_pred eeeeeecc-eeEEEEeecCCCChhhhcccccCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecc
Q 048425 437 IGICIEGR-TRCLVYELVHNGSVESHLHGVDKN------------RGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRD 503 (780)
Q Consensus 437 ~g~~~~~~-~~~LV~Ey~~~GSL~~~L~~~~~~------------~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrD 503 (780)
++++...+ ..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99988754 489999999999999999753221 223899999999999999999999998 99999
Q ss_pred cCCcceEEcCCCCCeeecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCC
Q 048425 504 FKASNVLLEDDFTPKVSDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDM 581 (780)
Q Consensus 504 IKpsNILLd~~~~vKLsDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~ 581 (780)
|||+|||+++++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999876544322 2334568899999999999999999999999999999998 9999965
Q ss_pred CCccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 582 SQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 582 ~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
..... .+... .... .... ........+.+++.+||+.||++||++.||++.|+.+...
T Consensus 254 ~~~~~--~~~~~----~~~~------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 254 VKIDE--EFCRR----LKEG------TRMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CCCSH--HHHHH----HHHT------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchhH--HHHHH----hccC------ccCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 43211 11110 0000 0011 1112234688999999999999999999999999988754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=362.08 Aligned_cols=272 Identities=26% Similarity=0.456 Sum_probs=218.4
Q ss_pred cccchHHHHHHhcCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceee
Q 048425 363 KTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVK 435 (780)
Q Consensus 363 ~~f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~ 435 (780)
..+..++++...++|...+.||+|+||.||+|... +++.||||++...... ....|.+|++++++++|+||++
T Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEee
Confidence 34555666677789999999999999999999864 3678999999755332 3356999999999999999999
Q ss_pred eeeeeeecceeEEEEeecCCCChhhhcccccC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcce
Q 048425 436 LIGICIEGRTRCLVYELVHNGSVESHLHGVDK------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNV 509 (780)
Q Consensus 436 L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNI 509 (780)
+++++.+++..++||||+++|+|.+++..... ....+++..+++++.|++.||+|||+.+ |+||||||+||
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NI 169 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNC 169 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGE
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceE
Confidence 99999999999999999999999999964221 1256799999999999999999999998 99999999999
Q ss_pred EEcCCCCCeeecccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCcccc
Q 048425 510 LLEDDFTPKVSDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQ 587 (780)
Q Consensus 510 LLd~~~~vKLsDFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~ 587 (780)
|+++++.+||+|||+++....... .......||..|+|||.+.+..++.++||||||+++|||+| |+.||......
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 247 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-- 247 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--
T ss_pred EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--
Confidence 999999999999999987644322 12233457889999999999999999999999999999999 88898654321
Q ss_pred chhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 588 ENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 588 ~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
.+.... . +... ..........+.+++.+|++.||++||++.|+++.|+.+..
T Consensus 248 -~~~~~~---~----------~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 248 -QVLRFV---M----------EGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -HHHHHH---H----------TTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -HHHHHH---H----------cCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 111110 0 0000 01112233568899999999999999999999999987754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=352.23 Aligned_cols=261 Identities=26% Similarity=0.415 Sum_probs=211.8
Q ss_pred cCcccce-eecccCceEEEEEEEe---CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKR-ILGEGGFGCVYHGVMD---NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~-~LG~G~fG~VYkg~l~---~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
++|...+ .||+|+||.||+|... ++..||||+++.... ...+++.+|++++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 5566665 9999999999999853 678899999976533 2346799999999999999999999999 55678999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++++|.+++. .....+++..+++++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 88 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHH---hCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 99999999999996 34557999999999999999999999998 9999999999999999999999999998775
Q ss_pred CCCccc--eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccc
Q 048425 530 EGSQHI--STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 530 ~~~~~~--~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
...... .....||..|+|||.+.+..++.++||||||+++|||+| |+.||...... .+...... .
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~i~~----~----- 229 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQ----G----- 229 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHHT----T-----
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHhc----C-----
Confidence 433221 233457899999999999999999999999999999999 99999754321 11111100 0
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCCCC
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDET 659 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~~~ 659 (780)
..+ ..+......+.+++..||+.+|++||++.||++.|+.++......
T Consensus 230 -~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 230 -KRM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp -CCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred -CcC----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 001 112233457889999999999999999999999999998765543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=359.08 Aligned_cols=262 Identities=23% Similarity=0.334 Sum_probs=207.7
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeee----cceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIE----GRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~~LV 449 (780)
++|...+.||+|+||.||++.. .+|+.||||++........+.+.+|++++++++|+||+++++++.. ....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 6789999999999999999997 4799999999977655566789999999999999999999999873 3477999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++|+|.+++.........+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 9999999999999765455678999999999999999999999998 9999999999999999999999999987653
Q ss_pred CCCcc--------ceeccccCccccCchhhccCC---CCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccc
Q 048425 530 EGSQH--------ISTRVMGTFGYVAPEYAMTGH---LLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLL 598 (780)
Q Consensus 530 ~~~~~--------~~t~~~GT~~Y~APE~l~~~~---~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll 598 (780)
..... ......||..|+|||.+.+.. ++.++||||||+++|||++|+.||+....... .+......
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~-- 262 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAVQN-- 262 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHHHC--
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHhhc--
Confidence 21110 012345799999999987554 68999999999999999999999853111110 01000000
Q ss_pred ccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 599 TTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 599 ~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
.............+.+++.+||+.||++||++.||++.|+.+..
T Consensus 263 ------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 263 ------------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp ------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred ------------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 00000111223578899999999999999999999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=361.55 Aligned_cols=262 Identities=26% Similarity=0.324 Sum_probs=202.7
Q ss_pred HHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeecc-----CCcchHHHHHHHHHhhhcCCCceeeeeeeeee
Q 048425 369 DLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRN-----NQNGDREFIAEVEMLSRLHHRNLVKLIGICIE 442 (780)
Q Consensus 369 el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~-----~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~ 442 (780)
++....++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34566788999999999999999999974 7889999998654 23345689999999999999999999999999
Q ss_pred cceeEEEEeecCCCChhhhcccccCC------------------------------------CCCCCHHHHHHHHHHHHH
Q 048425 443 GRTRCLVYELVHNGSVESHLHGVDKN------------------------------------RGPLDWEARMKIALGAAR 486 (780)
Q Consensus 443 ~~~~~LV~Ey~~~GSL~~~L~~~~~~------------------------------------~~~L~~~~rl~Ia~qIA~ 486 (780)
.+..++||||+++|+|.+++...... ...+++..++.|+.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521111 123456778899999999
Q ss_pred HHHHHhhCCCCcEEecccCCcceEEcCCC--CCeeecccccccccCCCc---cceeccccCccccCchhhcc--CCCCch
Q 048425 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDF--TPKVSDFGLAREATEGSQ---HISTRVMGTFGYVAPEYAMT--GHLLVK 559 (780)
Q Consensus 487 gL~yLH~~~~p~IvHrDIKpsNILLd~~~--~vKLsDFGLA~~~~~~~~---~~~t~~~GT~~Y~APE~l~~--~~~t~k 559 (780)
||+|||+.+ |+||||||+|||++.++ .+||+|||+++....... .......||+.|+|||.+.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999998 99999999999998776 899999999987643221 12345679999999999875 688999
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCC
Q 048425 560 SDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHR 639 (780)
Q Consensus 560 sDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~R 639 (780)
+|||||||++|||++|+.||........ +.. +..... ....+.. ......+.+++..|++.||++|
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~--~~~----~~~~~~---~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADT--ISQ----VLNKKL---CFENPNY-----NVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH----HHHCCC---CTTSGGG-----GGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHH--HHH----HHhccc---ccCCccc-----ccCCHHHHHHHHHHcCCChhHC
Confidence 9999999999999999999975432211 111 010000 0000100 1123568899999999999999
Q ss_pred CCHHHHHH
Q 048425 640 PFMGEVVQ 647 (780)
Q Consensus 640 Psm~EVv~ 647 (780)
|++.|+++
T Consensus 323 ps~~~~l~ 330 (345)
T 3hko_A 323 FDAMRALQ 330 (345)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhc
Confidence 99999976
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=363.85 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=205.8
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc------chHHHHHHHHHhhhcCCCceeeeeeeeeeccee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN------GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTR 446 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 446 (780)
.++|...+.||+|+||+||++... +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467899999999999999999976 6899999999765432 346799999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC----CCeeecc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF----TPKVSDF 522 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~----~vKLsDF 522 (780)
++||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999994 3457999999999999999999999998 99999999999998877 7999999
Q ss_pred cccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccc
Q 048425 523 GLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 523 GLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.. .+.....
T Consensus 164 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---~~~---~i~~~~~ 235 (361)
T 2yab_A 164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLA---NITAVSY 235 (361)
T ss_dssp SSCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH---HHHTTCC
T ss_pred CCceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHhcCC
Confidence 99987755322 244679999999999999999999999999999999999999997543211 111 0000000
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
. +++.... .....+.+++..|++.||++||++.|+++
T Consensus 236 ~----~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 D----FDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C----CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C----CCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0000001 11246789999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=350.62 Aligned_cols=264 Identities=21% Similarity=0.293 Sum_probs=201.1
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
++|+..+.||+|+||+||+|... +|+.||||+++..... ..+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999975 6899999999765432 23678999999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++ +|.+++. .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9975 5555553 33567999999999999999999999998 999999999999999999999999999876543
Q ss_pred CccceeccccCccccCchhhccCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccc----cccccccccc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARP----LLTTREGLEQ 606 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~-~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~----ll~~~~~l~~ 606 (780)
.. ......||..|+|||.+.+.. ++.++|||||||++|||++|+.|+....... ..+....+. ..........
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHHHHHHHCCCCTTTCTTGGG
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChhhhhhhcc
Confidence 22 224456899999999998766 7999999999999999999988864322111 111110000 0000000000
Q ss_pred ccCC---------ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 607 LVDP---------SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 607 lvDp---------~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+.+. .............+.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 0000111123457789999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=365.44 Aligned_cols=254 Identities=20% Similarity=0.278 Sum_probs=205.8
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC-----CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN-----QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
++|...+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 67899999999999999999875 78999999986431 2245789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC---Ceeeccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT---PKVSDFGLA 525 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~---vKLsDFGLA 525 (780)
||||+++|+|.+++.........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999888654444557999999999999999999999998 999999999999987654 999999999
Q ss_pred ccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccc
Q 048425 526 REATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLE 605 (780)
Q Consensus 526 ~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~ 605 (780)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+... +.....
T Consensus 181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~---i~~~~~--- 249 (351)
T 3c0i_A 181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEG---IIKGKY--- 249 (351)
T ss_dssp EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHH---HHHTCC---
T ss_pred eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHH---HHcCCC---
Confidence 87765332 2344579999999999999999999999999999999999999997532 111110 000000
Q ss_pred cccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 606 QLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 606 ~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..++.... .....+.+++.+||+.||++||++.|+++
T Consensus 250 -~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 -KMNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -CCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000000 11246789999999999999999999976
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=363.71 Aligned_cols=247 Identities=24% Similarity=0.326 Sum_probs=205.5
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeecc---CCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRN---NQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||+||+++.. +|+.||||++++. .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 68899999999999999999975 6899999999764 2344567899999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999853 356899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .+.... .
T Consensus 158 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~---~i~~~~--------~ 222 (337)
T 1o6l_A 158 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE---LILMEE--------I 222 (337)
T ss_dssp TTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHCC--------C
T ss_pred CCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHH---HHHcCC--------C
Confidence 222 234567999999999999999999999999999999999999999754321 1111 111100 0
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRP-----FMGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv~ 647 (780)
.++......+.+++.+|++.||++|| +++||++
T Consensus 223 ----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 11112235678999999999999999 8888865
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=360.37 Aligned_cols=271 Identities=29% Similarity=0.394 Sum_probs=211.9
Q ss_pred cccceeecccCceEEEEEEEe-----CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeec--ceeEE
Q 048425 377 FSSKRILGEGGFGCVYHGVMD-----NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEG--RTRCL 448 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l~-----~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~L 448 (780)
|+..+.||+|+||+||++.+. +|+.||||+++.... ...+.|.+|++++++++|+||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999998753 688999999976543 2345799999999999999999999999874 57799
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999953 24999999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCcc--ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 529 TEGSQH--ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 529 ~~~~~~--~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
...... ......||..|+|||.+.+..++.++||||||+++|||+||+.||...... ...+..+....... ..+.+
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~-~~~~~ 262 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-FLELIGIAQGQMTV-LRLTE 262 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-HHHHHCSCCHHHHH-HHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh-hhhhhcccccchhH-HHHHH
Confidence 654321 233456888999999999999999999999999999999999998642211 01111111111100 01112
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
.++.......+......+.+++.+||+.||++||++.|+++.|+.+.+...
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 222222222233445678999999999999999999999999999876543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.95 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=206.6
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeee---------
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIE--------- 442 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--------- 442 (780)
..++|+..+.||+|+||.||+|... +|+.||||+++... +.+.+|++++++++|+||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467999999999999999999986 79999999997543 357789999999999999999998854
Q ss_pred -------cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC
Q 048425 443 -------GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF 515 (780)
Q Consensus 443 -------~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~ 515 (780)
....++||||+++|+|.+++... ....+++..+++++.|++.||+|||+.+ |+||||||+|||+++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence 44579999999999999999642 3357999999999999999999999998 99999999999999999
Q ss_pred CCeeecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcc
Q 048425 516 TPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWAR 595 (780)
Q Consensus 516 ~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~ 595 (780)
.+||+|||+++....... .....||..|+|||.+.+..++.++||||||+++|||++|..|+... ....
T Consensus 160 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~---- 228 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFF---- 228 (284)
T ss_dssp EEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHH----
T ss_pred CEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHH----
Confidence 999999999987755432 23456999999999999999999999999999999999999876311 1110
Q ss_pred cccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 596 PLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 596 ~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
..+.+..+...+ ...+.+++.+|++.||++||++.|+++.|+.+....+
T Consensus 229 ---------~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 229 ---------TDLRDGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp ---------HHHHTTCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ---------HHhhcccccccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 111111111122 2457889999999999999999999999998875543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=359.52 Aligned_cols=252 Identities=19% Similarity=0.269 Sum_probs=206.4
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
.++|...+.||+|+||.||++... +|+.||+|.++... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 478999999999999999999976 68899999986542 3445789999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC--CCCCeeecccccccccC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED--DFTPKVSDFGLAREATE 530 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~--~~~vKLsDFGLA~~~~~ 530 (780)
+++|+|.+++. .....+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 99999999995 23457999999999999999999999998 999999999999987 78999999999988755
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... +.. .+...... .+.
T Consensus 157 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~---~i~~~~~~----~~~ 224 (321)
T 1tki_A 157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIE---NIMNAEYT----FDE 224 (321)
T ss_dssp TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HHHHTCCC----CCH
T ss_pred CCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HHH---HHHcCCCC----CCh
Confidence 432 344679999999999999889999999999999999999999997543211 111 01100000 000
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.... +....+.+++.+|++.||++|||+.|+++.
T Consensus 225 ~~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 225 EAFK----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000 123467899999999999999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=360.47 Aligned_cols=264 Identities=26% Similarity=0.405 Sum_probs=212.0
Q ss_pred HhcCcccceeecccCceEEEEEEEeC------CcEEEEEEeeccCCc-chHHHHHHHHHhhhc-CCCceeeeeeeeeecc
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMDN------GTEVAVKLLTRNNQN-GDREFIAEVEMLSRL-HHRNLVKLIGICIEGR 444 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~~------g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~ 444 (780)
..++|...+.||+|+||.||+|.... +..||||+++..... ..+.+.+|+++++++ +||||++++++|.+++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 35789999999999999999998642 247999999765432 345799999999999 8999999999999999
Q ss_pred eeEEEEeecCCCChhhhcccccC----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC
Q 048425 445 TRCLVYELVHNGSVESHLHGVDK----------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD 514 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~----------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~ 514 (780)
..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++++
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 99999999999999999964221 1346899999999999999999999998 9999999999999999
Q ss_pred CCCeeecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhh
Q 048425 515 FTPKVSDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVT 592 (780)
Q Consensus 515 ~~vKLsDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~ 592 (780)
+.+||+|||+++........ ......||..|+|||.+.+..++.++||||||+++|||+| |+.||....... .+..
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~ 278 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFYK 278 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HHHH
Confidence 99999999999876543322 2234567889999999999999999999999999999999 899986543211 1111
Q ss_pred hcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 593 WARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 593 wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
.. ... .. ...+......+.+++..||+.||.+||++.||++.|+.+...
T Consensus 279 ~~----~~~------~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 279 LV----KDG------YQ----MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HH----HHT------CC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----hcC------CC----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 11 000 00 011112235688999999999999999999999999987654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=360.16 Aligned_cols=261 Identities=23% Similarity=0.431 Sum_probs=204.9
Q ss_pred cCcccceeecccCceEEEEEEEeC-----CcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDN-----GTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~-----g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
++|...+.||+|+||+||+|.... +..||||+++..... ....|.+|++++++++|+||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 567778999999999999998753 245999999765332 34579999999999999999999999999999999
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 124 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999963 3457999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCcc--ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccc
Q 048425 529 TEGSQH--ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLE 605 (780)
Q Consensus 529 ~~~~~~--~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~ 605 (780)
...... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.... .. .
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~~---~~-~---- 266 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKAI---ND-G---- 266 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH---HT-T----
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH---HC-C----
Confidence 543221 1223456889999999999999999999999999999999 99999653321 111110 00 0
Q ss_pred cccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCCC
Q 048425 606 QLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDE 658 (780)
Q Consensus 606 ~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~~ 658 (780)
............+.+++.+||+.+|++||++.||++.|+.+....+.
T Consensus 267 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 267 ------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp ------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred ------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 00011122345788999999999999999999999999998875443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=363.29 Aligned_cols=252 Identities=21% Similarity=0.335 Sum_probs=199.8
Q ss_pred hcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCC--CceeeeeeeeeecceeEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHH--RNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~~~~~LV 449 (780)
.++|+..+.||+|+||.||++...+++.||||++...... ..+.|.+|++++.+++| +||+++++++.+++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3678899999999999999999988999999999765432 23678999999999976 9999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|| +.+|+|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||+++...
T Consensus 88 ~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 568899999953 457999999999999999999999998 99999999999997 5789999999998775
Q ss_pred CCCcc-ceeccccCccccCchhhcc-----------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccc
Q 048425 530 EGSQH-ISTRVMGTFGYVAPEYAMT-----------GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL 597 (780)
Q Consensus 530 ~~~~~-~~t~~~GT~~Y~APE~l~~-----------~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~l 597 (780)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~------- 227 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----I------- 227 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----H-------
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----H-------
Confidence 43322 2345679999999999875 77899999999999999999999999643211 0
Q ss_pred cccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 598 LTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 598 l~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
..+..++++.....++......+.+++..||+.||++|||+.|+++.-
T Consensus 228 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 228 ----SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp ----HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ----HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 111222232222223333335688999999999999999999998753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=352.66 Aligned_cols=260 Identities=27% Similarity=0.491 Sum_probs=196.3
Q ss_pred hcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
.++|+..+.||+|+||+||+|... ..||||+++..... ..+.|.+|++++++++|+||+++++++. ....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEE
Confidence 367899999999999999999864 35999999765432 3367999999999999999999999764 466899999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++++|.+++.. ....+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 100 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 100 WCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred ecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence 9999999999963 4567999999999999999999999998 999999999999999999999999999865432
Q ss_pred C-ccceeccccCccccCchhhc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 532 S-QHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 532 ~-~~~~t~~~GT~~Y~APE~l~---~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
. ........||+.|+|||.+. +..++.++||||||+++|||++|+.||...... ..+...... . .
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~----~-----~ 242 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVGR----G-----S 242 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHHHH----T-----S
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHhcc----c-----c
Confidence 1 22234457999999999986 667889999999999999999999999754321 111111100 0 0
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
..+.+ ..........+.+++..|++.+|++||++.|+++.|+.+..
T Consensus 243 ~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 243 LSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCcch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11111 01122334678999999999999999999999999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=355.81 Aligned_cols=269 Identities=25% Similarity=0.403 Sum_probs=203.3
Q ss_pred HHHHHHhcCcccceeecccCceEEEEEEEe----CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeee
Q 048425 368 SDLEKATEKFSSKRILGEGGFGCVYHGVMD----NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICI 441 (780)
Q Consensus 368 ~el~~at~~f~~~~~LG~G~fG~VYkg~l~----~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~ 441 (780)
+++....++|...+.||+|+||.||+|... ++..||||+++..... ..+.|.+|++++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 334445678999999999999999999875 3458999998765332 2357999999999999999999999998
Q ss_pred ecce-----eEEEEeecCCCChhhhccccc--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC
Q 048425 442 EGRT-----RCLVYELVHNGSVESHLHGVD--KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD 514 (780)
Q Consensus 442 ~~~~-----~~LV~Ey~~~GSL~~~L~~~~--~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~ 514 (780)
+.+. .++||||+++|+|.+++.... .....+++..+++++.|++.||+|||+.+ |+||||||+|||++++
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 7553 499999999999999985322 34467999999999999999999999998 9999999999999999
Q ss_pred CCCeeecccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhh
Q 048425 515 FTPKVSDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVT 592 (780)
Q Consensus 515 ~~vKLsDFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~ 592 (780)
+.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... +..
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~ 260 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYD 260 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHH
Confidence 9999999999987654322 12234567889999999999999999999999999999999 888886543221 111
Q ss_pred hcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 593 WARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 593 wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
.. .... .+ .........+.+++..|++.+|++||++.|+++.|+.+....
T Consensus 261 ~~---~~~~-------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 261 YL---LHGH-------RL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HH---HTTC-------CC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HH---HcCC-------CC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 10 0000 00 111223357889999999999999999999999999987654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=353.91 Aligned_cols=261 Identities=25% Similarity=0.410 Sum_probs=208.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcE--EEEEEeeccC-CcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTE--VAVKLLTRNN-QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~--VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV 449 (780)
++|...+.||+|+||.||+|... +|.. ||||+++... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67889999999999999999975 5664 4999987543 33446799999999999 999999999999999999999
Q ss_pred EeecCCCChhhhccccc------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCC
Q 048425 450 YELVHNGSVESHLHGVD------------KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP 517 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~------------~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~v 517 (780)
|||+++|+|.+++.... .....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996432 22357999999999999999999999998 9999999999999999999
Q ss_pred eeecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccc
Q 048425 518 KVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARP 596 (780)
Q Consensus 518 KLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ 596 (780)
||+|||+++...... ......+|..|+|||.+.+..++.++||||||+++|||+| |+.||...... .+....
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~~-- 254 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKL-- 254 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHG--
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---HHHHHh--
Confidence 999999997543221 1233457889999999999999999999999999999998 99999754321 111110
Q ss_pred ccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 597 LLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 597 ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
.. . .. ..........+.+++.+|++.+|++||++.|+++.|+.+.....
T Consensus 255 -~~-~------~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 255 -PQ-G------YR----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp -GG-T------CC----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred -hc-C------CC----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 00 0 00 01112233578899999999999999999999999999987643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=359.19 Aligned_cols=275 Identities=24% Similarity=0.367 Sum_probs=201.1
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHH--hhhcCCCceeeeeeeeee-----cceeE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEM--LSRLHHRNLVKLIGICIE-----GRTRC 447 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~i--L~~L~HpNIV~L~g~~~~-----~~~~~ 447 (780)
++|...+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++|+||+++++++.. ....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 6888999999999999999977 78999999996542 3445555555 455899999999986542 33568
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCcEEecccCCcceEEcCCCCCeeec
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS------NPRVIHRDFKASNVLLEDDFTPKVSD 521 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~------~p~IvHrDIKpsNILLd~~~~vKLsD 521 (780)
+||||+++|+|.+++.. ..++|..+++|+.||+.||+|||+.. .++|+||||||+|||+++++.+||+|
T Consensus 89 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 99999999999999953 24589999999999999999999981 11299999999999999999999999
Q ss_pred ccccccccCCCc-------cceeccccCccccCchhhcc-------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCcccc
Q 048425 522 FGLAREATEGSQ-------HISTRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ 587 (780)
Q Consensus 522 FGLA~~~~~~~~-------~~~t~~~GT~~Y~APE~l~~-------~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~ 587 (780)
||+++....... .......||..|+|||.+.+ ..++.++|||||||++|||+||+.|+........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999987654221 11234569999999999876 4566799999999999999999887643322111
Q ss_pred ch--hhhhccccccccccccc-----ccCCccCCCC--ChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCCC
Q 048425 588 EN--LVTWARPLLTTREGLEQ-----LVDPSLAGSY--DFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDE 658 (780)
Q Consensus 588 ~~--Lv~wa~~ll~~~~~l~~-----lvDp~L~~~~--~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~~ 658 (780)
.. +....... .....+.. ...+.+.... .......+.+++.+||+.||++|||+.||++.|+.+....+.
T Consensus 244 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 244 YQMAFQTEVGNH-PTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp CCCTTHHHHCSS-CCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred HHHhhhcccCCC-chHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence 00 00000000 00000000 0111111111 123456799999999999999999999999999999987765
Q ss_pred C
Q 048425 659 T 659 (780)
Q Consensus 659 ~ 659 (780)
.
T Consensus 323 ~ 323 (336)
T 3g2f_A 323 N 323 (336)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=355.35 Aligned_cols=265 Identities=22% Similarity=0.341 Sum_probs=191.9
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
.++|+..+.||+|+||+||+|... +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 367888999999999999999875 689999999976543 334678999999999999999999999999999999999
Q ss_pred ecCCCChhhhccccc--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 452 LVHNGSVESHLHGVD--KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 452 y~~~GSL~~~L~~~~--~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|++ |+|.+++.... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69999886432 22346999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-hhhhccc----cccc---
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LVTWARP----LLTT--- 600 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-Lv~wa~~----ll~~--- 600 (780)
.... ......||..|+|||.+.+ ..++.++|||||||++|||+||+.||.......... +...... .+..
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 4322 2234568999999999876 468999999999999999999999997654322111 0000000 0000
Q ss_pred ------------ccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 601 ------------REGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 601 ------------~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
...+.+.+.+.... .....+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKE----PLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSS----CCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhcccccc----cCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00001111111111 12246889999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=389.82 Aligned_cols=259 Identities=26% Similarity=0.421 Sum_probs=206.3
Q ss_pred cCcccce-eecccCceEEEEEEEe---CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKR-ILGEGGFGCVYHGVMD---NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~-~LG~G~fG~VYkg~l~---~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
+++...+ .||+|+||.||+|.+. ++..||||+++.... ...++|.+|+++|++++|+|||+++++|.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999999999999875 466799999976543 356789999999999999999999999976 568999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++|+|.++|.. ....+++..++.|+.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++...
T Consensus 414 ~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 999999999999963 4567999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccc--eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccc
Q 048425 530 EGSQHI--STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 530 ~~~~~~--~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
...... .....+|+.|+|||++.++.++.++|||||||+||||+| |+.||...... .+...+. ...
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i~----~~~---- 556 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIE----QGK---- 556 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHHH----TTC----
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHH----cCC----
Confidence 433221 122346789999999999999999999999999999998 99999754322 1111110 000
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
....+......+.+++..||+.+|++||++.+|++.|+.+.....
T Consensus 557 ------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 557 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp ------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred ------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 011122334678899999999999999999999999999876544
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=349.07 Aligned_cols=260 Identities=26% Similarity=0.376 Sum_probs=205.9
Q ss_pred CcccceeecccCceEEEEEEEeC----CcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeeccee-EEE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMDN----GTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTR-CLV 449 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~~----g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~-~LV 449 (780)
.|...++||+|+||+||+|...+ +..||+|++..... ...+.|.+|++++++++|+||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45566899999999999998642 23799999875443 2346799999999999999999999999876655 999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+.+|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999963 4567899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCC---ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 530 EGS---QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 530 ~~~---~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
... ........||..|+|||.+.+..++.++||||||+++|||++|+.|+..... ...+...... .
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~----~----- 244 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHFLAQ----G----- 244 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHHHHT----T-----
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHHhhc----C-----
Confidence 322 1122345688999999999999999999999999999999996666432211 1111111100 0
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
.. ...+......+.+++.+|++.||++||++.|+++.|+++.....
T Consensus 245 -~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 245 -RR----LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp -CC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred -CC----CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 00 01111223568899999999999999999999999999987643
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=359.22 Aligned_cols=271 Identities=25% Similarity=0.362 Sum_probs=211.4
Q ss_pred cCcccceeecccCceEEEEEEE-----eCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecc--eeE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-----DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGR--TRC 447 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~--~~~ 447 (780)
++|...+.||+|+||.||++.. .+|+.||||++........+.|.+|++++++++|+||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 5788899999999999999984 368999999998766555678999999999999999999999987654 679
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+||||+++++|.+++.. ....+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 121 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 99999999999999963 3456999999999999999999999998 99999999999999999999999999988
Q ss_pred ccCCCcc--ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccc---cc
Q 048425 528 ATEGSQH--ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTT---RE 602 (780)
Q Consensus 528 ~~~~~~~--~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~---~~ 602 (780)
....... ......+|..|+|||.+.+..++.++||||||+++|||+||+.|+..... ............ ..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCTHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccchhhhHH
Confidence 7554322 12334578889999999999999999999999999999999988753210 000000000000 00
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
.+.+.+...............+.+++.+||+.||++||++.||++.|+.+...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 01111111111111223346788999999999999999999999999988653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=352.45 Aligned_cols=258 Identities=27% Similarity=0.416 Sum_probs=206.7
Q ss_pred hcCcccce-eecccCceEEEEEEEe---CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecceeE
Q 048425 374 TEKFSSKR-ILGEGGFGCVYHGVMD---NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 374 t~~f~~~~-~LG~G~fG~VYkg~l~---~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 447 (780)
.++|...+ .||+|+||.||+|... +++.||||+++..... ..++|.+|++++++++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46777777 9999999999999653 4688999999765432 246799999999999999999999999 567789
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999953 356999999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCccc--eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccc
Q 048425 528 ATEGSQHI--STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 528 ~~~~~~~~--~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
........ .....||..|+|||.+.+..++.++||||||+++|||+| |+.||...... .+...... ..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~----~~-- 237 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAMLEK----GE-- 237 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHT----TC--
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHc----CC--
Confidence 75443221 223456789999999999999999999999999999999 99999754322 11111100 00
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
.+ ..+......+.+++..||+.||++||++.||++.|+.+....
T Consensus 238 ----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 238 ----RM----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp ----CC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ----CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 01 112233457889999999999999999999999999988654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=358.64 Aligned_cols=257 Identities=24% Similarity=0.403 Sum_probs=202.0
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcE----EEEEEeecc-CCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTE----VAVKLLTRN-NQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~----VAVK~l~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
++|+..+.||+|+||+||+|... +|+. ||+|.+... .....++|.+|++++++++||||++++++|..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 67899999999999999999964 4543 577777544 3345678999999999999999999999998754 789
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
|+||+++|+|.+++.. ....+++..++.|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 9999999999999963 3457999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccc
Q 048425 529 TEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 529 ~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
...... ......||..|+|||.+.+..++.++|||||||++|||++ |+.||........ ....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~~~------------ 232 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSIL------------ 232 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHH------------
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHHH------------
Confidence 543222 2233457889999999999999999999999999999999 9999976443221 1110
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
...............+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 233 --~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 233 --EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred --HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 00000111222334688999999999999999999999999998764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=366.65 Aligned_cols=252 Identities=20% Similarity=0.262 Sum_probs=206.8
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
.++|...+.||+|+||.||+|... +|+.||+|++..........+.+|++++++++|+||+++++++.++...++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 367999999999999999999975 7899999999776554556799999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC--CCCCeeecccccccccC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED--DFTPKVSDFGLAREATE 530 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~--~~~vKLsDFGLA~~~~~ 530 (780)
+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999853 3457999999999999999999999998 999999999999974 57899999999988754
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... +..... ..++
T Consensus 204 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~---i~~~~~----~~~~ 271 (387)
T 1kob_A 204 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQN---VKRCDW----EFDE 271 (387)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHH---HHHCCC----CCCS
T ss_pred Ccc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHHH---HHhCCC----CCCc
Confidence 322 23457999999999999999999999999999999999999999754321 11110 000000 0111
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.. .......+.+++..||+.||++||++.|+++
T Consensus 272 ~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 272 DA----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp ST----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 11 1122356889999999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=347.02 Aligned_cols=265 Identities=21% Similarity=0.310 Sum_probs=210.3
Q ss_pred hcCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeee-eecceeEEEEe
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGIC-IEGRTRCLVYE 451 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~-~~~~~~~LV~E 451 (780)
.++|...+.||+|+||.||+|.. .+|+.||||++..... .+++.+|++++++++|++++..++++ .+++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 47899999999999999999997 5799999999866543 35689999999999988877766666 45667799999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE---cCCCCCeeecccccccc
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREA 528 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL---d~~~~vKLsDFGLA~~~ 528 (780)
|+ +++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 9999999963 3457999999999999999999999998 9999999999999 58899999999999877
Q ss_pred cCCCcc------ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccc
Q 048425 529 TEGSQH------ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 529 ~~~~~~------~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||................ ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---~~-- 233 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS---EK-- 233 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH---HH--
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc---cc--
Confidence 654321 1245679999999999999999999999999999999999999997644322211111100 00
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
... ...+.+...+ ...+.+++.+||+.||++||++.||++.|+.+.....
T Consensus 234 ~~~-~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 234 KMS-TPIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHH-SCHHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccC-CchHHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 000 0000111112 2468899999999999999999999999999987654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=353.61 Aligned_cols=266 Identities=25% Similarity=0.387 Sum_probs=209.8
Q ss_pred HHHhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhh--cCCCceeeeeeeeeecc----
Q 048425 371 EKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSR--LHHRNLVKLIGICIEGR---- 444 (780)
Q Consensus 371 ~~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~--L~HpNIV~L~g~~~~~~---- 444 (780)
....++|...+.||+|+||.||+|.. +|+.||||+++.. ..+.+.+|++++.. ++|+||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 44567899999999999999999988 6899999998543 35678889999988 79999999999998775
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCcEEecccCCcceEEcCCCC
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH--------EDSNPRVIHRDFKASNVLLEDDFT 516 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH--------~~~~p~IvHrDIKpsNILLd~~~~ 516 (780)
..++||||+++|+|.+++.. ..+++..+++++.|++.||+||| +.+ |+||||||+|||++++++
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSC
T ss_pred eeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCC
Confidence 78999999999999999953 36899999999999999999999 555 999999999999999999
Q ss_pred CeeecccccccccCCCcc---ceeccccCccccCchhhccCC------CCchhhHHhHHHHHHHHHhC----------CC
Q 048425 517 PKVSDFGLAREATEGSQH---ISTRVMGTFGYVAPEYAMTGH------LLVKSDVYSYGVVLLELLSG----------RK 577 (780)
Q Consensus 517 vKLsDFGLA~~~~~~~~~---~~t~~~GT~~Y~APE~l~~~~------~t~ksDVySfGVvLlELlTG----------r~ 577 (780)
+||+|||+++........ ......||..|+|||.+.+.. ++.++|||||||++|||+|| +.
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 999999999877554322 124457999999999987762 33789999999999999999 66
Q ss_pred CCCCCCccccchhhhhcccccccccccccccCCccCCC-CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 578 PVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGS-YDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 578 P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~-~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
||....+... ....+..... .....+.+... ...+....+.+++.+||+.||++||++.||++.|+.+...
T Consensus 266 p~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 266 PYYDLVPSDP-SVEEMRKVVC------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTTTTSCSSC-CHHHHHHHHT------TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CccccCcCcc-cHHHHHHHHH------HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 7654322111 1111111000 11111111111 1235567899999999999999999999999999998765
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=350.54 Aligned_cols=252 Identities=25% Similarity=0.357 Sum_probs=200.3
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|...+.||+|+||+||++... +|..||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 67889999999999999999975 689999999976543 3457899999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE---cCCCCCeeeccccccccc
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL---d~~~~vKLsDFGLA~~~~ 529 (780)
+++|+|.+++.........+++..+++|+.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999999654444578999999999999999999999998 9999999999999 456789999999998765
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
.... .....||..|+|||.+. +.++.++||||||+++|||++|+.||.............+..
T Consensus 179 ~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-------------- 241 (285)
T 3is5_A 179 SDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE-------------- 241 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------------
T ss_pred Cccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC--------------
Confidence 4322 24456999999999875 578999999999999999999999997543221111111100
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+..... .......+.+++.+|++.||++||++.||++
T Consensus 242 ~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 242 PNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 0012246789999999999999999999964
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=347.90 Aligned_cols=266 Identities=20% Similarity=0.300 Sum_probs=206.7
Q ss_pred HhcCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeee-eecceeEEEE
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGIC-IEGRTRCLVY 450 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~-~~~~~~~LV~ 450 (780)
..++|...+.||+|+||+||+|.. .+|+.||||++..... .+++.+|++++++++|+|++..++++ .+++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999996 5789999998755432 24588999999999988877777766 5567789999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE---cCCCCCeeeccccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLARE 527 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL---d~~~~vKLsDFGLA~~ 527 (780)
||+ +++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++.
T Consensus 85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 9999999863 3456999999999999999999999998 9999999999999 7899999999999987
Q ss_pred ccCCCc------cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccc
Q 048425 528 ATEGSQ------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTR 601 (780)
Q Consensus 528 ~~~~~~------~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~ 601 (780)
...... .......||..|+|||.+.+..++.++|||||||++|||++|+.||............... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~- 233 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI---SEK- 233 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH---HHH-
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh---hcc-
Confidence 755432 1223567999999999999999999999999999999999999999764432221111100 000
Q ss_pred cccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 602 EGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 602 ~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
... ...+.+...+ ...+.+++..|++.+|++||++.||++.|+.+.....
T Consensus 234 -~~~-~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 234 -KMS-TPIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -HHH-SCHHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -ccc-chhhhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 000 0000011111 2478899999999999999999999999999987543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=348.63 Aligned_cols=260 Identities=28% Similarity=0.475 Sum_probs=204.2
Q ss_pred cCcccceeecccCceEEEEEEEeC----CcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeee-cceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDN----GTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIE-GRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~----g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~~~L 448 (780)
.+|...+.||+|+||+||+|...+ +..||||.++..... ..+.|.+|++++++++|+||++++++|.+ ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 567888999999999999998642 235899998764332 34679999999999999999999999754 457799
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||+++|+|.+++. .....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHH---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999996 34567899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCc---cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCC-CCCCCCCccccchhhhhccccccccccc
Q 048425 529 TEGSQ---HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGR-KPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 529 ~~~~~---~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr-~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
..... .......||..|+|||.+.+..++.++||||||+++|||++|+ .|+....... +... .....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~---~~~~~--- 249 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---LLQGR--- 249 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHH---HHTTC---
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHH---HhcCC---
Confidence 44321 1223456788999999999999999999999999999999954 4554332211 1110 00000
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
... .+......+.+++.+|++.+|++||++.|+++.|+.+.....
T Consensus 250 -~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 250 -RLL-------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp -CCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred -CCC-------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 000 011123468899999999999999999999999999987544
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=361.53 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=189.5
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
..++|...+.||+|+||+||+|... +++.||||+++... ..+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999986 58899999997643 34578899999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC---CCCCeeecccccccc
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED---DFTPKVSDFGLAREA 528 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~---~~~vKLsDFGLA~~~ 528 (780)
|+++|+|.+++. ....+++.+++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 129 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 999999999985 3456999999999999999999999998 999999999999975 889999999999876
Q ss_pred cCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 529 TEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 529 ~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.. .+.... ....
T Consensus 202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~---~i~~~~---~~~~ 271 (349)
T 2w4o_A 202 EHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMFR---RILNCE---YYFI 271 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHHH---HHHTTC---CCCC
T ss_pred Cccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHHH---HHHhCC---CccC
Confidence 5432 224467999999999999999999999999999999999999999654321 11111 011100 0000
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
. ....+....+.+++.+|++.||++||++.|+++
T Consensus 272 ~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 272 S-----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp T-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C-----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 111123356889999999999999999999865
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=376.16 Aligned_cols=261 Identities=21% Similarity=0.279 Sum_probs=210.9
Q ss_pred chHHHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeee
Q 048425 366 ALSDLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICI 441 (780)
Q Consensus 366 ~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~ 441 (780)
.+.+++...++|...+.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|+++++.++|||||++++++.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34556667789999999999999999999986 68999999997532 233456889999999999999999999999
Q ss_pred ecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeec
Q 048425 442 EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSD 521 (780)
Q Consensus 442 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsD 521 (780)
+++..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEec
Confidence 99999999999999999999853 35899999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCccceeccccCccccCchhhccCC----CCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccc
Q 048425 522 FGLAREATEGSQHISTRVMGTFGYVAPEYAMTGH----LLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL 597 (780)
Q Consensus 522 FGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~----~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~l 597 (780)
||+++.............+||+.|+|||++.+.. ++.++|||||||+||||++|+.||........ ...+
T Consensus 212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i 285 (410)
T 3v8s_A 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKI 285 (410)
T ss_dssp CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHH
T ss_pred cceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH------HHHH
Confidence 9999877654433344678999999999998765 78999999999999999999999975432211 1111
Q ss_pred cccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 048425 598 LTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTH--RPFMGEVVQA 648 (780)
Q Consensus 598 l~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~--RPsm~EVv~~ 648 (780)
...... +.-+. .......+.+++.+|++.+|++ ||+++||++.
T Consensus 286 ~~~~~~---~~~p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 286 MNHKNS---LTFPD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HTHHHH---CCCCT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred Hhcccc---ccCCC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 111100 00010 0112246788999999999998 9999998653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=366.11 Aligned_cols=248 Identities=25% Similarity=0.315 Sum_probs=198.2
Q ss_pred ccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCCC
Q 048425 378 SSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNG 456 (780)
Q Consensus 378 ~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~G 456 (780)
...+.||+|+||.||+|... +|+.||||+++.......++|.+|++++++++|+||+++++++.+.+..+|||||+++|
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 34678999999999999874 78999999998766556678999999999999999999999999999999999999999
Q ss_pred ChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE--cCCCCCeeecccccccccCCCcc
Q 048425 457 SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL--EDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 457 SL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL--d~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ ++++++||+|||+++.......
T Consensus 172 ~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~- 244 (373)
T 2x4f_A 172 ELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244 (373)
T ss_dssp EEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred cHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence 99998863 3346999999999999999999999998 9999999999999 5678999999999987754332
Q ss_pred ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCC
Q 048425 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAG 614 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~ 614 (780)
.....||+.|+|||++.++.++.++|||||||++|||++|+.||....... .+... ...... +.+. ...
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~i----~~~~~~---~~~~-~~~ 313 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE--TLNNI----LACRWD---LEDE-EFQ 313 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHH----HHTCCC---SCSG-GGT
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH----HhccCC---CChh-hhc
Confidence 234469999999999999999999999999999999999999997543221 11111 110000 0000 001
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 615 SYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 615 ~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.....+.+++.+|++.||++||++.|+++
T Consensus 314 ----~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 314 ----DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 12246889999999999999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=366.30 Aligned_cols=260 Identities=28% Similarity=0.484 Sum_probs=197.8
Q ss_pred cCcccceeecccCceEEEEEEEe--CC--cEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeee-cceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD--NG--TEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIE-GRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~--~g--~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~~~L 448 (780)
..|...+.||+|+||+||+|.+. ++ ..||||.++.... ...++|.+|++++++++||||++++++|.+ ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 34667789999999999999874 22 3689999875433 334679999999999999999999999765 457799
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||+++|+|.+++. .....+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 169 v~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEECCCCCCHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence 999999999999996 34456899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCcc---ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccc
Q 048425 529 TEGSQH---ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 529 ~~~~~~---~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
...... ......+|..|+|||.+.+..++.++|||||||++|||+| |..||....... +.... ....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~---~~~~--- 313 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL---LQGR--- 313 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHH---HTTC---
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHH---HcCC---
Confidence 443211 1234567889999999999999999999999999999999 666775433221 11110 0000
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
.... +......+.+++.+||+.||++||++.||++.|+.+.....
T Consensus 314 -~~~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 314 -RLLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp -CCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -CCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0011 11223568899999999999999999999999999987654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=361.81 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=205.7
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
..++|...+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++.+++..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4578999999999999999999975 6899999999765432 235689999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC---CCCeeecccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD---FTPKVSDFGLAR 526 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~---~~vKLsDFGLA~ 526 (780)
|||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 107 ~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999985 3457999999999999999999999998 9999999999999865 459999999998
Q ss_pred cccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 527 EATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 527 ~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.... .... ..
T Consensus 180 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~i---~~~~---~~ 248 (362)
T 2bdw_A 180 EVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQI---KAGA---YD 248 (362)
T ss_dssp CCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHTC---CC
T ss_pred EecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH---HhCC---CC
Confidence 7754322 24467999999999999999999999999999999999999999654321 111110 0000 00
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
...+. .......+.+++.+||+.||++||++.|+++.
T Consensus 249 ~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 YPSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCTTG-----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCccc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 01223567899999999999999999998764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=353.85 Aligned_cols=261 Identities=22% Similarity=0.293 Sum_probs=200.1
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcc---hHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNG---DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
.++|...+.||+|+||.||+|... +++.||||++....... .+.|.+|++++++++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 378999999999999999999975 78999999997653322 36789999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999953 346999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
...........||..|+|||.+.+..++.++||||||+++|||++|+.||...... .+.... ... ...
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~----~~~-----~~~ 253 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHI----NQA-----IPR 253 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHH----HSC-----CCC
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHh----ccC-----CCC
Confidence 54333334557999999999999999999999999999999999999999753321 111110 000 000
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHhhcC
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRP-FMGEVVQALKLIYNDT 656 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RP-sm~EVv~~L~~i~~~~ 656 (780)
+. .........+.+++.+||+.||++|| +++++++.|+.+....
T Consensus 254 ~~---~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 254 PS---TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp GG---GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred cc---ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 00 01111224688899999999999999 9999999999876544
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=361.83 Aligned_cols=211 Identities=27% Similarity=0.352 Sum_probs=184.3
Q ss_pred ccccchHHHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcC-----CCceee
Q 048425 362 VKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH-----HRNLVK 435 (780)
Q Consensus 362 ~~~f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-----HpNIV~ 435 (780)
...|++++.....++|...+.||+|+||+||+|... +|+.||||+++.. ....+.+..|++++++++ |+||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 445666666677799999999999999999999974 7899999999643 233456888999999986 999999
Q ss_pred eeeeeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC--
Q 048425 436 LIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED-- 513 (780)
Q Consensus 436 L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~-- 513 (780)
+++++...+..++||||+ +++|.+++.. .....+++..++.++.||+.||+|||+.+ |+||||||+|||+++
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITR--NNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPY 174 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTT
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccc
Confidence 999999999999999999 9999999964 23346999999999999999999999998 999999999999975
Q ss_pred -----------------------CCCCeeecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHH
Q 048425 514 -----------------------DFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLL 570 (780)
Q Consensus 514 -----------------------~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLl 570 (780)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 7899999999998654322 3457999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCC
Q 048425 571 ELLSGRKPVDMSQ 583 (780)
Q Consensus 571 ELlTGr~P~~~~~ 583 (780)
||+||+.||....
T Consensus 251 ell~g~~pf~~~~ 263 (360)
T 3llt_A 251 ELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHSSCSCCCSS
T ss_pred HHHHCCCCCCCCc
Confidence 9999999997644
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=355.05 Aligned_cols=260 Identities=26% Similarity=0.360 Sum_probs=192.8
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcC-CCceeeeeeeee--------ec
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH-HRNLVKLIGICI--------EG 443 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~--------~~ 443 (780)
..+|+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++.++. |+||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 468899999999999999999975 78999999997766556678999999999996 999999999984 33
Q ss_pred ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccc
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFG 523 (780)
...++||||+. |+|.+++... .....+++..+++|+.||+.||+|||+.+ ++|+||||||+|||+++++++||+|||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKM-ESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHH-HTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred ceEEEEEEecC-CCHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 45799999995 7999988642 23457999999999999999999999874 459999999999999999999999999
Q ss_pred ccccccCCCccc-----------eeccccCccccCchhh---ccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch
Q 048425 524 LAREATEGSQHI-----------STRVMGTFGYVAPEYA---MTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN 589 (780)
Q Consensus 524 LA~~~~~~~~~~-----------~t~~~GT~~Y~APE~l---~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~ 589 (780)
+++......... .....||+.|+|||.+ .+..++.++|||||||++|||+||+.||...... .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~ 260 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL---R 260 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---H
Confidence 998765432211 1134689999999998 5677899999999999999999999999643211 0
Q ss_pred hhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 590 LVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 590 Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
+. .. .... .........+.+++..||+.||++||++.|+++.|+.+....
T Consensus 261 ~~-------~~------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 261 IV-------NG------KYSI----PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp ------------------CCC----CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred hh-------cC------cccC----CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 00 00 0000 001111134678999999999999999999999999987643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=357.29 Aligned_cols=255 Identities=16% Similarity=0.195 Sum_probs=208.1
Q ss_pred HhcCcccceeecccCceEEEEEE------EeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcC---CCceeeeeeeeeec
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGV------MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH---HRNLVKLIGICIEG 443 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~------l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~ 443 (780)
..++|...+.||+|+||+||+|. ..+++.||||+++.. ...+|..|++++.+++ |+||+++++++..+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45789999999999999999994 447899999999643 4567888888888886 99999999999999
Q ss_pred ceeEEEEeecCCCChhhhcccccC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC---------
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDK-NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED--------- 513 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~-~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~--------- 513 (780)
+..++||||+++|+|.+++..... ....++|..++.|+.||+.||+|||+.+ |+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 999999999999999999974322 3567999999999999999999999998 999999999999998
Q ss_pred --CCCCeeecccccccccCC-CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchh
Q 048425 514 --DFTPKVSDFGLAREATEG-SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENL 590 (780)
Q Consensus 514 --~~~vKLsDFGLA~~~~~~-~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~L 590 (780)
++.+||+|||+++..... .....+...||.+|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----- 291 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG----- 291 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT-----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC-----
Confidence 899999999999865422 222345567999999999999999999999999999999999999998432110
Q ss_pred hhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHHhhc
Q 048425 591 VTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHR-PFMGEVVQALKLIYND 655 (780)
Q Consensus 591 v~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~R-Psm~EVv~~L~~i~~~ 655 (780)
.| . ++..+... .....+.+++..|++.+|.+| |++.++.+.|+.+...
T Consensus 292 -~~---------~----~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 292 -EC---------K----PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp -EE---------E----ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -ce---------e----echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 00 0 11111111 123456788999999999998 7889999999887754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=350.62 Aligned_cols=253 Identities=29% Similarity=0.444 Sum_probs=200.3
Q ss_pred hcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeec-ceeEEEEee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEG-RTRCLVYEL 452 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-~~~~LV~Ey 452 (780)
.++|...+.||+|+||+||+|.. +|+.||||+++... ..+.|.+|++++++++|+||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 47889999999999999999987 58999999986543 456799999999999999999999997654 478999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++|+|.+++... ....+++..+++++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 97 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 97 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 9999999999632 2234889999999999999999999998 9999999999999999999999999998654322
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
....++..|+|||.+.+..++.++||||||+++|||+| |+.||...... .+.... .. . ...
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~---~~-~------~~~- 233 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV---EK-G------YKM- 233 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH---TT-T------CCC-
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---hc-C------CCC-
Confidence 23357889999999999999999999999999999998 99999654321 111110 00 0 011
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 612 L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
.........+.+++..|++.||++||++.|+++.|+.+...
T Consensus 234 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 234 ---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 11222335788999999999999999999999999988653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=360.16 Aligned_cols=263 Identities=19% Similarity=0.244 Sum_probs=198.8
Q ss_pred cCcccceeecccCceEEEEEEEe----CCcEEEEEEeeccCCc-----------chHHHHHHHHHhhhcCCCceeeeeee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD----NGTEVAVKLLTRNNQN-----------GDREFIAEVEMLSRLHHRNLVKLIGI 439 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~----~g~~VAVK~l~~~~~~-----------~~~~f~~Ei~iL~~L~HpNIV~L~g~ 439 (780)
++|...+.||+|+||+||+|... ++..||||++...... ..+.+.+|+.+++.++|+||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 67889999999999999999985 5788999998765322 12346788899999999999999999
Q ss_pred eee----cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC
Q 048425 440 CIE----GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF 515 (780)
Q Consensus 440 ~~~----~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~ 515 (780)
+.. ....++||||+ +++|.+++.. ...+++..+++|+.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 988 67889999999 9999999963 237999999999999999999999998 99999999999999887
Q ss_pred --CCeeecccccccccCCCcc------ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCcccc
Q 048425 516 --TPKVSDFGLAREATEGSQH------ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ 587 (780)
Q Consensus 516 --~vKLsDFGLA~~~~~~~~~------~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~ 587 (780)
.+||+|||+++........ ......||..|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~- 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP- 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence 9999999999876433211 1134579999999999999999999999999999999999999996422111
Q ss_pred chhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 588 ENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 588 ~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
..+........ ..+...+..... .......+.+++..||+.||++||++.+|++.|+.+
T Consensus 268 ~~~~~~~~~~~---~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 VAVQTAKTNLL---DELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHHHH---HTTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHHHhhc---ccccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 11111000000 000000000000 012235788999999999999999999999999764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=366.35 Aligned_cols=243 Identities=26% Similarity=0.348 Sum_probs=197.6
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeecc---CCcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRN---NQNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~L 448 (780)
.++|+..+.||+|+||+||+|+.. +|+.||||++++. .....+.+.+|.+++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 378999999999999999999975 6899999999764 233456788999999998 79999999999999999999
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999953 356999999999999999999999998 999999999999999999999999999864
Q ss_pred cCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 529 TEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 529 ~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.. .+..
T Consensus 175 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~---~i~~--------- 238 (353)
T 3txo_A 175 ICNGV-TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---LFE---AILN--------- 238 (353)
T ss_dssp CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHH---------
T ss_pred ccCCc-cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---HHH---HHHc---------
Confidence 43222 2345679999999999999999999999999999999999999997543221 111 1111
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFM 642 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm 642 (780)
..+ .++......+.+++..|++.||++||++
T Consensus 239 -~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 239 -DEV--VYPTWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp -CCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred -CCC--CCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence 100 1112223467889999999999999998
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=355.96 Aligned_cols=244 Identities=25% Similarity=0.330 Sum_probs=204.0
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||+||+++.. +|+.||||++++.. ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 67899999999999999999975 79999999997642 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999953 456999999999999999999999998 99999999999999999999999999987644
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
. .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... . ...+...
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~---~~~i~~~---------- 218 (318)
T 1fot_A 159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---T---YEKILNA---------- 218 (318)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHHHHHC----------
T ss_pred c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHHHHhC----------
Confidence 2 234579999999999999999999999999999999999999997543211 1 1111111
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRP-----FMGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv~ 647 (780)
.+ .++......+.+++.+|++.||++|| +++||++
T Consensus 219 ~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 219 EL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 00 11112234678999999999999999 7888764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=344.04 Aligned_cols=250 Identities=21% Similarity=0.283 Sum_probs=205.0
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
.++|...+.||+|+||.||+|... ++..||+|++........+.|.+|++++++++|+||+++++++.+++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 467899999999999999999976 5779999999877666778899999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE---cCCCCCeeeccccccccc
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL---d~~~~vKLsDFGLA~~~~ 529 (780)
+++++|.+++.. ...+++..+++|+.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999853 356899999999999999999999998 9999999999999 788999999999998765
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
.... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||....... ..... ..... ....
T Consensus 161 ~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~----~~~~~---~~~~ 228 (277)
T 3f3z_A 161 PGKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--VMLKI----REGTF---TFPE 228 (277)
T ss_dssp TTSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH----HHCCC---CCCH
T ss_pred Cccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH--HHHHH----HhCCC---CCCc
Confidence 4332 234569999999998765 48999999999999999999999997543211 11110 00000 0000
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
... ......+.+++..|++.||++||++.|+++
T Consensus 229 ~~~-----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 KDW-----LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHH-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhh-----hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 012356889999999999999999999976
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=361.77 Aligned_cols=266 Identities=19% Similarity=0.244 Sum_probs=203.7
Q ss_pred cCcccceeeccc--CceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKRILGEG--GFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G--~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
++|+..+.||+| +||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++|||||++++++.+++..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 678899999999 99999999986 7999999999765432 235688899999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++|+|.+++.. .....+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 105 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 105 TSFMAYGSAKDLICT--HFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EECCTTCBHHHHHHH--TCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEccCCCCHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999964 23356999999999999999999999998 9999999999999999999999999987653
Q ss_pred CCCc------cceeccccCccccCchhhcc--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccc--
Q 048425 530 EGSQ------HISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLT-- 599 (780)
Q Consensus 530 ~~~~------~~~t~~~GT~~Y~APE~l~~--~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~-- 599 (780)
.... .......||..|+|||.+.+ ..++.++|||||||++|||++|+.||........ +.........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~ 257 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCL 257 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC--------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCcc
Confidence 3211 11223478999999999987 6789999999999999999999999975432211 1111000000
Q ss_pred --cc----c-------------ccccccC---Cc------cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 600 --TR----E-------------GLEQLVD---PS------LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 600 --~~----~-------------~l~~lvD---p~------L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.. + .+...+. +. ....+.......+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00 0 0000000 00 000011122356889999999999999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=349.55 Aligned_cols=265 Identities=24% Similarity=0.315 Sum_probs=199.7
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcc--hHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNG--DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
++|...+.||+|+||+||+|... +|+.||||++....... .+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67899999999999999999985 58999999986654322 3568899999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 83 ~~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999874 3456999999999999999999999998 999999999999999999999999999876543
Q ss_pred CccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhh-ccccc-------cccc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTW-ARPLL-------TTRE 602 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~w-a~~ll-------~~~~ 602 (780)
.. ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. ..... ....
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 22 2234568999999999876 6789999999999999999999999976543322111110 00000 0000
Q ss_pred cccc--ccCCccCCCC---ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 603 GLEQ--LVDPSLAGSY---DFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 603 ~l~~--lvDp~L~~~~---~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.... +.++.-.... .......+.+++..|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 0011000000 0112346889999999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=372.82 Aligned_cols=263 Identities=19% Similarity=0.228 Sum_probs=210.3
Q ss_pred cchHHHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeee
Q 048425 365 FALSDLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGIC 440 (780)
Q Consensus 365 f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~ 440 (780)
+.++++....++|...+.||+|+||+||+++.. +|+.||||++++.. ....+.+.+|.+++.+++|+||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 456667777899999999999999999999985 79999999997532 12234588999999999999999999999
Q ss_pred eecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeee
Q 048425 441 IEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVS 520 (780)
Q Consensus 441 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLs 520 (780)
.+.+..+|||||+++|+|.++|.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEe
Confidence 999999999999999999999963 2347999999999999999999999998 9999999999999999999999
Q ss_pred cccccccccCCCccceeccccCccccCchhhc-------cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhh
Q 048425 521 DFGLAREATEGSQHISTRVMGTFGYVAPEYAM-------TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTW 593 (780)
Q Consensus 521 DFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~-------~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~w 593 (780)
|||+++.............+||+.|+|||++. .+.++.++|||||||++|||++|+.||.........
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~----- 279 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY----- 279 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH-----
Confidence 99999887654433334568999999999987 357899999999999999999999999754322110
Q ss_pred cccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCC---CCHHHHHH
Q 048425 594 ARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHR---PFMGEVVQ 647 (780)
Q Consensus 594 a~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~R---Psm~EVv~ 647 (780)
..+..... .+.-+.+.. .....+.+++.+|++ +|++| |+++||++
T Consensus 280 -~~i~~~~~---~~~~p~~~~----~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 280 -GKIVHYKE---HLSLPLVDE----GVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp -HHHHTHHH---HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred -HHHHhccc---CcCCCcccc----CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 01111000 011111111 123467899999999 99998 58888754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=348.92 Aligned_cols=267 Identities=25% Similarity=0.303 Sum_probs=200.4
Q ss_pred HhcCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCC-----cchHHHHHHHHHhhhcC---CCceeeeeeeeeec
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQ-----NGDREFIAEVEMLSRLH---HRNLVKLIGICIEG 443 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~-----~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~ 443 (780)
..++|+..+.||+|+||+||+|.. .+|+.||||+++.... .....+.+|++++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999996 4789999999875432 22356778888888775 99999999999875
Q ss_pred c-----eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCe
Q 048425 444 R-----TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPK 518 (780)
Q Consensus 444 ~-----~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vK 518 (780)
. ..++||||+. |+|.+++.. .....+++..++.|+.|++.||+|||+.+ |+||||||+|||+++++++|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHT--CCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 4 4799999997 699999964 23345999999999999999999999998 99999999999999999999
Q ss_pred eecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-hhhhcccc
Q 048425 519 VSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LVTWARPL 597 (780)
Q Consensus 519 LsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-Lv~wa~~l 597 (780)
|+|||+++....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... +.......
T Consensus 161 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 161 LADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp ECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999999987654322 245679999999999999999999999999999999999999997654322111 00000000
Q ss_pred ----ccccccc-ccccCCccCC---CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 598 ----LTTREGL-EQLVDPSLAG---SYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 598 ----l~~~~~l-~~lvDp~L~~---~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+.....+ ...+.+.... ....+....+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000000 0000000000 000122357889999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=340.94 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=205.6
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
.++|+..+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 468999999999999999999976 789999999975543 334679999999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++++|.+++. ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999999985 3457999999999999999999999998 999999999999999999999999999876433
Q ss_pred Cc-cceeccccCccccCchhhccCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 532 SQ-HISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 532 ~~-~~~t~~~GT~~Y~APE~l~~~~~-t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
.. .......||..|+|||.+.+..+ +.++||||||+++|||++|+.||+...... ..+..|..... ...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~--------~~~ 229 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKT--------YLN 229 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHHTTCT--------TST
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhhhccc--------ccC
Confidence 21 22344679999999999987765 789999999999999999999997643221 11222211100 000
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
........+.+++..|++.||++||++.|+++
T Consensus 230 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 ------PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 01122346789999999999999999998864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=343.37 Aligned_cols=248 Identities=26% Similarity=0.422 Sum_probs=183.8
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 6788999999999999999997 479999999996542 233467999999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999963 3457999999999999999999999998 99999999999999999999999999987653
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ + ..... .+.
T Consensus 165 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~--------~~~ 229 (278)
T 3cok_A 165 PHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--L----NKVVL--------ADY 229 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCS--------SCC
T ss_pred CCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--H----HHHhh--------ccc
Confidence 3221 2345689999999999999999999999999999999999999975432111 0 00000 000
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+ +......+.+++.+|++.||++||+++|+++
T Consensus 230 ~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 EM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 11 1122346789999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=366.26 Aligned_cols=251 Identities=20% Similarity=0.332 Sum_probs=199.2
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCC--cchHHHHHHHHHhhhcC--CCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLH--HRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~--HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||+||++...+|+.||||++..... ...+.|.+|++++.+++ |+||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 56889999999999999999988899999999976543 23467999999999996 599999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
| +.+++|.+++.. ...+++.+++.|+.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++....
T Consensus 136 E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 578999999963 347899999999999999999999998 99999999999995 57999999999987754
Q ss_pred CCcc-ceeccccCccccCchhhcc-----------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccc
Q 048425 531 GSQH-ISTRVMGTFGYVAPEYAMT-----------GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLL 598 (780)
Q Consensus 531 ~~~~-~~t~~~GT~~Y~APE~l~~-----------~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll 598 (780)
.... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||...... .
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~------- 274 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I------- 274 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----H-------
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----H-------
Confidence 3322 2345679999999999875 47899999999999999999999999643211 0
Q ss_pred ccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 599 TTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 599 ~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
..+..++++.....++......+.+++..||+.||++||++.||++.-
T Consensus 275 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 275 ---SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp ---HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 011122222222222222235688999999999999999999998653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=349.78 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=205.7
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc------chHHHHHHHHHhhhcCCCceeeeeeeeeeccee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN------GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTR 446 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 446 (780)
.++|...+.||+|+||.||+|... +|+.||||+++..... ..++|.+|++++++++||||+++++++.+++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467899999999999999999976 6899999999765322 356799999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC----CCeeecc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF----TPKVSDF 522 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~----~vKLsDF 522 (780)
++||||+++++|.+++. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999995 3457899999999999999999999998 99999999999999888 7999999
Q ss_pred cccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccc
Q 048425 523 GLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 523 GLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
|+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .+.. +.....
T Consensus 164 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~----i~~~~~ 235 (321)
T 2a2a_A 164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLAN----ITSVSY 235 (321)
T ss_dssp TTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHH----HHTTCC
T ss_pred ccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH--HHHH----HHhccc
Confidence 99987755322 234569999999999999999999999999999999999999997543211 1111 000000
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..++.... .....+.+++..|++.||++||++.|+++
T Consensus 236 ----~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 ----DFDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp ----CCCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ----ccChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00111111 12246789999999999999999999965
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=364.48 Aligned_cols=248 Identities=24% Similarity=0.355 Sum_probs=204.1
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||.||++... +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67889999999999999999975 68899999997542 344567899999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 95 e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999995 3457999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccceeccccCccccCchhhcc---CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~---~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
.. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+......
T Consensus 168 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----------- 234 (384)
T 4fr4_A 168 ET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----------- 234 (384)
T ss_dssp TC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH-----------
T ss_pred CC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh-----------
Confidence 32 2345679999999999874 4589999999999999999999999975443222222111100
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-HHHHH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPF-MGEVV 646 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs-m~EVv 646 (780)
.. ..++......+.+++..||+.||++||+ +++|.
T Consensus 235 --~~--~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 235 --TV--VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp --CC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred --cc--cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 00 0112222357889999999999999999 66554
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=352.33 Aligned_cols=259 Identities=24% Similarity=0.352 Sum_probs=197.2
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcc---hHHHHHHHHHhhhcCCCceeeeeeeeeeccee----
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNG---DREFIAEVEMLSRLHHRNLVKLIGICIEGRTR---- 446 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~---- 446 (780)
++|...+.||+|+||.||++.. .+|+.||||+++...... ...|.+|++++++++||||+++++++......
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 6899999999999999999997 478999999997654333 34689999999999999999999998765543
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
++||||+++|+|.+++.. ...+++.++++++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 92 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred EEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 999999999999999963 346999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCcc--ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccc
Q 048425 527 EATEGSQH--ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 527 ~~~~~~~~--~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
........ ......||+.|+|||.+.+..++.++||||||+++|||+||+.||........ .... .......
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~----~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQH----VREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHH----HHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHH----hcCCCCC
Confidence 76543221 22345699999999999999999999999999999999999999975432211 0010 0000000
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHH-HHHHHHhh
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVV-QALKLIYN 654 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv-~~L~~i~~ 654 (780)
. ... .......+.+++.+||+.||++||+..+++ ..|..+..
T Consensus 239 ~----~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 239 P----SAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp H----HHH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred c----ccc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 0 000 011234688999999999999999766654 45555543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=363.93 Aligned_cols=275 Identities=20% Similarity=0.267 Sum_probs=213.5
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeeecc--eeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGR--TRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~--~~~LV~ 450 (780)
++|...++||+|+||+||+|... +|+.||||+++... ....+.+.+|++++++++|+||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 67889999999999999999986 58999999997643 234567889999999999999999999998755 679999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE----cCCCCCeeecccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL----EDDFTPKVSDFGLAR 526 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL----d~~~~vKLsDFGLA~ 526 (780)
||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 89 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred ecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 9999999999997432 2334999999999999999999999998 9999999999999 778889999999998
Q ss_pred cccCCCccceeccccCccccCchhhcc--------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccc-cchh-hhhccc
Q 048425 527 EATEGSQHISTRVMGTFGYVAPEYAMT--------GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQG-QENL-VTWARP 596 (780)
Q Consensus 527 ~~~~~~~~~~t~~~GT~~Y~APE~l~~--------~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~-~~~L-v~wa~~ 596 (780)
....... .....||..|+|||++.+ ..++.++|||||||++|||+||+.||....... .... ......
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 7654322 234569999999998875 567889999999999999999999996433211 1111 110000
Q ss_pred cccc-ccccccc------cCC--ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 597 LLTT-REGLEQL------VDP--SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 597 ll~~-~~~l~~l------vDp--~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
.... ...+... ... .............+.+++..|++.||++||++.|+++.++.+++.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 0000 0000000 000 111233456667889999999999999999999999999998764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=343.61 Aligned_cols=247 Identities=19% Similarity=0.268 Sum_probs=200.8
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEE
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~L 448 (780)
..++|...+.||+|+||+||+|... +|+.||||+++.... ....++.+|+.++.++ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3478999999999999999999986 799999999976533 3346789999999999 99999999999999999999
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC---------------
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED--------------- 513 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~--------------- 513 (780)
||||+++|+|.+++.........+++..+++|+.||+.||+|||+.+ |+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999754334467999999999999999999999998 999999999999984
Q ss_pred ----CCCCeeecccccccccCCCccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc
Q 048425 514 ----DFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE 588 (780)
Q Consensus 514 ----~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~ 588 (780)
+..+||+|||++....... ...||..|+|||.+.+. .++.++|||||||++|||++|+.++... .
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~ 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-----D 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----H
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----h
Confidence 4479999999998765432 23589999999999876 5668999999999999999998775421 1
Q ss_pred hhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 589 NLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 589 ~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
...... . -..+.+ +......+.+++.+|++.||++||++.|+++
T Consensus 236 ~~~~~~----~-------~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 QWHEIR----Q-------GRLPRI----PQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHHHHH----T-------TCCCCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHH----c-------CCCCCC----CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111100 0 000111 1122356889999999999999999999865
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=360.77 Aligned_cols=246 Identities=23% Similarity=0.323 Sum_probs=202.7
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||+||+|.. .+|+.||||++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6789999999999999999997 478999999986542 233467899999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+ +|+|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 89 E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 7899998853 356999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccceeccccCccccCchhhccCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~-t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
... .....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||+...... + ...+....
T Consensus 161 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~---~~~i~~~~-------- 224 (336)
T 3h4j_B 161 GNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---L---FKKVNSCV-------- 224 (336)
T ss_dssp SBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---C---BCCCCSSC--------
T ss_pred Ccc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---H---HHHHHcCC--------
Confidence 332 234579999999999988776 689999999999999999999997533211 0 00000000
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
...+......+.+++.+|++.||++|||++|+++.
T Consensus 225 ----~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 ----YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp ----CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ----CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 01111223467899999999999999999999764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=345.51 Aligned_cols=247 Identities=28% Similarity=0.389 Sum_probs=201.8
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
.++|...+.||+|+||.||+|... ++..||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 478999999999999999999875 67899999986542 23356789999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++++||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999853 346999999999999999999999988 9999999999999999999999999986654
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
... .....||..|+|||.+.+..++.++||||||+++|||++|+.||............ .. ..
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~--------~~ 223 (279)
T 3fdn_A 161 SSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI------SR--------VE 223 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HH--------TC
T ss_pred ccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH------Hh--------CC
Confidence 322 23457899999999999999999999999999999999999999754321110000 00 00
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
. ..+......+.+++..|++.||++||++.||++.
T Consensus 224 ~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 F----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp C----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred C----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 1111223467899999999999999999999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=362.09 Aligned_cols=253 Identities=21% Similarity=0.307 Sum_probs=195.0
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
.++|...+.||+|+||+||+++.. +|+.||||++..... ..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 367999999999999999999986 789999999976543 346789999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC--CeeecccccccccC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT--PKVSDFGLAREATE 530 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~--vKLsDFGLA~~~~~ 530 (780)
+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999853 346999999999999999999999998 999999999999987765 99999999985433
Q ss_pred CCccceeccccCccccCchhhccCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVK-SDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~k-sDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
... .....||+.|+|||.+.+..++.+ +|||||||++|||++|+.||....... ....... .+..
T Consensus 171 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~----------~~~~ 236 (361)
T 3uc3_A 171 HSQ--PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQ----------RILS 236 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHH----------HHHT
T ss_pred cCC--CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHH----------HHhc
Confidence 221 234569999999999988888766 899999999999999999997543221 1111111 1111
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
..............+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 237 VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 111000111123567899999999999999999999774
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.14 Aligned_cols=258 Identities=24% Similarity=0.339 Sum_probs=204.7
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeee--cceeEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIE--GRTRCL 448 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~L 448 (780)
.++|+..+.||+|+||.||++... +|+.||+|++..... ...+.|.+|++++++++|+||+++++++.+ +...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 368899999999999999999975 789999999976543 234579999999999999999999998854 567899
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS--NPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~--~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
||||+++|+|.+++.........+++..+++++.|++.||+|||+.+ ..+|+||||||+|||+++++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999765445567999999999999999999999976 2349999999999999999999999999998
Q ss_pred cccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 527 EATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 527 ~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
....... ......||..|+|||.+.+..++.++||||||+++|||+||+.||...... .+.... .. . ..
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i---~~-~-~~-- 233 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKI---RE-G-KF-- 233 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HH-T-CC--
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHHHH---hh-c-cc--
Confidence 7654322 123456899999999999999999999999999999999999999754321 111110 00 0 00
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
+.+ +......+.+++.+||+.||++||++.||++.+
T Consensus 234 ---~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 234 ---RRI----PYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp ---CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred ---ccC----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 011 112235788999999999999999999997754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=342.43 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=204.8
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
.++|+..+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999975 6899999999765432 2356889999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC---Ceeeccccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT---PKVSDFGLARE 527 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~---vKLsDFGLA~~ 527 (780)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999998853 356999999999999999999999998 999999999999986655 99999999987
Q ss_pred ccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 528 ATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 528 ~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... +... +... ....
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~---~~~~---~~~~ 226 (284)
T 3kk8_A 158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQ---IKAG---AYDY 226 (284)
T ss_dssp CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH---HHHT---CCCC
T ss_pred cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---HHHH---HHhc---cccC
Confidence 654332 234579999999999999999999999999999999999999996543211 1110 0000 0000
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
..+. .......+.+++..|++.||++||++.|+++.
T Consensus 227 ~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 227 PSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred Cchh-----hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0110 01223468899999999999999999999773
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=366.12 Aligned_cols=249 Identities=21% Similarity=0.325 Sum_probs=199.8
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV 449 (780)
++|...++||+|+||+||+++.. +++.||||++++... ...+.+.+|..++.++ +||||+++++++.+++..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 67899999999999999999976 688999999986532 2335688999999887 899999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++...
T Consensus 132 ~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999853 356999999999999999999999998 9999999999999999999999999998643
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc--hhhhhcccccccccccccc
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE--NLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~--~Lv~wa~~ll~~~~~l~~l 607 (780)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....+. ...+
T Consensus 205 ~~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~---------~~~i 274 (396)
T 4dc2_A 205 RPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------FQVI 274 (396)
T ss_dssp CTTC-CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH---------HHHH
T ss_pred cCCC-ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH---------HHHH
Confidence 3222 234567999999999999999999999999999999999999999653321110 000000 0011
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFM 642 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm 642 (780)
....+ .++......+.+++..||+.||++||++
T Consensus 275 ~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 275 LEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHCCC--CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred hcccc--CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11111 1122233567899999999999999996
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=388.89 Aligned_cols=250 Identities=27% Similarity=0.412 Sum_probs=200.9
Q ss_pred eeecccCceEEEEEEEe---CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMD---NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~---~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
+.||+|+||+||+|.+. +++.||||+++.... ...++|.+|+++|++++|+|||+++++|.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 57999999999999764 467899999976533 235789999999999999999999999964 568899999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc--
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ-- 533 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~-- 533 (780)
|+|.++|. ....+++..++.|+.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 454 g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999995 3457999999999999999999999998 99999999999999999999999999997754332
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
...+...||..|+|||++.+..++.++|||||||+||||+| |+.||....... +...+ ... .
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i----~~~----------~ 589 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAML----EKG----------E 589 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHH----HTT----------C
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcC----------C
Confidence 22234457889999999999999999999999999999999 999997543221 11110 000 0
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
....+......+.+++..||+.||++||++.+|++.|+.+..+
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0111223346788999999999999999999999999988653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=359.83 Aligned_cols=265 Identities=16% Similarity=0.251 Sum_probs=208.7
Q ss_pred cCcccceeecccCceEEEEEEEeC---------CcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceee----------
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDN---------GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVK---------- 435 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~---------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~---------- 435 (780)
++|...+.||+|+||.||+|.... ++.||||++... +.+.+|++++++++|+||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 688999999999999999999763 789999998654 46889999999999999988
Q ss_pred -----eeeeeee-cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcce
Q 048425 436 -----LIGICIE-GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNV 509 (780)
Q Consensus 436 -----L~g~~~~-~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNI 509 (780)
+++++.. ++..++||||+ +++|.+++... ....+++..+++|+.||+.||+|||+.+ |+||||||+||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 67889999999 99999999642 2357999999999999999999999998 99999999999
Q ss_pred EEcCCC--CCeeecccccccccCCCcc------ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 048425 510 LLEDDF--TPKVSDFGLAREATEGSQH------ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDM 581 (780)
Q Consensus 510 LLd~~~--~vKLsDFGLA~~~~~~~~~------~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~ 581 (780)
|++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+||||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999876543211 12345799999999999999999999999999999999999999975
Q ss_pred CCccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 582 SQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 582 ~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
..+.. ..+......... ....+.+.... .......+.+++..|++.||++||+++||++.|+.+.....
T Consensus 271 ~~~~~-~~~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 271 CLPNT-EDIMKQKQKFVD---KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GTTCH-HHHHHHHHHHHH---SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CCcCH-HHHHHHHHhccC---Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 43211 111111111110 11111111110 01123578899999999999999999999999999987654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=373.14 Aligned_cols=248 Identities=24% Similarity=0.327 Sum_probs=195.4
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeecc---CCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRN---NQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
.++|...+.||+|+||.||+|... +|+.||||+++.. .......+.+|++++++++||||++++++|.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999975 7899999999764 233345688999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE-DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~-~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999853 3479999999999999999999998 77 999999999999999999999999999865
Q ss_pred cCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 529 TEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 529 ~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
..... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...... .+... +....
T Consensus 300 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~---i~~~~------- 365 (446)
T 4ejn_A 300 IKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFEL---ILMEE------- 365 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---HHHCC-------
T ss_pred cCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHH---HHhCC-------
Confidence 43322 234567999999999999999999999999999999999999999654321 11111 01000
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRP-----FMGEVVQ 647 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv~ 647 (780)
. .++......+.+++..||+.||++|| +++|+++
T Consensus 366 -~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 -I----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -C----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -C----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0 11112235678999999999999999 9999865
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=358.96 Aligned_cols=244 Identities=23% Similarity=0.313 Sum_probs=204.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||.||+++.. +|+.||||++++.. ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 67899999999999999999975 78999999997542 234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999963 346999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +. ..+...
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~---~~i~~~---------- 253 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IY---EKIVSG---------- 253 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHC----------
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH---HH---HHHHcC----------
Confidence 3 234579999999999999999999999999999999999999997543211 11 111110
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPF-----MGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs-----m~EVv~ 647 (780)
.+ .++......+.+++.+||+.||++||+ ++||++
T Consensus 254 ~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 254 KV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CC--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 00 111122356889999999999999998 777754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=355.72 Aligned_cols=242 Identities=26% Similarity=0.380 Sum_probs=201.9
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--------chHHHHHHHHHhhhcCCCceeeeeeeeeec
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--------GDREFIAEVEMLSRLHHRNLVKLIGICIEG 443 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--------~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~ 443 (780)
..++|...+.||+|+||+||+|... +|+.||||+++..... ..+.+.+|++++++++|+||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3578999999999999999999864 7899999999765321 234678899999999999999999999999
Q ss_pred ceeEEEEeecCCC-ChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecc
Q 048425 444 RTRCLVYELVHNG-SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDF 522 (780)
Q Consensus 444 ~~~~LV~Ey~~~G-SL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDF 522 (780)
+..++||||+.+| +|.+++. ....+++..++.|+.|++.||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999877 9999985 3457999999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCccceeccccCccccCchhhccCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccc
Q 048425 523 GLAREATEGSQHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTR 601 (780)
Q Consensus 523 GLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~-t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~ 601 (780)
|+++....... .....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||..... .
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~----------- 236 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----T----------- 236 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----G-----------
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----H-----------
Confidence 99987755432 234579999999999988877 7899999999999999999999953110 0
Q ss_pred cccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 602 EGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 602 ~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
......+ +......+.+++..|++.||++||++.|+++
T Consensus 237 --~~~~~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 237 --VEAAIHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp --TTTCCCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HhhccCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 1112246889999999999999999999965
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=356.06 Aligned_cols=247 Identities=24% Similarity=0.364 Sum_probs=193.3
Q ss_pred cCcccceeecccCceEEEEEEE----eCCcEEEEEEeeccC----CcchHHHHHHHHHhhhcCCCceeeeeeeeeeccee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM----DNGTEVAVKLLTRNN----QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTR 446 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 446 (780)
++|...+.||+|+||.||+++. .+|+.||||++++.. ......+.+|++++++++||||+++++++.+++..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 6789999999999999999987 478999999997653 22345688999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 97 YLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999953 346899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 527 EATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 527 ~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .. ..+....
T Consensus 170 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~---~~i~~~~----- 237 (327)
T 3a62_A 170 ESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---TI---DKILKCK----- 237 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH---HHHHHTC-----
T ss_pred ccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---HH---HHHHhCC-----
Confidence 6543222 2244679999999999999999999999999999999999999997543211 11 1111100
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRP-----FMGEVVQ 647 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv~ 647 (780)
+ ..+......+.+++.+||+.||++|| ++.|+++
T Consensus 238 -----~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 -----L--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -----C--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -----C--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 11112235688999999999999999 6666654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=359.65 Aligned_cols=248 Identities=29% Similarity=0.420 Sum_probs=201.3
Q ss_pred hcCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcc---hHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNG---DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
.+.|...+.||+|+||+||+|.. .+|+.||||++....... .++|.+|++++++++||||+++++++.+++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35688999999999999999996 478999999997654322 35689999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+. |+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 133 ~e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99997 688888753 3457999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCccceeccccCccccCchhhc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~---~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
.. ....||+.|+|||++. .+.++.++|||||||++|||++|+.||....... .+.. +...
T Consensus 206 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--~~~~----~~~~------ 268 (348)
T 1u5q_A 206 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYH----IAQN------ 268 (348)
T ss_dssp SB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHH----HHHS------
T ss_pred CC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHH----HHhc------
Confidence 32 2356999999999985 5778999999999999999999999996543211 1111 1100
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
..+.+. .......+.+++..||+.||++||+++|+++..
T Consensus 269 -~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 269 -ESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp -CCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred -CCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 011111 111224678899999999999999999997643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=353.48 Aligned_cols=264 Identities=28% Similarity=0.444 Sum_probs=208.2
Q ss_pred hcCcccceeecccCceEEEEEEE------eCCcEEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeeeccee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVM------DNGTEVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTR 446 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 446 (780)
.++|...+.||+|+||.||+|.. .++..||||++.... .....+|.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 37889999999999999999984 257789999996543 23346799999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhcccccC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC---CCCCeee
Q 048425 447 CLVYELVHNGSVESHLHGVDK---NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED---DFTPKVS 520 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~---~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~---~~~vKLs 520 (780)
++||||+++|+|.+++..... ....+++..+++++.|++.||+|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999975322 1246999999999999999999999998 999999999999984 4569999
Q ss_pred cccccccccCCCc-cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccc
Q 048425 521 DFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLL 598 (780)
Q Consensus 521 DFGLA~~~~~~~~-~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll 598 (780)
|||+++....... .......||+.|+|||.+.++.++.++||||||+++|||+| |+.||...... .+..+...
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~~-- 260 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFVTS-- 260 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHHT--
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHHHhc--
Confidence 9999986643322 22234568999999999999999999999999999999998 99998654321 11111100
Q ss_pred ccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcCC
Q 048425 599 TTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657 (780)
Q Consensus 599 ~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~~ 657 (780)
.. .. .........+.+++..||+.||++||++.||++.|+.+....+
T Consensus 261 --~~------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 261 --GG------RM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp --TC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred --CC------CC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 00 00 1112223568899999999999999999999999998876544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.81 Aligned_cols=256 Identities=24% Similarity=0.346 Sum_probs=205.0
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc------chHHHHHHHHHhhhcCCCceeeeeeeeeecceeE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN------GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 447 (780)
++|...+.||+|+||.||++... +|+.||||+++..... ..+.|.+|++++++++||||+++++++.+++..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57889999999999999999986 6899999998765321 3577999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC----CCeeeccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF----TPKVSDFG 523 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~----~vKLsDFG 523 (780)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999953 346999999999999999999999998 99999999999998877 89999999
Q ss_pred ccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccc
Q 048425 524 LAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREG 603 (780)
Q Consensus 524 LA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~ 603 (780)
++........ .....||..|+|||.+.+..++.++||||||+++|||++|+.||....... .+.... ....
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~----~~~~- 228 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE--TLTNIS----AVNY- 228 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHH----TTCC-
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH--HHHHhH----hccc-
Confidence 9987654322 234569999999999999999999999999999999999999997543211 111100 0000
Q ss_pred cccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHHh
Q 048425 604 LEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ--ALKLIY 653 (780)
Q Consensus 604 l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~--~L~~i~ 653 (780)
..++... ......+.+++.+|++.||++||++.|+++ .++.+.
T Consensus 229 ---~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 229 ---DFDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp ---CCCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred ---CCcchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 0000000 112346889999999999999999999987 455554
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=347.12 Aligned_cols=257 Identities=28% Similarity=0.396 Sum_probs=197.9
Q ss_pred cCcccceeecccCceEEEEEEEe--CCc--EEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD--NGT--EVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~--~g~--~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 447 (780)
++|...+.||+|+||+||+|.+. +++ .||||+++... ....+.|.+|++++++++|+||+++++++.++. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 67889999999999999999864 333 68999987543 233467999999999999999999999998754 88
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+|+||+++|+|.+++.. ....+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 97 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 99999999999999963 2356899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCcc--ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccc
Q 048425 528 ATEGSQH--ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 528 ~~~~~~~--~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
....... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+... +.....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~---~~~~~~-- 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHK---IDKEGE-- 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH---HHTSCC--
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHHHH---HHccCC--
Confidence 7544322 2234567889999999999999999999999999999999 99999754321 11111 110000
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
...........+.+++.+|++.||++||++.|+++.|+++..
T Consensus 243 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 243 --------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred --------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 001112233578899999999999999999999999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=359.92 Aligned_cols=264 Identities=22% Similarity=0.346 Sum_probs=204.6
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|...+.||+|+||+||+|... +|..||+|+++.... ...+.+.+|++++++++|+||+++++++.+++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 67999999999999999999986 789999999976533 2346799999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED-SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~-~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
+++|+|.+++.. ...+++..+.+++.+++.||+|||+. + |+||||||+|||++.++++||+|||++......
T Consensus 113 ~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 113 MDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999953 34689999999999999999999986 6 999999999999999999999999999765432
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhh---------cccc-----
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTW---------ARPL----- 597 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~w---------a~~l----- 597 (780)
......||+.|+|||++.+..++.++|||||||++|||+||+.||.............. ....
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 12345799999999999999999999999999999999999999976443211110000 0000
Q ss_pred ------------cccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 598 ------------LTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 598 ------------l~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
....+.+..+................+.+++.+|++.||++|||++|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000000111100000111123468899999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=361.23 Aligned_cols=255 Identities=23% Similarity=0.328 Sum_probs=204.7
Q ss_pred hcCcccceeecccCceEEEEEEE----eCCcEEEEEEeeccC----CcchHHHHHHHHHhhhc-CCCceeeeeeeeeecc
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVM----DNGTEVAVKLLTRNN----QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGR 444 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~ 444 (780)
.++|...+.||+|+||.||+++. .+|+.||||+++... ....+.+.+|++++.++ +|+||+++++++..++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999997 378999999986542 23345678899999999 6999999999999999
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccc
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGL 524 (780)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999963 346999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCccceeccccCccccCchhhcc--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccc
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~--~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
++..............||+.|+|||++.+ ..++.++|||||||+||||+||+.||........ ...........
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~-- 281 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS-- 281 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHC--
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhcc--
Confidence 98765443333455679999999999986 3478999999999999999999999975432211 11111111100
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRP-----FMGEVVQAL 649 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv~~L 649 (780)
.+ .++.+....+.+++.+||+.||++|| ++.|+++..
T Consensus 282 ------~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 ------EP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ------CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ------CC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11 12222335678999999999999999 889887643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=345.68 Aligned_cols=253 Identities=25% Similarity=0.276 Sum_probs=189.1
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcc-h-HHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNG-D-REFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~-~-~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
.++|+..+.||+|+||+||+|... +|+.||||+++...... . +.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 478999999999999999999974 78999999997653322 2 23455555688889999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED-SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~-~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
||++ |+|.+++.........+++..+++|+.|++.||+|||+. + |+||||||+|||++.++++||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 588888865445667899999999999999999999997 7 9999999999999999999999999998765
Q ss_pred CCCccceeccccCccccCchhh----ccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccc
Q 048425 530 EGSQHISTRVMGTFGYVAPEYA----MTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLE 605 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l----~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~ 605 (780)
.... .....||+.|+|||.+ .+..++.++||||||+++|||+||+.||....... ..+...
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~------------ 226 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-QQLKQV------------ 226 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-HHHHHH------------
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-HHHHHH------------
Confidence 4322 2334699999999996 56678999999999999999999999997432111 111111
Q ss_pred cccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 606 QLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 606 ~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
................+.+++.+|++.||++|||+.|+++
T Consensus 227 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 227 --VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --HHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --hccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0000000011122356889999999999999999999987
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.87 Aligned_cols=260 Identities=25% Similarity=0.337 Sum_probs=198.3
Q ss_pred cCcccc-eeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSK-RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~-~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
+.|... ++||+|+||+||+|... +|+.||||+++.......+.+.+|++++.++ +|+||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567663 78999999999999864 7899999999877666678899999999995 79999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC---Ceeecccccccc
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT---PKVSDFGLAREA 528 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~---vKLsDFGLA~~~ 528 (780)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++..
T Consensus 92 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999963 346899999999999999999999998 999999999999998776 999999999865
Q ss_pred cCCCc------cceeccccCccccCchhhcc-----CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccc
Q 048425 529 TEGSQ------HISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL 597 (780)
Q Consensus 529 ~~~~~------~~~t~~~GT~~Y~APE~l~~-----~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~l 597 (780)
..... .......||..|+|||.+.. ..++.++|||||||++|||++|+.||......+. .|....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~~~~ 240 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC----GWDRGE 240 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCS----CC----
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccc----cccccc
Confidence 43211 11223469999999999875 5678999999999999999999999976543221 111000
Q ss_pred cc---cccccccccCCccCCCCCh----hhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 598 LT---TREGLEQLVDPSLAGSYDF----DDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 598 l~---~~~~l~~lvDp~L~~~~~~----ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.. .......+..... .++. .....+.+++.+|++.||++||++.|+++
T Consensus 241 ~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 241 ACPACQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CCHHHHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cchhHHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00 0000000111000 1111 12346889999999999999999999965
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=356.53 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=199.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc---chHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN---GDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV 449 (780)
++|...+.||+|+||+||+++.. +|+.||||++++.... ..+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 67889999999999999999986 6899999999865432 234588999999988 899999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999853 346999999999999999999999998 9999999999999999999999999998643
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc--hhhhhcccccccccccccc
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE--NLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~--~Lv~wa~~ll~~~~~l~~l 607 (780)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...... ...+
T Consensus 162 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~---------~~~i 231 (345)
T 3a8x_A 162 RPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------FQVI 231 (345)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHH---------HHHH
T ss_pred CCCC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHH---------HHHH
Confidence 3222 234567999999999999999999999999999999999999999653211110 000000 0001
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFM 642 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm 642 (780)
....+ .++......+.+++.+||+.||++||++
T Consensus 232 ~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 232 LEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HcCCC--CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11111 1122233568899999999999999996
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=367.32 Aligned_cols=253 Identities=23% Similarity=0.290 Sum_probs=204.4
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
..++|...+.||+|+||+||++... +|+.||+|++...... ..+.+.+|++++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3578999999999999999999874 7899999999765432 335689999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc---CCCCCeeecccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE---DDFTPKVSDFGLAR 526 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd---~~~~vKLsDFGLA~ 526 (780)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||+++
T Consensus 89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999853 456999999999999999999999998 99999999999998 46789999999998
Q ss_pred cccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 527 EATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 527 ~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... +.... ..
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~~~---i~~~~---~~ 231 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLYQQ---IKAGA---YD 231 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHH---HHHTC---CC
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHHHH---HHhCC---CC
Confidence 7654332 224467999999999999999999999999999999999999999654321 11110 00000 00
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
...+.. ......+.+++..|++.||++||++.|+++
T Consensus 232 ~~~~~~-----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 FPSPEW-----DTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCTTTT-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCcccc-----ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111110 122356789999999999999999999976
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=344.10 Aligned_cols=250 Identities=27% Similarity=0.431 Sum_probs=207.5
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
+.|...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++++++|+||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 56888999999999999999874 689999999976543 3457899999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++++|.+++. ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++++||+|||++.......
T Consensus 102 ~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999984 246999999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
. ......||..|+|||.+.+..++.++||||||+++|||++|+.||....... ..... .....+.+
T Consensus 174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~----------~~~~~~~~ 239 (303)
T 3a7i_A 174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VLFLI----------PKNNPPTL 239 (303)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHH----------HHSCCCCC
T ss_pred c-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HHHHh----------hcCCCCCC
Confidence 2 2234568999999999999999999999999999999999999997543211 11110 00011112
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
... ....+.+++..||+.||++||++.|+++..-
T Consensus 240 ~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 240 EGN----YSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp CSS----CCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred ccc----cCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 122 2346889999999999999999999987543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=360.57 Aligned_cols=248 Identities=24% Similarity=0.357 Sum_probs=204.3
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeE
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~ 447 (780)
..++|...+.||+|+||+||+|+.. +|+.||||++++.. ....+.+..|.+++..+ +||||+++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4578999999999999999999985 68999999997642 33456788999999987 9999999999999999999
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.
T Consensus 95 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999953 346999999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 528 ATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 528 ~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
...... .....+||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+.. .+...
T Consensus 168 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~---~i~~~------- 233 (345)
T 1xjd_A 168 NMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFH---SIRMD------- 233 (345)
T ss_dssp CCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHC-------
T ss_pred cccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHH---HHHhC-------
Confidence 543222 234567999999999999999999999999999999999999999754321 1111 01100
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHH-HHH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMG-EVV 646 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~-EVv 646 (780)
.+. ++......+.+++.+|++.||++||++. ||.
T Consensus 234 -~~~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 234 -NPF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -CCC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -CCC----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 011 1111234678999999999999999997 553
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=360.35 Aligned_cols=252 Identities=22% Similarity=0.287 Sum_probs=191.8
Q ss_pred cCcccc-eeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhh-cCCCceeeeeeeeee----cceeE
Q 048425 375 EKFSSK-RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSR-LHHRNLVKLIGICIE----GRTRC 447 (780)
Q Consensus 375 ~~f~~~-~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~-L~HpNIV~L~g~~~~----~~~~~ 447 (780)
++|... ++||+|+||+||++... +|+.||||+++. ...+.+|++++.+ .+|+||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456555 78999999999999975 689999999853 2467789998755 589999999999875 56789
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC---CCCCeeecccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED---DFTPKVSDFGL 524 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~---~~~vKLsDFGL 524 (780)
|||||+++|+|.+++.. .....+++..+..|+.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 136 lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999964 23356999999999999999999999998 999999999999997 78999999999
Q ss_pred cccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc-hhhhhcccccccccc
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE-NLVTWARPLLTTREG 603 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~-~Lv~wa~~ll~~~~~ 603 (780)
++...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||......... .+... +....
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---i~~~~-- 283 (400)
T 1nxk_A 211 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR---IRMGQ-- 283 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH---HHHTC--
T ss_pred ccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH---HHcCc--
Confidence 98765432 224567999999999999999999999999999999999999999754432110 00000 00000
Q ss_pred cccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 604 LEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 604 l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
..+..+. .......+.+++..||+.||++||++.||++.-
T Consensus 284 -~~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 284 -YEFPNPE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp -CCCCTTT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred -ccCCCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0000110 012235688999999999999999999998753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=349.16 Aligned_cols=262 Identities=19% Similarity=0.278 Sum_probs=206.1
Q ss_pred cchHHHHHHhcCcccc-eeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhc-CCCceeeeeee
Q 048425 365 FALSDLEKATEKFSSK-RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRL-HHRNLVKLIGI 439 (780)
Q Consensus 365 f~~~el~~at~~f~~~-~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L-~HpNIV~L~g~ 439 (780)
..++..+...+.|... +.||+|+||.||+|... +|+.||||+++.... ....++.+|+.++.++ +|+||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3444555566777777 89999999999999976 689999999976432 3357899999999999 56999999999
Q ss_pred eeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC---CCC
Q 048425 440 CIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED---DFT 516 (780)
Q Consensus 440 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~---~~~ 516 (780)
+.+.+..++||||+++|+|.+++.. .....+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 9999999999999999999999853 33467999999999999999999999998 999999999999997 789
Q ss_pred CeeecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccc
Q 048425 517 PKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARP 596 (780)
Q Consensus 517 vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ 596 (780)
+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........ +...
T Consensus 173 ~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i--- 245 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET--YLNI--- 245 (327)
T ss_dssp EEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH---
T ss_pred EEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHH---
Confidence 99999999987654322 2345799999999999999999999999999999999999999975432111 1000
Q ss_pred ccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 597 LLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 597 ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
... ...............+.+++.+|++.||++||+++|+++
T Consensus 246 -~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 246 -SQV--------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp -HHT--------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -Hhc--------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 000 000001111123356889999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=340.84 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=199.7
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
++|....+||+|+||.||+|... +++.||||.+........+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34556679999999999999974 78899999998776666678999999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC-CCCCeeecccccccccCCC
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED-DFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~-~~~vKLsDFGLA~~~~~~~ 532 (780)
++++|.+++... .....+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++......
T Consensus 102 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 999999999642 22345779999999999999999999998 999999999999987 8999999999998765432
Q ss_pred ccceeccccCccccCchhhccCC--CCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~--~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
. ......||..|+|||.+.++. ++.++||||||+++|||++|+.||....... ..... .. .....+
T Consensus 178 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~--~~--------~~~~~~ 245 (295)
T 2clq_A 178 P-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-AAMFK--VG--------MFKVHP 245 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-HHHHH--HH--------HHCCCC
T ss_pred C-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-HHHHh--hc--------cccccc
Confidence 1 223456999999999987654 8899999999999999999999996322110 00000 00 000111
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+ +......+.+++.+||+.||++||++.|+++
T Consensus 246 ~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 246 EI----PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CC----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cc----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 2223356789999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=355.61 Aligned_cols=246 Identities=22% Similarity=0.289 Sum_probs=178.5
Q ss_pred ceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcC-CCceeeeeeeeeecceeEEEEeecCCCC
Q 048425 380 KRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH-HRNLVKLIGICIEGRTRCLVYELVHNGS 457 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~Ey~~~GS 457 (780)
.+.||+|+||+||+|... +|+.||||++... ....+.+|++++.++. ||||+++++++.++...++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999985 6899999999653 3467889999999997 9999999999999999999999999999
Q ss_pred hhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC---CCeeecccccccccCCCcc
Q 048425 458 VESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF---TPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 458 L~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~---~vKLsDFGLA~~~~~~~~~ 534 (780)
|.+++.. ...+++.++..|+.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++........
T Consensus 93 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 93 LFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp HHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 9999953 457999999999999999999999998 99999999999997665 8999999999876543322
Q ss_pred ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc-hhhhhcccccccccccccccCCccC
Q 048425 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE-NLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~-~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
.....||..|+|||.+.+..++.++|||||||++|||++|+.||......... ..... +..+......
T Consensus 166 -~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~----------~~~i~~~~~~ 234 (325)
T 3kn6_A 166 -LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI----------MKKIKKGDFS 234 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHH----------HHHHTTTCCC
T ss_pred -ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHH----------HHHHHcCCCC
Confidence 23456899999999999999999999999999999999999999754321110 00110 1111111110
Q ss_pred CC--CChhhHHHHHHHHHHccccCCCCCCCHHHHH
Q 048425 614 GS--YDFDDMAKVAAIASMCVHPEVTHRPFMGEVV 646 (780)
Q Consensus 614 ~~--~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv 646 (780)
.. ........+.+++..|++.||++||++.|++
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 00 0011235788999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=364.95 Aligned_cols=243 Identities=14% Similarity=0.202 Sum_probs=190.7
Q ss_pred hcCcccceeecccCceEEEEEEE-eCCcEEEEEEeecc---CCcchHHHHHHH---HHhhhcCCCceeeee-------ee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRN---NQNGDREFIAEV---EMLSRLHHRNLVKLI-------GI 439 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~---~~~~~~~f~~Ei---~iL~~L~HpNIV~L~-------g~ 439 (780)
.++|...+.||+|+||+||+|.. .+|+.||||++... .....+.|.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 47888999999999999999996 47999999999754 233446799999 555666899999998 55
Q ss_pred eeecc-----------------eeEEEEeecCCCChhhhcccccC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcE
Q 048425 440 CIEGR-----------------TRCLVYELVHNGSVESHLHGVDK---NRGPLDWEARMKIALGAARGLAYLHEDSNPRV 499 (780)
Q Consensus 440 ~~~~~-----------------~~~LV~Ey~~~GSL~~~L~~~~~---~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~I 499 (780)
+.+.+ ..+|||||+ +|+|.+++..... ....++|..+++|+.||+.||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 54432 278999999 6899999974211 1224557899999999999999999998 9
Q ss_pred EecccCCcceEEcCCCCCeeecccccccccCCCccceeccccCccccCchhhccC-----------CCCchhhHHhHHHH
Q 048425 500 IHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG-----------HLLVKSDVYSYGVV 568 (780)
Q Consensus 500 vHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~-----------~~t~ksDVySfGVv 568 (780)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2344567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 569 LLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 569 LlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
||||+||+.||........ .. .+... . ..+ ...+.+++.+||+.||++||++.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~~---~~-------------~~~~~-~-~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG---SE-------------WIFRS-C-KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CC---SG-------------GGGSS-C-CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccc---hh-------------hhhhh-c-cCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999965332111 10 11110 0 111 246788999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=340.76 Aligned_cols=245 Identities=25% Similarity=0.359 Sum_probs=204.0
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67889999999999999999976 67899999986542 234567999999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999953 346899999999999999999999998 99999999999999999999999999976544
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
.. .....||..|+|||.+.+..++.++||||||+++|||++|+.||........ . ..+... +.
T Consensus 167 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~---~~~~~~--------~~ 229 (284)
T 2vgo_A 167 LR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET---H---RRIVNV--------DL 229 (284)
T ss_dssp SC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H---HHHHTT--------CC
T ss_pred cc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH---H---HHHhcc--------cc
Confidence 22 2345689999999999999999999999999999999999999975432111 0 000000 11
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
. ++......+.+++..|++.||++||+++|+++
T Consensus 230 ~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 K----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp C----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1 11122346789999999999999999999976
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=358.10 Aligned_cols=243 Identities=23% Similarity=0.319 Sum_probs=201.0
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~L 448 (780)
.++|...+.||+|+||+||+++.. +|+.||||++++.. ....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 478999999999999999999986 57899999997642 33456788999999988 89999999999999999999
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++..
T Consensus 99 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999953 346999999999999999999999998 999999999999999999999999999864
Q ss_pred cCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 529 TEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 529 ~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .+...
T Consensus 172 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~---~i~~~-------- 236 (353)
T 2i0e_A 172 IWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ---SIMEH-------- 236 (353)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHC--------
T ss_pred ccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHHH---HHHhC--------
Confidence 33222 234567999999999999999999999999999999999999999754321 1111 11111
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFM 642 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm 642 (780)
.+ .++......+.+++..|++.||++||++
T Consensus 237 --~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 237 --NV--AYPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp --CC--CCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred --CC--CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00 1112223568899999999999999964
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=353.91 Aligned_cols=263 Identities=24% Similarity=0.408 Sum_probs=201.0
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcc--hHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNG--DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
++|+..+.||+|+||.||+|... +|+.||||++....... .+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 67889999999999999999986 58999999986654332 3568899999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999999988864 3456999999999999999999999998 999999999999999999999999999876543
Q ss_pred CccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcc---c-------cccc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWAR---P-------LLTT 600 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~---~-------ll~~ 600 (780)
.. ......||..|+|||++.+. .++.++|||||||++|||++|+.||........ +..... . ....
T Consensus 178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHHHH
T ss_pred cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhhhHhhh
Confidence 22 22345689999999998875 789999999999999999999999976543211 111100 0 0000
Q ss_pred ccccccccCCccCCCCCh-----hhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 601 REGLEQLVDPSLAGSYDF-----DDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 601 ~~~l~~lvDp~L~~~~~~-----ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.........+.+...... .....+.+++.+||+.||++||++.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 001111111111111111 22357899999999999999999999876
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=343.02 Aligned_cols=248 Identities=24% Similarity=0.359 Sum_probs=204.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||.||++... +++.||+|++..... ...+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 67888999999999999999986 588999999876532 23457899999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 95 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 95 ELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp ECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999998852 357999999999999999999999998 99999999999999999999999999987653
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
.... .....||..|+|||.+.+..++.++||||||+++|||++|+.||....... .... +.... .
T Consensus 168 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~----~~~~~--------~ 232 (294)
T 2rku_A 168 DGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TYLR----IKKNE--------Y 232 (294)
T ss_dssp TTCC-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHH----HHTTC--------C
T ss_pred Cccc-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH----Hhhcc--------C
Confidence 3222 234569999999999999999999999999999999999999997543211 1110 00000 0
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.+ +......+.+++.+|++.||++||++.|+++.
T Consensus 233 ~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 SI----PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CC----ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 01 11222467889999999999999999999764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=349.83 Aligned_cols=263 Identities=17% Similarity=0.242 Sum_probs=205.2
Q ss_pred hcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcch-----------------HHHHHHHHHhhhcCCCceeee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGD-----------------REFIAEVEMLSRLHHRNLVKL 436 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~-----------------~~f~~Ei~iL~~L~HpNIV~L 436 (780)
.++|...+.||+|+||.||+|.. +|+.||||++........ +.|.+|++++++++|+||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36899999999999999999999 999999999875432211 789999999999999999999
Q ss_pred eeeeeecceeEEEEeecCCCChhhh------cccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCcEEecccCCcce
Q 048425 437 IGICIEGRTRCLVYELVHNGSVESH------LHGVDKNRGPLDWEARMKIALGAARGLAYLHE-DSNPRVIHRDFKASNV 509 (780)
Q Consensus 437 ~g~~~~~~~~~LV~Ey~~~GSL~~~------L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~-~~~p~IvHrDIKpsNI 509 (780)
++++.+.+..++||||+++|+|.++ +.. .....+++..++.++.|++.||+|||+ .+ |+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhE
Confidence 9999999999999999999999999 532 225689999999999999999999998 77 99999999999
Q ss_pred EEcCCCCCeeecccccccccCCCccceeccccCccccCchhhccC-CCCc-hhhHHhHHHHHHHHHhCCCCCCCCCcccc
Q 048425 510 LLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG-HLLV-KSDVYSYGVVLLELLSGRKPVDMSQPQGQ 587 (780)
Q Consensus 510 LLd~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~-~~t~-ksDVySfGVvLlELlTGr~P~~~~~~~~~ 587 (780)
|++.++.+||+|||++...... ......||..|+|||.+.+. .++. ++||||||+++|||++|+.||......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 9999999999999999876543 23445799999999999887 6666 999999999999999999999764431
Q ss_pred chhhhhccc-ccccccccccccCCccC---CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 588 ENLVTWARP-LLTTREGLEQLVDPSLA---GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 588 ~~Lv~wa~~-ll~~~~~l~~lvDp~L~---~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..+...... .............+... ..........+.+++.+||+.||++||++.|+++
T Consensus 259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111100 00000000000000000 0001223357889999999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.09 Aligned_cols=263 Identities=21% Similarity=0.289 Sum_probs=193.0
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
.++|...+.||+|+||+||+|... +|+.||||+++..... ..+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 468999999999999999999865 7899999999755332 2356889999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc-----CCCCCeeeccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE-----DDFTPKVSDFGLA 525 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd-----~~~~vKLsDFGLA 525 (780)
||++ |+|.+++. ....+++..+..|+.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||++
T Consensus 113 e~~~-~~L~~~~~----~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 113 EYAE-NDLKKYMD----KNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp ECCS-EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred ecCC-CCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 9997 59999985 3446999999999999999999999998 99999999999994 5556999999999
Q ss_pred ccccCCCccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccc-------
Q 048425 526 REATEGSQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL------- 597 (780)
Q Consensus 526 ~~~~~~~~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~l------- 597 (780)
+....... ......||..|+|||++.+. .++.++|||||||++|||++|+.||........ +.......
T Consensus 185 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 185 RAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTT
T ss_pred cccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHHHHHHhCCCchhh
Confidence 87654322 22345689999999999874 589999999999999999999999976443211 11110000
Q ss_pred ccccccccccc--CCccCCC-----CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 598 LTTREGLEQLV--DPSLAGS-----YDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 598 l~~~~~l~~lv--Dp~L~~~-----~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+.....+.... .+..... ........+.+++.+|++.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000000000 0000000 00012256789999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=355.10 Aligned_cols=274 Identities=23% Similarity=0.309 Sum_probs=201.8
Q ss_pred cchHHHHHHhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcc-----------hHHHHHHHHHhhhcCCCce
Q 048425 365 FALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNG-----------DREFIAEVEMLSRLHHRNL 433 (780)
Q Consensus 365 f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~-----------~~~f~~Ei~iL~~L~HpNI 433 (780)
..++++....++|...+.||+|+||.||+|...+|+.||||++....... .+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 45678889999999999999999999999998889999999986543221 2679999999999999999
Q ss_pred eeeeeeeeec-----ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcc
Q 048425 434 VKLIGICIEG-----RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASN 508 (780)
Q Consensus 434 V~L~g~~~~~-----~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsN 508 (780)
+++++++... ...++||||++ |+|.+++. .....+++..+..++.||+.||+|||+.+ |+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH---DQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHH
Confidence 9999998542 35799999997 68888886 34557999999999999999999999998 9999999999
Q ss_pred eEEcCCCCCeeecccccccccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCcccc
Q 048425 509 VLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ 587 (780)
Q Consensus 509 ILLd~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~ 587 (780)
||+++++.+||+|||+++....... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||........
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEEcCCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999986544322 244578999999999877 6789999999999999999999999976442211
Q ss_pred c-hhhhhccccc-c-----cccccccccCCccCCC-------CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 588 E-NLVTWARPLL-T-----TREGLEQLVDPSLAGS-------YDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 588 ~-~Lv~wa~~ll-~-----~~~~l~~lvDp~L~~~-------~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
. .+........ . ........+...+... ........+.+++..|++.||++|||+.|+++
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1 0111000000 0 0000000010100000 00112346889999999999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=344.21 Aligned_cols=250 Identities=24% Similarity=0.354 Sum_probs=202.5
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
.++|...+.||+|+||.||++... +|+.||||+++.......+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 367889999999999999999975 7899999999876555556799999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE---cCCCCCeeeccccccccc
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL---d~~~~vKLsDFGLA~~~~ 529 (780)
+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||++ ++++.+||+|||+++...
T Consensus 88 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999853 346899999999999999999999998 9999999999999 788999999999997654
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
.. ......||..|+|||.+.+..++.++||||||+++|||++|+.||...... .+... +.... ... .
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~---i~~~~---~~~-~ 227 (304)
T 2jam_A 161 NG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEK---IKEGY---YEF-E 227 (304)
T ss_dssp CB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH---HHHCC---CCC-C
T ss_pred CC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHH---HHcCC---CCC-C
Confidence 32 123456999999999999999999999999999999999999999754321 11110 00000 000 0
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..........+.+++..|++.||++||++.|+++
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 228 ----SPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ----TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111122357889999999999999999999976
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=339.70 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=197.5
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeee----cceeE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIE----GRTRC 447 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~~ 447 (780)
+.|...+.||+|+||.||+|... ++..||+|++..... ...+.|.+|++++++++||||+++++++.. +...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34677789999999999999875 688999999876532 234578999999999999999999999875 35679
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc-CCCCCeeecccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE-DDFTPKVSDFGLAR 526 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd-~~~~vKLsDFGLA~ 526 (780)
+||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||||||+|||++ +++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999953 356899999999999999999999874 4599999999999998 78999999999997
Q ss_pred cccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 527 EATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 527 ~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
...... .....||+.|+|||.+. +.++.++||||||+++|||++|+.||...... ..+.... ...
T Consensus 181 ~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~---~~~------ 245 (290)
T 1t4h_A 181 LKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRV---TSG------ 245 (290)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHH---TTT------
T ss_pred cccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH--HHHHHHH---hcc------
Confidence 654432 23456999999999776 56899999999999999999999999653321 1111110 000
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
...... +......+.+++..||+.||++||++.|+++
T Consensus 246 ~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 246 VKPASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCCGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcccc----CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 000011 1112246889999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=367.63 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=204.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||.||+|... +|+.||||+++... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 67889999999999999999976 79999999997542 233467899999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 96 E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999995 3457999999999999999999999998 99999999999999999999999999987754
Q ss_pred CCccceeccccCccccCchhhccCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~-t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
... .....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||+..... .+.. .+. +
T Consensus 169 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~---~i~----------~ 230 (476)
T 2y94_A 169 GEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFK---KIC----------D 230 (476)
T ss_dssp TCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHH---HHH----------T
T ss_pred ccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHH---HHh----------c
Confidence 322 234579999999999988765 68999999999999999999999754321 1111 111 1
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
... ..+......+.+++.+|++.||++|||+.|+++
T Consensus 231 ~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 231 GIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp TCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 100 011112246789999999999999999999987
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=353.58 Aligned_cols=265 Identities=23% Similarity=0.324 Sum_probs=195.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcc-hHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNG-DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|...+.||+|+||+||+|... +|+.||||+++...... ...+.+|++++++++|+||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999986 78999999986543322 22466799999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
++ |+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++......
T Consensus 82 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 589888863 3457999999999999999999999998 9999999999999999999999999998654332
Q ss_pred ccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhh-hhcccc----cc---cccc
Q 048425 533 QHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV-TWARPL----LT---TREG 603 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv-~wa~~l----l~---~~~~ 603 (780)
. ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+ ...... +. ....
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 2 2234568999999999876 56899999999999999999999999765432211110 000000 00 0000
Q ss_pred cccccCCccCCCC----ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 604 LEQLVDPSLAGSY----DFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 604 l~~lvDp~L~~~~----~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
......+...... .......+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000000000 0112246789999999999999999999976
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=360.30 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=192.6
Q ss_pred HHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--------cchHHHHHHHHHhhhcCCCceeeeeeeeee
Q 048425 372 KATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--------NGDREFIAEVEMLSRLHHRNLVKLIGICIE 442 (780)
Q Consensus 372 ~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~ 442 (780)
...++|...+.||+|+||+||+|... +++.||||++..... .....+.+|+++|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45689999999999999999999875 689999999875421 122358899999999999999999999754
Q ss_pred cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC---CCCee
Q 048425 443 GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD---FTPKV 519 (780)
Q Consensus 443 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~---~~vKL 519 (780)
+..++||||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.+ +.+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence 56799999999999999985 3457999999999999999999999998 9999999999999654 45999
Q ss_pred ecccccccccCCCccceeccccCccccCchhhcc---CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccc
Q 048425 520 SDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARP 596 (780)
Q Consensus 520 sDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~---~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ 596 (780)
+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... ..+......
T Consensus 284 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~~i~~ 359 (419)
T 3i6u_A 284 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQITS 359 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHHHHHHT
T ss_pred eecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHHHHHhc
Confidence 9999998765432 2345679999999999863 67889999999999999999999999753321 111111000
Q ss_pred ccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 597 LLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 597 ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.. .. ..+... ......+.+++.+|++.||++||++.|+++
T Consensus 360 ---~~---~~-~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 360 ---GK---YN-FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp ---TC---CC-CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---CC---CC-CCchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 00 000000 112356889999999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=349.63 Aligned_cols=263 Identities=27% Similarity=0.417 Sum_probs=201.6
Q ss_pred ccccchHHHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeee
Q 048425 362 VKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGI 439 (780)
Q Consensus 362 ~~~f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~ 439 (780)
...+++.++....++|...+.||+|+||.||+|... +|+.||||++.... ...+++.+|+++++++ +|+||++++++
T Consensus 11 ~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 11 LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp -----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred chhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 344566666677899999999999999999999974 78999999997543 3457899999999999 89999999999
Q ss_pred eee------cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC
Q 048425 440 CIE------GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED 513 (780)
Q Consensus 440 ~~~------~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~ 513 (780)
+.. .+..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~ 164 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTE 164 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECT
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcC
Confidence 986 45789999999999999999642 2357899999999999999999999998 999999999999999
Q ss_pred CCCCeeecccccccccCCCccceeccccCccccCchhhc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc
Q 048425 514 DFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE 588 (780)
Q Consensus 514 ~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~-----~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~ 588 (780)
++.+||+|||++........ ......||..|+|||.+. +..++.++|||||||++|||++|+.||........
T Consensus 165 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~- 242 (326)
T 2x7f_A 165 NAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA- 242 (326)
T ss_dssp TCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-
T ss_pred CCCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-
Confidence 99999999999987653321 123456999999999987 56789999999999999999999999965432111
Q ss_pred hhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 589 NLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 589 ~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+... .. ...+.+. .......+.+++.+||+.||++||++.|+++
T Consensus 243 -~~~~----~~-------~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 243 -LFLI----PR-------NPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -HHHH----HH-------SCCCCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHHh----hc-------CccccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1000 00 0001110 1112346889999999999999999999976
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=346.25 Aligned_cols=262 Identities=25% Similarity=0.406 Sum_probs=187.2
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
.++|...+.||+|+||.||+|... +|+.||||++.... ....+++.+|++++++++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 478999999999999999999864 78999999986543 2344678999999999999999999999999999999999
Q ss_pred ecCCCChhhhccccc----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 452 LVHNGSVESHLHGVD----KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 452 y~~~GSL~~~L~~~~----~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
|+++++|.+++.... .....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 999999999986321 13456999999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCc----cceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccc
Q 048425 528 ATEGSQ----HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 528 ~~~~~~----~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
...... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ +.... .....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~---~~~~~ 245 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LMLTL---QNDPP 245 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHHH---TSSCC
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HHHHh---ccCCC
Confidence 654321 11234579999999999876 5789999999999999999999999976443211 11000 00000
Q ss_pred cc-ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 603 GL-EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 603 ~l-~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.. ....++..... ....+.+++.+||+.||++||++.|+++
T Consensus 246 ~~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 SLETGVQDKEMLKK----YGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CTTC-----CCCCC----CCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhhh----hhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00 01111111122 2346889999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=347.29 Aligned_cols=266 Identities=22% Similarity=0.316 Sum_probs=200.0
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeee--------c
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIE--------G 443 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--------~ 443 (780)
++|...+.||+|+||+||+|.. .+|+.||||++..... .....+.+|++++++++|+||+++++++.. +
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6789999999999999999998 4789999999865533 234678899999999999999999999987 3
Q ss_pred ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccc
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFG 523 (780)
+..++||||+++ +|.+.+. .....+++..++.|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 467999999975 7777775 33456999999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCC---ccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhh-ccc--
Q 048425 524 LAREATEGS---QHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTW-ARP-- 596 (780)
Q Consensus 524 LA~~~~~~~---~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~w-a~~-- 596 (780)
+++...... ........||+.|+|||.+.+ ..++.++|||||||++|||+||+.||.............. ...
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 998765322 112244578999999998876 4579999999999999999999999986543322111110 000
Q ss_pred --ccccccccc--cccCCccCCCCCh-hh------HHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 597 --LLTTREGLE--QLVDPSLAGSYDF-DD------MAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 597 --ll~~~~~l~--~lvDp~L~~~~~~-ee------~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+....... ............. +. ...+.+++.+|++.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 000000000 0000000000011 11 134789999999999999999999865
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=352.34 Aligned_cols=257 Identities=23% Similarity=0.379 Sum_probs=206.1
Q ss_pred HHHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--------chHHHHHHHHHhhhc-CCCceeeee
Q 048425 368 SDLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--------GDREFIAEVEMLSRL-HHRNLVKLI 437 (780)
Q Consensus 368 ~el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--------~~~~f~~Ei~iL~~L-~HpNIV~L~ 437 (780)
.......++|...+.||+|+||.||+|.+. +|+.||||++...... ..+.+.+|++++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344556688999999999999999999985 7999999998765421 134578999999999 899999999
Q ss_pred eeeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCC
Q 048425 438 GICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP 517 (780)
Q Consensus 438 g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~v 517 (780)
+++......++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 999999999999999999999999953 356999999999999999999999998 9999999999999999999
Q ss_pred eeecccccccccCCCccceeccccCccccCchhhcc------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhh
Q 048425 518 KVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT------GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV 591 (780)
Q Consensus 518 KLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~------~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv 591 (780)
||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... ...
T Consensus 240 kl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~ 314 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LML 314 (365)
T ss_dssp EECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH
T ss_pred EEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHH
Confidence 9999999987754332 244679999999999864 35788999999999999999999999653321 111
Q ss_pred hhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 592 TWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 592 ~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.. +.... .....+.. ......+.+++.+|++.||++||++.|+++
T Consensus 315 ~~---i~~~~---~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 315 RM---IMEGQ---YQFSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HH---HHHTC---CCCCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HH---HHhCC---CCCCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 10 00000 00000000 011246889999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=350.14 Aligned_cols=248 Identities=24% Similarity=0.358 Sum_probs=204.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||.||++... +++.||+|++..... ...+.+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 67889999999999999999975 588999999876532 23457899999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++++|.+++.. ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 121 e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 121 ELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp CCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999998853 357999999999999999999999998 99999999999999999999999999987653
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
... ......||..|+|||.+.+..++.++||||||+++|||++|+.||....... .+.. +... ..
T Consensus 194 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~----~~~~--------~~ 258 (335)
T 2owb_A 194 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TYLR----IKKN--------EY 258 (335)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHH----HHHT--------CC
T ss_pred Ccc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH--HHHH----HhcC--------CC
Confidence 322 2234569999999999999999999999999999999999999997543211 1100 0000 00
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.+ .......+.+++.+||+.||++||++.|+++.
T Consensus 259 ~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 SI----PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 11122467889999999999999999999763
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=352.01 Aligned_cols=253 Identities=23% Similarity=0.374 Sum_probs=201.6
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEE
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
..++|...+.||+|+||+||++... +|+.||||++++.... +.+|++++.++ +||||+++++++.+++..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3578999999999999999999976 6899999999765432 35688888888 7999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC----CCCeeecccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD----FTPKVSDFGLAR 526 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~----~~vKLsDFGLA~ 526 (780)
||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+++
T Consensus 96 E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999999999985 3457999999999999999999999998 9999999999998543 359999999998
Q ss_pred cccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 527 EATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 527 ~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........+... +....
T Consensus 169 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---i~~~~----- 239 (342)
T 2qr7_A 169 QLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR---IGSGK----- 239 (342)
T ss_dssp ECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH---HHHCC-----
T ss_pred cCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH---HccCC-----
Confidence 7654332 22345789999999999988899999999999999999999999975322211111111 11000
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
..+...+.......+.+++..|++.||++||++.|+++.
T Consensus 240 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 240 ---FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ---CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 001111112233567899999999999999999998764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.50 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=195.1
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHH-hhhcCCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEM-LSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~i-L~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
++|...+.||+|+||+||+++.+ +++.||||++++... ...+.+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 67899999999999999999986 688999999976542 233456777776 5778999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 118 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 118 LDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999953 346899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ..+..
T Consensus 191 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~---~~i~~---------- 253 (373)
T 2r5t_A 191 EHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMY---DNILN---------- 253 (373)
T ss_dssp CCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---HHH---HHHHH----------
T ss_pred cCCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHH---HHHHh----------
Confidence 3322 234567999999999999999999999999999999999999999754321 111 11111
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQAL 649 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L 649 (780)
..+ .+.......+.+++..|++.||++||++.+.++.+
T Consensus 254 ~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 254 KPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp SCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred ccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 101 11112234678999999999999999986544333
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=349.62 Aligned_cols=267 Identities=22% Similarity=0.275 Sum_probs=198.2
Q ss_pred HHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc-----chHHHHHHHHHhhhcCCCceeeeeeeeeecce
Q 048425 372 KATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN-----GDREFIAEVEMLSRLHHRNLVKLIGICIEGRT 445 (780)
Q Consensus 372 ~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~-----~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 445 (780)
...++|...+.||+|+||.||+|... +|+.||||+++..... ..+.+.+|++++++++|+||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999975 6899999998654321 13468899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccc
Q 048425 446 RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA 525 (780)
.++||||+++ +|.+++. .....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHH---hcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999986 8888885 34457999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccc----ccc
Q 048425 526 REATEGSQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL----LTT 600 (780)
Q Consensus 526 ~~~~~~~~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~l----l~~ 600 (780)
+....... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ +....... ...
T Consensus 160 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 160 KSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTPTEEQ 236 (346)
T ss_dssp STTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTT
T ss_pred eeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHcCCCChhh
Confidence 87654322 23445789999999998764 588999999999999999999999876442211 11110000 000
Q ss_pred ccccccccCCccCC---CCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 601 REGLEQLVDPSLAG---SYD-----FDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 601 ~~~l~~lvDp~L~~---~~~-----~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
......+.+..... ... ......+.+++..|++.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000000000000 001 1223578899999999999999999998653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=355.06 Aligned_cols=273 Identities=21% Similarity=0.272 Sum_probs=202.8
Q ss_pred HHHHhcCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeec-----
Q 048425 370 LEKATEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEG----- 443 (780)
Q Consensus 370 l~~at~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~----- 443 (780)
++...++|...+.||+|+||+||+|.. .+|+.||||++...... +.+|+++++.++|+||+++++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345668899999999999999999987 47999999998655332 33799999999999999999998543
Q ss_pred ---------------------------------ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHH
Q 048425 444 ---------------------------------RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY 490 (780)
Q Consensus 444 ---------------------------------~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~y 490 (780)
...++||||++ |+|.+.+.........+++..+..++.|+++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 23789999998 58888886554566789999999999999999999
Q ss_pred HhhCCCCcEEecccCCcceEEc-CCCCCeeecccccccccCCCccceeccccCccccCchhhccC-CCCchhhHHhHHHH
Q 048425 491 LHEDSNPRVIHRDFKASNVLLE-DDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVV 568 (780)
Q Consensus 491 LH~~~~p~IvHrDIKpsNILLd-~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVv 568 (780)
||+.+ |+||||||+|||++ +++.+||+|||+++....... .....||..|+|||.+.+. .++.++|||||||+
T Consensus 157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99998 99999999999998 689999999999987654432 2345689999999998775 58999999999999
Q ss_pred HHHHHhCCCCCCCCCccccchhhhhccccccc--------ccccccccCCccC-----CCCChhhHHHHHHHHHHccccC
Q 048425 569 LLELLSGRKPVDMSQPQGQENLVTWARPLLTT--------REGLEQLVDPSLA-----GSYDFDDMAKVAAIASMCVHPE 635 (780)
Q Consensus 569 LlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~--------~~~l~~lvDp~L~-----~~~~~ee~~~l~~La~~Cl~~d 635 (780)
+|||++|+.||......+ .+.......-.. .....+..-+.+. ..++......+.+++.+|++.|
T Consensus 232 l~ell~g~~pf~~~~~~~--~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 232 FGELILGKPLFSGETSID--QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 999999999997654322 111111100000 0000000001100 0011123356889999999999
Q ss_pred CCCCCCHHHHHH--HHHHHhh
Q 048425 636 VTHRPFMGEVVQ--ALKLIYN 654 (780)
Q Consensus 636 P~~RPsm~EVv~--~L~~i~~ 654 (780)
|++|||+.|+++ .++.+.+
T Consensus 310 P~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 310 PDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp GGGSCCHHHHHTSGGGHHHHH
T ss_pred hhhCCCHHHHhcCHHHHHHHh
Confidence 999999999985 3444443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=343.37 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=199.2
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
.++|+..+.||+|+||.||+|... +|+.||+|++........+.|.+|++++++++||||+++++++.+++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 478899999999999999999986 5899999999877666778899999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 98 CPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred CCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999863 3456999999999999999999999998 9999999999999999999999999986543211
Q ss_pred ccceeccccCccccCchhhc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 533 QHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~-----~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
.......||..|+|||++. +..++.++||||||+++|||++|+.|+....... .+.... ...
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~----~~~------ 238 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIA----KSD------ 238 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHH----HSC------
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHHHHh----ccC------
Confidence 1123356899999999884 6678999999999999999999999997543211 111110 000
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+.+ ..+......+.+++.+|++.||++||++.|+++
T Consensus 239 -~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 239 -PPTL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -CCCC--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -Cccc--CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000 011122356889999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=350.30 Aligned_cols=262 Identities=19% Similarity=0.260 Sum_probs=201.6
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcC--------CCceeeeeeeee----
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH--------HRNLVKLIGICI---- 441 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~--------HpNIV~L~g~~~---- 441 (780)
++|...+.||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|++++++++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 78999999999999999999864 6889999999643 233467899999999985 888999999987
Q ss_pred ecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCcEEecccCCcceEEcCCC-----
Q 048425 442 EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED-SNPRVIHRDFKASNVLLEDDF----- 515 (780)
Q Consensus 442 ~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~-~~p~IvHrDIKpsNILLd~~~----- 515 (780)
++...++||||+ +++|.+++.. .....+++..++.|+.||+.||+|||+. + |+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 556889999999 6666666643 2345799999999999999999999998 7 99999999999999775
Q ss_pred --------------------------------------------CCeeecccccccccCCCccceeccccCccccCchhh
Q 048425 516 --------------------------------------------TPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA 551 (780)
Q Consensus 516 --------------------------------------------~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l 551 (780)
.+||+|||+++..... .....||..|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 8999999999876543 2345689999999999
Q ss_pred ccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch----h---hhhcc--------------cccccccccccccCC
Q 048425 552 MTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN----L---VTWAR--------------PLLTTREGLEQLVDP 610 (780)
Q Consensus 552 ~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~----L---v~wa~--------------~ll~~~~~l~~lvDp 610 (780)
.+..++.++|||||||+||||+||+.||.......... + ..... ........+..+.+.
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 99999999999999999999999999997654322110 0 00000 000000000000000
Q ss_pred cc---------CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 611 SL---------AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 611 ~L---------~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.. ......+....+.+|+.+||+.||++|||+.|+++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 01234456678999999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=340.66 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=201.0
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
..++|...+.||+|+||.||+|... +|+.||||++.... ..+++.+|++++++++|+||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3578999999999999999999976 58999999997643 45679999999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++++|.+++.. ....+++..++.++.+++.||+|||+.+ |+||||||+||+++.++++||+|||++......
T Consensus 105 ~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999852 3457999999999999999999999998 999999999999999999999999999876543
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
.. ......||..|+|||.+.+..++.++||||||+++|||++|+.||........ +.. ... ...+.
T Consensus 179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~----~~~-------~~~~~ 244 (314)
T 3com_A 179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA--IFM----IPT-------NPPPT 244 (314)
T ss_dssp BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHH----HHH-------SCCCC
T ss_pred cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--HHH----Hhc-------CCCcc
Confidence 22 22345689999999999999999999999999999999999999975432111 000 000 00000
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 612 L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+ .........+.+++..|++.||++||++.|+++
T Consensus 245 ~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 F--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp C--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 001112356889999999999999999999976
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=335.87 Aligned_cols=247 Identities=24% Similarity=0.338 Sum_probs=196.1
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 67889999999999999999986 79999999986542 334567999999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 91 EYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp ECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred eccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999953 346899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccceeccccCccccCchhhccCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~-t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||+..... .+.... ... .
T Consensus 164 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~---~~~---~----- 227 (276)
T 2h6d_A 164 GEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFKKI---RGG---V----- 227 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHC---C-----
T ss_pred Ccc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHh---hcC---c-----
Confidence 322 234568999999999988765 58999999999999999999999753321 111110 000 0
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
..+ +......+.+++.+|++.||++||++.|+++.
T Consensus 228 ~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 FYI----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ccC----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 001 11123467899999999999999999999773
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=356.30 Aligned_cols=254 Identities=14% Similarity=0.092 Sum_probs=183.9
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc---chHHHHHHHHHhhhc--CCCceeeee-------eee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN---GDREFIAEVEMLSRL--HHRNLVKLI-------GIC 440 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L--~HpNIV~L~-------g~~ 440 (780)
..+|...+.||+|+||+||+|... +|+.||||+++..... ..+.+.+|+++++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 356888999999999999999975 7899999999876432 234577885555554 699988855 333
Q ss_pred eec-----------------ceeEEEEeecCCCChhhhcccccCCCCCCCHHHH------HHHHHHHHHHHHHHhhCCCC
Q 048425 441 IEG-----------------RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEAR------MKIALGAARGLAYLHEDSNP 497 (780)
Q Consensus 441 ~~~-----------------~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~r------l~Ia~qIA~gL~yLH~~~~p 497 (780)
... ...+|||||++ |+|.+++... ...+.+..+ +.++.||+.||+|||+.+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 322 34799999999 8999999743 234566667 888899999999999998
Q ss_pred cEEecccCCcceEEcCCCCCeeecccccccccCCCccceeccccCccccCchhhcc--CCCCchhhHHhHHHHHHHHHhC
Q 048425 498 RVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLSG 575 (780)
Q Consensus 498 ~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~--~~~t~ksDVySfGVvLlELlTG 575 (780)
|+||||||+|||+++++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||+||||+||
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999876432 124557799999999987 7899999999999999999999
Q ss_pred CCCCCCCCccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 576 RKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 576 r~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+.||....+.... .|....... .....+...........+.+++.+||+.||++||++.|+++
T Consensus 290 ~~Pf~~~~~~~~~---~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKG---SWKRPSLRV------PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTT---CCCBCCTTS------CCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCccccc---chhhhhhhh------ccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999765432211 111110000 00001100111123457889999999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=358.85 Aligned_cols=202 Identities=28% Similarity=0.428 Sum_probs=163.9
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcC-CCceeeeeeeeeecc--ee
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLH-HRNLVKLIGICIEGR--TR 446 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~--~~ 446 (780)
..++|...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++.++. |+||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999875 789999999865422 23456889999999997 999999999997544 67
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999997 689988853 46899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCC--------------------ccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 048425 527 EATEGS--------------------QHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQ 583 (780)
Q Consensus 527 ~~~~~~--------------------~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~ 583 (780)
...... ....+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 653311 112344679999999999886 678999999999999999999999997654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=364.02 Aligned_cols=193 Identities=26% Similarity=0.422 Sum_probs=154.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeec-----cee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEG-----RTR 446 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~~ 446 (780)
++|...+.||+|+||+||+|... +|+.||||++...... ..+.+.+|+++|++++|+|||++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 68999999999999999999875 7899999999654322 346789999999999999999999998543 568
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
++||||+ +|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++
T Consensus 133 ~lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 9999998 578998884 3457999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCc--------------------------cceeccccCccccCchhh-ccCCCCchhhHHhHHHHHHHHHhC
Q 048425 527 EATEGSQ--------------------------HISTRVMGTFGYVAPEYA-MTGHLLVKSDVYSYGVVLLELLSG 575 (780)
Q Consensus 527 ~~~~~~~--------------------------~~~t~~~GT~~Y~APE~l-~~~~~t~ksDVySfGVvLlELlTG 575 (780)
....... ...+..+||++|+|||++ ....++.++|||||||+||||+||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 7643211 122446789999999976 466799999999999999999994
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=347.71 Aligned_cols=271 Identities=23% Similarity=0.281 Sum_probs=195.1
Q ss_pred HHHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecce-
Q 048425 368 SDLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRT- 445 (780)
Q Consensus 368 ~el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~- 445 (780)
++.....++|...+.||+|+||+||+|... +|+.||||++..... ....+.+|++.++.++|+||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 445567789999999999999999999985 689999999865433 34567788999999999999999999976443
Q ss_pred ------eEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCcEEecccCCcceEEcC-CCC
Q 048425 446 ------RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH--EDSNPRVIHRDFKASNVLLED-DFT 516 (780)
Q Consensus 446 ------~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH--~~~~p~IvHrDIKpsNILLd~-~~~ 516 (780)
.++||||+++ +|.+.+.........+++..+..++.|++.||+||| +.+ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 7899999986 555555433345678999999999999999999999 777 999999999999997 899
Q ss_pred CeeecccccccccCCCccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcc
Q 048425 517 PKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWAR 595 (780)
Q Consensus 517 vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~ 595 (780)
+||+|||+++....... .....||..|+|||++.+. .++.++|||||||++|||+||+.||........ +....+
T Consensus 171 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~~ 246 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIVR 246 (360)
T ss_dssp EEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH
T ss_pred EEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHHHH
Confidence 99999999987754332 2345689999999998765 489999999999999999999999976543211 111111
Q ss_pred cccccccccccccCC----------------ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 596 PLLTTREGLEQLVDP----------------SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 596 ~ll~~~~~l~~lvDp----------------~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.............++ .+...........+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000000 0001112234567899999999999999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=367.04 Aligned_cols=263 Identities=23% Similarity=0.293 Sum_probs=195.1
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeec------c
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEG------R 444 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~ 444 (780)
.++|...+.||+|+||+||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999865 68999999997652 23346789999999999999999999998654 3
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccc
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGL 524 (780)
..++||||++++ |.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+
T Consensus 141 ~~~lv~E~~~~~-l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 569999999765 656553 24899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchh-hh--------hcc
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENL-VT--------WAR 595 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~L-v~--------wa~ 595 (780)
++...... ..+...||+.|+|||++.+..++.++|||||||+||||++|+.||......++... .. +..
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 211 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp C-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 98765432 23456799999999999999999999999999999999999999976542211100 00 000
Q ss_pred c-------ccccc-----cccccccCCccCCCCC---hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 596 P-------LLTTR-----EGLEQLVDPSLAGSYD---FDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 596 ~-------ll~~~-----~~l~~lvDp~L~~~~~---~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
. ..... ..+...+...+..... ......+.+|+.+||+.||++|||++|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00000 0000111111100000 1114568999999999999999999999763
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=369.93 Aligned_cols=252 Identities=26% Similarity=0.408 Sum_probs=206.6
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
.++|...++||+|+||+||+++.. +|+.||||++.+.. ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 368899999999999999999985 69999999997542 23456789999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++|+|.+++.........+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999754444567999999999999999999999998 9999999999999999999999999998775
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||........ .......+. .
T Consensus 341 ~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~----------~ 407 (543)
T 3c4z_A 341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVL----------E 407 (543)
T ss_dssp TTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHH----------H
T ss_pred CCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHh----------h
Confidence 44322 2345799999999999999999999999999999999999999975432111 111111111 1
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMG 643 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~ 643 (780)
... .++......+.+++..|++.||++||++.
T Consensus 408 ~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 408 QAV--TYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp CCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred ccc--CCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 100 11222335678999999999999999763
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=349.26 Aligned_cols=263 Identities=23% Similarity=0.373 Sum_probs=202.1
Q ss_pred HHHHHHhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecce
Q 048425 368 SDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRT 445 (780)
Q Consensus 368 ~el~~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 445 (780)
+++....++|...+.||+|+||.||+|...+ .||||+++.... ...+.|.+|++++++++|+||+++++++.+.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3344445789999999999999999998853 499999875432 233568899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccc
Q 048425 446 RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA 525 (780)
.++||||+++++|.+++.. ....+++..+++++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp EEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred eEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCc
Confidence 9999999999999999963 3457999999999999999999999998 99999999999998 679999999998
Q ss_pred ccccCCC----ccceeccccCccccCchhhcc---------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhh
Q 048425 526 REATEGS----QHISTRVMGTFGYVAPEYAMT---------GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVT 592 (780)
Q Consensus 526 ~~~~~~~----~~~~t~~~GT~~Y~APE~l~~---------~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~ 592 (780)
+...... ........||..|+|||.+.. ..++.++||||||+++|||++|+.||....... +..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~ 253 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---IIW 253 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH---HHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH
Confidence 7653211 112233468999999999874 457899999999999999999999997543211 110
Q ss_pred hcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 593 WARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 593 wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
.+.. -..+.+.. ......+.+++..||+.||++||++.||++.|+.+...
T Consensus 254 ---~~~~-------~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 254 ---QMGT-------GMKPNLSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp ---HHHT-------TCCCCCCC---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred ---Hhcc-------CCCCCCCc---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 0000 01111110 01123578899999999999999999999999887654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=358.66 Aligned_cols=261 Identities=25% Similarity=0.328 Sum_probs=196.8
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeec------ceeE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEG------RTRC 447 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~~~~ 447 (780)
.+|...+.||+|+||.||+|++. +|+.||||++..... .+.+|+++|++++|+|||+++++|... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999985 699999999865432 234799999999999999999998642 2357
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC-CCCeeecccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD-FTPKVSDFGLAR 526 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~-~~vKLsDFGLA~ 526 (780)
+||||+++ +|.+.+.........+++..+..++.||++||+|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 666666543345678999999999999999999999998 9999999999999965 568999999999
Q ss_pred cccCCCccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccc-cccc
Q 048425 527 EATEGSQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTT-REGL 604 (780)
Q Consensus 527 ~~~~~~~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~-~~~l 604 (780)
....... .....||..|+|||++.+. .++.++|||||||+||||++|+.||...... +.+......+-.. .+.+
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence 7654332 2345789999999998765 7899999999999999999999999764422 2222221110000 0000
Q ss_pred -------ccccCCccCC-----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 605 -------EQLVDPSLAG-----SYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 605 -------~~lvDp~L~~-----~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+...+.+.. .+.......+.+|+.+||+.||++||++.|+++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0111111110 011122357889999999999999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=337.09 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=202.7
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---------cchHHHHHHHHHhhhcC-CCceeeeeeeeee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---------NGDREFIAEVEMLSRLH-HRNLVKLIGICIE 442 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---------~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~ 442 (780)
.++|...+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+++++++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 378999999999999999999985 689999999975531 12346889999999995 9999999999999
Q ss_pred cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecc
Q 048425 443 GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDF 522 (780)
Q Consensus 443 ~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDF 522 (780)
++..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999953 356999999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCccceeccccCccccCchhhc------cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccc
Q 048425 523 GLAREATEGSQHISTRVMGTFGYVAPEYAM------TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARP 596 (780)
Q Consensus 523 GLA~~~~~~~~~~~t~~~GT~~Y~APE~l~------~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ 596 (780)
|++........ .....||..|+|||.+. ...++.++||||||+++|||++|+.||...... .... .
T Consensus 169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~---~ 240 (298)
T 1phk_A 169 GFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLR---M 240 (298)
T ss_dssp TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---H
T ss_pred cchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HHHH---H
Confidence 99987654322 23456899999999885 456789999999999999999999999653321 1111 0
Q ss_pred ccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 597 LLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 597 ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+.... .....+ ........+.+++.+|++.||++||++.|+++
T Consensus 241 ~~~~~---~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IMSGN---YQFGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHTC---CCCCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhcCC---cccCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 00000 000000 01123357889999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=340.19 Aligned_cols=262 Identities=21% Similarity=0.307 Sum_probs=203.0
Q ss_pred cCcccceeecccCceEEEEEEE--eCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCc------eeeeeeeeeeccee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM--DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN------LVKLIGICIEGRTR 446 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l--~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN------IV~L~g~~~~~~~~ 446 (780)
++|...+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+++++.++|+| ++++++++.+.+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 6899999999999999999986 368899999996432 23467889999999997665 99999999999999
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC-------------
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED------------- 513 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~------------- 513 (780)
++||||+ +++|.+++.. .....+++..+++++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKE--NGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEcCC-CCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 9999999 8999999964 23347899999999999999999999998 999999999999987
Q ss_pred ------CCCCeeecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCcccc
Q 048425 514 ------DFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ 587 (780)
Q Consensus 514 ------~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~ 587 (780)
++.+||+|||+++..... .....||..|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 678999999999875432 2345689999999999999999999999999999999999999976543221
Q ss_pred chhhhhc-cccc----c---cc-----------------cccccccCCccC-CCCChhhHHHHHHHHHHccccCCCCCCC
Q 048425 588 ENLVTWA-RPLL----T---TR-----------------EGLEQLVDPSLA-GSYDFDDMAKVAAIASMCVHPEVTHRPF 641 (780)
Q Consensus 588 ~~Lv~wa-~~ll----~---~~-----------------~~l~~lvDp~L~-~~~~~ee~~~l~~La~~Cl~~dP~~RPs 641 (780)
....... .+.. . .. ........+... ..........+.+++.+|++.||++|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 1111000 0000 0 00 000000000000 0112344577899999999999999999
Q ss_pred HHHHHH
Q 048425 642 MGEVVQ 647 (780)
Q Consensus 642 m~EVv~ 647 (780)
+.|+++
T Consensus 323 ~~ell~ 328 (339)
T 1z57_A 323 LREALK 328 (339)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=371.31 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=207.3
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
.++|...++||+|+||.||+|... +|+.||||++.+.. ......+.+|+++|++++|||||++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999975 79999999997642 33456789999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++|+|.+++.. .....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++...
T Consensus 263 mEy~~gg~L~~~l~~--~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHS--SSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999964 23345999999999999999999999998 9999999999999999999999999998875
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCcccc-chhhhhccccccccccccccc
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ-ENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~-~~Lv~wa~~ll~~~~~l~~lv 608 (780)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+.... ...
T Consensus 338 ~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i---~~~-------- 404 (576)
T 2acx_A 338 EGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV---KEV-------- 404 (576)
T ss_dssp TTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH---HHC--------
T ss_pred cCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh---hcc--------
Confidence 5432 2345799999999999999999999999999999999999999976432211 1111100 000
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRP-----FMGEVVQ 647 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv~ 647 (780)
. ..++......+.+++..|++.||++|| +++||++
T Consensus 405 ~----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 P----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred c----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0 111222235788999999999999999 6777754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=340.32 Aligned_cols=266 Identities=24% Similarity=0.354 Sum_probs=202.2
Q ss_pred HhcCcccceeecccCceEEEEEEE--eCCcEEEEEEeeccCC--cchHHHHHHHHHhhhc---CCCceeeeeeeee----
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVM--DNGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRL---HHRNLVKLIGICI---- 441 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l--~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~---- 441 (780)
+.++|...+.||+|+||.||+|.. .+|+.||||+++.... .....+.+|+++++++ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 4688999999875432 2234677888888776 8999999999987
Q ss_pred -ecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeee
Q 048425 442 -EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVS 520 (780)
Q Consensus 442 -~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLs 520 (780)
.....++||||++ |+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999998 6999998642 3345999999999999999999999998 9999999999999999999999
Q ss_pred cccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc-hhh--------
Q 048425 521 DFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE-NLV-------- 591 (780)
Q Consensus 521 DFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~-~Lv-------- 591 (780)
|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||......... .+.
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 999998764322 224457899999999999999999999999999999999999999765432111 010
Q ss_pred -hhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 592 -TWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 592 -~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.|..................+ ..+.......+.+++.+||+.||++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCccccccchhhhcccCcchh-hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111000000000000000000 0111223356789999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=345.08 Aligned_cols=261 Identities=20% Similarity=0.321 Sum_probs=200.8
Q ss_pred ccchHHHHHHhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCc--chHHHHHHHHHhhhcC--CCceeeeeee
Q 048425 364 TFALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLH--HRNLVKLIGI 439 (780)
Q Consensus 364 ~f~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~--HpNIV~L~g~ 439 (780)
.+.++.+....++|...+.||+|+||.||++...+|+.||||++...... ..+.|.+|++++.+++ |+||++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 34444444456789999999999999999999988999999999765332 3467899999999997 5999999999
Q ss_pred eeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCee
Q 048425 440 CIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKV 519 (780)
Q Consensus 440 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKL 519 (780)
+.+++..++||| +.+++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++ +.+||
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEE
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEE
Confidence 999999999999 668999999953 357899999999999999999999998 999999999999965 89999
Q ss_pred ecccccccccCCCcc-ceeccccCccccCchhhcc-----------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCcccc
Q 048425 520 SDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMT-----------GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ 587 (780)
Q Consensus 520 sDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~-----------~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~ 587 (780)
+|||+++........ ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||.......
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 246 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI- 246 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-
Confidence 999999876543322 2234569999999999875 478899999999999999999999996432110
Q ss_pred chhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 588 ENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 588 ~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
. .+..+.++.....+.......+.+++.+||+.||++||++.|+++.
T Consensus 247 ~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 247 S--------------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp H--------------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H--------------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 0 1111222222112222223568899999999999999999999764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=357.09 Aligned_cols=199 Identities=27% Similarity=0.403 Sum_probs=167.9
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeec-----ce
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEG-----RT 445 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~ 445 (780)
.++|...+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+++|++++|+||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 368999999999999999999975 688999999976432 2346789999999999999999999999776 56
Q ss_pred eEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccc
Q 048425 446 RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA 525 (780)
.++||||+. |+|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999986 69999985 3457999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCc---------------------cceeccccCccccCchhh-ccCCCCchhhHHhHHHHHHHHHhCCCCCC
Q 048425 526 REATEGSQ---------------------HISTRVMGTFGYVAPEYA-MTGHLLVKSDVYSYGVVLLELLSGRKPVD 580 (780)
Q Consensus 526 ~~~~~~~~---------------------~~~t~~~GT~~Y~APE~l-~~~~~t~ksDVySfGVvLlELlTGr~P~~ 580 (780)
+....... ...+...||++|+|||++ ....++.++|||||||+||||++|..|+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 87654321 112556799999999986 56679999999999999999998766553
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=361.96 Aligned_cols=264 Identities=21% Similarity=0.321 Sum_probs=209.8
Q ss_pred hcCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCC-CceeeeeeeeeecceeEEEEe
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHH-RNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H-pNIV~L~g~~~~~~~~~LV~E 451 (780)
.++|...++||+|+||.||+|.. .+|+.||||+++.... ..++.+|+++++.++| ++|..+..++.+++..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 36899999999999999999996 4799999998865433 3458899999999976 566666677777888899999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE---cCCCCCeeecccccccc
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREA 528 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL---d~~~~vKLsDFGLA~~~ 528 (780)
|+ +++|.+++.. ....+++..++.|+.||+.||+|||+.+ |+||||||+|||| ++++.+||+|||+++..
T Consensus 84 ~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 9999999963 3457999999999999999999999998 9999999999999 68899999999999977
Q ss_pred cCCCcc------ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccc
Q 048425 529 TEGSQH------ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 529 ~~~~~~------~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
...... ......||..|+|||++.+..++.++|||||||+||||++|+.||................. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~---~-- 231 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---K-- 231 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH---H--
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh---c--
Confidence 654321 12356799999999999999999999999999999999999999976543222221111100 0
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
.+...++ .+...+ ...+.+++..||+.+|++||++.+|++.|+.+....
T Consensus 232 ~~~~~~~-~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 232 KVATSIE-ALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHSCHH-HHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cccccHH-HHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 0000000 011111 247889999999999999999999999999987643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.47 Aligned_cols=257 Identities=20% Similarity=0.293 Sum_probs=199.8
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcchHHHHHHHHHhhhcC-CCceeeeeeeeee--cceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH-HRNLVKLIGICIE--GRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~--~~~~~LV~ 450 (780)
++|+..+.||+|+||+||+|.. .+|+.||||+++. ...+.+.+|++++++++ |+||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6789999999999999999986 4789999999864 34578999999999997 9999999999987 56789999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC-CCeeeccccccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF-TPKVSDFGLAREAT 529 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~-~vKLsDFGLA~~~~ 529 (780)
||+++++|.+++. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 113 e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999884 3889999999999999999999998 99999999999999776 89999999998765
Q ss_pred CCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccc----------
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLL---------- 598 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll---------- 598 (780)
.... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ..+.......-
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHHHHhcCCchhhhHHHH
Confidence 4332 234568999999999887 678999999999999999999999995433211 11111100000
Q ss_pred ---ccccccccccC--------CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 599 ---TTREGLEQLVD--------PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 599 ---~~~~~l~~lvD--------p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
........+.. ..............+.+++..|++.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000000 00111111123467899999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=340.38 Aligned_cols=252 Identities=24% Similarity=0.332 Sum_probs=196.8
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--------cchHHHHHHHHHhhhcCCCceeeeeeeeeec
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--------NGDREFIAEVEMLSRLHHRNLVKLIGICIEG 443 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~ 443 (780)
..++|...+.||+|+||.||+|... +|+.||||++..... .....|.+|++++++++|+||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3468999999999999999999975 688999999865421 1224588999999999999999999998765
Q ss_pred ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC---Ceee
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT---PKVS 520 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~---vKLs 520 (780)
+ .++||||+++|+|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence 4 899999999999999985 3457999999999999999999999998 999999999999987654 9999
Q ss_pred cccccccccCCCccceeccccCccccCchhhc---cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccc
Q 048425 521 DFGLAREATEGSQHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL 597 (780)
Q Consensus 521 DFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~---~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~l 597 (780)
|||+++...... ......||..|+|||++. ...++.++|||||||++|||++|+.||...... ..+......
T Consensus 160 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~- 234 (322)
T 2ycf_A 160 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQITS- 234 (322)
T ss_dssp CCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS--SCHHHHHHH-
T ss_pred cCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH--HHHHHHHHh-
Confidence 999998765432 223456999999999874 567899999999999999999999999754321 111111100
Q ss_pred cccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 598 LTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 598 l~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.. .. ..+.... .....+.+++.+|++.||++||++.|+++
T Consensus 235 --~~--~~--~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 --GK--YN--FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --TC--CC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --Cc--cc--cCchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00 00 0000001 12356889999999999999999999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=335.14 Aligned_cols=251 Identities=23% Similarity=0.305 Sum_probs=198.8
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC----CcchHHHHHHHHHhhhcCCCceeeeeeeee--eccee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN----QNGDREFIAEVEMLSRLHHRNLVKLIGICI--EGRTR 446 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~--~~~~~ 446 (780)
.++|...+.||+|+||.||++... +++.||||+++... ....+.+.+|++++++++|+||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999975 68999999997542 234567999999999999999999999984 44578
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
++||||++++ |.+++.. .....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDS--VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHH--STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHh--CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999877 7777653 23457999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCC-ccceeccccCccccCchhhccCCC--CchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccc
Q 048425 527 EATEGS-QHISTRVMGTFGYVAPEYAMTGHL--LVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREG 603 (780)
Q Consensus 527 ~~~~~~-~~~~t~~~GT~~Y~APE~l~~~~~--t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~ 603 (780)
...... ........||..|+|||.+.+... +.++||||||+++|||++|+.||....... +.. .+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~i~~~~-- 229 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK---LFE---NIGKGS-- 229 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH---HHHHCC--
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH---HHH---HHhcCC--
Confidence 765322 222344569999999999876543 789999999999999999999997543211 110 000000
Q ss_pred cccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 604 LEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 604 l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.. ........+.+++.+|++.||++||++.|+++.
T Consensus 230 ------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 ------YA----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ------CC----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------CC----CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01 111223567899999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.81 Aligned_cols=252 Identities=23% Similarity=0.390 Sum_probs=194.0
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeee---------
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIE--------- 442 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--------- 442 (780)
..++|+..+.||+|+||.||+|... +|+.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3578999999999999999999975 7899999999653 2344678999999999999999999998865
Q ss_pred ----cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCe
Q 048425 443 ----GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPK 518 (780)
Q Consensus 443 ----~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vK 518 (780)
.+..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 4567999999999999999963 3456788999999999999999999998 99999999999999999999
Q ss_pred eecccccccccCCC-------------ccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCc
Q 048425 519 VSDFGLAREATEGS-------------QHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQP 584 (780)
Q Consensus 519 LsDFGLA~~~~~~~-------------~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~ 584 (780)
|+|||+++...... ........||..|+|||.+.+. .++.++|||||||++|||++ |+....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~- 232 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM- 232 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-
Confidence 99999998764321 1112345689999999998764 78999999999999999998 443210
Q ss_pred cccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 585 QGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 585 ~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
....+... +.. ....+...+.......+.+++.+|++.||++||++.|+++
T Consensus 233 -~~~~~~~~---~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 -ERVNILKK---LRS--------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -HHHHHHHH---HHS--------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hHHHHHHh---ccc--------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11111111 000 0111122233444567889999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=361.67 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=199.1
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
.++|...+.||+|+||+||+|... ++..||||++.... ......+.+|++++++++||||++++++|.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467899999999999999999976 78999999997653 334567999999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC---CCCCeeeccccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED---DFTPKVSDFGLARE 527 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~---~~~vKLsDFGLA~~ 527 (780)
||+++|+|.+++.. ...+++..+..|+.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 116 e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999998853 356999999999999999999999998 999999999999976 45599999999987
Q ss_pred ccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 528 ATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 528 ~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
...... .....||+.|+|||++. +.++.++|||||||++|||++|+.||....... +... +.... ...
T Consensus 189 ~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~---i~~~~---~~~ 256 (494)
T 3lij_A 189 FENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---ILRK---VEKGK---YTF 256 (494)
T ss_dssp CBTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH---HHHTC---CCC
T ss_pred CCCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HHhCC---CCC
Confidence 754322 24457999999999876 578999999999999999999999997543321 1110 00000 000
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
..+.. . .....+.+++..||+.+|++|||+.|+++.
T Consensus 257 ~~~~~-~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 257 DSPEW-K----NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CSGGG-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred Cchhc-c----cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 01111 1 122467899999999999999999999863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=361.59 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=204.9
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
.++|...+.||+|+||.||++... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367899999999999999999976 78999999997543 33457799999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE---cCCCCCeeecccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAR 526 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL---d~~~~vKLsDFGLA~ 526 (780)
|||+.+|+|.+++. ....+++..+..|+.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 105 ~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999985 3457999999999999999999999998 9999999999999 567899999999998
Q ss_pred cccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 527 EATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 527 ~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
....... .....||+.|+|||.+.+ .++.++|||||||++|||++|+.||....... +...+ ..... .
T Consensus 178 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i---~~~~~---~ 245 (484)
T 3nyv_A 178 HFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---ILKKV---EKGKY---T 245 (484)
T ss_dssp HBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HHCCC---C
T ss_pred Ecccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH---HcCCC---C
Confidence 7755432 234569999999998865 68999999999999999999999997643221 11110 00000 0
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
...+. .......+.+++.+|++.+|++|||+.|+++.
T Consensus 246 ~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 246 FELPQ-----WKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CCSGG-----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00000 01223567899999999999999999999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=377.35 Aligned_cols=263 Identities=26% Similarity=0.391 Sum_probs=208.5
Q ss_pred HHHHHhcCcccceeecccCceEEEEEEEe----CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeec
Q 048425 369 DLEKATEKFSSKRILGEGGFGCVYHGVMD----NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEG 443 (780)
Q Consensus 369 el~~at~~f~~~~~LG~G~fG~VYkg~l~----~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~ 443 (780)
+++...++|...+.||+|+||+||+|.+. .+..||||+++..... ..+.|.+|+.++++++||||+++++++.+
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE- 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence 33344578999999999999999999874 2567999998754332 33679999999999999999999999854
Q ss_pred ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccc
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFG 523 (780)
+..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence 568999999999999999963 3456999999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccc
Q 048425 524 LAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 524 LA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
+++..............||+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+..... . ..
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i~---~-~~ 609 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIE---N-GE 609 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH---H-TC
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH---c-CC
Confidence 998875544333344567889999999999999999999999999999997 99999754321 1111110 0 00
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
.. ..+......+.+++.+||+.||++||++.||++.|+.+.+.
T Consensus 610 ------~~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 610 ------RL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CC----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 00 11122335788999999999999999999999999988653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=340.38 Aligned_cols=263 Identities=22% Similarity=0.338 Sum_probs=194.2
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeee------------
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICI------------ 441 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~------------ 441 (780)
++|...+.||+|+||.||+|... +|+.||||++........+++.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 67889999999999999999986 58999999997766555678999999999999999999999873
Q ss_pred --ecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc-CCCCCe
Q 048425 442 --EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE-DDFTPK 518 (780)
Q Consensus 442 --~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd-~~~~vK 518 (780)
+....++||||++ |+|.+++. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467799999997 69999984 246899999999999999999999998 99999999999997 577999
Q ss_pred eecccccccccCCCc--cceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcc
Q 048425 519 VSDFGLAREATEGSQ--HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWAR 595 (780)
Q Consensus 519 LsDFGLA~~~~~~~~--~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~ 595 (780)
|+|||+++....... .......||..|+|||.+.+ ..++.++||||||+++|||+||+.||................
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999987643221 11234567999999998875 788999999999999999999999997654321111000000
Q ss_pred ccccccccccccc-------CCccC-CCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 596 PLLTTREGLEQLV-------DPSLA-GSYD-----FDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 596 ~ll~~~~~l~~lv-------Dp~L~-~~~~-----~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+..... ...++. ..... .... ......+.+++.+|++.||++||+++|+++
T Consensus 242 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 242 PVVHEE-DRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCCHH-HHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCchh-hhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000000 000000 00000 0000 112357889999999999999999999976
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=356.03 Aligned_cols=199 Identities=23% Similarity=0.335 Sum_probs=173.3
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhc------CCCceeeeeeeeeeccee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRL------HHRNLVKLIGICIEGRTR 446 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L------~HpNIV~L~g~~~~~~~~ 446 (780)
..+|...+.||+|+||+||+|... +++.||||+++.. ....+++.+|+++++.+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 357899999999999999999875 6899999999653 22346788899988887 577999999999999999
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC--Ceeecccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT--PKVSDFGL 524 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~--vKLsDFGL 524 (780)
++||||+. ++|.+++.. .....+++..+.+|+.||+.||+|||+.+ |+||||||+||||+.++. +||+|||+
T Consensus 175 ~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKK--NKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEECCCC-CBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEeccC-CCHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999996 699999864 23346999999999999999999999998 999999999999999987 99999999
Q ss_pred cccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQ 583 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~ 583 (780)
++..... .....||+.|+|||++.+..++.++|||||||+||||+||+.||....
T Consensus 249 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 249 SCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9765432 234578999999999999999999999999999999999999997654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=377.17 Aligned_cols=243 Identities=23% Similarity=0.326 Sum_probs=202.8
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeecc---CCcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRN---NQNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~L 448 (780)
.++|...++||+|+||+||+|... +|+.||||++++. .....+.+..|.+++..+ +|+||+++++++.+.+..+|
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 478999999999999999999975 6889999999754 233456788999999988 79999999999999999999
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||+++|+|.++|.. ...+++..++.++.||+.||+|||+.+ ||||||||+||||++++++||+|||+++..
T Consensus 420 V~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999963 346999999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 529 TEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 529 ~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
..... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...... .+. ..+.
T Consensus 493 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~~~-------------~~i~ 555 (674)
T 3pfq_A 493 IWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELF-------------QSIM 555 (674)
T ss_dssp CCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH-------------HHHH
T ss_pred ccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---HHH-------------HHHH
Confidence 43322 234567999999999999999999999999999999999999999754321 111 1111
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFM 642 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm 642 (780)
...+ .++......+.+|+..||+.||++||++
T Consensus 556 ~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 556 EHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp SSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred hCCC--CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 1111 1222233578899999999999999998
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=358.99 Aligned_cols=251 Identities=26% Similarity=0.367 Sum_probs=202.0
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
.++|...+.||+|+||+||++... +|+.||||++.... ......+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 367999999999999999999975 78999999986542 334578999999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc---CCCCCeeeccccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE---DDFTPKVSDFGLARE 527 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd---~~~~vKLsDFGLA~~ 527 (780)
||+++|+|.+++.. ...+++..+..|+.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999998853 346999999999999999999999998 99999999999995 566899999999987
Q ss_pred ccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 528 ATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 528 ~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
...... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||....... +... +..... ..
T Consensus 174 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~---i~~~~~---~~ 241 (486)
T 3mwu_A 174 FQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKR---VETGKY---AF 241 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH---HHHTCC---CS
T ss_pred CCCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HHhCCC---CC
Confidence 654322 234579999999998875 58999999999999999999999997543211 1110 000000 00
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
..+. .......+.+++..||+.||++|||+.|+++.
T Consensus 242 ~~~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 DLPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CSGG-----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCcc-----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 01123467899999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=360.17 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=200.8
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-------------cchHHHHHHHHHhhhcCCCceeeeee
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-------------NGDREFIAEVEMLSRLHHRNLVKLIG 438 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-------------~~~~~f~~Ei~iL~~L~HpNIV~L~g 438 (780)
..++|...+.||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999975 688999999875431 23467999999999999999999999
Q ss_pred eeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC---
Q 048425 439 ICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF--- 515 (780)
Q Consensus 439 ~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~--- 515 (780)
++.++...++||||+++|+|.+++.. ...+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999999853 356999999999999999999999998 99999999999998776
Q ss_pred CCeeecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcc
Q 048425 516 TPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWAR 595 (780)
Q Consensus 516 ~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~ 595 (780)
.+||+|||+++....... .....||+.|+|||.+. +.++.++|||||||++|||++|+.||....... +...
T Consensus 187 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~-- 258 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD---IIKK-- 258 (504)
T ss_dssp SEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH--
T ss_pred cEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH--
Confidence 699999999987755322 24456999999999876 568999999999999999999999997543221 1110
Q ss_pred cccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 596 PLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 596 ~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
+..... ..+..... .....+.+++..|++.||++|||+.|+++.
T Consensus 259 -i~~~~~----~~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 259 -VEKGKY----YFDFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp -HHHCCC----CCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHcCCC----CCCccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000 00000000 112468899999999999999999999763
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=347.90 Aligned_cols=260 Identities=23% Similarity=0.362 Sum_probs=195.0
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecc------
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGR------ 444 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------ 444 (780)
.++|...+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++|+||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 368999999999999999999974 7999999998654322 2357899999999999999999999997653
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccc
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGL 524 (780)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 8899999853 46899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchh-hh--------hc
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENL-VT--------WA 594 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~L-v~--------wa 594 (780)
++..... .+...||..|+|||.+.+ ..++.++|||||||++|||++|+.||.......+... .. +.
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9876432 234578999999999887 7899999999999999999999999976543211110 00 00
Q ss_pred cccccc--cc---ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 595 RPLLTT--RE---GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 595 ~~ll~~--~~---~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..+... .. .+.......+. .........+.+++.+|++.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000000 00 00000000110 011122356889999999999999999999876
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=341.01 Aligned_cols=256 Identities=24% Similarity=0.364 Sum_probs=180.6
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc-chHHHHHHHH-HhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN-GDREFIAEVE-MLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~-iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
++|...+.||+|+||.||+|... +|+.||||+++..... ...++..|+. +++.++|+||+++++++.+++..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 67888999999999999999985 7899999999765332 2345666666 7777899999999999999999999999
Q ss_pred ecCCCChhhhccccc-CCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 452 LVHNGSVESHLHGVD-KNRGPLDWEARMKIALGAARGLAYLHED-SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 452 y~~~GSL~~~L~~~~-~~~~~L~~~~rl~Ia~qIA~gL~yLH~~-~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|+++ +|.+++.... .....+++..+.+++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9985 8877775321 2356799999999999999999999998 7 9999999999999999999999999998765
Q ss_pred CCCccceeccccCccccCchhh----ccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccc
Q 048425 530 EGSQHISTRVMGTFGYVAPEYA----MTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLE 605 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l----~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~ 605 (780)
.... .....||..|+|||.+ .+..++.++||||||+++|||++|+.||...... ..........
T Consensus 178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~----- 245 (327)
T 3aln_A 178 DSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-----FDQLTQVVKG----- 245 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCCS-----
T ss_pred cccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-----HHHHHHHhcC-----
Confidence 4322 2334699999999998 4667899999999999999999999999643211 0111111110
Q ss_pred cccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 606 QLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 606 ~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
..+.+...........+.+++.+||+.||++||++.||++.
T Consensus 246 --~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 246 --DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp --CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 00111111112233578899999999999999999999773
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=343.60 Aligned_cols=262 Identities=24% Similarity=0.319 Sum_probs=200.5
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeec-----cee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEG-----RTR 446 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~~ 446 (780)
.++|+..+.||+|+||.||+|... +++.||||++...... ..+.+.+|++++.+++|+||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999875 7889999999754332 236789999999999999999999998754 367
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
++||||+. |+|.+++.. ..+++..+..|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999997 589998852 35999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCcc--ceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchh-hhhcccc-----
Q 048425 527 EATEGSQH--ISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENL-VTWARPL----- 597 (780)
Q Consensus 527 ~~~~~~~~--~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~L-v~wa~~l----- 597 (780)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... .......
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 76543222 1244579999999998764 4589999999999999999999999976543322111 0000000
Q ss_pred ---cc--cccccccccCCccCCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 598 ---LT--TREGLEQLVDPSLAGSYD-----FDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 598 ---l~--~~~~l~~lvDp~L~~~~~-----~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.. .......+..+ .... ......+.+++.+|++.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHK---NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HTCCCHHHHHHHHTSCCC---CCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhhhhHHHHHHhcCCc---cCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 00000000000 0011 112346889999999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=344.96 Aligned_cols=260 Identities=23% Similarity=0.293 Sum_probs=192.1
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecc------e
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGR------T 445 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------~ 445 (780)
++|...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 68999999999999999999875 689999999976432 23356889999999999999999999997654 6
Q ss_pred eEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccc
Q 048425 446 RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA 525 (780)
.++||||++ |+|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 105 VYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred eEEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 799999997 57888774 24899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccc-------
Q 048425 526 REATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLL------- 598 (780)
Q Consensus 526 ~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll------- 598 (780)
+...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||........ +......+.
T Consensus 175 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 175 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHC-CCCCCHHHH
T ss_pred ccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHH
Confidence 8765432 22445799999999999999999999999999999999999999976442211 000000000
Q ss_pred -----------cc-----ccccccccCCccCCCCC---hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 599 -----------TT-----REGLEQLVDPSLAGSYD---FDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 599 -----------~~-----~~~l~~lvDp~L~~~~~---~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
.. ...+..+....+..... ......+.+++.+|++.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00 00001111111100000 1224578999999999999999999999773
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=344.84 Aligned_cols=265 Identities=23% Similarity=0.268 Sum_probs=198.2
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeec-----cee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEG-----RTR 446 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~~ 446 (780)
.++|...+.||+|+||.||+|... +|+.||||+++.... .....+.+|++++++++|+||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 478999999999999999999975 689999999965432 2345788999999999999999999998754 678
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
++||||+. |+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 689998853 46999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCcc---------ceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhh-hhcc
Q 048425 527 EATEGSQH---------ISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV-TWAR 595 (780)
Q Consensus 527 ~~~~~~~~---------~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv-~wa~ 595 (780)
........ ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||............ ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 76533211 1123578999999998765 77899999999999999999999999765422111000 0000
Q ss_pred ccc-----c--cccccccccCCcc-CCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 596 PLL-----T--TREGLEQLVDPSL-AGSYD-----FDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 596 ~ll-----~--~~~~l~~lvDp~L-~~~~~-----~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
... . ......+.+.... ..... ......+.+++.+|++.||++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 0 0000000000000 00000 112356789999999999999999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=349.53 Aligned_cols=261 Identities=22% Similarity=0.298 Sum_probs=195.4
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecce------eEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRT------RCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~------~~L 448 (780)
.+|...+.||+|+||+||+|+..++..||+|++...... ..+|+++++.++|+||+++++++..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 578899999999999999999987777999988654332 2369999999999999999999865433 789
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc-CCCCCeeeccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE-DDFTPKVSDFGLARE 527 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd-~~~~vKLsDFGLA~~ 527 (780)
||||++++.+. .+.........+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+||+|||+++.
T Consensus 116 v~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 116 VLEYVPETVYR-ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEECCSEEHHH-HHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeeccCccHHH-HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999875443 33322234567999999999999999999999998 99999999999999 799999999999987
Q ss_pred ccCCCccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccc-ccccc
Q 048425 528 ATEGSQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTT-REGLE 605 (780)
Q Consensus 528 ~~~~~~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~-~~~l~ 605 (780)
....... ....||+.|+|||.+.+. .++.++|||||||++|||++|+.||....... .+......+-.. .+.+.
T Consensus 192 ~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 192 LIAGEPN--VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CCTTCCC--CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHH
T ss_pred ccCCCCC--cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHH
Confidence 7544322 345689999999998765 58999999999999999999999997654321 111111100000 00000
Q ss_pred c----ccC---CccC-----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 606 Q----LVD---PSLA-----GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 606 ~----lvD---p~L~-----~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
. ..+ +... ..+.......+.+++.+||+.||++||++.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0 000 0000 0011123357889999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=337.85 Aligned_cols=244 Identities=23% Similarity=0.372 Sum_probs=191.9
Q ss_pred HHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc------chHHHHHHHHHhhhc----CCCceeeeee
Q 048425 370 LEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN------GDREFIAEVEMLSRL----HHRNLVKLIG 438 (780)
Q Consensus 370 l~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L----~HpNIV~L~g 438 (780)
.+...++|...+.||+|+||.||+|... +|+.||||+++..... ....+.+|++++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3445688999999999999999999864 7899999999765332 223467799999998 8999999999
Q ss_pred eeeecceeEEEEee-cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc-CCCC
Q 048425 439 ICIEGRTRCLVYEL-VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE-DDFT 516 (780)
Q Consensus 439 ~~~~~~~~~LV~Ey-~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd-~~~~ 516 (780)
++.+.+..++|+|| +.+++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++ +++.
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence 99998999999999 789999999963 346999999999999999999999998 99999999999999 8899
Q ss_pred CeeecccccccccCCCccceeccccCccccCchhhccCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcc
Q 048425 517 PKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWAR 595 (780)
Q Consensus 517 vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t-~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~ 595 (780)
+||+|||+++...... .....||..|+|||++.+..+. .++||||||+++|||++|+.||.... ....
T Consensus 179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~--- 247 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EILE--- 247 (312)
T ss_dssp EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH---
T ss_pred EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HHhh---
Confidence 9999999998775432 2345699999999999877765 59999999999999999999986321 1100
Q ss_pred cccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 596 PLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 596 ~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.. . .+.......+.+++.+|++.||++||++.|+++
T Consensus 248 ----~~--------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 248 ----AE--------L----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ----TC--------C----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----hc--------c----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0 011122346789999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=344.23 Aligned_cols=262 Identities=20% Similarity=0.291 Sum_probs=198.6
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCCcchHHHHHHHHHhhhcC-----------CCceeeeeeeeee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH-----------HRNLVKLIGICIE 442 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-----------HpNIV~L~g~~~~ 442 (780)
++|...+.||+|+||+||+|.. .+|+.||||++... ....+.+.+|++++++++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 6789999999999999999997 47899999999643 223467889999999886 8999999999886
Q ss_pred cc----eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCcEEecccCCcceEEc-----
Q 048425 443 GR----TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED-SNPRVIHRDFKASNVLLE----- 512 (780)
Q Consensus 443 ~~----~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~-~~p~IvHrDIKpsNILLd----- 512 (780)
.+ ..++||||+ +++|.+++... ....+++..+++|+.||+.||+|||+. + |+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 54 789999999 99999999642 344699999999999999999999998 7 99999999999994
Q ss_pred -CCCCCeeecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc---
Q 048425 513 -DDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE--- 588 (780)
Q Consensus 513 -~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~--- 588 (780)
+++.+||+|||+++...... ....||+.|+|||.+.+..++.++|||||||++|||+||+.||.........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 44589999999998765432 3456899999999999999999999999999999999999999754322110
Q ss_pred -hh---hhhccc--------------ccccccccccccCCc---------cCCCCChhhHHHHHHHHHHccccCCCCCCC
Q 048425 589 -NL---VTWARP--------------LLTTREGLEQLVDPS---------LAGSYDFDDMAKVAAIASMCVHPEVTHRPF 641 (780)
Q Consensus 589 -~L---v~wa~~--------------ll~~~~~l~~lvDp~---------L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs 641 (780)
.+ ...... .......+..+.... -...++......+.+++..||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 00 000000 000000000000000 001234456678999999999999999999
Q ss_pred HHHHHH
Q 048425 642 MGEVVQ 647 (780)
Q Consensus 642 m~EVv~ 647 (780)
+.|+++
T Consensus 328 ~~ell~ 333 (373)
T 1q8y_A 328 AGGLVN 333 (373)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999965
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=329.56 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=202.2
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
..++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3478999999999999999999986 78999999987643 33457899999999999999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC---CCCeeecccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD---FTPKVSDFGLAR 526 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~---~~vKLsDFGLA~ 526 (780)
+||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.+ +.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 999999999998853 346899999999999999999999998 9999999999999754 479999999998
Q ss_pred cccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 527 EATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 527 ~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
....... .....||..|+|||.+.+ .++.++||||||+++|||++|+.||...... .+... +..... .
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~---~~~~~~---~ 240 (287)
T 2wei_A 173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKR---VETGKY---A 240 (287)
T ss_dssp TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---HHHCCC---C
T ss_pred eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHH---HHcCCC---C
Confidence 7654332 233458999999998765 5899999999999999999999999754321 11110 000000 0
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
...+.. . .....+.+++.+|++.||++||++.|+++
T Consensus 241 ~~~~~~-~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FDLPQW-R----TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCSGGG-T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchhh-h----hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000000 1 12346889999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.25 Aligned_cols=262 Identities=21% Similarity=0.289 Sum_probs=199.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CC-cEEEEEEeeccCCcchHHHHHHHHHhhhcCCCc------eeeeeeeeeeccee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NG-TEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN------LVKLIGICIEGRTR 446 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN------IV~L~g~~~~~~~~ 446 (780)
++|...+.||+|+||+||+|... ++ +.||||+++.. ....+.+.+|++++++++|+| ++.+++++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 78999999999999999999974 34 78999999643 233467889999999998766 99999999999999
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE---------------
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL--------------- 511 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL--------------- 511 (780)
++||||+ +++|.+++.. .....+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 9999999 6677777753 23357999999999999999999999998 9999999999999
Q ss_pred ----cCCCCCeeecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCcccc
Q 048425 512 ----EDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ 587 (780)
Q Consensus 512 ----d~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~ 587 (780)
+.++.+||+|||+++...... ....||..|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 678899999999998654322 345799999999999999999999999999999999999999976443211
Q ss_pred chhhhhc-cccc-------ccc-----------------cccccccCCcc-CCCCChhhHHHHHHHHHHccccCCCCCCC
Q 048425 588 ENLVTWA-RPLL-------TTR-----------------EGLEQLVDPSL-AGSYDFDDMAKVAAIASMCVHPEVTHRPF 641 (780)
Q Consensus 588 ~~Lv~wa-~~ll-------~~~-----------------~~l~~lvDp~L-~~~~~~ee~~~l~~La~~Cl~~dP~~RPs 641 (780)
....... .+.. ... ........+.. .......+...+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 1100000 0000 000 00000000000 00112233557899999999999999999
Q ss_pred HHHHHH
Q 048425 642 MGEVVQ 647 (780)
Q Consensus 642 m~EVv~ 647 (780)
+.|+++
T Consensus 328 ~~e~l~ 333 (355)
T 2eu9_A 328 LAEALL 333 (355)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=344.16 Aligned_cols=204 Identities=23% Similarity=0.319 Sum_probs=172.9
Q ss_pred HHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcC-CC-----ceeeeeeeeeec
Q 048425 371 EKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH-HR-----NLVKLIGICIEG 443 (780)
Q Consensus 371 ~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-Hp-----NIV~L~g~~~~~ 443 (780)
....++|...+.||+|+||+||+|... +|+.||||+++.. ....+++..|++++..++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 344689999999999999999999875 6889999999643 223467788999988885 44 499999999999
Q ss_pred ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc--CCCCCeeec
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE--DDFTPKVSD 521 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd--~~~~vKLsD 521 (780)
+..++||||++ |+|.+++.. .....+++..+..++.|++.||+|||.. +.+|+||||||+|||++ +++.+||+|
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRN--TNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CceEEEEecCC-CCHHHHHhh--cCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999996 599999964 2335699999999999999999999952 12399999999999994 578899999
Q ss_pred ccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 048425 522 FGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQ 583 (780)
Q Consensus 522 FGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~ 583 (780)
||+++..... .....||+.|+|||++.+..++.++|||||||+||||+||+.||....
T Consensus 205 FG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 205 FGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999876542 234578999999999999999999999999999999999999998654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=346.24 Aligned_cols=260 Identities=24% Similarity=0.368 Sum_probs=182.8
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeec------c
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEG------R 444 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~ 444 (780)
.++|...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++|+||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 378999999999999999999864 789999999965432 2345788999999999999999999998654 5
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccc
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGL 524 (780)
..++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 7899988842 46999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhh-hhccc------
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV-TWARP------ 596 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv-~wa~~------ 596 (780)
++..... .+...||..|+|||.+.+ ..++.++|||||||++|||++|+.||.......+...+ .....
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9875432 234579999999999887 68899999999999999999999999765432211100 00000
Q ss_pred -ccccccccccccCCcc-CCCCCh-----hhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 597 -LLTTREGLEQLVDPSL-AGSYDF-----DDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 597 -ll~~~~~l~~lvDp~L-~~~~~~-----ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.... ......+.... ...... .....+.+|+.+|++.||++|||+.|+++
T Consensus 255 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 255 KKISS-ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TTCCC-HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhh-HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000 00000000000 000111 11246789999999999999999999865
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=339.75 Aligned_cols=259 Identities=22% Similarity=0.349 Sum_probs=195.5
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeeccee----
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTR---- 446 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~---- 446 (780)
.++|...+.||+|+||+||+|... +|+.||||++...... ..+.+.+|++++++++|+||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 368999999999999999999875 6899999999765332 236789999999999999999999999877654
Q ss_pred --EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccc
Q 048425 447 --CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524 (780)
Q Consensus 447 --~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGL 524 (780)
++||||+. ++|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 68888773 24999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-hhh--------hc
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LVT--------WA 594 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-Lv~--------wa 594 (780)
++..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......... +.. +.
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence 9865432 234568999999999887 788999999999999999999999997644221100 000 00
Q ss_pred cccccc--ccccccccCCccCCC---CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 595 RPLLTT--REGLEQLVDPSLAGS---YDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 595 ~~ll~~--~~~l~~lvDp~L~~~---~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..+... ......+. ...... ........+.+++..|++.||++|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLP-QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp TTCSCHHHHHHHHHSC-CCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhhhhhhhhhhccC-CCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 000000 00000000 000000 00112357889999999999999999999865
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=353.40 Aligned_cols=203 Identities=24% Similarity=0.358 Sum_probs=156.0
Q ss_pred cCccc-ceeecccCceEEEEEEEe---CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeee--cceeEE
Q 048425 375 EKFSS-KRILGEGGFGCVYHGVMD---NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIE--GRTRCL 448 (780)
Q Consensus 375 ~~f~~-~~~LG~G~fG~VYkg~l~---~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~L 448 (780)
+.|.. .++||+|+||+||+|... +++.||||++.... ....+.+|+++|++++||||+++++++.. +...++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34554 458999999999999975 57889999996543 34578899999999999999999999954 668899
Q ss_pred EEeecCCCChhhhccccc-----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE----cCCCCCee
Q 048425 449 VYELVHNGSVESHLHGVD-----KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL----EDDFTPKV 519 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~-----~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL----d~~~~vKL 519 (780)
||||+. |+|.+++.... .....+++..++.|+.||+.||+|||+.+ |+||||||+|||| ++++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 57887775221 12335999999999999999999999998 9999999999999 77899999
Q ss_pred ecccccccccCCCc--cceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 048425 520 SDFGLAREATEGSQ--HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQ 583 (780)
Q Consensus 520 sDFGLA~~~~~~~~--~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~ 583 (780)
+|||+++....... .......||+.|+|||++.+. .++.++|||||||+||||++|+.||....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999987654321 223456799999999998874 58999999999999999999999997544
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=337.01 Aligned_cols=253 Identities=20% Similarity=0.264 Sum_probs=173.2
Q ss_pred hcCcccc-eeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeee----cceeE
Q 048425 374 TEKFSSK-RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIE----GRTRC 447 (780)
Q Consensus 374 t~~f~~~-~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~~ 447 (780)
.++|... ++||+|+||+||+|... +|+.||||++... .....+....+..++|+||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4678884 57999999999999986 7999999998643 1222223334566799999999999876 45579
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC---CCCCeeecccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED---DFTPKVSDFGL 524 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~---~~~vKLsDFGL 524 (780)
+||||+++|+|.+++.. .....+++.++++++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 103 lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999964 23357999999999999999999999998 999999999999976 45599999999
Q ss_pred cccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccc
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ..........
T Consensus 178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~--- 249 (336)
T 3fhr_A 178 AKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GMKRRIRLGQ--- 249 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hHHHhhhccc---
Confidence 98765322 234568999999999998899999999999999999999999996543221100 0000000000
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
..... .........+.+++..|++.||++||++.|+++.
T Consensus 250 ~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 250 YGFPN-----PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -CCCT-----TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cccCc-----hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 0111233568899999999999999999999873
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=339.99 Aligned_cols=245 Identities=21% Similarity=0.355 Sum_probs=200.1
Q ss_pred HHHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc------chHHHHHHHHHhhhcC--CCceeeeeee
Q 048425 369 DLEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN------GDREFIAEVEMLSRLH--HRNLVKLIGI 439 (780)
Q Consensus 369 el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~--HpNIV~L~g~ 439 (780)
+.....++|...+.||+|+||.||+|... +|+.||||+++..... ..+.+.+|++++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 33445678999999999999999999864 7899999999765432 2245778999999996 5999999999
Q ss_pred eeecceeEEEEeecCC-CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc-CCCCC
Q 048425 440 CIEGRTRCLVYELVHN-GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE-DDFTP 517 (780)
Q Consensus 440 ~~~~~~~~LV~Ey~~~-GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd-~~~~v 517 (780)
+.+++..++|+||+.+ ++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++ +++.+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCE
Confidence 9999999999999986 899999853 457899999999999999999999998 99999999999999 78999
Q ss_pred eeecccccccccCCCccceeccccCccccCchhhccCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccc
Q 048425 518 KVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARP 596 (780)
Q Consensus 518 KLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~-t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ 596 (780)
||+|||+++...... .....||..|+|||++.+..+ +.++||||||+++|||++|+.||.... ....
T Consensus 190 kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~---- 257 (320)
T 3a99_A 190 KLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIR---- 257 (320)
T ss_dssp EECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH----
T ss_pred EEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hhhc----
Confidence 999999998765432 234569999999999987776 688999999999999999999996321 1100
Q ss_pred ccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 597 LLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 597 ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.. .. . .......+.+++.+||+.||++||+++||++
T Consensus 258 ---~~----~~----~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 258 ---GQ----VF----F----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ---CC----CC----C----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---cc----cc----c----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 00 1 1112246789999999999999999999965
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=351.38 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=187.3
Q ss_pred CcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEEeecC
Q 048425 376 KFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +||||+++++++.+++..++||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34556889999999998766668999999998653 245688999999986 89999999999999999999999995
Q ss_pred CCChhhhcccccCCCCC---CCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC-------------CCCe
Q 048425 455 NGSVESHLHGVDKNRGP---LDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD-------------FTPK 518 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~---L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~-------------~~vK 518 (780)
|+|.+++......... .++..+++|+.||+.||+|||+.+ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 7999999643222211 234456889999999999999998 9999999999999754 4899
Q ss_pred eecccccccccCCCcc---ceeccccCccccCchhhcc-------CCCCchhhHHhHHHHHHHHHh-CCCCCCCCCcccc
Q 048425 519 VSDFGLAREATEGSQH---ISTRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQ 587 (780)
Q Consensus 519 LsDFGLA~~~~~~~~~---~~t~~~GT~~Y~APE~l~~-------~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~ 587 (780)
|+|||+++........ ......||++|+|||++.+ ..++.++|||||||++|||+| |+.||.......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 9999999987654322 1234579999999999875 678999999999999999999 999996543211
Q ss_pred chhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 588 ENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 588 ~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.++... .. .. +.+...........+.+++.+|++.||++||++.||++
T Consensus 248 ~~i~~~---~~----~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 SNIIRG---IF----SL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHT---CC----CC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHhcC---CC----Cc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111110 00 00 01111112344567899999999999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=335.12 Aligned_cols=258 Identities=22% Similarity=0.353 Sum_probs=195.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecce------
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRT------ 445 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~------ 445 (780)
++|...+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.++++++|+||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 67889999999999999999975 7899999999764332 23578999999999999999999999987654
Q ss_pred eEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccc
Q 048425 446 RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA 525 (780)
.++||||+. |+|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 104 ~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred EEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 68888773 24899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-hh--------hhcc
Q 048425 526 REATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LV--------TWAR 595 (780)
Q Consensus 526 ~~~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-Lv--------~wa~ 595 (780)
+..... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... +. .|..
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 875432 234568999999999887 678999999999999999999999997644221100 00 0000
Q ss_pred ccccc--ccccccc---cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 596 PLLTT--REGLEQL---VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 596 ~ll~~--~~~l~~l---vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+... ...+..+ ..+.+. .........+.+++.+|++.||++||++.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 0000000 000010 111233467889999999999999999999865
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=329.28 Aligned_cols=251 Identities=24% Similarity=0.405 Sum_probs=179.4
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcc-h-HHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNG-D-REFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~-~-~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
.++|...+.||+|+||.||+|... +|+.||||++....... . +.+.++..+++.++|+||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 478889999999999999999985 78999999997654322 2 23445556788889999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED-SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~-~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
||+ ++.+..++. .....+++..++.++.|++.||+|||+. + |+||||||+|||++.++++||+|||++....
T Consensus 104 e~~-~~~~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 445554443 2245799999999999999999999985 7 9999999999999999999999999998765
Q ss_pred CCCccceeccccCccccCchhhc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccc
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~-----~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
.... .....||..|+|||.+. ...++.++||||||+++|||++|+.||...... ..... ......
T Consensus 177 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~---~~~~~~--- 246 (318)
T 2dyl_A 177 DDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLT---KVLQEE--- 246 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHH---HHHHSC---
T ss_pred CCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHH---HHhccC---
Confidence 4322 23456999999999984 567889999999999999999999999753211 11110 001000
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+.+.. .......+.+++.+||+.||++||++.|+++
T Consensus 247 ----~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 ----PPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ----CCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 011100 0112346889999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=342.30 Aligned_cols=249 Identities=23% Similarity=0.327 Sum_probs=186.6
Q ss_pred hcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEEEee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
..+|...++||+|+||+||.....+|+.||||++..... ..+.+|+++++++ +|||||++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 356888899999999996655556899999999965432 3456899999999 799999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC-----CCCCeeeccccccc
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED-----DFTPKVSDFGLARE 527 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~-----~~~vKLsDFGLA~~ 527 (780)
+. |+|.+++.. ....+.+..++.++.||+.||+|||+.+ |+||||||+|||++. +..+||+|||+++.
T Consensus 100 ~~-g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 100 CA-ATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CS-EEHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CC-CCHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 96 699999963 3334556667899999999999999998 999999999999943 33577999999987
Q ss_pred ccCCCc--cceeccccCccccCchhhc---cCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccc
Q 048425 528 ATEGSQ--HISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTR 601 (780)
Q Consensus 528 ~~~~~~--~~~t~~~GT~~Y~APE~l~---~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~ 601 (780)
...... .......||++|+|||++. ...++.++|||||||++|||+| |+.||........ .. ... .
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~------~~~-~ 244 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NI------LLG-A 244 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HH------HTT-C
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HH------Hhc-c
Confidence 754321 1234567999999999987 4677889999999999999999 8889854321110 00 000 0
Q ss_pred cccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 602 EGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 602 ~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.... .+ .........+.+++.+||+.||++||++.||++
T Consensus 245 ~~~~-----~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 CSLD-----CL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCT-----TS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcc-----cc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0000 00 011223445789999999999999999999983
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=358.13 Aligned_cols=240 Identities=21% Similarity=0.314 Sum_probs=194.5
Q ss_pred cCcccceeecccCceEEEEEEEe--CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecce-----e
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD--NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRT-----R 446 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~--~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~-----~ 446 (780)
++|...+.||+|+||+||+|... +|+.||||++..... ...+.|.+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 78999999999999999999975 689999999865432 234578999999999999999999999987665 6
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
+|||||+++++|.+++.. .++|.+++.|+.||+.||+|||+.+ |+||||||+|||++++ .+||+|||+++
T Consensus 160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 999999999999987742 6999999999999999999999998 9999999999999986 99999999998
Q ss_pred cccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 527 EATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 527 ~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
..... ....||++|+|||++.++. +.++|||||||+||||++|..|+...... .
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~---------- 283 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD----------G---------- 283 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS----------S----------
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc----------c----------
Confidence 76543 3456999999999987765 89999999999999999998877531100 0
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-HHHHHHHHHHHhh
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPF-MGEVVQALKLIYN 654 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs-m~EVv~~L~~i~~ 654 (780)
+.. ..........+.+++.+|++.||++||+ ++++...|..+..
T Consensus 284 ~~~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 284 LPE----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp CCT----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ccc----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 000 0000112246889999999999999995 6667777766653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.15 Aligned_cols=233 Identities=13% Similarity=0.062 Sum_probs=184.7
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcc---hHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNG---DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||.||+|... +|+.||||++....... .+.|.+|+.++.+++|+||+++++++.+++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 67889999999999999999986 58999999997654332 367999999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++++|.+++.. + ....+..+|+.|++.||+|||+.+ |+||||||+|||+++++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 99999999999842 1 355678999999999999999998 9999999999999999999998443
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
|++| ++.++|||||||+||||+||+.||......... ..+............
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~---- 226 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL---APAERDTAGQPIEPA---- 226 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS---EECCBCTTSCBCCHH----
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh---HHHHHHhccCCCChh----
Confidence 4443 689999999999999999999999765432111 000000000000000
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
.+ ..+....+.+++.+||+.||++| |+.|+++.|+.+....
T Consensus 227 ~~----~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 227 DI----DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HH----CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred hc----ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 01 11223468899999999999999 9999999999987543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=354.73 Aligned_cols=269 Identities=24% Similarity=0.334 Sum_probs=207.2
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeee------ccee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIE------GRTR 446 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~------~~~~ 446 (780)
++|...+.||+|+||.||+|... +|+.||||+++.... ...+.|.+|++++++++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999874 689999999876432 234679999999999999999999999765 6677
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC---Ceeeccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT---PKVSDFG 523 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~---vKLsDFG 523 (780)
++||||+++|+|.+++... .....+++..++.|+.+++.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~-~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSS-SCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 9999999999999999742 23346999999999999999999999998 999999999999997765 8999999
Q ss_pred ccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccc
Q 048425 524 LAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREG 603 (780)
Q Consensus 524 LA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~ 603 (780)
+++....... .....||..|+|||.+.+..++.++||||||+++|||++|+.||.... ....|..........
T Consensus 170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-----~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-----QPVQWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-----HHHHSSTTCC-----
T ss_pred cccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-----chhhhhhhhhcccch
Confidence 9987755432 244679999999999999999999999999999999999999996532 222333222111100
Q ss_pred cccccCC----------c--cCCCCChhhHHHHHHHHHHccccCCCCCCCHHH-----HHHHHHHHhhc
Q 048425 604 LEQLVDP----------S--LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGE-----VVQALKLIYND 655 (780)
Q Consensus 604 l~~lvDp----------~--L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~E-----Vv~~L~~i~~~ 655 (780)
...... . ............+.+++..|++.||++||++.| ..+.++.+.+.
T Consensus 243 -~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 243 -HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred -hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 000000 0 111233456678999999999999999999988 56677777654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=334.56 Aligned_cols=244 Identities=16% Similarity=0.212 Sum_probs=182.5
Q ss_pred HhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC---cchHHHHHHHHHhhhcCC-Cce--------------
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ---NGDREFIAEVEMLSRLHH-RNL-------------- 433 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~H-pNI-------------- 433 (780)
.+.+|...++||+|+||+||+|... +|+.||||+++.... ...+.|.+|+.+++.++| +|.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 4466888899999999999999964 799999999874432 235779999999999977 221
Q ss_pred -eee------eeeeee-----cceeEEEEeecCCCChhhhcccc---cCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCc
Q 048425 434 -VKL------IGICIE-----GRTRCLVYELVHNGSVESHLHGV---DKNRGPLDWEARMKIALGAARGLAYLHEDSNPR 498 (780)
Q Consensus 434 -V~L------~g~~~~-----~~~~~LV~Ey~~~GSL~~~L~~~---~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~ 498 (780)
+.+ +.++.. ....+++|+++ +++|.+++... ......++|..++.|+.|+++||+|||+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 111 111111 12346666654 78999888422 123456889999999999999999999998
Q ss_pred EEecccCCcceEEcCCCCCeeecccccccccCCCccceeccccCccccCchhh----------ccCCCCchhhHHhHHHH
Q 048425 499 VIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA----------MTGHLLVKSDVYSYGVV 568 (780)
Q Consensus 499 IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l----------~~~~~t~ksDVySfGVv 568 (780)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999999875432 344567 999999999 55568899999999999
Q ss_pred HHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 569 LLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 569 LlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
||||+||+.||........ . ..++... ..+ ...+.+++..||+.||++||++.|+++
T Consensus 307 l~elltg~~Pf~~~~~~~~------~----------~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGG------S----------EWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSC------S----------GGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCcchhhh------H----------HHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999975432111 0 1111100 111 256889999999999999999888754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=308.86 Aligned_cols=227 Identities=20% Similarity=0.294 Sum_probs=178.0
Q ss_pred cCcccc-eeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHh-hhcCCCceeeeeeeeee----cceeE
Q 048425 375 EKFSSK-RILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEML-SRLHHRNLVKLIGICIE----GRTRC 447 (780)
Q Consensus 375 ~~f~~~-~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL-~~L~HpNIV~L~g~~~~----~~~~~ 447 (780)
++|... ++||+|+||.||++... +|+.||||+++. ...+.+|++++ +.++|+||+++++++.. +...+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 566666 78999999999999974 789999999853 34677899988 55699999999999876 67789
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC---CCCCeeecccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED---DFTPKVSDFGL 524 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~---~~~vKLsDFGL 524 (780)
+||||+++|+|.+++.. .....+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999964 23457999999999999999999999998 999999999999998 78999999999
Q ss_pred cccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccc
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
+..... ..++.++|||||||++|||+||+.||.......... .....
T Consensus 167 a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--~~~~~-------- 213 (299)
T 3m2w_A 167 AKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKTR-------- 213 (299)
T ss_dssp CEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--CSCCS--------
T ss_pred cccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--HHHHH--------
Confidence 865432 345789999999999999999999996543211000 00000
Q ss_pred ccccCCccCCCCC----hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 605 EQLVDPSLAGSYD----FDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 605 ~~lvDp~L~~~~~----~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
+..... ... ......+.+++..|++.||++||++.|+++.
T Consensus 214 --~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 214 --IRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp --SCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --Hhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000 001 1123578899999999999999999999763
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=316.36 Aligned_cols=241 Identities=18% Similarity=0.185 Sum_probs=182.0
Q ss_pred hcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCC--------cchHHHHHHHHHhhhcC---------CCceeee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQ--------NGDREFIAEVEMLSRLH---------HRNLVKL 436 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~--------~~~~~f~~Ei~iL~~L~---------HpNIV~L 436 (780)
.++|...+.||+|+||+||+|+. +|+.||||+++.... ...+.+.+|++++++++ |+|||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 36788889999999999999988 789999999976532 22377899999999886 6666666
Q ss_pred eee-----------------eee-------------cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHH
Q 048425 437 IGI-----------------CIE-------------GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAAR 486 (780)
Q Consensus 437 ~g~-----------------~~~-------------~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~ 486 (780)
.++ +.+ ++..+|||||+++|++.+.+. +..+++..+..|+.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHH
Confidence 555 332 678899999999998777763 246899999999999999
Q ss_pred HHHHHh-hCCCCcEEecccCCcceEEcCCC--------------------CCeeecccccccccCCCccceeccccCccc
Q 048425 487 GLAYLH-EDSNPRVIHRDFKASNVLLEDDF--------------------TPKVSDFGLAREATEGSQHISTRVMGTFGY 545 (780)
Q Consensus 487 gL~yLH-~~~~p~IvHrDIKpsNILLd~~~--------------------~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y 545 (780)
||+||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...||+.|
T Consensus 173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 888 99999999999999887 8999999999976542 34699999
Q ss_pred cCchhhccCCCCchhhHHhHHHH-HHHHHhCCCCCCCCCccccchhhhhcccccccccccccc-cCCccCCCCChhhHHH
Q 048425 546 VAPEYAMTGHLLVKSDVYSYGVV-LLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL-VDPSLAGSYDFDDMAK 623 (780)
Q Consensus 546 ~APE~l~~~~~t~ksDVySfGVv-LlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l-vDp~L~~~~~~ee~~~ 623 (780)
+|||.+.+.. +.++||||+|++ .+++++|..||.. ..|....... .+... ................
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDK--MLKQMTFKTKCNTPAMKQIKRK 311 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHH--HHHTCCCSSCCCSHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHh--hhhhhccCcccchhhhhhcCHH
Confidence 9999998766 899999998776 7778889888732 0111100000 00000 0000000111234567
Q ss_pred HHHHHHHccccCCCCCCCHHHHH
Q 048425 624 VAAIASMCVHPEVTHRPFMGEVV 646 (780)
Q Consensus 624 l~~La~~Cl~~dP~~RPsm~EVv 646 (780)
+.+++.+||+.| |++|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 899999999976 888886
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-29 Score=290.75 Aligned_cols=186 Identities=17% Similarity=0.113 Sum_probs=131.9
Q ss_pred eeecccCceEEEEEEE-eCCcEEEEEEeeccCC----------cchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEE
Q 048425 381 RILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQ----------NGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~----------~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~L 448 (780)
...+.|++|.+..++. --|+.+|||++.+... ...++|.+|+++|+++ +|+||+++++++.+++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3467777777766542 3589999999976421 1235699999999999 79999999999999999999
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||++|++|.+.|. ..++++.. +|+.||+.||+|||+++ ||||||||+||||++++++||+|||+|+..
T Consensus 320 VMEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 320 VMEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EEecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 999999999999995 34567654 58899999999999998 999999999999999999999999999977
Q ss_pred cCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCC
Q 048425 529 TEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578 (780)
Q Consensus 529 ~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P 578 (780)
...... .+..+||++|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 390 ~~~~~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 390 PQDCSW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C---CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCCcc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 554332 345679999999998865 567789999999999888766443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=267.59 Aligned_cols=184 Identities=14% Similarity=0.175 Sum_probs=147.8
Q ss_pred ccceeecccCceEEEEEEEeCCcEEEEEEeeccCCc--------chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 378 SSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQN--------GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 378 ~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~--------~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
...++||+|+||+||+|.. .+..+++|+....... ..+.|.+|++++++++|+||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 6788999986543221 123589999999999999999777777778888999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++++|.+++.. +++++.|+++||+|||+.+ |+||||||+|||+++ ++||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999953 5689999999999999998 999999999999999 99999999999875
Q ss_pred CCCcc------ceeccccCccccCchhhcc--CCCCchhhHHhHHHHHHHHHhCCCCC
Q 048425 530 EGSQH------ISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLSGRKPV 579 (780)
Q Consensus 530 ~~~~~------~~t~~~GT~~Y~APE~l~~--~~~t~ksDVySfGVvLlELlTGr~P~ 579 (780)
..... ......||+.|||||++.. ..|+.++|+|+..+-.++-+.++.++
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 43221 1235689999999999987 67788999999999999998887665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.8e-23 Score=219.83 Aligned_cols=154 Identities=17% Similarity=0.152 Sum_probs=124.4
Q ss_pred chHHHHHHhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCc------------------chHHHHHHHHHhhh
Q 048425 366 ALSDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQN------------------GDREFIAEVEMLSR 427 (780)
Q Consensus 366 ~~~el~~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~------------------~~~~f~~Ei~iL~~ 427 (780)
.+..+......|...+.||+|+||.||+|...+|+.||||+++..... ....|.+|++++++
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 344555556677788999999999999999977999999998643211 23468999999999
Q ss_pred cCCCceeeeeeeeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCc
Q 048425 428 LHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKAS 507 (780)
Q Consensus 428 L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKps 507 (780)
++ | +++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||+|||+.+ |+||||||+
T Consensus 161 l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~ 222 (282)
T 1zar_A 161 LQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQY 222 (282)
T ss_dssp TT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred cc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHH
Confidence 99 5 777776543 56799999999999998 521 224579999999999999998 999999999
Q ss_pred ceEEcCCCCCeeecccccccccCCCccceeccccCccccCchhhc
Q 048425 508 NVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM 552 (780)
Q Consensus 508 NILLd~~~~vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~ 552 (780)
|||++ ++.+||+|||+|+. +..|+|||++.
T Consensus 223 NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 223 NVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp SEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred HEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99999 99999999999963 33478999774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=6.2e-19 Score=184.46 Aligned_cols=136 Identities=16% Similarity=0.104 Sum_probs=106.7
Q ss_pred cccceeecccCceEEEEEEE-eCCcE--EEEEEeeccCCcc------------------------hHHHHHHHHHhhhcC
Q 048425 377 FSSKRILGEGGFGCVYHGVM-DNGTE--VAVKLLTRNNQNG------------------------DREFIAEVEMLSRLH 429 (780)
Q Consensus 377 f~~~~~LG~G~fG~VYkg~l-~~g~~--VAVK~l~~~~~~~------------------------~~~f~~Ei~iL~~L~ 429 (780)
|...+.||+|+||.||+|.. .+|+. ||||+++...... ...+.+|+++|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 68999 9999875432110 125889999999998
Q ss_pred CCce--eeeeeeeeecceeEEEEeecC-CC----ChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCcEEe
Q 048425 430 HRNL--VKLIGICIEGRTRCLVYELVH-NG----SVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH-EDSNPRVIH 501 (780)
Q Consensus 430 HpNI--V~L~g~~~~~~~~~LV~Ey~~-~G----SL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH-~~~~p~IvH 501 (780)
|+++ ..++++ +..+|||||+. +| +|.++... .++.....++.|++.||.||| +.+ |+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 8764 334432 46689999995 25 55555421 235567889999999999999 887 999
Q ss_pred cccCCcceEEcCCCCCeeecccccccc
Q 048425 502 RDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 502 rDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
|||||+|||+++ .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999765
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=4.2e-16 Score=172.78 Aligned_cols=137 Identities=15% Similarity=0.173 Sum_probs=98.4
Q ss_pred CcccceeecccCceEEEEEEEeCCcEEEEEEeeccCC--------------cchHHHH--------HHHHHhhhcCCCce
Q 048425 376 KFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQ--------------NGDREFI--------AEVEMLSRLHHRNL 433 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~--------------~~~~~f~--------~Ei~iL~~L~HpNI 433 (780)
-|++.+.||+|+||.||+|...+|+.||||+++.... ....... .|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3888999999999999999998999999998754211 0111222 34555555543332
Q ss_pred eeeeeeeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC
Q 048425 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED 513 (780)
Q Consensus 434 V~L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~ 513 (780)
.-..-+. ....+|||||+++++|.++... ....+++.|++.+|.|||+.+ ||||||||.|||+++
T Consensus 176 ~vp~p~~--~~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIA--QSRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEE--EETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred CCCeeee--ccCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence 2111111 1234799999999988766421 123568899999999999998 999999999999988
Q ss_pred CCC----------Ceeeccccccc
Q 048425 514 DFT----------PKVSDFGLARE 527 (780)
Q Consensus 514 ~~~----------vKLsDFGLA~~ 527 (780)
++. +.|+||+.+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 773 78999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=5.8e-12 Score=130.44 Aligned_cols=148 Identities=17% Similarity=0.130 Sum_probs=116.4
Q ss_pred HHHHhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcC-CCceeeeeeeeeecceeEE
Q 048425 370 LEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH-HRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 370 l~~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~L 448 (780)
+....++|.....++.|+.+.||+... +|..+++|+...........+.+|+++++.+. +.++.++++++.+.+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 444556788888899999999999875 47899999986532233446889999999984 6778899999988888999
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhC----------------------------------
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED---------------------------------- 494 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~---------------------------------- 494 (780)
||||++|.+|.+.+. +......++.+++++|+.||+.
T Consensus 88 v~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 999999999987642 1122357888999999999981
Q ss_pred ----------------------CCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 495 ----------------------SNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 495 ----------------------~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
..+.++|+|+++.|||++++..+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 114599999999999998765667999987643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=1.6e-11 Score=125.67 Aligned_cols=138 Identities=16% Similarity=0.061 Sum_probs=102.2
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCc--eeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN--LVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~L~g~~~~~~~~~LV~Ey 452 (780)
.++....+.+.|..+.||+....+|..++||+.... ....+.+|+++++.+.+.+ +.+++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 445443333455569999998777888999997543 2346788999999986545 45688888877788999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS------------------------------------- 495 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~------------------------------------- 495 (780)
+++.+|. ... .+ ...++.++++.|+.||+..
T Consensus 97 i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 97 VPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred cCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9998884 211 11 2356778888888888643
Q ss_pred ------------------CCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 496 ------------------NPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 496 ------------------~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
.+.++|+|+++.|||++++..++|+|||.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=1.4e-09 Score=118.23 Aligned_cols=143 Identities=15% Similarity=0.192 Sum_probs=108.4
Q ss_pred cceeecccCceEEEEEEEeCCcEEEEEEee--ccCC-cchHHHHHHHHHhhhcC--CCceeeeeeeeeec---ceeEEEE
Q 048425 379 SKRILGEGGFGCVYHGVMDNGTEVAVKLLT--RNNQ-NGDREFIAEVEMLSRLH--HRNLVKLIGICIEG---RTRCLVY 450 (780)
Q Consensus 379 ~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~--~~~~-~~~~~f~~Ei~iL~~L~--HpNIV~L~g~~~~~---~~~~LV~ 450 (780)
..+.|+.|.++.||+.... +..+++|+.. .... .....+.+|+++++.+. +.++.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4578999999999998875 4678888775 3221 22346888999999996 45688899998776 3478999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS----------------------------------- 495 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~----------------------------------- 495 (780)
||+++..+.+.. ...++..++..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999998875422 124778889999999999999999731
Q ss_pred --------------------CCcEEecccCCcceEEcCCCC--Ceeecccccccc
Q 048425 496 --------------------NPRVIHRDFKASNVLLEDDFT--PKVSDFGLAREA 528 (780)
Q Consensus 496 --------------------~p~IvHrDIKpsNILLd~~~~--vKLsDFGLA~~~ 528 (780)
.+.++|||+++.|||+++++. +.|.||+.+...
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 256999999999999997753 589999988753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.95 E-value=5.4e-10 Score=118.75 Aligned_cols=186 Identities=19% Similarity=0.264 Sum_probs=122.3
Q ss_pred ceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcC-CCc--eeeeeeeeeecc---eeEEEEeec
Q 048425 380 KRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH-HRN--LVKLIGICIEGR---TRCLVYELV 453 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpN--IV~L~g~~~~~~---~~~LV~Ey~ 453 (780)
.+.++.|....||+.. ..+++|+.... .....+.+|+++|+.+. +.. +.+++++...++ ..++||||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4569999999999852 56888886432 23467889999998883 332 445555543333 347899999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhC---------------------------------------
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED--------------------------------------- 494 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~--------------------------------------- 494 (780)
+|.+|.+... ..++..++..++.++++.|+.||+.
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9988865332 2466777788888888888888861
Q ss_pred ----------------CCCcEEecccCCcceEEcC--CCCCeeecccccccccCCCccce-------------eccccCc
Q 048425 495 ----------------SNPRVIHRDFKASNVLLED--DFTPKVSDFGLAREATEGSQHIS-------------TRVMGTF 543 (780)
Q Consensus 495 ----------------~~p~IvHrDIKpsNILLd~--~~~vKLsDFGLA~~~~~~~~~~~-------------t~~~GT~ 543 (780)
..+.++|+|+++.||++++ +..+.|+||+.+........... ..+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 1246899999999999998 45678999999875432110000 0000011
Q ss_pred cccC-chhhccCCCCchhhHHhHHHHHHHHHhCCCCC
Q 048425 544 GYVA-PEYAMTGHLLVKSDVYSYGVVLLELLSGRKPV 579 (780)
Q Consensus 544 ~Y~A-PE~l~~~~~t~ksDVySfGVvLlELlTGr~P~ 579 (780)
++.. |++.... ....+.|++|.++|++.+|+.++
T Consensus 253 ~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 1122 2221111 22368999999999999998665
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=2.7e-06 Score=90.64 Aligned_cols=137 Identities=22% Similarity=0.207 Sum_probs=93.8
Q ss_pred ceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCC---ceeeeeeeee-ecceeEEEEeecCC
Q 048425 380 KRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHR---NLVKLIGICI-EGRTRCLVYELVHN 455 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp---NIV~L~g~~~-~~~~~~LV~Ey~~~ 455 (780)
.+.++.|....||+. |..++||+-.. ......+.+|+++|+.+.+. .+.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 467889999999987 56788888522 22345788999999999653 3566677664 33456899999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-----------------------------------------
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED----------------------------------------- 494 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~----------------------------------------- 494 (780)
.+|.+... ..++..++..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 88865321 1233444444555555555555432
Q ss_pred ----------------CCCcEEecccCCcceEEcC---CCCC-eeecccccccc
Q 048425 495 ----------------SNPRVIHRDFKASNVLLED---DFTP-KVSDFGLAREA 528 (780)
Q Consensus 495 ----------------~~p~IvHrDIKpsNILLd~---~~~v-KLsDFGLA~~~ 528 (780)
..+.++|+|+++.|||+++ ++.+ .|+||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2345799999999999987 4554 89999987653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=1.8e-06 Score=93.34 Aligned_cols=81 Identities=7% Similarity=-0.018 Sum_probs=57.8
Q ss_pred ceee-cccCceEEEEEEEe-------CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCC---Cceeeeeeeeeec--
Q 048425 380 KRIL-GEGGFGCVYHGVMD-------NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHH---RNLVKLIGICIEG-- 443 (780)
Q Consensus 380 ~~~L-G~G~fG~VYkg~l~-------~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~H---pNIV~L~g~~~~~-- 443 (780)
.+.| +.|....+|+.... +|..+++|+..... ......+.+|+.+++.+.. -.+.++++++.++
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88889999998764 26788999865432 1112457789999988843 3577788887655
Q ss_pred -ceeEEEEeecCCCChhh
Q 048425 444 -RTRCLVYELVHNGSVES 460 (780)
Q Consensus 444 -~~~~LV~Ey~~~GSL~~ 460 (780)
+..++||||+++..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 34689999999877654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=2.1e-06 Score=88.83 Aligned_cols=136 Identities=18% Similarity=0.102 Sum_probs=96.3
Q ss_pred eeecccCce-EEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcC-CCceeeeeeeeeecceeEEEEeecCCCC
Q 048425 381 RILGEGGFG-CVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH-HRNLVKLIGICIEGRTRCLVYELVHNGS 457 (780)
Q Consensus 381 ~~LG~G~fG-~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~Ey~~~GS 457 (780)
+.+..|..| .||+-... ++..++||+-... ...++.+|...|+.+. +--+.++++++.+++..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345666665 68987765 4677999986432 3456888999998884 3347788999988889999999999988
Q ss_pred hhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-------------------------------------------
Q 048425 458 VESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED------------------------------------------- 494 (780)
Q Consensus 458 L~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~------------------------------------------- 494 (780)
+.+.... .......++.++++.|+-||..
T Consensus 107 ~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 7665421 1122334555555666666642
Q ss_pred ------------CCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 495 ------------SNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 495 ------------~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
..+.++|+|+.+.|||+++++.+-|.||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112489999999999999887777999997754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.07 E-value=1.5e-05 Score=84.76 Aligned_cols=142 Identities=17% Similarity=0.256 Sum_probs=82.3
Q ss_pred ceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCC--Cceeeeee------eeeecceeEEEEe
Q 048425 380 KRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHH--RNLVKLIG------ICIEGRTRCLVYE 451 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H--pNIV~L~g------~~~~~~~~~LV~E 451 (780)
.+.|+.|..+.||+...++| .+++|+.... ..++..|++++..+.. -.+.+++. +...++..++|||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 35576677899999887555 5889988642 2344456666665531 12344443 1123566789999
Q ss_pred ecCCCChh--------------hhcccccCCC----------CCCCHHHHHH----------------------------
Q 048425 452 LVHNGSVE--------------SHLHGVDKNR----------GPLDWEARMK---------------------------- 479 (780)
Q Consensus 452 y~~~GSL~--------------~~L~~~~~~~----------~~L~~~~rl~---------------------------- 479 (780)
|++|..+. ..||...... ..-.|...+.
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99987653 1123211100 1123432110
Q ss_pred ---HHHHHHHHHHHHhh--------C--CCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 480 ---IALGAARGLAYLHE--------D--SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 480 ---Ia~qIA~gL~yLH~--------~--~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
+...+.+++++|+. . ..+.++|+|+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11123345667763 1 23469999999999999888899999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=3.9e-05 Score=84.22 Aligned_cols=75 Identities=13% Similarity=0.082 Sum_probs=50.7
Q ss_pred ceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-------cchHHHHHHHHHhhhcCC--C-ceeeeeeeeeecceeEE
Q 048425 380 KRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-------NGDREFIAEVEMLSRLHH--R-NLVKLIGICIEGRTRCL 448 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-------~~~~~f~~Ei~iL~~L~H--p-NIV~L~g~~~~~~~~~L 448 (780)
.+.||.|..+.||++... ++..++||....... .....+..|.++++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 568999999999999764 568899998643211 123457789999988742 3 34456654 3455689
Q ss_pred EEeecCCC
Q 048425 449 VYELVHNG 456 (780)
Q Consensus 449 V~Ey~~~G 456 (780)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.95 E-value=4.6e-05 Score=80.01 Aligned_cols=79 Identities=23% Similarity=0.206 Sum_probs=59.2
Q ss_pred CcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCC---ceeeeeeeeeecceeEEEEee
Q 048425 376 KFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHR---NLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp---NIV~L~g~~~~~~~~~LV~Ey 452 (780)
.+...+.+|.|..+.||+..+.||+.|.||+...........|..|++.|+.|.-. -+.+++++ +..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 45567889999999999999999999999987655444445688999999888422 24455544 234789999
Q ss_pred cCCCCh
Q 048425 453 VHNGSV 458 (780)
Q Consensus 453 ~~~GSL 458 (780)
++.+..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00014 Score=78.11 Aligned_cols=141 Identities=21% Similarity=0.231 Sum_probs=94.9
Q ss_pred ccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcC---CCceeeeeeeeeecceeEEEEeecC
Q 048425 378 SSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH---HRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 378 ~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
...+.|+.|....+|+... ++..++||+.... ....|..|.+.|+.|. ...+.++++++...+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3457799999999999876 5678889987543 3456889999998884 3568888988887788899999999
Q ss_pred CCChhh-----------hcccccC-C-----------------CCCCCHHHHH---HHH--HH--------------HHH
Q 048425 455 NGSVES-----------HLHGVDK-N-----------------RGPLDWEARM---KIA--LG--------------AAR 486 (780)
Q Consensus 455 ~GSL~~-----------~L~~~~~-~-----------------~~~L~~~~rl---~Ia--~q--------------IA~ 486 (780)
+..+.. .||.... . ...-+|.... ++. .+ +..
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 886532 2333211 0 0012564321 111 11 111
Q ss_pred H-HHHHhh-CCCCcEEecccCCcceEEcCCCCCeeeccc
Q 048425 487 G-LAYLHE-DSNPRVIHRDFKASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 487 g-L~yLH~-~~~p~IvHrDIKpsNILLd~~~~vKLsDFG 523 (780)
- ...|.. ...|.++|+|+.+.||++++++ +.|.||+
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 223422 2357899999999999999887 8888874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.73 E-value=6.2e-05 Score=83.56 Aligned_cols=79 Identities=16% Similarity=0.124 Sum_probs=50.2
Q ss_pred CCcEEecccCCcceEEcCCCCCeeecccccccccCCCccceecc-ccCccccCchhhccC---CCCchhhHHhHHHHHHH
Q 048425 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRV-MGTFGYVAPEYAMTG---HLLVKSDVYSYGVVLLE 571 (780)
Q Consensus 496 ~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~~t~~-~GT~~Y~APE~l~~~---~~t~ksDVySfGVvLlE 571 (780)
.+.++|+|+++.|||+++++ ++|.||+.+......... .... .-...|++|++.... .-....+++.....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 45699999999999999876 999999998765422110 0000 001346676655421 11234566788888888
Q ss_pred HHhCC
Q 048425 572 LLSGR 576 (780)
Q Consensus 572 LlTGr 576 (780)
..+++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00046 Score=73.03 Aligned_cols=159 Identities=13% Similarity=0.125 Sum_probs=90.4
Q ss_pred cchHHHHHHhcCccc-----ceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCc--eeeee
Q 048425 365 FALSDLEKATEKFSS-----KRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN--LVKLI 437 (780)
Q Consensus 365 f~~~el~~at~~f~~-----~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~L~ 437 (780)
++.+++....+.|.. .+.|+.|....+|+....+| .+++|+.... ....++..|++++..+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 455666666666654 34577788899999887666 5788987542 12345667888887774222 33333
Q ss_pred ee------eeecceeEEEEeecCCCChhh--------------hcccccCC----C----CCCCHHHHHHH---------
Q 048425 438 GI------CIEGRTRCLVYELVHNGSVES--------------HLHGVDKN----R----GPLDWEARMKI--------- 480 (780)
Q Consensus 438 g~------~~~~~~~~LV~Ey~~~GSL~~--------------~L~~~~~~----~----~~L~~~~rl~I--------- 480 (780)
.. ....+..+++++|++|..+.. .||..... . ....|...+.-
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 112345689999999865432 12221110 0 01124332111
Q ss_pred ---HHHHHHHHHHHhhC----CCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 481 ---ALGAARGLAYLHED----SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 481 ---a~qIA~gL~yLH~~----~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
...+.+.++++.+. ....++|+|+.+.|||++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 01234455555532 23468999999999999987656899998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0018 Score=68.70 Aligned_cols=159 Identities=16% Similarity=0.159 Sum_probs=91.1
Q ss_pred cchHHHHHHhcCcc-----cceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCC--ceeeee
Q 048425 365 FALSDLEKATEKFS-----SKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHR--NLVKLI 437 (780)
Q Consensus 365 f~~~el~~at~~f~-----~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp--NIV~L~ 437 (780)
.+.+++..+.+.|. ....|+ |....||+....+|+.+++|+..... .....+..|..++..+... .+++++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 44455555444443 234577 88889999877778789999986432 2345677788888887422 244455
Q ss_pred ee-----eeecceeEEEEeecCCCChhh--------------hcccccC-----CCCCCCHHHH----HHHH--------
Q 048425 438 GI-----CIEGRTRCLVYELVHNGSVES--------------HLHGVDK-----NRGPLDWEAR----MKIA-------- 481 (780)
Q Consensus 438 g~-----~~~~~~~~LV~Ey~~~GSL~~--------------~L~~~~~-----~~~~L~~~~r----l~Ia-------- 481 (780)
.. ...++..++||||+++..+.. .||.... ....+++... ..+.
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 43 112345578999998865431 0221111 1112333211 0010
Q ss_pred -------HHHHHHHHHHhh----CCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 482 -------LGAARGLAYLHE----DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 482 -------~qIA~gL~yLH~----~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
..+.+.++.+.. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 011112223322 1234589999999999999 4 889999987754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0009 Score=74.83 Aligned_cols=73 Identities=16% Similarity=0.231 Sum_probs=51.2
Q ss_pred ceeecccCceEEEEEEEeC--------CcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCce-eeeeeeeeecceeEEEE
Q 048425 380 KRILGEGGFGCVYHGVMDN--------GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL-VKLIGICIEGRTRCLVY 450 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LV~ 450 (780)
.+.|+.|....+|+....+ +..+++|+.... .....+.+|..++..+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4678888899999998753 578999987332 122566689999988853333 567776542 3899
Q ss_pred eecCCCCh
Q 048425 451 ELVHNGSV 458 (780)
Q Consensus 451 Ey~~~GSL 458 (780)
||+++.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0012 Score=69.65 Aligned_cols=140 Identities=11% Similarity=0.054 Sum_probs=76.6
Q ss_pred ceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCce-eeeeeeeeecceeEEEEeec-CCCC
Q 048425 380 KRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL-VKLIGICIEGRTRCLVYELV-HNGS 457 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LV~Ey~-~~GS 457 (780)
.+.|+.|....+|+. ..+++|+....... .....+|+.+++.+...++ .++++++ .+..++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 578999999999998 56888887543211 1123468887777743233 4555543 33457899999 5544
Q ss_pred hhh------------------hcccccCC-CCCCCHHHH-HHHHH--------------HHHHHH----HHHhh-CCCCc
Q 048425 458 VES------------------HLHGVDKN-RGPLDWEAR-MKIAL--------------GAARGL----AYLHE-DSNPR 498 (780)
Q Consensus 458 L~~------------------~L~~~~~~-~~~L~~~~r-l~Ia~--------------qIA~gL----~yLH~-~~~p~ 498 (780)
|.. -||..... ....+.... .+... .+.+.+ +.|.. ...+.
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 431 11211100 000111111 11100 011111 11111 22345
Q ss_pred EEecccCCcceEEcCCCCCeeecccccccc
Q 048425 499 VIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 499 IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
++|+|+.+.||+ .+++.+.|+||..+...
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 56667899999988643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0024 Score=68.03 Aligned_cols=144 Identities=15% Similarity=0.068 Sum_probs=73.7
Q ss_pred eeecccCceE-EEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCC--CceeeeeeeeeecceeEEEEeecCCCC
Q 048425 381 RILGEGGFGC-VYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHH--RNLVKLIGICIEGRTRCLVYELVHNGS 457 (780)
Q Consensus 381 ~~LG~G~fG~-VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~~~~~LV~Ey~~~GS 457 (780)
+.|+.|+... +|+....+|..+++|....... .++..|+.++..+.. -.+.+++.+..+. -+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4566665554 6676554467777776433221 234456666666632 2355667664332 278999998766
Q ss_pred hhhhcccc---------------------cCC-CCCCCHHHHH-------H-------------HHHHHHHHHHHHh---
Q 048425 458 VESHLHGV---------------------DKN-RGPLDWEARM-------K-------------IALGAARGLAYLH--- 492 (780)
Q Consensus 458 L~~~L~~~---------------------~~~-~~~L~~~~rl-------~-------------Ia~qIA~gL~yLH--- 492 (780)
+.+++.+. ... ...++..... . ....+.+.++.|-
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65443211 000 0111111100 0 0001112222221
Q ss_pred hCCCCcEEecccCCcceEEcCC----CCCeeeccccccccc
Q 048425 493 EDSNPRVIHRDFKASNVLLEDD----FTPKVSDFGLAREAT 529 (780)
Q Consensus 493 ~~~~p~IvHrDIKpsNILLd~~----~~vKLsDFGLA~~~~ 529 (780)
....+.++|||+.+.|||++++ ..+.|.||+.+....
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 1123469999999999999875 678999999887543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.005 Score=69.49 Aligned_cols=74 Identities=11% Similarity=0.043 Sum_probs=48.2
Q ss_pred ceeecccCceEEEEEEEeC-CcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCce-eeeeeeeeecceeEEEEeecCCCC
Q 048425 380 KRILGEGGFGCVYHGVMDN-GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL-VKLIGICIEGRTRCLVYELVHNGS 457 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~~-g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LV~Ey~~~GS 457 (780)
.+.|+.|-...+|+....+ +..+++|+........ -+..+|..++..|...++ .++++++. + .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4678888889999988754 4788898874332111 112578888888865444 56777663 2 25999998765
Q ss_pred h
Q 048425 458 V 458 (780)
Q Consensus 458 L 458 (780)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0029 Score=69.72 Aligned_cols=142 Identities=15% Similarity=0.185 Sum_probs=84.0
Q ss_pred eeecccCceEEEEEEEe--------CCcEEEEEEeeccCCcchHHHHHHHHHhhhcC-CCceeeeeeeeeecceeEEEEe
Q 048425 381 RILGEGGFGCVYHGVMD--------NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH-HRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~--------~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~E 451 (780)
+.|..|-...+|+.... ++..+++|+.... ......+.+|..+++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 56777888899998864 2478999986332 223456778999998884 3223566766643 29999
Q ss_pred ecCCCChhhh-----------------cccccC-CCCCCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 048425 452 LVHNGSVESH-----------------LHGVDK-NRGPLD--WEARMKIALGAAR-------------------GLAYL- 491 (780)
Q Consensus 452 y~~~GSL~~~-----------------L~~~~~-~~~~L~--~~~rl~Ia~qIA~-------------------gL~yL- 491 (780)
|++|.+|..- ||.... ...... |.++.++..++.. .++.|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665421 122211 112223 4444444433321 22333
Q ss_pred ---hhC-CCCcEEecccCCcceEEcCC----CCCeeeccccccc
Q 048425 492 ---HED-SNPRVIHRDFKASNVLLEDD----FTPKVSDFGLARE 527 (780)
Q Consensus 492 ---H~~-~~p~IvHrDIKpsNILLd~~----~~vKLsDFGLA~~ 527 (780)
... ....++|+|+.+.|||++++ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 222 23468999999999999876 7899999987753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0042 Score=67.26 Aligned_cols=74 Identities=11% Similarity=0.116 Sum_probs=44.7
Q ss_pred ceeecccCceEEEEEEEeC---------CcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCc-eeeeeeeeeecceeEEE
Q 048425 380 KRILGEGGFGCVYHGVMDN---------GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN-LVKLIGICIEGRTRCLV 449 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~~---------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN-IV~L~g~~~~~~~~~LV 449 (780)
.+.|+.|....+|+....+ +..+++|+...... ...+...|.++++.+...+ ..++++.. ...+|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 3567888888999988754 26888888654321 1112357888888875334 34666543 13689
Q ss_pred EeecCCCCh
Q 048425 450 YELVHNGSV 458 (780)
Q Consensus 450 ~Ey~~~GSL 458 (780)
|||+++..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.022 Score=61.23 Aligned_cols=33 Identities=24% Similarity=0.268 Sum_probs=28.4
Q ss_pred CCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 496 ~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
...++|+|+.+.||++++++.+.|.||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 346999999999999998888999999877643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.94 E-value=0.076 Score=59.26 Aligned_cols=142 Identities=13% Similarity=0.166 Sum_probs=84.3
Q ss_pred ceeecccCceEEEEEEEeC--------CcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCc-eeeeeeeeeecceeEEEE
Q 048425 380 KRILGEGGFGCVYHGVMDN--------GTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN-LVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN-IV~L~g~~~~~~~~~LV~ 450 (780)
.+.|..|-...+|+....+ +..+++|+....... .-+..+|..+++.+.-.+ ..++++.+. ..+||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 4567778888999988753 578999986443211 112357888888774222 345555432 37899
Q ss_pred eecCCCChhhh-----------------cccccC---------CCCCCCHHHHHHHHHHH-------------------H
Q 048425 451 ELVHNGSVESH-----------------LHGVDK---------NRGPLDWEARMKIALGA-------------------A 485 (780)
Q Consensus 451 Ey~~~GSL~~~-----------------L~~~~~---------~~~~L~~~~rl~Ia~qI-------------------A 485 (780)
||+++.+|..- ||.... ...+.-|.+..++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998765321 121111 11222344443333221 1
Q ss_pred HHHHHHhh---------------------CCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 486 RGLAYLHE---------------------DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 486 ~gL~yLH~---------------------~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
..+..|.+ .....++|+|+.+.||+ ++++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 11235899999999999 8888999999988754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.59 E-value=0.32 Score=49.56 Aligned_cols=101 Identities=17% Similarity=0.150 Sum_probs=65.9
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCccc
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~~ 535 (780)
-||.+.|. ..+.+++..+.|.++.|.+++|.-+-...++ ..+=+.+..|++..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~---~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILR---LYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHH---HcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---------
Confidence 47888886 3567999999999999999998776221111 1222446899999999988764 1110
Q ss_pred eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCC
Q 048425 536 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGR 576 (780)
Q Consensus 536 ~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr 576 (780)
.....+.+||... ...+.+.=|||+|++||.-+-=.
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 0122366888653 34578999999999999988633
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.08 E-value=0.13 Score=38.99 Aligned_cols=29 Identities=31% Similarity=0.454 Sum_probs=15.2
Q ss_pred ceeehhHHHHHHHHHHHHHHHHHHhhhcc
Q 048425 285 RTIAIIALSAFVLLLVFVGAISILIKWRK 313 (780)
Q Consensus 285 ~~i~ii~v~~~vlllvli~~il~~~~~Rk 313 (780)
..|++.+++++++++++++++++++|+|+
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 34555555555555555544455555544
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.07 E-value=0.11 Score=39.35 Aligned_cols=30 Identities=10% Similarity=0.234 Sum_probs=15.3
Q ss_pred ceeehhHHHHHHHHHHHHHHHHHHhhhccc
Q 048425 285 RTIAIIALSAFVLLLVFVGAISILIKWRKA 314 (780)
Q Consensus 285 ~~i~ii~v~~~vlllvli~~il~~~~~Rk~ 314 (780)
..|++.+++++++++++++++++++|+|+.
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 445555555555555555444555555443
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=91.69 E-value=0.11 Score=38.14 Aligned_cols=29 Identities=7% Similarity=0.155 Sum_probs=17.3
Q ss_pred CCCccceeehhHHHHHHHHHHHHHHHHHH
Q 048425 280 QRMNFRTIAIIALSAFVLLLVFVGAISIL 308 (780)
Q Consensus 280 ~~~s~~~i~ii~v~~~vlllvli~~il~~ 308 (780)
.+++.+.|+.|++++++.+++++++++++
T Consensus 6 ~~ls~GaIAGiVvG~v~gv~li~~l~~~~ 34 (38)
T 2k1k_A 6 RGLTGGEIVAVIFGLLLGAALLLGILVFR 34 (38)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCceeeeehHHHHHHHHHHHHHHHH
Confidence 34566778777777666555555444433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.75 E-value=1.2 Score=48.82 Aligned_cols=29 Identities=24% Similarity=0.373 Sum_probs=24.4
Q ss_pred EEecccCCcceEE------cCCCCCeeeccccccc
Q 048425 499 VIHRDFKASNVLL------EDDFTPKVSDFGLARE 527 (780)
Q Consensus 499 IvHrDIKpsNILL------d~~~~vKLsDFGLA~~ 527 (780)
++|+|+.+.|||+ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4566789999988754
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=87.12 E-value=0.52 Score=35.57 Aligned_cols=26 Identities=31% Similarity=0.429 Sum_probs=10.5
Q ss_pred eehhHHHHHHHHHHHHHHHHHHhhhcc
Q 048425 287 IAIIALSAFVLLLVFVGAISILIKWRK 313 (780)
Q Consensus 287 i~ii~v~~~vlllvli~~il~~~~~Rk 313 (780)
|++++++ +++++++.+++++++|||+
T Consensus 14 Ia~~vVG-vll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 14 IISAVVG-ILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHH-HHHHHHHHHHHHHHHHHHC
T ss_pred hHHHHHH-HHHHHHHHHHHHhheehhh
Confidence 4444444 3333333333344445444
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 780 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-70 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-62 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-23 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 9e-70
Identities = 68/288 (23%), Positives = 123/288 (42%), Gaps = 23/288 (7%)
Query: 369 DLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL 428
D E + + + +G G FG VY G V + +T + F EV +L +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 429 HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGL 488
H N++ +G + +V + S+ HLH + + IA A+G+
Sbjct: 62 RHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGM 117
Query: 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ-HISTRVMGTFGYVA 547
YLH +IHRD K++N+ L +D T K+ DFGLA + S H ++ G+ ++A
Sbjct: 118 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 548 PEYAMT---GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604
PE +SDVY++G+VL EL++G+ P + Q + L +
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652
++ + + C+ + RP +++ +++L+
Sbjct: 235 RSNCPKAM------------KRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 3e-67
Identities = 72/285 (25%), Positives = 126/285 (44%), Gaps = 27/285 (9%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
E LG G FG V+ G + T+VAVK L + + + F+AE ++ +L H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+L + + ++ E + NGS+ L + L + +A A G+A++ E
Sbjct: 72 RLYAVVTQEP-IYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG 554
IHRD +A+N+L+ D + K++DFGLAR + + APE G
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 555 HLLVKSDVYSYGVVLLELLSGRKPV--DMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612
+KSDV+S+G++L E+++ + M+ P+ +NL R V P
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-----------VRPD- 233
Query: 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657
+ ++ + +C RP + L+ + T+
Sbjct: 234 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 5e-65
Identities = 77/278 (27%), Positives = 125/278 (44%), Gaps = 23/278 (8%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
+ + + +G G FG V+ G N +VA+K + + + +FI E E++ +L H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLV 63
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+L G+C+E CLV+E + +G + +L RG E + + L G+AYL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE- 119
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG 554
VIHRD A N L+ ++ KVSDFG+ R + ST + +PE
Sbjct: 120 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 555 HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAG 614
KSDV+S+GV++ E+ S K ++ + ++ +L P LA
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRLAS 228
Query: 615 SYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652
+ V I + C RP +++ L I
Sbjct: 229 T-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 214 bits (547), Expect = 2e-64
Identities = 69/290 (23%), Positives = 118/290 (40%), Gaps = 23/290 (7%)
Query: 369 DLEKATEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSR 427
E + K LG G +G VY GV VAVK L + EF+ E ++
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKE 69
Query: 428 LHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARG 487
+ H NLV+L+G+C ++ E + G++ +L + NR + + +A +
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSA 127
Query: 488 LAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVA 547
+ YL + IHRD A N L+ ++ KV+DFGL+R T + + A
Sbjct: 128 MEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 548 PEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607
PE +KSDV+++GV+L E+ + Q + +L
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYEL 228
Query: 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTD 657
++ KV + C + RP E+ QA + ++ ++
Sbjct: 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 2e-64
Identities = 68/277 (24%), Positives = 118/277 (42%), Gaps = 25/277 (9%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
+ + + LG G FG V +G +VA+K++ + + + EFI E +++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLV 62
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+L G+C + R ++ E + NG + ++L + R + +++ + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLE-- 117
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG 554
+ + +HRD A N L+ D KVSDFGL+R + S + PE M
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 555 HLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613
KSD++++GV++ E+ S G+ P + + L P LA
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR----------LYRPHLA 226
Query: 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650
KV I C H + RP ++ +
Sbjct: 227 SE-------KVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 5e-64
Identities = 69/296 (23%), Positives = 122/296 (41%), Gaps = 31/296 (10%)
Query: 380 KRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGI 439
+ +G+G FG V+ G G EVAVK+ + + AE+ L H N++ I
Sbjct: 8 QESIGKGRFGEVWRGK-WRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAA 65
Query: 440 CIEGR----TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED- 494
+ LV + +GS+ +L+ R + E +K+AL A GLA+LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 495 ----SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR---EATEGSQHISTRVMGTFGYVA 547
P + HRD K+ N+L++ + T ++D GLA AT+ +GT Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 548 PEYAMTGHLL------VKSDVYSYGVVLLELLSGRKP----VDMSQPQGQENLVTWARPL 597
PE + ++D+Y+ G+V E+ D P +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 598 LTTREGLEQLVDPSLAGSYDFDDMAK-VAAIASMCVHPEVTHRPFMGEVVQALKLI 652
+ + EQ + P++ + + + +A I C + R + + L +
Sbjct: 241 M-RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 7e-64
Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 11/213 (5%)
Query: 370 LEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDRE-FIAEVEMLSR 427
+E + F LG G G V+ +G +A KL+ + R I E+++L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 428 LHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARG 487
+ +V G + E + GS++ L G + + K+++ +G
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKG 116
Query: 488 LAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVA 547
L YL E +++HRD K SN+L+ K+ DFG++ + + ++ +GT Y++
Sbjct: 117 LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMS 171
Query: 548 PEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVD 580
PE H V+SD++S G+ L+E+ GR P+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (530), Expect = 5e-62
Identities = 69/315 (21%), Positives = 128/315 (40%), Gaps = 40/315 (12%)
Query: 362 VKTFALSDLEKATEKFSSK---------RILGEGGFGCVYHGVM----DNGTEVAVKLLT 408
+ F D +A +F+ + +++G G FG V G + VA+K L
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 409 RN-NQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDK 467
+ R+F++E ++ + H N++ L G+ + ++ E + NGS++S L +
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---Q 120
Query: 468 NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527
N G + + G A G+ YL + +HRD A N+L+ + KVSDFGL+R
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 528 ATEGSQHISTR----VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQ 583
+ + + + APE SDV+SYG+V+ E++S +
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237
Query: 584 PQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMG 643
T + + ++ D + + + C + HRP G
Sbjct: 238 ----------------TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 644 EVVQALKLIYNDTDE 658
++V L + + +
Sbjct: 282 QIVNTLDKMIRNPNS 296
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 3e-61
Identities = 63/296 (21%), Positives = 120/296 (40%), Gaps = 30/296 (10%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGVMDNGTE-----VAVKLLTRNNQNGDR-EFIAEVEM 424
E + ++++G G FG VY G++ + VA+K L R +F+ E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 425 LSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGA 484
+ + H N+++L G+ + + ++ E + NG+++ L + G + + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGI 119
Query: 485 ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRV--MGT 542
A G+ YL N +HRD A N+L+ + KVSDFGL+R + + T
Sbjct: 120 AAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 543 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTRE 602
+ APE SDV+S+G+V+ E+++ + +
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--------------- 221
Query: 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDE 658
+ + ++ D + + + C E RP ++V L + D
Sbjct: 222 -VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 8e-61
Identities = 72/282 (25%), Positives = 122/282 (43%), Gaps = 31/282 (10%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
++ + +G+G FG V G G +VAVK + N + F+AE ++++L H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 63
Query: 435 KLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
+L+G+ +E + +V E + GS+ +L + R L + +K +L + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMT 553
+HRD A NVL+ +D KVSDFGL +EA+ + APE
Sbjct: 122 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALRE 174
Query: 554 GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLT-TREGLEQLVDPSL 612
KSDV+S+G++L E+ S + P + L + + P++
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 229
Query: 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654
+ C H + RP ++ + L+ I
Sbjct: 230 ------------YEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 9e-61
Identities = 68/284 (23%), Positives = 117/284 (41%), Gaps = 23/284 (8%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
E + LG+G FG V+ G + T VA+K L + F+ E +++ +L H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 75
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
+L + E +V E + GS+ L G + L + +A A G+AY+
Sbjct: 76 QLYAVVSEEP-IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVE-- 130
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG 554
+HRD +A+N+L+ ++ KV+DFGLAR + + APE A+ G
Sbjct: 131 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 555 HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAG 614
+KSDV+S+G++L EL + + + + V+
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQVERGYRM 233
Query: 615 SYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDTDE 658
+ + + C E RP + L+ + T+
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 6e-60
Identities = 73/305 (23%), Positives = 122/305 (40%), Gaps = 41/305 (13%)
Query: 375 EKFSSKRILGEGGFGCVYHGVM------DNGTEVAVKLLTRNNQNGDRE-FIAEVEMLSR 427
+ S + LG G FG V D VAVK+L + +RE ++E+++LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 428 L-HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHG--------------VDKNRGPL 472
L +H N+V L+G C G ++ E G + + L ++ + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 473 DWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532
D E + + A+G+A+L IHRD A N+LL K+ DFGLAR+ S
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 533 QH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV 591
+ + ++APE +SDV+SYG+ L EL S P +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256
Query: 592 TWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651
+++ A++ I C + RP ++VQ ++
Sbjct: 257 ------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
Query: 652 IYNDT 656
+++
Sbjct: 305 QISES 309
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-59
Identities = 73/295 (24%), Positives = 117/295 (39%), Gaps = 32/295 (10%)
Query: 369 DLEKATEKFSSKRI-LGEGGFGCVYHGVM---DNGTEVAVKLLTRNNQNGDRE-FIAEVE 423
L + I LG G FG V GV +VA+K+L + + D E + E +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 424 MLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALG 483
++ +L + +V+LIG+C + LV E+ G + L G R + ++
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQ 117
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR--VMG 541
+ G+ YL +HRD A NVLL + K+SDFGL++ + + R
Sbjct: 118 VSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 542 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTT 600
+ APE +SDV+SYGV + E LS G+KP + + + +
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 234
Query: 601 REGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655
E +L + S C + RP V Q ++ Y
Sbjct: 235 PECPPELYA-----------------LMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-59
Identities = 77/285 (27%), Positives = 125/285 (43%), Gaps = 31/285 (10%)
Query: 380 KRILGEGGFGCVYHGVMDN----GTEVAVKLLTRNNQNGD-REFIAEVEMLSRLHHRNLV 434
++G G FGCVYHG + + AVK L R G+ +F+ E ++ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 435 KLIGICIEGRTR-CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
L+GIC+ +V + +G + + + + + L A+G+ +L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLA- 147
Query: 494 DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG---SQHISTRVMGTFGYVAPEY 550
+ + +HRD A N +L++ FT KV+DFGLAR+ + S H T ++A E
Sbjct: 148 --SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 551 AMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610
T KSDV+S+GV+L EL++ P P N LL R L+ P
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR----LLQP 256
Query: 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655
+ + C HP+ RP E+V + I++
Sbjct: 257 E-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (510), Expect = 4e-59
Identities = 69/314 (21%), Positives = 122/314 (38%), Gaps = 47/314 (14%)
Query: 367 LSDLEKATEKFSSKRILGEGGFGCVYHGV------MDNGTEVAVKLLTRN-NQNGDREFI 419
L LE R +GEG FG V+ + T VAVK+L + + +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 420 AEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKN----------- 468
E +++ + N+VKL+G+C G+ CL++E + G + L + +
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 469 ---------RGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKV 519
PL ++ IA A G+AYL E + +HRD N L+ ++ K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181
Query: 520 SDFGLAREATEGSQ-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
+DFGL+R ++ PE +SDV++YGVVL E+ S
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 579 VDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTH 638
+ E + + D ++ + + ++ + +C
Sbjct: 242 PYYG---------------MAHEEVIYYVRDGNILACPE-NCPLELYNLMRLCWSKLPAD 285
Query: 639 RPFMGEVVQALKLI 652
RP + + L+ +
Sbjct: 286 RPSFCSIHRILQRM 299
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 6e-59
Identities = 66/281 (23%), Positives = 110/281 (39%), Gaps = 27/281 (9%)
Query: 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGD--REFIAEVEMLSRLHHR 431
E + +G G +G +G + K L + + ++EV +L L H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 432 NLVKLIGICIE--GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLA 489
N+V+ I+ T +V E G + S + K R LD E +++ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 490 YLHE--DSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVA 547
H D V+HRD K +NV L+ K+ DFGLAR + + +GT Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYYMS 182
Query: 548 PEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVD-MSQPQGQENLVTWARPLLTTREGLEQ 606
PE KSD++S G +L EL + P SQ + + +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI-------- 234
Query: 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647
Y + D I + ++ + HRP + E+++
Sbjct: 235 --------PYRYSDELN--EIITRMLNLKDYHRPSVEEILE 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (507), Expect = 1e-58
Identities = 70/282 (24%), Positives = 114/282 (40%), Gaps = 37/282 (13%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGD---REFIAEVEMLSRLH 429
+ FS R +G G FG VY + N VA+K ++ + + + ++ I EV L +L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLA 489
H N ++ G + T LV E + + ++ PL + GA +GLA
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLA 129
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549
YLH +IHRD KA N+LL + K+ DFG A + +GT ++APE
Sbjct: 130 YLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPE 181
Query: 550 YAMT---GHLLVKSDVYSYGVVLLELLSGRKP-VDMSQPQGQENLVTWARPLLTTREGLE 605
+ G K DV+S G+ +EL + P +M+ ++ P L + E
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 241
Query: 606 QLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647
+ C+ RP +++
Sbjct: 242 YFRN-----------------FVDSCLQKIPQDRPTSEVLLK 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 4e-58
Identities = 70/304 (23%), Positives = 118/304 (38%), Gaps = 46/304 (15%)
Query: 375 EKFSSKRILGEGGFGCVYHGVM------DNGTEVAVKLLTRNNQNGDRE-FIAEVEMLSR 427
E ++LG G FG V + +VAVK+L + +RE ++E++M+++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 428 L-HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHG-------------------VDK 467
L H N+V L+G C L++E G + ++L ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 468 NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527
+ L +E + A A+G+ +L +HRD A NVL+ K+ DFGLAR+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 528 ATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQG 586
S + + ++APE G +KSDV+SYG++L E+ S P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 587 QENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVV 646
+L+ F ++ I C + RP +
Sbjct: 274 AN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
Query: 647 QALK 650
L
Sbjct: 319 SFLG 322
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-57
Identities = 68/284 (23%), Positives = 114/284 (40%), Gaps = 33/284 (11%)
Query: 381 RILGEGGFGCVYHGVMDN---GTEVAVKLLTRNNQNGD--REFIAEVEMLSRLHHRNLVK 435
+ LG G FG V G VAVK+L + E +AE ++ +L + +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 436 LIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS 495
+IGIC E + LV E+ G + +L + + +++ + G+ YL
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLE--- 124
Query: 496 NPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTR--VMGTFGYVAPEYAMT 553
+HRD A NVLL K+SDFGL++ + + + APE
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 554 GHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612
KSDV+S+GV++ E S G+KP + ++ + ++ D
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD--- 241
Query: 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656
+ ++C +V +RP V L+ Y D
Sbjct: 242 --------------LMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 1e-57
Identities = 64/280 (22%), Positives = 115/280 (41%), Gaps = 28/280 (10%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN 432
+ + LG+G FG VY + A K++ ++ +++ E+++L+ H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
+VKL+ ++ E G+V++ + + PL + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLH 127
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM 552
+ ++IHRD KA N+L D K++DFG++ + T Q + + GT ++APE M
Sbjct: 128 D---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVM 183
Query: 553 TGHLL-----VKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607
K+DV+S G+ L+E+ P P + + P
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP----------- 232
Query: 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647
P+LA + K C+ V R +++Q
Sbjct: 233 --PTLAQPSRWSSNFK--DFLKKCLEKNVDARWTTSQLLQ 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 1e-56
Identities = 68/277 (24%), Positives = 106/277 (38%), Gaps = 32/277 (11%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTR---NNQNGDREFIAEVEMLSRLHH 430
E F R LG+G FG VY + +A+K+L + + + EVE+ S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY 490
N+++L G + L+ E G+V L D + A L+Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSY 121
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
H RVIHRD K N+LL K++DFG + A + + GT Y+ PE
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEM 175
Query: 551 AMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610
K D++S GV+ E L G+ P + + Q ++ V
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFVTE 229
Query: 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647
+ S + + RP + EV++
Sbjct: 230 GA------------RDLISRLLKHNPSQRPMLREVLE 254
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-56
Identities = 72/293 (24%), Positives = 117/293 (39%), Gaps = 30/293 (10%)
Query: 369 DLEKATEKFSSKRILGEGGFGCVYHGVM----DNGTEVAVKLLTRNNQNGDRE-FIAEVE 423
D E E+ R +GEG FG V+ G+ + VA+K + RE F+ E
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 424 MLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALG 483
+ + H ++VKLIG+ E ++ EL G + S L + LD + + A
Sbjct: 61 TMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQ 116
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF 543
+ LAYL R +HRD A NVL+ + K+ DFGL+R + + + +++
Sbjct: 117 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 544 GYVAPEYAMTGHLLVKSDVYSYGVVLLELL-SGRKPVDMSQPQGQENLVTWARPLLTTRE 602
++APE SDV+ +GV + E+L G KP + + L
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 233
Query: 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655
L + + C + + RP E+ L I +
Sbjct: 234 CPPTLYS-----------------LMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-56
Identities = 62/276 (22%), Positives = 108/276 (39%), Gaps = 32/276 (11%)
Query: 380 KRILGEGGFGCVYHGV-MDNGTEVAVKLL--TRNNQNGDREFIAEVEMLSRLHHRNLVKL 436
+G G F VY G+ + EVA L + ++ + F E EML L H N+V+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 437 IGICIE----GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
+ LV EL+ +G+++++L + + +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 493 EDSNPRVIHRDFKASNVLLED-DFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA 551
P +IHRD K N+ + + K+ D GLA + V+GT ++APE
Sbjct: 130 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEM- 184
Query: 552 MTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611
DVY++G+ +LE+ + P Q Q ++
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------YRRVTSGV 229
Query: 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647
S+D + +V I C+ R + +++
Sbjct: 230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 1e-54
Identities = 64/275 (23%), Positives = 116/275 (42%), Gaps = 25/275 (9%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRN 432
+K++ +G+G G VY + + G EVA++ + Q I E+ ++ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
+V + + G +V E + GS+ + +D + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH 133
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM 552
+ +VIHRD K+ N+LL D + K++DFG + T ST V GT ++APE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVT 189
Query: 553 TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612
K D++S G++ +E++ G P P L+ G +L +P
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI--------ATNGTPELQNPE- 240
Query: 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647
+ + + C+ +V R E++Q
Sbjct: 241 ----KLSAIFR--DFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-54
Identities = 65/277 (23%), Positives = 104/277 (37%), Gaps = 26/277 (9%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLL-TRNNQNGDREFIAEVEMLSRLHHRN 432
E + + LGEG +G V V VAVK++ + + E+ + L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
+VK G EG + L E G + + + + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ-HISTRVMGTFGYVAPEYA 551
+ HRD K N+LL++ K+SDFGLA ++ + ++ GT YVAPE
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 552 MTGHLL-VKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610
DV+S G+VL +L+G P D QE +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-------------T 224
Query: 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647
L D A+ + + R + ++ +
Sbjct: 225 YLNPWKKIDSAPL--ALLHKILVENPSARITIPDIKK 259
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 4e-54
Identities = 66/300 (22%), Positives = 119/300 (39%), Gaps = 42/300 (14%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNG---TEVAVKLLTRN-NQNGDREFIAEVEMLSRL-H 429
+ ++GEG FG V + + A+K + +++ R+F E+E+L +L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHG------------VDKNRGPLDWEAR 477
H N++ L+G C L E +G++ L + L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 478 MKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIST 537
+ A ARG+ YL + + IHRD A N+L+ +++ K++DFGL+R + T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 538 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP--VDMSQPQGQENLVTWAR 595
++A E SDV+SYGV+L E++S M+ + E L R
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244
Query: 596 PLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655
+ +V + C + RP +++ +L + +
Sbjct: 245 L------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-53
Identities = 77/303 (25%), Positives = 110/303 (36%), Gaps = 43/303 (14%)
Query: 357 TCILSVKTFALSDLEKATEKFSSKRILGEGGFGCVYHGVMD----NGTEVAVKLLTR--- 409
TC++ K L LG+G FG V G D VAVK L
Sbjct: 2 TCLIGEKDLRL------------LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL 49
Query: 410 NNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNR 469
+ +FI EV + L HRNL++L G+ + +V EL GS+ L K++
Sbjct: 50 SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLR---KHQ 105
Query: 470 GPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529
G + A+ A G+ YL R IHRD A N+LL K+ DFGL R
Sbjct: 106 GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162
Query: 530 EGSQH--ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ 587
+ H + F + APE T SD + +GV L E+ + + P
Sbjct: 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIG 217
Query: 588 ENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647
N + E L + D + + C + RP +
Sbjct: 218 LNGSQILHKIDKEGERLPRPEDCP----------QDIYNVMVQCWAHKPEDRPTFVALRD 267
Query: 648 ALK 650
L
Sbjct: 268 FLL 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 5e-53
Identities = 67/297 (22%), Positives = 128/297 (43%), Gaps = 31/297 (10%)
Query: 366 ALSDLEKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVK-----LLTRNNQNGDREFI 419
AL + K TE F ++LG G FG VY G+ + G +V + L + ++E +
Sbjct: 1 ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 59
Query: 420 AEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMK 479
E +++ + + ++ +L+GIC+ T L+ +L+ G L V +++ + + +
Sbjct: 60 DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGC---LLDYVREHKDNIGSQYLLN 115
Query: 480 IALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE-ATEGSQHISTR 538
+ A+G+ YL + R++HRD A NVL++ K++DFGLA+ E ++ +
Sbjct: 116 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
Query: 539 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLL 598
++A E + +SDV+SYGV + EL++ P +
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------- 221
Query: 599 TTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655
+ +++ V I C + RP E++ + D
Sbjct: 222 -----ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 5e-52
Identities = 74/296 (25%), Positives = 134/296 (45%), Gaps = 33/296 (11%)
Query: 369 DLEKATEKFSSKRILGEGGFGCVYHGV------MDNGTEVAVKLLTRNNQNGDR-EFIAE 421
+ E A EK + R LG+G FG VY GV + T VA+K + +R EF+ E
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 422 VEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLH------GVDKNRGPLDWE 475
++ + ++V+L+G+ +G+ ++ EL+ G ++S+L + P
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 476 ARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ-H 534
+++A A G+AYL+ + +HRD A N ++ +DFT K+ DFG+ R+ E
Sbjct: 134 KMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWA 594
+ + +++PE G SDV+S+GVVL E+ + +
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG------------ 238
Query: 595 RPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650
L+ + L +++ L D + + + MC RP E++ ++K
Sbjct: 239 ---LSNEQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 176 bits (448), Expect = 7e-50
Identities = 48/207 (23%), Positives = 82/207 (39%), Gaps = 11/207 (5%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL 433
+ + LG G FG V+ G A K + +++ E++ +S L H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
V L + ++YE + G + + + + ++ +GL ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 494 DSNPRVIHRDFKASNVLL--EDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA 551
+H D K N++ + K+ DFGL T GT + APE A
Sbjct: 143 ---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVA 197
Query: 552 MTGHLLVKSDVYSYGVVLLELLSGRKP 578
+ +D++S GV+ LLSG P
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSP 224
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-49
Identities = 70/301 (23%), Positives = 122/301 (40%), Gaps = 42/301 (13%)
Query: 375 EKFSSKRILGEGGFGCVYHGVM--------DNGTEVAVKLLTRN-NQNGDREFIAEVEML 425
++ + LGEG FG V + T+VAVK+L + + + I+E+EM+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 426 SRL-HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLH------------GVDKNRGPL 472
+ H+N++ L+G C + ++ E G++ +L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 473 DWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532
+ + A ARG+ YL + IHRD A NVL+ +D K++DFGLAR+
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 533 QHISTRVM-GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV 591
+ T ++APE +SDV+S+GV+L E+ + P +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245
Query: 592 TWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651
L +L+ + ++ + C H + RP ++V+ L
Sbjct: 246 ------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
Query: 652 I 652
I
Sbjct: 294 I 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 8e-49
Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 12/213 (5%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRN---NQNGDREFIAEVEMLS 426
+K E F +ILGEG F V + E A+K+L + +N E +++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 427 RLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAAR 486
RL H VKL + NG + ++ G D
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVS 119
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE-ATEGSQHISTRVMGTFGY 545
L YLH +IHRD K N+LL +D +++DFG A+ + E Q + +GT Y
Sbjct: 120 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 546 VAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP 578
V+PE SD+++ G ++ +L++G P
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 9e-49
Identities = 68/298 (22%), Positives = 118/298 (39%), Gaps = 40/298 (13%)
Query: 375 EKFSSKRILGEGGFGCVYHGVM------DNGTEVAVKLLTRNNQNGD-REFIAEVEMLSR 427
++ + LG G FG V VAVK+L + + R ++E+++L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 428 -LHHRNLVKLIGICIE-GRTRCLVYELVHNGSVESHLHG------------VDKNRGPLD 473
HH N+V L+G C + G ++ E G++ ++L D + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 474 WEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533
E + + A+G+ +L + IHRD A N+LL + K+ DFGLAR+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 534 HI-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVT 592
++ ++APE ++SDV+S+GV+L E+ S P +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDE 244
Query: 593 WARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650
L + + ++ C H E + RP E+V+ L
Sbjct: 245 EFCRRLKEGTRMRAPDYTT----------PEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 170 bits (432), Expect = 1e-47
Identities = 47/207 (22%), Positives = 80/207 (38%), Gaps = 11/207 (5%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL 433
+ + LG G FG V+ V G K + E+ ++++LHH L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
+ L + L+ E + G + + + + A GL ++HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 494 DSNPRVIHRDFKASNVLLE--DDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA 551
++H D K N++ E + K+ DFGLA + T T + APE
Sbjct: 146 ---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIV 200
Query: 552 MTGHLLVKSDVYSYGVVLLELLSGRKP 578
+ +D+++ GV+ LLSG P
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSP 227
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 167 bits (425), Expect = 1e-47
Identities = 67/292 (22%), Positives = 116/292 (39%), Gaps = 32/292 (10%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGD---REFIAEVEMLSRLH 429
++++ ILG GG V+ + +VAVK+L + F E + + L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 430 HRNLVKLIGICIE----GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAA 485
H +V + G +V E V ++ +H GP+ + +++ A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADAC 121
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI--STRVMGTF 543
+ L + H+ +IHRD K +N+++ KV DFG+AR + + + V+GT
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 544 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREG 603
Y++PE A + +SDVYS G VL E+L+G P P P+
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI------ 232
Query: 604 LEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRP-FMGEVVQALKLIYN 654
P A A+ + +R E+ L ++N
Sbjct: 233 ------PPSARHEGLSADLD--AVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 166 bits (422), Expect = 4e-47
Identities = 64/290 (22%), Positives = 110/290 (37%), Gaps = 40/290 (13%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLL---------TRNNQNGDREFIAEVEM 424
E + K ILG G V + E AVK++ Q + EV++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 425 LSRLH-HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALG 483
L ++ H N+++L LV++L+ G + +L + L + KI
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRA 118
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTF 543
+ LH+ ++HRD K N+LL+DD K++DFG + + G + V GT
Sbjct: 119 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTP 173
Query: 544 GYVAPEYAMTGHLL------VKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL 597
Y+APE + D++S GV++ LL+G P + ++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 598 LTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647
+ E D+ D K + S + + R E +
Sbjct: 234 FGSPE------------WDDYSDTVK--DLVSRFLVVQPQKRYTAEEALA 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (417), Expect = 4e-46
Identities = 58/279 (20%), Positives = 96/279 (34%), Gaps = 22/279 (7%)
Query: 371 EKATEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDRE-FIAEVEMLSRL 428
E + + + +LG G F V VA+K + + G E+ +L ++
Sbjct: 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI 64
Query: 429 HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGL 488
H N+V L I G L+ +LV G + + +G ++ +
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAV 120
Query: 489 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAP 548
YLH+ + L++D +SDFGL++ GS + + GT GYVAP
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAP 178
Query: 549 EYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608
E D +S GV+ LL G P + L+
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI------------LKAEY 226
Query: 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647
+ D D AK + + R + +Q
Sbjct: 227 EFDSPYWDDISDSAK--DFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 6e-46
Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 13/227 (5%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDRE---FIAEVEMLSR-LH 429
E F ++LG+G FG V+ A+K L ++ D + + E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 430 HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLA 489
H L + V E ++ G + H+ + D A GL
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQ 117
Query: 490 YLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549
+LH +++RD K N+LL+ D K++DFG+ +E G +T GT Y+APE
Sbjct: 118 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE 173
Query: 550 YAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARP 596
+ D +S+GV+L E+L G+ P + + + P
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 220
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 165 bits (418), Expect = 1e-45
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 18/225 (8%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTR---NNQNGDREFIAEVEMLSRLH- 429
FS RI+G GGFG VY D G A+K L + + G+ + E MLS +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 430 --HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARG 487
+V + + +L++ G + HL G A G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILG 119
Query: 488 LAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVA 547
L ++H V++RD K +N+LL++ ++SD GLA + ++ H +GT GY+A
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMA 173
Query: 548 PEYAMTGHLL-VKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV 591
PE G +D +S G +L +LL G P + + + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-45
Identities = 45/225 (20%), Positives = 81/225 (36%), Gaps = 12/225 (5%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL 433
EK+ LG G FG V+ V + K + + E+ +L+ HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNI 63
Query: 434 VKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
+ L +++E + + ++ + L+ + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 494 DSNPRVIHRDFKASNVLL--EDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA 551
+ H D + N++ T K+ +FG AR+ G + Y APE
Sbjct: 121 ---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVH 175
Query: 552 MTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARP 596
+ +D++S G ++ LLSG P Q + A
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 4e-44
Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 9/223 (4%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDRE-FIAEVEMLSRLHHR 431
++++ +GEG +G V N VA+K ++ + + E+++L R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
N++ + I + + + + L+ + K L + RGL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKYI 125
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIS--TRVMGTFGYVAPE 549
H V+HRD K SN+LL K+ DFGLAR A H T + T Y APE
Sbjct: 126 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 550 YAMTGHLLVKS-DVYSYGVVLLELLSGRKPVDMSQPQGQENLV 591
+ KS D++S G +L E+LS R Q N +
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 158 bits (400), Expect = 4e-44
Identities = 58/286 (20%), Positives = 107/286 (37%), Gaps = 20/286 (6%)
Query: 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLL--TRNNQNGDREFIAEVEMLSRLHHRN 432
EK+ +GEG +G VY + G A+K + + ++ I E+ +L L H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
+VKL + + LV+E + +D G L+ L G+AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDL----KKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAM 552
+ RV+HRD K N+L+ + K++DFGLAR + + ++ +
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 553 TGHLLVKSDVYSYGVVLLELLSGRKPVD----------MSQPQGQENLVTWARPLLTTRE 602
+ D++S G + E+++G + + G N W +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 603 GLEQLVDPSLAGSYDFDDMAKVAA-IASMCVHPEVTHRPFMGEVVQ 647
V L + + + S + + R + ++
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-43
Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 9/207 (4%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLL--TRNNQNGDREFIAEVEMLSRLHHR 431
E F +GEG +G VY G VA+K + + I E+ +L L+H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
N+VKL+ + LV+E +H + + +GLA+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA 551
H RV+HRD K N+L+ + K++DFGLAR + + V+ +
Sbjct: 119 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 552 MTGHLLVKSDVYSYGVVLLELLSGRKP 578
+ D++S G + E+++ R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 1e-42
Identities = 68/299 (22%), Positives = 110/299 (36%), Gaps = 33/299 (11%)
Query: 372 KATEKFSSKRILGEGGFGCVYHG--VMDNGTEVAVKLL--TRNNQNGDREFIAEVEMLSR 427
+A +++ +GEG +G V+ + + G VA+K + + I EV +L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 428 L---HHRNLVKLIGICIEGRTR-----CLVYELVHNGSVESHLHGVDKNRGPLDWEARMK 479
L H N+V+L +C RT LV+E V + E
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKD 120
Query: 480 IALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRV 539
+ RGL +LH RV+HRD K N+L+ K++DFGLAR + T V
Sbjct: 121 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSV 175
Query: 540 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV-------- 591
+ T Y APE + D++S G + E+ + S Q +
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 592 --TWARPLLTTREGLEQLVDPSLAGSY-DFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647
W R + R+ + D D++ K + C+ R +
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGK--DLLLKCLTFNPAKRISAYSALS 292
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (387), Expect = 4e-42
Identities = 52/286 (18%), Positives = 94/286 (32%), Gaps = 30/286 (10%)
Query: 376 KFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
++ R +G G FG +Y G + G EVA+KL + + E ++ + +
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGI 65
Query: 435 KLIGICI-EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
I C EG +V EL+ + + + +A + Y+H
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPS----LEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 494 DSNPRVIHRDFKASNVLLED---DFTPKVSDFGLAREATEGSQHI------STRVMGTFG 544
IHRD K N L+ + DFGLA++ + H + + GT
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 545 YVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604
Y + + + D+ S G VL+ G P + + R
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY--------ERISE 230
Query: 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650
+++ P + + C +P + Q +
Sbjct: 231 KKMSTPIEVLCKGYPSEFA--TYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 152 bits (385), Expect = 1e-41
Identities = 53/226 (23%), Positives = 92/226 (40%), Gaps = 15/226 (6%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRN---NQNGDREFIAEVEMLSRLHH 430
+ F R LG G FG V+ NG A+K+L + E MLS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY 490
++++ G + + ++ + + L + + A L Y
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
LH +I+RD K N+LL+ + K++DFG A+ + ++ + GT Y+APE
Sbjct: 120 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEV 172
Query: 551 AMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARP 596
T D +S+G+++ E+L+G P S + A
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL 218
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-41
Identities = 53/219 (24%), Positives = 89/219 (40%), Gaps = 17/219 (7%)
Query: 377 FSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVK 435
++ +++G G FG VY D+G VA+K + ++ + +RE ++++ +L H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVR 77
Query: 436 LIGICIEGRTR------CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLA 489
L + LV + V H + + L R LA
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 490 YLHEDSNPRVIHRDFKASNVLL-EDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAP 548
Y+H + HRD K N+LL D K+ DFG A++ G ++ + + +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYRAPE 192
Query: 549 EYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ 587
DV+S G VL ELL G+ Q
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 7e-41
Identities = 58/222 (26%), Positives = 90/222 (40%), Gaps = 20/222 (9%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDR------EFIAEVEMLSR 427
+ + + LG G F V G + A K + + R + EV +L
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 428 LHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARG 487
+ H N++ L + L+ ELV G L + L E + G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 488 LAYLHEDSNPRVIHRDFKASNVLLEDDFTP----KVSDFGLAREATEGSQHISTRVMGTF 543
+ YLH ++ H D K N++L D P K+ DFGLA + G++ + GT
Sbjct: 126 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTP 180
Query: 544 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQ 585
+VAPE L +++D++S GV+ LLSG P Q
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 222
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 149 bits (377), Expect = 8e-41
Identities = 45/291 (15%), Positives = 83/291 (28%), Gaps = 36/291 (12%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRN 432
+ R +GEG FG ++ G + N +VA+K R + + E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTG 62
Query: 433 LVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLH 492
+ + EG LV +L+ S +D + A + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 493 EDSNPRVIHRDFKASNVLLEDDFTP-----KVSDFGLAREATEGS------QHISTRVMG 541
E +++RD K N L+ + V DFG+ + + + G
Sbjct: 119 E---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 542 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWA--RPLLT 599
T Y++ + + D+ + G V + L G P + + + T
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 600 TREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650
L + P +
Sbjct: 236 PLRELCAGFPEEF------------YKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-40
Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 15/218 (6%)
Query: 381 RILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDRE-----FIAEVEMLSRLHHRNLV 434
LGEG F VY + VA+K + +++ ++ + E+++L L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 435 KLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED 494
L+ LV++ + + N L L +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ- 118
Query: 495 SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTG 554
++HRD K +N+LL+++ K++DFGLA+ ++ + +V T Y APE
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 555 HLL-VKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV 591
+ V D+++ G +L ELL + Q +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-39
Identities = 58/277 (20%), Positives = 100/277 (36%), Gaps = 31/277 (11%)
Query: 380 KRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLI 437
++LG G G V + A+K+L + EVE+ R ++V+++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIV 71
Query: 438 GIC----IEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE 493
+ + +V E + G + S + D+ +I + YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 494 DSNPRVIHRDFKASNVLL---EDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
+ HRD K N+L + K++DFG A+E T + + T YVAPE
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEV 184
Query: 551 AMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610
D++S GV++ LL G P L R G + +P
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPP-----FYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647
+ + + K + + E T R + E +
Sbjct: 240 EWS---EVSEEVK--MLIRNLLKTEPTQRMTITEFMN 271
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 9e-39
Identities = 48/207 (23%), Positives = 86/207 (41%), Gaps = 10/207 (4%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLL--TRNNQNGDREFIAEVEMLSRLHHR 431
+K+ +GEG +G V+ + VA+K + +++ + E+ +L L H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 432 NLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYL 491
N+V+L + + LV+E D G LD E +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 492 HEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYA 551
H + V+HRD K N+L+ + K+++FGLAR + S V+ +
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 552 MTGHLLVKSDVYSYGVVLLELLSGRKP 578
D++S G + EL + +P
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-38
Identities = 48/214 (22%), Positives = 85/214 (39%), Gaps = 20/214 (9%)
Query: 376 KFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDRE------FIAEVEMLSRL 428
++ +LG GGFG VY G+ + + VA+K + ++ + E EV +L ++
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 429 H--HRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAAR 486
+++L+ + L+ E RG L E
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLE 121
Query: 487 GLAYLHEDSNPRVIHRDFKASNVLL-EDDFTPKVSDFGLAREATEGSQHISTRVMGTFGY 545
+ + H V+HRD K N+L+ + K+ DFG + + T GT Y
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVY 175
Query: 546 VAPEYAMTGHLLVKS-DVYSYGVVLLELLSGRKP 578
PE+ +S V+S G++L +++ G P
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 5e-38
Identities = 49/236 (20%), Positives = 91/236 (38%), Gaps = 13/236 (5%)
Query: 363 KTFALSDLEKATEKFSSK----RILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGD-- 415
F ++ K + + + +G G +G V V G +VA+K L R Q+
Sbjct: 2 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA 61
Query: 416 REFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWE 475
+ E+ +L + H N++ L+ + T + G L +
Sbjct: 62 KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 121
Query: 476 ARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 535
+ +GL Y+H +IHRD K N+ + +D K+ DFGLAR+A +
Sbjct: 122 RIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEM 175
Query: 536 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV 591
+ V+ + D++S G ++ E+++G+ S Q +
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-38
Identities = 56/226 (24%), Positives = 81/226 (35%), Gaps = 12/226 (5%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDRE---FIAEVEMLSRLHH 430
F ++LG+G FG V G A+K+L + E + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY 490
L L C V E + G + HL E L Y
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEY 120
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
LH V++RD K N++L+ D K++DFGL +E GT Y+APE
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEV 176
Query: 551 AMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARP 596
D + GVV+ E++ GR P + L+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 222
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-36
Identities = 54/232 (23%), Positives = 95/232 (40%), Gaps = 22/232 (9%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGD--REFIAEVEMLSRLHHR 431
K+ +G+G FG V+ G +VA+K + N+ + E+++L L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 432 NLVKLIGICIEGRTR--------CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALG 483
N+V LI IC + LV++ + + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQM 125
Query: 484 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ---HISTRVM 540
GL Y+H +++HRD KA+NVL+ D K++DFGLAR + + T +
Sbjct: 126 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 541 GTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV 591
T Y PE + D++ G ++ E+ + + + Q Q L+
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (349), Expect = 2e-36
Identities = 53/226 (23%), Positives = 92/226 (40%), Gaps = 15/226 (6%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDRE---FIAEVEMLSRLHH 430
++F + LG G FG V ++G A+K+L + ++ + E +L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY 490
LVKL + +V E V G + SHL G A Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEY 156
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
LH +I+RD K N+L++ +V+DFG A+ + + + GT +APE
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPEALAPEI 209
Query: 551 AMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARP 596
++ D ++ GV++ E+ +G P QP + +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 7e-33
Identities = 52/215 (24%), Positives = 86/215 (40%), Gaps = 18/215 (8%)
Query: 375 EKFSSKRILGEGGFGCVYHGV----MDNGTEVAVKLLTRNNQNGD----REFIAEVEMLS 426
E F ++LG G +G V+ D G A+K+L + E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 427 RL-HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAA 485
+ LV L L+ + ++ G + +HL R
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIV 139
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGY 545
L +LH+ +I+RD K N+LL+ + ++DFGL++E + GT Y
Sbjct: 140 LALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 546 VAPEYAMTGHLLV--KSDVYSYGVVLLELLSGRKP 578
+AP+ G D +S GV++ ELL+G P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-32
Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 21/226 (9%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTR--NNQNGDREFIAEVEMLSRLHHR 431
+++ + + +G G G V VA+K L+R NQ + E+ ++ ++H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 432 NLVKLIGICI------EGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAA 485
N++ L+ + E + LV EL+ + + LD E +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQML 129
Query: 486 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGY 545
G+ +LH +IHRD K SN++++ D T K+ DFGLAR T G+ + T + T Y
Sbjct: 130 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 184
Query: 546 VAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV 591
APE + D++S G ++ E++ + Q N V
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-32
Identities = 52/221 (23%), Positives = 89/221 (40%), Gaps = 9/221 (4%)
Query: 374 TEKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGD--REFIAEVEMLSRLHH 430
E++ + +G G +G V G VAVK L+R Q+ + E+ +L + H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY 490
N++ L+ + R+ ++ + L + + RGL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPEY 550
+H +IHRD K SN+ + +D K+ DFGLAR ++ V +
Sbjct: 137 IHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIM 190
Query: 551 AMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV 591
H D++S G ++ ELL+GR + Q L+
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (313), Expect = 6e-32
Identities = 45/210 (21%), Positives = 88/210 (41%), Gaps = 21/210 (10%)
Query: 375 EKFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRN 432
+ + R LG G + V+ + + N +V VK+L + ++ E+++L L N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 433 LVKLIGICIE--GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY 490
++ L I + RT LV+E V+N + L + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDY 144
Query: 491 LHEDSNPRVIHRDFKASNVLL-EDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAPE 549
H ++HRD K NV++ + ++ D+GLA G ++ + + + PE
Sbjct: 145 CHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPE 199
Query: 550 YAMTGHLL-VKSDVYSYGVVLLELLSGRKP 578
+ + D++S G +L ++ ++P
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (283), Expect = 8e-28
Identities = 54/275 (19%), Positives = 102/275 (37%), Gaps = 19/275 (6%)
Query: 376 KFSSKRILGEGGFGCVYHGV-MDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLV 434
++ R LG G F V+ M N T VA+K++ R ++ E+++L R++ +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 435 KLIGICIEGRTRCLVYE-----------LVHNGSVESHLHGVDKNRGPLDWEARMK-IAL 482
K + + L + +V E+ L + K +K I+
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 483 GAARGLAYLHEDSNPRVIHRDFKASNVLLE-DDFTPKVSDFGLAREATEGS-QHISTRVM 540
GL Y+H +IH D K NVL+E D + +A T +
Sbjct: 133 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 541 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ-ENLVTWARPLLT 599
T Y +PE + +D++S ++ EL++G + + ++ A+ +
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 600 TREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHP 634
E L+ F+ + I+ + P
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP 285
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 95.6 bits (237), Expect = 3e-23
Identities = 29/157 (18%), Positives = 52/157 (33%), Gaps = 21/157 (13%)
Query: 381 RILGEGGFGCVYHGVMDNGTEVAVKLL----------TRNNQNGDREFIAEVEMLSRLHH 430
+++GEG V++ + E VK GD F +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 431 RNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAY 490
R L KL G+ + VY N + + + R ++ + +A
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118
Query: 491 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527
+ ++H D NVL+ + + DF + E
Sbjct: 119 FYH---RGIVHGDLSQYNVLV-SEEGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 780 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.54 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.89 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.31 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.63 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.44 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.6 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=435.67 Aligned_cols=256 Identities=30% Similarity=0.467 Sum_probs=202.5
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
++|+..+.||+|+||+||+|.+.+++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788889999999999999999889999999997643 456789999999999999999999999999999999999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+|+|.+++. .....++|..+++|+.|||.||+|||+.+ |+||||||+|||+++++++||+|||+++........
T Consensus 84 ~g~L~~~l~---~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999999986 34567999999999999999999999998 999999999999999999999999999987655444
Q ss_pred ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCC-CCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP-VDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P-~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
......||..|+|||++.++.++.|+|||||||+||||+|++.| +..... ..+...+. . . .....|
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~~i~---~-~---~~~~~p--- 224 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDIS---T-G---FRLYKP--- 224 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHHHHH---H-T---CCCCCC---
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHHHHH---h-c---CCCCCc---
Confidence 44556799999999999999999999999999999999996554 433221 11211111 0 0 001111
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
......+.+++.+||+.||++||||+||++.|++|.+
T Consensus 225 ----~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 ----RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1223578899999999999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=437.93 Aligned_cols=261 Identities=25% Similarity=0.393 Sum_probs=214.3
Q ss_pred HhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 373 ATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 373 at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
..++|+..+.||+|+||+||+|.+++++.||||+++... ...++|.+|++++++++|||||+++|+|.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 357888999999999999999999888999999997643 456789999999999999999999998865 567999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++|+|.++++. .....++|..+++|+.|||+||+|||+.+ |+||||||+||||++++.+||+|||+|+......
T Consensus 89 ~~~g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999998864 23346999999999999999999999987 9999999999999999999999999999876654
Q ss_pred ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
....+...||+.|||||++.++.++.|+|||||||+||||+||+.|+...... ..+...+.. -..+..
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~~i~~----------~~~~~~ 231 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNLER----------GYRMVR 231 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHT----------TCCCCC
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHHHHHh----------cCCCCC
Confidence 44445567999999999999999999999999999999999976665432211 111111110 001111
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
+......+.+++.+||+.||++||||+||++.|+.+...+
T Consensus 232 ----p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 232 ----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 1122356889999999999999999999999999887643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-51 Score=438.64 Aligned_cols=270 Identities=27% Similarity=0.468 Sum_probs=208.3
Q ss_pred cccchHHHHHHhcCc---------ccceeecccCceEEEEEEEe-CC---cEEEEEEeeccCC-cchHHHHHHHHHhhhc
Q 048425 363 KTFALSDLEKATEKF---------SSKRILGEGGFGCVYHGVMD-NG---TEVAVKLLTRNNQ-NGDREFIAEVEMLSRL 428 (780)
Q Consensus 363 ~~f~~~el~~at~~f---------~~~~~LG~G~fG~VYkg~l~-~g---~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L 428 (780)
..|+++|+.+|+.+| +..++||+|+||+||+|.+. +| ..||||++..... ...++|.+|+++|+++
T Consensus 5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l 84 (299)
T d1jpaa_ 5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84 (299)
T ss_dssp CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence 356777777776555 44689999999999999975 23 3589998865433 3346799999999999
Q ss_pred CCCceeeeeeeeeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcc
Q 048425 429 HHRNLVKLIGICIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASN 508 (780)
Q Consensus 429 ~HpNIV~L~g~~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsN 508 (780)
+|||||+++|+|.+++..++||||+++|+|.+++. .....++|.++++|+.|||+||+|||+.+ |+||||||+|
T Consensus 85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~---~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~N 158 (299)
T d1jpaa_ 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARN 158 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeec---cccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccce
Confidence 99999999999999999999999999999999886 34557999999999999999999999987 9999999999
Q ss_pred eEEcCCCCCeeecccccccccCCCccc----eeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCC
Q 048425 509 VLLEDDFTPKVSDFGLAREATEGSQHI----STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQ 583 (780)
Q Consensus 509 ILLd~~~~vKLsDFGLA~~~~~~~~~~----~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~ 583 (780)
|||++++++||+|||+++......... .....||+.|||||.+.++.++.++|||||||+||||+| |+.||....
T Consensus 159 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 159 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp EEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999775432211 123468999999999999999999999999999999998 899997543
Q ss_pred ccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 584 PQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 584 ~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
.. .+...+.. . .....+.+....+.+|+.+||+.||++||+|.||++.|++++++
T Consensus 239 ~~---~~~~~i~~----~----------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 239 NQ---DVINAIEQ----D----------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp HH---HHHHHHHT----T----------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HH---HHHHHHHc----C----------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 22 22221110 0 00112223446788999999999999999999999999988764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-51 Score=437.70 Aligned_cols=264 Identities=25% Similarity=0.381 Sum_probs=219.3
Q ss_pred HHHHhcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 370 LEKATEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 370 l~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
++...++|+..+.||+|+||+||+|++. +|+.||||+++... ...++|.+|+++|++++|||||+++|+|.+++..++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 3334578899999999999999999986 68899999997654 356789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||+++|+|.++|.. .....++|..+++|+.|||+||+|||+.+ |+||||||+||||++++++||+|||+|+..
T Consensus 91 v~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence 9999999999999964 34568999999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 529 TEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 529 ~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
........+...||+.|+|||++.++.++.|+|||||||+||||++|+.|+...... ..+...+
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~~~i-------------- 229 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELL-------------- 229 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHH--------------
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHHHHH--------------
Confidence 665544445567899999999999999999999999999999999987776432211 1111111
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
........+......+.+|+..||+.||++||||.||++.|+.+...
T Consensus 230 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred hcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11111112223345788999999999999999999999999987654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-51 Score=431.24 Aligned_cols=262 Identities=27% Similarity=0.476 Sum_probs=206.2
Q ss_pred hcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
.++|...+.||+|+||+||+|+++ ..||||+++... ....+.|.+|+++|++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467889999999999999999874 369999997543 3345689999999999999999999999865 56899999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+++|+|.++|+. ....++|..+++|+.|||+||+|||+.+ ||||||||+||||++++++||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 9999999999963 4457999999999999999999999987 999999999999999999999999999876543
Q ss_pred Cc-cceeccccCccccCchhhcc---CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 532 SQ-HISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 532 ~~-~~~t~~~GT~~Y~APE~l~~---~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
.. ...+...||+.|||||++.+ +.++.|+|||||||+||||+||+.||........ +...+ .. ..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~~~~----~~-----~~ 226 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIFMV----GR-----GY 226 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHHH----HH-----TS
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HHHHH----hc-----CC
Confidence 22 23356789999999999864 4589999999999999999999999975432211 11110 00 01
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
..+.+. ....+....+.+++.+||+.||++||||+||++.|+.+.+..
T Consensus 227 ~~p~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 227 LSPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CCCCGG-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCcch-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 111110 112223357889999999999999999999999999987643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=419.83 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=214.4
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecC
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVH 454 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 454 (780)
++|+..+.||+|+||+||+|++++++.||||+++.... ..++|++|++++++++|||||+++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57888999999999999999998888999999986543 56789999999999999999999999999999999999999
Q ss_pred CCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc
Q 048425 455 NGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 534 (780)
Q Consensus 455 ~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~ 534 (780)
+|+|.+++.. ....+++..+++|+.|+|+||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999999863 4457899999999999999999999998 999999999999999999999999999877655444
Q ss_pred ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 535 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 535 ~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
......||..|+|||.+.+..++.|+|||||||++|||+| |+.||...... .+..- +.. . ..+..
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~~~---i~~-~---~~~~~---- 222 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEH---IAQ-G---LRLYR---- 222 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHH---HHT-T---CCCCC----
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHHHH---HHh-C---CCCCC----
Confidence 4455679999999999999999999999999999999998 89999754422 11111 111 0 00111
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKL 651 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~ 651 (780)
+......+.+++.+||+.||++|||++||++.|.+
T Consensus 223 ---p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 223 ---PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ---cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 12233578899999999999999999999998864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-50 Score=422.67 Aligned_cols=259 Identities=22% Similarity=0.417 Sum_probs=204.3
Q ss_pred cCcccceeecccCceEEEEEEEeCC-----cEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNG-----TEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g-----~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
+.|+..++||+|+||+||+|.+++. ..||||+++..... ...+|.+|++++++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4678889999999999999997642 36999999765433 33579999999999999999999999999999999
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||+.+|+|.+++. .....++|.++++++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhh---cccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 999999999999875 34567999999999999999999999988 999999999999999999999999999987
Q ss_pred cCCCcc--ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 529 TEGSQH--ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 529 ~~~~~~--~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
...... ......||+.|||||++.++.++.|+|||||||+||||+||+.|+...... ..+...+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i------------ 226 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAI------------ 226 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH------------
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHHH------------
Confidence 544322 233456899999999999999999999999999999999977665432211 1121111
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
........+.+....+.+|+.+||+.||++||+|.||++.|+.+...
T Consensus 227 --~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 227 --NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp --HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11111122233446789999999999999999999999999988764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=419.84 Aligned_cols=257 Identities=27% Similarity=0.430 Sum_probs=209.4
Q ss_pred cCccccee-ecccCceEEEEEEEe---CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKRI-LGEGGFGCVYHGVMD---NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~-LG~G~fG~VYkg~l~---~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
++|...+. ||+|+||+||+|.+. ++..||||+++..... ..++|.+|+++|++++|||||+++|+|.+ +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 56767774 999999999999864 4567999999765433 34679999999999999999999999865 568999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++|+|.+++. ..+..+++..+++|+.|||+||+|||+.+ |+||||||+||||++++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 99999999999985 34567999999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCcc--ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccc
Q 048425 530 EGSQH--ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 530 ~~~~~--~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
..... ......||+.|||||++.++.++.|+|||||||++|||+| |+.||...... .+...+ ..+..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~i----~~~~~--- 230 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFI----EQGKR--- 230 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHH----HTTCC---
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCCC---
Confidence 54322 2234568999999999999999999999999999999998 99999754321 111111 11110
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
+ ..+......+.+|+.+||+.||++||+|.+|++.|+.+...
T Consensus 231 ---~----~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 231 ---M----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ---C----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---C----CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1 11222335788999999999999999999999999877643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=415.81 Aligned_cols=251 Identities=25% Similarity=0.344 Sum_probs=203.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|+..+.||+|+||+||+|+.. +|+.||||+++.... ...+.|.+|++++++++|||||++++++.+++..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 67999999999999999999975 799999999976533 2345699999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+++|+|.++|. ....+++.++..++.||+.||+|||+.+ |+||||||+|||+++++++||+|||+|+......
T Consensus 85 ~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999995 3557999999999999999999999998 9999999999999999999999999999875433
Q ss_pred -ccceeccccCccccCchhhccCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 533 -QHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 533 -~~~~t~~~GT~~Y~APE~l~~~~~-t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
....+..+||+.|||||++.+..+ +.++|||||||+||||+||+.||........ .+..+.. ..
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~~~~~----~~--------- 223 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE----KK--------- 223 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHHHHHT----TC---------
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHHHHhc----CC---------
Confidence 223456789999999999988876 5789999999999999999999975432211 1111100 00
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
............+.+++.+||+.||++|||++|+++
T Consensus 224 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 224 -TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000001112246778999999999999999999843
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=420.74 Aligned_cols=259 Identities=25% Similarity=0.395 Sum_probs=205.9
Q ss_pred hcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
.++|+..+.||+|+||+||+|++++++.||||+++.. ....+.|.+|+.++++++|+|||+++|+|.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 3679999999999999999999988889999999654 3456789999999999999999999999865 5679999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++|+|.+++.. .....++|.++++|+.|||.||+|||+.+ |+||||||+|||||+++++||+|||+++.......
T Consensus 94 ~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 94 SKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 99999999874 23346999999999999999999999998 99999999999999999999999999998765544
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
...+...||+.|+|||++.++.++.|+|||||||+||||+||+.|+...... ..+..++.. . ..
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~~----~------~~---- 232 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVER----G------YR---- 232 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHT----T------CC----
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHh----c------CC----
Confidence 4445567999999999999999999999999999999999977665432211 112222111 0 00
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
...+.+....+.+++.+||+.||++||+|++|+++|+.....
T Consensus 233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 111222335788999999999999999999999999876644
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=418.03 Aligned_cols=255 Identities=25% Similarity=0.340 Sum_probs=196.5
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeee--cceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIE--GRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~LV 449 (780)
++|+..+.||+|+||+||+|+.. +|+.||||+++..... ..+.|.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 68999999999999999999875 7999999999765432 23568999999999999999999999865 3567899
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS--NPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~--~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
|||+++|+|.+++....+....+++..++.++.|++.||+|||+.+ ..+||||||||+||||++++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999765555678999999999999999999999865 23599999999999999999999999999998
Q ss_pred ccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 528 ATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 528 ~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
...... ..+...||+.|||||++.+..++.|+|||||||+||||+||+.||...... .+... +... ..
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~---i~~~--~~--- 231 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGK---IREG--KF--- 231 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHH---HHHT--CC---
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHHH---HHcC--CC---
Confidence 755332 234568999999999999999999999999999999999999999754321 11111 1100 00
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+.+... ....+.+++.+||+.||++|||+.|+++
T Consensus 232 --~~~~~~----~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 --RRIPYR----YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --CCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCcc----cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111112 2346889999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-49 Score=414.12 Aligned_cols=249 Identities=27% Similarity=0.418 Sum_probs=199.7
Q ss_pred eeecccCceEEEEEEEeC---CcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeecCC
Q 048425 381 RILGEGGFGCVYHGVMDN---GTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELVHN 455 (780)
Q Consensus 381 ~~LG~G~fG~VYkg~l~~---g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 455 (780)
+.||+|+||+||+|.+.+ ++.||||+++..... ..++|.+|+++|++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998753 468999999654332 34679999999999999999999999964 567899999999
Q ss_pred CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCcc-
Q 048425 456 GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH- 534 (780)
Q Consensus 456 GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~~- 534 (780)
|+|.++++ ....++|..+++|+.|||.||+|||+.+ |+||||||+||||+.++.+||+|||+++........
T Consensus 92 g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999985 3457999999999999999999999988 999999999999999999999999999977554332
Q ss_pred -ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 535 -ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 535 -~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
......||+.|||||.+.++.++.|+|||||||++|||+| |+.||...... .+...+ ..+.
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~~i----~~~~---------- 227 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAML----EKGE---------- 227 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH----HTTC----------
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHHHH----HcCC----------
Confidence 2234679999999999999999999999999999999998 89999754321 111111 1110
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
....+......+.+|+.+||+.||++||+|+||++.|+....
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 011122233578899999999999999999999999987643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=422.18 Aligned_cols=258 Identities=27% Similarity=0.454 Sum_probs=207.4
Q ss_pred hcCcccceeecccCceEEEEEEEeC-C-----cEEEEEEeeccC-CcchHHHHHHHHHhhhc-CCCceeeeeeeeeecce
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDN-G-----TEVAVKLLTRNN-QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRT 445 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~-g-----~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~ 445 (780)
.++|+..+.||+|+||+||+|+... + ..||||++.... ......|.+|+.+|.++ +|||||+++|+|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4689999999999999999999753 2 369999986543 33446799999999998 89999999999999999
Q ss_pred eEEEEeecCCCChhhhcccccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCC
Q 048425 446 RCLVYELVHNGSVESHLHGVDK-------------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKA 506 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~-------------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKp 506 (780)
.++||||+++|+|.++|+.... ....++|..++.|+.||+.||+|||+.+ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999975321 1246899999999999999999999998 99999999
Q ss_pred cceEEcCCCCCeeecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCc
Q 048425 507 SNVLLEDDFTPKVSDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQP 584 (780)
Q Consensus 507 sNILLd~~~~vKLsDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~ 584 (780)
+|||++.++++||+|||+|+........ ......||+.|||||++.++.++.++|||||||+||||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999877654433 2345678999999999999999999999999999999998 8999975432
Q ss_pred cccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048425 585 QGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALK 650 (780)
Q Consensus 585 ~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~ 650 (780)
. ..+... +... .....+......+.+|+.+||+.||++||||+||++.|.
T Consensus 273 ~--~~~~~~----~~~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 D--ANFYKL----IQNG----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp S--HHHHHH----HHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H--HHHHHH----HhcC----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 111111 1111 111112223357889999999999999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-49 Score=411.58 Aligned_cols=245 Identities=27% Similarity=0.389 Sum_probs=206.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeecc---CCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRN---NQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|+..+.||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57899999999999999999985 7899999998653 2344577999999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++++||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999953 356999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
.. .....||+.|||||++.+..++.++|||||||+||||+||+.||....... +.. .+.... .
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~---~i~~~~--------~ 221 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYK---RISRVE--------F 221 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HHHTTC--------C
T ss_pred Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HHH---HHHcCC--------C
Confidence 32 245679999999999999999999999999999999999999997543221 111 011100 0
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
. ++......+.+++.+||+.||++|||++|+++
T Consensus 222 ~----~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 T----FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C----CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1 11122346788999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=413.80 Aligned_cols=249 Identities=25% Similarity=0.375 Sum_probs=208.2
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
++|+..+.||+|+||+||+|... +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999964 79999999998776666778999999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++|+|.+++.. ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+|+.......
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 99999998752 36999999999999999999999998 99999999999999999999999999998754432
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCccC
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLA 613 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~ 613 (780)
......||+.|+|||++.++.++.++|||||||++|||+||+.||........ +... .... .+.+
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~----~~~~-------~~~~- 236 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLI----ATNG-------TPEL- 236 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHH----HHHC-------SCCC-
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH--HHHH----HhCC-------CCCC-
Confidence 23456799999999999999999999999999999999999999975432211 1110 0000 0000
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 614 GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 614 ~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..+......+.+++.+||+.||++|||+.|+++
T Consensus 237 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122356789999999999999999999853
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-49 Score=422.21 Aligned_cols=262 Identities=23% Similarity=0.355 Sum_probs=205.6
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
.++|+..+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+.+|++++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 478999999999999999999975 7899999999765433 34679999999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED-SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~-~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
|+++|+|.+++.. .+.+++..+..++.|++.||+|||+. + |+||||||+||||++++++||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999963 34699999999999999999999974 6 99999999999999999999999999997654
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccc----------
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTT---------- 600 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~---------- 600 (780)
.. .+..+||+.|||||++.+..++.++||||+||++|||+||+.||......... +. +.......
T Consensus 158 ~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 158 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE-LM-FGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHH-HH-C-----------------
T ss_pred Cc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HH-HHHHhcCCcccCCccccc
Confidence 22 24568999999999999999999999999999999999999999764422110 00 00000000
Q ss_pred ------------------ccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 601 ------------------REGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 601 ------------------~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+.+..+................+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000000000000000112246788999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-48 Score=416.53 Aligned_cols=266 Identities=26% Similarity=0.440 Sum_probs=214.3
Q ss_pred HHHHHHhcCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeee
Q 048425 368 SDLEKATEKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGIC 440 (780)
Q Consensus 368 ~el~~at~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~ 440 (780)
.+++...++|+..+.||+|+||+||+|+.. +++.||||+++..... ..++|.+|+++|++++|+||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 445556789999999999999999999864 3578999999765433 345799999999999999999999999
Q ss_pred eecceeEEEEeecCCCChhhhcccccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEE
Q 048425 441 IEGRTRCLVYELVHNGSVESHLHGVDK--------------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVI 500 (780)
Q Consensus 441 ~~~~~~~LV~Ey~~~GSL~~~L~~~~~--------------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~Iv 500 (780)
.+++..++||||+++|+|.++|+.... ....++|..+++|+.|+|.||+|||+.+ ||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 999999999999999999999964221 2335899999999999999999999998 99
Q ss_pred ecccCCcceEEcCCCCCeeecccccccccCCC-ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCC-C
Q 048425 501 HRDFKASNVLLEDDFTPKVSDFGLAREATEGS-QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRK-P 578 (780)
Q Consensus 501 HrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~-~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~-P 578 (780)
||||||+|||||.++++||+|||+|+...... ....+...||+.|+|||++.+..++.|+|||||||+||||++|.. |
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998765432 223345679999999999999999999999999999999999864 6
Q ss_pred CCCCCccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 048425 579 VDMSQPQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIY 653 (780)
Q Consensus 579 ~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~ 653 (780)
|...... .+...+. .+ .. ...+......+.+|+.+||+.+|++||||.||+++|++|.
T Consensus 243 ~~~~~~~---e~~~~v~----~~---------~~-~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHE---EVIYYVR----DG---------NI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHH---HHHHHHH----TT---------CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHH---HHHHHHH----cC---------CC-CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 6543322 1111111 01 00 1112233457889999999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=412.94 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=206.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
+.|+..+.||+|+||+||+|+.. +|+.||||+++.......+.|.+|+++|++++|||||++++++.+++..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46888999999999999999975 78999999998776666788999999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++|+|.+++.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+|+.......
T Consensus 92 ~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 92 AGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 99999999853 3457999999999999999999999998 99999999999999999999999999986543211
Q ss_pred cceeccccCccccCchhhc-----cCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 534 HISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~-----~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
......||+.|||||++. +..++.|+|||||||+||||+||+.||....+... +... .... .
T Consensus 166 -~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~~~i----~~~~--~---- 232 (288)
T d2jfla1 166 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--LLKI----AKSE--P---- 232 (288)
T ss_dssp -HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHH----HHSC--C----
T ss_pred -cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--HHHH----HcCC--C----
Confidence 123467999999999984 45688999999999999999999999975443211 1110 1100 0
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+.+ ..+......+.+++.+||+.||++|||++|+++
T Consensus 233 -~~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 -PTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -CCC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 111222356889999999999999999999854
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=408.41 Aligned_cols=258 Identities=26% Similarity=0.392 Sum_probs=199.6
Q ss_pred hcCcccceeecccCceEEEEEEEeC----CcEEEEEEeeccCCcc-hHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDN----GTEVAVKLLTRNNQNG-DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~----g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
.++|...+.||+|+||+||+|++.. +..||||.++...... .+.|.+|++++++++|||||+++|+|.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 4689999999999999999998742 4568999986544333 4579999999999999999999999964 67899
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
||||+++|+|.+++. .....+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+..
T Consensus 85 v~E~~~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhh---ccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 999999999999875 34567999999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 529 TEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 529 ~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
........+...||+.|+|||.+.++.++.++|||||||+||||+| |+.||....... +...+ .. ...
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i---~~-~~~---- 227 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI---EN-GER---- 227 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH---HT-TCC----
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHH---Hc-CCC----
Confidence 6554444556779999999999999999999999999999999998 888987654321 11111 00 100
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
+ ..+......+.+|+.+||+.||++|||+.||++.|+.+++.
T Consensus 228 --~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 228 --L----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --C----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0 11122335788999999999999999999999999988654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=404.41 Aligned_cols=246 Identities=25% Similarity=0.388 Sum_probs=195.5
Q ss_pred ccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeee----cceeEEEE
Q 048425 378 SSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIE----GRTRCLVY 450 (780)
Q Consensus 378 ~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~~LV~ 450 (780)
+..+.||+|+||+||+|... +++.||||++..... ...+.|.+|+++|++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45578999999999999975 688999999876532 234579999999999999999999999865 34679999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc-CCCCCeeeccccccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE-DDFTPKVSDFGLAREAT 529 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd-~~~~vKLsDFGLA~~~~ 529 (780)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ ++|+||||||+||||+ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999953 357999999999999999999999874 5699999999999996 57899999999998654
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
.. ......||+.|||||++.+ +++.++|||||||+||||+||+.||...... ..+...+ ... ...
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~~~~i---~~~------~~~ 231 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRV---TSG------VKP 231 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHH---TTT------CCC
T ss_pred CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHHHHHH---HcC------CCC
Confidence 32 2245679999999998765 6999999999999999999999999643321 1111111 100 000
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+.+ +......+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 ASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccc----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111 1112245788999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=411.18 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=205.2
Q ss_pred cCcccceeecccCceEEEEEEEe-CCc----EEEEEEeeccC-CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGT----EVAVKLLTRNN-QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~----~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 448 (780)
++|+..++||+|+||+||+|.+. +|+ .||||+++... ....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46899999999999999999874 444 68999886543 34567899999999999999999999999864 5678
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA 528 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~ 528 (780)
++||+.+|+|.+++. .....++|..+++|+.|||.||+|||+.+ ||||||||+||||+.++++||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHH---HTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccc---ccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 899999999999886 34567999999999999999999999997 999999999999999999999999999987
Q ss_pred cCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccccc
Q 048425 529 TEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 529 ~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
...... ......||+.|||||++.++.++.|+|||||||+||||+| |+.||+...... +... +..+.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~----i~~~~---- 230 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LEKGE---- 230 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHH----HHHTC----
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCC----
Confidence 654332 2344568999999999999999999999999999999999 788887543221 1111 11110
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
....+......+.+|+.+||+.||++|||+.||++.|+.+..+
T Consensus 231 ------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 231 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 0111223345788999999999999999999999999988654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=403.63 Aligned_cols=251 Identities=29% Similarity=0.457 Sum_probs=200.1
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeec-ceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEG-RTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-~~~~LV~Ey~ 453 (780)
++|+..+.||+|+||.||+|.+ .|+.||||+++.. ...++|.+|++++++++|||||+++|+|.++ +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 5678889999999999999998 5889999999654 3457899999999999999999999999654 5679999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++|+|.++|+. .....++|..+++|+.|||.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~- 157 (262)
T d1byga_ 84 AKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 157 (262)
T ss_dssp TTEEHHHHHHH--HHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC-
Confidence 99999999964 22336899999999999999999999987 9999999999999999999999999998764432
Q ss_pred cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhcccccccccccccccCCcc
Q 048425 534 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPSL 612 (780)
Q Consensus 534 ~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L 612 (780)
....+|..|+|||++.++.++.++|||||||++|||+| |+.|+..... .++..++.. . ..+
T Consensus 158 ---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i~~----~------~~~-- 219 (262)
T d1byga_ 158 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEK----G------YKM-- 219 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHTT----T------CCC--
T ss_pred ---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHc----C------CCC--
Confidence 33468899999999999999999999999999999999 6777764332 222222211 0 011
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 613 AGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 613 ~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
..+......+.+++.+||+.||++||||.||+++|+++..
T Consensus 220 --~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 220 --DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 1222233578899999999999999999999999998864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=408.33 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=204.7
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|+..+.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999975 79999999997542 334567999999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999985 3457999999999999999999999998 99999999999999999999999999998754
Q ss_pred CC-ccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 531 GS-QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 531 ~~-~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
.. ........||+.|||||++.+..++.++|||||||+||||+||+.||....... +.. .+....
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~---~i~~~~-------- 226 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IFQ---KIIKLE-------- 226 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHTTC--------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---HHH---HHHcCC--------
Confidence 32 223345679999999999999999999999999999999999999997543211 111 111110
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQA 648 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~ 648 (780)
. .++......+.+++.+||+.||++|||++|+...
T Consensus 227 ~----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 227 Y----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp C----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred C----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 0 1111223467899999999999999999998653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=407.69 Aligned_cols=269 Identities=26% Similarity=0.390 Sum_probs=203.2
Q ss_pred hHHHHHHhcCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCC-cchHHHHHHHHHhhhc-CCCceeeeee
Q 048425 367 LSDLEKATEKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRL-HHRNLVKLIG 438 (780)
Q Consensus 367 ~~el~~at~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~g 438 (780)
..+++...++|+..+.||+|+||+||+|... +++.||||+++.... ...++|.+|++++.++ +|+|||.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 3444444578999999999999999999864 346899999976543 3346788899988887 7899999999
Q ss_pred eeeec-ceeEEEEeecCCCChhhhcccccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccC
Q 048425 439 ICIEG-RTRCLVYELVHNGSVESHLHGVDK------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFK 505 (780)
Q Consensus 439 ~~~~~-~~~~LV~Ey~~~GSL~~~L~~~~~------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIK 505 (780)
++.+. ...++||||+++|+|.++|+.... ....++|.+++.++.||++||+|||+.+ |||||||
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlK 161 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 161 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCC
Confidence 98765 467999999999999999974322 2346999999999999999999999998 9999999
Q ss_pred CcceEEcCCCCCeeecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCC-CCCCCCC
Q 048425 506 ASNVLLEDDFTPKVSDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGR-KPVDMSQ 583 (780)
Q Consensus 506 psNILLd~~~~vKLsDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr-~P~~~~~ 583 (780)
|+||||++++++||+|||+|+........ ..+...||+.|||||.+.++.++.++|||||||++|||+||. .||....
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876544332 234567999999999999999999999999999999999975 4665432
Q ss_pred ccccchhhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 584 PQGQENLVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 584 ~~~~~~Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
.. ..+.. .+..+. .+ ..+......+.+++.+||+.||++||||.||++.|+.+++
T Consensus 242 ~~--~~~~~----~~~~~~------~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 242 ID--EEFCR----RLKEGT------RM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CS--HHHHH----HHHHTC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH--HHHHH----HHhcCC------CC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 21 11111 111110 11 1112223468899999999999999999999999998864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-47 Score=410.64 Aligned_cols=245 Identities=28% Similarity=0.408 Sum_probs=200.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcc---hHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNG---DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
+.|+..+.||+|+||+||+|+.. +|+.||||+++...... .+.|.+|+++|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45889999999999999999964 78999999997654332 246899999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|..++. ...++++.+++.++.||+.||+|||+.+ |+||||||+||||++++++||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999977663 3457999999999999999999999998 99999999999999999999999999987543
Q ss_pred CCccceeccccCccccCchhhcc---CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccc
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQL 607 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~---~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~l 607 (780)
. ....||+.|||||++.+ +.++.++|||||||++|||++|+.||....... .+.. ....
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~--~~~~----i~~~------- 229 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYH----IAQN------- 229 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHH----HHHS-------
T ss_pred C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH--HHHH----HHhC-------
Confidence 2 34579999999999864 468999999999999999999999996543211 1100 0000
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 608 VDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 608 vDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..+.+. +......+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 230 ESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCCCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 011111 1112346889999999999999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=403.05 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=207.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCc--EEEEEEeeccC-CcchHHHHHHHHHhhhc-CCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGT--EVAVKLLTRNN-QNGDREFIAEVEMLSRL-HHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~--~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV 449 (780)
++|+..++||+|+||+||+|++. +|. .||||+++... ....++|.+|+++|+++ +|||||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67888999999999999999976 444 47888876543 33456899999999999 799999999999999999999
Q ss_pred EeecCCCChhhhccccc------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCC
Q 048425 450 YELVHNGSVESHLHGVD------------KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTP 517 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~------------~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~v 517 (780)
|||+++|+|.++|+... .....++|..+++++.|||+||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999997431 23467999999999999999999999997 9999999999999999999
Q ss_pred eeecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCC-CCCCCCccccchhhhhccc
Q 048425 518 KVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRK-PVDMSQPQGQENLVTWARP 596 (780)
Q Consensus 518 KLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~-P~~~~~~~~~~~Lv~wa~~ 596 (780)
||+|||+++....... .....||..|+|||.+.++.++.++|||||||++|||++|.. ||..... ..+...+..
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~~~i~~ 241 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLPQ 241 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHGGG
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHHHHHHh
Confidence 9999999986543322 234468999999999999999999999999999999999765 5654321 222222110
Q ss_pred ccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 597 LLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 597 ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
+. .+ ..+......+.+|+.+||+.||++||||+||++.|+++.+.
T Consensus 242 ----~~------~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 242 ----GY------RL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp ----TC------CC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----cC------CC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 00 01 11223345788999999999999999999999999998764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-47 Score=410.00 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=190.1
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
.+.|+..+.||+|+||+||+|+.. +|+.||||++..... .....|.+|+++|++++|||||++++++.+++..+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999975 689999999976543 234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc---CCCCCeeecccccccc
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE---DDFTPKVSDFGLAREA 528 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd---~~~~vKLsDFGLA~~~ 528 (780)
|+++|+|.++|. ....+++.++..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+|+..
T Consensus 88 ~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999995 3567999999999999999999999998 99999999999994 5789999999999876
Q ss_pred cCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccccc
Q 048425 529 TEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLV 608 (780)
Q Consensus 529 ~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lv 608 (780)
..... ....+||+.|||||.+.++.++.++|||||||+||||+||+.||...... .+... +.....
T Consensus 161 ~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~---i~~~~~------ 226 (307)
T d1a06a_ 161 DPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQ---ILKAEY------ 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHH---HHTTCC------
T ss_pred cCCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHHH---HhccCC------
Confidence 54332 24467999999999999999999999999999999999999999754321 11111 111100
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 609 DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 609 Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
........+....+.+++..||+.||++|||++|+++
T Consensus 227 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 --EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp --CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0001111122356889999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=404.41 Aligned_cols=271 Identities=23% Similarity=0.349 Sum_probs=203.6
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHH--HHHHhhhcCCCceeeeeeeeeecc----eeEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIA--EVEMLSRLHHRNLVKLIGICIEGR----TRCL 448 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~--Ei~iL~~L~HpNIV~L~g~~~~~~----~~~L 448 (780)
++|...+.||+|+||.||+|++ +|+.||||+++.. ..+++.. |+..+.+++|||||+++|+|.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 5677889999999999999997 6899999998643 2334444 555556789999999999998654 5789
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCcEEecccCCcceEEcCCCCCeeeccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHED-----SNPRVIHRDFKASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~-----~~p~IvHrDIKpsNILLd~~~~vKLsDFG 523 (780)
||||+++|+|.++|+. ..++|..+++++.|+|.||+|||+. ...+||||||||+||||++++++||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 9999999999999963 3699999999999999999999974 13469999999999999999999999999
Q ss_pred ccccccCCCcc---ceeccccCccccCchhhccCC------CCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhc
Q 048425 524 LAREATEGSQH---ISTRVMGTFGYVAPEYAMTGH------LLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWA 594 (780)
Q Consensus 524 LA~~~~~~~~~---~~t~~~GT~~Y~APE~l~~~~------~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa 594 (780)
+++........ ......||+.|+|||++.+.. ++.|+|||||||+||||+||..|+........ ......
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~-~~~~~~ 232 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-PYYDLV 232 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC-TTTTTS
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc-chhhcc
Confidence 99987654322 234567999999999987643 57799999999999999999988754332111 000000
Q ss_pred cccccccccccccc----CCccCCCC-ChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 595 RPLLTTREGLEQLV----DPSLAGSY-DFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 595 ~~ll~~~~~l~~lv----Dp~L~~~~-~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
............+. +|.+...+ ..+....+.+++.+||+.||++||||.||++.|+++.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 00000000111122 22222221 224556799999999999999999999999999998754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=403.10 Aligned_cols=255 Identities=28% Similarity=0.398 Sum_probs=197.5
Q ss_pred cCcccceeecccCceEEEEEEEeC--C--cEEEEEEeeccC---CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDN--G--TEVAVKLLTRNN---QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~--g--~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 447 (780)
++|+..+.||+|+||.||+|++.. + ..||||++++.. ....++|.+|+++|++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 578889999999999999998642 2 378999987643 2234679999999999999999999999976 4678
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+||||+++|+|.+++.. ....+++..+++++.|||+||+|||+.+ |+||||||+||||+.++++||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999998863 3456999999999999999999999988 99999999999999999999999999998
Q ss_pred ccCCCcc--ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccchhhhhccccccccccc
Q 048425 528 ATEGSQH--ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 528 ~~~~~~~--~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
....... ......||..|+|||.+.+..++.++|||||||++|||+| |+.||...... .+..++ ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~~~i---~~~~~~- 233 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKI---DKEGER- 233 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH---HTSCCC-
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHHHHH---HhCCCC-
Confidence 7554332 2344568899999999999999999999999999999998 89999654322 122211 111100
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLI 652 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i 652 (780)
..........+.+++.+||+.||++||||.||++.|++.
T Consensus 234 ---------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 ---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 011122235688999999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-46 Score=411.04 Aligned_cols=252 Identities=20% Similarity=0.296 Sum_probs=208.0
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
.++|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 368999999999999999999975 7999999999776655567799999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc--CCCCCeeecccccccccC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE--DDFTPKVSDFGLAREATE 530 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd--~~~~vKLsDFGLA~~~~~ 530 (780)
+++|+|.+++. .....+++..+..|+.||+.||+|||+.+ ||||||||+|||++ .++.+||+|||+|+....
T Consensus 105 ~~gg~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999999985 34457999999999999999999999998 99999999999996 467899999999998755
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
... .....||+.|||||++.+..++.++|||||||++|||+||+.||....... +.. .+...... .+.
T Consensus 179 ~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~---~i~~~~~~----~~~ 246 (350)
T d1koaa2 179 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLR---NVKSCDWN----MDD 246 (350)
T ss_dssp TSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHTCCC----SCC
T ss_pred ccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH---HHH---HHHhCCCC----CCc
Confidence 432 345679999999999999999999999999999999999999997543211 111 11110000 001
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.. .......+.+++.+||+.||++|||++|+++
T Consensus 247 ~~----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 247 SA----FSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GG----GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cc----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0112246789999999999999999999865
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=403.23 Aligned_cols=255 Identities=28% Similarity=0.498 Sum_probs=204.9
Q ss_pred ceeecccCceEEEEEEEeCC----cEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeec-ceeEEEEeec
Q 048425 380 KRILGEGGFGCVYHGVMDNG----TEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEG-RTRCLVYELV 453 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~~g----~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-~~~~LV~Ey~ 453 (780)
.++||+|+||+||+|.+.++ ..||||+++.... ...++|.+|+++|++++|||||+++|+|.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999997532 3589999975433 3346799999999999999999999998764 5789999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCCc
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 533 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~~ 533 (780)
++|+|.++++ .....+++..+++++.|+|+||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~---~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhc---cccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999986 34557889999999999999999999998 99999999999999999999999999997754432
Q ss_pred c---ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 534 H---ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 534 ~---~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
. ......||..|+|||.+.++.++.|+||||||++||||+||+.|+..... ..++..++ .... ....|
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i---~~g~----~~~~p 256 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYL---LQGR----RLLQP 256 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---HTTC----CCCCC
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHH---HcCC----CCCCc
Confidence 2 22345799999999999999999999999999999999998888754321 11222221 1111 01111
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
......+.+++.+||+.||++||+|.||++.|+.+++..
T Consensus 257 -------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 257 -------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp -------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 122346889999999999999999999999999998753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=397.09 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=204.7
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC------cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ------NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 447 (780)
+.|...+.||+|+||+||+|+.. +|+.||||++++... ...+.|.+|+++|++++|||||++++++.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 67999999999999999999974 799999999975422 23467999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC----CCeeeccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF----TPKVSDFG 523 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~----~vKLsDFG 523 (780)
|||||+++|+|.++|.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999953 357999999999999999999999998 99999999999998776 48999999
Q ss_pred ccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccc
Q 048425 524 LAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREG 603 (780)
Q Consensus 524 LA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~ 603 (780)
+|+....... .....||+.|+|||++.+..++.++|||||||+||||+||+.||....... ... .+......
T Consensus 163 ~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~---~i~~~~~~ 234 (293)
T d1jksa_ 163 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLA---NVSAVNYE 234 (293)
T ss_dssp TCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHTTCCC
T ss_pred hhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HHH---HHHhcCCC
Confidence 9988754432 244579999999999999999999999999999999999999997543221 111 00110000
Q ss_pred cccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 604 LEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 604 l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.. +... ......+.+++.+||+.||++|||++|+++
T Consensus 235 ~~----~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 FE----DEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CC----HHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC----chhc----CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000 112246788999999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=403.81 Aligned_cols=263 Identities=26% Similarity=0.401 Sum_probs=212.9
Q ss_pred hcCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCCc-chHHHHHHHHHhhhc-CCCceeeeeeeeeecce
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRL-HHRNLVKLIGICIEGRT 445 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~ 445 (780)
.++|+..+.||+|+||.||+|++. +++.||||+++..... ...+|.+|+.+++++ +|||||+++|+|.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 478888999999999999999863 4578999999765443 335799999999999 79999999999999999
Q ss_pred eEEEEeecCCCChhhhcccccC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE
Q 048425 446 RCLVYELVHNGSVESHLHGVDK--------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL 511 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~--------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL 511 (780)
.++||||+++|+|.++|+.... ....+++..+++++.||++||+|||+++ |+||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 9999999999999999974321 2346999999999999999999999998 9999999999999
Q ss_pred cCCCCCeeecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCC-CCCCCccccch
Q 048425 512 EDDFTPKVSDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKP-VDMSQPQGQEN 589 (780)
Q Consensus 512 d~~~~vKLsDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P-~~~~~~~~~~~ 589 (780)
+.++.+||+|||+++........ ..+...||+.|+|||++.++.++.++|||||||++|||+|++.| +...... ..
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--~~ 256 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--SK 256 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--HH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--HH
Confidence 99999999999999987654432 33457899999999999999999999999999999999995555 4332211 11
Q ss_pred hhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 590 LVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 590 Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
+... ++.......+......+.+|+.+||+.||++||||.||+++|+++..+
T Consensus 257 ~~~~--------------i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 257 FYKM--------------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHH--------------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH--------------HhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 1111 111111111222335788999999999999999999999999987654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.6e-46 Score=408.48 Aligned_cols=251 Identities=20% Similarity=0.268 Sum_probs=208.1
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYELV 453 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 453 (780)
++|+..+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..+|||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999974 79999999998765555567899999999999999999999999999999999999
Q ss_pred CCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc--CCCCCeeecccccccccCC
Q 048425 454 HNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE--DDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 454 ~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd--~~~~vKLsDFGLA~~~~~~ 531 (780)
++|+|.+++. ....++++.+.+.|+.||+.||+|||+.+ |+||||||+||||+ +++.+||+|||+|+.....
T Consensus 109 ~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999998875 34557999999999999999999999998 99999999999998 6789999999999987654
Q ss_pred CccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCCc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDPS 611 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp~ 611 (780)
. ......||+.|||||++.+..++.++|||||||+||||+||+.||....... +... +.... ..
T Consensus 183 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~---i~~~~--------~~ 246 (352)
T d1koba_ 183 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQN---VKRCD--------WE 246 (352)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHH---HHHCC--------CC
T ss_pred C--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HHhCC--------CC
Confidence 3 2355679999999999999999999999999999999999999997543211 1110 01000 00
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 612 LAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 612 L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
............+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011111122346789999999999999999999854
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=399.38 Aligned_cols=262 Identities=27% Similarity=0.403 Sum_probs=208.5
Q ss_pred hcCcccceeecccCceEEEEEEEeC--------CcEEEEEEeeccCCc-chHHHHHHHHHhhhc-CCCceeeeeeeeeec
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMDN--------GTEVAVKLLTRNNQN-GDREFIAEVEMLSRL-HHRNLVKLIGICIEG 443 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~~--------g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~ 443 (780)
.++|...+.||+|+||.||+|+... +..||||+++..... ...+|.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3678888999999999999998632 357999999776543 346799999999998 899999999999999
Q ss_pred ceeEEEEeecCCCChhhhcccccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEE
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDK------------NRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLL 511 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~------------~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILL 511 (780)
+..++||||+++|+|.++|..... ....+++.++++++.|||.||+|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999964321 2356999999999999999999999998 9999999999999
Q ss_pred cCCCCCeeecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCccccch
Q 048425 512 EDDFTPKVSDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLS-GRKPVDMSQPQGQEN 589 (780)
Q Consensus 512 d~~~~vKLsDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlT-Gr~P~~~~~~~~~~~ 589 (780)
+.++.+||+|||+++........ ......||+.|+|||.+.++.++.|+|||||||++|||+| |+.||...... .
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~ 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---H
Confidence 99999999999999977654322 3345679999999999999999999999999999999998 67787643321 1
Q ss_pred hhhhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhc
Q 048425 590 LVTWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYND 655 (780)
Q Consensus 590 Lv~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~ 655 (780)
+..++ ..+. . ...+......+.+|+.+||+.||++|||+.||++.|++|...
T Consensus 246 ~~~~i----~~~~------~----~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 246 LFKLL----KEGH------R----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHH----HTTC------C----CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHH----HcCC------C----CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 22211 1111 0 111122235688999999999999999999999999998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.5e-46 Score=390.33 Aligned_cols=259 Identities=25% Similarity=0.340 Sum_probs=202.7
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcc---hHHHHHHHHHhhhcCCCceeeeeeeeeecc----ee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNG---DREFIAEVEMLSRLHHRNLVKLIGICIEGR----TR 446 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~----~~ 446 (780)
++|...+.||+|+||+||+|... +|+.||||+++...... .+.|.+|++++++++|||||++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 67999999999999999999974 79999999997654332 346999999999999999999999987654 37
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
+|||||+++|+|.+++. ..+.+++.+++.|+.||+.||+|||+.+ |+||||||+|||++.++..+|+|||.++
T Consensus 87 ~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 89999999999999885 3457999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCc--cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccc
Q 048425 527 EATEGSQ--HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 527 ~~~~~~~--~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
....... .......||+.|||||++.+..++.++|||||||+||||+||+.||....+... + ..........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~----~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--A----YQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H----HHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH--H----HHHHhcCCCC
Confidence 6643322 233456799999999999999999999999999999999999999975432211 1 1111111000
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHhh
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRP-FMGEVVQALKLIYN 654 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RP-sm~EVv~~L~~i~~ 654 (780)
... ...+....+.+++.+|++.||++|| +++|+...|.++.+
T Consensus 234 ~~~--------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 234 PSA--------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp GGG--------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred Cch--------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 000 1112235688999999999999999 89999999988764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=401.52 Aligned_cols=264 Identities=27% Similarity=0.442 Sum_probs=211.9
Q ss_pred HHHHhcCcccceeecccCceEEEEEEEe------CCcEEEEEEeeccCCc-chHHHHHHHHHhhhcCCCceeeeeeeeee
Q 048425 370 LEKATEKFSSKRILGEGGFGCVYHGVMD------NGTEVAVKLLTRNNQN-GDREFIAEVEMLSRLHHRNLVKLIGICIE 442 (780)
Q Consensus 370 l~~at~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~ 442 (780)
++...++|...+.||+|+||+||+|.+. +++.||||+++..... ....|.+|++++++++|||||+++|+|..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3334578889999999999999999863 3578999999765332 23469999999999999999999999999
Q ss_pred cceeEEEEeecCCCChhhhccccc------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCC
Q 048425 443 GRTRCLVYELVHNGSVESHLHGVD------KNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFT 516 (780)
Q Consensus 443 ~~~~~LV~Ey~~~GSL~~~L~~~~------~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~ 516 (780)
++..++||||+++|+|.++++... .....++|..+++++.|+|+||.|||+.+ |+||||||+|||++++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCce
Confidence 999999999999999999986421 23346899999999999999999999987 999999999999999999
Q ss_pred CeeecccccccccCCCcc-ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCC-CCCCCCCccccchhhhhc
Q 048425 517 PKVSDFGLAREATEGSQH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGR-KPVDMSQPQGQENLVTWA 594 (780)
Q Consensus 517 vKLsDFGLA~~~~~~~~~-~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr-~P~~~~~~~~~~~Lv~wa 594 (780)
+||+|||+|+........ ......||+.|+|||.+.++.++.++||||||++||||+||+ .|+...... .+..
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~---~~~~-- 246 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVLR-- 246 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHHH--
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH---HHHH--
Confidence 999999999877544322 234457899999999999999999999999999999999985 566433211 1111
Q ss_pred ccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHh
Q 048425 595 RPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIY 653 (780)
Q Consensus 595 ~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~ 653 (780)
.+.+... ...+......+.+++.+||+.+|++||||+||++.|++..
T Consensus 247 -----------~i~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 247 -----------FVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp -----------HHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred -----------HHHhCCC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1111111 0111222357899999999999999999999999987654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-45 Score=394.82 Aligned_cols=244 Identities=24% Similarity=0.330 Sum_probs=204.7
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeecc---CCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRN---NQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|+..+.||+|+||+||+|+.. +|+.||||++++. .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57899999999999999999974 7999999999754 2344578999999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|..++. ....+++.....++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999885 4557889999999999999999999998 99999999999999999999999999988754
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
.. +...||+.|||||++.+..++.++|||||||+||||+||+.||....... +. ..+.... .
T Consensus 157 ~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~---~~i~~~~--------~ 218 (316)
T d1fota_ 157 VT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TY---EKILNAE--------L 218 (316)
T ss_dssp CB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHHCC--------C
T ss_pred cc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH---HH---HHHHcCC--------C
Confidence 32 34679999999999999999999999999999999999999997543211 11 1111110 0
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRP-----FMGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv~ 647 (780)
.++......+.+++.+|++.||.+|+ +++|+++
T Consensus 219 ----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 ----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11112224678999999999999996 8888865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=397.25 Aligned_cols=247 Identities=24% Similarity=0.327 Sum_probs=205.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeecc---CCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRN---NQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|...+.||+|+||+||+|+.. +|+.||||++++. .....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 67999999999999999999974 7999999999754 2344577999999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+++|+|.+++. ....++......++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 9999999999985 3457899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
... .....+||+.|||||++.+..++.++||||+||+||||++|+.||...... .+.. ...... .
T Consensus 158 ~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~~---~i~~~~--------~ 222 (337)
T d1o6la_ 158 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE---LILMEE--------I 222 (337)
T ss_dssp TTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHCC--------C
T ss_pred CCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HHHH---HHhcCC--------C
Confidence 322 234568999999999999999999999999999999999999999764422 1111 111100 1
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPF-----MGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs-----m~EVv~ 647 (780)
. ++......+.+++..||+.||++||+ ++|+++
T Consensus 223 ~----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 R----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C----CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1 11122345788999999999999995 677654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.5e-45 Score=384.17 Aligned_cols=250 Identities=25% Similarity=0.340 Sum_probs=204.0
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcc---------hHHHHHHHHHhhhcC-CCceeeeeeeeeec
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNG---------DREFIAEVEMLSRLH-HRNLVKLIGICIEG 443 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~---------~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~ 443 (780)
++|+..+.||+|+||+||+|+.. +|+.||||+++...... .+.+.+|++++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999974 78999999997653221 235889999999997 99999999999999
Q ss_pred ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccc
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFG 523 (780)
+..+|||||+++|+|.++|. ....+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999995 3457999999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCccceeccccCccccCchhhcc------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccc
Q 048425 524 LAREATEGSQHISTRVMGTFGYVAPEYAMT------GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL 597 (780)
Q Consensus 524 LA~~~~~~~~~~~t~~~GT~~Y~APE~l~~------~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~l 597 (780)
+++....... .+...||..|+|||++.+ ..++.++||||+||+||||+||+.||.......... .+
T Consensus 156 ~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~------~i 227 (277)
T d1phka_ 156 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR------MI 227 (277)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HH
T ss_pred heeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH------HH
Confidence 9998765432 345679999999998864 356889999999999999999999997644221110 01
Q ss_pred cccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 598 LTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 598 l~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..... .. ...........+.+++.+||+.||++||++.||++
T Consensus 228 ~~~~~---~~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 MSGNY---QF-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHTCC---CC-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhCCC---CC-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11100 00 00111122357889999999999999999999854
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-44 Score=397.15 Aligned_cols=248 Identities=25% Similarity=0.358 Sum_probs=199.3
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHH---HHHhhhcCCCceeeeeeeeeecceeE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAE---VEMLSRLHHRNLVKLIGICIEGRTRC 447 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~E---i~iL~~L~HpNIV~L~g~~~~~~~~~ 447 (780)
++|+..++||+|+||+||+|+.. +|+.||||++.+.. ......+.+| +++++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999975 79999999986532 2233344444 66777788999999999999999999
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
+||||+++|+|.++|.. ...+++..+..++.||+.||+|||+.+ ||||||||+|||+++++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999953 457899999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccccc
Q 048425 528 ATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQ 606 (780)
Q Consensus 528 ~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~ 606 (780)
..... .....||+.|+|||++.. ..++.++|||||||+||||+||+.||..........+... ....
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~~~------ 224 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTM------ 224 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH---SSSC------
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cccC------
Confidence 75532 234579999999999875 4689999999999999999999999976543222111111 0000
Q ss_pred ccCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 048425 607 LVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPF-----MGEVVQ 647 (780)
Q Consensus 607 lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs-----m~EVv~ 647 (780)
...+ +......+.+++.+||+.||++||+ ++|+++
T Consensus 225 --~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 --AVEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --CCCC----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --CCCC----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0111 1122346789999999999999999 466654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=383.54 Aligned_cols=261 Identities=22% Similarity=0.233 Sum_probs=195.5
Q ss_pred cceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc-----chHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 379 SKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN-----GDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 379 ~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~-----~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
..++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999975 6999999998654322 134689999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+.++++..++ .....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9998877665 34567999999999999999999999998 9999999999999999999999999998775543
Q ss_pred ccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchh-hhhcc----ccccccccccc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENL-VTWAR----PLLTTREGLEQ 606 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~L-v~wa~----~ll~~~~~l~~ 606 (780)
.. .....||+.|+|||.+..+ .++.++|||||||++|||+||+.||......+.... ..... ..+........
T Consensus 155 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 155 RA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 22 2345799999999988754 579999999999999999999999976543221100 00000 00000000000
Q ss_pred ccCCccCCCCCh-----hhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 607 LVDPSLAGSYDF-----DDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 607 lvDp~L~~~~~~-----ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
...-......+. .....+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000000010 11246889999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-44 Score=395.00 Aligned_cols=244 Identities=23% Similarity=0.311 Sum_probs=204.4
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeecc---CCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRN---NQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 450 (780)
++|+..+.||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 7999999998653 2334567999999999999999999999999999999999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccC
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE 530 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~ 530 (780)
||+.+|+|.+++.. ...+++..+..++.||+.||+|||+.+ ||||||||+||||+.++++||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999853 347999999999999999999999998 99999999999999999999999999998754
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
.. ....||+.|||||++.+..++.++|||||||+||||+||+.||....+.. +.. .+.... .
T Consensus 194 ~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~---~i~~~~--------~ 255 (350)
T d1rdqe_ 194 RT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYE---KIVSGK--------V 255 (350)
T ss_dssp CB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHCC--------C
T ss_pred cc----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH---HHH---HHhcCC--------C
Confidence 32 34679999999999999999999999999999999999999997543211 111 111100 0
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRP-----FMGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RP-----sm~EVv~ 647 (780)
. .+......+.+++..||+.||++|+ +++|+++
T Consensus 256 ~----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 R----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C----CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0 1112234678999999999999994 8888865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=388.26 Aligned_cols=251 Identities=20% Similarity=0.270 Sum_probs=205.1
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
.++|.+.+.||+|+||+||+|... +|+.||||+++.... ....+.+|+++|++++|||||++++++.+++..+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 478999999999999999999975 789999999976532 345688999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCC--CCCeeecccccccccC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDD--FTPKVSDFGLAREATE 530 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~--~~vKLsDFGLA~~~~~ 530 (780)
+++|+|.++|. .....+++.++..|+.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+++....
T Consensus 83 ~~gg~L~~~i~---~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 99999999995 23457999999999999999999999998 9999999999999854 5899999999987754
Q ss_pred CCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccCC
Q 048425 531 GSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVDP 610 (780)
Q Consensus 531 ~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvDp 610 (780)
... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... +. ..+....... +.
T Consensus 157 ~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~---~~i~~~~~~~----~~ 224 (321)
T d1tkia_ 157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---II---ENIMNAEYTF----DE 224 (321)
T ss_dssp TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHHTCCCC----CH
T ss_pred CCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHhCCCCC----Ch
Confidence 332 344579999999999999999999999999999999999999997643221 11 1111110000 00
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 611 SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 611 ~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..... ....+.+++..|++.||++|||+.|+++
T Consensus 225 ~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 225 EAFKE----ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhccC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001 1245789999999999999999999976
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=382.74 Aligned_cols=266 Identities=24% Similarity=0.331 Sum_probs=199.3
Q ss_pred cCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
++|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999997 4799999999965432 235689999999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
|+.++. .+++.. .....+++..+..++.|++.||+|||+.+ ||||||||+|||++.++++||+|||+|+.....
T Consensus 82 ~~~~~~-~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDL-KKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEH-HHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCch-hhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 997654 444432 34567999999999999999999999998 999999999999999999999999999877544
Q ss_pred CccceeccccCccccCchhhccCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-hhhhc-cccccccccccccc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-LVTWA-RPLLTTREGLEQLV 608 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~-~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-Lv~wa-~~ll~~~~~l~~lv 608 (780)
... .....||+.|+|||.+.... ++.++|||||||++|||++|+.||.......... ...-. .+............
T Consensus 156 ~~~-~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 156 VRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp SBC-TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred ccc-ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 322 33457999999999877665 5789999999999999999999997654221100 00000 00000000000000
Q ss_pred C--CccCC--CCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 609 D--PSLAG--SYD-----FDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 609 D--p~L~~--~~~-----~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+ ..... ... ......+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0 00000 000 011246788999999999999999999965
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=390.32 Aligned_cols=247 Identities=24% Similarity=0.353 Sum_probs=203.5
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC---CcchHHHHHHHHHhh-hcCCCceeeeeeeeeecceeEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN---QNGDREFIAEVEMLS-RLHHRNLVKLIGICIEGRTRCLV 449 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~-~L~HpNIV~L~g~~~~~~~~~LV 449 (780)
++|...+.||+|+||+||+|+.. +|+.||||++++.. ....+.+..|+.++. .++|||||++++++.+++..+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 67999999999999999999975 78999999997542 334566778888776 58999999999999999999999
Q ss_pred EeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccccc
Q 048425 450 YELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREAT 529 (780)
Q Consensus 450 ~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~ 529 (780)
|||+++|+|.+++.. ...++..++..++.||+.||+|||+.+ |+||||||+|||+++++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999953 456899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccccccccC
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGLEQLVD 609 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l~~lvD 609 (780)
.... ..+...||+.|+|||++.++.++.++|||||||++|||+||+.||....+.. +.. .+... .
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~---~i~~~--------~ 219 (320)
T d1xjda_ 155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFH---SIRMD--------N 219 (320)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHC--------C
T ss_pred cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HHH---HHHcC--------C
Confidence 4332 2345679999999999999999999999999999999999999997644321 111 01100 1
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 048425 610 PSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMG-EVVQ 647 (780)
Q Consensus 610 p~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~-EVv~ 647 (780)
+.+ +......+.+|+.+||+.||++||++. |+++
T Consensus 220 ~~~----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 PFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCC----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111 111234678999999999999999995 6643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=389.09 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=197.0
Q ss_pred cCcccc-eeecccCceEEEEEEE-eCCcEEEEEEeeccCCcchHHHHHHHHHhhhc-CCCceeeeeeeeee----cceeE
Q 048425 375 EKFSSK-RILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQNGDREFIAEVEMLSRL-HHRNLVKLIGICIE----GRTRC 447 (780)
Q Consensus 375 ~~f~~~-~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~----~~~~~ 447 (780)
++|.+. ++||+|+||+||+|+. .+|+.||||+++. ...+.+|++++.++ +|||||++++++.+ +...+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 678776 4699999999999997 4789999999853 34677899987665 89999999999865 45689
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC---CCCCeeecccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED---DFTPKVSDFGL 524 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~---~~~vKLsDFGL 524 (780)
+|||||++|+|.++|.. +....+++.++..|+.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 99999999999999963 23457999999999999999999999998 999999999999985 56799999999
Q ss_pred cccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccccc
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREGL 604 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~l 604 (780)
|+....... .....||+.|||||++.+..++.++|||||||+||||+||+.||......... ..........
T Consensus 161 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~~--- 232 (335)
T d2ozaa1 161 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMG--- 232 (335)
T ss_dssp CEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSC---
T ss_pred eeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHhcC---
Confidence 987765432 24567999999999999999999999999999999999999999654322110 0000000000
Q ss_pred ccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 605 EQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 605 ~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
+..+...........+.+++.+||+.||++|||+.|+++
T Consensus 233 ----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 ----QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ----SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000000000122356889999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.2e-44 Score=376.22 Aligned_cols=265 Identities=23% Similarity=0.298 Sum_probs=201.1
Q ss_pred cCcccceeecccCceEEEEEEEeCCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|...+.||+|+||+||+|+.++|+.||||+++... ....+.|.+|+++|++++|||||++++++..++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999999999999996653 23356899999999999999999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCCC
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 532 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~~ 532 (780)
+.++.+..+. .....+++..+..|+.||+.||+|||+.+ ||||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9887777665 34567999999999999999999999988 9999999999999999999999999998875433
Q ss_pred ccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhh--cc---ccccccccccc
Q 048425 533 QHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTW--AR---PLLTTREGLEQ 606 (780)
Q Consensus 533 ~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~w--a~---~ll~~~~~l~~ 606 (780)
.. .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||..........-... .. ..+........
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 155 RK-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cc-cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 22 2344689999999998754 568999999999999999999999976442211100000 00 00000000000
Q ss_pred cc------CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 607 LV------DPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 607 lv------Dp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.. ++.............+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000000011112346789999999999999999999863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=377.86 Aligned_cols=239 Identities=21% Similarity=0.358 Sum_probs=195.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc------chHHHHHHHHHhhhcC--CCceeeeeeeeeecce
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN------GDREFIAEVEMLSRLH--HRNLVKLIGICIEGRT 445 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~--HpNIV~L~g~~~~~~~ 445 (780)
++|++.++||+|+||+||+|+.. +|+.||||++++.... ....+.+|++++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999975 7999999999754321 1234778999999996 8999999999999999
Q ss_pred eEEEEeecCC-CChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC-CCCCeeeccc
Q 048425 446 RCLVYELVHN-GSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED-DFTPKVSDFG 523 (780)
Q Consensus 446 ~~LV~Ey~~~-GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~-~~~vKLsDFG 523 (780)
.++||||+.+ +++.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 9999999976 67777774 3457999999999999999999999998 999999999999985 5799999999
Q ss_pred ccccccCCCccceeccccCccccCchhhccCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccccccccc
Q 048425 524 LAREATEGSQHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTRE 602 (780)
Q Consensus 524 LA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~-t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~ 602 (780)
+|+..... ..+...||+.|+|||++.+..+ +.++|||||||+||||+||+.||.... .... ..
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~~-------~~- 220 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIR-------GQ- 220 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH-------CC-
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHhh-------cc-
Confidence 99876443 2345679999999999988776 567899999999999999999996421 1110 00
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..+...+ ...+.+++.+||+.||++|||++|+++
T Consensus 221 -------~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 -------VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -------CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------cCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0011112 246788999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=376.04 Aligned_cols=265 Identities=24% Similarity=0.319 Sum_probs=199.1
Q ss_pred hcCcccceeecccCceEEEEEEEe-C-CcEEEEEEeeccCC--cchHHHHHHHHHhhhc---CCCceeeeeeeeee----
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-N-GTEVAVKLLTRNNQ--NGDREFIAEVEMLSRL---HHRNLVKLIGICIE---- 442 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~-g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~---- 442 (780)
.++|+..+.||+|+||+||+|+.. + ++.||||+++.... .....+.+|+++|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 378999999999999999999973 4 66799999865432 2334577888887766 79999999999853
Q ss_pred -cceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeec
Q 048425 443 -GRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSD 521 (780)
Q Consensus 443 -~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsD 521 (780)
....+++|||+.++++..... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 346799999999887765543 34567999999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhh----------
Q 048425 522 FGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV---------- 591 (780)
Q Consensus 522 FGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv---------- 591 (780)
||+++...... ......||+.|+|||++.+..++.++||||+||++|||+||+.||............
T Consensus 160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 99998654432 234567999999999999999999999999999999999999999765432211100
Q ss_pred hhcccccccccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 592 TWARPLLTTREGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 592 ~wa~~ll~~~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.|..................+ ..+.......+.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccccchhhhhccccccch-hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 111000000000000000000 0111122346778999999999999999999865
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-42 Score=366.21 Aligned_cols=266 Identities=21% Similarity=0.284 Sum_probs=195.7
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccC--CcchHHHHHHHHHhhhcCCCceeeeeeeeee--------c
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNN--QNGDREFIAEVEMLSRLHHRNLVKLIGICIE--------G 443 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--------~ 443 (780)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|+||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 68999999999999999999974 79999999986542 3345679999999999999999999999865 3
Q ss_pred ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccc
Q 048425 444 RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 523 (780)
Q Consensus 444 ~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFG 523 (780)
...++||||+.++.+.... .....++...+..|+.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 4578999999988776655 34567889999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCc---cceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhc-cccc
Q 048425 524 LAREATEGSQ---HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWA-RPLL 598 (780)
Q Consensus 524 LA~~~~~~~~---~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa-~~ll 598 (780)
+++....... .......||+.|+|||.+.+. .++.|+|||||||++|||++|+.||............... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9987653321 112335799999999998765 6899999999999999999999999764432221111100 0000
Q ss_pred cc------ccccccccCCccCCCCChh-------hHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 599 TT------REGLEQLVDPSLAGSYDFD-------DMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 599 ~~------~~~l~~lvDp~L~~~~~~e-------e~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.. ................... ....+.+|+.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00 0000000000000011111 1234678999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-42 Score=363.87 Aligned_cols=260 Identities=20% Similarity=0.286 Sum_probs=199.8
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeee-eeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKL-IGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L-~g~~~~~~~~~LV~Ey 452 (780)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ..++..|++++++++|+|++.. .++..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 56999999999999999999874 789999999876433 3468899999999987765555 4555677788999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEc---CCCCCeeeccccccccc
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLE---DDFTPKVSDFGLAREAT 529 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd---~~~~vKLsDFGLA~~~~ 529 (780)
+ +|+|.+.+. .....+++..++.++.|++.||+|||+.+ |+||||||+|||++ .+..+||+|||+|+...
T Consensus 85 ~-~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 L-GPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp C-CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred c-CCchhhhhh---hccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9 566666654 34567999999999999999999999998 99999999999985 45679999999999875
Q ss_pred CCCcc------ceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhh-hhccccccccc
Q 048425 530 EGSQH------ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLV-TWARPLLTTRE 602 (780)
Q Consensus 530 ~~~~~------~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv-~wa~~ll~~~~ 602 (780)
..... ......||+.|||||.+.+..++.++|||||||++|||+||+.||............ .+....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~----- 232 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK----- 232 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH-----
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc-----
Confidence 43321 234567999999999999999999999999999999999999999754432211111 110000
Q ss_pred ccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhh
Q 048425 603 GLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYN 654 (780)
Q Consensus 603 ~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~ 654 (780)
+. ...+.+...+ ...+.+++..|++.+|++||++.++.+.|+.+..
T Consensus 233 -~~-~~~~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 233 -MS-TPIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -HH-SCHHHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -CC-CChhHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 00 0001111122 2468899999999999999999999999988764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-42 Score=371.23 Aligned_cols=260 Identities=24% Similarity=0.306 Sum_probs=194.0
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCceeeeeeeeeec------ceeEE
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNLVKLIGICIEG------RTRCL 448 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~~~~L 448 (780)
+|+..++||+|+||+||+|+.. +|+.||||+++..... +.+|+++|++++|+||++++++|... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778899999999999999975 7999999999765432 23799999999999999999998643 24689
Q ss_pred EEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC-CCeeeccccccc
Q 048425 449 VYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF-TPKVSDFGLARE 527 (780)
Q Consensus 449 V~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~-~vKLsDFGLA~~ 527 (780)
||||++++.+....+ .......+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 999998765444332 2345668999999999999999999999998 99999999999999775 899999999987
Q ss_pred ccCCCccceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcc-----------
Q 048425 528 ATEGSQHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWAR----------- 595 (780)
Q Consensus 528 ~~~~~~~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~----------- 595 (780)
....... ....||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +....+
T Consensus 173 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 173 LVRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CCTTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHHHHH
T ss_pred ccCCccc--ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhCCChHHhhh
Confidence 7554322 34579999999998765 5789999999999999999999999976543221 111100
Q ss_pred ccccc--ccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 596 PLLTT--REGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 596 ~ll~~--~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
..... .......................+.+|+.+|++.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 00000000000000111122346789999999999999999999875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-41 Score=361.59 Aligned_cols=263 Identities=17% Similarity=0.210 Sum_probs=208.9
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcCC-CceeeeeeeeeecceeEEEEee
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHH-RNLVKLIGICIEGRTRCLVYEL 452 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H-pNIV~L~g~~~~~~~~~LV~Ey 452 (780)
++|.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+|+++++.++| +|++.+++++.++...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 68999999999999999999975 78999999986543 23457789999999965 8999999999999999999999
Q ss_pred cCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcC-----CCCCeeeccccccc
Q 048425 453 VHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLED-----DFTPKVSDFGLARE 527 (780)
Q Consensus 453 ~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~-----~~~vKLsDFGLA~~ 527 (780)
+ +++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 83 ~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 83 L-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp C-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 8 7899998863 3457999999999999999999999998 999999999999974 57899999999998
Q ss_pred ccCCCc------cceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccc
Q 048425 528 ATEGSQ------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTR 601 (780)
Q Consensus 528 ~~~~~~------~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~ 601 (780)
...... .......||+.|||||.+.+..++.++|||||||++|||+||+.||............... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i---~~~~ 232 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI---GEKK 232 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH---HHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH---Hhcc
Confidence 654321 1233567999999999999999999999999999999999999999755433221111110 0000
Q ss_pred cccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHhhcC
Q 048425 602 EGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQALKLIYNDT 656 (780)
Q Consensus 602 ~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~~L~~i~~~~ 656 (780)
. ...-+.+.... ...+.+++..|++.+|++||+++.+.+.|+++.+..
T Consensus 233 ~---~~~~~~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 233 Q---STPLRELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp H---HSCHHHHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred C---CCChHHhcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 0 00001111122 246888999999999999999999999999887644
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=356.12 Aligned_cols=265 Identities=21% Similarity=0.282 Sum_probs=203.0
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCC--cchHHHHHHHHHhhhcCCCceeeeeeeeeecceeEEEEe
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQ--NGDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLVYE 451 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 451 (780)
++|+..+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999974 789999999976543 234679999999999999999999999999999999999
Q ss_pred ecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccccccccCC
Q 048425 452 LVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG 531 (780)
Q Consensus 452 y~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~~~~~ 531 (780)
++.+++|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999888774 4567899999999999999999999998 999999999999999999999999999987654
Q ss_pred CccceeccccCccccCchhhccCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCcccc-ch-hhhhccc-ccccccccccc
Q 048425 532 SQHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQ-EN-LVTWARP-LLTTREGLEQL 607 (780)
Q Consensus 532 ~~~~~t~~~GT~~Y~APE~l~~~~-~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~-~~-Lv~wa~~-ll~~~~~l~~l 607 (780)
... .....++..|+|||.+.... ++.++|||||||++|||++|+.||........ .. +...... ...........
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 322 23345788899999887665 68999999999999999999999754322111 00 0000000 00000000000
Q ss_pred cC----CccC-----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 608 VD----PSLA-----GSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 608 vD----p~L~-----~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.+ +... ..........+.+++.+|++.||++|||++||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000 0111122346788999999999999999999854
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=367.68 Aligned_cols=265 Identities=22% Similarity=0.272 Sum_probs=196.6
Q ss_pred hcCcccceeecccCceEEEEEEE-eCCcEEEEEEeeccCC-cchHHHHHHHHHhhhcCCCceeeeeeeeeecc----eeE
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVM-DNGTEVAVKLLTRNNQ-NGDREFIAEVEMLSRLHHRNLVKLIGICIEGR----TRC 447 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~----~~~ 447 (780)
+++|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+++|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35799999999999999999986 4899999999975443 23457899999999999999999999987643 335
Q ss_pred EEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 448 LVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 448 LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||+++ ||||||||+|||+++++.+||+|||+++.
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 56677789999999852 36999999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCc--cceeccccCccccCchhhcc-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccc---
Q 048425 528 ATEGSQ--HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTR--- 601 (780)
Q Consensus 528 ~~~~~~--~~~t~~~GT~~Y~APE~l~~-~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~--- 601 (780)
...... .......||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+...............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 644322 12345679999999999854 567899999999999999999999997654322211111000000000
Q ss_pred ------cccccccCCccCCCCCh-----hhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 602 ------EGLEQLVDPSLAGSYDF-----DDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 602 ------~~l~~lvDp~L~~~~~~-----ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
........+.. ...+. ....++.+++..|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp TCCCHHHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000 01111 11136789999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=367.85 Aligned_cols=260 Identities=23% Similarity=0.345 Sum_probs=192.3
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeecc------
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEGR------ 444 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------ 444 (780)
.++|+..+.||+|+||+||+|... +|+.||||+++..... ..+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 378999999999999999999974 7999999999754332 2357899999999999999999999997654
Q ss_pred eeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeecccc
Q 048425 445 TRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 524 (780)
Q Consensus 445 ~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGL 524 (780)
..++||||+ +.+|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 469999999 567777663 346999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhccc-------
Q 048425 525 AREATEGSQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARP------- 596 (780)
Q Consensus 525 A~~~~~~~~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~------- 596 (780)
|+...... +...||+.|+|||.+.+. .++.++||||+||++|||++|+.||.................
T Consensus 168 a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 168 ARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 98765432 445799999999998764 568999999999999999999999976542211100000000
Q ss_pred -cccc------ccccccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 597 -LLTT------REGLEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 597 -ll~~------~~~l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.... ...+.......+.. ........+.+|+.+|++.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhcchhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 00000000000000 00111245678999999999999999999976
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-40 Score=357.86 Aligned_cols=258 Identities=19% Similarity=0.273 Sum_probs=196.3
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcC-CCceeeeeeeeeec--ceeEEEE
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH-HRNLVKLIGICIEG--RTRCLVY 450 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~--~~~~LV~ 450 (780)
++|+..+.||+|+||+||+|+.. +|+.||||+++.. ..+.+.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 68999999999999999999974 7999999998643 3567899999999995 99999999998743 5689999
Q ss_pred eecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCC-CCeeeccccccccc
Q 048425 451 ELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDF-TPKVSDFGLAREAT 529 (780)
Q Consensus 451 Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~-~vKLsDFGLA~~~~ 529 (780)
||+.+++|..+. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+|+...
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 999999997764 25899999999999999999999998 99999999999998655 69999999998775
Q ss_pred CCCccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccch-----------hhhhcccc
Q 048425 530 EGSQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQEN-----------LVTWARPL 597 (780)
Q Consensus 530 ~~~~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~-----------Lv~wa~~l 597 (780)
.... .....||..|+|||.+.+. .++.++||||+||+++||++|+.||.......... ...|....
T Consensus 182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 5432 2445789999999998765 47999999999999999999999996543221100 00010000
Q ss_pred -cccccccccccCC--------ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 598 -LTTREGLEQLVDP--------SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 598 -l~~~~~l~~lvDp--------~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
............. .............+.+|+.+|++.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000000 0000011122346789999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-41 Score=362.33 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=201.3
Q ss_pred cCcccceeecccCceEEEEEEEe----CCcEEEEEEeeccC----CcchHHHHHHHHHhhhcCC-Cceeeeeeeeeecce
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD----NGTEVAVKLLTRNN----QNGDREFIAEVEMLSRLHH-RNLVKLIGICIEGRT 445 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~----~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L~H-pNIV~L~g~~~~~~~ 445 (780)
++|+..+.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 58899999986542 2234678899999999976 899999999999999
Q ss_pred eEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccc
Q 048425 446 RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA 525 (780)
.++||||+.+|+|.+++.. ...+.......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999853 345778889999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCccceeccccCccccCchhhccC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccccccccc
Q 048425 526 REATEGSQHISTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPLLTTREG 603 (780)
Q Consensus 526 ~~~~~~~~~~~t~~~GT~~Y~APE~l~~~--~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~ll~~~~~ 603 (780)
+..............||+.|+|||.+.+. .++.++|||||||+||||+||+.||............ ......
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~~---- 250 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILK---- 250 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHH----
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhccc----
Confidence 87765444444556799999999998764 4678999999999999999999999765433211110 000000
Q ss_pred cccccCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 048425 604 LEQLVDPSLAGSYDFDDMAKVAAIASMCVHPEVTHRPF-----MGEVVQ 647 (780)
Q Consensus 604 l~~lvDp~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPs-----m~EVv~ 647 (780)
..+. ++......+.+++.+||+.||++||+ ++|+++
T Consensus 251 ----~~~~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 251 ----SEPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----CCCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----CCCC----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0111 11223457888999999999999995 677754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-40 Score=356.18 Aligned_cols=261 Identities=23% Similarity=0.291 Sum_probs=189.2
Q ss_pred cCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeee------cce
Q 048425 375 EKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIE------GRT 445 (780)
Q Consensus 375 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~------~~~ 445 (780)
++|+..++||+|+||+||+|+.. +|+.||||++...... ....+.+|+.++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999975 6999999999765432 23568999999999999999999999864 367
Q ss_pred eEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccc
Q 048425 446 RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA 525 (780)
.++||||+.++.+. .++ ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 79999999766554 442 35899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchh-h--------hhccc
Q 048425 526 REATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENL-V--------TWARP 596 (780)
Q Consensus 526 ~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~L-v--------~wa~~ 596 (780)
+...... ..+...||+.|+|||++.+..++.++||||+||+++||++|+.||........... . ++...
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 8765533 23456799999999999999999999999999999999999999975432211000 0 00000
Q ss_pred cc-------cc-----ccccccccCCccCCCCC---hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 597 LL-------TT-----REGLEQLVDPSLAGSYD---FDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 597 ll-------~~-----~~~l~~lvDp~L~~~~~---~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
.. .. ................. ......+.+|+.+|++.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 00 00001111111111111 123456889999999999999999999965
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-40 Score=354.27 Aligned_cols=262 Identities=23% Similarity=0.335 Sum_probs=194.0
Q ss_pred hcCcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCc--chHHHHHHHHHhhhcCCCceeeeeeeeeec-----ce
Q 048425 374 TEKFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQN--GDREFIAEVEMLSRLHHRNLVKLIGICIEG-----RT 445 (780)
Q Consensus 374 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~ 445 (780)
.++|+..+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+++|++++|+|||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999964 7999999999765432 235689999999999999999999998643 34
Q ss_pred eEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCeeeccccc
Q 048425 446 RCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 525 (780)
Q Consensus 446 ~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA 525 (780)
.+++++|+.+|+|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 577788889999999984 246999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCccceeccccCccccCchhhccC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCccccchhhhhcccc-----cc
Q 048425 526 REATEGSQHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQENLVTWARPL-----LT 599 (780)
Q Consensus 526 ~~~~~~~~~~~t~~~GT~~Y~APE~l~~~-~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~~Lv~wa~~l-----l~ 599 (780)
...... .....||..|+|||.+.+. .++.++|||||||++|||++|+.||.................. ..
T Consensus 169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 169 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp -CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred cccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 765432 2345689999999987765 4688999999999999999999999764422111110000000 00
Q ss_pred c--ccccccccCCcc-CCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048425 600 T--REGLEQLVDPSL-AGSYD-----FDDMAKVAAIASMCVHPEVTHRPFMGEVVQ 647 (780)
Q Consensus 600 ~--~~~l~~lvDp~L-~~~~~-----~ee~~~l~~La~~Cl~~dP~~RPsm~EVv~ 647 (780)
. ............ ..... ......+.+|+.+|++.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 000000000000 00000 011245788999999999999999999975
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.1e-36 Score=324.71 Aligned_cols=263 Identities=21% Similarity=0.239 Sum_probs=189.9
Q ss_pred CcccceeecccCceEEEEEEEe-CCcEEEEEEeeccCCcchHHHHHHHHHhhhcC-----------CCceeeeeeeeeec
Q 048425 376 KFSSKRILGEGGFGCVYHGVMD-NGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH-----------HRNLVKLIGICIEG 443 (780)
Q Consensus 376 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-----------HpNIV~L~g~~~~~ 443 (780)
+|++.++||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|++++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4889999999999999999974 799999999975432 3457888999998875 57899999988653
Q ss_pred --ceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCcEEecccCCcceEEcCCCC----
Q 048425 444 --RTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHE-DSNPRVIHRDFKASNVLLEDDFT---- 516 (780)
Q Consensus 444 --~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~-~~~p~IvHrDIKpsNILLd~~~~---- 516 (780)
...+++++++..+........ ......+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred cccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 455677777665543333221 2455678999999999999999999998 65 999999999999986653
Q ss_pred --CeeecccccccccCCCccceeccccCccccCchhhccCCCCchhhHHhHHHHHHHHHhCCCCCCCCCccccc----hh
Q 048425 517 --PKVSDFGLAREATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLSGRKPVDMSQPQGQE----NL 590 (780)
Q Consensus 517 --vKLsDFGLA~~~~~~~~~~~t~~~GT~~Y~APE~l~~~~~t~ksDVySfGVvLlELlTGr~P~~~~~~~~~~----~L 590 (780)
+|++|||.+....... ....||+.|+|||.+.+..++.++||||+||+++||++|+.||......... .+
T Consensus 169 ~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 8999999998664422 3457999999999999999999999999999999999999999754322111 01
Q ss_pred hhhcccc-------cccccccccccC---------C----------ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHH
Q 048425 591 VTWARPL-------LTTREGLEQLVD---------P----------SLAGSYDFDDMAKVAAIASMCVHPEVTHRPFMGE 644 (780)
Q Consensus 591 v~wa~~l-------l~~~~~l~~lvD---------p----------~L~~~~~~ee~~~l~~La~~Cl~~dP~~RPsm~E 644 (780)
...+..+ ...........+ . .............+.+|+.+|++.||++|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 1110000 000000000000 0 0011223455678899999999999999999999
Q ss_pred HHH
Q 048425 645 VVQ 647 (780)
Q Consensus 645 Vv~ 647 (780)
+++
T Consensus 325 ~L~ 327 (362)
T d1q8ya_ 325 LVN 327 (362)
T ss_dssp HHT
T ss_pred Hhc
Confidence 864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1e-22 Score=201.13 Aligned_cols=164 Identities=18% Similarity=0.190 Sum_probs=121.0
Q ss_pred ccceeecccCceEEEEEEEeCCcEEEEEEeeccCCc------------------chHHHHHHHHHhhhcCCCceeeeeee
Q 048425 378 SSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQN------------------GDREFIAEVEMLSRLHHRNLVKLIGI 439 (780)
Q Consensus 378 ~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~------------------~~~~f~~Ei~iL~~L~HpNIV~L~g~ 439 (780)
...+.||+|+||+||+|...+|+.||||+++..... ....+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356899999999999999989999999987532110 01234568889999999999988866
Q ss_pred eeecceeEEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCcEEecccCCcceEEcCCCCCee
Q 048425 440 CIEGRTRCLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKV 519 (780)
Q Consensus 440 ~~~~~~~~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~~p~IvHrDIKpsNILLd~~~~vKL 519 (780)
. ..+++|||+++..+.+ ++.....+++.|++++|+|||+.+ |+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence 3 3479999998765433 233445689999999999999998 9999999999999976 4899
Q ss_pred ecccccccccCCCccceeccccCccccC------chhhccCCCCchhhHHhHHHHHH
Q 048425 520 SDFGLAREATEGSQHISTRVMGTFGYVA------PEYAMTGHLLVKSDVYSYGVVLL 570 (780)
Q Consensus 520 sDFGLA~~~~~~~~~~~t~~~GT~~Y~A------PE~l~~~~~t~ksDVySfGVvLl 570 (780)
+|||+|......... .|.. .|++ .++|..++||||..--++
T Consensus 144 iDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 144 IDFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred EECCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHHh
Confidence 999999766432111 0111 1222 356788899999754443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.54 E-value=1.7e-07 Score=93.99 Aligned_cols=150 Identities=16% Similarity=0.126 Sum_probs=104.5
Q ss_pred HHHHHHhcCcccceeecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcC-CCceeeeeeeeeeccee
Q 048425 368 SDLEKATEKFSSKRILGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLH-HRNLVKLIGICIEGRTR 446 (780)
Q Consensus 368 ~el~~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~ 446 (780)
.|+.+..++|+..+..+-+..+.||+... ++..++||+...........+.+|..++..+. +--+.+++.++.+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 46677777887766554444578998765 56677889876655444556788998888774 44467788888888888
Q ss_pred EEEEeecCCCChhhhcccccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------
Q 048425 447 CLVYELVHNGSVESHLHGVDKNRGPLDWEARMKIALGAARGLAYLHEDS------------------------------- 495 (780)
Q Consensus 447 ~LV~Ey~~~GSL~~~L~~~~~~~~~L~~~~rl~Ia~qIA~gL~yLH~~~------------------------------- 495 (780)
++||+++++.++.+.... .....+++.++++.|+.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 999999999887654421 1112334555555566666421
Q ss_pred -------------------------CCcEEecccCCcceEEcCCCCCeeeccccccc
Q 048425 496 -------------------------NPRVIHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 496 -------------------------~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
.+.++|+|+.+.|||++++...-|.||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12389999999999999876677999987753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.89 E-value=2.7e-05 Score=77.04 Aligned_cols=77 Identities=17% Similarity=0.066 Sum_probs=55.6
Q ss_pred eeecccCc-eEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCC--CceeeeeeeeeecceeEEEEeecCCCC
Q 048425 381 RILGEGGF-GCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHH--RNLVKLIGICIEGRTRCLVYELVHNGS 457 (780)
Q Consensus 381 ~~LG~G~f-G~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~~~~~LV~Ey~~~GS 457 (780)
+.+..|.. +.||+...++|..+++|...... ...+..|++.++.+.. -.+.++++++.+++..++||+|+++.+
T Consensus 16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp EECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EEcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 34555554 68999988888889999764432 2346778888877743 336677888888888899999998876
Q ss_pred hhh
Q 048425 458 VES 460 (780)
Q Consensus 458 L~~ 460 (780)
+.+
T Consensus 93 ~~~ 95 (255)
T d1nd4a_ 93 LLS 95 (255)
T ss_dssp TTT
T ss_pred ccc
Confidence 643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.31 E-value=0.00039 Score=74.13 Aligned_cols=77 Identities=14% Similarity=0.120 Sum_probs=49.3
Q ss_pred ceeecccCceEEEEEEEe-CCcEEEEEEeecc----C---CcchHHHHHHHHHhhhcC-C--CceeeeeeeeeecceeEE
Q 048425 380 KRILGEGGFGCVYHGVMD-NGTEVAVKLLTRN----N---QNGDREFIAEVEMLSRLH-H--RNLVKLIGICIEGRTRCL 448 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~-~g~~VAVK~l~~~----~---~~~~~~f~~Ei~iL~~L~-H--pNIV~L~g~~~~~~~~~L 448 (780)
.+.||.|....||+.... +|+.|+||.-... . .........|.+.|+.+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 357999999999998865 4678999974321 1 112234456888887663 2 345666655 3456689
Q ss_pred EEeecCCCCh
Q 048425 449 VYELVHNGSV 458 (780)
Q Consensus 449 V~Ey~~~GSL 458 (780)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.63 E-value=0.0033 Score=64.71 Aligned_cols=136 Identities=17% Similarity=0.185 Sum_probs=78.4
Q ss_pred eEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCce--eeeee-----eeeecceeEEEEeecCCCChhhh
Q 048425 389 GCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL--VKLIG-----ICIEGRTRCLVYELVHNGSVESH 461 (780)
Q Consensus 389 G~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI--V~L~g-----~~~~~~~~~LV~Ey~~~GSL~~~ 461 (780)
-.||+...++|+.+++|+.+.. ....+++..|...+..|...++ +..+. ....++..+.+++|++|..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 5899999999999999987554 3356778889988888753222 11111 12234566889999976543210
Q ss_pred --------------ccc----c-cCCCCCCCHHHH-------------------HHHHHHHHHHHHHHhh----CCCCcE
Q 048425 462 --------------LHG----V-DKNRGPLDWEAR-------------------MKIALGAARGLAYLHE----DSNPRV 499 (780)
Q Consensus 462 --------------L~~----~-~~~~~~L~~~~r-------------------l~Ia~qIA~gL~yLH~----~~~p~I 499 (780)
+|. . ...+..+++... -.+...+.+.++.+.. .....+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 111 0 011122222211 1111112222333322 223458
Q ss_pred EecccCCcceEEcCCCCCeeeccccccc
Q 048425 500 IHRDFKASNVLLEDDFTPKVSDFGLARE 527 (780)
Q Consensus 500 vHrDIKpsNILLd~~~~vKLsDFGLA~~ 527 (780)
||+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899997764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.44 E-value=0.0071 Score=63.81 Aligned_cols=73 Identities=18% Similarity=0.243 Sum_probs=49.8
Q ss_pred ceeecccCceEEEEEEEeCC--------cEEEEEEeeccCCcchHHHHHHHHHhhhcCCCce-eeeeeeeeecceeEEEE
Q 048425 380 KRILGEGGFGCVYHGVMDNG--------TEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL-VKLIGICIEGRTRCLVY 450 (780)
Q Consensus 380 ~~~LG~G~fG~VYkg~l~~g--------~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LV~ 450 (780)
.+.|+.|-.-.+|+...+++ ..|.+++.. . ........+|..+++.+.-.++ .++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 35788888899999887543 456666654 2 2233456689999888853344 477777643 5899
Q ss_pred eecCCCCh
Q 048425 451 ELVHNGSV 458 (780)
Q Consensus 451 Ey~~~GSL 458 (780)
||+++.+|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.60 E-value=0.12 Score=51.65 Aligned_cols=159 Identities=12% Similarity=0.052 Sum_probs=82.4
Q ss_pred cchHHHHHHhcCccccee-----ecccCceEEEEEEEeCCcEEEEEEeeccCCcchHHHHHHHHHhhhcCCCce--eeee
Q 048425 365 FALSDLEKATEKFSSKRI-----LGEGGFGCVYHGVMDNGTEVAVKLLTRNNQNGDREFIAEVEMLSRLHHRNL--VKLI 437 (780)
Q Consensus 365 f~~~el~~at~~f~~~~~-----LG~G~fG~VYkg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI--V~L~ 437 (780)
.+-+|++....+|...++ |..|---+.|+...++|+ +++|+..... ..++...|++++..+...++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 456788888888876443 345555788998876665 8889875432 22345556777777642221 1111
Q ss_pred ee------eeecceeEEEEeecCCCChhhhc--------------ccc------cCCCCCCCH-----------------
Q 048425 438 GI------CIEGRTRCLVYELVHNGSVESHL--------------HGV------DKNRGPLDW----------------- 474 (780)
Q Consensus 438 g~------~~~~~~~~LV~Ey~~~GSL~~~L--------------~~~------~~~~~~L~~----------------- 474 (780)
-. .........++.++.+......- |.. ........+
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 11 11234456677776654332110 000 000000000
Q ss_pred HHHHHHHHHHHHHHHHHhhC-CCCcEEecccCCcceEEcCCCCCeeecccccc
Q 048425 475 EARMKIALGAARGLAYLHED-SNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR 526 (780)
Q Consensus 475 ~~rl~Ia~qIA~gL~yLH~~-~~p~IvHrDIKpsNILLd~~~~vKLsDFGLA~ 526 (780)
......+..+...+.-.... -...+||+|+.+.||+++++...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 01112222222222222221 12359999999999999988777899999774
|